Citrus Sinensis ID: 001838
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1007 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.938 | 0.935 | 0.367 | 1e-162 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.945 | 0.923 | 0.366 | 1e-157 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.957 | 0.940 | 0.346 | 1e-138 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.901 | 0.726 | 0.333 | 1e-131 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.961 | 0.825 | 0.308 | 1e-127 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.896 | 0.721 | 0.330 | 1e-124 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.942 | 0.861 | 0.326 | 1e-123 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.965 | 0.864 | 0.314 | 1e-122 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.802 | 0.773 | 0.336 | 1e-119 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.943 | 0.862 | 0.317 | 1e-117 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 573 bits (1477), Expect = e-162, Method: Compositional matrix adjust.
Identities = 372/1011 (36%), Positives = 544/1011 (53%), Gaps = 66/1011 (6%)
Query: 25 TDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTI 84
TD+Q+LL K+ +S D + +W S +C+W G+TCG + +V L + L G I
Sbjct: 24 TDRQALLQFKSQVSED-KRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 85 PPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLG 144
P +GNLS L +LDL N G IP + + L+ LD N L G + ++N S +L
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ L NR G +PS L L L L NN+ G
Sbjct: 143 LRLDSNRLGG-------------------------SVPSELGSLTNLVQLNLYGNNMRGK 177
Query: 205 IPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLK 264
+P +GNLT L+ + L+ N L GEIP ++ L + L L NN GV P ++N+S+LK
Sbjct: 178 LPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLK 237
Query: 265 KLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSG 324
L + N G L + + LPN+ N+G N F+G+IP++++N S L + N+ +G
Sbjct: 238 LLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTG 297
Query: 325 FIPNTIGNLRNLEFLNIADNYLTS-STPELSFLSSLTNCQKIRVLILAGNPLDGILPSSI 383
IP T GN+ NL+ L + N L S S+ +L FL+SLTNC ++ L + N L G LP SI
Sbjct: 298 SIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISI 356
Query: 384 GNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
NLS L + ISG IP I NL NL L L N L+G +P + +LLNL+ L L
Sbjct: 357 ANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSL 416
Query: 444 AFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPST 503
N+L+ IP I ++ L+ L L N F G +P+ GN + L L++G N+ +P
Sbjct: 417 FSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLE 476
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563
I ++ +L D+S NSL G L DIG L+ + L+L N LSG +P T+G ++ LFL
Sbjct: 477 IMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFL 536
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
N G IP+ GL ++ +DLS N +SG IP L+ LNLSFN LEG++P
Sbjct: 537 EGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVK 595
Query: 624 GPFANLTAKSFLGNELLC-GLPDLHNSPCKLNKPKT--HHKSRKMMLLLVIALPLSTAAL 680
G F N T S +GN LC G+ PC P H SR +++ +++ ++ L
Sbjct: 596 GIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLL 655
Query: 681 IIVVTLTLKWKLIRCWKSITGSSNDGINSPQAI-RRFSYHELLQATDRFSKNNLLGIGSF 739
+ + ++TL W +R K ++N ++ + + + SY +L AT+ FS +N++G GSF
Sbjct: 656 LFMASVTLIW--LRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSF 713
Query: 740 GSVYVA-RLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD--- 795
G+VY A L + VAVKV + + A+KSF ECE +K IRHRNLVK+++ACS+ D
Sbjct: 714 GTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQG 773
Query: 796 --FKALIMEYMPNGSLE--------NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
F+ALI E+MPNGSL+ ++ + L + +RLNI IDVA L+YLH
Sbjct: 774 NEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHE 833
Query: 846 PIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQ-----TLATIGYMAPEYG 888
PI H + AH+SDF +A+ L D+ S Q TIGY APEYG
Sbjct: 834 PIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYG 893
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948
V G+ S GDVYS+GI+L+E FTGK+PT+E+F G +L+ + LP +++++D ++L
Sbjct: 894 VGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH 953
Query: 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999
R + L + + C ESP R+ +V L+ IR+ K+
Sbjct: 954 IGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKA 1004
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1436), Expect = e-157, Method: Compositional matrix adjust.
Identities = 377/1028 (36%), Positives = 542/1028 (52%), Gaps = 76/1028 (7%)
Query: 10 LLLSLAIAAAA--SNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNS 67
LLL + I A A SN TD Q+LL K+ +S + +W S+ C+WIG+TCG
Sbjct: 14 LLLQVCIFAQARFSN-ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRR 72
Query: 68 HKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQ 127
+VI LN+ GF L G I P +GNLS L L+L+ N IP + + L+ L+ N
Sbjct: 73 ERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNL 132
Query: 128 LFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSK 187
L G + S + N S + +DLS N HG +PS L
Sbjct: 133 LEGRIPSSLSNCSRLSTVDLSSNHLG------------------------HG-VPSELGS 167
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
+L L L NNL+G P +GNLT L+ + N++RGEIP E+ L +V +A N
Sbjct: 168 LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALN 227
Query: 248 NLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSIT 307
+ G P ++N+S+L+ LSL +N+ G+L + LPN+ L LGTN+F+G IP ++
Sbjct: 228 SFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLA 287
Query: 308 NASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNI-ADNYLTSSTPELSFLSSLTNCQKIR 366
N S L F + N SG IP + G LRNL +L I ++ +S+ L F+ ++ NC ++
Sbjct: 288 NISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLE 347
Query: 367 VLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTG 426
L + N L G LP+SI NLS +L + ISG IP I NL +L L L N L+G
Sbjct: 348 YLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSG 407
Query: 427 SIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSL 486
+PV+F +LLNLQ + L N ++ IP ++ +L KL L+ N F G IP G L
Sbjct: 408 ELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYL 467
Query: 487 RALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSG 546
L++ +NR +P I + + + D+S+N L G ++G L++++ L S N LSG
Sbjct: 468 LDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSG 527
Query: 547 DIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYL 606
+P IGG +++ LF+ N +G IP+ S L SL+ +D S N +SG IP L L L
Sbjct: 528 KMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSL 586
Query: 607 KKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLC-GLPDLHNSPCKLNKPKTHHKSRKM 665
+ LNLS NK EG +P G F N TA S GN +C G+ ++ PC + K +
Sbjct: 587 RNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSV 646
Query: 666 MLLLVIALPLSTAA-LIIVVTLTLKWKLIRCWK--SITGSSNDGINSPQAIRRFSYHELL 722
+V + + A+ L+I++ +L W + R K + G+ +D + SY EL
Sbjct: 647 RKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELH 706
Query: 723 QATDRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH 781
AT RFS NL+G G+FG+V+ L + VAVKV + A KSF ECE K IRH
Sbjct: 707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766
Query: 782 RNLVKIISACSN-----DDFKALIMEYMPNGSLE--------NRLYSGTCMLDIFQRLNI 828
RNLVK+I+ CS+ +DF+AL+ E+MP GSL+ R+ + L ++LNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826
Query: 829 MIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQ- 875
IDVA ALEYLH P+ H + AH+SDF +A+ L D+ S Q
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQF 886
Query: 876 ----TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN 931
TIGY APEYG+ G+ S +GDVYS+GI+L+E F+GKKPTDE F G+ +L +
Sbjct: 887 SSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK 946
Query: 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991
+L SG A ++ L +L + +C+ E P R+ E V L+
Sbjct: 947 SILSGCTS--------SGGSN---AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELIS 995
Query: 992 IRDTLVKS 999
IR S
Sbjct: 996 IRSKFFSS 1003
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1270), Expect = e-138, Method: Compositional matrix adjust.
Identities = 360/1039 (34%), Positives = 546/1039 (52%), Gaps = 75/1039 (7%)
Query: 6 LVHCLLLSLA------IAAAASNIT--TDQQSLLALKAHISYDPTNLFAKNWTSSTSVCS 57
LV LL+S++ + A +T TD+Q+LL K+ +S + + + +W S +CS
Sbjct: 12 LVSALLVSVSLEHSDMVCAQTIRLTEETDKQALLEFKSQVS-ETSRVVLGSWNDSLPLCS 70
Query: 58 WIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHT 117
W G+ CG+ +V +++ G KL+G + + N+
Sbjct: 71 WTGVKCGLKHRRVTGVDLGGL------------------------KLTGVVSPFVGNLSF 106
Query: 118 LKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMF 177
L+ L+ DN G++ S + N+ + +++S N F G +P + N +L L L N
Sbjct: 107 LRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPV-VLSNCSSLSTLDLSSNHL 165
Query: 178 HGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLP 237
+P +L L L NNL+G P +GNLT L+ + N++ GEIP ++ L
Sbjct: 166 EQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLK 225
Query: 238 YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNR 297
++ +A N GV P I+N+S+L LS+ N+ G+L LPN++ L +G N
Sbjct: 226 QMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINS 285
Query: 298 FSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTS-STPELSFL 356
F+G IP +++N S L + N +G IP + G L+NL L + +N L + S+ +L FL
Sbjct: 286 FTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFL 345
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
+LTNC +++ L + N L G LP I NLS L + ISG IP I NL +L
Sbjct: 346 GALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQT 405
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
LDLG N LTG +P + L L+ + L N L+ IP + +++ L L L N F G+I
Sbjct: 406 LDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSI 465
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
PS G+ + L L LG+N+ ++P + L ++ +VS N L GPL DIG LK ++
Sbjct: 466 PSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLA 525
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L++S N LSG IP T+ +L+ L L N GPIP+ GL+ L LDLSKN +SG I
Sbjct: 526 LDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTI 584
Query: 597 PTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLC-GLPDLHNSPCKLNK 655
P + L+ LNLS N +G +P G F N +A S GN LC G+P L PC +
Sbjct: 585 PEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVEL 644
Query: 656 PKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRR 715
P+ H RK++ + V + ++ L+ + + L W +R KS+ ++N+ S ++
Sbjct: 645 PRRHSSVRKIITICV-SAVMAALLLLCLCVVYLCWYKLRV-KSVRANNNENDRSFSPVKS 702
Query: 716 F----SYHELLQATDRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQ 770
F SY EL + T FS +NL+G G+FG+V+ L VA+KV + A KSF
Sbjct: 703 FYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFI 762
Query: 771 DECEVMKRIRHRNLVKIISACSN-----DDFKALIMEYMPNGSLENRLYSGTC------- 818
ECE + IRHRNLVK+++ CS+ +DF+AL+ E+MPNG+L+ L+
Sbjct: 763 AECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPS 822
Query: 819 -MLDIFQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLN 865
L +F RLNI IDVA AL YLH PI H + AH+SDF +A+ L
Sbjct: 823 RTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLL 882
Query: 866 GQDQLSMQTQ-----TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIF 920
D+ + Q TIGY APEYG+ G S GDVYS+GI+L+E FTGK+PT+++F
Sbjct: 883 KFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLF 942
Query: 921 IGELSLSRWVNDLLPI-SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKR 979
+ L+L + L +++ D +L G + L + + C+ ESP R
Sbjct: 943 VDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNR 1002
Query: 980 INAREIVTGLLKIRDTLVK 998
I+ E ++ L+ IR++ +
Sbjct: 1003 ISMAEAISKLVSIRESFFR 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1209), Expect = e-131, Method: Compositional matrix adjust.
Identities = 337/1009 (33%), Positives = 514/1009 (50%), Gaps = 101/1009 (10%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+LN++ +L G IP QLG +S L+ L L N+L G IP S+ ++ L+ LD N L G
Sbjct: 243 ILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGE 302
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ +NMS +L + L+ N SG LP +IC N NL++L+L G+IP LSKC+ L
Sbjct: 303 IPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSL 362
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
+ L L N+L+G+IP+ + L +L D+ L++N L G + + NL L L L NNL G
Sbjct: 363 KQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEG 422
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+P I + L+ L L EN G +P I + +++ +++ N F G IP SI +
Sbjct: 423 KLPKEISALRKLEVLFLYENRFSGEIPQEIG-NCTSLKMIDMFGNHFEGEIPPSIGRLKE 481
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILA 371
L + LR N G +P ++GN L L++ADN L+ S P SS + + L+L
Sbjct: 482 LNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIP-----SSFGFLKGLEQLMLY 536
Query: 372 GNPLDGILPSSIGNLSISLERFQMFNCRISG-----------------------KIPQVI 408
N L G LP S+ +L +L R + + R++G +IP +
Sbjct: 537 NNSLQGNLPDSLISLR-NLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLEL 595
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
N NL L LG N+LTG IP T ++ L L ++ N L +IP ++ KL + L+
Sbjct: 596 GNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLN 655
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDI 528
N SG IP G L+ L L L SN+F +LP+ ++N +L + NSL+G + +I
Sbjct: 656 NNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEI 715
Query: 529 GNLKV------------------------VIELNLSRNNLSGDIPITIGGLKNLQK-LFL 563
GNL + EL LSRN+L+G+IP+ IG L++LQ L L
Sbjct: 716 GNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDL 775
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
+ N G IP + LS LE LDLS N+++G +P S+ + L LN+SFN L G++ +
Sbjct: 776 SYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK- 834
Query: 624 GPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIV 683
F+ A SFLGN LCG P + + N + +R ++++ I+ + +I+V
Sbjct: 835 -QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILV 893
Query: 684 VTLTLKWKLIRCWKSITGSS--NDGINSPQAIRR-----------FSYHELLQATDRFSK 730
+ L K + K GS+ +S QA + + ++++AT S+
Sbjct: 894 IALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSE 953
Query: 731 NNLLGIGSFGSVYVARLQDGMEVAV-KVFHQRYERALKSFQDECEVMKRIRHRNLVKIIS 789
++G G G VY A L++G VAV K+ + + KSF E + + RIRHR+LVK++
Sbjct: 954 EFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013
Query: 790 ACS--NDDFKALIMEYMPNGSLENRLYSGTC-------MLDIFQRLNIMIDVALALEYLH 840
CS ++ LI EYM NGS+ + L+ +LD RL I + +A +EYLH
Sbjct: 1014 YCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 841 FGHSTPIIHY------------MVAHISDFSIAKFL--NGQDQLSMQTQTLATIGYMAPE 886
PI+H M AH+ DF +AK L N T + GY+APE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM---EVID 943
Y + + + DVYS GI+LME TGK PTD +F E+ + RWV L ++ ++ID
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLID 1193
Query: 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
L + +E + +L +A +CT SP +R ++R+ LL +
Sbjct: 1194 PKL----KPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 355/1152 (30%), Positives = 556/1152 (48%), Gaps = 184/1152 (15%)
Query: 14 LAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWT--SSTSVCSWIGITCGVNSHKVI 71
IA A + + ++L + K IS DP + + +WT S C+W GITC H V+
Sbjct: 18 FGIALAKQSFEPEIEALKSFKNGISNDPLGVLS-DWTIIGSLRHCNWTGITCDSTGH-VV 75
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+++ L+G + P + NL+ L+ LDL+ N +G IP+ I + L L N GS
Sbjct: 76 SVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGS 135
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICK-----------------------NLPNLK 168
+ S I+ + ++ +DL N SG++P ICK +L +L+
Sbjct: 136 IPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQ 195
Query: 169 KLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGE 228
+ N G IP ++ L L L N L+G IP++ GNL L+ ++L +N L G+
Sbjct: 196 MFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGD 255
Query: 229 IPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPS--------- 279
IP E+GN LV+L L N L G +P + N+ L+ L + +N L S+PS
Sbjct: 256 IPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLT 315
Query: 280 RIDLS--------------LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGF 325
+ LS L ++E L L +N F+G P SITN LTV + N+ SG
Sbjct: 316 HLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGE 375
Query: 326 IPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGN 385
+P +G L NL L+ DN LT P SS++NC +++L L+ N + G +P G
Sbjct: 376 LPADLGLLTNLRNLSAHDNLLTGPIP-----SSISNCTGLKLLDLSHNQMTGEIPRGFGR 430
Query: 386 L-----SISLERF------QMFNCR----------------------------------- 399
+ SI F +FNC
Sbjct: 431 MNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNS 490
Query: 400 ISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHL 459
++G IP+ I NL +L +L L N TG IP S L LQGL + N L IP+E+ +
Sbjct: 491 LTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDM 550
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLK-----DI---- 510
L L L NKFSG IP+ L SL L L N+F ++P+++ +L DI
Sbjct: 551 KLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNL 610
Query: 511 -----------------LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIG 553
L+ + S+N L G + ++G L++V E++LS N SG IP ++
Sbjct: 611 LTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQ 670
Query: 554 GLKNL---------------QKLF----------LANNRLEGPIPESFSGLSSLEILDLS 588
KN+ ++F L+ N G IP+SF ++ L LDLS
Sbjct: 671 ACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLS 730
Query: 589 KNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHN 648
N ++G IP SL L LK L L+ N L+G +P G F N+ A +GN LCG
Sbjct: 731 SNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG-SKKPL 789
Query: 649 SPCKLNKPKTHHKSRKMMLLLVI-ALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGI 707
PC + + +H R ++L+++ + L++V+ LT K + ++ + SS +
Sbjct: 790 KPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDL 849
Query: 708 NSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERAL- 766
+S ++RF EL QATD F+ N++G S +VY +L+DG +AVKV + + A
Sbjct: 850 DSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAES 909
Query: 767 -KSFQDECEVMKRIRHRNLVKIIS-ACSNDDFKALIMEYMPNGSLENRLY-SGTCMLDIF 823
K F E + + +++HRNLVKI+ A + KAL++ +M NG+LE+ ++ S + +
Sbjct: 910 DKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLL 969
Query: 824 QRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLS 871
+++++ + +A ++YLH G+ PI+H VAH+SDF A+ L ++ S
Sbjct: 970 EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGS 1029
Query: 872 MQTQTLA---TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR 928
T A TIGY+APE+ +V+T+ DV+S+GI++ME T ++PT E S
Sbjct: 1030 TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTS--LNDEDSQDM 1087
Query: 929 WVNDLLPISV-------MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN 981
+ L+ S+ + V+D L G+ +E+++ L L CT P R +
Sbjct: 1088 TLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPD 1145
Query: 982 AREIVTGLLKIR 993
EI+T L+K+R
Sbjct: 1146 MNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-124, Method: Compositional matrix adjust.
Identities = 334/1010 (33%), Positives = 500/1010 (49%), Gaps = 107/1010 (10%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
LN+ + G IP QLG+L S++ L+L N+L G IP + + L+ LD N L G
Sbjct: 244 TLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGV 303
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ + M+ + + L+ NR SG LP IC N +LK+L L G+IP+ +S C+ L
Sbjct: 304 IHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSL 363
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
+ L L N L+G IP + L +L ++ LN+N L G + + NL L TL NNL G
Sbjct: 364 KLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEG 423
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
VP I + L+ + L EN G +P I + ++ ++ NR SG IPSSI
Sbjct: 424 KVPKEIGFLGKLEIMYLYENRFSGEMPVEIG-NCTRLQEIDWYGNRLSGEIPSSIGRLKD 482
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP-ELSFLSSLTNCQKIRVLIL 370
LT LR N G IP ++GN + +++ADN L+ S P FL++L + ++
Sbjct: 483 LTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTAL------ELFMI 536
Query: 371 AGNPLDGILPSSIGNLSISLERFQM----FNCRIS-------------------GKIPQV 407
N L G LP S+ NL +L R FN IS G IP
Sbjct: 537 YNNSLQGNLPDSLINLK-NLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLE 595
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+ +NL L LG N+ TG IP TF ++ L L ++ N L+ IP E+ KL + L
Sbjct: 596 LGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDL 655
Query: 468 HGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI--LFFDVSS-------- 517
+ N SG IP+ G L L L L SN+F +LP+ I++L +I LF D +S
Sbjct: 656 NNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQE 715
Query: 518 --------------NSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQK-LF 562
N L GPL IG L + EL LSRN L+G+IP+ IG L++LQ L
Sbjct: 716 IGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALD 775
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622
L+ N G IP + S L LE LDLS N++ G +P + + L LNLS+N LEG++ +
Sbjct: 776 LSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK 835
Query: 623 GGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHK-SRKMMLLLVIALPLSTAALI 681
F+ A +F+GN LCG P H C K S K ++++ L+ AL+
Sbjct: 836 --QFSRWQADAFVGNAGLCGSPLSH---CNRAGSKNQRSLSPKTVVIISAISSLAAIALM 890
Query: 682 IVVTLTLKWKLIRCWKSITGS----------------SNDGINSPQAIRRFSYHELLQAT 725
++V + + +K + G SN G S + ++++AT
Sbjct: 891 VLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKS-----DIKWDDIMEAT 945
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAV-KVFHQRYERALKSFQDECEVMKRIRHRNL 784
++ ++G G G VY A L++G +AV K+ + + KSF E + + IRHR+L
Sbjct: 946 HYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHL 1005
Query: 785 VKIISACSN--DDFKALIMEYMPNGSLENRLYSGTC-----MLDIFQRLNIMIDVALALE 837
VK++ CS+ D LI EYM NGS+ + L++ +L RL I + +A +E
Sbjct: 1006 VKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVE 1065
Query: 838 YLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL--ATIGYM 883
YLH+ PI+H + AH+ DF +AK L G + ++ T+ + GY+
Sbjct: 1066 YLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYI 1125
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
APEY + + + DVYS GI+LME TGK PT+ +F E + RWV +L
Sbjct: 1126 APEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAR 1185
Query: 944 TNLLSGE-ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
L+ E + +E++ +L +A +CT P +R ++R+ LL +
Sbjct: 1186 EKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1142), Expect = e-123, Method: Compositional matrix adjust.
Identities = 349/1068 (32%), Positives = 522/1068 (48%), Gaps = 119/1068 (11%)
Query: 26 DQQSLLALKAHISYDPTNLFAKNWTSSTSV-CSWIGITCGVNSH--KVIVLNISGFNLQG 82
+ Q LL +K+ NL +NW S+ SV C W G+ C S +V+ LN+S L G
Sbjct: 30 EGQYLLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSG 87
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSM 142
+ P +G L L+ LDLS+N LSG IP I N +L++L +NQ G + I + S+
Sbjct: 88 KLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSL 147
Query: 143 LGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
+ + NR SG LP I NL +L +L+ N G++P ++ K+L N +S
Sbjct: 148 ENLIIYNNRISGSLPVEI-GNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMIS 206
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
G++P EIG L + L N+L GE+P+E+G L L ++ L N G +P I N ++
Sbjct: 207 GSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTS 266
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
L+ L+L +N L G +P + L ++EFL L N +G IP I N S N+
Sbjct: 267 LETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENAL 325
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTP-ELSFLSSLTNC---------------QKIR 366
+G IP +GN+ LE L + +N LT + P ELS L +L+ Q +R
Sbjct: 326 TGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLR 385
Query: 367 ---VLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNK 423
+L L N L G +P +G S L M + +SG+IP + SN+++L+LG N
Sbjct: 386 GLFMLQLFQNSLSGTIPPKLGWYS-DLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 424 LTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNL 483
L+G+IP + L L LA N L P +C + + L N+F G+IP GN
Sbjct: 445 LSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNC 504
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
++L+ L L N FT LP I L + ++SSN L G + +I N K++ L++ NN
Sbjct: 505 SALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNN 564
Query: 544 LSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKL 603
SG +P +G L L+ L L+NN L G IP + LS L L + N +G IP L L
Sbjct: 565 FSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSL 624
Query: 604 LYLK-KLNLSFNKLEGEIPRG----------------------GPFANLTA--------- 631
L+ LNLS+NKL GEIP FANL++
Sbjct: 625 TGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN 684
Query: 632 --------------KSFLGNELLCGLPDLHNSPCKLNKP----KTHHKSRKMMLLLVIAL 673
SF+GNE LCG P L+ C +P ++ K M +IA+
Sbjct: 685 SLTGPIPLLRNISMSSFIGNEGLCG-PPLNQ--CIQTQPFAPSQSTGKPGGMRSSKIIAI 741
Query: 674 PLSTAALIIVVTLTL----KWKLIRCWKSITGSSNDGINSPQAI-------RRFSYHELL 722
TAA+I V+L L + + R +++ S+ DG S ++ F++ +L+
Sbjct: 742 ---TAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 723 QATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-----RALKSFQDECEVMK 777
ATD F ++ ++G G+ G+VY A L G +AVK +E SF+ E +
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
IRHRN+VK+ C++ L+ EYMP GSL L+ +C LD +R I + A L
Sbjct: 859 NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918
Query: 838 YLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
YLH I H + AH+ DF +AK ++ SM + + GY+AP
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSM-SAIAGSYGYIAP 977
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME--VID 943
EY +V+ + D+YSYG++L+E TGK P I G + WV + + V+D
Sbjct: 978 EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYIRRDALSSGVLD 1036
Query: 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991
L +ER + +L++L +A CT SP R + R++V L++
Sbjct: 1037 ARLTLEDERIVS----HMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 346/1100 (31%), Positives = 523/1100 (47%), Gaps = 128/1100 (11%)
Query: 6 LVHCLLLSLAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTS-STSVCSWIGITCG 64
V L L + + ++ +D Q LL LK D N NW + C+WIG+ C
Sbjct: 16 FVGVLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRL-HNWNGIDETPCNWIGVNCS 74
Query: 65 VNSHK-------VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHT 117
V L++S NL G + P +G L +L L+L++N L+G+IP I N
Sbjct: 75 SQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSK 134
Query: 118 LKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANIC---------------- 161
L+++ +NQ GS+ I +S + ++ N+ SG LP I
Sbjct: 135 LEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLT 194
Query: 162 ----KNLPNLKKLL---LGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
++L NL KL G+N F G IP+ + KC L+ L L N +SG +PKEIG L K
Sbjct: 195 GPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVK 254
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
L+++IL N+ G IP+++GNL L L L N+LVG +P I NM +LKKL L +N L
Sbjct: 255 LQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLN 314
Query: 275 GSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLR 334
G++P + L V ++ N SG IP ++ S+L + L N +G IPN + LR
Sbjct: 315 GTIPKELG-KLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLR 373
Query: 335 NLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQ 394
NL L+++ N LT P N +R L L N L G++P +G L L
Sbjct: 374 NLAKLDLSINSLTGPIP-----PGFQNLTSMRQLQLFHNSLSGVIPQGLG-LYSPLWVVD 427
Query: 395 MFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPD 454
++SGKIP I SNL+LL+LG N++ G+IP R +L L + N+L P
Sbjct: 428 FSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487
Query: 455 EICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFD 514
E+C L L + L N+FSG +P G L+ L+L +N+F+S LP+ I L +++ F+
Sbjct: 488 ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFN 547
Query: 515 VSSNSLDGPLSLDIGNLKVVIELNLSRNNL------------------------SGDIPI 550
VSSNSL GP+ +I N K++ L+LSRN+ SG+IP
Sbjct: 548 VSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607
Query: 551 TIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEI-------------------------L 585
TIG L +L +L + N G IP LSSL+I L
Sbjct: 608 TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCG--- 642
L+ N +SG IPT+ E L L N S+N L G++P F N+T SFLGN+ LCG
Sbjct: 668 SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL 727
Query: 643 --LPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSIT 700
H+S ++ K R ++++V ++ + L+I + + +
Sbjct: 728 RSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYV 787
Query: 701 GSSNDGINSPQAI----RRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVK 756
RF+ ++L+AT F + ++G G+ G+VY A + G +AVK
Sbjct: 788 HDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVK 847
Query: 757 VFH-------QRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA--LIMEYMPNG 807
SF+ E + +IRHRN+V++ S C + + L+ EYM G
Sbjct: 848 KLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRG 907
Query: 808 SLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AH 854
SL L+ G +D R I + A L YLH IIH + AH
Sbjct: 908 SLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAH 967
Query: 855 ISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913
+ DF +AK ++ LS +A + GY+APEY +V+ + D+YS+G++L+E TGK
Sbjct: 968 VGDFGLAKVID--MPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGK 1025
Query: 914 KPTDEIFIGELSLSRWVNDLLPISVM--EVIDTNLLSGEERYFAAKEQSLLSILNLATEC 971
P + G L+ W + + + E++D L E+ ++++ +A C
Sbjct: 1026 APVQPLEQGG-DLATWTRNHIRDHSLTSEILDPYLTKVEDDVIL---NHMITVTKIAVLC 1081
Query: 972 TIESPGKRINAREIVTGLLK 991
T SP R RE+V L++
Sbjct: 1082 TKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-119, Method: Compositional matrix adjust.
Identities = 296/880 (33%), Positives = 450/880 (51%), Gaps = 72/880 (8%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
K+ ++S L G IPP+LG+LS+L+TL L NKL+G+IPS I + + + DN L
Sbjct: 143 KLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLL 202
Query: 129 FGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
G + S N++ ++ + L IN SG +P+ I NLPNL++L L RN GKIPS+
Sbjct: 203 TGPIPSSFGNLTKLVNLYLFINSLSGSIPSEI-GNLPNLRELCLDRNNLTGKIPSSFGNL 261
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
K + L + N LSG IP EIGN+T L + L+ N+L G IP +GN+ L L L N
Sbjct: 262 KNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQ 321
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
L G +P + M ++ L + EN L G +P L +E+L L N+ SG IP I N
Sbjct: 322 LNGSIPPELGEMESMIDLEISENKLTGPVPDSFG-KLTALEWLFLRDNQLSGPIPPGIAN 380
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
+++LTV QL N+F+GF+P+TI LE L + DN+ P+ SL +C+ + +
Sbjct: 381 STELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIRV 435
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSI 428
GN G + + G + +L + N G++ L+ L N +TG+I
Sbjct: 436 RFKGNSFSGDISEAFG-VYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAI 494
Query: 429 PVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRA 488
P + L L L+ N++ +P+ I ++ ++ KL L+GN+ SG IPS LT+L
Sbjct: 495 PPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEY 554
Query: 489 LYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDI 548
L L SNRF+S +P T+ NL + + +NLSRN+L I
Sbjct: 555 LDLSSNRFSSEIPPTLNNLPRLYY------------------------MNLSRNDLDQTI 590
Query: 549 PITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKK 608
P + L LQ L L+ N+L+G I F L +LE LDLS N +SG IP S + +L L
Sbjct: 591 PEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTH 650
Query: 609 LNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHN--SPCKLNKPKTHHKSRKMM 666
+++S N L+G IP F N +F GN+ LCG + PC + K HK R ++
Sbjct: 651 VDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLI 710
Query: 667 LLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFS--------- 717
+ +++ + A+II L++ + C++ T + +S S
Sbjct: 711 IYILVPI---IGAIII---LSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVR 764
Query: 718 YHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERAL------KSFQD 771
Y E+++AT F L+G G G VY A+L + + +AVK ++ + ++ + F +
Sbjct: 765 YQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLN 823
Query: 772 ECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSG--TCMLDIFQRLNIM 829
E + IRHRN+VK+ CS+ L+ EYM GSL L + LD +R+N++
Sbjct: 824 EIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVV 883
Query: 830 IDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL 877
VA AL Y+H S I+H + A ISDF AK L + S +
Sbjct: 884 KGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLL--KPDSSNWSAVA 941
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTD 917
T GY+APE +V+ + DVYS+G++ +E G+ P D
Sbjct: 942 GTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGD 981
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 424 bits (1089), Expect = e-117, Method: Compositional matrix adjust.
Identities = 342/1076 (31%), Positives = 510/1076 (47%), Gaps = 126/1076 (11%)
Query: 22 NITTDQQSLLALKAHISYDPTNLFAKNWTS-STSVCSWIGITCGVNSHKVIVLNISGFNL 80
++ + + LL KA + + +N + +W ++ C+W GI C + V ++++G NL
Sbjct: 23 SLNEEGRVLLEFKAFL--NDSNGYLASWNQLDSNPCNWTGIAC-THLRTVTSVDLNGMNL 79
Query: 81 QGT------------------------IPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMH 116
GT IP L SLE LDL N+ G IP + +
Sbjct: 80 SGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMII 139
Query: 117 TLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNM 176
TLK L +N LFGS+ I N+SS+ + + N +G +P ++ K L L+ + GRN
Sbjct: 140 TLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAK-LRQLRIIRAGRNG 198
Query: 177 FHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNL 236
F G IPS +S C+ L+ L L N L G++PK++ L L D+IL N L GEIP +GN+
Sbjct: 199 FSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNI 258
Query: 237 PYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
L L L N G +P I ++ +K+L L N L G +P I +L + ++ N
Sbjct: 259 SRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIG-NLIDAAEIDFSEN 317
Query: 297 RFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP-ELSF 355
+ +G IP + L + L N G IP +G L LE L+++ N L + P EL F
Sbjct: 318 QLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQF 377
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLL 415
L L + Q L N L+G +P IG S + M +SG IP L+
Sbjct: 378 LPYLVDLQ------LFDNQLEGKIPPLIGFYS-NFSVLDMSANSLSGPIPAHFCRFQTLI 430
Query: 416 LLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGA 475
LL LG NKL+G+IP +L L L N+L S+P E+ +L L L LH N SG
Sbjct: 431 LLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGN 490
Query: 476 IPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVI 535
I + G L +L L L +N FT +P I NL I+ F++SSN L G + ++G+ +
Sbjct: 491 ISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQ 550
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS-------------- 581
L+LS N SG I +G L L+ L L++NRL G IP SF L+
Sbjct: 551 RLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSEN 610
Query: 582 -----------------------------------LEILDLSKNKISGVIPTSLEKLLYL 606
LEIL L+ NK+SG IP S+ L+ L
Sbjct: 611 IPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSL 670
Query: 607 KKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSP------CKLNKPKTHH 660
N+S N L G +P F + + +F GN LC H P KLN
Sbjct: 671 LICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGS 730
Query: 661 KSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITG----SSNDGINSPQAIRR- 715
+ +K++ + I + ++ ++ L L W + R + + D ++S ++
Sbjct: 731 QRQKILTITCIVI----GSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKG 786
Query: 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALK--SFQDEC 773
F+Y L+ AT FS++ +LG G+ G+VY A + G +AVK + R E A SF+ E
Sbjct: 787 FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEI 846
Query: 774 EVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSG--TCMLDIFQRLNIMID 831
+ +IRHRN+VK+ C + + L+ EYM GSL +L G C+LD R I +
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906
Query: 832 VALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLAT 879
A L YLH I+H + AH+ DF +AK ++ SM + +
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM-SAVAGS 965
Query: 880 IGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP--IS 937
GY+APEY +V+ + D+YS+G++L+E TGK P + G L WV + I
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIP 1024
Query: 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993
+E+ D L + ++R E SL +L +A CT SP R RE+V + + R
Sbjct: 1025 TIEMFDARLDTNDKR--TVHEMSL--VLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1007 | ||||||
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.975 | 0.901 | 0.453 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.901 | 0.472 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.914 | 0.868 | 0.493 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.948 | 0.937 | 0.452 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.972 | 0.938 | 0.468 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.902 | 0.625 | 0.491 | 0.0 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.905 | 0.758 | 0.507 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.912 | 0.747 | 0.485 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.899 | 0.751 | 0.485 | 0.0 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.897 | 0.636 | 0.492 | 0.0 |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 878 bits (2269), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/1075 (45%), Positives = 665/1075 (61%), Gaps = 93/1075 (8%)
Query: 12 LSLAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVI 71
L ++A SN+T D +LL LK H ++DP +KNW+S+TS C W G+TC ++V+
Sbjct: 18 LQFSLAIPKSNLT-DLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVV 74
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
L +S ++G +PP +GNLS L +D+S+N SG++P+ + N+H LK ++F +N G
Sbjct: 75 ALTLSNMGIKGIVPPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGE 134
Query: 132 L-----------------------SSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLK 168
+ S IFN++++ +DL+ N G + NI NL NL+
Sbjct: 135 IPSSLAMLPKLQHLLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQ 194
Query: 169 KLLLG-------------------------------------------------RNMFHG 179
L +G N +G
Sbjct: 195 VLNMGLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYG 254
Query: 180 KIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL 239
+IPS L KCK+L L L N +G+IP+ IGNLTKLK + L N L G IP E+GNL L
Sbjct: 255 QIPSDLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNL 314
Query: 240 VRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS 299
+ L+ NNL G +P +FN+ST+K +++ N L G+LP+ + L LPN+ +L LG N+ S
Sbjct: 315 QIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLS 374
Query: 300 GNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTS--STPELSFLS 357
G IPS I+NASKLT+ +L NSF+GFIP+++G+LRNL+ L + N L+S ++ EL+ S
Sbjct: 375 GPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFS 434
Query: 358 SLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLL 417
SL NCQ ++ L L+ NPLDG LP S+GNLS SLE F + I G + + I NLS+L L
Sbjct: 435 SLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRL 494
Query: 418 DLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIP 477
+LG N LTG IP T L +LQGL L N L SIP E+C L L L L GNK SG+IP
Sbjct: 495 NLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIP 554
Query: 478 SCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIEL 537
+C NLTSLR L+L SNRF S + ST+W LKDIL +++SN L G L +I NL+ V +
Sbjct: 555 TCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMI 614
Query: 538 NLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIP 597
N+S+N LSG+IPI+IGGL++L +L+L+ N+L+GPIP+S + SLE LDLS N +SG+IP
Sbjct: 615 NISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIP 674
Query: 598 TSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPK 657
SL+ LLYLK N+SFN L+GEIP GG F+N +A+SF+GNE LCG L SPCK + +
Sbjct: 675 KSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSR 734
Query: 658 THHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFS 717
++L + + A ++ + LK C + S D + IRR S
Sbjct: 735 ATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKR---YCERKAKFSIEDDFLALTTIRRIS 791
Query: 718 YHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMK 777
YHEL AT+ F ++N LG+GSFGSVY L DG +A KVF+ + ERA KSF ECEV++
Sbjct: 792 YHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLR 851
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
+RHRNLVKII++CS +FKAL++E+MPN SLE LYS L+ QRLNIM+DVA LE
Sbjct: 852 NLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLE 911
Query: 838 YLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
YLH G++ P+ H MVA ++DF I+K L G++ MQT TLATIGYMAP
Sbjct: 912 YLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAP 970
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945
EYG +G VS RGDVYSYG++LMETFT KKPTD++F +LSL WV L V +VID N
Sbjct: 971 EYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDAN 1030
Query: 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKSV 1000
LL EE + AAK+ ++SIL LA +C+ + P RI+ + +VT L KI+ ++ +
Sbjct: 1031 LLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2199), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/1076 (47%), Positives = 657/1076 (61%), Gaps = 96/1076 (8%)
Query: 7 VHCLLLSLAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVN 66
V + S +A + SN T DQ SLLALKAHI+ DP ++ A NW++ TS C WIG++C
Sbjct: 14 VFIVQFSACVAMSLSNFT-DQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQ 72
Query: 67 SHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLS-------------------------- 100
+VI L++S L+GTIPP LGNLS L +LDLS
Sbjct: 73 QQRVIALDLSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYN 132
Query: 101 ----------------------HNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFN 138
+N +G IP SI NM L+ L N L G++ I
Sbjct: 133 LLSGQIPPSFGNLNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGK 192
Query: 139 MSSMLGID------------------------LSINRFSGELPANICKN-LPNLKKLLLG 173
+S+M +D L+ N SG+LP+++C + L L+ + L
Sbjct: 193 LSTMKILDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLS 252
Query: 174 RNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM 233
N F G IPS LSKC +L+ LYL FN +G IP+ I +LTKL + L N L GE+P E+
Sbjct: 253 ANRFTGPIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEI 312
Query: 234 GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL 293
G+L L L + N+L G +PF IFN+S++ SL N L G+LP LPN+E L L
Sbjct: 313 GSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLIL 372
Query: 294 GTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYL--TSSTP 351
N SG IPSSI NASKL N +G IP+ +G+LR LE LN+ N L S
Sbjct: 373 EINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQ 432
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNL 411
ELSFL+SLTNC+++R+L L+ NPL GILP SIGNLS SL+RF+ C++ G IP I NL
Sbjct: 433 ELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNL 492
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
SNL LL L N LTG+IP + +L LQGL L NKL SIP++IC L L +L L N+
Sbjct: 493 SNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQ 552
Query: 472 FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNL 531
SG+IP+C G LT LR LYLGSN+ S +PST+W+L IL D+SSN L G L D+GNL
Sbjct: 553 LSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNL 612
Query: 532 KVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNK 591
KV+++++LSRN LSG+IP IGGL++L L LA+NR EGPI SFS L SLE +DLS N
Sbjct: 613 KVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNA 672
Query: 592 ISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPC 651
+ G IP SLE L+YLK L++SFN L GEIP GPFAN +A+SF+ N+ LCG P L PC
Sbjct: 673 LFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPC 732
Query: 652 KLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQ 711
+ T + LLL LP + + ++ + L W R ++ + ++ + +
Sbjct: 733 RTG---TRWSTTISWLLLKYILP-AILSTLLFLALIFVWTRCRKRNAVLPTQSESLLT-A 787
Query: 712 AIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQD 771
RR SY E+ QAT+ FS NLLG GS GSVY L DG A+KVF+ + E A KSF
Sbjct: 788 TWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDA 847
Query: 772 ECEVMKRIRHRNLVKIISACSND--DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIM 829
ECEVM IRHRNL+KI+S+CSN DFKAL++EY+PNGSLE LYS LDI QRLNIM
Sbjct: 848 ECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIM 907
Query: 830 IDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL 877
IDVALA+EYLH G STP++H + H+ DF IAK L ++ + +TQTL
Sbjct: 908 IDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIR-ETQTL 966
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS 937
ATIGYMAP+Y G V+T GDVYSYGI+LMETFT ++PTDEIF E+S+ WV D L S
Sbjct: 967 ATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGS 1026
Query: 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993
+ EV+D NLL GE+ F AK+Q + IL LA +C +SP +RI +++VT L KI+
Sbjct: 1027 ITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/970 (49%), Positives = 619/970 (63%), Gaps = 49/970 (5%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDN----- 126
LN+ G ++G I ++ NLS+L+ LDL HN SG I +FNM +L+L++ R N
Sbjct: 92 TLNLEGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLSGI 151
Query: 127 ----------------------QLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNL 164
QL G + S + + + +DL NRF+G +P IC L
Sbjct: 152 LQVVMIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEIC-TL 210
Query: 165 PNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNE 224
LK+L LG+N G+IP +++ LE L L N L+G IP+EIGN T L +I + +N
Sbjct: 211 TKLKELYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNN 270
Query: 225 LRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS 284
L G IP EMGNL L L L NN+ G +P T FN S L+++++ N L G LPS L
Sbjct: 271 LTGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLG 330
Query: 285 LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADN 344
LPN+E L L N SG IP SI NASKL V L NSFSG IP+ +GNLRNL+ LN+A+N
Sbjct: 331 LPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAEN 390
Query: 345 YLTSSTPELSFLSSLT--NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISG 402
LTS + + NC+ + L GNPL G LP SIGNLS SLE F+CRI G
Sbjct: 391 ILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIG 450
Query: 403 KIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKL 462
IP+ I NLSNL+ L L N+LTG+IP RL +LQ LA NKL IP+EICHL +L
Sbjct: 451 NIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERL 510
Query: 463 DKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDG 522
L L N FSG++P+C N+TSLR LYLGSNRFTS +P+T W+LKD+L ++S NSL G
Sbjct: 511 SYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTG 569
Query: 523 PLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSL 582
L L+IGNLKVV ++ S N LSGDIP +I L+NL L++NR++GPIP SF L SL
Sbjct: 570 TLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSL 629
Query: 583 EILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCG 642
E LDLS+N +SG IP SLEKL++LK N+SFN+L+GEI GGPFAN + +SF+ NE LCG
Sbjct: 630 EFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCG 689
Query: 643 LPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGS 702
+ PCK TH +S++ ++ + + A +I+V+ L + R K +
Sbjct: 690 PIRMQVPPCK--SISTHRQSKRPREFVIRYIVPAIAFIILVLALAV-IIFRRSHKRKLST 746
Query: 703 SNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY 762
D + P R+ SYHEL +AT+ F++ NLLG GS GSVY L DG+ +AVKVFH +
Sbjct: 747 QEDPL-PPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQL 805
Query: 763 ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDI 822
E L F ECEV++ +RHRNLVKIIS+C N DFKALI+E++P+GSLE LYS LDI
Sbjct: 806 EGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDI 865
Query: 823 FQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQL 870
QRLNIMIDVA ALEYLH G + P++H MVAH+SDF I++ L D +
Sbjct: 866 LQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAV 925
Query: 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWV 930
+ QT TLATIGYMAPEYG++G VS +GDVYSYGI LMETFT KKPTD++F GE+SL WV
Sbjct: 926 T-QTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWV 984
Query: 931 NDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990
LP ++ EVID NLL EE +F AK+ + SILNLA EC+ + PG+RI R+++ L
Sbjct: 985 KQSLPKAITEVIDANLLI-EEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALE 1043
Query: 991 KIRDTLVKSV 1000
KI+ K V
Sbjct: 1044 KIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/1042 (45%), Positives = 646/1042 (61%), Gaps = 87/1042 (8%)
Query: 6 LVHCLLLSL---AIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGIT 62
LV LL+SL I+ SN T DQ +LLA K HI++DP N+ +W+S TS C+W+G++
Sbjct: 9 LVSMLLMSLPKKCISIPTSNFT-DQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVS 67
Query: 63 CGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLD 122
C + +V L++S L GTIPPQLGNLS L+ L L +N G++PS I N+ L+++D
Sbjct: 68 CSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMD 127
Query: 123 -------------------------FRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELP 157
F N L G++ S IFN+SS+ +DL N G LP
Sbjct: 128 IGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLP 187
Query: 158 ANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKD 217
N+C +LP L+ LLL N G+IPS L KC++L+ L+L +NN +G IP
Sbjct: 188 KNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIP----------- 236
Query: 218 IILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSL 277
+E+G LP L L L N L G +P +IFNM++L+ + + N L GS+
Sbjct: 237 -------------EELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSI 283
Query: 278 PSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLE 337
P + LPN+E L L N +G++P + N S+L + L N +G + GNLR L+
Sbjct: 284 PQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQ 343
Query: 338 FLNIADNYLTS--STPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
L++ N T+ S+ L+F++SLTN ++++ L + NPLDG+LP+S+GNLS L +F +
Sbjct: 344 VLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYV 403
Query: 396 FNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
+ ++ G IP I NLSNL++L L N L G IP T L +Q L L N L SIP +
Sbjct: 404 YASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSD 463
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
IC +L + L+ N SG IPSC GNLTSLR LYL N +S +P +W+LKD+L ++
Sbjct: 464 ICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNL 523
Query: 516 SSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
SN L G L +G ++ I + LS N LSG+IP TIG L+NL + L+ N +G IPE+
Sbjct: 524 HSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEA 583
Query: 576 FSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL 635
F GL SLE+LDLS+N +SG IP SLE L YL+ ++SFN L+GEIPRGGPFAN TA+SF+
Sbjct: 584 FGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFI 643
Query: 636 GNELLCGLPDLHNSPCKLNKPK-THHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIR 694
N+ LCG L PC + K + KSR LL +LP + L++V + L R
Sbjct: 644 MNKGLCGPSRLQVPPCSIESRKDSKTKSR----LLRFSLPTVASILLVVAFIFLVMGCRR 699
Query: 695 CWKSITGSSNDGINSPQAI------RRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ 748
++ D I P+A+ RR SY ELL AT+ F ++NLLGIGSFGSVY RL+
Sbjct: 700 RYRK------DPI--PEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLR 751
Query: 749 DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808
DG+ VAVK+F+ + +RA +SF ECE+M+ IRHRNLVKII +CSN DFKAL++EYMP GS
Sbjct: 752 DGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGS 811
Query: 809 LENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHIS 856
LE LYS LDI QR+NIMIDVA ALEYLH G+ +P++H MVAH+
Sbjct: 812 LEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVC 871
Query: 857 DFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPT 916
DF IAK L G+++ QT+TLATIGYMAPEYG+ G VST+ DVYS+GIMLME T K+PT
Sbjct: 872 DFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPT 930
Query: 917 DEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESP 976
DE+F GE+SL R V + LP SV++++D+N+L+ + Y KE + SI+ LA +C ESP
Sbjct: 931 DEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESP 990
Query: 977 GKRINAREIVTGLLKIRDTLVK 998
G+R+ EI+ L I+ ++
Sbjct: 991 GERMAMVEILARLKNIKAEFLR 1012
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/1029 (46%), Positives = 645/1029 (62%), Gaps = 50/1029 (4%)
Query: 14 LAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVL 73
++IA +NI +DQ +LLALK I DP NL A NW+ +TSVC+W+G+TCG +V L
Sbjct: 22 VSIADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTAL 81
Query: 74 NISGFNLQGTIPPQLGNLSSL------------------------ETLDLSHNKLSGNIP 109
++S L GTIPP LGNLS L + +S N SG IP
Sbjct: 82 DLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIP 141
Query: 110 SSIFNMHTLKLLDFRDNQLFGSLSSFIFN--MSSMLGIDLSINRFSGELPANICKNLPNL 167
S I + L+ L N+ G L + + N +SS+ +D N +G LP NI +L NL
Sbjct: 142 SWIGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANL 201
Query: 168 KKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG 227
+ L L N+F+G IPSTL C+QL+ L L FN+ G+I K+IGNLT L+++ L N G
Sbjct: 202 RALYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSG 261
Query: 228 EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPN 287
IP E+G+L +L + L N L G+VP I+N S + + L N L G LPS +L PN
Sbjct: 262 TIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSSSNL--PN 319
Query: 288 VEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
+EF + N F+G IP S+ NASKL L NSF G IP+ +GNL++LE + N+LT
Sbjct: 320 LEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLT 379
Query: 348 --SSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIP 405
SS+ LS SSLT C+ +R L+ NPL+G LP S+GNLS SLE ++F+C I+G IP
Sbjct: 380 VKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIP 439
Query: 406 QVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKL 465
+ I NLS+L LDLG N L G+IP T +L LQ L L +N+L S P E+C L L L
Sbjct: 440 KEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYL 499
Query: 466 ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
L N SG IPSC GN+ SLR L +G N+F+S +PST+W L DIL ++SSNSL G L+
Sbjct: 500 YLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLA 559
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEIL 585
+DIGNLK V ++LS N LSG IP +IGGLK L L LA NRLEG IP+ F SL++L
Sbjct: 560 VDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLL 619
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPD 645
DLS N +SG IP SLE+L YL N+SFN+L+GEIP G F NL+AKSF+GN+ LCG
Sbjct: 620 DLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAK 679
Query: 646 LHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSND 705
L PC+ + H+ K L + L L I+ + IR K +
Sbjct: 680 LQVQPCE----TSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKR-NMRITE 734
Query: 706 GINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERA 765
G+ ++R SY EL QATD+F++ NLLG GSFGSVY DG VAVKVF+ + E A
Sbjct: 735 GLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGA 794
Query: 766 LKSFQDECEVMKRIRHRNLVKIISACS--NDDFKALIMEYMPNGSLENRLYSGTCMLDIF 823
KSF ECEV++ IRHRNLVKII++CS N DFKAL++E+MPN SLE L S L++
Sbjct: 795 FKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELL 854
Query: 824 QRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLS 871
+RLNIM+DVA A+EYLH G++ PI+H MVAH++DF IAK L G +
Sbjct: 855 ERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLL-GDEHSF 913
Query: 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN 931
+QT TLAT+GYMAPEYG +G VST GD+YS+GI+LMETFT KKPTD++F E+S+ +WV
Sbjct: 914 IQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQ 973
Query: 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991
+ +P V ++ D +LL EE++F+AK+ +LS++ +A +C+ + P +R N R+++ L
Sbjct: 974 ESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNH 1033
Query: 992 IRDTLVKSV 1000
+ +K +
Sbjct: 1034 TKVKFLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/930 (49%), Positives = 602/930 (64%), Gaps = 21/930 (2%)
Query: 82 GTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSS 141
G IP +G+LS+LE L L++N L G IP I N+ L +LDF + + G + IFN+SS
Sbjct: 531 GGIPQAIGSLSNLEELYLAYNNLVGGIPREIGNLSNLNILDFGSSGISGPIPPEIFNISS 590
Query: 142 MLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL 201
+ DL+ N G LP +I K+LPNL++L L N G++PSTLS C QL+ L L N
Sbjct: 591 LQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWNKLSGQLPSTLSLCGQLQSLSLWGNRF 650
Query: 202 SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMS 261
+G IP GNLT L+D+ L DN ++G IP E+GNL L L L+ NNL G++P IFN+S
Sbjct: 651 TGNIPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNIS 710
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
L+ LSL +N GSLPS + LP++E L +G N FSG IP SI+N S+LT + N
Sbjct: 711 KLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNF 770
Query: 322 FSGFIPNTIGNLRNLEFLNIADNYLTS--STPELSFLSSLTNCQKIRVLILAGNPLDGIL 379
F+G +P +GNLR LEFLN+ N LT S E+ FL+SLTNC +R L + NPL GIL
Sbjct: 771 FTGDVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGIL 830
Query: 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ 439
P+S+GNLSISLE F C+ G IP I NL++L+ L+LG N LTG IP T +L LQ
Sbjct: 831 PNSLGNLSISLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQ 890
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA 499
LG+A N+L SIP+++C L L L L N+ +G+IPSC G L LR LYL SN S
Sbjct: 891 ELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASN 950
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
+P ++W L+ +L ++SSN L G L ++GN+K + L+LS+N +SG IP T+G L+NL+
Sbjct: 951 IPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLE 1010
Query: 560 KLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGE 619
L L+ NRL+GPIP F L SL+ LDLS+N +SGVIP SL+ L YLK LN+SFNKL+GE
Sbjct: 1011 DLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGE 1070
Query: 620 IPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAA 679
IP GGPF N TA+SF+ NE LCG P C +K R + +L LP +
Sbjct: 1071 IPDGGPFMNFTAESFIFNEALCGAPHFQVIAC--DKSTRSRSWRTKLFILKYILPPVISI 1128
Query: 680 LIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSF 739
+ +VV L L W IR K++ + P + + S+ +LL AT+ F ++NL+G GS
Sbjct: 1129 ITLVVFLVL-W--IRRRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSL 1185
Query: 740 GSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799
VY L +G+ VAVKVF+ ++ A +SF ECEVM+ IRHRNLVKII+ CSN DFKAL
Sbjct: 1186 SMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKAL 1245
Query: 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY--------- 850
++EYMP GSL+ LYS LD+ QRLNIMIDVA ALEYLH + ++H
Sbjct: 1246 VLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILL 1305
Query: 851 ---MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLM 907
MVAH+ DF IA+ L + + QT+TL TIGYMAPEYG G VST+GDV+SYGIMLM
Sbjct: 1306 DDDMVAHVGDFGIARLLTETESMQ-QTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLM 1364
Query: 908 ETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNL 967
E F KKP DE+F G+L+L WV L S++EV+D NLL E+ FA K L SI+ L
Sbjct: 1365 EVFARKKPMDEMFNGDLTLKSWVESLAD-SMIEVVDANLLRREDEDFATKLSCLSSIMAL 1423
Query: 968 ATECTIESPGKRINAREIVTGLLKIRDTLV 997
A CT +SP +RI+ +++V GL KI+ L+
Sbjct: 1424 ALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/936 (50%), Positives = 621/936 (66%), Gaps = 24/936 (2%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+L++S G IP +G+LS+LETL L N+L+G IP I N+ L LL+ + L G
Sbjct: 266 LLDLSINQFTGFIPQAIGSLSNLETLYLGFNQLAGGIPGEIGNLSNLNLLNSASSGLSGP 325
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ + IFN+SS+ I + N SG LP +ICK+LPNL+ LLL N G++P+TLS C +L
Sbjct: 326 IPAEIFNISSLQEIGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTTLSLCGEL 385
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
L L +NN +G+IP+EIGNL+KL+ I + G IP+E+GNL L L+L NNL G
Sbjct: 386 LTLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLTG 445
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+VP IFN+S L+ LSL N L GSLPS I LPN+E L +G N FSG IP SI+N S
Sbjct: 446 IVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSN 505
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTS--STPELSFLSSLTNCQKIRVLI 369
L + N F G +P +GNLR L+ L ++ N LT+ S EL+FL+SLTNC +R L
Sbjct: 506 LISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLS 565
Query: 370 LAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIP 429
++ NPL G++P+S+GNLSISLE +C++ G IP ISNL+NL+ L L N LTG IP
Sbjct: 566 ISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIP 625
Query: 430 VTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRAL 489
F RL LQ L ++ N++ SIP +CHL L L L NK SG IPSCSGNLT LR +
Sbjct: 626 TPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNV 685
Query: 490 YLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP 549
YL SN S +PS++ NL+ +L ++SSN L+ L L +GN+K ++ L+LS+N SG+IP
Sbjct: 686 YLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIP 745
Query: 550 ITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKL 609
TI L+NL +L+L++N+L+G IP +F L SLE LDLS N +SG IP SLE L YL+ L
Sbjct: 746 STISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYL 805
Query: 610 NLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLL 669
N+SFNKL+GEIP GGPFAN TA+SF+ N LCG P C+ K K+ K +LL
Sbjct: 806 NVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACE----KDSRKNTKSLLLK 861
Query: 670 VIALPLSTA-ALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELLQATDRF 728
I +PLS + + II+V L ++WK R KS T D ++ P+ R + ELL AT+ F
Sbjct: 862 CI-VPLSVSLSTIILVVLFVQWKR-RQTKSETPIQVD-LSLPRMHRMIPHQELLYATNYF 918
Query: 729 SKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKII 788
++NL+G GS G VY L DG+ VAVKVF+ + A KSF+ ECEVM+ IRHRNL KII
Sbjct: 919 GEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKII 978
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
S+CSN DFKAL++EYMPNGSLE LYS LD QRL IMIDVA LEYLH +S P++
Sbjct: 979 SSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVV 1038
Query: 849 HY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTR 896
H MVAHISDF IAK L G + + +T+TL T+GYMAPEYG +G VST+
Sbjct: 1039 HCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTVGYMAPEYGSEGIVSTK 1097
Query: 897 GDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956
GD+YSYGI+LMETF KKPTDE+F+ EL+L WV ++MEVID NLL+ E+ FA
Sbjct: 1098 GDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFAL 1156
Query: 957 KEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
K SI+ LA +CT+E P KRIN +++V L K+
Sbjct: 1157 KRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKL 1192
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/940 (48%), Positives = 603/940 (64%), Gaps = 21/940 (2%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
VL++S G IP +G+LS+LE L LSHNKL+G IP I N+ L +L N + G
Sbjct: 296 VLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNGISGP 355
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ + IFN+SS+ I + N SG LP +ICK+LPNL+ L L +N G++P+TLS C +L
Sbjct: 356 IPAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLCGEL 415
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
L L FN G+IPKEIGNL+KL+ I L N L G IP GNL L L L NNL G
Sbjct: 416 LFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLTG 475
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
VP IFN+S L+ L++++N L GSLPS I L ++E L + N FSG IP SI+N SK
Sbjct: 476 TVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSK 535
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSS--TPELSFLSSLTNCQKIRVLI 369
LTV L NSF+G +P +GNL L+ L++A N LT E+ FL+SLTNC+ ++ L
Sbjct: 536 LTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLW 595
Query: 370 LAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIP 429
+ NP G LP+S+GNL I+LE F C+ G IP I NL+NL+ LDLG N LTGSIP
Sbjct: 596 IGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIP 655
Query: 430 VTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRAL 489
T RL LQ L + N+L SIP+++CHL L L L NK SG+IPSC G+L +L+ L
Sbjct: 656 TTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQEL 715
Query: 490 YLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP 549
+L SN +P+++W+L+D+L ++SSN L G L ++GN+K + L+LS+N +SG IP
Sbjct: 716 FLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIP 775
Query: 550 ITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKL 609
+G +NL KL L+ N+L+GPIP F L SLE LDLS+N +SG IP SLE L+YLK L
Sbjct: 776 RKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYL 835
Query: 610 NLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLL 669
N+S NKL+GEIP GGPF N TA+SF+ NE LCG P C N +T K +L
Sbjct: 836 NVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILK 894
Query: 670 VIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELLQATDRFS 729
I LP+ +++ +V + W R I + + P + S+ +LL AT+ F
Sbjct: 895 YILLPV--GSIVTLVVFIVLWIRRRDNMEIPTPIDSWL--PGTHEKISHQQLLYATNDFG 950
Query: 730 KNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIIS 789
++NL+G GS G VY L +G+ VA+KVF+ ++ AL+SF ECEVM+ IRHRNLV+II+
Sbjct: 951 EDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIIT 1010
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
CSN DFKAL++EYMPNGSLE LYS LD+ QRLNIMIDVA ALEYLH S+ ++H
Sbjct: 1011 CCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVH 1070
Query: 850 Y------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRG 897
MVAH++DF I K L + + QT+TL TIGYMAPE+G G VST+
Sbjct: 1071 CDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQ-QTKTLGTIGYMAPEHGSDGIVSTKS 1129
Query: 898 DVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957
DVYSYGI+LME F+ KKP DE+F G+L+L WV L SV++V+D NLL E+ A K
Sbjct: 1130 DVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDANLLRREDEDLATK 1188
Query: 958 EQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997
L SI+ LA CT +SP +R+N ++ V L K R L+
Sbjct: 1189 LSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/946 (48%), Positives = 600/946 (63%), Gaps = 40/946 (4%)
Query: 76 SGFN-LQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSS 134
S FN G IP +G+L +LE L L+ NKL+G IP I N+ L +L N + G + +
Sbjct: 275 SSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPA 334
Query: 135 FIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGL 194
IFN+SS+ ID + N SG LP ICK+LPNL+ L L +N G++P+TLS C +L L
Sbjct: 335 EIFNISSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFL 394
Query: 195 YLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVP 254
L FN G+IP+EIGNL+KL+ I L N L G IP GNL L L L N L G VP
Sbjct: 395 SLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVP 454
Query: 255 FTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTV 314
IFN+S L+ L+L++N L GSLPS I LP++E L +G N FSG IP SI+N SKLTV
Sbjct: 455 EAIFNISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTV 514
Query: 315 FQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSS--TPELSFLSSLTNCQKIRVLILAG 372
L NSF+G +P + NL L+FLN+A N LT + FL+SLTNC+ +R L +
Sbjct: 515 LSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGY 574
Query: 373 NPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTF 432
NPL G LP+S+GNL I+LE F + C+ G IP I NL+NL+ LDLG N LTGSIP T
Sbjct: 575 NPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTL 634
Query: 433 SRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLG 492
RL LQ L +A N++ SIP+++CHL L L L NK SG+ PSC G+L +LR L+L
Sbjct: 635 GRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLD 694
Query: 493 SNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI 552
SN +P+++W+L+D+L ++SSN L G L ++GN+K + L+LS+N +SG IP +
Sbjct: 695 SNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRM 754
Query: 553 GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLS 612
G L+ L L L+ NRL+GPI F L SLE LDLS N +SG IP SLE L+YLK LN+S
Sbjct: 755 GKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVS 814
Query: 613 FNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIA 672
FNKL+GEIP GGPF TA+SF+ NE LCG P C N +T K +L I
Sbjct: 815 FNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNN-RTQSWKTKSFILKYIL 873
Query: 673 LPL-STAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAI--------RRFSYHELLQ 723
LP+ ST L++ + L ++ + D + P I + S+ +LL
Sbjct: 874 LPVGSTVTLVVFIVLWIRRR-------------DNMEIPTPIDSWLLGTHEKISHQQLLY 920
Query: 724 ATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
AT+ F ++NL+G GS G VY L +G+ VA+KVF+ ++ AL+SF ECEVM+ IRHRN
Sbjct: 921 ATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRN 980
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
LV+II+ CSN DFKAL++EYMPNGSLE LYS LD+ QRLNIMIDVA ALEYLH
Sbjct: 981 LVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDC 1040
Query: 844 STPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
S+ ++H MVAH++DF IAK L + + QT+TL TIGYMAPE+G G
Sbjct: 1041 SSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQ-QTKTLGTIGYMAPEHGSAG 1099
Query: 892 RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951
VST+ DVYSYGI+LME F KKP DE+F G+L+L WV L SV++V+D NLL E+
Sbjct: 1100 IVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRRED 1158
Query: 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997
A K L SI+ LA CT +SP +RI+ ++ V L K R L+
Sbjct: 1159 EDLATKLSCLSSIMALALACTTDSPKERIDMKDAVVELKKSRIKLL 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/934 (49%), Positives = 597/934 (63%), Gaps = 30/934 (3%)
Query: 82 GTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSS 141
G IP +G+LS+LE + L++N L+G IP I N+ L L + G + IFN+SS
Sbjct: 277 GGIPQAIGSLSNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCGISGPIPPEIFNISS 336
Query: 142 MLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL 201
+ IDL+ N G LP +ICK+L NL+ L L N G++P+TLS C QL L L N
Sbjct: 337 LQMIDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSLCGQLLSLSLWGNRF 396
Query: 202 SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMS 261
+G IP GNLT L+D+ L +N ++G IP E+GNL L L L+ NNL G++P IFN+S
Sbjct: 397 TGNIPPSFGNLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVNNLTGIIPEAIFNIS 456
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
L+ L L +N GSLPS I LP++E L +G N FSG IP SI+N S+LTV + N
Sbjct: 457 KLQTLXLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANF 516
Query: 322 FSGFIPNTIGNLRNLEFLNIADNYLTS--STPELSFLSSLTNCQKIRVLILAGNPLDGIL 379
F+G +P +GNLR LEFLN+ N LT ST E+ FL+SLTNC+ +R L + NPL GIL
Sbjct: 517 FTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGIL 576
Query: 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ 439
P+S+GNLSISLE F C+ G IP I NL NL+ L L N LTG IP++F L LQ
Sbjct: 577 PNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQ 636
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA 499
++ N++ SIP +CHL L L L NK SG IP C GNLT+LR + L SN S
Sbjct: 637 WFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASE 696
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
+PS++W L+D+L ++SSN L+ L L++GN+K ++ L+LS+N SG+IP TI L+NL
Sbjct: 697 IPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLL 756
Query: 560 KLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGE 619
+L+L++N+L+G +P +F L SLE LDLS N SG IPTSLE L YLK LN+SFNKL+GE
Sbjct: 757 QLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGE 816
Query: 620 IPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAA 679
IP GPFAN TA+SF+ N LCG P C + ++ ++L ++ L +S +
Sbjct: 817 IPNRGPFANFTAESFISNLALCGAPRFQVMAC---EKDARRNTKSLLLKCIVPLSVSLST 873
Query: 680 LIIVVTLTLKWKLIRCWKSITGSSNDGINS----PQAIRRFSYHELLQATDRFSKNNLLG 735
+I+VV TL WK S + P+ R S+ ELL AT F + NL+G
Sbjct: 874 MILVVLFTL-------WKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIG 926
Query: 736 IGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD 795
GS G VY L DG+ VAVKVF+ A KSF+ ECEVM+ IRHRNL KIIS+CSN D
Sbjct: 927 KGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLD 986
Query: 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY----- 850
FKAL++EYMPN SLE LYS LD QRL IMIDVA LEYLH +S P++H
Sbjct: 987 FKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPS 1046
Query: 851 -------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYG 903
MVAHISDF IAK L G + + +T+TL TIGYMAPEYG +G VST+ D YSYG
Sbjct: 1047 NVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTIGYMAPEYGSEGIVSTKCDTYSYG 1105
Query: 904 IMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLS 963
I+LME F KKPTDE+F+ EL+L WV ++MEVID NLL+ E+ FA K+ S
Sbjct: 1106 IILMEIFVRKKPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALKQACFSS 1164
Query: 964 ILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997
I+ LA +CTIE P KRIN +++V L KI + +V
Sbjct: 1165 IMTLALDCTIEPPEKRINMKDVVARLKKILNQIV 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1007 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.765 | 0.752 | 0.384 | 2.7e-154 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.742 | 0.740 | 0.351 | 2.2e-135 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.743 | 0.742 | 0.344 | 5.3e-132 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.743 | 0.730 | 0.344 | 3.7e-131 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.742 | 0.739 | 0.332 | 2.6e-130 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.786 | 0.675 | 0.301 | 2.4e-123 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.760 | 0.671 | 0.304 | 5.4e-115 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.762 | 0.685 | 0.308 | 2.3e-114 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.758 | 0.610 | 0.308 | 2.7e-112 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.688 | 0.852 | 0.372 | 5.3e-111 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1244 (443.0 bits), Expect = 2.7e-154, Sum P(2) = 2.7e-154
Identities = 313/813 (38%), Positives = 450/813 (55%)
Query: 99 LSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPA 158
L + LSG I S+ N+ L+ LD DN L G + + +S + ++LS N G +PA
Sbjct: 86 LRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPA 145
Query: 159 NICXXXXXXXXXXXGRNMFHGKIPSTL-SKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKD 217
I N G IP + + K L LYL N LSG IP +GNLT L++
Sbjct: 146 AI-GACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQE 204
Query: 218 IILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSL 277
L+ N L G IP +G L L+ + L NNL G++P +I+N+S+L+ S+ EN L G +
Sbjct: 205 FDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMI 264
Query: 278 PSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLE 337
P+ +L +E +++GTNRF G IP+S+ NAS LTV Q+ GN FSG I + G LRNL
Sbjct: 265 PTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLT 324
Query: 338 FLNIADN-YLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMF 396
L + N + T + F+S LTNC K++ L L N L G+LP+S NLS SL +
Sbjct: 325 ELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALE 384
Query: 397 NCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTFSRLLNLQGLGLAF-NKLARSIPDE 455
+I+G IP+ I S+P + RL NL G+ LA+ N L+ SIP
Sbjct: 385 LNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNL-GILLAYENNLSGSIPLA 443
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI-LFFD 514
I +L +L+ L+L NKFSG IP NLT+L +L L +N + +PS ++N++ + + +
Sbjct: 444 IGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMIN 503
Query: 515 VSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE 574
VS N+L+G + +IG+LK ++E + N LSG IP T+G + L+ L+L NN L G IP
Sbjct: 504 VSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPS 563
Query: 575 SFSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSF 634
+ L LE LDLS N +SG IPT GE+P G FA + S
Sbjct: 564 ALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISI 623
Query: 635 LGNELLCG-LPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLI 693
GN LCG +PDLH C P ++RK +L I++ L+ AAL I+ +L L LI
Sbjct: 624 QGNAKLCGGIPDLHLPRCC---PLL--ENRKHFPVLPISVSLA-AALAILSSLYL---LI 674
Query: 694 RCWKSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEV 753
W T S + SY +L++ATD F+ NLLG GSFGSVY +L V
Sbjct: 675 T-WHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHV 733
Query: 754 AVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN-----DDFKALIMEYMPNGS 808
AVKV +ALKSF ECE ++ +RHRNLVKI++ CS+ +DFKA++ ++MPNGS
Sbjct: 734 AVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGS 793
Query: 809 LENRLYSGTC------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHY------------ 850
LE+ ++ T L++ +R+ I++DVA AL+YLH P++H
Sbjct: 794 LEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSD 853
Query: 851 MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
MVAH+ DF +A+ L D S+ Q+ +++G++
Sbjct: 854 MVAHVGDFGLARIL--VDGTSLIQQSTSSMGFI 884
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 2.2e-135, Sum P(2) = 2.2e-135
Identities = 271/772 (35%), Positives = 402/772 (52%)
Query: 97 LDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGEL 156
L+L +L G I SI N+ L LD +N G++ + +S + +D+ IN G +
Sbjct: 71 LELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPI 130
Query: 157 PANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
P + N G +PS L L L L NN+ G +P +GNLT L+
Sbjct: 131 PLGLYNCSRLLNLRLDS-NRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLE 189
Query: 217 DIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGS 276
+ L+ N L GEIP ++ L + L L NN GV P ++N+S+LK L + N G
Sbjct: 190 QLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGR 249
Query: 277 LPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNL 336
L + + LPN+ N+G N F+G+IP++++N S L + N+ +G IP T GN+ NL
Sbjct: 250 LRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNL 308
Query: 337 EFLNIADNYLTS-STPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
+ L + N L S S+ +L FL+SLTNC ++ L + N L G LP SI NLS L +
Sbjct: 309 KLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDL 368
Query: 396 FNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
ISG IP I +P + +LLNL+ L L N+L+ IP
Sbjct: 369 GGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAF 428
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
I ++ L+ L L N F G +P+ GN + L L++G N+ +P I ++ +L D+
Sbjct: 429 IGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDM 488
Query: 516 SSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
S NSL G L DIG L+ + L+L N LSG +P T+G ++ LFL N G IP+
Sbjct: 489 SGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD- 547
Query: 576 FSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSFL 635
GL ++ +DLS N +SG IP G++P G F N T S +
Sbjct: 548 LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIV 607
Query: 636 GNELLCG-LPDLHNSPCKLNKPKT--HHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKL 692
GN LCG + PC P H SR +++ +++ ++ L+ + ++TL W
Sbjct: 608 GNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW-- 665
Query: 693 IRCWKSITGSSNDGINSPQAIR-RFSYHELLQATDRFSKNNLLGIGSFGSVYVARL-QDG 750
+R K ++N ++ + + + SY +L AT+ FS +N++G GSFG+VY A L +
Sbjct: 666 LRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEK 725
Query: 751 MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDF-----KALIMEYMP 805
VAVKV + + A+KSF ECE +K IRHRNLVK+++ACS+ DF +ALI E+MP
Sbjct: 726 KVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMP 785
Query: 806 NGSLE--------NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
NGSL+ ++ + L + +RLNI IDVA L+YLH PI H
Sbjct: 786 NGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 837
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 5.3e-132, Sum P(2) = 5.3e-132
Identities = 265/770 (34%), Positives = 393/770 (51%)
Query: 97 LDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGEL 156
LDL +L G I SI N+ L LD +N G++ + N+ + + + N GE+
Sbjct: 71 LDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEI 130
Query: 157 PANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
PA++ N+ G +PS L ++L LYL N+L G P I NLT L
Sbjct: 131 PASLSNCSRLLYLDLFSNNLGDG-VPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLI 189
Query: 217 DIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGS 276
+ L N L GEIP ++ L +V LTL NN GV P +N+S+L+ L LL N G+
Sbjct: 190 VLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGN 249
Query: 277 LPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNL 336
L LPN+ L+L N +G IP+++ N S L +F + N +G I G L NL
Sbjct: 250 LKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENL 309
Query: 337 EFLNIADNYLTS-STPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
+L +A+N L S S +L+FL +LTNC + L ++ N L G LP+SI N+S L +
Sbjct: 310 HYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNL 369
Query: 396 FNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
I G IP I +P + L+ L L L N+ + IP
Sbjct: 370 KGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSF 429
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
I +L +L KL L N F G +P G+ + + L +G N+ +P I + ++ ++
Sbjct: 430 IGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNM 489
Query: 516 SSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
SNSL G L DIG L+ ++EL L NNLSG +P T+G +++ ++L N +G IP+
Sbjct: 490 ESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD- 548
Query: 576 FSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSFL 635
GL ++ +DLS N +SG I G +P G F N T S
Sbjct: 549 IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVF 608
Query: 636 GNELLCG-LPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIR 694
GN+ LCG + +L PC P + ++ + I + + A L+++ ++L W R
Sbjct: 609 GNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKR 668
Query: 695 CWKSITGSSNDGINSPQAIR-RFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGME 752
K+ +N + + + SY +L ATD FS +N++G GSFG+V+ A LQ +
Sbjct: 669 --KNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKI 726
Query: 753 VAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDF-----KALIMEYMPNG 807
VAVKV + + A+KSF ECE +K IRHRNLVK+++AC++ DF +ALI E+MPNG
Sbjct: 727 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNG 786
Query: 808 SLEN--------RLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
SL+ ++ + L + +RLNI IDVA L+YLH PI H
Sbjct: 787 SLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 836
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 3.7e-131, Sum P(2) = 3.7e-131
Identities = 266/773 (34%), Positives = 400/773 (51%)
Query: 97 LDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGEL 156
+DL KL+G + + N+ L+ L+ DN G++ S + N+ + +++S N F G +
Sbjct: 86 VDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVI 145
Query: 157 PANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
P + ++ G +P +L L L NNL+G P +GNLT L+
Sbjct: 146 PVVLSNCSSLSTLDLSSNHLEQG-VPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQ 204
Query: 217 DIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGS 276
+ N++ GEIP ++ L ++ +A N GV P I+N+S+L LS+ N+ G+
Sbjct: 205 MLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGT 264
Query: 277 LPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNL 336
L LPN++ L +G N F+G IP +++N S L + N +G IP + G L+NL
Sbjct: 265 LRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNL 324
Query: 337 EFLNIADNYLTS-STPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
L + +N L + S+ +L FL +LTNC +++ L + N L G LP I NLS L +
Sbjct: 325 LLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSL 384
Query: 396 FNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
ISG IP I +P + L L+ + L N L+ IP
Sbjct: 385 GGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSS 444
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
+ +++ L L L N F G+IPS G+ + L L LG+N+ ++P + L ++ +V
Sbjct: 445 LGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNV 504
Query: 516 SSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
S N L GPL DIG LK ++ L++S N LSG IP T+ +L+ L L N GPIP+
Sbjct: 505 SFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD- 563
Query: 576 FSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSFL 635
GL+ L LDLSKN +SG IP G +P G F N +A S
Sbjct: 564 IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVF 623
Query: 636 GNELLCG-LPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIR 694
GN LCG +P L PC + P+ H RK++ + V A+ ++ L+ + + L W +R
Sbjct: 624 GNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAV-MAALLLLCLCVVYLCWYKLR 682
Query: 695 CWKSITGSSNDGINSPQAIRRF----SYHELLQATDRFSKNNLLGIGSFGSVYVARL-QD 749
KS+ ++N+ S ++ F SY EL + T FS +NL+G G+FG+V+ L
Sbjct: 683 V-KSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSK 741
Query: 750 GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN-----DDFKALIMEYM 804
VA+KV + A KSF ECE + IRHRNLVK+++ CS+ +DF+AL+ E+M
Sbjct: 742 NKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFM 801
Query: 805 PNGSLENRLY------SG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
PNG+L+ L+ +G + L +F RLNI IDVA AL YLH PI H
Sbjct: 802 PNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAH 854
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 257/773 (33%), Positives = 393/773 (50%)
Query: 97 LDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGEL 156
L+L +L G + SI N+ L LD DN G + + N+ + + ++ N G +
Sbjct: 71 LNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGI 130
Query: 157 PANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
PA + + G +PS L +L L L NNL G +P+ +GNLT LK
Sbjct: 131 PATLSNCSRLLNLDLYSNPLRQG-VPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLK 189
Query: 217 DIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGS 276
+ DN + GE+P E+ L +V L L+ N GV P I+N+S L+ L L + GS
Sbjct: 190 SLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGS 249
Query: 277 LPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNL 336
L LPN+ LNLG N G IP++++N S L F + N +G I G + +L
Sbjct: 250 LKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSL 309
Query: 337 EFLNIADNYLTSST-PELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
++L++++N L S T +L F+ SLTNC +++L + L G LP+SI N+S L +
Sbjct: 310 QYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNL 369
Query: 396 FNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
G IPQ I +P + +LL L L L N+++ IP
Sbjct: 370 IGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSF 429
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
I +L +L+ L L N F G +P G + + L +G N+ +P I + ++ +
Sbjct: 430 IGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSM 489
Query: 516 SSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
NSL G L DIG+L+ +++L+L N SG +P T+G +++LFL N +G IP +
Sbjct: 490 EGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-N 548
Query: 576 FSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSFL 635
GL + +DLS N +SG IP G++P G F N T
Sbjct: 549 IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVF 608
Query: 636 GNELLCG-LPDLHNSPCKLNKP--KTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKL 692
GN+ LCG + DL PC +P +T H S + +++++ ++ L+++ ++ L W
Sbjct: 609 GNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFR 668
Query: 693 IRCWKSITGSSNDGINSPQAI--RRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-D 749
R T N+ + S I + SY +L AT+ FS +N++G GSFG+V+ A L +
Sbjct: 669 KRRKNQQT---NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTE 725
Query: 750 GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDF-----KALIMEYM 804
VAVKV + + A+KSF ECE +K RHRNLVK+++AC++ DF +ALI EY+
Sbjct: 726 SKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYL 785
Query: 805 PNGSLENRLYSGTC--------MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
PNGS++ L+ L + +RLNI+IDVA L+YLH PI H
Sbjct: 786 PNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAH 838
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
Identities = 252/836 (30%), Positives = 409/836 (48%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSL 132
L++SG L G IP GNL +L++L L+ N L G+IP+ I N +L L+ DNQL G +
Sbjct: 221 LDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKI 280
Query: 133 SSFIFNMSSMLGIDLSINRFSGELPANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQLE 192
+ + N+ + + + N+ + +P+++ N G I + + LE
Sbjct: 281 PAELGNLVQLQALRIYKNKLTSSIPSSL-FRLTQLTHLGLSENHLVGPISEEIGFLESLE 339
Query: 193 GLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGV 252
L L NN +G P+ I NL L + + N + GE+P ++G L L L+ N L G
Sbjct: 340 VLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGP 399
Query: 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKL 312
+P +I N + LK L L N + G +P N+ F+++G N F+G IP I N S L
Sbjct: 400 IPSSISNCTGLKLLDLSHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNL 457
Query: 313 TVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAG 372
+ N+ +G + IG L+ L L ++ N LT P + N + + +L L
Sbjct: 458 ETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR-----EIGNLKDLNILYLHS 512
Query: 373 NPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVTF 432
N G +P + NL++ L+ +M++ + G IP+ + IP F
Sbjct: 513 NGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALF 571
Query: 433 SRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPS-CSGNLTSLRALYL 491
S+L +L L L NK SIP + L+ L+ + N +G IP +L +++ LYL
Sbjct: 572 SKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ-LYL 630
Query: 492 G--SNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP 549
+N T +P + L+ + D+S+N G + + K V L+ S+NNLSG IP
Sbjct: 631 NFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIP 690
Query: 550 ITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTXXXXXXXXXX 608
+ G+ + L L+ N G IP+SF ++ L LDLS N ++G IP
Sbjct: 691 DEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKH 750
Query: 609 XXXXXXXXXGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLL 668
G +P G F N+ A +GN LCG PC + + +H R ++L
Sbjct: 751 LKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVIL 809
Query: 669 LVIALPLSTAALIIVVTLTLKWKLIRCWKS----ITGSSNDGI---NSPQAIRRFSYHEL 721
+++ S AAL++V+ L L ++ C K I SS + +S ++RF EL
Sbjct: 810 IILG---SAAALLLVLLLVL---ILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKEL 863
Query: 722 LQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERAL--KSFQDECEVMKRI 779
QATD F+ N++G S +VY +L+DG +AVKV + + A K F E + + ++
Sbjct: 864 EQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923
Query: 780 RHRNLVKIIS-ACSNDDFKALIMEYMPNGSLENRLYSGTCML-DIFQRLNIMIDVALALE 837
+HRNLVKI+ A + KAL++ +M NG+LE+ ++ + + +++++ + +A ++
Sbjct: 924 KHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGID 983
Query: 838 YLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIG 881
YLH G+ PI+H VAH+SDF A+ L ++ S T A G
Sbjct: 984 YLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEG 1039
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 5.4e-115, Sum P(2) = 5.4e-115
Identities = 243/797 (30%), Positives = 381/797 (47%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
VL++S L G IP L L +LETL L+ N+L+G IP I LK L DN L GS
Sbjct: 133 VLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGS 192
Query: 132 LSSFIFNMSSMLGIDLSINR-FSGELPANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQ 190
+ + + +S + I + N+ SG++P+ I G +PS+L K K+
Sbjct: 193 IPTELGKLSGLEVIRIGGNKEISGQIPSEI-GDCSNLTVLGLAETSVSGNLPSSLGKLKK 251
Query: 191 LEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLV 250
LE L + +SG IP ++GN ++L D+ L +N L G IP+E+G L L +L L N+LV
Sbjct: 252 LETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLV 311
Query: 251 GVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNAS 310
G +P I N S LK + L N L GS+PS I L +E + N+FSG+IP++I+N S
Sbjct: 312 GGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG-RLSFLEEFMISDNKFSGSIPTTISNCS 370
Query: 311 KLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLIL 370
L QL N SG IP+ +G L L N L S P L +C ++ L L
Sbjct: 371 SLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPP-----GLADCTDLQALDL 425
Query: 371 AGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPV 430
+ N L G +PS + L +L + + + +SG IPQ I IP
Sbjct: 426 SRNSLTGTIPSGLFMLR-NLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPS 484
Query: 431 TFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALY 490
L + L + N+L +PDEI ++L + L N G++P+ +L+ L+ L
Sbjct: 485 GIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLD 544
Query: 491 LGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPI 550
+ +N+F+ +P+++ L + +S N G + +G + L+L N LSG+IP
Sbjct: 545 VSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPS 604
Query: 551 TIGGLKNLQ-KLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXX 609
+G ++NL+ L L++NRL G IP + L+ L ILDLS N + G +
Sbjct: 605 ELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLN 664
Query: 610 XXXXXXXXGEIPRGGPFANLTAKSFLGNELLCGLPD-----LHNSPCKLNKPKTHHKSRK 664
G +P F L+ + GN+ LC + L ++RK
Sbjct: 665 ISYNSFS-GYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRK 723
Query: 665 MMLLLVIALPLSTAALII--VVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELL 722
+ L L + + L+ +I+ V + + + S G + +P FS +++
Sbjct: 724 LRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQII 783
Query: 723 QATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVF--------HQRYERALK-SFQDEC 773
+ + N++G G G VY A + +G +AVK H + ++ SF E
Sbjct: 784 RC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEV 840
Query: 774 EVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDV 832
+ + IRH+N+V+ + C N + + L+ +YMPNGSL + L+ LD R I++
Sbjct: 841 KTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGA 900
Query: 833 ALALEYLHFGHSTPIIH 849
A L YLH PI+H
Sbjct: 901 AQGLAYLHHDCLPPIVH 917
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 2.3e-114, Sum P(2) = 2.3e-114
Identities = 247/800 (30%), Positives = 393/800 (49%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
N ++VL + L G IPP+LGN+ S+ L LS NKL+G+IPS++ N+ L +L +
Sbjct: 196 NLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYE 255
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICXXXXXXXXXXXGRNMFHGKIPSTL 185
N L G + I NM SM + LS N+ +G +P+++ +N G IP L
Sbjct: 256 NYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLF-QNYLTGGIPPKL 314
Query: 186 SKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245
+ + L L N L+G+IP +GNL L + L +N L G IP E+GN+ ++ L L
Sbjct: 315 GNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLN 374
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS 305
N L G +P + N+ L L L N L G +P + ++ ++ L+L N+ +G++P S
Sbjct: 375 NNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELG-NMESMINLDLSQNKLTGSVPDS 433
Query: 306 ITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKI 365
N +KL LR N SG IP + N +L L + N T PE ++ +K+
Sbjct: 434 FGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPE-----TVCKGRKL 488
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISXXXXXXXXXXXXXXXX 425
+ + L N L+G +P S+ + SL R + + +G I +
Sbjct: 489 QNISLDYNHLEGPIPKSLRDCK-SLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFH 547
Query: 426 XSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTS 485
I + + L L ++ N + +IP EI ++ +L +L L N G +P GNLT+
Sbjct: 548 GEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTN 607
Query: 486 LRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLS 545
L L L N+ + +P+ + L ++ D+SSN+ + + + ++NLSRN
Sbjct: 608 LSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFD 667
Query: 546 GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTXXXXXXX 605
G IP + L L +L L++N+L+G IP S L SL+ LDLS N +SG+IPT
Sbjct: 668 GSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIA 726
Query: 606 XXXXXXXXXXXXGEIPRGGPFANLTAKSFLGNELLCG-LPDLHNSPCK-LNKPKTHHKSR 663
G +P F TA + N LC +P PC+ L KPK K+
Sbjct: 727 LTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPK---KNG 783
Query: 664 KMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSND---GINSP--QAIRRFSY 718
+++ +++ + L ++ + T + IR K G + D G N +F Y
Sbjct: 784 NLVVWILVPI-LGVLVILSICANTFTY-CIRKRKLQNGRNTDPETGENMSIFSVDGKFKY 841
Query: 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERAL------KSFQDE 772
+++++T+ F +L+G G + VY A LQD + +AVK H + + + F +E
Sbjct: 842 QDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLNE 900
Query: 773 CEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSG---TCMLDIFQRLNIM 829
+ + IRHRN+VK+ CS+ LI EYM GSL N+L + L +R+N++
Sbjct: 901 VKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSL-NKLLANDEEAKRLTWTKRINVV 959
Query: 830 IDVALALEYLHFGHSTPIIH 849
VA AL Y+H TPI+H
Sbjct: 960 KGVAHALSYMHHDRITPIVH 979
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 2.7e-112, Sum P(2) = 2.7e-112
Identities = 246/798 (30%), Positives = 399/798 (50%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGS 131
L++S NL G I + ++ LE L L+ N+LSG++P +I + +T LK L + QL G
Sbjct: 293 LDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGE 352
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICXXXXXXXXXXXGRNMFHGKIPSTLSKCKQL 191
+ + I N S+ +DLS N +G++P ++ N G + S++S L
Sbjct: 353 IPAEISNCQSLKLLDLSNNTLTGQIPDSL-FQLVELTNLYLNNNSLEGTLSSSISNLTNL 411
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
+ L NNL G +PKEIG L KL+ + L +N GE+P E+GN L + N L G
Sbjct: 412 QEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSG 471
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+P +I + L +L L EN L G++P+ + + + ++L N+ SG+IPSS +
Sbjct: 472 EIPSSIGRLKDLTRLHLRENELVGNIPASLG-NCHQMTVIDLADNQLSGSIPSSFGFLTA 530
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILA 371
L +F + NS G +P+++ NL+NL +N + N S L SS + +
Sbjct: 531 LELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFD------VT 584
Query: 372 GNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISXXXXXXXXXXXXXXXXXSIPVT 431
N +G +P +G S +L+R ++ + +G+IP+ IPV
Sbjct: 585 ENGFEGDIPLELGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVE 643
Query: 432 FSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYL 491
L + L N L+ IP + L L +L L NKF G++P+ +LT++ L+L
Sbjct: 644 LGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFL 703
Query: 492 GSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPIT 551
N ++P I NL+ + ++ N L GPL IG L + EL LSRN L+G+IP+
Sbjct: 704 DGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVE 763
Query: 552 IGGLKNLQK-LFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTXXXXXXXXXXXX 610
IG L++LQ L L+ N G IP + S L LE LDLS N++ G +P
Sbjct: 764 IGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLN 823
Query: 611 XXXXXXXGEIPRGGPFANLTAKSFLGNELLCGLPDLH-NSPCKLNKPKTHHKSRKMMLLL 669
G++ + F+ A +F+GN LCG P H N N+ K+ ++++
Sbjct: 824 LSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKT--VVIIS 879
Query: 670 VIALPLSTAALIIVVTLTLK-----WKLIRCWKSITGSSNDGINSPQ-----AIRRFSYH 719
I+ + A +++V+ L K +K +R S S++ +P A +
Sbjct: 880 AISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWD 939
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-RALKSFQDECEVMKR 778
++++AT ++ ++G G G VY A L++G +AVK + + + KSF E + +
Sbjct: 940 DIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGT 999
Query: 779 IRHRNLVKIISACSN--DDFKALIMEYMPNGSLENRLYSG--TCMLDIF---QRLNIMID 831
IRHR+LVK++ CS+ D LI EYM NGS+ + L++ T ++ RL I +
Sbjct: 1000 IRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALG 1059
Query: 832 VALALEYLHFGHSTPIIH 849
+A +EYLH+ PI+H
Sbjct: 1060 LAQGVEYLHYDCVPPIVH 1077
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 266/715 (37%), Positives = 386/715 (53%)
Query: 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICXXXXXXXXXXXGRN 175
H + L R + L G +S + N+S + + LS N SG++P + N
Sbjct: 78 HRVVKLRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQEL-SRLSRLQQLVLNFN 136
Query: 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGN 235
G+IP+ L L L L N LSGAIP +G LT L D+ L +N L G IP G
Sbjct: 137 SLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQ 196
Query: 236 LPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGT 295
L L L+LA NNL G +P I+N+S+L ++ N L G+LP+ +LP+++ + +
Sbjct: 197 LRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYY 256
Query: 296 NRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSS-TPELS 354
N+F G IP+SI NAS +++F + NSFSG +P IG +RNL+ L + + + T +
Sbjct: 257 NQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWK 316
Query: 355 FLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISXXXXX 414
F+++LTNC ++ + L G G+LP S+ NLS SL + + +ISG +P+ I
Sbjct: 317 FMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNL 376
Query: 415 XXXXXXXXXXXXSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
S+P +FS+L NL+ L + NKL S+P I +L +L + + N F G
Sbjct: 377 QYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGG 436
Query: 475 AIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDIL-FFDVSSNSLDGPLSLDIGNLKV 533
IPS GNLT L + LG N F +P I+++ + DVS N+L+G + +IG LK
Sbjct: 437 TIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKN 496
Query: 534 VIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKIS 593
++E + N LSG+ P TIG + LQ LFL NN L G IP + + L L+ LDLS N +S
Sbjct: 497 IVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLS 556
Query: 594 GVIPTXXXXXXXXXXXXXXXXXXXGEIPRGGPFANLTAKSFLGNELLCG-LPDLHNSPCK 652
G IP GE+P G FAN + GN +CG +P+LH C
Sbjct: 557 GQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCS 616
Query: 653 LNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQA 712
L K K +++LL+V+ +ST A+ +L + L+ C K S Q
Sbjct: 617 LKSRKK--KKHQILLLVVVICLVSTLAVF-----SLLYMLLTCHKR-RKKEVPATTSMQG 668
Query: 713 IRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARL--QDG---MEVAVKVFHQRYERALK 767
+Y +L++ATD FS ++LLG GSFGSVY QDG VAV+V +ALK
Sbjct: 669 HPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALK 728
Query: 768 SFQDECEVMKRIRHRNLVKIISACSN-----DDFKALIMEYMPNGSLENRLYSGT 817
SF ECE ++ RHRNLVKI++ CS+ +DFKA++ ++MPNGSLE+ L+ T
Sbjct: 729 SFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPET 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3679 | 0.9384 | 0.9356 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00025217001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1007 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-110 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-10 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 4e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.002 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.002 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.004 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.004 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.004 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 365 bits (938), Expect = e-110
Identities = 308/1004 (30%), Positives = 475/1004 (47%), Gaps = 133/1004 (13%)
Query: 30 LLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPP--- 86
LL+ K+ I+ DP + NW SS VC W GITC NS +V+ +++SG N+ G I
Sbjct: 34 LLSFKSSIN-DPLK-YLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90
Query: 87 -----QLGNLS-----------------SLETLDLSHNKLSGNIPS-SIFNMHTLKLLDF 123
Q NLS SL L+LS+N +G+IP SI N+ TL D
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETL---DL 147
Query: 124 RDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS 183
+N L G + + I + SS+ +DL N G++P ++ NL +L+ L L N G+IP
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL-TNLTSLEFLTLASNQLVGQIPR 206
Query: 184 TLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLT 243
L + K L+ +YL +NNLSG IP EIG LT L + L N L G IP +GNL L L
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 244 LATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIP 303
L N L G +P +IF++ L L L +N+L G +P + + L N+E L+L +N F+G IP
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIP 325
Query: 304 SSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQ 363
++T+ +L V QL N FSG IP +G NL L+++ N LT PE L +
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE-----GLCSSG 380
Query: 364 KIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNK 423
+ LIL N L+G +P S+G SL R ++ + SG++P + L + LD+ N
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACR-SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 424 LTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNL 483
L G I + +LQ L LA NK +PD +L+ L L N+FSGA+P G+L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
+ L ++L LS N
Sbjct: 499 SEL------------------------------------------------MQLKLSENK 510
Query: 544 LSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKL 603
LSG+IP + K L L L++N+L G IP SFS + L LDLS+N++SG IP +L +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 604 LYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLC------GLPDLHNSPCKLNKPK 657
L ++N+S N L G +P G F + A + GN LC GLP PCK + K
Sbjct: 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP-----PCKRVR-K 624
Query: 658 THHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFS 717
T + L L L+ A V ++ ++ G+ + + +
Sbjct: 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSIT 684
Query: 718 YHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVM 776
+++L + + N++ G G+ Y + +++GM+ VK + D M
Sbjct: 685 INDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----M 737
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
+++H N+VK+I C ++ LI EY+ +L L + L +R I I +A AL
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKAL 793
Query: 837 EYLHFGHSTPIIHYMVAHISDFSIAKFLNGQDQ----------LSMQTQTLATIGYMAPE 886
+LH +P + +V ++S I ++G+D+ L T+ + Y+APE
Sbjct: 794 RFLHC-RCSPAV--VVGNLSPEKI--IIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPE 848
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV-IDTN 945
++ + D+Y +G++L+E TGK P D F S+ W + +D
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR----YCYSDCHLDMW 904
Query: 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
+ + + ++ ++NLA CT P R A +++ L
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 21/191 (10%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISAC 791
LG G FG+VY+AR + G +VA+K+ + L+ E E++K++ H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-- 849
+++ L+MEY GSL++ L L + L I++ + LEYL HS IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-YGVQGRVSTRG 897
++DF ++K L L + T YMAPE +G S +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 898 DVYSYGIMLME 908
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 80/269 (29%), Positives = 121/269 (44%), Gaps = 36/269 (13%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVF--HQRYERALKSFQDECEVMKRIRHRNLVKIISA 790
LG GSFG+VY A+ + G VAVK+ + ++ + E +++R+ H N+V++I A
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH- 849
+ D L+MEY G L + L G L + I + + LEYL HS IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYL---HSNGIIHR 122
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-YGVQGRVSTRG 897
V I+DF +AK L S+ T T YMAPE +
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFV-GTPWYMAPEVLLGGNGYGPKV 180
Query: 898 DVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957
DV+S G++L E TGK P F GE L + ++ I L +E +++
Sbjct: 181 DVWSLGVILYELLTGKPP----FSGENILD-------QLQLIRRILGPPLEFDEPKWSSG 229
Query: 958 EQSLLSILNLATECTIESPGKRINAREIV 986
+ ++ +C + P KR A EI+
Sbjct: 230 SEEAKDLIK---KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 734 LGIGSFGSVYVARL-----QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG VY L +VAVK + E + F +E +MK++ H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 847
+ C+ + ++ EYMP G L + L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL---ESKNF 123
Query: 848 IH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVST 895
+H +V ISDF +++ + D + I +MAPE G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 896 RGDVYSYGIMLMETFT-GKKP 915
+ DV+S+G++L E FT G++P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 729 SKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHR 782
+ LG G+FG VY +L+ +EVAVK + E+ ++ F E +M+++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
N+VK++ C+ ++ ++MEYM G L + L L + L+ + +A +EYL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL--- 118
Query: 843 HSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
S IH +V ISDF +++ L D + I +MAPE +
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 891 GRVSTRGDVYSYGIMLMETFT-GKKPTDEI 919
G+ +++ DV+S+G++L E FT G++P +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 732 NLLGIGSFGSVYVARLQDG----MEVAVKVFHQRYERALKS-FQDECEVMKRIRHRNLVK 786
LG G+FG VY +L+ EVAVK + + F E VMK++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 787 IISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCMLDIF---QRLNIMIDVALALEY 838
++ C+ ++ L++EYM G L ++R + L+ I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 839 LHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
L S +H +V ISDF +++ + D +T I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
G +++ DV+S+G++L E FT G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 729 SKNNLLGIGSFGSVYVARLQDG-----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHR 782
+ LG G+FG VY L+ +EVAVK + E+ ++ F E +M+++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHF 841
N+VK++ C+ ++ ++MEYMP G L + L + L + L+ + +A +EYL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL-- 119
Query: 842 GHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
S IH +V ISDF +++ L D I +MAPE
Sbjct: 120 -ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESLK 177
Query: 890 QGRVSTRGDVYSYGIMLMETFT-GKKP 915
+G+ +++ DV+S+G++L E FT G++P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 38/272 (13%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLV 785
+ LG GSFG VY+AR + G VA+KV ++ ++ + E +++K+++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ ++D L+MEY G L + L L + + + ALEYL HS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYL---HSK 116
Query: 846 PIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
I+H ++DF +A+ L+ ++L T + T YMAPE +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGY 173
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953
D++S G++L E TGK P F G+ L + +S E +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 954 FAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ +L P KR+ A E
Sbjct: 230 L------IRKLLVK-------DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 73/296 (24%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRN 783
+++ LLG GSFGSVY+A +D G +AVK E L++ + E ++ ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 784 LVKIISACSNDDFKAL--IMEYMPNGSLENRLYSGTCMLDIFQRLNI------MIDVALA 835
+V+ + +++ L +EY+ GSL + L F +L +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEG 113
Query: 836 LEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
L YLH S I+H V ++DF AK L + T +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
APE D++S G ++E TGK P W P++ + I
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP-------------WSELGNPMAALYKIG 217
Query: 944 TN--------LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991
++ LS E + F K C P KR A E LL+
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVK 786
F +G G FG VY AR + G EVA+KV + + +E +++K+ +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN------IMIDVALALEYLH 840
+ D ++ME+ GSL++ L T Q L + ++ LEYLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTN-----QTLTESQIAYVCKELLKGLEYLH 115
Query: 841 FGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEY 887
IIH ++ + DF ++ L+ + T+ T +MAPE
Sbjct: 116 SNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS----DTKARNTMVGTPYWMAPEV 168
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ D++S GI +E GK P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 734 LGIGSFGSVYVARL------QDGMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVK 786
LG G+FG V++ D VAVK + A K F+ E E++ +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSG-------------TCMLDIFQRLNIMIDVA 833
C+ D ++ EYM +G L L S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 834 LALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
+ YL HF H + + + +V I DF +++ + D + T+ I +M
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
PE + + +T DV+S+G++L E FT GK+P
Sbjct: 193 PESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 730 KNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIIS 789
+G G FG V + + G +VAVK + A ++F E VM +RH NLV+++
Sbjct: 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
+ ++ EYM GSL + L S G ++ + Q+L +DV +EYL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFV 124
Query: 849 HY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTR 896
H +VA +SDF +AK + + L + + APE + + ST+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLP-VKWTAPEALREKKFSTK 179
Query: 897 GDVYSYGIMLMETFT-GKKPTDEIFIGELS 925
DV+S+GI+L E ++ G+ P I + ++
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 63/193 (32%), Positives = 89/193 (46%), Gaps = 16/193 (8%)
Query: 733 LLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALK-SFQDECEVMKRIRHRNLVKIISAC 791
+G G+FG VY L+ EVAVK LK F E E++K+ H N+VK+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM 851
++ME +P GSL L L + + L + +D A +EYL S IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRD 118
Query: 852 VA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
+A ISDF +++ G I + APE GR ++ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 900 YSYGIMLMETFTG 912
+SYGI+L ETF+
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 734 LGIGSFGSVYVARL------QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG V++A QD M VAVK + E A + FQ E E++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYS--------------GTCMLDIFQRLNIMIDVA 833
C+ ++ EYM +G L L S L + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 834 LALEY---LHFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
+ Y LHF H + + +V I DF +++ + D + +T+ I +M
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
PE + + +T D++S+G++L E FT GK+P
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-21
Identities = 56/161 (34%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 533 VVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+ L L L G IP I L++LQ + L+ N + G IP S ++SLE+LDLS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 593 SGVIPTSLEKLLYLKKLNLSFNKLEGEIPR--GGPFANLTAKSFLGNELLCGLPDLHNSP 650
+G IP SL +L L+ LNL+ N L G +P GG + + +F N LCG+P L
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--A 536
Query: 651 CKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWK 691
C + + IA +S A L +V+ WK
Sbjct: 537 CGPHLSVGAK--------IGIAFGVSVAFLFLVICAMCWWK 569
|
Length = 623 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 726 DRFSKN-NLLGIGSFGSVYVARL-----QDGMEVAVKVF-HQRYERALKSFQDECEVMKR 778
R K LG G FG V + R G +VAVK H E+ F+ E E+++
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT 62
Query: 779 IRHRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
+ H N+VK C ++ LIMEY+P+GSL + L +++ + L + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 837 EYLHFGHSTPIIHYMVA------------HISDFSIAKFLN-GQDQLSMQTQTLATIGYM 883
+YL S IH +A ISDF +AK L +D ++ + I +
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFT 911
APE + S+ DV+S+G+ L E FT
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 54/302 (17%)
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVARL--QDGME----VAVKVFHQRYERALKS-FQDE 772
E+ + RF + LG G+FG VY L + VA+K + E ++ F+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 773 CEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS---------------GT 817
E+M ++H N+V ++ C+ + ++ EY+ +G L L
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 818 CMLDIFQRLNIMIDVALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQD 868
LD L+I I +A +EYL HF H + + + ISDF +++ + D
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927
+Q+++L + +M PE + G+ +T D++S+G++L E F+ G +P + G
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYG----- 229
Query: 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987
+ N V+E+I + L E + L EC E P +R ++I T
Sbjct: 230 -FSNQ----EVIEMIRSRQL------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278
Query: 988 GL 989
L
Sbjct: 279 RL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
F+ LG G FG V+ ++ + VA+K+ + FQ E + +KR+RH++L+ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTP 846
+ CS + +I E M GSL L S +L + +++ VA + YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 847 IIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
IH +V ++DF +A+ + ++ + + + + APE G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 895 TRGDVYSYGIMLMETFT-GKKP 915
T+ DV+S+GI+L E FT G+ P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 734 LGIGSFGSVY--VARLQDG--MEVAVKVFHQRYERALKS-FQDECEVMKRIRHRNLVKII 788
LG G+FGSV V ++ G +EVAVK Q + A K F E VM ++ H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 789 SACSNDDFKALIMEYMPNGSLENRL--YSGTCMLDIFQRLNIMIDVALALEYL---HFGH 843
C + L+ME P G L L + D+ + VA+ + YL HF H
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHFVH 118
Query: 844 ----STPII----HYMVAHISDFSIAKFLN-GQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
+ ++ H A ISDF +++ L G D T + + APE G+ S
Sbjct: 119 RDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 895 TRGDVYSYGIMLMETFT-GKKPTDEI 919
++ DV+SYG+ L E F+ G KP E+
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ +VAVK + ++F E ++MK++RH LV++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID----VALALEYLHFGHSTPIIH 849
++ ++ EYM GSL + L SG RL ++D +A + YL S IH
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYL---ESRNYIH 126
Query: 850 ------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRG 897
+V I+DF +A+ + D+ + + I + APE GR + +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 898 DVYSYGIMLMETFT-GKKP 915
DV+S+GI+L E T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVK--VFHQRYERALKSFQDECEVMKRIRHRN 783
+ +L+G G+FG VY L+ G VA+K + E ALKS E +++K ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+VK I + D +I+EY NGSL + F + + V L+ L + H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 844 STPIIHYMV--AHI----------SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
+IH + A+I +DF +A LN + + T +MAPE
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMS 174
Query: 892 RVSTRGDVYSYGIMLMETFTGKKP 915
ST D++S G ++E TG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISAC 791
+LG G++G VY AR L + +A+K +R R ++ +E + ++HRN+V+ + +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-- 849
S + F + ME +P GSL L S L ++ I+ LE L + H I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 850 ----------YM-VAHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYGVQGRVSTRG 897
Y V ISDF +K L G ++ T+T T+ YMAPE +G RG
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAG---INPCTETFTGTLQYMAPEVIDKG---PRG 187
Query: 898 -----DVYSYGIMLMETFTGKKPTDEI 919
D++S G ++E TGK P E+
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 51/283 (18%)
Query: 734 LGIGSFGSVYVAR------LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG V++A +D M VAVK A K FQ E E++ ++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 788 ISACSNDDFKALIMEYMPNGSLEN--RLYSGTCM-------------LDIFQRLNIMIDV 832
C + D ++ EYM +G L R + M L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 833 ALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
A + YL HF H + + ++ I DF +++ + D + T+ I +M
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942
PE + + +T DV+S+G++L E FT GK+P W L V+E I
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQ-LSNTEVIECI 238
Query: 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ R KE + ++ C P +R+N +EI
Sbjct: 239 TQGRVLERPR-VCPKE-----VYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHRNLVKIISAC 791
LG G FG V++ + + ++VA+K+ E A+ F +E +VM ++ H NLV++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM 851
+ ++ EYM NG L N L L L++ DV A+EYL S IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRD 125
Query: 852 VA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
+A +SDF +A+++ DQ + T + + PE R S++ DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 900 YSYGIMLMETFT-GKKPTD 917
+S+G+++ E F+ GK P +
Sbjct: 185 WSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.3 bits (217), Expect = 2e-18
Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 733 LLGIGSFGSVYVARLQDGMEVAVKVF---HQRYERALKSFQDECEVMKRIRH-RNLVKII 788
LG GSFG VY+AR D VA+KV + + ++ F E +++ + H N+VK+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTP 846
++ L+MEY+ GSLE+ L L + L I+ + ALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 847 IIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA----TIGYMAPEY-- 887
IIH V + DF +AK L S + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 888 -GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
S+ D++S GI L E TG P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 732 NLLGIGSFGSVYVARLQD-------GMEVAVKVFHQ-RYERALKSFQDECEVMKRIRHRN 783
N LG G+FG VY D + VAVK + ++ K F E +M H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS------GTCMLDIFQRLNIMIDVALALE 837
+VK++ C ++ + +IME M G L + L G +L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 838 YL---HFGH-----------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
YL HF H V I DF +A+ + D + + L + +M
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
APE + G+ +T+ DV+S+G+++ E T G++P
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 733 LLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALK-SFQDECEVMKRIRHRNLVKIISAC 791
LLG G+FG V+ L+D VAVK + + LK F E ++K+ H N+VK+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM 851
+ ++ME +P G + L L Q + +D A + YL S IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118
Query: 852 VA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
+A ISDF +++ + S + + I + APE GR S+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-IKWTAPEALNYGRYSSESDV 177
Query: 900 YSYGIMLMETFT 911
+SYGI+L ETF+
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G FG+V G +VAVK + + ++F +E VM ++ H+NLV+++ +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 794 DDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY-- 850
+ ++ME M G+L N L + G ++ + Q L +DVA +EYL S ++H
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 851 ----------MVAHISDFSIAKF-LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
VA +SDF +A+ G D + + + APE + S++ DV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDN------SKLPVKWTAPEALKHKKFSSKSDV 180
Query: 900 YSYGIMLMETFT-GKKPTDEIFIGELS 925
+SYG++L E F+ G+ P ++ + E+
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 727 RFSKNNLLGIGSFGSVY-VARLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRN 783
++ +G GSFG VY V R DG +K E+ + +E +++K++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALEYLH 840
++K + ++MEY G L ++ F Q L+ + + LAL+YL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL- 119
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEY 887
HS I+H + + DF I+K L+ L +T+ T Y++PE
Sbjct: 120 --HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL---AKTVVGTPYYLSPEL 174
Query: 888 GVQGR-VSTRGDVYSYGIMLMETFTGKKP 915
Q + + + D++S G +L E T K P
Sbjct: 175 -CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G FG V++ + +VA+K + + + F +E +VM ++ H LV++ C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY--- 850
L+ E+M +G L + L + L + +DV + YL S+ +IH
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLA 127
Query: 851 ---------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYS 901
V +SDF + +F+ DQ + T T + + +PE + S++ DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 902 YGIMLMETFT-GKKPTD 917
+G+++ E F+ GK P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G FG V + + G +VAVK + + ++F E VM ++RH NLV+++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 794 DDFKALIM-EYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYL---HFGH----- 843
+ I+ EYM GSL + L S G +L L +DV A+EYL +F H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 844 -STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSY 902
+ + VA +SDF + K + S Q + + APE + + ST+ DV+S+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 903 GIMLMETFT-GKKPTDEIFIGEL 924
GI+L E ++ G+ P I + ++
Sbjct: 186 GILLWEIYSFGRVPYPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRN 783
R+ + N +G G+FG VY A L G +AVK + +K DE +V++ ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFG 842
LVK + + + MEY G+LE L G + + + + + LA YL
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA--YL--- 115
Query: 843 HSTPIIHYMV--AHI----------SDFSIAKFL--NGQDQLSMQTQTLATIGYMAPEYG 888
HS I+H + A+I DF A L N T YMAPE
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 889 VQGRVSTRG---DVYSYGIMLMETFTGKKP 915
G+ G D++S G +++E TGK+P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V + + +VA+K+ + + F +E +VM ++ H LV++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA 853
++ EYM NG L N L Q L + DV + YL S IH +A
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127
Query: 854 ------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYS 901
+SDF +++++ D+ + + + + PE + + S++ DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 902 YGIMLMETFT-GKKPTD 917
+G+++ E ++ GK P +
Sbjct: 187 FGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 734 LGIGSFGSVYVARL------QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG V++A QD + VAVK + A K F E E++ ++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYS----GTCM--------LDIFQRLNIMIDVALA 835
C D ++ EYM +G L L + M L Q L+I +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 836 LEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+ YL HF H + + ++ I DF +++ + D + T+ I +M PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ + +T DV+S G++L E FT GK+P
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 722 LQATDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIR 780
++ TD K+ L G G +G VY + + VAVK + ++ F E VMK I+
Sbjct: 3 MERTDITMKHKLGG-GQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYL 839
H NLV+++ C+ + +I E+M G+L + L ++ L + ++ A+EYL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 840 ---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
+F H + + + ++DF +++ + G D + I + APE
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAY 179
Query: 891 GRVSTRGDVYSYGIMLMETFT 911
+ S + DV+++G++L E T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 19/196 (9%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V+ + VAVK + K F E ++MK++RH L+++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV 852
++ ++ E M GSL L G L + Q +++ VA + YL + IH +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDL 129
Query: 853 A------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVY 900
A ++DF +A+ + +D + I + APE + R S + DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 901 SYGIMLMETFT-GKKP 915
S+GI+L E T G+ P
Sbjct: 189 SFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 41/206 (19%)
Query: 734 LGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
+G G+ G VY A G EVA+K R + + +E +MK +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLD-IFQRLN------IMIDVALALEYLHFGHST 845
D ++MEYM GSL T ++ F R+N + +V LEYLH S
Sbjct: 86 VGDELWVVMEYMDGGSL-------TDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQ 135
Query: 846 PIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATI-G---YMAPEYGV 889
+IH +++ ++DF A QL+ + ++ G +MAPE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA------QLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + D++S GIM +E G+ P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFH----QRYERALKSFQDECEVMKRIRHR 782
+ +LG GS G VY R + G A+K H + + + L E + ++
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESP 59
Query: 783 NLVKIISACSNDDFK----ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+VK C +K ++++EYM GSL + L + + I + L+Y
Sbjct: 60 YVVK----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDY 114
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQT-LATIGYMA 884
LH IIH I+DF I+K L N D Q T + T+ YM+
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD----QCNTFVGTVTYMS 168
Query: 885 PEYGVQGRV-STRGDVYSYGIMLMETFTGKKP 915
PE +QG S D++S G+ L+E GK P
Sbjct: 169 PER-IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD---ECEVMKRIRHRNLVKIIS 789
LG GSFG V + R G A+KV ++ K + E ++ RI H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
A ++ L++EY P G L + L + R ++ LALEYL HS II+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYL---HSLGIIY 116
Query: 850 YMV------------AHISDFSIAK-FLNGQDQLSMQTQTLA-TIGYMAPEYGVQGRVST 895
+ ++DF +AK + +T T T Y+APE +
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 896 RGDVYSYGIMLMETFTGKKP 915
D +S G++L E TGK P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 41/211 (19%)
Query: 734 LGIGSFGSVY---VARLQDG---MEVAVKV------FHQRYERALKSFQDECEVMKRIRH 781
LG GSFG VY + G VA+K +R E F +E VMK
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-----FLNEASVMKEFNC 68
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYS------GTCMLDIFQRLNIM---IDV 832
++V+++ S ++ME M G L++ L S L + ++
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 833 ALALEYLHFGHSTPIIHY-------MVAH-----ISDFSIAKFLNGQDQLSMQTQTLATI 880
A + YL + +H MVA I DF + + + D + L +
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 881 GYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
+MAPE G +T+ DV+S+G++L E T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRNLVKIISAC 791
+G G+FG V+ RL+ D VAVK + LK+ F E ++K+ H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM 851
+ ++ME + G L + L + + + ++ + A +EYL H IH
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119
Query: 852 VA------------HISDFSIAKFLNGQDQLSMQTQTLATI--GYMAPEYGVQGRVSTRG 897
+A ISDF +++ +D + T + I + APE GR S+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 898 DVYSYGIMLMETFT 911
DV+S+GI+L E F+
Sbjct: 178 DVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDG----MEVAVKVFHQRYER-ALKSFQDECEVMKRIR 780
K +LG G+FG+VY + +G + VA+KV + A K DE VM +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H ++V+++ C + LI + MP G L + + + + LN + +A + YL
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 841 FGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
++H +A I+DF +AK L+ ++ I +MA E
Sbjct: 127 EKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKPTDEI 919
+ + + DV+SYG+ + E T G KP + I
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 733 LLGIGSFGSVYVAR---LQD--GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FGSV + R LQD G VAVK L+ F+ E E++K ++H N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 788 ISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
C + + L+MEY+P GSL + L LD + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSK 127
Query: 846 PIIHYMVA------------HISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +A I DF + K L ++ ++ + I + APE + +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 893 VSTRGDVYSYGIMLMETFT 911
S DV+S+G++L E FT
Sbjct: 188 FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 72/294 (24%), Positives = 113/294 (38%), Gaps = 66/294 (22%)
Query: 734 LGIGSFGSVYVARL------QDGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRNLVK 786
+G G+FG V+ AR + VAVK+ + +++ FQ E +M H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 787 IISACSNDDFKALIMEYMPNGSLEN--------------------RLYSGT-CMLDIFQR 825
++ C+ L+ EYM G L R L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 826 LNIMIDVALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQT 876
L I VA + YL F H + + MV I+DF +++ + D
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLP 935
I +M PE R +T DV++YG++L E F+ G +P + G
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP----YYG------------- 235
Query: 936 ISVMEVI----DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
++ EVI D N+LS + L + NL C + P R + I
Sbjct: 236 MAHEEVIYYVRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ +VAVK + + +SF +E ++MK++RH LV++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEY---LHFGH----ST 845
+ ++ EYM GSL + L G L + +++ VA + Y +++ H S
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA 131
Query: 846 PII--HYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYG 903
I+ +V I+DF +A+ + + + Q I + APE + GR + + DV+S+G
Sbjct: 132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFG 190
Query: 904 IMLMETFT-GKKP 915
I+L E T G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 44/222 (19%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFH---------QRYERALKSFQDECEVM 776
++ K L+G GSFGSVY+ G +AVK R L + E ++
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------NIMI 830
K ++H N+V+ + + + D + +EY+P GS+ +L+ + N +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSV-------AALLNNYGAFEETLVRNFVR 113
Query: 831 DVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQT-- 876
+ L YL H+ IIH + ISDF I+K L + LS +T
Sbjct: 114 QILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA-NSLSTKTNGAR 169
Query: 877 ---LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
++ +MAPE Q + + D++S G +++E TGK P
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 52/193 (26%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ VA+K + + ++F E +VMK++RH LV++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEY---LHFGH------ 843
+ ++ EYM GSL + L L + Q +++ +A + Y +++ H
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 131
Query: 844 STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYG 903
+ + +V ++DF +A+ + + + Q I + APE + GR + + DV+S+G
Sbjct: 132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFG 190
Query: 904 IMLMETFT-GKKP 915
I+L E T G+ P
Sbjct: 191 ILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGME----VAVKVFHQRYERALK--SFQDE 772
EL + RF + LG +FG +Y L GM+ VA+K + + FQ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQE 57
Query: 773 CEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY--------------SGTC 818
+M + H N+V ++ + + ++ EY+ G L L GT
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 819 M--LDIFQRLNIMIDVALALEYL--HF-------GHSTPIIHYMVAHISDFSIAKFLNGQ 867
LD L+I I +A +EYL HF + I + ISD +++ +
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSL 926
D +Q ++L I +M PE + G+ S+ D++S+G++L E F+ G +P + G
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----YYG---- 229
Query: 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
S EVI+ + + + E + +L TEC E P +R ++I
Sbjct: 230 ---------FSNQEVIE---MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277
Query: 987 TGL 989
T L
Sbjct: 278 TRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 734 LGIGSFGSVY--VARLQDG-MEVAVKVFHQRYERALK-SFQDECEVMKRIRHRNLVKIIS 789
LG G+FG V V +++ ++VA+KV E++++ E E+M ++ + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH--- 843
C + L+ME G L L + + + +M V++ ++YL +F H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 844 ---STPIIHYMVAHISDFSIAKFLNGQDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
+ +++ A ISDF ++K L D ++ + + APE + S+R DV
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 900 YSYGIMLMETFT-GKKP 915
+SYGI + E F+ G+KP
Sbjct: 182 WSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 63/305 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQ-RYERALKSFQDECEVMKR 778
DR + LG G+FG V A VAVK+ E+ L E E+MK
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 779 I-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL---------YSGTCMLDIFQRL-- 826
I +H+N++ ++ C+ + +++EY +G+L + L S + L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 827 ----NIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870
+ VA +E+L S IH +A I+DF +A+ ++ D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 871 SMQTQTLATIGYMAPEYGVQGRVST-RGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSR 928
T + +MAPE + RV T + DV+S+G++L E FT G P I + EL
Sbjct: 189 RKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 244
Query: 929 WVNDLLPISVMEVIDTNLLSGEERYFAAKEQSL-LSILNLATECTIESPGKRINAREIVT 987
LL +E Y K Q+ + +L +C E P +R +++V
Sbjct: 245 ---KLL---------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
Query: 988 GLLKI 992
L ++
Sbjct: 287 DLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 730 KNNLLGIGSFGSVYVAR-LQDGMEVAVK-VFHQR-----YERALKSFQDECEVMKRIRHR 782
K LG G+F S Y AR ++ G +AVK V + R E +++ + E +M R+ H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR---LNIMIDVALALEYL 839
++++++ A D L +E+M GS+ + L F+ +N + L YL
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL 119
Query: 840 HFGHSTPIIHYMVA-------------HISDFSIAKFLN----GQDQLSMQTQTLATIGY 882
H IIH V I+DF A L G + Q Q L TI +
Sbjct: 120 ---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQLLGTIAF 174
Query: 883 MAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP 915
MAPE ++G R DV+S G +++E T K P
Sbjct: 175 MAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 728 FSKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRYERALKSFQDECEVMKRIRHR 782
F ++G G+FG V + + +D M+ K + ++++ +E +++ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHP 60
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
LV + + +++ L+++ + G L L + + + ++ LALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH-- 117
Query: 843 HSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
S IIH + HI+DF+IA + T T T GYMAPE +
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
S D +S G+ E GK+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 52/193 (26%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ +VA+K + ++F E ++MK++RH LV + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEY---LHFGH------ 843
+ ++ E+M GSL + L G L + Q +++ +A + Y +++ H
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 844 STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYG 903
+ + +V I+DF +A+ + + + Q I + APE + GR + + DV+S+G
Sbjct: 132 NILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFG 190
Query: 904 IMLMETFT-GKKP 915
I+L E T G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 22/197 (11%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQ--RYERALKSFQDECEVMKRIRHRNLVKIISAC 791
LG G FG V++ + + ++VA+K ++ E + F +E +VM ++ H LV++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM 851
+ ++ E+M NG L N L L L++ DV +EYL IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRD 125
Query: 852 VA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
+A +SDF + +++ D+ + + + + PE + S++ DV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 900 YSYGIMLMETFT-GKKP 915
+S+G+++ E FT GK P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 730 KNNLLGIGSFGSVYVARLQD-GMEVAVKVFH-----QRYERALKSFQDECEVMKRIRHRN 783
+ LLG G+FG VY+ D G E+AVK ++ + + + E +++K ++H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR-LNIMIDVALALEYLHFG 842
+V+ +D+ ++ MEYMP GS++++L + + + R I LE + +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-----LEGVEYL 120
Query: 843 HSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIG---YMAPE- 886
HS I+H + DF +K L Q S T + G +M+PE
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSPEV 178
Query: 887 -----YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
YG + DV+S G ++E T K P
Sbjct: 179 ISGEGYG------RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 732 NLLGIGSFGSVY--VARLQDG----MEVAVKVFHQRYERALKS-FQDECEVMKRIRHRNL 784
LG G+FG VY + R +DG ++VAVK + +S F E +M + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLY---------SGTCMLDIFQRLNIMIDVALA 835
V++I + +++E M G L++ L S M D+ L DVA
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKG 128
Query: 836 LEYLHFGHSTPIIHY---------------MVAHISDFSIAKFLNGQDQLSMQTQTLATI 880
+YL H IH VA I+DF +A+ + + + I
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 881 GYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
+M PE + G +++ DV+S+G++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 24/198 (12%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERAL-KSFQDECEVMKRIRHRNLVKIISAC 791
LG G+ G V + G +AVK A+ K E +++ + +V A
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 792 SNDDFKALIMEYMPNGSLEN--RLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
N+ ++ MEYM GSL+ + G I + I + V L YLH H IIH
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124
Query: 850 -------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRG 897
+V + DF ++ L S+ + T YMAPE S +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 898 DVYSYGIMLMETFTGKKP 915
D++S G+ L+E TG+ P
Sbjct: 181 DIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 13/193 (6%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ + +VAVK + ++++F +E +MK ++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 794 DDFKALIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALAL----EYLH---FGH 843
++ +I EYM GSL + L S G +L + I +A Y+H
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 132
Query: 844 STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYG 903
+ + ++ I+DF +A+ + ++ + + I + APE G + + DV+S+G
Sbjct: 133 NVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 904 IMLMETFT-GKKP 915
I+L E T GK P
Sbjct: 192 ILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 43/238 (18%)
Query: 726 DRFSKNNLLGIGSFGSVYVA--------RLQDGMEVAVKVFHQR-YERALKSFQDECEVM 776
D+ + LG G FG V +A + ++ + VAVK+ E+ L E E+M
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 777 KRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL-----------YSGTCMLD--- 821
K I +H+N++ ++ AC+ D +I+EY G+L L Y + D
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 822 IFQRL-NIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868
F+ L + VA +EYL S IH +A I+DF +A+ +N D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVST-RGDVYSYGIMLMETFT-GKKPTDEIFIGEL 924
T + +MAPE + RV T + DV+S+G+++ E FT G P I + EL
Sbjct: 192 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 48/219 (21%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVK 786
F LG GS+GSVY A + G VA+KV E L+ E ++K+ +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN----------IMIDVALAL 836
+ + ++MEY GS+ DI + N I+ L
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 837 EYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM-QTQTLATIG-- 881
EYLH IH + A ++DF ++ GQ +M + T+ IG
Sbjct: 113 EYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVS----GQLTDTMAKRNTV--IGTP 163
Query: 882 -YMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEI 919
+MAPE + + + D++S GI +E GK P +I
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 728 FSKNNL-----LGIGSFGSVYVA------RLQDGMEVAVKVF----HQRYERALKSFQDE 772
F +NNL LG G+FG V A + M+VAVK+ H AL S E
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88
Query: 773 CEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMI 830
++M + H N+V ++ AC+ +I EY G L N L L + L+
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 831 DVALALEYLHF---------GHSTPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIG 881
VA + +L + + H + I DF +A+ + ++ +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
+MAPE + DV+SYGI+L E F+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 733 LLGIGSFGSV----YVARLQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKI 787
LG GSFG V + + VAVK + + F E +M + H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLY-SGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 846
++ E P GSL +RL I + + +A + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 847 IIHYMVA------------HISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
IH +A I DF + + L +D M+ + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
S DV+ +G+ L E FT G++P
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 43/278 (15%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIRHRN 783
++ K ++G G+FG V++ R D V +K Q + + Q+EC+V+K + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 842
+++ D ++MEY P G+L + +LD L+ + + LAL ++
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV--- 117
Query: 843 HSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
H+ I+H MV I DF I+K L+ + S + T Y++PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SKAYTVVGTPCYISPELCE 174
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949
+ + D+++ G +L E + K+ + LP V++++
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE-------------AANLPALVLKIMSGTFAPI 221
Query: 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987
+RY Q +LS+LNL P KR +I+
Sbjct: 222 SDRYSPDLRQLILSMLNL-------DPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 63/295 (21%), Positives = 111/295 (37%), Gaps = 57/295 (19%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRYERALKS-FQDECEVMKRIR 780
+ + +G G FG VY + VAVK +++ F E +M++
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSL-------ENRLYSGTCMLDIFQRLNIMIDVA 833
H ++VK+I + ++ ++ME P G L + L + +L +Q ++
Sbjct: 66 HPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ-------LS 117
Query: 834 LALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIG 881
AL YL S +H +A + DF ++++L + L I
Sbjct: 118 TALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-IK 173
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVME 940
+MAPE R ++ DV+ +G+ + E G KP + V + I +E
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVIGRIE 222
Query: 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995
+GE ++ +L T+C P KR E+ L I
Sbjct: 223 -------NGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 727 RFSKNNLLGIGSFGSVYVA---RLQDGME--------------VAVKVFHQRY-ERALKS 768
F + LG G FG V++ LQD E VAVKV + A +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 769 FQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY------SGTCM--- 819
F E +++ R+ N+ +++ C+ D +IMEYM NG L L SG
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 820 -LDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866
L L + +A + YL S +H +A I+DF +++ L
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
D +Q + I +MA E + G+ +T+ DV+++G+ L E T
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVF-----HQRYERALKSFQDECEVMKRIR 780
R+ K LLG GSFGSVY L DG AVK Q + A+K + E ++ +++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H N+V+ + +D + +E +P GSL L + L LEYL
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYL- 118
Query: 841 FGHSTPIIHYMV--AHI----------SDFSIAKFLNGQDQLSMQTQTLATIG---YMAP 885
H +H + A+I +DF +AK Q+ + + G +MAP
Sbjct: 119 --HDRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP 170
Query: 886 EYGV-QGRVSTRGDVYSYGIMLMETFTGKKP 915
E QG D++S G ++E TGK P
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 66/240 (27%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 724 ATDRFSKNNLLGIGSFGSVYVARLQDGME---------VAVKVFHQ-RYERALKSFQDEC 773
DR LG G FG V +A G++ VAVK+ E+ L E
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74
Query: 774 EVMKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL-----------YSGTC--- 818
E+MK I +H+N++ ++ AC+ D +I+EY G+L L Y+ T
Sbjct: 75 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 819 -MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865
L ++ VA +EYL S IH +A I+DF +A+ ++
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGEL 924
D T + +MAPE + + DV+S+G++L E FT G P + + EL
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 43/220 (19%)
Query: 733 LLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKI 787
++G GSF +V +A+ + E A+K+ +R E+ +K + E EV+ R+ H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 788 ISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 846
+++ ++EY PNG L + G+ LD ++ LALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH---SKG 122
Query: 847 IIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIG------------- 881
IIH M I+DF AK L+ + + AT
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDP-NSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 882 ------YMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
Y++PE + D+++ G ++ + TGK P
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 733 LLGIGSFGSVYVARL-QDGME---VAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKI 787
++G G FG V RL G VA+K Y E+ + F E +M + H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH- 843
+ +I E+M NG+L++ L + Q + ++ +A ++YL ++ H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130
Query: 844 -----STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLA-----TIGYMAPEYGVQGRV 893
+ + +V +SDF +++FL +D S T T + I + APE +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
++ DV+SYGI++ E + G++P
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 721 LLQATDRFSKNNLLGIGSFGSVYVAR-LQDG----MEVAVKVFHQRYE-RALKSFQDECE 774
+L+ T+ F K +LG G+FG+VY + +G + VA+K + +A K DE
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 775 VMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIM 829
VM + + ++ +++ C + LI + MP G L E++ G+ L LN
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 115
Query: 830 IDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877
+ +A + YL ++H +A I+DF +AK L ++
Sbjct: 116 VQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELS 925
I +MA E + + + DV+SYG+ + E T G KP D I E+S
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 44/277 (15%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
++++ +G G+ G+VY A + G EVA+K + + + + +E VM+ +H N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ + D ++MEY+ GSL + + + TCM D Q + + ALE+LH S
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCM-DEGQIAAVCRECLQALEFLH---SN 134
Query: 846 PIIHYMVAHISDFSIAKFLNGQDQL-------------SMQTQTLATIGYMAPEYGVQGR 892
+IH I +I ++G +L S ++ + T +MAPE +
Sbjct: 135 QVIH---RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 893 VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952
+ D++S GIM +E G+ P ++N+ P+ + +I TN G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP-------------YLNE-NPLRALYLIATN---GTPE 234
Query: 953 YFAAKEQSLL--SILNLATECTIESPGKRINAREIVT 987
++ S + LN E +E KR +A+E++
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVE---KRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 56/234 (23%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 728 FSKNNL-----LGIGSFGSVYVARLQDGME------VAVKVFHQRYERALKS-FQDECEV 775
F ++NL LG G FG V++A+ + E V VK + + L+S F+ E ++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRL--------YSGTCMLDIFQRLN 827
+++ H+N+V+++ C + +I+EY G L+ L L Q++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 828 IMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875
+ +AL +++L +H +A +S S++K + + ++
Sbjct: 122 LCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-N 177
Query: 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP----TDEIFIGEL 924
L + ++APE + ST+ DV+S+G+++ E FT G+ P +DE + L
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVK--VFHQR----YERALKSFQDECEVMKRIRH 781
++K +LG G++G+VY G +AVK E+ + Q+E +++K ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLH 840
N+V+ + C +D+ ++ ME++P GS+ + L G +F + I L+ +
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-----LDGVA 116
Query: 841 FGHSTPIIH---------YM---VAHISDFSIAKFL-----NGQDQLSMQTQTLATIGYM 883
+ H+ ++H M + + DF A+ L +G +M T +M
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS-NMLKSMHGTPYWM 175
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
APE + + D++S G + E TGK P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 26/67 (38%), Positives = 46/67 (68%)
Query: 68 HKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQ 127
+ +N+SG +++G IPP LG+++SLE LDLS+N +G+IP S+ + +L++L+ N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 128 LFGSLSS 134
L G + +
Sbjct: 502 LSGRVPA 508
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 1/94 (1%)
Query: 144 GIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSG 203
G+ L G +P +I K L +L+ + L N G IP +L LE L L +N+ +G
Sbjct: 422 GLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 204 AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLP 237
+IP+ +G LT L+ + LN N L G +P +G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 727 RFSKNNLLGIGSFGSVYVA--------RLQDGMEVAVKVFHQR-YERALKSFQDECEVMK 777
R + LG G FG V +A + + VAVK+ ++ L E E+MK
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 778 RI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL---------YS-GTCMLD----I 822
I +H+N++ ++ AC+ D +++EY G+L L YS TC L
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 823 FQRL-NIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869
F+ L + VA +EYL S IH +A I+DF +A+ ++ D
Sbjct: 133 FKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVST-RGDVYSYGIMLMETFT-GKKPTDEIFIGEL 924
T + +MAPE + RV T + DV+S+G++L E FT G P I + EL
Sbjct: 190 YKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 61/216 (28%)
Query: 734 LGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQ---DECEVMKRIRHRNLVKIIS 789
LG GSFG V + R + + A+K+ + LK + +E +++ IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 790 ACSNDDFKALIMEYMPNGSL------ENRLYSGTCMLDIFQRLNIMIDVALALEYLH--- 840
+ +D L+MEY+P G L R Q V LALEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-------VVLALEYLHSLD 121
Query: 841 ---------------FGHSTPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMA 884
G+ I+DF AK + G +T TL T Y+A
Sbjct: 122 IVYRDLKPENLLLDSDGYIK---------ITDFGFAKRVKG------RTYTLCGTPEYLA 166
Query: 885 PEYGVQGRVSTRG-----DVYSYGIMLMETFTGKKP 915
PE + ++G D ++ GI++ E G P
Sbjct: 167 PEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGME------------------VAVKVFHQRYER-AL 766
R + LG G FG V++ + GME VAVK+ + + A
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63
Query: 767 KSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL---------ENRLYSGT 817
F E ++M R++ N++++++ C D +I EYM NG L +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 818 CMLDIFQRLNIM-IDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864
+ + L M +A ++YL S +H +A I+DF +++ L
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 865 NGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
D +Q + + I +M+ E + G+ +T DV+++G+ L E T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 47/203 (23%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 729 SKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRN 783
+K ++G G FG V+ L+ + VA+K Y E+ + F E +M + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---H 840
++++ + +I EYM NG+L+ L +Q + ++ +A ++YL +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 841 FGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQ-TLATIGYMAPEYGVQGRV 893
+ H + + + +SDF +++ L + + T I + APE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
++ DV+S+GI++ E + G++P
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 49/290 (16%)
Query: 734 LGIGSFGSVYVARL-----QDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G FG V + R G +VAVK + + + E E+++ + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 788 ISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
C+ D LIME++P+GSL+ L +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSR 128
Query: 846 PIIHYMVA------------HISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +A I DF + K + ++ +++ + + + APE +Q +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 893 VSTRGDVYSYGIMLMETFT----GKKPTDEIFI------GELSLSRWVNDLLPISVMEVI 942
DV+S+G+ L E T P G+++++R V V+E
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR------VLE-- 240
Query: 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
E + + L +C P KR + ++ G I
Sbjct: 241 -------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 728 FSKNNLLGIGSFGSVY-VARLQDGMEVAVK-VFHQRYERALKSFQ-DECEVMKRIRHRNL 784
F N +G GSFG V+ V R D A+K + + R + DE V+ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRL--YSGTCMLDIFQRLNIMIDVALALEYLHFG 842
++ + + ++MEY NG L L G + + Q I + L L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED-QVWRFFIQILLGLAHL--- 117
Query: 843 HSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
HS I+H Y I D +AK L+ + T + T Y++PE
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA-NT-IVGTPYYLSPELCED 175
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTD 917
+ + DV++ G++L E TGK P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 732 NLLGIGSFGSVYVARL-QDG--MEVAVKVFHQRYERA-LKSFQDECEVMKRI-RHRNLVK 786
+++G G+FG V AR+ +DG M+ A+K + + + F E EV+ ++ H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 787 IISACSNDDFKALIMEYMPNGSLENRL---------------YSGTCMLDIFQRLNIMID 831
++ AC + + L +EY P+G+L + L S L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 832 VALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGY 882
VA ++YL F H + + VA I+DF +++ GQ+ +T + +
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRW 189
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLME 908
MA E +T DV+SYG++L E
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+ F+ +G GSFG VY A + VA+KV L+ +DE E +++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDIQQ-----E 49
Query: 785 VKIISACSN-----------DDFK-ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDV 832
++ +S C + K +IMEY GS + L G LD I+ +V
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREV 107
Query: 833 ALALEYLHFGHSTPIIHYMV--AHI----------SDFSIAKFLNGQDQLSMQTQTLATI 880
L LEYLH IH + A+I +DF ++ L T + T
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNT-FVGTP 162
Query: 881 GYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+MAPE Q + D++S GI +E G+ P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRYERALKS-FQDE 772
E+ +T RF + LG FG VY L + VA+K + E L+ F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 773 CEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR------- 825
+ R++H N+V ++ + + ++I Y + L L + D+
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 826 --------LNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865
++I+ +A +E+L H ++H +A ISD + + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
D + +L I +M+PE + G+ S D++SYG++L E F+ G +P
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 45/228 (19%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFH----------QRYERALKSFQDECEV 775
++ K L+G G++G VY+A + G +AVK R + +K+ + E E
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTC--MLDIFQRLNIMIDVA 833
+K + H N+V+ + + +++ ++ +EY+P GS+ G+C F+ +
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI------GSCLRTYGRFEEQLVRFFTE 115
Query: 834 LALEYLHFGHSTPIIHY------------MVAHISDFSIAK-----FLNGQDQLSMQTQT 876
LE L + HS I+H + ISDF I+K + N Q+ +SMQ
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-MSMQ--- 171
Query: 877 LATIGYMAPE--YGVQGRVSTRGDVYSYGIMLMETFTGKKP--TDEIF 920
++ +MAPE + S + D++S G +++E F G++P +E
Sbjct: 172 -GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 733 LLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKI 787
++G G FG V RL+ + VA+K Y E+ + F E +M + H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH---FGH- 843
+ ++ EYM NGSL+ L + Q + ++ +A ++YL + H
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130
Query: 844 -----STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQ-TLATIGYMAPEYGVQGRVSTRG 897
+ + +V +SDF +++ L + + T+ I + APE + ++
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 898 DVYSYGIMLMETFT-GKKP 915
DV+SYGI++ E + G++P
Sbjct: 191 DVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 734 LGIGSFGSVYVARLQDGME---------------VAVKVFHQRYER-ALKSFQDECEVMK 777
LG G FG V++ + E VAVK+ + A F E ++M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN---------- 827
R+++ N+++++ C +DD +I EYM NG L N+ S + F N
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANNIPSVSIANL 131
Query: 828 --IMIDVALALEY---LHFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQT 876
+ + +A ++Y L+F H + + ++ I+DF +++ L D +Q +
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
+ I +MA E + G+ +T DV+++G+ L E FT
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 31/89 (34%), Positives = 53/89 (59%)
Query: 191 LEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLV 250
++GL L L G IP +I L L+ I L+ N +RG IP +G++ L L L+ N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 251 GVVPFTIFNMSTLKKLSLLENTLWGSLPS 279
G +P ++ +++L+ L+L N+L G +P+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 32/89 (35%), Positives = 49/89 (55%)
Query: 402 GKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAK 461
G IP IS L +L ++L GN + G+IP + + +L+ L L++N SIP+ + L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLRALY 490
L L L+GN SG +P+ G RA +
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASF 520
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 266 LSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGF 325
L L L G +P+ I L +++ +NL N GNIP S+ + + L V L NSF+G
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 326 IPNTIGNLRNLEFLNIADNYLTSSTP 351
IP ++G L +L LN+ N L+ P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKIISAC 791
+G+G+ VY A L + +VA+K ++ + ++ + E + M + H N+VK ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN------------IMIDVALALEYL 839
D L+M Y+ GS +LDI + ++ +V LEYL
Sbjct: 69 VVGDELWLVMPYLSGGS----------LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 840 H-FGHSTPIIHYMV------------AHISDFSIAKFL--NGQDQLSMQTQTLATIGYMA 884
H G IH + I+DF ++ L G ++ + T +MA
Sbjct: 119 HSNGQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 885 PEYGVQGRVST-RGDVYSYGIMLMETFTGKKP 915
PE Q + D++S+GI +E TG P
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 20/196 (10%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++ +VA+K Q + ++F E +MK+++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIH--- 849
+ +I EYM NGSL + L + + L I + +++ +A + ++ + IH
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 850 ----YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVY 900
+V+ I+DF +A+ + ++ + + I + APE G + + DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 901 SYGIMLMETFT-GKKP 915
S+GI+L E T G+ P
Sbjct: 188 SFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 29/76 (38%), Positives = 45/76 (59%)
Query: 179 GKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPY 238
G IP+ +SK + L+ + L N++ G IP +G++T L+ + L+ N G IP+ +G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 239 LVRLTLATNNLVGVVP 254
L L L N+L G VP
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRH---R 782
+ + L+G G++G+VY + + G VA+K+ + + + Q E ++ ++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
N+ K + +IMEY GS+ + +G + + + + I+ +V +AL+Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISV-IIREVLVALKYIH-- 118
Query: 843 HSTPIIHYMV--AHI----------SDFSIAKFLNGQDQLSMQTQTLATIGY-MAPEYGV 889
+IH + A+I DF +A LN Q S + T Y MAPE
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVIT 174
Query: 890 QGRV-STRGDVYSYGIMLMETFTGKKP 915
+G+ T+ D++S GI + E TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V++A +VAVK + ++++F E VMK ++H LVK+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIH--- 849
+ +I E+M GSL + L S Q L +ID + + E + F IH
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 850 ---------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVY 900
+V I+DF +A+ + + + + I + APE G + + DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 187
Query: 901 SYGIMLMETFT-GKKP 915
S+GI+LME T G+ P
Sbjct: 188 SFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-10
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 748 QDGMEVAVKVF---HQRYERALKSFQDECEVMKRIRHRNLVKII-SACSNDDFKALIMEY 803
G EVA+K+ E F+ E + R+ H N+V ++ S + + EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMV---- 852
+P +L L + L + +M+ V L+ L H+ I+H MV
Sbjct: 61 VPGRTLREVL-AADGALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 853 ----AHISDFSIAKFLNG-----QDQLSMQTQTLATIGYMAPEYGVQGR---VSTRGDVY 900
A + DF I L G L+ T+ L T Y APE Q R V+ D+Y
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE---QLRGEPVTPNSDLY 173
Query: 901 SYGIMLMETFTGK 913
++G++ +E TG+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 732 NLLGIGSFGSVYVARLQ-DG--MEVAVKVFHQ-RYERALKSFQDECEVMKRI-RHRNLVK 786
+++G G+FG V A ++ DG M A+K+ + E + F E EV+ ++ H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 787 IISACSNDDFKALIMEYMPNGSLEN---------------RLYSGTCMLDIFQRLNIMID 831
++ AC N + + +EY P G+L + + + L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 832 VALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGY 882
VA ++YL F H + + + + I+DF +++ G++ +T + +
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVRW 184
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLME 908
MA E +T+ DV+S+G++L E
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 26/205 (12%)
Query: 734 LGIGSFGSVY-VARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISA 790
+G GSFG+V V R DG + K E+ + E +++ ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 791 CSNDDFKAL--IMEYMPNGSLEN---RLYSGTCMLDIFQRLNIMIDVALALEYLHFGH-- 843
+ + L +MEY G L + ++ I+ + LAL H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQT-LATIGYMAPEYGVQ 890
++H + DF +AK L S +T + T YM+PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYVGTPYYMSPEQLNH 184
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
+ D++S G ++ E P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 725 TDRFSKNNLLGIGSFGSVYVA-RLQDG----MEVAVKVFHQRYERALKSFQ---DECEVM 776
K LLG G FG+V+ + +G + VA+K R R ++FQ D M
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAM 63
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
+ H +V+++ C + L+ + P GSL + + LD + LN + +A +
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122
Query: 837 EYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
YL ++H +A I+DF +A L D+ ++ I +MA
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
E + GR + + DV+SYG+ + E + G +P
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-09
Identities = 25/60 (41%), Positives = 37/60 (61%)
Query: 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
NL+ L L+NNRL +F GL +L++LDLS N ++ + P + L L+ L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 9/119 (7%)
Query: 288 VEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
++ L L G IP+ I+ L L GNS G IP ++G++ +LE L+++ N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 348 SSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFN----CRISG 402
S PE SL +R+L L GN L G +P+++G + F + C I G
Sbjct: 480 GSIPE-----SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 721 LLQATDRFSKNNLLGIGSFGSVYVA-RLQDG----MEVAVKVFHQRY-ERALKSFQDECE 774
+L+ T+ + +LG G+FG+VY + +G + VA+K+ ++ +A F DE
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 775 VMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIM 829
+M + H +LV+++ C + + L+ + MP+G L E++ G+ +L LN
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWC 115
Query: 830 IDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877
+ +A + YL ++H +A I+DF +A+ L G ++
Sbjct: 116 VQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEI 919
I +MA E + + + DV+SYG+ + E T G KP D I
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 734 LGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
LG G+FG VY A+ ++ G A KV + E L+ + E E++ H +VK++ A
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDI---FQRLNIMIDVALALEYLHFGHSTPIIH 849
D +++E+ P G+++ ML++ I + LE L + HS IIH
Sbjct: 80 WDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 850 -------YMVAHISDFSIAKF-LNGQDQLSMQTQT--LATIGYMAPEYGV-----QGRVS 894
++ D +A F ++ ++ ++Q + + T +MAPE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 895 TRGDVYSYGIMLMETFTGKKPTDEI 919
+ D++S GI L+E + P E+
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
RF K +G G+ G+VY A + G EVA++ + + + + +E VM+ ++ N+V
Sbjct: 24 RFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ + D ++MEY+ GSL + + + TCM D Q + + ALE+LH S
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCM-DEGQIAAVCRECLQALEFLH---SN 135
Query: 846 PIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+IH + ++DF + + S ++ + T +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 894 STRGDVYSYGIMLMETFTGKKP 915
+ D++S GIM +E G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
++++ +G G+ G+V+ A + G EVA+K + + + + +E VMK +++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ + D ++MEY+ GSL + + + TCM D Q + + ALE+L H+
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCM-DEAQIAAVCRECLQALEFL---HAN 134
Query: 846 PIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+IH + ++DF + + S ++ + T +MAPE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 192
Query: 894 STRGDVYSYGIMLMETFTGKKP 915
+ D++S GIM +E G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 72/214 (33%), Positives = 105/214 (49%), Gaps = 31/214 (14%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+ L+NL LDL N +T P+ NL+ L L+ NK+ S+P + +L L L L
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDL 170
Query: 468 HGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
N S +P NL++L L L N+ + LP I L + D+S+NS+
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII------ 222
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDL 587
++ ++ LKNL L L+NN+LE +PES LS+LE LDL
Sbjct: 223 -------------------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL 262
Query: 588 SKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621
S N+IS +SL L L++L+LS N L +P
Sbjct: 263 SNNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 26/203 (12%)
Query: 730 KNNLLGIGSFGSVYVARLQ-----DGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRN 783
K +LG G FG V + G VAVK + + S ++ E ++K + H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 784 LVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+VK CS K LIMEY+P GSL R Y L++ Q L + + YLH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSL--RDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 842 GHSTPIIHYMVA------------HISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYG 888
H IH +A I DF +AK + G + ++ + + + A E
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 889 VQGRVSTRGDVYSYGIMLMETFT 911
+ + S DV+S+G+ L E T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 60/249 (24%)
Query: 698 SITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVK 756
S + SS+ + S EL +R N +G G+ G+VY + G A+K
Sbjct: 53 SSSSSSSSSASGSAPSAAKSLSEL----ERV---NRIGSGAGGTVYKVIHRPTGRLYALK 105
Query: 757 VFHQRYERALK-SFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLEN-RLY 814
V + +E ++ E E+++ + H N+VK ++ +++E+M GSLE +
Sbjct: 106 VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 815 SGTCMLDI-FQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIA 861
+ D+ Q L+ + YLH H I+H + I+DF ++
Sbjct: 166 DEQFLADVARQILS-------GIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 862 KFLNGQDQLSMQT-----QTLATIGYMAPEYGVQGRVST----------RGDVYSYGIML 906
+ L QT ++ TI YM+PE R++T GD++S G+ +
Sbjct: 216 RILA-------QTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSI 263
Query: 907 METFTGKKP 915
+E + G+ P
Sbjct: 264 LEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 36/127 (28%), Positives = 60/127 (47%), Gaps = 28/127 (22%)
Query: 220 LNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPS 279
L++ LRG IP ++ L +L + L+ N++ G +P ++ ++++L
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL---------------- 468
Query: 280 RIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN--LRNLE 337
E L+L N F+G+IP S+ + L + L GNS SG +P +G L
Sbjct: 469 ---------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519
Query: 338 FLNIADN 344
F N DN
Sbjct: 520 F-NFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 58 WIGITCGVNSHK----VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF 113
W G C +S K + L + L+G IP + L L++++LS N + GNIP S+
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 114 NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPA 158
++ +L++LD N GS+ + ++S+ ++L+ N SG +PA
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 731 NNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLV 785
++G G FG V RL+ ++VA+K ++ F E +M + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL------ 839
++ + +I EYM NGSL+ L + Q + ++ +A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 840 HFGHSTPII---HYMVAHISDFSIAKFLNGQDQLSMQTQTLATIG------YMAPEYGVQ 890
H + I +V +SDF +++ L + T T G + APE
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA------TYTTKGGKIPIRWTAPEAIAY 182
Query: 891 GRVSTRGDVYSYGIMLMETFT-GKKP 915
+ ++ DV+S+GI++ E + G++P
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
+G GS G V +AR + G +VAVK+ R ++ + +E +M+ +H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV 852
+ ++ME++ G+L + + L+ Q + V AL YLH S +IH
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIH--- 140
Query: 853 AHISDFSIAKFLNGQDQLS-------------MQTQTLATIGYMAPEYGVQGRVSTRGDV 899
I SI L+G+ +LS + + T +MAPE + T D+
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 900 YSYGIMLMETFTGKKP 915
+S GIM++E G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 74/306 (24%), Positives = 116/306 (37%), Gaps = 72/306 (23%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR 782
+++ ++G G++G V R + G VA+K F + E K+ E +V++++RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLE------NRLYSGTCMLDIFQRLNIMIDVALAL 836
N+V + A L+ EY+ LE L I+Q L A+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ-------AI 113
Query: 837 EYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
Y HS IIH V + DF A+ L + + T +AT Y A
Sbjct: 114 AYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRA 169
Query: 885 PE-------YG--VQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE-----LSLSRWV 930
PE YG V DV++ G ++ E G+ +F G+ L L +
Sbjct: 170 PELLVGDTNYGKPV--------DVWAIGCIMAELLDGEP----LFPGDSDIDQLYLIQKC 217
Query: 931 NDLLPISVMEVIDTN-LLSGE-----------ERYFAAKEQSLLSILNLATECTIESPGK 978
LP S E+ +N +G ER + K S L+ C P +
Sbjct: 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA--LDFLKACLRMDPKE 275
Query: 979 RINARE 984
R+ E
Sbjct: 276 RLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 25/80 (31%), Positives = 46/80 (57%)
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
+P+ I L+ + ++S NS+ G + +G++ + L+LS N+ +G IP ++G L +L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 560 KLFLANNRLEGPIPESFSGL 579
L L N L G +P + G
Sbjct: 494 ILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 32/88 (36%), Positives = 47/88 (53%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
L L L G IP S+L +LQ + L+ N + +IP + + L+ L L N F+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTI 504
P G LTSLR L L N + +P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRN 783
R+ +G GSFG +Y+A+ + D +K + + ++ + E ++ +++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+V ++ + ++MEY G L R+ + Q L+ + ++L L+++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI--- 117
Query: 843 HSTPIIHY-------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
H I+H MVA + DF IA+ LN D + + + T Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + D++S G +L E T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 55/209 (26%), Positives = 79/209 (37%), Gaps = 29/209 (13%)
Query: 727 RFSKNNLLGIGSFGSVY-VARLQDGMEVAVKVFHQRY----ERALKSFQDECEVMKRIRH 781
F LG GS+GSVY V RL D A+K ER +E ++ + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAVNEIRILASVNH 58
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR---LNIMIDVALALEY 838
N++ A + + ++MEY P G L + + I I + L+
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 839 LHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
L H I+H + I D I+K L +TQ T YMAPE
Sbjct: 119 L---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-GTPHYMAPE 171
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
S + D++S G +L E T P
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
RF K +G G+ G+VY A + G EVA+K + + + + +E VM+ ++ N+V
Sbjct: 23 RFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ + D ++MEY+ GSL + + + TCM D Q + + AL++LH S
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCM-DEGQIAAVCRECLQALDFLH---SN 134
Query: 846 PIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+IH + ++DF + + S ++ + T +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 192
Query: 894 STRGDVYSYGIMLMETFTGKKP 915
+ D++S GIM +E G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 733 LLGIGSFGSVYVARL--QDG--MEVAVKVF----HQRYERALKSFQDECEVMKRIRHRNL 784
+LG G FGSV +L DG ++VAVK H E ++ F E MK H N+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNV 63
Query: 785 VKIISAC----SNDDFKA--LIMEYMPNGSLENRL-YSGTCMLDIF---QRL-NIMIDVA 833
+K+I C S +I+ +M +G L + L YS L Q L M+D+A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 834 LALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIG 881
L +EYL + IH M ++DF ++K + D +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++A E +++ DV+++G+ + E T G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 49/241 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVA--------RLQDGMEVAVKVFHQR-YERALKSFQDECEVM 776
DR LG G FG V A R + VAVK+ ++ L E E+M
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 777 KRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL-----------YSGT------- 817
K I +H+N++ ++ C+ + +I+EY G+L L + T
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 818 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865
D+ ++ VA +EYL S IH +A I+DF +A+ ++
Sbjct: 132 SFKDL---VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVST-RGDVYSYGIMLMETFT-GKKPTDEIFIGE 923
D + + +MAPE + RV T + DV+S+GI++ E FT G P I + E
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244
Query: 924 L 924
L
Sbjct: 245 L 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 55/215 (25%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
+G G++G VY AR + G VA+KV + Q E ++K RH N+V +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN----------IMIDVALALEYLHFG 842
D ++MEY GSL+ DI+Q + + L YL
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYL--- 117
Query: 843 HSTPIIHYMV--AHI----------SDFSIAKFLNGQDQLSMQTQTLAT----IG---YM 883
H T IH + A+I +DF ++ L T T+A IG +M
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPYWM 168
Query: 884 APEYG---VQGRVSTRGDVYSYGIMLMETFTGKKP 915
APE +G + D+++ GI +E + P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 32/206 (15%)
Query: 732 NLLGIGSFGSVYVARLQ-DG--MEVAVKVFHQ-RYERALKSFQDECEVMKRI-RHRNLVK 786
+++G G+FG V AR++ DG M+ A+K + + + F E EV+ ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 787 IISACSNDDFKALIMEYMPNGSLEN---------------RLYSGTCMLDIFQRLNIMID 831
++ AC + + L +EY P+G+L + S L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 832 VALALEYL---HFGH------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGY 882
VA ++YL F H + + VA I+DF +++ GQ+ +T + +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRW 177
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLME 908
MA E +T DV+SYG++L E
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 721 LLQATDRFSKNNLLGIGSFGSVYVA-RLQDG----MEVAVKVFHQRYE-RALKSFQDECE 774
+L+ T+ K +LG G+FG+VY + DG + VA+KV + +A K DE
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 775 VMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIM 829
VM + + +++ C + L+ + MP G L EN+ G+ L LN
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWC 115
Query: 830 IDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877
+ +A + YL ++H +A I+DF +A+ L+ +
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEI 919
I +MA E + R + + DV+SYG+ + E T G KP D I
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
LG G+FG VY A+ + G+ A K+ E L+ F E +++ +H N+V + A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH--- 849
++ +++E+ G+L++ + L Q + + AL +L HS +IH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDL 129
Query: 850 -----YMVAH----ISDFSI-AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVST---- 895
+ ++DF + AK + L + + T +MAPE
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAK---NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 896 -RGDVYSYGIMLMETFTGKKPTDEI 919
+ D++S GI L+E + P E+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
D F K +G GS G V +A G +VAVK R ++ + +E +M+ +H N+
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
V++ S+ D ++ME++ G+L + + + T M + Q + + V AL +LH +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRM-NEEQIATVCLAVLKALSFLH---A 133
Query: 845 TPIIHYMVAHISDFSIAKFLNGQDQLS-----MQTQT--------LATIGYMAPEYGVQG 891
+IH + SD SI +G+ +LS Q + T +MAPE +
Sbjct: 134 QGVIHRDIK--SD-SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 892 RVSTRGDVYSYGIMLMETFTGKKP 915
T D++S GIM++E G+ P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 733 LLGIGSFGSVYVARLQD-GMEVAVKVFHQRYE-----RALKSFQDECEVMKRIRHRNLVK 786
LLG G+FG VY+ D G E+AVK E + + + + E +++K + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 787 IISACSNDDFK---ALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 842
C D + ++ ME+MP GS++++L S G ++ ++ I LE + +
Sbjct: 69 YY-GCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122
Query: 843 HSTPIIHYMV--AHISDFSIAKFLNGQDQLSMQTQTLATIG-----------YMAPEYGV 889
HS I+H + A+I S+ G S + QT+ G +M+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDE 918
+ D++S G ++E T K P E
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 51/223 (22%)
Query: 734 LGIGSFGSVYVARLQDGME-----------------VAVKVFHQRYER-ALKSFQDECEV 775
LG G FG V++ + + + VAVK+ + A F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS----------------GTCM 819
+ R++ N+++++ C ++D +I EYM NG L L S C+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 820 LDIFQR--LNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865
I L++ + +A ++YL S +H +A I+DF +++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLME 908
D +Q + + I +MA E + G+ +T DV+++G+ L E
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 724 ATDRFSKNNLLGIGSFGSVY------VARLQDGMEVAVKVFHQRYE-RALKSFQDECEVM 776
A ++ + + LG GSFG VY V + + VA+K ++ R F +E VM
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS---------GTCMLDIFQRLN 827
K ++V+++ S +IME M G L++ L S + + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 828 IMIDVALALEYLHFGHSTPIIHY-------MVAH-----ISDFSIAKFLNGQDQLSMQTQ 875
+ ++A + YL+ + +H MVA I DF + + + D +
Sbjct: 124 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT 911
L + +M+PE G +T DV+S+G++L E T
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 728 FSKNNLLGIGSFGSVYVA---RLQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
F+K +G GSFG V+ R Q VA+K+ + E ++ Q E V+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+ K + D +IMEY+ GS + L G LD Q I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118
Query: 844 STPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
S IH + ++DF +A L D + + T +MAPE Q
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 892 RVSTRGDVYSYGIMLMETFTGKKPTDEI 919
++ D++S GI +E G+ P E+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 24/198 (12%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISA 790
+G GS+G V + R DG + +K + R R K+ + E +++ +++H N+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 791 CSNDD-FKALIMEYMPNGSLENRL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 847
+D ++M + G L ++L G + + Q + + +A+AL+YLH H I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEKH---I 123
Query: 848 IH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVST 895
+H + + D IA+ L ++Q M + + T YM+PE +
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 896 RGDVYSYGIMLMETFTGK 913
+ DV++ G + E T K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGME-VAVKVFHQRYERALKSFQ---DECEVMKRIRH 781
D + +G G+FG V++ R + A+KV LK Q +E V+K + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIMIDVALAL 836
++++ + F ++MEY+P G L + +S + L F I+ AL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL--FYASEIVC----AL 114
Query: 837 EYLHFGHSTPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTL-ATIGYM 883
EYL HS I++ + HI +DF AK +L +T TL T Y+
Sbjct: 115 EYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYL 165
Query: 884 APEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP 915
APE +Q + + D ++ GI++ E G P
Sbjct: 166 APEV-IQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-08
Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 24/116 (20%)
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA 499
GLGL L IP++I L L + L GN G IP G++TSL L
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---------- 471
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGL 555
D+S NS +G + +G L + LNL+ N+LSG +P +GG
Sbjct: 472 --------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 733 LLGIGSFGSVYVARLQD-GMEVAVKVF-----HQRYERALKSFQDECEVMKRIRHRNLVK 786
LLG G+FG VY+ D G E+AVK Q + + + + E +++K +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 787 IISACSNDDFKAL--IMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 843
+ + K L +EYMP GS++++L + G ++ +R I L+ + + H
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVSYLH 123
Query: 844 STPIIHYMV--AHISDFSIAKFLNGQDQLSMQTQTLATIG-----------YMAPEYGVQ 890
S I+H + A+I S G S + QT+ G +M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDE 918
+ DV+S ++E T K P E
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 728 FSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFH-----QRYERALKSFQDECEVMKRIRH 781
+ + LLG G+FG VY+ D G E+A K + + + + E +++K ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 782 RNLVKIISACSNDDFKAL--IMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEY 838
+V+ + K L MEYMP GS++++L + G + ++ I LE
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI-----LEG 118
Query: 839 LHFGHSTPIIHYMV--AHISDFSIAKFLNGQDQLSMQTQTLATIG-----------YMAP 885
+ + HS I+H + A+I S G S + QT+ G +M+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918
E + DV+S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 63/249 (25%)
Query: 734 LGIGSFGSVYVARLQDGMEV-AVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIIS 789
LG+G FG V + +++ A+K +R+ + E E+++ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID---------VALALEYLH 840
+ + ++MEY G L I + + + V LA EYL
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFEYL- 109
Query: 841 FGHSTPIIH-------YMVAH-----ISDFSIAKFL-NGQDQLSMQTQTL-ATIGYMAPE 886
H+ II+ ++ + DF AK L +GQ +T T T Y+APE
Sbjct: 110 --HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWTFCGTPEYVAPE 162
Query: 887 YGVQGRVSTRG-DVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945
+ + D +S GI+L E TG+ P F + D P+ + I
Sbjct: 163 I-ILNKGYDFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI--- 206
Query: 946 LLSGEERYF 954
L G +
Sbjct: 207 -LKGNGKLE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 734 LGIGSFGSV-YVARLQDGMEVAVKVFHQRYERAL-KSFQDECEVMKRIRHRNLVKIISAC 791
LG G+ GSV V + G +A KV H + ++ K E ++M R +V A
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 792 SNDDFKALIMEYMPNGSLENRLYS--GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
N++ + ME+M GSL+ R+Y G ++I + I + V L YL+ H I+H
Sbjct: 73 LNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMH 127
Query: 850 YMV----------AHIS--DFSIA-KFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTR 896
+ I DF ++ + +N + T T YM+PE G+ + +
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST-----YMSPERIQGGKYTVK 182
Query: 897 GDVYSYGIMLMETFTGKKPTDE 918
DV+S GI ++E GK P
Sbjct: 183 SDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 728 FSKNNLLGIGSFGSVYVA---RLQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
F+K +G GSFG V+ R Q VA+K+ + E ++ Q E V+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+ K + +IMEY+ GS + L +G D FQ ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH--- 118
Query: 844 STPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
S IH + ++DF +A L Q+ T + T +MAPE Q
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNT-FVGTPFWMAPEVIQQS 176
Query: 892 RVSTRGDVYSYGIMLMETFTGKKPTDEI 919
++ D++S GI +E G+ P ++
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 35/198 (17%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRY------ERALKSFQDECEVMKRIRHRNLVK 786
+G G+ G V+ A+ + G VA+K R +AL+ E + ++ +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQ--RLNIMIDVALALEYLHFGHS 844
++ + L+MEYMP L L L Q M+ L+ + + H+
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGVAYMHA 117
Query: 845 TPIIH--------YMVAH----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE--YGVQ 890
I+H + A I+DF +A+ + ++ Q +AT Y APE YG +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR 176
Query: 891 GRVSTRGDVYSYGIMLME 908
+ D+++ G + E
Sbjct: 177 -KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 734 LGIGSFGSVYVARLQDGME------VAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVK 786
LG GSFG VY +D ++ VAVK ++ R F +E VMK ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYS---------GTCMLDIFQRLNIMIDVALALE 837
++ S ++ME M +G L++ L S G + + + + ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 838 YLHFGHSTPIIHY-------MVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
YL+ + +H MVAH I DF + + + D + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFT 911
E G +T D++S+G++L E +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 50/220 (22%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYE------RALKSFQDECEVMKRIRHRNLVK 786
+G G++G VY AR G VA+K R+E AL+ E +++K + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL-------NIMIDVALALEYL 839
++ + L+ E+M + LY ++ QR + + + L +
Sbjct: 63 LLDVFRHKGDLYLVFEFM-----DTDLYK---LIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 840 HFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY 887
HS I+H V ++DF +A+ + T + T Y APE
Sbjct: 115 ---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPEL 169
Query: 888 GVQGRVSTRG-DVYSYGIMLMET------FTGKKPTDEIF 920
+ + + D++S G + E F GK D++F
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 737 GSFGSVYVAR-LQDGMEVAVKVF---HQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
G++G V++A+ G A+KV + + E +++ + + +VK+ +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV 852
L+MEY+P G L + L + + + R + ++ LALEYL HS IIH +
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYL---HSNGIIHRDL 119
Query: 853 ----------AHI--SDFSIAKF------LNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
H+ +DF ++K +N D + + T Y+APE + S
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179
Query: 895 TRGDVYSYGIMLMETFTGKKP-----TDEIF 920
D +S G +L E G P +EIF
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 44/207 (21%)
Query: 733 LLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHRNLVKIIS 789
L+G GS+G V + ++ G VA+K F + + + K E ++K++RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 790 ACSNDDFKALIMEYM-----------PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
L+ E++ PNG E+R+ +FQ L +E+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK-----YLFQILR-------GIEF 115
Query: 839 LHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
HS IIH V + DF A+ L ++ T +AT Y APE
Sbjct: 116 C---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPE 170
Query: 887 YGVQGRVSTRG-DVYSYGIMLMETFTG 912
V R D+++ G ++ E TG
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-07
Identities = 16/40 (40%), Positives = 26/40 (65%), Gaps = 2/40 (5%)
Query: 25 TDQQSLLALKAHISYDPTNLFAKNWTSSTSV-CSWIGITC 63
D+ +LLA K+ ++ DP+ + +W S+S CSW G+TC
Sbjct: 3 DDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-07
Identities = 26/57 (45%), Positives = 32/57 (56%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
L+LS N L+ GL NL+ L L+ N L PE+FSGL SL LDLS N +
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 60/240 (25%), Positives = 93/240 (38%), Gaps = 61/240 (25%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKS-----FQDECEVMKRI 779
D F ++G G+FG V++ R G A+KV R +K + E +++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL--RKSDMIKRNQIAHVRAERDILADA 58
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQ----RLNIMIDVALA 835
+VK+ + +++ L+MEYMP G L N L D+F R I ++ LA
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFYIA-ELVLA 113
Query: 836 LEYLH-FGHSTPIIHYMV----------AHI--SDFSIAK----------FLNGQDQLSM 872
L+ +H G IH + HI +DF + K +LN L
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 873 QTQTLA--------------TIG---YMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ L T+G Y+APE D +S G++L E G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 723 QATDRFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH 781
+ D F K +G GS G V +A G +VAVK R ++ + +E +M+ H
Sbjct: 22 EYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH 78
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
N+V + ++ D ++ME++ G+L + + + T M + Q + + V AL YL
Sbjct: 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNE-EQIATVCLSVLRALSYL-- 134
Query: 842 GHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
H+ +IH + +SDF ++ ++ + + T +MAPE
Sbjct: 135 -HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGTPYWMAPEVIS 191
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE--LSLSRWVNDLLPISVME 940
+ T D++S GIM++E G+ P + E L R + D LP V +
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 734 LGIGSFGSV---YVARLQDGMEVAVKVF-HQRYERALK-SFQDECEVMKRIRHRNLVKII 788
LG G+FG+V + VAVK+ + + ALK E VM+++ + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH-- 843
C + + L+ME G L N+ + ++ V++ ++YL +F H
Sbjct: 63 GICEAESW-MLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 844 ----STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLAT--IGYMAPEYGVQGRVSTRG 897
+ ++ A ISDF ++K L G D+ + +T + + APE + S++
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 898 DVYSYGIMLMETFT-GKKP 915
DV+S+G+++ E F+ G+KP
Sbjct: 180 DVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 46/223 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
D+F +G G++G VY AR +D G VA+K E+ A++ E +++++
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQ 62
Query: 779 IRHRNLVKIISACSND----DFKA------LIMEYMPN---GSLENRLYSGTCMLDIFQR 825
+ HRN+V + ++ DFK L+ EYM + G LE+ L F
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-------FSE 115
Query: 826 LNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873
+I + LE L++ H +H + ++DF +A+ N ++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPY 174
Query: 874 TQTLATIGYMAPEYGV-QGRVSTRGDVYSYGIMLMETFTGKKP 915
T + T+ Y PE + + R DV+S G +L E FT KKP
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 734 LGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
LG G+FG VY A+ ++ G+ A KV + E L+ + E +++ H N+VK++ A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 849
++ +++E+ G+++ ML++ + L I + LE L++ H IIH
Sbjct: 73 YENNLWILIEFCAGGAVD------AVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 850 -------YMVAHISDFSIAKF-LNGQDQLSMQTQT--LATIGYMAPEYGVQGRVST---- 895
+ D +A F ++ ++ ++Q + + T +MAPE V S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV-VMCETSKDRPY 185
Query: 896 --RGDVYSYGIMLMETFTGKKPTDEI 919
+ DV+S GI L+E + P E+
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 7e-07
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 43/217 (19%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD---------ECEVM 776
R+ +G G++G V A + G +VA+K F D E +++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLL 53
Query: 777 KRIRHRNLVK---IISACSNDDFKAL--IMEYMPNGSLENRLYSG-TCMLDIFQRLNIMI 830
+ +RH N++ I+ S +DF + + E M L + S D Q +
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLY 110
Query: 831 DVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQ-DQLSMQTQTL 877
+ L+YLH + +IH +V I DF +A+ ++ D+ T+ +
Sbjct: 111 QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 878 ATIGYMAPE-YGVQGRVSTRGDVYSYGIMLMETFTGK 913
T Y APE R + D++S G + E T K
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-07
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 375 LDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSR 434
L G +P+ I L L+ + I G IP + ++++L +LDL N GSIP + +
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 435 LLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKF 472
L +L+ L L N L+ +P A L +LH F
Sbjct: 489 LTSLRILNLNGNSLSGRVP------AALGGRLLHRASF 520
|
Length = 623 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 734 LGIGSFGSVYVARL-QDG--MEVAVKVFH----QRYERALKSFQDECEVMKRIRHRNLVK 786
LG G FGSV +L QD ++VAVK R E ++ F E MK H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64
Query: 787 IISAC----SNDDFKA--LIMEYMPNGSLEN-RLYS--GTCMLDIFQRL--NIMIDVALA 835
+I C ++ + + +I+ +M +G L + LYS G C + ++ M D+A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 836 LEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
+EYL S IH M ++DF ++K + D + ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
A E +T+ DV+S+G+ + E T G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 8e-07
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 53/213 (24%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKRIRHRNLVK 786
+G G++G VY AR + G VA+K E+ A++ E ++++++RH N+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 787 II----SACSNDDFKALIMEYMP---NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+ S + ++ EYM G L++ Q M + L+YL
Sbjct: 63 LKEIVTSKGKGSIY--MVFEYMDHDLTGLLDSPEVK----FTESQIKCYMKQLLEGLQYL 116
Query: 840 HFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE- 886
HS I+H V ++DF +A+ ++ T + T+ Y PE
Sbjct: 117 ---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPEL 172
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGK 913
YG D++S G +L E F GK
Sbjct: 173 LLGATRYG------PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSL 132
L+++ L+ I L L++L +LDL +N ++ P LK LD DN++ SL
Sbjct: 98 LDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155
Query: 133 SSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLE 192
S + N+ ++ +DLS N S +LP + NL NL L L N +P + LE
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 193 GLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGV 252
L L N++ + + NL L + L++N+L ++P+ +GNL L L L+ N + +
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI 270
Query: 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL 293
+ +++ L++L L N+L +LP L L LNL
Sbjct: 271 SS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNL 309
|
Length = 394 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 728 FSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRYERA--LKSFQDECEVMKRIRH 781
F+ +LG G FGSV A+L+ +VAVK+ + ++ F E MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 782 RNLVKIISACSNDDFKA------LIMEYMPNGSLE-----NRLYSGTCMLDIFQRLNIMI 830
N++K+I K +I+ +M +G L +R+ L + + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 831 DVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLA 878
D+A +EYL S IH M ++DF ++K + D +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ ++A E +T DV+++G+ + E T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 733 LLGIGSFGSVYVARLQ----DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKI 787
+LG G FG + L+ + VA+ ++ + F E + + H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH---FGHS 844
+ + ++ EYM NG+L++ L L Q + ++ +A ++YL + H
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131
Query: 845 TPIIHYMVAHISDFS--IAKFLNGQ-DQLSMQTQTL---ATIGYMAPEYGVQGRVSTRGD 898
H ++ + SD I+ F Q D+ T+ + + + APE S+ D
Sbjct: 132 GLAAHKVLVN-SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD 190
Query: 899 VYSYGIMLMETFT-GKKP 915
V+S+GI++ E + G++P
Sbjct: 191 VWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD---ECEVMKRIRHRNLVKIIS 789
+G GSFG+VY AR ++ VA+K +++ + +QD E ++++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 790 ACSNDDFKA-LIMEYMPNGSLENRLYSGTCMLDI----FQRLNIMIDVALALEYLHFGHS 844
C + A L+MEY L S + +L++ Q + I AL+ L + HS
Sbjct: 82 GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 845 TPIIHYMVAH----ISDFSIAKFLN-GQDQLSMQTQT-LATIGYMAPEYGV---QGRVST 895
IH + +++ K + G L + + T +MAPE + +G+
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 896 RGDVYSYGIMLMETFTGKKP 915
+ DV+S GI +E K P
Sbjct: 194 KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 733 LLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKS----FQDECEVMKRIRHRNLVKII 788
++G G+FG V + R + +V ++E +S F +E ++M +V++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
A +D + ++MEYMP G L N L S + + + R +V LAL+ + HS I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAI---HSMGFI 164
Query: 849 HYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY----GVQGR 892
H V ++DF +N + + T + T Y++PE G G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 893 VSTRGDVYSYGIMLMETFTGKKP 915
D +S G+ L E G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 40/232 (17%)
Query: 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQ---DECEVMKRIRHRN 783
F LG GSFG V +A+ + G A+K +R +K Q E ++ + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 842
+V ++ + +++ ++E++ G L L G D+ + + ++ LA EYL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH--AELVLAFEYL--- 134
Query: 843 HSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYGV 889
HS II+ + ++DF AK ++ +T TL T Y+APE +
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPEV-I 187
Query: 890 QGRVSTRG-DVYSYGIMLMETFTGKKP---------TDEIFIGELSLSRWVN 931
Q + + D ++ G++L E G P ++I G L W +
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 35/205 (17%)
Query: 734 LGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQ---DECEVMKRIRHRNLVKIIS 789
LG G FG V +++ G A K ++ + K Q +E ++++++ R +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLH-------- 840
A D L+M M G L+ +Y+ G + + + LE+LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 841 ----------FGHSTPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
G+ ISD +A L G ++ T GYMAPE
Sbjct: 121 LKPENVLLDDHGN---------VRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQG 168
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
D ++ G L E G+ P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 733 LLGIGSFGSVYVARLQDG-------MEVAVK--VFHQRYERALKSFQD---ECEVMK-RI 779
LG G+FG VY R ++ E+ V F + KS D E ++K ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------NIMIDVA 833
RH N+V+ +D ++M+ + L S + + QR NI + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEERIWNIFVQMV 123
Query: 834 LALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIG 881
LAL YLH I+H M+ I+DF +AK + +L T + TI
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTIL 178
Query: 882 YMAPEYGVQGRVST-RGDVYSYGIMLMETFTGKKP 915
Y PE V+ + DV+++G +L + T + P
Sbjct: 179 YSCPEI-VKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 50/225 (22%), Positives = 91/225 (40%), Gaps = 46/225 (20%)
Query: 734 LGIGSFGSV------YVARLQDGMEVAVKVFHQRYERA-LKSFQDECEVMKRIRHRNLVK 786
LG G FG V + VAVK+ + + L+ E ++K++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 787 IISACSNDDFKALIMEYMPNGSLENRL-----------------------YSGTCMLDIF 823
+ ACS D LI+EY GSL + L L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 824 QRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871
++ ++ ++YL ++H +A ISDF +++ + +D
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+++ + +MA E +T+ DV+S+G++L E T G P
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 734 LGIGSFGSVYVARLQDGME-VAVK-----VFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
+G G +G V++A+ +D E VA+K + + E + E +++ + LVK+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH-FGHSTP 846
+ A +D++ L MEY+P G L + +L M ++ A++ LH G
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFYMAEMFEAVDALHELG---- 121
Query: 847 IIH-------YMV---AHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
IH +++ HI +DF ++K ++ + + YMAPE ++G+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEV-LRGKGY 175
Query: 895 TRG-DVYSYGIMLMETFTGKKP-----TDEIFIGELSLSRW 929
D +S G ML E G P +E + +L W
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 4e-06
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 9/74 (12%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFH----QRYERALKSFQDECEVMKRIR-HRNLVKII 788
+ S V+ A L+DG EVAVKV +R LK + +++K+ +L ++
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKVQRPGVKKRIRSDLKLLKFLAKILKKFFPGFDLDWLV 78
Query: 789 SACSNDDFKALIME 802
K+L E
Sbjct: 79 DEFR----KSLPQE 88
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 732 NLLGIGSFGSVYVARL--QDGMEV--AVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVK 786
++G G FG VY L DG ++ AVK ++ + ++ F E +MK H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 787 IISACSNDDFKALI-MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ C + L+ + YM +G L N + S T + + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 846 PIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLAT--IGYMAPEYGVQG 891
+H +A ++DF +A+ + ++ S+ T A + +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 892 RVSTRGDVYSYGIMLMETFTGKKP 915
+ +T+ DV+S+G++L E T P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 64/230 (27%), Positives = 85/230 (36%), Gaps = 39/230 (16%)
Query: 734 LGIGSFGSVYVARL-QDGMEVAVKVFHQRYERAL-KSFQDECEVMKRIRHRNLVKIISAC 791
LG G+ GSV RL GM A+K L K E E+ K + +VK A
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 792 SNDDFK--ALIMEYMPNGSLENRLY------SGTCMLDIFQRLNIMIDVALALEYLHFGH 843
++ + MEY GSL+ +Y G + + I V L YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGK--IAESVLKGLSYLH--- 122
Query: 844 STPIIHYMVAHISDFSIAKFLNGQDQL-----------SMQTQTLATIGYMAPEYGVQGR 892
S IIH I +I GQ +L S+ T YMAPE
Sbjct: 123 SRKIIH---RDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 893 VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942
S DV+S G+ L+E + P F E L PI ++ I
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFP----FPPEGEPP-----LGPIELLSYI 220
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER---ALKSFQDECEVMKRIRHRN 783
F K N +G G++G VY AR G VA+K ER + S + E ++ +RH N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67
Query: 784 LVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+V++ + L+MEY L + L + Q +M+ + L+YL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL-- 124
Query: 842 GHSTPIIH--------YMVAH----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
H IIH + I+DF +A+ G M T + T+ Y APE +
Sbjct: 125 -HENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPM-TPKVVTLWYRAPELLL 181
Query: 890 QGRVSTRG-DVYSYGIMLMETFTGK 913
T D+++ G +L E K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFH-QRYERALKSFQDECEVMKRIRHRNLV 785
F+K +G GSFG VY EV A+K+ + E ++ Q E V+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ + +IMEY+ GS + L G L+ I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120
Query: 846 PIIH-------YMVAHISDFSIAKF-LNGQ--DQLSMQTQTLATIGYMAPEYGVQGRVST 895
IH +++ D +A F + GQ D + + T +MAPE Q
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 896 RGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955
+ D++S GI +E G+ P +DL P+ V+ +I N E ++
Sbjct: 181 KADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLIPKNSPPTLEGQYS 226
Query: 956 AKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995
+ + C + P R A+E++ R T
Sbjct: 227 KPFKEFVE------ACLNKDPRFRPTAKELLKHKFITRYT 260
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 7e-06
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 27/122 (22%)
Query: 734 LGIGSFGSVYVARLQDGME-VAVKVFHQRYERALKSFQDEC----EV---MKRIRHRNLV 785
LG G+FGSVY+AR ++ E VA+K +++ S+ +EC EV K H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKF----YSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL-------NIMIDVALALEY 838
K+ +D + EYM E LY M D + +I+ + L +
Sbjct: 62 KLKEVFRENDELYFVFEYM-----EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 839 LH 840
+H
Sbjct: 115 IH 116
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 8e-06
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 47/212 (22%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK-VFHQRYERALKSFQD--------ECEVM 776
R+ K LG G++ VY AR + G VA+K + + A +D E +++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA----KDGINFTALREIKLL 56
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
+ ++H N++ ++ + L+ E+M LE + + +L + M+ L
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 837 EYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
EYL HS I+H V ++DF +A+ G M Q + T Y A
Sbjct: 116 EYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQ-VVTRWYRA 170
Query: 885 PE-------YGVQGRVSTRG-DVYSYGIMLME 908
PE YGV G D++S G + E
Sbjct: 171 PELLFGARHYGV-------GVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 733 LLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKS----FQDECEVMKRIRHRNLVKII 788
++G G+FG V + R + +V ++E +S F +E ++M +V++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
A +D + ++MEYMP G L N L S + + + + +V LAL+ + HS +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAI---HSMGLI 164
Query: 849 HYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY----GVQGR 892
H V ++DF ++ + T + T Y++PE G G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 893 VSTRGDVYSYGIMLMETFTGKKP 915
D +S G+ L E G P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 28/204 (13%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQD----ECEVMKRIRHRNLVKIIS 789
+G G FG V + GM A V + A Q E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCML------DIFQRLNIMIDVA---LALEYLH 840
C L++E+ P G L+N L S M+ D+ QR+ +VA L L
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120
Query: 841 FGHS------TPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY--GVQGR 892
F HS + + I D+ +A +D + + ++APE
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 893 VST-----RGDVYSYGIMLMETFT 911
+ + +++S G+ + E FT
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 721 LLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRI 779
L T F ++G G++G VY AR + G VA+K+ + + ++E ++++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 780 -RHRNLVKIISA------CSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN----- 827
H N+ A NDD L+ME GS+ + L G +RL
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGL--RKKGKRLKEEWIA 116
Query: 828 -IMIDVALALEYLHFGHSTPIIHYMV----------AHIS--DFSIAKFLNGQDQLSMQT 874
I+ + L YLH +IH + A + DF ++ L D +
Sbjct: 117 YILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRR 170
Query: 875 QTLATIG---YMAPE-----YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
T IG +MAPE R DV+S GI +E GK P
Sbjct: 171 NT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
D F K +G GS G V +A ++ G VAVK R ++ + +E +M+ +H N+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
V++ ++ D ++ME++ G+L + + + T M + Q + + V AL L H+
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNE-EQIAAVCLAVLKALSVL---HA 134
Query: 845 TPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+IH ++ H +SDF ++ ++ + + T +MAPE +
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVPRRKSLVGTPYWMAPELISRLP 192
Query: 893 VSTRGDVYSYGIMLMETFTGKKP 915
D++S GIM++E G+ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRN 783
D F K + LG G+ G V+ V+ G+ +A K+ H + A+++ E +V+
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 842
+V A +D ++ ME+M GSL+ L +G I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122
Query: 843 HSTPIIH-------YMVAHISDFSIAKF-LNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
H I+H +V + + F ++GQ SM + T YM+PE S
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 895 TRGDVYSYGIMLMETFTGKKP 915
+ D++S G+ L+E G+ P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 733 LLGIGSFGSVYVARLQDGMEV----AVKVFHQRYERALKSFQD------ECEVMKRIRHR 782
+LG GSFG V++ R G + A+KV ++A +D E +++ + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL----KKATLKVRDRVRTKMERDILAEVNHP 58
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+VK+ A + LI++++ G L RL S M + ++ALAL++LH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH-- 115
Query: 843 HSTPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
S II+ + HI +DF ++K D T+ YMAPE +
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
+ D +S+G+++ E TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD---ECEVMKRIRHRN 783
F+ +G GSFG+VY AR ++ VA+K +++ + +QD E + ++RI+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL----ALEYL 839
++ + L+MEY L S + +L++ ++ +++A AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 840 HFGHSTPIIH-------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV--- 889
+ HS +IH ++ +A F S + T +MAPE +
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADF-GSASIASPANSFVGTPYWMAPEVILAMD 197
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
+G+ + DV+S GI +E K P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 34/209 (16%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHR 782
+++ K + +G GS+G V+ R ++ G VA+K F + + + K E ++K+++H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
NLV +I L+ EY + ++ N L + I+ A+ F
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVN---FC 116
Query: 843 HSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE---- 886
H IH V + DF A+ L G T +AT Y APE
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVG 174
Query: 887 ---YGVQGRVSTRGDVYSYGIMLMETFTG 912
YG DV++ G + E TG
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 733 LLGIGSFGSVYVARLQDG--------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRN- 783
+LG G++G V++ R G M+V K + + ++ + E V++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI---DVALALEYLH 840
LV + A + LI++Y+ G + LY D F + ++ LALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLH 122
Query: 841 FGHSTPIIHYMV----------AHI--SDFSIAK-FLNGQDQLSMQTQTLATIGYMAPEY 887
I++ + H+ +DF ++K FL+ + + + TI YMAPE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--CGTIEYMAPEI 177
Query: 888 GVQGRVSTRG---DVYSYGIMLMETFTGKKP 915
++G+ G D +S GI++ E TG P
Sbjct: 178 -IRGK-GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERA----LKSFQDECEVMKRIRHRNLVKIIS 789
+G G FG V + + G A V + A F +E + + ++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSG------TCMLDIFQRLNIMIDVALALEYLH--- 840
C+ L+ME+ P G L+ L S T QR+ ++AL L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120
Query: 841 FGHSTPIIHY------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY--GVQGR 892
F HS + + I D+ ++ +D Q + ++APE V G
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 893 V-----STRGDVYSYGIMLMETFT-GKKP 915
+ + +V+S G+ + E F G +P
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 17/126 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEV-AVKVF-------HQRYERALKSFQDECEVMK 777
F K LLG G G V++ RL+ ++ A+KV + +R L E E++
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT----EQEILA 56
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY---SGTCMLDIFQRLNIMIDVAL 834
+ H L + ++ + + L+M+Y P G L RL G C+ + R +V L
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAA-EVLL 114
Query: 835 ALEYLH 840
ALEYLH
Sbjct: 115 ALEYLH 120
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 37/205 (18%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD---ECEVMKRIRHRNLVKIIS 789
+G GSFG+VY AR +++ VA+K +++ + +QD E ++++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL----ALEYLHFGHST 845
+ L+MEY L S + +L++ ++ +++A AL+ L + HS
Sbjct: 83 CYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 846 PIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV---Q 890
+IH V + DF A + + + T +MAPE + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILAMDE 188
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
G+ + DV+S GI +E K P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRN 783
D F + + LG G+ G V + + G+ +A K+ H + A+++ E +V+
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFG 842
+V A +D ++ ME+M GSL+ L + +I +++I + LA YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 122
Query: 843 HSTPIIH-------YMVAHISDFSIAKF-LNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
H I+H +V + + F ++GQ SM + T YM+PE S
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 895 TRGDVYSYGIMLMETFTGKKP 915
+ D++S G+ L+E G+ P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 47/225 (20%)
Query: 728 FSKNNL-----LGIGSFGSVYVARLQD-GMEVAVK-VFHQRYERALKSFQDECEVMKRIR 780
F+ +L +G G+FG+V + G +AVK + E+ K + +V+ R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 781 H-RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL--NIMIDVAL--- 834
+VK A + + ME M + SL+ Y + + I+ +A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDK-FYK-YVYEVLKSVIPEEILGKIAVATV 117
Query: 835 -ALEYLHFGHSTPIIHYMV----------AHIS--DFSIAKFLNGQDQLSMQTQTLATIG 881
AL YL IIH V +I DF I+ L D ++ +T+
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIA-KTRDAGCRP 172
Query: 882 YMAPEYGVQGRVST--------RGDVYSYGIMLMETFTGKKPTDE 918
YMAPE R+ R DV+S GI L E TGK P +
Sbjct: 173 YMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 52/216 (24%)
Query: 737 GSFGSVYVARLQ-DGMEVAVKVFHQ------------RYERALKSFQDECEVMKRIRHRN 783
G+FGSVY+A+ + G A+KV + + ERA+ Q E
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP--------Y 58
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+ K+ + + D+ L+MEY+ G + + + + + + + + +V L +E L H
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDL---H 114
Query: 844 STPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPE--YGV 889
IIH + H+ +DF +++ NG + + T Y+APE GV
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAPETILGV 168
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP-----TDEIF 920
D +S G ++ E G P D +F
Sbjct: 169 GD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 8e-05
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 39/183 (21%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKRIR 780
+ K LG G++G VY AR + G VA+K E AL+ E ++K ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 781 HRNLVKIISACSNDDFKALIMEYMPN---GSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
H N+VK++ + L+ EY L+ R L +IM + L
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP----LSPNLIKSIMYQLLRGLA 112
Query: 838 YLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQ--TQTLATIGYM 883
Y HS I+H V ++DF +A+ + ++ T + T+ Y
Sbjct: 113 YC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYR 165
Query: 884 APE 886
APE
Sbjct: 166 APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 725 TDRFS-KNNLLGIGSFGSVYVAR-LQDGMEVAVK-VFHQRYERALKSFQD---------- 771
++R+ K LG G++G V A G VA+K V + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 772 ---ECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNI 828
E ++M I+H N++ ++ DF L+M+ M L+ ++ L Q I
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-KVVDRKIRLTESQVKCI 124
Query: 829 MIDVALALEYLH---FGHS--TP----IIHYMVAHISDFSIA-------------KFLNG 866
++ + L LH F H +P I + I+DF +A K
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 867 QDQLSMQTQTLATIGYMAPE--YGVQGRVSTRGDVYSYGIMLMETFTGKK---PTDEI 919
Q + M T + T+ Y APE G + + D++S G + E TGK +EI
Sbjct: 185 QRREEM-TSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 734 LGIGSFGSVYVA---RLQDG-----MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
LG G+F ++ + D EV +KV + + +SF + +M ++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
C D ++ EY+ GSL+ L +++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKS----FQDECEVMKRIRHR 782
F ++G G+FG V + R + +V A+K+ ++E +S F +E ++M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+V++ A +D + ++MEYMP G L N L S + + + R +V LAL+ +
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAI--- 158
Query: 843 HSTPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY--- 887
HS IH V H+ +DF ++ + T + T Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKS 217
Query: 888 -GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
G G D +S G+ L E G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 734 LGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
LG GS G V+ A D VAVK +++K E ++++R+ H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 793 ------NDDFKAL--------IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+D +L + EYM L N L G + + RL M + L+Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LSEEHARL-FMYQLLRGLKY 129
Query: 839 LHFGHSTPIIHY-------------MVAHISDFSIAKFLNGQ-DQLSMQTQTLATIGYMA 884
+ HS ++H +V I DF +A+ ++ ++ L T Y +
Sbjct: 130 I---HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 885 PEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
P + T+ D+++ G + E TGK
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 733 LLGIGSFGSVYVARLQDG--------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+LG G +G V+ R G M+V K R ++ + E +++ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDI--FQRLNIMIDVALALEYLHF 841
V +I A LI+EY+ G L L G M D F + +++LALE+L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF----YLSEISLALEHL-- 116
Query: 842 GHSTPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYG 888
H II+ + H+ +DF + K + + T T TI YMAPE
Sbjct: 117 -HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEYMAPEIL 172
Query: 889 VQGRVSTRGDVYSYGIMLMETFTG---------KKPTDEIFIGELSL 926
++ D +S G ++ + TG KK D+I G+L+L
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 54/217 (24%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVK-VFHQRYERALK-SFQDECEVMKRIR---HRNLVKI 787
+G+G++G+VY AR G VA+K V Q E L S E ++KR+ H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 788 ISACS-----------------NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI 830
+ C+ + D + + + P G + D+ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK------DLMRQF---- 117
Query: 831 DVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLA 878
L L F H+ I+H + ++DF +A+ + Q L T +
Sbjct: 118 -----LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---TPVVV 169
Query: 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
T+ Y APE +Q +T D++S G + E F +KP
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 30/231 (12%)
Query: 721 LLQATDRFSKNNLLGIGSFGSVYVARLQDGM-----EVAVK-VFHQRYERALKSFQDECE 774
+ + DR + ++LL G+FG ++ L D EV VK V E + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 775 VMKRIRHRNLVKIISACSND-DFKALIMEYMPNGSLEN-----RLYSGTCMLDIFQR--L 826
++ + H+N++ I+ C D + ++ YM G+L+ RL + + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 827 NIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874
++ I +A + YL H +IH +A I+D ++++ L D +
Sbjct: 121 HMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGEL 924
+ +MA E V S+ DV+S+G++L E T G+ P EI E+
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 727 RFSKNNLLGIGSFG-SVYVARLQDGMEVAVKVFH----QRYERALKSFQDECEVMKRIRH 781
++ K +G GSFG ++ V +DG + +K + ER + + E V+ ++H
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER--EESRKEVAVLSNMKH 58
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIM---IDVALALEY 838
N+V+ + + ++M+Y G L ++ + +L F I+ + + LAL++
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKH 116
Query: 839 LHFGHSTPIIH--------YMVAH----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+H I+H ++ + DF IA+ LN +L+ + T Y++PE
Sbjct: 117 VH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA--RTCIGTPYYLSPE 171
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGK 913
+ + D+++ G +L E T K
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 35/134 (26%), Positives = 58/134 (43%), Gaps = 17/134 (12%)
Query: 733 LLGIGSFG--SVYVARLQD-GMEVAVKVFH--QRYERALKSFQDECEVMKRIRHRNLVKI 787
L+G V++A+ + VAVK + + LK Q E ++++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 788 ISACSNDDFKALIMEYMPNGS----LENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+++ D ++ M GS L+ G L I I+ DV AL+Y+ H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AFILKDVLNALDYI---H 118
Query: 844 STPIIHYMV--AHI 855
S IH V +HI
Sbjct: 119 SKGFIHRSVKASHI 132
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 40/188 (21%), Positives = 77/188 (40%), Gaps = 29/188 (15%)
Query: 749 DGMEVAVKVF---HQRYERALKSFQDECEVMKRIRHRNLVKI----ISACSNDDFKALIM 801
+ EV ++ F H+ ++ + ++E + ++RI N++KI I + +LI+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVAHISDFS-- 859
EY G L L L +L++ ID L L+ + P +++ S
Sbjct: 102 EYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP-----YKNLTSVSFL 155
Query: 860 -----IAKFLNGQDQLSMQTQTLATIGYMAPEY-------GVQGRVSTRGDVYSYGIMLM 907
K + + + + + +M Y + + + D+YS G++L
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLW 213
Query: 908 ETFTGKKP 915
E FTGK P
Sbjct: 214 EIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 45/229 (19%)
Query: 734 LGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERAL-KSFQDECEVMKRIRHRNLVKIISAC 791
LG G+ G+VY A L +AVKV L K E E++ + ++ A
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------NIMIDVALALEYLHFGHST 845
++ ++ E+M GSL D+++++ I + V L YL S
Sbjct: 69 FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYLW---SL 114
Query: 846 PIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
I+H V + DF ++ L S+ + T YMAPE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQY 170
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942
DV+S GI ME G+ P +I + S L+P+ +++ I
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------LMPLQLLQCI 212
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 57/231 (24%), Positives = 79/231 (34%), Gaps = 55/231 (23%)
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL---NLQGLGLAFNKLARSIPDEICHLAK 461
Q ++ L LDL N L LL +LQ L L N L +
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA---- 129
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
+ +L L LG NR A S +L
Sbjct: 130 ------------KGLKDLP---PALEKLVLGRNRLEGA----------------SCEALA 158
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGD-IPITIGGLK---NLQKLFLANNRLE----GPIP 573
L +LK ELNL+ N + I GLK NL+ L L NN L +
Sbjct: 159 KALRA-NRDLK---ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214
Query: 574 ESFSGLSSLEILDLSKNKISGVI-----PTSLEKLLYLKKLNLSFNKLEGE 619
E+ + L SLE+L+L N ++ L + L L+LS N + +
Sbjct: 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 733 LLGIGSFGSVYVARLQDG--------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRN- 783
+LG G++G V++ R G M+V K + + + + E +V++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI-DVALALEYLHFG 842
LV + A D LI++Y+ G L L + Q + I ++ LALE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122
Query: 843 HSTPIIHYMV----------AHI--SDFSIAK-FLNGQDQLSMQTQTLATIGYMAPEY-- 887
II+ + H+ +DF ++K F +D++ TI YMAP+
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH--EDEVERAYSFCGTIEYMAPDIVR 179
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
G G D +S G+++ E TG P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 734 LGIGSFGSVYVARLQDG--------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRN-L 784
LG G++G V++ R G M+V K + + + + E +V++ +R L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
V + A D LI++Y+ G L LY + R+ I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 845 TPIIHYMV----------AHI--SDFSIAK-FLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
II+ + H+ +DF ++K FL +++ + TI YMAPE ++G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF--CGTIEYMAPEV-IRG 180
Query: 892 RVSTRGDV---YSYGIMLMETFTGKKP 915
+S G++ E TG P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 52/294 (17%)
Query: 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERAL--KSFQDECEVMKRIRH 781
T+R+ +G+G+FG V AR Q G VA+K + + + K E +++K +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 782 RNLV---KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
N++ I + D + + E + G+ +RL + + F + + + L+Y
Sbjct: 69 ENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQILRGLKY 123
Query: 839 LHFGHSTPIIH-------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE----- 886
+ HS ++H ++ D I F + Q T ++T Y APE
Sbjct: 124 V---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTW 180
Query: 887 --YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW--VNDLLPISVMEVI 942
Y V+ D++S G + E GK +F G+ ++++ + DLL +VI
Sbjct: 181 QKYDVE------VDIWSAGCIFAEMLEGKP----LFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 943 DT-----------NLLSGEERYFAAKEQSL-LSILNLATECTIESPGKRINARE 984
+T +L E F+ K ++ S ++L + + P KRI+A E
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 16/188 (8%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
+G G++G VY AR + G A+KV Q E +MK +H N+V +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF---------GH 843
D + ME+ GSL++ +Y T L Q + + L YLH G
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGA 135
Query: 844 STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV---QGRVSTRGDVY 900
+ + ++DF ++ + ++ + + T +MAPE +G + D++
Sbjct: 136 NILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 193
Query: 901 SYGIMLME 908
+ GI +E
Sbjct: 194 AVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 27/200 (13%)
Query: 734 LGIGSFGSVYVARLQDGME-VAVKVFHQRYERALKSFQD---ECEVMKRIRHRNLVKIIS 789
+G GSFG+VY A E VAVK ++ + +QD E + +++++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL----ALEYLHFGHST 845
+ L+MEY L S + +L++ ++ +++A AL+ L + HS
Sbjct: 89 CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 846 PIIH-------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV---QGRVST 895
+IH ++ +A F + S + T +MAPE + +G+
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADF-GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199
Query: 896 RGDVYSYGIMLMETFTGKKP 915
+ DV+S GI +E K P
Sbjct: 200 KVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 389 SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKL 448
+L+ + N R++ L NL +LDL GN LT P FS L +L+ L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 44/215 (20%)
Query: 734 LGIGSFGSVYVARLQD---------GMEVAV--KVFHQRYERALKSFQDECEVMKRIRHR 782
LG G+F ++Y L+ G EV+V KV + +L +F + +M ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+LVK+ C D+ ++ EY+ G L+ L+ + + +L++ +A AL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117
Query: 843 HSTPIIHYMV-------------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
++H V +SD I + +++ + I ++
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPWI 171
Query: 884 APEY--GVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
APE Q ++ D +S+G L+E + G++P
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFH-----QRYERALKSFQDECEVMKRIRHRNLVK 786
++G G+FG V V +L++ +V A+K+ + +R E A F++E +V+ ++ +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVNGDNQWITT 65
Query: 787 IISACSNDDFKALIMEYMPNGSL-------ENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+ A +++ L+M+Y G L E+RL + + + I ID L Y+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDSVHQLHYV 124
Query: 840 HFG-HSTPIIHYMVAHI--SDF-SIAKFLNGQDQLSMQTQTLATIGYMAPEY-----GVQ 890
H I+ M HI +DF S K + +D + + T Y++PE +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP 915
G+ D +S G+ + E G+ P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVKVFHQRYERALKS-FQDECEVMKRIRHRN 783
D F K LG G+ G V V G+ +A K+ H + A+++ E +V+
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 842
+V A +D ++ ME+M GSL+ L G +I + I I V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREK 118
Query: 843 HSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
H I+H V + DF ++ GQ SM + T YM+PE +Q
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER-LQ 171
Query: 891 G-RVSTRGDVYSYGIMLMETFTGKKP 915
G + + D++S G+ L+E G+ P
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 25/206 (12%)
Query: 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQ---DECEVMKRIRHRN 783
F + +LG G FG V +++ G A K ++ + K +E ++++++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLH-- 840
+V + A D L++ M G L+ +Y G + + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 841 ---FGHSTPIIHYMVAH----ISDFSIAKFLNGQDQLSMQTQTL----ATIGYMAPEYGV 889
+ P + H ISD +A + + QT+ T+GYMAPE
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-------EGQTIKGRVGTVGYMAPEVVK 174
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
R + D ++ G +L E G+ P
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 18/60 (30%), Positives = 24/60 (40%)
Query: 166 NLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNEL 225
NLK L L N L+ L L NNL+ P+ L L+ + L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 311 KLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLIL 370
L L N + L NL+ L+++ N LTS +PE + + +R L L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55
Query: 371 AGNPL 375
+GN L
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 45/179 (25%), Positives = 67/179 (37%), Gaps = 40/179 (22%)
Query: 763 ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDI 822
ER + E + H +VK +DD LIMEY G L + I
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ---------I 156
Query: 823 FQRLN------------IMIDVALALEYLH--------------FGHSTPIIHYMVAHIS 856
QRL + + LAL+ +H F T II +
Sbjct: 157 KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK-----LG 211
Query: 857 DFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
DF +K + L + + T Y+APE + R S + D++S G++L E T +P
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 31/201 (15%)
Query: 734 LGIGSFGSVYVARLQDGME-VAVKVFHQRYERALKSFQ-DECEVMKRIRHRNLVKIISAC 791
LG G++ +VY R + E VA+K H E S E +MK ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 792 SNDDFKALIMEYMPNGSLENRL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
++ L+ EYM + L+ + + LD + + L+ + F H ++H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 850 YMVAHISDFSIAKFL-NGQDQLSMQTQTLA---------------TIGYMAPEYGVQGRV 893
D L N + +L + LA T+ Y AP+ + R
Sbjct: 124 ------RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 894 -STRGDVYSYGIMLMETFTGK 913
ST D++S G ++ E TG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 59/271 (21%), Positives = 109/271 (40%), Gaps = 34/271 (12%)
Query: 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQ---DECEVMKRIRHRN 783
F + +LG G FG V +++ G A K ++ + K +E ++++++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLH-- 840
+V + A D L++ M G L+ +Y+ G + + L ++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 841 ---FGHSTP----IIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+ P + Y ISD +A + + + + + T+GYMAPE R
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRY 178
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953
+ D + G ++ E G+ P F G + E +D +L EE Y
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSP----FRGRKEKVK----------REEVDRRVLETEEVY 224
Query: 954 FAAKEQSLLSILNLATECTIESPGKRINARE 984
A + SI + + P +R+ +E
Sbjct: 225 SAKFSEEAKSICKM---LLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 727 RFSKNNLLGIGSFGSVYVA-RLQDGMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHRN 783
R++ +G G++GSV A + G +VA+K + ++ + K E ++K ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 784 LVKII----SACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
++ ++ SA S D+F+ L+M YM + M + V L
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 838 YLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
L + HS IIH + I DF +A+ + + T + T Y AP
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 183
Query: 886 EYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
E + + D++S G ++ E TGK
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 76/304 (25%), Positives = 119/304 (39%), Gaps = 63/304 (20%)
Query: 727 RFSKNNLLGIGSFGSV-YVARLQDGMEVAVKVF------HQRYERALKSFQDECEVMKRI 779
++ + +LG G+ G+V R+ DG AVKV RA Q E +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA----QAEVCCLLNC 88
Query: 780 RHRNLVKIISACSNDDFK------------ALIMEYMPNGSLENRLYSGTCMLDIFQRLN 827
++VK C D K AL+++Y G L + S F+
Sbjct: 89 DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 828 ---IMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872
+ I V LA+ H HS +IH + + DF +K +
Sbjct: 145 AGLLFIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL---SLS-R 928
T Y+APE + S + D++S G++L E T K+P D + E+ +L+ R
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
Query: 929 WVNDLLPISV---MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ D LP S+ M+ I T LLS + + + S +LN+ C + G EI
Sbjct: 262 Y--DPLPPSISPEMQEIVTALLSSDPK----RRPSSSKLLNMPI-CKLFISG----LLEI 310
Query: 986 VTGL 989
V
Sbjct: 311 VQTQ 314
|
Length = 496 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 39/213 (18%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHR 782
DR+ + +G G++G V A G +VA+K + ++ A+ K E ++K + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 783 NLVKIIS----ACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLN---IMIDVA 833
N++ ++ A S +DF+ L+ M L N + Q+L+ I V
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVY 125
Query: 834 LALEYLHFGHSTPIIHY-----MVA-------HISDFSIAKFLNGQDQLSMQTQTLATIG 881
L L + HS IIH +A I DF +A+ + + M T +AT
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----M-TGYVATRW 180
Query: 882 YMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGK 913
Y APE + + D++S G ++ E TGK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 18/41 (43%), Positives = 29/41 (70%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSI 112
VL++S + G+IP LG L+SL L+L+ N LSG +P+++
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 23/57 (40%), Positives = 26/57 (45%), Gaps = 1/57 (1%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL 201
+DLS NR + +P K LPNLK L L N P S L L L NNL
Sbjct: 5 LDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 44/224 (19%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR---YERALKSFQDECEVMKRIRH 781
F +L+G G FG V V R G A+KV + + + F++E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 782 RNLVKIISACSNDDFKALIMEYMPNG---SLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+ ++ A + D L+MEY P G SL NR Y D F +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR-YE-----DQFDEDMAQFYLAELVLA 114
Query: 839 LHFGHSTPIIHYMV----------AHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+H H +H + HI +DF A L +++ + T Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPE 173
Query: 887 ------------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918
YGV+ D +S G++ E G+ P E
Sbjct: 174 VLTTMNGDGKGTYGVE------CDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 66/229 (28%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDEC-EVMKRI-----RHRNLV 785
+LG GSFG V +A L+ E+ AVKV + + L+ EC KR+ +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 786 KIISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDV 832
++ S D +MEY+ G L E R Y+ ++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--------------EI 105
Query: 833 ALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAK--FLNGQDQLSMQTQTL- 877
L L++L H II+ ++ I+DF + K L G T T
Sbjct: 106 VLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-----TTSTFC 157
Query: 878 ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE + + D ++ G++L E G+ P DE+F
Sbjct: 158 GTPDYIAPEI-LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 17/57 (29%), Positives = 26/57 (45%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
L++S L L +L+ LDLS N L+ P + + +L+ LD N L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 43/215 (20%)
Query: 726 DRFSKNNLLGIGSFGSV-YVARLQDGMEVAVKVFHQRYERAL--KSFQDECEVMKRIRHR 782
DR+ +G G++G+V + G +VA+K ++ ++ L K E ++K ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 783 NLVKIISACSND-------DFKALIMEYMPN--GSL--ENRLYSGTCMLDIFQRLNIMID 831
N++ ++ + D DF L+M +M G L +L ++Q L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK---- 129
Query: 832 VALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLAT 879
L+Y+H + IIH + I DF +A+ + S T + T
Sbjct: 130 ---GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVT 178
Query: 880 IGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
Y APE + T+ D++S G ++ E TGK
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 733 LLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECE-VMKRI-----RHRNLV 785
+LG GSFG V++A L+ A+K + + L EC V KR+ H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHS 844
+ + +MEY+ G L + +C D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 845 TPIIHY----------MVAHISDFSIAKFLNGQDQLSMQTQTLATIG---YMAPEYGVQG 891
I++ HI IA F ++ + +T G Y+APE +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIK---IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 892 RVSTRGDVYSYGIMLMETFTGKKP 915
+ +T D +S+G++L E G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVK---VFHQRYERALKSFQDECEVMKRIRHRN 783
F +G G F VY A L DG+ VA+K +F +A E +++K++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY----- 838
++K ++ D+ +++E G L M+ F++ +I +Y
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSR-------MIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 839 --LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
L HS ++H V + D + +F + + + + T YM+
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMS 174
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
PE + + + D++S G +L E + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 71/296 (23%), Positives = 115/296 (38%), Gaps = 63/296 (21%)
Query: 732 NLLGIGSFGSVYVAR-LQDGMEVAVK--VFHQRYERALKSFQDECEVMKRIR---HRNLV 785
+G G++G+VY AR L G VA+K E S E ++K++ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 786 KIISACSNDDFK-----ALIMEYMP---NGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
+++ C L+ E++ L G L ++M + ++
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLLRGVD 121
Query: 838 YLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
+L HS I+H +V I+DF +A+ + + L T + T+ Y AP
Sbjct: 122 FL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAP 175
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETF---------TGKKPTDEIF--IGELSLSRW-VNDL 933
E +Q +T D++S G + E F + D+IF IG S W N
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235
Query: 934 LPISVMEVIDTNLLSGEERYFAAKEQSLL-----SILNLATECTIESPGKRINARE 984
LP S Y +S + L+L + +P KRI+A E
Sbjct: 236 LPRSSF-----------PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1007 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.65 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.58 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.51 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.47 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.47 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.42 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.4 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.39 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.31 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.3 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.29 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.24 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.22 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.99 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.95 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.91 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.87 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.8 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.8 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.58 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.34 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.3 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.2 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.0 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.88 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.82 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.77 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-116 Score=1127.68 Aligned_cols=911 Identities=31% Similarity=0.508 Sum_probs=721.5
Q ss_pred CcchHHHHHHHHHhcccCCCCccccCCCCCCCCccccceEeCCCCCcEEEEEeCCCCCcccCcccccCCCCCCEEEcCCC
Q 001838 23 ITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHN 102 (1007)
Q Consensus 23 ~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~C~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N 102 (1007)
.++|++||++||+++. +|.+.+. +|..+++||.|.||+|++ .++|+.|||++|+++|.+++.|..+++|++|||++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~-~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLS-NWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCC-CCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 5689999999999985 7877776 898888999999999986 469999999999999999999999999999999999
Q ss_pred CCCCCCCcccc-CcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEEccCccccccC
Q 001838 103 KLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKI 181 (1007)
Q Consensus 103 ~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~ 181 (1007)
++++.+|..+. ++++|++|+|++|++++.+|. ..+++|+.|||++|.+++.+|..+. ++++|++|+|++|.+.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHh-cCCCCCEEECccCcccccC
Confidence 99998998765 899999999999999887775 4578889999999998888887764 7888999999999888888
Q ss_pred CccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeeccCccccccccccccCCC
Q 001838 182 PSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMS 261 (1007)
Q Consensus 182 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 261 (1007)
|..|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+.+++
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 88888888899999998888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccccCCCCEEEecCCCcCCCCCcccccccccccccc
Q 001838 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNI 341 (1007)
Q Consensus 262 ~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 341 (1007)
+|+.|++++|.+.+.+|..+. .+++|++|+|++|.+++.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 888888888877777776654 5677777777777777777777777777777777777777777766666666666666
Q ss_pred cccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceeeeccccccccCChhhhccCCCcEEEccC
Q 001838 342 ADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421 (1007)
Q Consensus 342 s~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 421 (1007)
++|.+++ .+|..+..+. .|+.|++++|++++.+|..++.+++|+.|++++
T Consensus 340 ~~n~l~~-----------------------------~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~ 389 (968)
T PLN00113 340 WSNKFSG-----------------------------EIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389 (968)
T ss_pred cCCCCcC-----------------------------cCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcC
Confidence 6665554 4444444443 556666666666667777777788888888888
Q ss_pred CeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCcccCceeecCCcccccCCC
Q 001838 422 NKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALP 501 (1007)
Q Consensus 422 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 501 (1007)
|++.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|
T Consensus 390 n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p 469 (968)
T PLN00113 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469 (968)
T ss_pred CEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecC
Confidence 88888888888888888888888888888888888888888888888888888888888888888999999998888888
Q ss_pred cccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEeccccccccccCccCcCCCC
Q 001838 502 STIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS 581 (1007)
Q Consensus 502 ~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 581 (1007)
..+ ..++|+.||+++|++++.+|..+.+++.|++|+|++|++++.+|..++.+++|++|+|++|+++|.+|..|.++++
T Consensus 470 ~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 548 (968)
T PLN00113 470 DSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548 (968)
T ss_pred ccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCccc
Confidence 765 4578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCEEECCCCcccccCCcchhhhcCCCeeeCcCCccccccCCCCcCCCCcccccccccccCCCCC-CCCCCCCCCCCcccc
Q 001838 582 LEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPD-LHNSPCKLNKPKTHH 660 (1007)
Q Consensus 582 L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ip~~~~~~~~~~~~~~~n~~lc~~p~-~~~~~c~~~~~~~~~ 660 (1007)
|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..++|.++...++.||+.+||.+. ...++|... .+
T Consensus 549 L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~----~~ 624 (968)
T PLN00113 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV----RK 624 (968)
T ss_pred CCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc----cc
Confidence 9999999999999999999999999999999999999999999999999999999999998642 234566421 11
Q ss_pred ccchhhhHHHhhhhhhHHHHHHHHHHHhHHHhhhhccc-cCCCCCCCCCC-----ccccccccHHHHHHhccccccccee
Q 001838 661 KSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIRCWKS-ITGSSNDGINS-----PQAIRRFSYHELLQATDRFSKNNLL 734 (1007)
Q Consensus 661 ~s~~~~~~~~i~i~~~~~~~i~~~~~~~~~~~~r~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~i 734 (1007)
. ...+++++++++ ++++++++++.++++++|++.. .......+.+. ......++++++.. .|...+.|
T Consensus 625 ~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i 698 (968)
T PLN00113 625 T-PSWWFYITCTLG--AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS---SLKEENVI 698 (968)
T ss_pred c-ceeeeehhHHHH--HHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHh---hCCcccEE
Confidence 1 111221222221 1112222222222221121111 11111111111 11123355555544 46778899
Q ss_pred cccCceEEEEEEE-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhh
Q 001838 735 GIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRL 813 (1007)
Q Consensus 735 g~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l 813 (1007)
|+|+||+||+|+. .+|+.||||+++.... ...+|++++++++|||||+++|+|.+++..|+|||||++|+|.+++
T Consensus 699 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred ccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence 9999999999987 4789999999875432 1235688999999999999999999999999999999999999999
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccccc---c--------ceeecceecCCCCcccccccccCCccc
Q 001838 814 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVAH---I--------SDFSIAKFLNGQDQLSMQTQTLATIGY 882 (1007)
Q Consensus 814 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~k---l--------~DFGla~~~~~~~~~~~~~~~~gt~~y 882 (1007)
+. ++|.++.+|+.|+|+|++|||+.++++|+|||++- + .+||.+..... .....||++|
T Consensus 775 ~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~------~~~~~~t~~y 844 (968)
T PLN00113 775 RN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT------DTKCFISSAY 844 (968)
T ss_pred hc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEecccccccc------CCCccccccc
Confidence 63 78999999999999999999877789999998751 1 12443332211 1234688999
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc-cHHHHhhhhhccchhhhHHHHHHHH
Q 001838 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI-SVMEVIDTNLLSGEERYFAAKEQSL 961 (1007)
Q Consensus 883 ~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~ 961 (1007)
||||++.+..++.|+|||||||++|||+||+.||+........+.+|+...... .....+|+.+..... ...+..
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 920 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----VNQNEI 920 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----ccHHHH
Confidence 999999999999999999999999999999999976655566778887655432 334445544422111 122345
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 001838 962 LSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 962 ~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
.++.+++.+||+.||++||||+||+++|+++.+.....
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence 67899999999999999999999999999997755444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-62 Score=627.54 Aligned_cols=519 Identities=36% Similarity=0.579 Sum_probs=447.2
Q ss_pred CCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhh-hcCCCCeecccCcccCCCCchhHhhcCCCCcEE
Q 001838 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKL 170 (1007)
Q Consensus 92 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L 170 (1007)
.+++.|||++|.++|.+|..|..+++|++|+|++|++++.+|..+. ++++|+.|||++|+++|.+|. ..+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence 4788999999999999999999999999999999999877776554 888999999999998888876 357888889
Q ss_pred EccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeeccCcccc
Q 001838 171 LLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLV 250 (1007)
Q Consensus 171 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 250 (1007)
+|++|.+++.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccccCCCCEEEecCCCcCCCCCccc
Q 001838 251 GVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTI 330 (1007)
Q Consensus 251 ~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 330 (1007)
+.+|..+.++++|++|++++|.+.+.+|..+. .+++|++|++++|.+++.+|..+.++++|+.|++++|.+++.+|..+
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 88888887777777777777777666665543 56667777777777766666666666666667766666666666665
Q ss_pred ccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceeeeccccccccCChhhhc
Q 001838 331 GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISN 410 (1007)
Q Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~ 410 (1007)
.++++|++|++++| .+.+.+|..+..++ +|+.|++++|.+++.+|..++.
T Consensus 305 ~~l~~L~~L~l~~n-----------------------------~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~ 354 (968)
T PLN00113 305 IQLQNLEILHLFSN-----------------------------NFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGK 354 (968)
T ss_pred cCCCCCcEEECCCC-----------------------------ccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhC
Confidence 55555555555555 44445555555555 7888888899999999999999
Q ss_pred cCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCcccCceee
Q 001838 411 LSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALY 490 (1007)
Q Consensus 411 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 490 (1007)
+++|+.|+|++|++++.+|.++..+.+|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.++++|+.|+
T Consensus 355 ~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 434 (968)
T PLN00113 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434 (968)
T ss_pred CCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEecccccccc
Q 001838 491 LGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG 570 (1007)
Q Consensus 491 Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 570 (1007)
+++|++++.+|..++.+++|+.|++++|++.+.+|..++ .++|+.||+++|++++.+|..+..+++|+.|+|++|++++
T Consensus 435 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 513 (968)
T PLN00113 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513 (968)
T ss_pred CcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCccee
Confidence 999999999999999999999999999999998887664 5889999999999999999999999999999999999999
Q ss_pred ccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccccccCCC-CcCCCCcccccccccccCCCCC
Q 001838 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG-GPFANLTAKSFLGNELLCGLPD 645 (1007)
Q Consensus 571 ~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ip~~-~~~~~~~~~~~~~n~~lc~~p~ 645 (1007)
.+|+.++++++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+..|.
T Consensus 514 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred eCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 99999999999999999999999999999999999999999999999999974 2455677778889988776554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=438.10 Aligned_cols=278 Identities=40% Similarity=0.661 Sum_probs=237.8
Q ss_pred ccccccHHHHHHhcccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 001838 712 AIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISAC 791 (1007)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 791 (1007)
..+.|+++++.+||++|+..+.||+|+||.||+|.+++|..||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765432135699999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCChhHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccce
Q 001838 792 SNDD-FKALIMEYMPNGSLENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISD 857 (1007)
Q Consensus 792 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~D 857 (1007)
.+.+ +.+||||||++|+|+++|+.... .++|.+|++||.++|+||+|||+.+.++|||||+ +||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999998765 7999999999999999999999988899999976 49999
Q ss_pred eecceecCCCCcccccccc-cCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccc-cCcchHHHHHHhhcC
Q 001838 858 FSIAKFLNGQDQLSMQTQT-LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIF-IGELSLSRWVNDLLP 935 (1007)
Q Consensus 858 FGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~-~~~~~l~~~~~~~~~ 935 (1007)
||+|+..... .... ... .||.+|+||||+..+..+.|+|||||||+++|++||++|.+... .++..+..|+.....
T Consensus 221 FGLa~~~~~~-~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc-ccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999876541 1111 112 79999999999999999999999999999999999999988644 455668999876654
Q ss_pred c-cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 936 I-SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 936 ~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
. .+.+++|+.+....... .+.+.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 4 78899999876321111 14567799999999999999999999999999666543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=379.19 Aligned_cols=244 Identities=30% Similarity=0.465 Sum_probs=198.2
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-eeEEEEEecCCC
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD-FKALIMEYMPNG 807 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~E~~~~g 807 (1007)
.+.+|+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45599999999999999844449999998653 222678999999999999999999999999887 799999999999
Q ss_pred ChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecccc-------------ccceeecceecCCCCcccc
Q 001838 808 SLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTP-IIHYMVA-------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 808 sL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~~~~-------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|.+++++ ....+++..++++|.|||+||+||| +.. |||||++ ||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999988 4667999999999999999999995 555 9999764 899999999875322 22
Q ss_pred cccccCCcccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 873 QTQTLATIGYMAPEYGV--QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.+..... ....+ +...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~~~v-----------~~~~----- 262 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VASAV-----------VVGG----- 262 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHH-----------HhcC-----
Confidence 34478999999999999 5689999999999999999999999999754311 11111 0000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
.++..+..+...+..++.+||..||++||++.|++..|+.+......
T Consensus 263 -~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 263 -LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 01111222456789999999999999999999999999999887654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=377.77 Aligned_cols=242 Identities=29% Similarity=0.471 Sum_probs=203.4
Q ss_pred cccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 729 SKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
...+.||+|-||+||.|.++....||||.++... ...++|.+|+.+|++++|+|||+++|+|..++..|||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3467899999999999999877799999998653 223678999999999999999999999999999999999999999
Q ss_pred hhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 809 LENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 809 L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
|.++|+. .+..+...+.+.++.|||+||+|| .++.+||||++ ||+|||+||.+. ++++.....
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecCC
Confidence 9999997 456788999999999999999999 89999999864 999999999543 445544444
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
..-+..|.|||.+..++++.|||||||||+||||+| |+.||..+... ++.+.++ ...++
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------ev~~~le------~GyRl 423 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------EVLELLE------RGYRL 423 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------------HHHHHHh------ccCcC
Confidence 455778999999999999999999999999999998 89998864321 1122222 12334
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
+.++.|+.++.++|..||..+|++|||++.+...++.+...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 55667888999999999999999999999999888887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=356.65 Aligned_cols=191 Identities=30% Similarity=0.505 Sum_probs=172.5
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
..++|...+.||+|+||+||+|+++ ++.+||||.+.+. ..+..+.+..|+++|+.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4567888899999999999999976 5899999999876 456677889999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------------ccceeecce
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------------HISDFSIAK 862 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------------kl~DFGla~ 862 (1007)
||||.||+|.+|+++++ .+++.....++.|+|.||++| |+++|||||++ ||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998875 488999999999999999999 78999999875 899999999
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI 921 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~ 921 (1007)
.+.... ...+.+|++-|||||++..++|+.|+|+||.|+|+|++++|+.||+....
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 987442 33567999999999999999999999999999999999999999986543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=379.88 Aligned_cols=488 Identities=27% Similarity=0.363 Sum_probs=321.2
Q ss_pred cEEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeeccc
Q 001838 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLS 148 (1007)
Q Consensus 69 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs 148 (1007)
..+.|++++|+++ .+.+++.+|..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|..++.+.+|..||.|
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4677899999998 56778899999999999999998 68889999999999999999996 456778889999999999
Q ss_pred CcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCC
Q 001838 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGE 228 (1007)
Q Consensus 149 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 228 (1007)
+|.+. ++|++++ .+..|+.|+..+|+++ ..|+++.++.+|..|++.+|++....|..+ +++.|++|+...|-++ .
T Consensus 123 ~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-c
Confidence 99998 7888887 5889999999999998 778889999999999999999985555444 4999999999999998 7
Q ss_pred CCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccc
Q 001838 229 IPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308 (1007)
Q Consensus 229 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 308 (1007)
+|..++.+.+|+.|+|..|++.. .| .|.+++.|++|+++.|.+ ..+|......++.+..|||..|+++ ..|..+.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i-~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQI-EMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHH-HhhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 88899999999999999999975 44 788999999999999988 5788888778888888999888888 57888888
Q ss_pred cCCCCEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccE----EEccCCCCCCCCCCCcc
Q 001838 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRV----LILAGNPLDGILPSSIG 384 (1007)
Q Consensus 309 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~----L~Ls~N~l~~~~p~~~~ 384 (1007)
+.+|.+||+|+|.|++ +|.+++++ .|++|-+.+|.+..+..++..-..-.-++.|+. =-++.- .|. ..+-.
T Consensus 274 LrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s--e~~-~e~~~ 348 (565)
T KOG0472|consen 274 LRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS--EGG-TETAM 348 (565)
T ss_pred hhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC--ccc-ccccC
Confidence 8888888888888885 56678888 888888888887754332211000000111111 000000 000 00000
Q ss_pred ccccccceeeeccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccc---cCccccCCCccCCCCchhhhcccc
Q 001838 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLN---LQGLGLAFNKLARSIPDEICHLAK 461 (1007)
Q Consensus 385 ~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~ 461 (1007)
+ ..++..| ....+.+.+.|++++-+++ .+|+....... ....+++.|++. .+|..+..++.
T Consensus 349 t-------------~~~~~~~-~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lke 412 (565)
T KOG0472|consen 349 T-------------LPSESFP-DIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKE 412 (565)
T ss_pred C-------------CCCCccc-chhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHH
Confidence 0 0000011 1122334444444444444 22322222111 344444444443 24444444433
Q ss_pred ccee-ecccccccCCCCCCCCCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCc
Q 001838 462 LDKL-ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLS 540 (1007)
Q Consensus 462 L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls 540 (1007)
+.+. ++++|.+ +.+|..+..+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+..++.+-.+
T Consensus 413 lvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas 489 (565)
T KOG0472|consen 413 LVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLAS 489 (565)
T ss_pred HHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhc
Confidence 3322 2222222 244444444444445555444443 24444444444555555555443 234334444444444445
Q ss_pred cccCCCCccccccCCCCccEEeccccccccccCccCcCCCCCCEEECCCCccc
Q 001838 541 RNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKIS 593 (1007)
Q Consensus 541 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 593 (1007)
+|++....|..+.++.+|+.|||.+|.|. .+|+.++++++|+.|+|++|.|.
T Consensus 490 ~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 490 NNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 56665444444666666666666666665 56666677777777777777666
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.58 Aligned_cols=236 Identities=24% Similarity=0.329 Sum_probs=199.0
Q ss_pred ccccccceecccCceEEEEEEE-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
.+|...+.||+|||++||.++. .+|..||+|++.+.. ....+...+||+|.++++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999997 789999999998743 345677899999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|+|++|+|.++++++ ..+++.++..++.||+.||.|| |+.+|+|||++ ||+|||+|..+..+++
T Consensus 98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 999999999999844 4689999999999999999999 78889999875 9999999999875433
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
. ..+.+|||-|+|||++....++..+||||+||++|.|+.|++||+... +.+..+......
T Consensus 174 r--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vkety~~Ik~~~ 234 (592)
T KOG0575|consen 174 R--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VKETYNKIKLNE 234 (592)
T ss_pred c--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HHHHHHHHHhcC
Confidence 2 356899999999999999999999999999999999999999998632 122222111111
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ..+.....++.+|+.++|+.+|.+|||+.+|+..
T Consensus 235 Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 Y----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1122335578999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.50 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=199.6
Q ss_pred ccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Q 001838 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSN 793 (1007)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 793 (1007)
++.+|+.+ .+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||+++|+|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 55566554 678999999999999987 6899999999533 34556889999999999999999999999999
Q ss_pred CC-eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 794 DD-FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 794 ~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
.+ ...++||||++|||++++...+ .+++...-+|+.+|++||.||| ++.+|||||++ ||||||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 88 5999999999999999998653 4888899999999999999997 46899999986 9999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
++.+... ...+.+||..|||||.+.+..|+.++||||||+.++|+++|+.||......... ..+
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~------------~~~ 289 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD------------IFE 289 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC------------HHH
Confidence 9987543 345678999999999999999999999999999999999999999864111111 122
Q ss_pred HhhhhhccchhhhHHHHH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKE-QSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.++....... +..++ ..+.++.+++..|++.||.+|||++|++++-
T Consensus 290 Ll~~Iv~~pp---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 290 LLCAIVDEPP---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHhcCCC---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 2222221111 11122 2567899999999999999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.86 Aligned_cols=242 Identities=26% Similarity=0.345 Sum_probs=195.7
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHH-------HHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYER-------ALKSFQDECEVMKRIRHRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 796 (1007)
.+.|...+.+|+|+||.|-+|..+ +|+.||||++.++.-. ......+|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356788899999999999999854 7999999999765311 12335799999999999999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeecc
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIA 861 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGla 861 (1007)
.|||||||+||+|.+.+-..+. +.+.....+++|++.|+.|| |+.+|+|||++ ||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999976653 66667778999999999999 79999999875 89999999
Q ss_pred eecCCCCcccccccccCCcccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccH
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQGR---VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
|..... ..+.+.+||+.|.|||++.... +..|+|+||+|||||-+++|.+||.+...+ ..+
T Consensus 327 K~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------------~sl 390 (475)
T KOG0615|consen 327 KVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------------PSL 390 (475)
T ss_pred hccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-------------ccH
Confidence 987533 3456789999999999998765 344889999999999999999999864322 122
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.+.+-.. .....+....+..++..+++.+||..||++|||+.|++++-
T Consensus 391 ~eQI~~G---~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 391 KEQILKG---RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred HHHHhcC---cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 2332221 11112233445677899999999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=374.10 Aligned_cols=494 Identities=27% Similarity=0.383 Sum_probs=401.7
Q ss_pred ccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCC
Q 001838 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNL 167 (1007)
Q Consensus 88 l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L 167 (1007)
++.-..|+.|++++|.++ .+-+.+.+|..|..|++.+|+++. .|.+++.+..++.++.|+|+++ .+|+.+. .+.+|
T Consensus 41 wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l 116 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISL 116 (565)
T ss_pred hhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhh
Confidence 344467899999999998 566688999999999999999974 5667899999999999999999 8999997 79999
Q ss_pred cEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeeccCc
Q 001838 168 KKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247 (1007)
Q Consensus 168 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 247 (1007)
+.|+.+.|.+. .+|++++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++...|..+. ++.|++||.-+|
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N 193 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSN 193 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchh
Confidence 99999999998 78889999999999999999999 7888999999999999999999976666665 999999999999
Q ss_pred cccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCcccc-ccCCCCEEEecCCCcCCCC
Q 001838 248 NLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSIT-NASKLTVFQLRGNSFSGFI 326 (1007)
Q Consensus 248 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~ 326 (1007)
-+. .+|..++.+.+|..|+|..|++ ..+|+ |.+...|.+|+++.|.|. .+|.+.. +++++.+|||..|+++ ..
T Consensus 194 ~L~-tlP~~lg~l~~L~~LyL~~Nki-~~lPe--f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 194 LLE-TLPPELGGLESLELLYLRRNKI-RFLPE--FPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhh-cCChhhcchhhhHHHHhhhccc-ccCCC--CCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 886 6788899999999999999999 46773 235677999999999998 5666654 9999999999999998 67
Q ss_pred CcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCcccccc-ccceeee--cccccccc
Q 001838 327 PNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI-SLERFQM--FNCRISGK 403 (1007)
Q Consensus 327 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-~l~~L~l--~~n~l~~~ 403 (1007)
|+.++-+++|+.||+|+|.|++.++ +++++ .|+.|.+.+|++..+-.+-+..-.. -+++|.- ..-.++..
T Consensus 268 Pde~clLrsL~rLDlSNN~is~Lp~------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s 340 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDISSLPY------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS 340 (565)
T ss_pred chHHHHhhhhhhhcccCCccccCCc------ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence 9999999999999999999999876 46777 8999999999987432211111100 1222210 00000000
Q ss_pred CChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccc---cceeecccccccCCCCCCC
Q 001838 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAK---LDKLILHGNKFSGAIPSCS 480 (1007)
Q Consensus 404 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~ 480 (1007)
+ -.+-..-++ ..+..| ....+.+.+.|+++.-+++. +|++.....+ ....+++.|++. .+|..+
T Consensus 341 --e----~~~e~~~t~----~~~~~~-~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L 407 (565)
T KOG0472|consen 341 --E----GGTETAMTL----PSESFP-DIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRL 407 (565)
T ss_pred --c----ccccccCCC----CCCccc-chhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhh
Confidence 0 000000000 111112 23456788999999999974 6776665555 889999999998 788888
Q ss_pred CCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccE
Q 001838 481 GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQK 560 (1007)
Q Consensus 481 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 560 (1007)
..+..+.+.-+.+|+..+.+|..+..+++|+.|++++|-+. .+|.+++.+..|++||+|.|++. .+|..+..+..|+.
T Consensus 408 ~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEt 485 (565)
T KOG0472|consen 408 VELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLET 485 (565)
T ss_pred HHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHH
Confidence 77777776555555555689999999999999999999886 58899999999999999999998 89999988888999
Q ss_pred EeccccccccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccc
Q 001838 561 LFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617 (1007)
Q Consensus 561 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 617 (1007)
+-.++|++....|+.+.+|.+|..|||.+|.|. .+|..+++|++|+.|++++|+|.
T Consensus 486 llas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 486 LLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 988999998777777999999999999999999 78999999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=385.28 Aligned_cols=246 Identities=31% Similarity=0.501 Sum_probs=206.2
Q ss_pred ccccceecccCceEEEEEEEc------CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
....+.||+|+||+||+|+.. +...||||.++..... ..++|++|+++++.++|||||+++|+|..++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 344678999999999999743 3567999999977654 778999999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cc
Q 001838 801 MEYMPNGSLENRLYSG-------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HI 855 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl 855 (1007)
+|||..|||.++|+.. ...++..+.+.||.|||.||+|| .+..+||||+| ||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceEEEe
Confidence 9999999999999732 12377889999999999999999 78889999875 99
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhc
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
+|||++|.+...+.+.......-..+|||||.+..++|+++||||||||+|||++| |+.||.+...++
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----------- 713 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----------- 713 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----------
Confidence 99999999877776665545556789999999999999999999999999999998 999998643322
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
+.+.+.. +...+.++.++.++++||..||+..|++||+++||-.+|+...+.-
T Consensus 714 ---VIe~i~~------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---VIECIRA------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---HHHHHHc------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1111111 1113456678889999999999999999999999999999876543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=359.53 Aligned_cols=275 Identities=24% Similarity=0.268 Sum_probs=136.7
Q ss_pred EEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccC
Q 001838 70 VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSI 149 (1007)
Q Consensus 70 v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~ 149 (1007)
+..||+++|.+...-+..|.++++|+.+.|..|.++ .+|.......+|+.|+|.+|.|+..-...+..+..|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 344555555555444445555555555555555554 3444444444455555555555555555555555555555555
Q ss_pred cccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCC
Q 001838 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEI 229 (1007)
Q Consensus 150 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 229 (1007)
|.|+ .||..-|..-.++++|+|++|.|+..-.+.|.++.+|..|.|+.|.++...+..|.+|++|+.|+|..|+|.-.-
T Consensus 159 N~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 159 NLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred chhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 5554 444444433445555555555555444455555555555555555555444444555555555555555554322
Q ss_pred CcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCcccccc
Q 001838 230 PQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNA 309 (1007)
Q Consensus 230 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 309 (1007)
-..|.+|++|+.|.|..|++.....+.|..+.++++|+|..|++. .+.+.+...++.|+.|+||+|.|..+-++.+...
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 334555555555555555555555555555555555555555442 2222222344445555555555544444444444
Q ss_pred CCCCEEEecCCCcCCCCCcccccccccccccccccccc
Q 001838 310 SKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347 (1007)
Q Consensus 310 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 347 (1007)
++|+.|||++|+|+...+++|..+..|++|+|++|.++
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 44555555555554444444444444444444444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=359.94 Aligned_cols=388 Identities=24% Similarity=0.281 Sum_probs=249.6
Q ss_pred EEEEeCCCCCcccCcccccCC--CCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeeccc
Q 001838 71 IVLNISGFNLQGTIPPQLGNL--SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLS 148 (1007)
Q Consensus 71 ~~L~L~~~~l~~~~~~~l~~l--~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs 148 (1007)
..||.+++.+...--..+.++ +.-++||+|+|+++.+-+..|.++++|+.++|.+|.|+ .+|.+....+.|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 345555555543211111111 24567999999999988999999999999999999986 456666666678888888
Q ss_pred CcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCC
Q 001838 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGE 228 (1007)
Q Consensus 149 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 228 (1007)
+|.|+ .+..+....++.|+.||||.|.|+.+...+|..-.++++|+|++|.|+..--..|.++.+|.+|.|+.|+++..
T Consensus 134 ~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 134 HNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred ccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 88887 66666666788888888888888866666777778888888888888877777888888888888888888876
Q ss_pred CCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccc
Q 001838 229 IPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308 (1007)
Q Consensus 229 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 308 (1007)
.+..|.+|++|+.|+|..|+|.-+.-.+|.++.+|+.|.|..|.+. .+... .|..
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG------------------------~Fy~ 267 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDG------------------------AFYG 267 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCc------------------------ceee
Confidence 6777888888888888888876555556666666666666666552 34444 4444
Q ss_pred cCCCCEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCcccccc
Q 001838 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI 388 (1007)
Q Consensus 309 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 388 (1007)
+.+++.|+|+.|+++..-.+++.+++.|+.|+||+|.|..+.++ +..-+++|++|+|++|+++..
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d-----~WsftqkL~~LdLs~N~i~~l---------- 332 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID-----SWSFTQKLKELDLSSNRITRL---------- 332 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc-----hhhhcccceeEeccccccccC----------
Confidence 45555555555555444445555555555555555555443322 222334444444444443322
Q ss_pred ccceeeeccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCch---hhhccccccee
Q 001838 389 SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPD---EICHLAKLDKL 465 (1007)
Q Consensus 389 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L 465 (1007)
-++.|..++.|++|+|++|.|+..-...|..+.+|+.|||++|.|+..+-+ .|..+++|+.|
T Consensus 333 ---------------~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 333 ---------------DEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred ---------------ChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 223344445555555555555544445555555555555555555544432 35556677777
Q ss_pred ecccccccCCCCCCCCCcccCceeecCCcccccCCCcccccccccccccCC
Q 001838 466 ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVS 516 (1007)
Q Consensus 466 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls 516 (1007)
+|.+|++......+|.++.+|++|||.+|.|.++-|.+|..+ .|..|-++
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 777777765555566777777777777777766666666665 55555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.92 Aligned_cols=260 Identities=24% Similarity=0.431 Sum_probs=214.5
Q ss_pred ccccccHHHHHHhcccc---------cccceecccCceEEEEEEEcC----CceEEEEEechhh-HHHHHHHHHHHHHHH
Q 001838 712 AIRRFSYHELLQATDRF---------SKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRY-ERALKSFQDECEVMK 777 (1007)
Q Consensus 712 ~~~~~~~~~~~~~~~~~---------~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~ 777 (1007)
...+++|+|--+|...| .+.++||.|.||+||+|+++- ...||||.++... ++.+.+|+.|+.||.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 35567777665554444 456899999999999999763 4579999999764 566789999999999
Q ss_pred hcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----
Q 001838 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---- 853 (1007)
Q Consensus 778 ~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---- 853 (1007)
++.||||++|.|+.......+||.|||++|+|+.+|+.+.+.+.+.+...+..+||.||.|| .+.++||||++
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNI 762 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhhe
Confidence 99999999999999999999999999999999999998888899999999999999999999 89999999764
Q ss_pred --------ccceeecceecCCCCcccc-cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCc
Q 001838 854 --------HISDFSIAKFLNGQDQLSM-QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGE 923 (1007)
Q Consensus 854 --------kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~ 923 (1007)
||+|||++|.+.++.+... ..+..-..+|.|||.+...+++.++||||||||+||.++ |+.||-++...+
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 9999999998865542221 122233678999999999999999999999999999776 999987643211
Q ss_pred chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
+...++. ..+.+.+.+++..+.+||..||++|-.+||++.+|+..|.++-+
T Consensus 843 --------------VIkaIe~------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 --------------VIKAIEQ------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --------------HHHHHHh------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1222221 22334556778899999999999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.65 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=196.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+...++|+|+||+||||+.+ +|+.||||++.... +...+-.++|+++|++++|||+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999977 59999999997543 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||+. ++.+-|.+....++.....+|..|+++|+.|+ |++++||||++ |+||||+|+.+... .
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence 9987 55555666666689999999999999999999 78899999875 99999999998632 2
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccc-CcchH-HHHHHhhcCccHHHHhhhhh-
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFI-GELSL-SRWVNDLLPISVMEVIDTNL- 946 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~-~~~~l-~~~~~~~~~~~~~~~~d~~~- 946 (1007)
...+..+.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+-|.+..+ +.... ..-.....| +-.+++...-
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-rhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-RHQSIFSSNPF 234 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-HHHHHhccCCc
Confidence 23466789999999999887 6899999999999999999999998876432 11111 111122222 2222222111
Q ss_pred c-----cchh---hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 L-----SGEE---RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~-----~~~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .... .-....+....-+++++..|++.||++|++.+|++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 0000 0001112334468999999999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=347.70 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=198.2
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+.....+.||+|+||+||+|++. ..||||++... ..+..+.|.+||.++++-+|.||+-+.|||..+.. .||.-+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 33455788999999999999986 37999999754 35578999999999999999999999999999987 999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
|+|-+|+.+++-....++..+.+.||.|||+||.|| |.++|||||++ ||+|||++..-..-....
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 999999999998777899999999999999999999 78999999764 899999997643222222
Q ss_pred ccccccCCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 872 MQTQTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......|...|||||++.. .+|++.+||||||||+|||+||..||..... +..-|+... ...+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGr--G~l~--------- 611 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGR--GYLM--------- 611 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecc--cccC---------
Confidence 2244568889999999875 4699999999999999999999999983211 111121111 0000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.+.......+.+++.+|+..||.+++++||.+.+|+.+|+++..+
T Consensus 612 --pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 --PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 011112234566899999999999999999999999999988776
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=375.62 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=205.5
Q ss_pred ccccceecccCceEEEEEEEcC--Cc----eEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQD--GM----EVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
-...+.||+|+||.||+|...+ |. .||||.+++. ..+...+|.+|..+|++++|||||+++|+|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3456889999999999998653 43 4999998765 356678999999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 801 MEYMPNGSLENRLYSG------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
+|||++|+|..+|++. ...+...+.+.++.|||+|+.|| ++++.||||++ ||+|||+||
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999876 55789999999999999999999 78889999764 999999999
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
.+...+.+.......-...|||||++.++.++.|+|||||||++||++| |..||.+... .++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------~~v 913 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------FEV 913 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------HHH
Confidence 7765555544333344578999999999999999999999999999999 8999986321 111
Q ss_pred hhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 942 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
+...+..+ +.+.++.|+..++++|..||+.+|++||+++.+++++..|......
T Consensus 914 ~~~~~~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 914 LLDVLEGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHHHhCC---ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 11111111 3445567788899999999999999999999999999998876543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=319.38 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=191.9
Q ss_pred ccccccceecccCceEEEEEE-EcCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEE-EEecCCe-eEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIIS-ACSNDDF-KALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 800 (1007)
.+|.+.++||+|+||+|||+. ..+|..||.|.++-. +.+.++....|+.+|++++|||||++++ -|.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357888999999999999997 558999999998743 3566678899999999999999999998 4444444 8999
Q ss_pred EEecCCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecccc------------ccceeeccee
Q 001838 801 MEYMPNGSLENRLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~~~~------------kl~DFGla~~ 863 (1007)
||||.+|+|.++++ +++..+++..++++..|+++||.++|+.- ++ |+|||++ |++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999886 34567999999999999999999997521 34 8999764 9999999999
Q ss_pred cCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
+..... ...+.+|||+||+||.+...+|+.|+||||+||++|||..-++||.+. ++.+..+.
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K----------- 239 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK----------- 239 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-----------
Confidence 864432 335678999999999999999999999999999999999999999863 12111111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
+...... +-..+..+.++..++..|+..||+.||+.-..++.++
T Consensus 240 --I~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 240 --IEQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --HHcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111100 0112344667899999999999999999655555544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.93 Aligned_cols=240 Identities=25% Similarity=0.387 Sum_probs=195.1
Q ss_pred ccccccHHHHHHhcccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 001838 712 AIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISAC 791 (1007)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 791 (1007)
..+++.|++|.+ .+-+|+|+.|.||+|+++ ++.||||+++.-. ..+|+-|++++||||+.+.|+|
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee
Confidence 356677777755 577999999999999997 7899999886542 2578899999999999999999
Q ss_pred ecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceee
Q 001838 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFS 859 (1007)
Q Consensus 792 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFG 859 (1007)
...-.+|||||||+.|-|+..|+.+.. +.......+..+||.||.|| |.+.|||||+ +||+|||
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999999987664 66677888999999999999 6778999965 4999999
Q ss_pred cceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHH
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM 939 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 939 (1007)
.++...+. .+.-..+||..|||||++...+.++|+||||||||||||+||..||.+..... ..| .+....
T Consensus 258 TS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---IIw--GVGsNs-- 327 (904)
T KOG4721|consen 258 TSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---IIW--GVGSNS-- 327 (904)
T ss_pred chHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eEE--eccCCc--
Confidence 99977533 33456789999999999999999999999999999999999999998632110 011 000011
Q ss_pred HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 940 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
...+.+..++.-+.-|++.||+..|..||++++|+.+|.-.
T Consensus 328 ------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 328 ------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11223445666788899999999999999999999998643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=348.16 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=198.1
Q ss_pred ccccceecccCceEEEEEEEcC--C--ce-EEEEEech---hhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQD--G--ME-VAVKVFHQ---RYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
-...+.||+|+||+||+|++.. + .. ||||..+. .......+|.+|+++|++++|||||+++|++......|+
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3345899999999999998653 2 23 89999985 235677899999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|||+|+||+|.++|++....++..++.+++.++|.||+|| |+++++|||+| ||+|||+++...
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-- 313 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-- 313 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCCc--
Confidence 9999999999999998776799999999999999999999 78999999875 999999998653
Q ss_pred Ccccccc-cccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHH-HhhcCccHHHHhhh
Q 001838 868 DQLSMQT-QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWV-NDLLPISVMEVIDT 944 (1007)
Q Consensus 868 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~-~~~~~~~~~~~~d~ 944 (1007)
.+.... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.... ....++ ....+
T Consensus 314 -~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r--------- 381 (474)
T KOG0194|consen 314 -QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYR--------- 381 (474)
T ss_pred -ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCcc---------
Confidence 122212 2234678999999999999999999999999999998 89999874321 122222 11100
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
.+.+...+.++..++.+||..+|++||||.++.+.++.+......
T Consensus 382 ---------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 ---------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011112355688888999999999999999999999999877553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.08 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHH-HHHHHHHHHHHHhcC-CCceeEEEEEEecCC-eeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERA-LKSFQDECEVMKRIR-HRNLVKIISACSNDD-FKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lv 800 (1007)
.++|...+.||.|+||.||+|+-. +|..||||++++..... .---.+|+..|++++ |||||++.+++.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 468899999999999999999854 69999999998775322 122368999999998 999999999998887 99999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
||||+. +|+++++++...+++..++.|+.||.+||+|+ |.+|+.|||++ ||+|||+||.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999986 99999998888999999999999999999999 78899999764 999999999987554
Q ss_pred cccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C--ccHHH----
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P--ISVME---- 940 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~--~~~~~---- 940 (1007)
.+ +..+.|++|+|||++.. +.|+.++||||+|||++|+.+=++-|.+..+-+ .+.+...-.. | ....+
T Consensus 165 PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 165 PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccchhHHHH
Confidence 44 66789999999998765 569999999999999999999998887643211 1111111111 0 01111
Q ss_pred --Hhhhhhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 --VIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 --~~d~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+.-..... ........+....++.+++.+|+.+||.+||||.|++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 110000000 000011122356689999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.66 Aligned_cols=254 Identities=26% Similarity=0.324 Sum_probs=196.0
Q ss_pred cccccccceecccCceEEEEEEE-cCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 799 (1007)
.+.|+..++||+|.||.||+|+. .+|+.||+|++.... +.......+||.||+++.|||||++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677889999999999999985 479999999997654 34456678999999999999999999988776 68999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|+|||++ +|.-++......++..++..|+.|++.||+|+ |..+|+|||++ ||+|||+|++....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 89999988777799999999999999999999 78999999886 99999999988654
Q ss_pred CcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHH-------------HHHhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR-------------WVNDL 933 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~-------------~~~~~ 933 (1007)
.. ...+..+-|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.+.+..+ +...+ |-...
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhcccccc
Confidence 33 234666789999999998875 699999999999999999999999886422 11111 21111
Q ss_pred cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 934 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.|. ...+.+.- .......+.....+...++|+..+|..||++|.||.++++.
T Consensus 349 LP~--~~~~kp~~-~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPH--ATIFKPQQ-PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCc--ccccCCCC-cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 110 00000000 00111111122334578999999999999999999998863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.83 Aligned_cols=230 Identities=25% Similarity=0.333 Sum_probs=187.9
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.++|+..++||+|+||+||.++.+ +++.+|+|++++.. .+..+....|..+|.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999999865 59999999998764 33457788999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
+||+.||.|..+|.+++ .+++..+.-++.+|+.||.|| |+.+|||||++ +++|||+++......
T Consensus 104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999998765 478877778999999999999 78999999885 899999999654332
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......+||+.|||||++.+..|+..+|+||+||++|||++|.+||.... ..++. +.....
T Consensus 180 --~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~------------~~I~~~ 240 (357)
T KOG0598|consen 180 --DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMY------------DKILKG 240 (357)
T ss_pred --CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHH------------HHHhcC
Confidence 22345799999999999999999999999999999999999999998632 11222 221111
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRI 980 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 980 (1007)
.... .+.-...+..+++.+.+..||++|.
T Consensus 241 k~~~---~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 KLPL---PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCC---CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1000 0111244688999999999999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.15 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=196.9
Q ss_pred ccccccceecccCceEEEEEEE-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
..|.....||+|+.|.||.|+. .+++.||||++........+-..+|+.+|+..+|+|||.+++.|...+..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999974 468999999998766555577899999999999999999999999889999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+||+|.+.+.... +++.++..|+.++++||+|| |..+|+|||++ ||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 9999999887543 88999999999999999999 78999999875 9999999998865432 3
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.++.+||++|||||++....|++|+||||+|++++||+-|++||-... .-..-|. +-. ....
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyL-----------Ia~----ng~P 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYL-----------IAT----NGTP 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHH-----------Hhh----cCCC
Confidence 356789999999999999999999999999999999999999987421 1011111 000 0111
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....++.....+.+++.+||+.|+++||++.|++++
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 112234456689999999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.06 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=205.5
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
+...+.++||+|-||+|..|....+..||||+++.... ..+.+|.+|+++|.+++|||||+++|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34566789999999999999998789999999987654 34589999999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
++|+|.+++..+..+ .+.....+|+.|||.||+|| .+.++||||++ ||+|||.++.+...+.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999877433 35667788999999999999 88999999764 999999999887777777
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT--GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.+...+-..+|||||.+..++++.++|||+|||++||+++ .+.||....+++. ++-. .++++..-
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~--------~~~~~~~~--- 761 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENA--------GEFFRDQG--- 761 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhh--------hhhcCCCC---
Confidence 7666777889999999999999999999999999999876 7889986543221 1111 11111110
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.......+.-++.++++++.+||..|.++||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111222344567899999999999999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.94 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=196.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|...+.||+|+||+||||+-+ +.+.||+|.+.+.. ++..+...+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999855 68999999997653 4567789999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
||.| +|+.++..... ++++.+..|+.|++.||.|| |+.+|.|||. +|+||||+||.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9987 99999987654 89999999999999999999 7899999976 49999999998754 33
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.+.+...|||.|||||+..+..|+..+|+||+|||+||+++|++||.... + .+.+........
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i------------~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----I------------TQLVKSILKDPV 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----H------------HHHHHHHhcCCC
Confidence 45577889999999999999999999999999999999999999997421 1 122211111111
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+......+..++...+..||.+|.|-.+++.+
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122445678999999999999999999998765
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=367.05 Aligned_cols=506 Identities=28% Similarity=0.336 Sum_probs=259.2
Q ss_pred EEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCccc
Q 001838 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF 152 (1007)
Q Consensus 73 L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l 152 (1007)
+|++..+++ .||..+..-..++.|++++|-+-...-+...+.-+|+.|||++|++ +..|..+..+.+|+.|++|.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhhH
Confidence 455666655 5565555555577777777766532222233333477777777776 35566666777777777777777
Q ss_pred CCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcc
Q 001838 153 SGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQE 232 (1007)
Q Consensus 153 ~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 232 (1007)
. ..|.+.. ++.+|++|+|.+|++. ..|..+..+++|++|++++|++. .+|..+..++.++.+..++|......+.
T Consensus 81 ~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~- 155 (1081)
T KOG0618|consen 81 R-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ- 155 (1081)
T ss_pred h-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc-
Confidence 6 5664443 6677777777777766 56777777777777777777765 5666666777777777777622212222
Q ss_pred cCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccccCCC
Q 001838 233 MGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKL 312 (1007)
Q Consensus 233 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 312 (1007)
.. ++.++|..|.+.+.++..+.++.. .|+|.+|.+. .. ....+++|+.+....|+++... -.-++|
T Consensus 156 ---~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~---dls~~~~l~~l~c~rn~ls~l~----~~g~~l 221 (1081)
T KOG0618|consen 156 ---TS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VL---DLSNLANLEVLHCERNQLSELE----ISGPSL 221 (1081)
T ss_pred ---cc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hh---hhhhccchhhhhhhhcccceEE----ecCcch
Confidence 11 566666666666666666555555 5666666653 11 1123455666666666555321 123455
Q ss_pred CEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccce
Q 001838 313 TVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLER 392 (1007)
Q Consensus 313 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~ 392 (1007)
+.|+.++|.++...+ -..-.+|+++++++|++++.+ + .+..|.+|..+...+|+|. .+|..+.... +++.
T Consensus 222 ~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp-~-----wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~ 291 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNLP-E-----WIGACANLEALNANHNRLV-ALPLRISRIT-SLVS 291 (1081)
T ss_pred heeeeccCcceeecc--ccccccceeeecchhhhhcch-H-----HHHhcccceEecccchhHH-hhHHHHhhhh-hHHH
Confidence 666666665552211 112235555555555555543 1 2344455555555555552 3333333332 4444
Q ss_pred eeeccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccc-cCccccCCCccCCCCchhhhcccccceeeccccc
Q 001838 393 FQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLN-LQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471 (1007)
Q Consensus 393 L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 471 (1007)
+...+|.+. -+|.....+++|+.|||..|+|...++..|.-+.. |..|+.+.|+++......=..++.|+.|++.+|.
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~ 370 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNH 370 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCc
Confidence 555555554 34444444555555555555554332222222222 4444555555443221111223445555555555
Q ss_pred ccCCCCCCCCCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCcccc
Q 001838 472 FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPIT 551 (1007)
Q Consensus 472 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 551 (1007)
++...-+.+.+...|+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+.++..|++|...+|+|. ..| +
T Consensus 371 Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e 447 (1081)
T KOG0618|consen 371 LTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-E 447 (1081)
T ss_pred ccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-h
Confidence 54443334444555555555555554333334444555555555555554 23344555555555555555554 344 4
Q ss_pred ccCCCCccEEeccccccccc-cCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCC
Q 001838 552 IGGLKNLQKLFLANNRLEGP-IPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614 (1007)
Q Consensus 552 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N 614 (1007)
+..++.|+.+|+|.|+|+.. +|...-. ++|++|||++|.=.-..-+.|..+.++...+++-|
T Consensus 448 ~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 448 LAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 45555555555555555422 2222111 44555555555422122233444444444444433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.16 Aligned_cols=265 Identities=25% Similarity=0.281 Sum_probs=196.3
Q ss_pred ccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHh--cCCCceeEEEEEEecCC----eeEEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKR--IRHRNLVKIISACSNDD----FKALIM 801 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~ 801 (1007)
....++||+|+||.||||.+. ++.||||++.... ++.|++|-+|.+- ++|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 444678999999999999997 5999999997653 4678888888775 57999999999987665 789999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCceecccc------------ccceeeccee
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF------GHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~------~~~~~ivH~~~~------------kl~DFGla~~ 863 (1007)
||.+.|+|.+||..+. ++|....+|+.-+++||+|||+ +|.++|+|||++ .|+|||+|..
T Consensus 288 ~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999999998765 8999999999999999999995 467899999875 5999999998
Q ss_pred cCCCCcccccccccCCcccccccccccCC-C-----CchhhHHHHHHHHHHHHhCCCCCCccccC--cchHHHHHHhhcC
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGR-V-----STRGDVYSYGIMLMETFTGKKPTDEIFIG--ELSLSRWVNDLLP 935 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwS~Gvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~ 935 (1007)
+............+||.+|||||++.+.. + -.+.||||+|.|+|||+++...++..... +..+..-+.....
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 86554444445578999999999987642 2 24689999999999999987655321111 1112211211111
Q ss_pred -ccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 936 -ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 936 -~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
+++.+.+-....+..-+........+..+.+.+..||..||+.|.|+.=|.+++.++......
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 112222211111111112222234456789999999999999999999999999988765543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=298.63 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=194.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|...+.+|+|.||.||+|+.. +|+.||||+++.... .......+|++.|+.++||||+.++++|.+.+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999854 799999999986532 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||+. +|+..++.....+...++..++.++.+|++|+ |++.|+|||++ ||+|||+|+........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9986 99999998888899999999999999999999 78899999875 99999999998654433
Q ss_pred cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC---c------cHHH
Q 001838 871 SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP---I------SVME 940 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---~------~~~~ 940 (1007)
. +..+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..+- ..+....+.... + .+.+
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCcccccccc
Confidence 2 334679999999988775 5999999999999999999988766543211 111111111110 0 1111
Q ss_pred HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+-.......... .-..+..++++++..++.+||.+|+|+.|++++
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111000000000 111234567999999999999999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.02 Aligned_cols=245 Identities=27% Similarity=0.364 Sum_probs=191.6
Q ss_pred ccccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--eeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD--FKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~E 802 (1007)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456778999999999999998764 9999999997654333577899999999999999999999865554 6899999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~~~~ 869 (1007)
|+++|+|.+++.+.+..+++..+.+++.||++||+|| |+++|||+|++ ||+|||+++.......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999987665689999999999999999999 68999999764 8999999997763111
Q ss_pred -ccccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 870 -LSMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 870 -~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
........||+.|||||++..+. ...++||||+||++.||+||++||.+. .+ ...++-... .
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~---~~~~~~~ig------------~ 237 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE---EAEALLLIG------------R 237 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc---hHHHHHHHh------------c
Confidence 11223567999999999998643 345999999999999999999999863 11 111111000 0
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.. ..+..++..+.+..+++.+|++.+|++||||.|++++...
T Consensus 238 ~~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 238 ED--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cC--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 00 0001222345678999999999999999999999998654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=335.32 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=191.5
Q ss_pred cccccccceecccCceEEEEEEE------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC-
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDD- 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 795 (1007)
.++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|||||+++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999974 235789999997543 33456789999999999 8999999999987654
Q ss_pred eeEEEEEecCCCChhHhhhcCC----------------------------------------------------------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------------------------------------------------- 817 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 817 (1007)
..++|||||++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccCCccc
Q 001838 818 ---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGY 882 (1007)
Q Consensus 818 ---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y 882 (1007)
..+++..+.+++.||++||+|| |+.+|+|||++ ||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2367788899999999999999 57899999774 89999999876433322222334567889
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHH
Q 001838 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSL 961 (1007)
Q Consensus 883 ~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 961 (1007)
+|||++....++.++|||||||++|||++ |+.||......+. ...... +.... ..+...+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~-----------~~~~~-------~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK-----------DGTRM-------RAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh-----------cCCCC-------CCCCCCC
Confidence 99999988899999999999999999997 9999975322111 110000 00000 0011224
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 962 LSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 962 ~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.06 Aligned_cols=241 Identities=26% Similarity=0.421 Sum_probs=198.3
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
+....+++|-|-||.||.|.|+. .-.||||.++.... ..++|..|+.+|+.++|||+|+++|+|..+..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44556889999999999999874 67899999986543 45889999999999999999999999999999999999999
Q ss_pred CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+||++.. ..++....+.+|.||+.||+|| ..+.+||||+ +||+|||+++++.++ .+..
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTA 422 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceec
Confidence 999999998743 3466667888999999999999 7888999976 499999999999754 3322
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....-...|.|||.+....++.|+|||+|||+|||+.| |..||.+.. +.+ +.+.+.. .
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSq---------VY~LLEk------g 482 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ---------VYGLLEK------G 482 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHH---------HHHHHhc------c
Confidence 223334668999999999999999999999999999998 889987642 111 1222221 2
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.++..++.|+..+++||+.||+++|++||+++|+-+.++.+
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 33445667888999999999999999999999999999754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.45 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=203.0
Q ss_pred cccceecccCceEEEEEEEcC-----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 729 SKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
...+.||+|-||.||+|.+.+ ...||||..+... ....+.|..|..+|++++|||||+++|+|.+. ..|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 446889999999999998543 2359999998643 45578899999999999999999999999865 5899999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
.++.|.|.+||......++......++.||+.||.|| ++.+.||||++ |++|||+++.+.++..+
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999998888899999999999999999999 78999999885 89999999999766555
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.. +...-...|||||.+.-.+++.++|||-|||.+||+++ |..||.+....++ ...-.
T Consensus 548 ka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------------I~~iE 606 (974)
T KOG4257|consen 548 KA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------------IGHIE 606 (974)
T ss_pred hc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------------EEEec
Confidence 43 23445678999999999999999999999999999986 9999986433221 11112
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
.+.+.+.++.|+..++.++.+||.++|.+||.+.|+...|..|..
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233445567788899999999999999999999999999999877
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.09 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=195.5
Q ss_pred cccccccceecccCceEEEEEEE-cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.+.|+..+.||.|..++||+|+. +.+..||||++.-.. ....+.+++|+..|+.++|||||+++..|..++..|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35788899999999999999985 468999999998553 3346889999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||.+||+.+.++.. ...+++..+..|.+++++||.|| |.++.||||++ ||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999753 34588889999999999999999 68899999875 8999999877654321
Q ss_pred c-ccc-ccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhh
Q 001838 870 L-SMQ-TQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 870 ~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
. ... ...+||++|||||++.. ..|+.|+|||||||+..||++|..||.......+-+... +...|.......|
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~~-- 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGLD-- 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccCC--
Confidence 1 111 45689999999999543 469999999999999999999999998654322222111 1111111111111
Q ss_pred hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..........+.+++..|+++||++|||+.++++.
T Consensus 259 --------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 --------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11122234578999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.48 Aligned_cols=238 Identities=24% Similarity=0.392 Sum_probs=192.3
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechh----hH-HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR----YE-RALKSFQDECEVMKRIR-HRNLVKIISACSNDD 795 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 795 (1007)
...++|...+.||+|+||+||.|+.. +|..||||++++. .. ...+...+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999754 6899999987664 11 23456678999999999 999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecce
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAK 862 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~ 862 (1007)
..|+|||||.||+|.+++.+ ...+.+....+++.|++.|++|+ |+.+|+|||++ ||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999998 45688899999999999999999 78899999875 899999999
Q ss_pred ecCCCCcccccccccCCcccccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGR-VS-TRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
.... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++..... +.. .
T Consensus 170 ~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--l~~---k-------- 234 (370)
T KOG0583|consen 170 ISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--LYR---K-------- 234 (370)
T ss_pred ccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--HHH---H--------
Confidence 8741 112335678999999999999877 85 78999999999999999999999722111 110 0
Q ss_pred HhhhhhccchhhhHHHHHHH-HHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKEQS-LLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~-~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
+ .... ...+... ..++.+++.+|++.||.+|+|+.||++
T Consensus 235 -i----~~~~---~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 -I----RKGE---FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -H----hcCC---ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0 0000 0011112 456899999999999999999999993
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=318.81 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=191.9
Q ss_pred cccccHHHHHHhcccccccceecccCceEEEEEEEcCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEE
Q 001838 713 IRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIIS 789 (1007)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~ 789 (1007)
.+.++.+++.. .....||+|++|.||+|.+ +|+.||||+++... ....+.|.+|++++++++|||||+++|
T Consensus 12 ~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 45566666632 2246799999999999998 58999999997543 223577889999999999999999999
Q ss_pred EEec----CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 790 ACSN----DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 790 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
++.+ ....++|||||++|+|.+++.... .+++....+++.|++.|+.|||. ..+++||+++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcE
Confidence 9876 346899999999999999998654 58899999999999999999962 3467798764
Q ss_pred ccceeecceecCCCCcccccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~ 931 (1007)
||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +...+.
T Consensus 163 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i~ 235 (283)
T PHA02988 163 KIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLII 235 (283)
T ss_pred EEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 899999998654321 23468899999999876 679999999999999999999999998532111 111110
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
. . ... ...+..++.++.+++.+||+.||++|||++|+++.|+.++
T Consensus 236 ~-----------~----~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 236 N-----------K----NNS--LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred h-----------c----CCC--CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 0 000 0001123456899999999999999999999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.03 Aligned_cols=251 Identities=27% Similarity=0.344 Sum_probs=201.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
..|...+.||+|+||.||||... +++.||+|++.-.. +...+..++|+.++.+++|+||.++||.|..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777789999999999999865 68999999998654 44567889999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
|.||++.+.++.+.. +++....-|++++..|+.|| |..+.+|||++ |++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 999999999986543 46666777899999999999 67788999764 8999999998764322
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....+||+.|||||++....|+.|+||||+|++.+||++|.+|+.+......- ..+|.....
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flIpk~~PP----------- 229 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLIPKSAPP----------- 229 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------EeccCCCCC-----------
Confidence 225678999999999999889999999999999999999999999875431110 001111000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH-----------HHHHHHHhhhcccc
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG-----------LLKIRDTLVKSVGM 1002 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~-----------L~~i~~~~~~~~~~ 1002 (1007)
.........+.+++..|+.++|+.||+|.+++++ |.++-+++++|..+
T Consensus 230 ---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 230 ---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVK 288 (467)
T ss_pred ---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhc
Confidence 0111234568899999999999999999999985 66666677777654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.32 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=196.0
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDF 796 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 796 (1007)
.+...+|..++.||+|+|++||+|+.. +++++|||++.++. ++..+-...|-++|.++ .||.||+|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 334567888999999999999999855 69999999998764 33345567899999999 79999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~ 864 (1007)
.|+|+||+++|+|.++|++-+ .+++.-...+|.+|+.|++|| |+.+|||||++ ||+|||-|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998764 488888888999999999999 79999999886 89999999988
Q ss_pred CCCCcc-----------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 001838 865 NGQDQL-----------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 865 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
.+.... ....+.+||..|.+||++..+..++.+|+|+||||+|.|++|++||.... +..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyli------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLI------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHH-------
Confidence 542111 11145789999999999999999999999999999999999999998642 1111
Q ss_pred cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 934 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+++-.. +.++..++.+.+|+.+.|..||.+|+|+.||-++
T Consensus 296 ----FqkI~~l~y--------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ----FQKIQALDY--------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHHHHhcc--------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111111 1112223568999999999999999999888665
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.45 Aligned_cols=256 Identities=23% Similarity=0.269 Sum_probs=189.6
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSND--DFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 799 (1007)
.+.|+..+.|++|+||.||+|+.+ +++.||+|+++...+ ..--...+||.+|.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345777899999999999999965 689999999975532 1122457899999999999999999987643 47999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|||||+. +|...+..-...+...++..++.|+++|++|| |...|+|||++ ||+|||+||.+...
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 99999987766788899999999999999999 67899999875 89999999987543
Q ss_pred CcccccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C-ccHH-----
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P-ISVM----- 939 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~-~~~~----- 939 (1007)
....+..+-|.+|+|||.+.+.+ |++.+|+||+|||+.||+++++-|.+...-+ .+.+.+.... | +..-
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCccc
Confidence 23346677899999999988764 9999999999999999999999887532211 1111111111 1 0000
Q ss_pred -HHhhhhhcc-----chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 -EVIDTNLLS-----GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 -~~~d~~~~~-----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+...-.. .....+.... ....-++|+...+.+||++|.||.|.++.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000000000 0000111110 23567899999999999999999998864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=296.66 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=193.2
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++.|+..+.||+|.|+.||++... +|+.+|+|++.... ....+.+.+|+.|-+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999999754 69999999886432 234577889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeecceecCC
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIAKFLNG 866 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGla~~~~~ 866 (1007)
|+|.||+|..-+-.+ ...++..+-.++.||++||+|+ |.++|||||++ |++|||+|..+.+
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999997655433 3467777888999999999999 78999999874 8999999998863
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
. ....+.+|||+|||||++...+|+..+|||+.|||||-|+.|++||.+.... ++.+.+.
T Consensus 166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------------rlye~I~--- 225 (355)
T KOG0033|consen 166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------------RLYEQIK--- 225 (355)
T ss_pred c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------------HHHHHHh---
Confidence 2 3346678999999999999999999999999999999999999999763211 1111111
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........+..+...++..+|+++|+..||++|.|+.|++++
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111111111223345678999999999999999999998875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.00 Aligned_cols=484 Identities=29% Similarity=0.364 Sum_probs=393.7
Q ss_pred EEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEEccCc
Q 001838 96 TLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175 (1007)
Q Consensus 96 ~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N 175 (1007)
.+|+|...+. .||..+..-..|+.|++++|.+-..+-.+...--.|+.||||+|+++ ..|..+. .+..|+.|+++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it-~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQIT-LLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhh-hHHHHhhcccchh
Confidence 4677888887 78888777777999999999986655445544444999999999997 8888887 6899999999999
Q ss_pred cccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeeccCccccccccc
Q 001838 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPF 255 (1007)
Q Consensus 176 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 255 (1007)
.|. ..|.+.+++.+|++|.|.+|.+. ..|.++..+.+|+.|+++.|++. .+|..+..+..++.+..++|......+.
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~ 155 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ 155 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc
Confidence 998 77888999999999999999998 78999999999999999999998 8899999999999999999933222222
Q ss_pred cccCCCCCCeEEcccccccCcCCchhhcCCCCCc-EEeccCCCCCCCCCccccccCCCCEEEecCCCcCCCCCccccccc
Q 001838 256 TIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVE-FLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLR 334 (1007)
Q Consensus 256 ~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 334 (1007)
...+.+++..|.+.+.++..+. +++ .|+|.+|++.. -.+.++.+|+.+....|+++... -..+
T Consensus 156 -----~~ik~~~l~~n~l~~~~~~~i~----~l~~~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~----~~g~ 219 (1081)
T KOG0618|consen 156 -----TSIKKLDLRLNVLGGSFLIDIY----NLTHQLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE----ISGP 219 (1081)
T ss_pred -----ccchhhhhhhhhcccchhcchh----hhheeeecccchhhh---hhhhhccchhhhhhhhcccceEE----ecCc
Confidence 2288889988888877776554 334 49999998872 34667888999999999887432 2457
Q ss_pred ccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceeeeccccccccCChhhhccCCC
Q 001838 335 NLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNL 414 (1007)
Q Consensus 335 ~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L 414 (1007)
+|+.|+.++|.++...+. .--.+++++++++|++++. |++++.+. +++.+...+|+++ .+|..+....+|
T Consensus 220 ~l~~L~a~~n~l~~~~~~-------p~p~nl~~~dis~n~l~~l-p~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L 289 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVH-------PVPLNLQYLDISHNNLSNL-PEWIGACA-NLEALNANHNRLV-ALPLRISRITSL 289 (1081)
T ss_pred chheeeeccCcceeeccc-------cccccceeeecchhhhhcc-hHHHHhcc-cceEecccchhHH-hhHHHHhhhhhH
Confidence 889999999998854332 1224688899999999864 58888887 8999999999994 788888888999
Q ss_pred cEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhccc-ccceeecccccccCCCCCCCCCcccCceeecCC
Q 001838 415 LLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLA-KLDKLILHGNKFSGAIPSCSGNLTSLRALYLGS 493 (1007)
Q Consensus 415 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 493 (1007)
+.|++.+|.+. -+|....+++.|++|+|..|+|....+..+.-+. +|+.|+.+.|+++...-..-..+..|+.|++.+
T Consensus 290 ~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 290 VSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhc
Confidence 99999999998 5677777889999999999999654443333333 378888888888743322234577899999999
Q ss_pred cccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEeccccccccccC
Q 001838 494 NRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573 (1007)
Q Consensus 494 N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 573 (1007)
|.++...-..+.+.+.|+.|+|++|++.......+.++..|++|+||+|.++ .+|..+..++.|++|...+|+|. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 9999887778888999999999999999777778899999999999999999 89999999999999999999998 567
Q ss_pred ccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCc
Q 001838 574 ESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNK 615 (1007)
Q Consensus 574 ~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~ 615 (1007)
.+..++.|+.+|+|.|+|+...-.....-++|++|||++|.
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 78999999999999999996543333333899999999997
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.31 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=196.0
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEec-----
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSN----- 793 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----- 793 (1007)
.....+|...+.||+|+||.|+.|... +|+.||||++.... .-..++..+|+++++.++|+|||.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344566777899999999999999865 69999999998443 4456788999999999999999999999876
Q ss_pred CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecc
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIA 861 (1007)
Q Consensus 794 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla 861 (1007)
-+..|+|+|+|+ -+|.+.++.+.. ++......++.|+++||.|+ |+.+|+|||++ ||+|||+|
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccce
Confidence 246899999995 489999987653 78888888999999999999 78999999875 99999999
Q ss_pred eecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc---Ccc
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---PIS 937 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~ 937 (1007)
+...........+..+.|.+|.|||++.. ..|+..+||||.|||+.||++|++-|.+.. .......+.... ++.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQLILELLGTPSEE 250 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHHHHHhcCCCCHH
Confidence 98864423334467789999999998765 569999999999999999999999887532 122222221111 111
Q ss_pred HHHHhh---------hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 VMEVID---------TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~~~~~d---------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+. .............-+.....+++|+.+||..||.+|+|++|++++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 100111111111122334578999999999999999999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.68 Aligned_cols=237 Identities=26% Similarity=0.409 Sum_probs=195.0
Q ss_pred cceecccCceEEEEEEEcC--C--ceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 731 NNLLGIGSFGSVYVARLQD--G--MEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.+.||+|+||+|++|.|+. | ..||||.++.... ..+.+|.+|+.+|.+++|||+|+|||+..+ ....+|||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 5789999999999998763 4 3689999986653 367899999999999999999999999987 66889999999
Q ss_pred CCChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC-ccc
Q 001838 806 NGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD-QLS 871 (1007)
Q Consensus 806 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~-~~~ 871 (1007)
.|+|.+.|++ ....+-......++.|||.||.|| .+++.||||++ ||+|||+.+-+...+ .+.
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999987 455677888999999999999999 89999999874 999999999886543 343
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
+.....-.+.|.|||.+...+++.++|||+|||++|||+| |+.||.+... ..+.+.+|.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~qIL~~iD~------ 330 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------IQILKNIDA------ 330 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------HHHHHhccc------
Confidence 4444445678999999999999999999999999999998 7899876421 122333331
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
..+.+.++.|++++++++..||..+|++|||+..+.+.+-.
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 12233445678899999999999999999999999866543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.90 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=190.4
Q ss_pred cccccccceecccCceEEEEEEE------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 796 (1007)
.++|+..+.||+|+||+||+|+. .++..||||+++... ....+.+.+|+.+++.+ +|||||+++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688899999999999999963 236689999997542 33456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC-----------------------------------------------------------
Q 001838 797 KALIMEYMPNGSLENRLYSGT----------------------------------------------------------- 817 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 817 (1007)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 818 ---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 818 ---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
..+++..+.+++.||++||+|| |+.+|+|||++ ||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1467888999999999999999 56789999764 89999999876543322
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.......++..|+|||++....++.++|||||||++|||++ |..||....... ...+++... ....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~------------~~~~ 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEG------------YRML 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhC------------ccCC
Confidence 22223345678999999998899999999999999999998 888987532211 111221110 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.+...+.++.+++.+||+.||++||||.||+++|++
T Consensus 338 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.43 Aligned_cols=224 Identities=25% Similarity=0.329 Sum_probs=184.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.+|.|+||+|..++.+ +|..+|+|+++++. -+..+...+|..+|+.+.||.+|++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777899999999999999976 58999999998764 345567789999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||++||.|..++++.+ .++...+.-+|.||+.|++|| |+..|++||++ ||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 9999999999998755 488888888999999999999 78899999876 89999999988543
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
+-+.+|||.|+|||++....|..++|+|||||++|||+.|.+||.+... ++..++.+...
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~~iY~KI~~~~ 257 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------IQIYEKILEGK 257 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------HHHHHHHHhCc
Confidence 2457899999999999999999999999999999999999999986322 11122211111
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKR 979 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 979 (1007)
. . .+.....++.+|+...++.|-.+|
T Consensus 258 v-~---fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V-K---FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c-c---CCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 0 111223467788888888888888
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.38 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=190.8
Q ss_pred cccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 796 (1007)
.++|+..+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++++ +|||||+++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999999742 24579999997542 34456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC-----------------------------------------------------------
Q 001838 797 KALIMEYMPNGSLENRLYSGT----------------------------------------------------------- 817 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 817 (1007)
.++|||||++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 818 ----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 818 ----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
..+++..+.+++.||+.||+|| |+.+|+|||++ ||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1367888899999999999999 57899999774 8999999987643322222223
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
..++..|||||++....++.++|||||||++|||++ |+.||....... .... .+........
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~------------~~~~~~~~~~---- 336 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYK------------MVKRGYQMSR---- 336 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHH------------HHHcccCccC----
Confidence 345678999999988899999999999999999997 999997532211 1111 1110000000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
+...+.++.+++.+||+.||++|||+.||+++|+++.
T Consensus 337 --~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 --PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0011346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.98 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=188.6
Q ss_pred ccccccceecccCceEEEEEEEcC-----------------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-----------------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKI 787 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 787 (1007)
++|...+.||+|+||+||+|.+++ +..||||++.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 3469999987543 3445679999999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCChhHhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 001838 788 ISACSNDDFKALIMEYMPNGSLENRLYSGT------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849 (1007)
Q Consensus 788 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 849 (1007)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.|++.||+|| |+.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence 999999999999999999999999986421 2367788999999999999999 5678999
Q ss_pred cccc------------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 001838 850 YMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT--GKKP 915 (1007)
Q Consensus 850 ~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p 915 (1007)
||++ ||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9764 8999999987654333222234456889999999988889999999999999999987 5567
Q ss_pred CCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 916 TDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 916 ~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
|...... .....+........... . ...++.++..+.+++.+||+.||++||||.||.+.|+
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGRQV--------Y---LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhccccc--------c---ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7653211 11111111100000000 0 0001122456899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.71 Aligned_cols=230 Identities=23% Similarity=0.305 Sum_probs=190.5
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 799 (1007)
.++|...+++|+|.||+|+++..+ +++.+|||++++.. ....+..+.|.+|+.-.. ||.++.++.+|.+.++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457888999999999999999976 58899999998764 345677889999988885 9999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
||||+.||++..+.+. ..++..++.-||..|+.||+|| |+++||+||++ ||+|||++|.....
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999995544433 4589999999999999999999 78999999885 99999999975422
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
...+++.+||+.|||||++.+..|+..+|+|||||++|||+.|+.||.+.. -.+++|..+.
T Consensus 522 --g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-----------------Eee~FdsI~~ 582 (694)
T KOG0694|consen 522 --GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-----------------EEEVFDSIVN 582 (694)
T ss_pred --CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-----------------HHHHHHHHhc
Confidence 234567899999999999999999999999999999999999999998532 1233443332
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
.... .+...+.+..+++.+.+..+|++|.-+
T Consensus 583 d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 2211 122345678999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=320.42 Aligned_cols=236 Identities=24% Similarity=0.334 Sum_probs=193.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
.-|+.++.+|.|+-|.|..|++. +|+.+|||++.+.. ......+.+|+.+|+-+.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45677889999999999999854 79999999997652 223356789999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|.|++++.+++. +...++.+++.||..|+.|+ |.-+|+|||++ ||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999987654 77788889999999999999 56779999875 89999999876543
Q ss_pred ccccccccCCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
....+.||++.|.|||++.+.+| +.++||||.|||||.|+||+.||++. ++........ .
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~-------------~ 226 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQ-------------R 226 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHH-------------c
Confidence 23356799999999999999988 56899999999999999999999852 2222111111 0
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
+ .+..+...+.++.+|+.+|+..||++|.|++||+++-
T Consensus 227 G---~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 G---VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred C---cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1 1112234566899999999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.87 Aligned_cols=237 Identities=32% Similarity=0.516 Sum_probs=181.4
Q ss_pred ccceecccCceEEEEEEEc-----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 730 KNNLLGIGSFGSVYVARLQ-----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
..+.||.|+||.||+|.+. .+..||||+++... ....+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 26789999996543 44568899999999999999999999999988889999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++|+|.+++... ...+++..+.+++.|||+||.||| +.+++|+++ +||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999886 567899999999999999999995 567999854 499999999987433333
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.......+...|+|||.+....++.++||||||+++||+++ |+.||.+... .++... +.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~---------~~~~~~-- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEK---------LKQGQR-- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHH---------HHTTEE--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccc---------cccccc--
Confidence 33334457789999999988889999999999999999999 7889875311 111111 100000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
...+..++..+.+++..||..+|++||||+|+++.|
T Consensus 224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 000111244688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.15 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=191.6
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
..++|+...+||+|+||.||.|+.+ +|..+|+|++++.. ....+....|-.+|....+|.||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4678999999999999999999866 59999999998764 3456778899999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC-
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG- 866 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~- 866 (1007)
||||.+||++..+|.+.+ .++...+..++.+.+-|++.+ |..++||||++ |++||||++-+..
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998765 478888888999999999999 78899999886 8999999964311
Q ss_pred --------------------CCccc-----c-------------------cccccCCcccccccccccCCCCchhhHHHH
Q 001838 867 --------------------QDQLS-----M-------------------QTQTLATIGYMAPEYGVQGRVSTRGDVYSY 902 (1007)
Q Consensus 867 --------------------~~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~ 902 (1007)
..... . ....+|||-|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00000 0 013579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccccCc--chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 001838 903 GIMLMETFTGKKPTDEIFIGE--LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI 980 (1007)
Q Consensus 903 Gvil~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 980 (1007)
|||+|||+.|.+||......+ ..+..|.....-. .......++.||+.+|+. ||++|.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-------------------~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-------------------EEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-------------------CcCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999998654332 2344454332110 011123578999999999 999997
Q ss_pred C---HHHHHH
Q 001838 981 N---AREIVT 987 (1007)
Q Consensus 981 t---~~evl~ 987 (1007)
- +.||-+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5 455443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=322.50 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=193.0
Q ss_pred hcccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSNDD 795 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 795 (1007)
..++|.+.+.||+|+||+||+|+.. .+..||||+++... ....+.+.+|+++++++. |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568889999999999999999853 13479999997543 344567999999999996 999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCC----------------------------------------------------------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------------------------------------------------- 817 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 817 (1007)
..|+|||||++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 818 -------------------------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 818 -------------------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
..+++..+.+++.|+++|++|| |+.+|+|++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEe
Confidence 2367788899999999999999 56789999764
Q ss_pred -----ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~ 927 (1007)
|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 8999999987643332222233457788999999988889999999999999999997 9999875322111 11
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
..+. .... ...+...+.++.+++.+||+.+|++|||+.+|+++|+++.+
T Consensus 351 ~~~~------------~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIK------------SGYR------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHh------------cCCC------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1000 0000 00111234578999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=311.47 Aligned_cols=238 Identities=20% Similarity=0.295 Sum_probs=187.1
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|+..+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999864 69999999987543 22334678999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|++|+|.+++... ...+++..+..++.|++.|++|| |+.+|+|||++ ||+|||+++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888643 33588999999999999999999 67899999774 7999999987643221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . +.++..+....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~-------------~~~~~~~~~~~ 221 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-R-------------EEVDRRVKEDQ 221 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-H-------------HHHHHHhhccc
Confidence 2345789999999999999999999999999999999999999985322110 0 11111110000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
. ..+.....++.+++.+||+.||++||+ ++|++++
T Consensus 222 ~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 E---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred c---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 001122446889999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.88 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=191.2
Q ss_pred ccccccceecccCceEEEEEEEc----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||.||+|.+. .+..||+|+++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999753 36789999987643 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++......+++.+++.++.|++.|++|| |+.+++|||+ .|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999987655689999999999999999999 5778999976 3899999876543221
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.. ......++..|+|||++....++.++|||||||++||+++ |+.||...... ...+.+... ..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~-----------~~- 226 (266)
T cd05064 162 IY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG-----------FR- 226 (266)
T ss_pred hh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC-----------CC-
Confidence 11 1122345678999999988999999999999999999775 99999753211 111111100 00
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+.+..++..+.+++.+||+.+|++||++.|+.+.|.++
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 001122345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.77 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe-eEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDF-KALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv 800 (1007)
.++|...+.+|+|+||.++..+.+ +++.+|+|.+.-. .....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467888999999999999998866 5789999988643 24445678899999999999999999999999887 9999
Q ss_pred EEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 801 MEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
||||+||++.+.+.+.+ ..++...+.+++.|++.|+.|| |++.|+|||++ |+.|||+||.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998665 6789999999999999999999 68899999764 89999999998755
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
. ....+.+||+.||.||.+.+.+|+.|+||||+||++|||++=+++|...... ..+-....
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----------------~Li~ki~~ 220 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----------------ELILKINR 220 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----------------HHHHHHhh
Confidence 4 2346688999999999999999999999999999999999999999853211 11111111
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.. ..+.+.....++..++..|++.+|+.||++.+++.+
T Consensus 221 ~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 00 112233445678999999999999999999999988
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=318.50 Aligned_cols=234 Identities=26% Similarity=0.400 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChh
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLE 810 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 810 (1007)
-++|+|.||+||.|++. +...+|||.+..+..+..+-+.+|+.+.++++|+|||+++|.|.+.++.-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36899999999999966 46679999998777666677889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCCCCccccccc
Q 001838 811 NRLYSGTCML--DIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 811 ~~l~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+.|+..=+++ .+...-.+.+||++||.|| |...|||||++ ||+|||.+|.+.+- ...+.+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998764445 4556667899999999999 78889999775 99999999987532 223456
Q ss_pred ccCCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 876 TLATIGYMAPEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
..||..|||||++..++ |+.++|||||||++.||.||++||.+......... ...+ ....
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---------------kVGm---yKvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---------------KVGM---YKVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---------------hhcc---eecC
Confidence 78999999999998764 89999999999999999999999976432211110 0000 1122
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
++.+++...++..++.+|..+||.+||+|.++++.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 33455667789999999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=279.60 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=195.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.++|+..+.+|+|-||.||.|+.+ ++-.||+|++-+.. .+...++.+|++|-+.++||||.++++||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999865 57889999986543 23346789999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 801 MEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
+||.++|++...|..+. ..++......++.|+|.|+.|+ |.+.|+|||++ |++|||.+-..+.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999998543 3578888889999999999999 89999999875 8999999986542
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
......+||.-|.|||...+..++.++|+|++||+.||++.|.+||+....++ .+.+... .+..
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k-------~~~~----- 240 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRK-------VDLK----- 240 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHH-------cccc-----
Confidence 22356789999999999999999999999999999999999999998643211 1111100 0001
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.+......+.+++.+|+..+|.+|.+..||++.-.
T Consensus 241 --------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 --------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred --------CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11233457899999999999999999999988643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.95 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=192.9
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.++|+..+.||+|+||+||+|+.. +|..||+|++... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999876 5889999998754 23445779999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|+++|+|.+++.... .+++..+..++.|++.||.||| ...+|+|+|++ ||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999997654 4788899999999999999996 23469999763 89999999866432
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc----------------
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---------------- 934 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---------------- 934 (1007)
......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +........
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccc
Confidence 1234568999999999998889999999999999999999999996432111 111110000
Q ss_pred ---------------CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 935 ---------------PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 935 ---------------~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.....+..+.......... .......++.+++.+||+.||++|||+.|++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000011110000000000 00112457899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.58 Aligned_cols=257 Identities=19% Similarity=0.194 Sum_probs=189.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||+||+|+.+ +++.||||+++... ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999976 58899999987542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|++++.+..+.. ....+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999887765543 334588889999999999999999 57789999763 89999999876432211
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHh--hcCccHHHHh--hhh-
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVND--LLPISVMEVI--DTN- 945 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~--~~~~~~~~~~--d~~- 945 (1007)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........ ..+....... ++.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 -NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1234568999999999988889999999999999999999999997532211 11110000 0011000000 000
Q ss_pred -------hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 946 -------LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 946 -------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...............+.++.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000111234579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.72 Aligned_cols=233 Identities=22% Similarity=0.333 Sum_probs=193.3
Q ss_pred cccccceecccCceEEEEEEE-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
+|++.+.+|+|.||+|-+|+. ..|+.||||.+++.. ++..-.+.+|++||+.++||||++++++|+..+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 577788999999999999985 579999999997653 4556678999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|..+|.|++|+.+.+ .+++.+..+++.||+.|+.|+ |.++++|||++ ||+|||++-......-
T Consensus 134 YaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf- 208 (668)
T KOG0611|consen 134 YASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF- 208 (668)
T ss_pred ecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhccccH-
Confidence 999999999998765 488999999999999999999 78999999874 9999999988754322
Q ss_pred cccccccCCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
..+.+|++-|.+||.+.+.+| .+.+|-||+||+||.|+.|..||++... ...+ .++..+
T Consensus 209 --LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lv-------------rQIs~G 268 (668)
T KOG0611|consen 209 --LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLV-------------RQISRG 268 (668)
T ss_pred --HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHH-------------HHhhcc
Confidence 356899999999999999887 6799999999999999999999986311 1111 112222
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.++. +.+..-|+++|+..+|++|.|+.+|..+
T Consensus 269 aYrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 269 AYREPET----PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccCCCC----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2222111 3356788999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.81 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=191.4
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHh--cCCCceeEEEEEEecCC----eeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKR--IRHRNLVKIISACSNDD----FKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~l 799 (1007)
.+....+.||+|.||+||+|.++ |+.||||++...++ +.+.+|.+|... ++|+||..+++.-..+. +.||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34566789999999999999997 89999999987654 567788888876 49999999998865443 6899
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecccc------------ccceeecce
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF-----GHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
|.||.+.|||+|||.+. .++....++++..+|.||+|||. ...+.|.|||++ .|+|+|+|-
T Consensus 287 vTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999874 48899999999999999999993 357789999885 499999997
Q ss_pred ecCCC-Ccc-cccccccCCcccccccccccCC----C--CchhhHHHHHHHHHHHHhCC----------CCCCccccCcc
Q 001838 863 FLNGQ-DQL-SMQTQTLATIGYMAPEYGVQGR----V--STRGDVYSYGIMLMETFTGK----------KPTDEIFIGEL 924 (1007)
Q Consensus 863 ~~~~~-~~~-~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwS~Gvil~elltG~----------~p~~~~~~~~~ 924 (1007)
....+ +.. ......+||.+|||||++.... + -..+||||||.|+||++.+. .||.+....+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 65433 111 1224568999999999986532 1 23689999999999998642 46655443333
Q ss_pred hHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 925 SLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 925 ~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
+..+. .+++-....+..........+.+..+.++|+.||..+|..|-|+-.|-+.|.++.+.
T Consensus 445 s~eeM---------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 445 SFEEM---------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CHHHH---------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 33222 122111111111111222334577899999999999999999999999999988753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.35 Aligned_cols=239 Identities=23% Similarity=0.407 Sum_probs=189.0
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|+..+.||+|+||.||+|+.+++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999998888899999886432 223578899999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.++++.....+++..+..++.|++.||+|| |+.+|+|+++ +|++|||.++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 9999999986555689999999999999999999 5778999865 38999999987643221 111
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ......+..... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~----------~~----- 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR----------LY----- 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC----------CC-----
Confidence 23345678999999988889999999999999999999 8999875321 111111111000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.+.....++.+++.+||+.+|++||+|.|+++.|
T Consensus 222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011134689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.07 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=199.6
Q ss_pred cccceecccCceEEEEEEE-cC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 729 SKNNLLGIGSFGSVYVARL-QD----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~-~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
...++||+|+||+||||.+ +. ..+||||++.... .+...++.+|+-+|.+++|||+++++|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468899999999999974 33 4579999986543 455678999999999999999999999998776 789999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||+.|+|.++++.++..+.....+.+..|||+||.|| |..++|||+++ ||.|||+|+....++..
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999998888888899999999999999999 68899999764 89999999998755432
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
-......-.+.|||=|.+....|+.++|||||||++||++| |..||++...++ +.+.+.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------I~dlle------ 914 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------IPDLLE------ 914 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------hhHHHh------
Confidence 22233344678999999999999999999999999999998 999998753222 111111
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
...+.+.++-+..+++-++.+||..|+..||+++|+.....++.+.
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1112445566778899999999999999999999999998887654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.60 Aligned_cols=363 Identities=28% Similarity=0.429 Sum_probs=184.1
Q ss_pred CCcEEEccCcccc-ccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeec
Q 001838 166 NLKKLLLGRNMFH-GKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTL 244 (1007)
Q Consensus 166 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 244 (1007)
-.+-.|+++|.|+ +.+|.....+++++.|.|...+|. .+|.+++.+.+|++|.+++|++. .+-.++..++.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3344555555555 344555555555555555555554 44555555555555555555554 33344444445554444
Q ss_pred cCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccccCCCCEEEecCCCcCC
Q 001838 245 ATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSG 324 (1007)
Q Consensus 245 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 324 (1007)
.+|++.. .-+|..+| .+..|+.||||+|+++ ..|..+....++.+|+||+|+|..
T Consensus 86 R~N~LKn-----------------------sGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet 140 (1255)
T KOG0444|consen 86 RDNNLKN-----------------------SGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET 140 (1255)
T ss_pred hcccccc-----------------------CCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc
Confidence 4444421 22555554 5666666666666666 456666666677777777777765
Q ss_pred CCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceeeeccccc-ccc
Q 001838 325 FIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRI-SGK 403 (1007)
Q Consensus 325 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~l-~~~ 403 (1007)
++...|.+++.|-+||||+|++...+|. ...+..|++|.|++|++.-.--..+..+. +|+.|.+++.+- ...
T Consensus 141 IPn~lfinLtDLLfLDLS~NrLe~LPPQ------~RRL~~LqtL~Ls~NPL~hfQLrQLPsmt-sL~vLhms~TqRTl~N 213 (1255)
T KOG0444|consen 141 IPNSLFINLTDLLFLDLSNNRLEMLPPQ------IRRLSMLQTLKLSNNPLNHFQLRQLPSMT-SLSVLHMSNTQRTLDN 213 (1255)
T ss_pred CCchHHHhhHhHhhhccccchhhhcCHH------HHHHhhhhhhhcCCChhhHHHHhcCccch-hhhhhhcccccchhhc
Confidence 5545566677777777777777666654 34455666677777765421001111111 344444443321 123
Q ss_pred CChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCc
Q 001838 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNL 483 (1007)
Q Consensus 404 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 483 (1007)
+|.++..+.+|..+|||.|.+. .+|..+.++.+|+.|+||+|+|+. +........+|+.|+||.|+++ .+|.++..+
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 5555555556666666666655 455555555555555555555542 2222333445555555555554 344444444
Q ss_pred ccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEec
Q 001838 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563 (1007)
Q Consensus 484 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 563 (1007)
+.|+.|++.+|+++- ..+|..+|.+.+|+.+..++|.+. .+|..+..+..|+.|.|
T Consensus 291 ~kL~kLy~n~NkL~F-----------------------eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L 346 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTF-----------------------EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL 346 (1255)
T ss_pred HHHHHHHhccCcccc-----------------------cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence 444444444444431 113333333334444444444443 44444444444444444
Q ss_pred cccccccccCccCcCCCCCCEEECCCC
Q 001838 564 ANNRLEGPIPESFSGLSSLEILDLSKN 590 (1007)
Q Consensus 564 s~N~l~~~~p~~~~~l~~L~~LdLs~N 590 (1007)
++|++- .+|+.+.-|+.|+.|||..|
T Consensus 347 ~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 347 DHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred ccccee-echhhhhhcCCcceeeccCC
Confidence 444443 34444444444444444444
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=313.86 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=194.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
.+|+..+.||+|+||+||+|++. +|. .||||+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 343 48999987542 34457789999999999999999999999875 4689
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|+||+++|+|.+++......+++..+.+++.||+.||+|| |+.+|+|||++ ||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999999987666688999999999999999999 57899999764 89999999977543
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
..........++..|+|||++....++.++|||||||++|||++ |+.||++....+ +..+... ..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~------------~~ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK------------GE 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhC------------CC
Confidence 32222223345678999999998899999999999999999998 999987532111 1111110 00
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~ 997 (1007)
.. +.+..+..++.+++.+||+.+|++||++.|++..+.++.....
T Consensus 229 ~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 229 RL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred CC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 00 0011123468899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=305.51 Aligned_cols=244 Identities=27% Similarity=0.482 Sum_probs=193.1
Q ss_pred ccccccceecccCceEEEEEEEcC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
++|+..+.||+|+||.||+|.... +..||+|.++... .....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998643 2579999987543 344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------
Q 001838 799 LIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------- 853 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------- 853 (1007)
++|||+++|+|.+++.... ..+++..+..++.|++.||+|| |+.+++|++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence 9999999999999997531 3478888999999999999999 56789998764
Q ss_pred --ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 001838 854 --HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWV 930 (1007)
Q Consensus 854 --kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~ 930 (1007)
||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||...... .+..++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 8999999987654333333344567889999999988899999999999999999998 99998753211 111111
Q ss_pred HhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 931 NDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 931 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
...... ..+...+.++.+++.+||+.||.+||+++||+++|+++
T Consensus 240 ------------~~~~~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 ------------RSRQLL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------------HcCCcC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 110000 01123356799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=304.70 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=195.6
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|...+.||+|+||+||++... ++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999742 356799999986655566789999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cc
Q 001838 800 IMEYMPNGSLENRLYSGT------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HI 855 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl 855 (1007)
||||+++|+|.+++.... ..+++..+..++.|++.||+|| |+.+++||+++ |+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999997432 2489999999999999999999 57889999764 79
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhc
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
+|||+++...............++..|+|||++....++.++|||||||++|||+| |+.||......+ ....+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~-- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ-- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc--
Confidence 99999987643332222233456788999999988889999999999999999998 999987532111 1111100
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
. .... .+...+.++.+++.+||+.+|.+|||+.||.+.|+++...
T Consensus 238 -~--------~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 -G--------RVLQ-------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -C--------CcCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 0000 0011234689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.61 Aligned_cols=239 Identities=22% Similarity=0.310 Sum_probs=190.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++.+++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58999999998653 234467889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997644 478889999999999999999 57789999764 8999999986543
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcc--hHHHHHHhhcCccHHHHhhhhhc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL--SLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+..|... +.....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---------LQRPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc---------ccCCCC
Confidence 12345799999999999988999999999999999999999999975322110 01111000 000000
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.. .......++.+++.+|+..+|++||++.|++++
T Consensus 223 --~~----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 --DD----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --Cc----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 001224568899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.53 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=193.7
Q ss_pred ccccccceecccCceEEEEEEEcC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||+||+|.+.. ...||||+++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998752 4579999987543 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++......+++..+.+++.|++.|++|| |+.+|+|++++ |++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999987666789999999999999999999 56889999663 899999999875222
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.........++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+.+......
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~----------- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL----------- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC-----------
Confidence 2112223345678999999988889999999999999999998 99998653211 111111110000
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
+.+...+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=324.52 Aligned_cols=239 Identities=21% Similarity=0.270 Sum_probs=189.2
Q ss_pred cccccceecccCceEEEEEEEc-C-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-D-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.|...+.||+|+||.||+|... + +..||+|.+..........+.+|+.++++++|||||+++++|..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999754 3 6789999876555555567888999999999999999999999999999999999
Q ss_pred CCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 805 PNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 805 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
++|+|.++++.. ...+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 33578889999999999999999 57799999874 8999999997654322
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.......+||++|+|||++....++.++|||||||++|||++|+.||..... ...+.. .....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~------------~~~~~ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQ------------VLYGK 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH------------HHhCC
Confidence 2223456799999999999988999999999999999999999999975311 111111 00000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.. +.+.....++.+++.+||+.||++||++.|++..
T Consensus 288 ~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 YD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 0011123468899999999999999999999754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=305.28 Aligned_cols=256 Identities=19% Similarity=0.247 Sum_probs=187.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|...+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999876 68999999987432 22235678899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++ +|.+++......+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 985 99999876655678899999999999999999 67899999764 8999999986542211
Q ss_pred ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc--Ccc-HHHHh-----
Q 001838 872 MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--PIS-VMEVI----- 942 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~-~~~~~----- 942 (1007)
......|++.|+|||++.+ ..++.++||||+||++|||+||+.||......+. +........ +.. ..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhh
Confidence 1234568999999998865 5689999999999999999999999975322111 111111000 000 00000
Q ss_pred hhhhccch--hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLLSGE--ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........ ............+..+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00000011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=307.60 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=188.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.++|...+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 689999999875432 223457789999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|++ |+|.+++......++...+..++.|++.||+|| |+.+|+|||++ ||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 996 688888876656688889999999999999999 57889999774 899999998653221
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCcc------HHH--H
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS------VME--V 941 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------~~~--~ 941 (1007)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+........... ... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568999999998765 45899999999999999999999999864321111111111100000 000 0
Q ss_pred hhhhhc---cchh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 942 IDTNLL---SGEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 ~d~~~~---~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.++... .... ...........++.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 0000 0000000112467899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=312.58 Aligned_cols=232 Identities=24% Similarity=0.393 Sum_probs=188.3
Q ss_pred cceecccCceEEEEEEEc-CCceEEEEEechh----hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe--eEEEEEe
Q 001838 731 NNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR----YERALKSFQDECEVMKRIRHRNLVKIISACSNDDF--KALIMEY 803 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~E~ 803 (1007)
..+||+|+|-+||||.+. +|.+||.-.++.. .++..++|..|+++|+.++|||||+++.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999876 5899987655432 24556899999999999999999999999987664 7789999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~~~~~ 870 (1007)
|..|+|..|.++.+. .+......++.||++||.|||. |.+||+|||++ ||+|.|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999988764 7888999999999999999997 88999999875 999999999875432
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
...+.|||.|||||... ..|++.+||||||+.++||+|+..||..+.....-+.+......|..+..+-|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------- 270 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------- 270 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC-------
Confidence 24478999999999765 78999999999999999999999999875432222222222222333333222
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+++.+++.+|+.. .++|||+.|+++.
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2688999999999 9999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.71 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=186.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 799 (1007)
-.|...+++|.|+||.||+|... +++.||||++-+..+ --.+|+++|+++.|||||++..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677899999999999999976 478999999875532 1246999999999999999999886432 3458
Q ss_pred EEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeeccee
Q 001838 800 IMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKF 863 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~ 863 (1007)
|||||+. +|.++++. ....++...+.-++.|+.+||.|| |+.+|+|||++ ||||||-|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999986 99998874 233467777778999999999999 56899999886 9999999999
Q ss_pred cCCCCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHH-
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV- 941 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~- 941 (1007)
+...+.. .+...|+.|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. +...++..++......-.++
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence 8655433 345679999999998875 59999999999999999999999887632 22334444443332221111
Q ss_pred -hh--------hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 942 -ID--------TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 -~d--------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+. +.+....... -.......+.++++.++++++|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11 1111111000 0112334579999999999999999999999876
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.39 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=195.5
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
.+|...+.||+|+||.||+|... ++..||+|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999742 356799999986665556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------
Q 001838 800 IMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------- 853 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------- 853 (1007)
||||+++|+|.+++..+. ..+++..+..++.|++.|++|| |+.+|+|++++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence 999999999999996532 2478999999999999999999 67889999764
Q ss_pred -ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 001838 854 -HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 854 -kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~ 931 (1007)
|++|||+++...............++..|+|||++....++.++|||||||++|||+| |+.||......+ ..+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence 8999999987643322222234457889999999988889999999999999999999 999986532211 111110
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
. ...... ....+..+.+++.+||+.+|++|||++||+++|+++.+.
T Consensus 240 ~------------~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 Q------------GRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred C------------CCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0 000000 011244688999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.98 Aligned_cols=230 Identities=22% Similarity=0.272 Sum_probs=182.9
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999998643 233466789999999999999999999999999999999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+|.+++.... .+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999987654 578999999999999999999 57799999774 899999998643221 11234
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 955 (1007)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. . .. .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~---~--------~~--------~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM---E--------EI--------R 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHc---C--------CC--------C
Confidence 57999999999999889999999999999999999999999753111 11111000 0 00 0
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 956 AKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 956 ~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+||+.||++|| ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0112244688999999999999999 78988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=307.00 Aligned_cols=233 Identities=22% Similarity=0.293 Sum_probs=187.2
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|... +|+.||||++.... .+..+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999876 68999999997543 234467889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999997654 478888899999999999999 67899999764 89999999876432
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i--------~~~~~~-- 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKI--------LAGKLE-- 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH--------HhCCcC--
Confidence 12346899999999998888999999999999999999999999753211 111110 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
.+......+.+++.+|++.||.+||+ +.|++++
T Consensus 217 ------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00111346889999999999999995 8888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=311.96 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=184.5
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 798 (1007)
+|+..+.||+|+||.||+|+.. +|..||||++.... .....++.+|++++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999865 68999999987432 233456889999999999999999999886432 479
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
+|||||+ ++|.+++.... .+++..+..++.|+++||+|| |+.+|+|||++ ||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68999887654 488999999999999999999 57789999773 8999999986532
Q ss_pred CCcc-cccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc-------
Q 001838 867 QDQL-SMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI------- 936 (1007)
Q Consensus 867 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 936 (1007)
.... .......||+.|+|||++.. ..++.++|||||||++|||+||+.||..... .....++......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence 2211 11234579999999998765 6789999999999999999999999975321 1111111111110
Q ss_pred -----cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 937 -----SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 -----~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+.++..............+....++.+++.+||+.||++|||+.|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0001111000000000000001123467899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.68 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=193.9
Q ss_pred ccccccceecccCceEEEEEEEcCC-ceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEE-Eec---C---Ce
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDG-MEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISA-CSN---D---DF 796 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~---~---~~ 796 (1007)
-++.+.+.|.+|||+.||.|+...+ ..||+|++-..++...+...+||++|++++ |||||.+++. ... . -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456778999999999999997765 999999998777888889999999999997 9999999993 322 1 25
Q ss_pred eEEEEEecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeeccee
Q 001838 797 KALIMEYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~ 863 (1007)
.+|.||||+||.|-+++..+ ...+++.++++|+.|+++|+.+||+ ..++|||||++ ||||||-|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 78999999999999999743 3359999999999999999999997 68899999987 8999999875
Q ss_pred cCCCC-cccc------cccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 001838 864 LNGQD-QLSM------QTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 864 ~~~~~-~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
..... .... .-...-|+.|+|||.+. +...++|+||||+||+||-|+....||++.. ...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--~la-------- 265 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--KLA-------- 265 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--cee--------
Confidence 43211 1000 01124689999999764 4578999999999999999999999998631 100
Q ss_pred cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 934 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
++. +.... +..+.....+.+|+..||+.||.+||++.+|++.+.+++..
T Consensus 266 -------Iln-----g~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -------ILN-----GNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------EEe-----ccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 011 11111 11123466899999999999999999999999999988764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.96 Aligned_cols=187 Identities=26% Similarity=0.342 Sum_probs=161.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.++|+..+.||+|+||.||+|... +|..||+|+++.. .....+.+.+|++++++++|||||+++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999876 5889999988754 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|+++|+|.+++.... .+++.....++.|++.|+.||| +..+|+|++++ ||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999997644 4788888999999999999996 34579999664 89999999865322
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 11335689999999999888899999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=302.22 Aligned_cols=242 Identities=28% Similarity=0.442 Sum_probs=190.9
Q ss_pred ccccccceecccCceEEEEEEEcC------CceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
++|...+.||+|+||.||+|+..+ ++.||||+++.... +..+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467888999999999999998643 47899999976543 34578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 799 LIMEYMPNGSLENRLYSGT-------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
+||||+++|+|.+++.... ..+++..+..++.|++.|+.|| |+.+++|++++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCeE
Confidence 9999999999999997532 3478889999999999999999 67789998753
Q ss_pred ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 932 (1007)
|++|||+++...............+++.|+|||++....++.++|||||||++|||++ |+.||...... .....+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECITQ 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 8999999987643332222233456788999999999999999999999999999999 99998753211 11111110
Q ss_pred hcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 933 LLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 933 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
. .... .+...+..+.+++.+||+.||++||++.||+++|+
T Consensus 240 ~------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 G------------RLLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred C------------CcCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0000 01122456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=313.25 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=190.5
Q ss_pred cccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 796 (1007)
.++|...+.||+|+||.||+|++. .++.||||+++... ....+.+.+|++++.++. |||||+++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 24689999997543 333457899999999997 9999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC-----------------------------------------------------------
Q 001838 797 KALIMEYMPNGSLENRLYSGT----------------------------------------------------------- 817 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 817 (1007)
.++|||||++|+|.+++++..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------
Q 001838 818 --------------------------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------ 853 (1007)
Q Consensus 818 --------------------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------ 853 (1007)
..+++.+..+++.|++.||+|| |+++|+|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceEEE
Confidence 1356778889999999999999 57889999764
Q ss_pred ------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchH
Q 001838 854 ------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSL 926 (1007)
Q Consensus 854 ------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l 926 (1007)
|++|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||......+. .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence 8999999987543222212233457889999999988889999999999999999998 8999865321110 0
Q ss_pred HHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 927 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
. +.+...... ..+.....++.+++.+||+.+|++||+++||++.|+++.
T Consensus 352 ~------------~~~~~~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 Y------------NAIKRGYRM------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------------HHHHcCCCC------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 111110000 001112356899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=310.84 Aligned_cols=233 Identities=21% Similarity=0.272 Sum_probs=187.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999976 58999999997643 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999997654 478888888999999999999 57889999774 899999998764321
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
....||+.|+|||++....++.++|||||||++|||++|+.||.+.... +..... ......
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i--------~~~~~~-- 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKI--------LAGRLK-- 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHH--------hcCCcC--
Confidence 2356999999999999888999999999999999999999999753210 111110 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
.+.....++.+++.+||+.||++||+ ++|++++
T Consensus 234 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00011335789999999999999997 6777755
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.10 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=197.4
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 799 (1007)
.+.|...+.||+|.||+||+|+.+ +|+.+|+|++.+... ...+...+|+.+|+++. |||||.+.++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999977 499999999986643 23468899999999998 9999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------------ccceeeccee
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------------HISDFSIAKF 863 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------------kl~DFGla~~ 863 (1007)
|||+|.||.|.+.+... .+++..+..++.|++.|+.|| |+.+|+|||++ |++|||+|+.
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999876 388999999999999999999 67999999764 8999999998
Q ss_pred cCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.... ......+||++|+|||++....|+.++||||.||++|.|++|.+||......+... .+..
T Consensus 189 ~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~ 252 (382)
T KOG0032|consen 189 IKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILR 252 (382)
T ss_pred ccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHc
Confidence 8652 23356789999999999998999999999999999999999999998643222111 1111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... ....+..+.....+.+++..|+..||.+|+|+.+++++
T Consensus 253 ~~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 GDF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 000 00011122335678999999999999999999999995
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=309.82 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=190.7
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC-Ce
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSND-DF 796 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 796 (1007)
++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57889999999999999999642 35789999987532 33346788899999999 799999999988654 57
Q ss_pred eEEEEEecCCCChhHhhhcCC-----------------------------------------------------------
Q 001838 797 KALIMEYMPNGSLENRLYSGT----------------------------------------------------------- 817 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 817 (1007)
.++||||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccCCccccc
Q 001838 818 -CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884 (1007)
Q Consensus 818 -~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 884 (1007)
..+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999 57799999774 8999999987643332222234456788999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHH
Q 001838 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLS 963 (1007)
Q Consensus 885 PE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 963 (1007)
||++.+..++.++|||||||++|||++ |+.||......+ .+...... .... ..+.....+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~------------~~~~------~~~~~~~~~ 304 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKE------------GTRM------RAPEYATPE 304 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhc------------cCCC------CCCccCCHH
Confidence 999999999999999999999999998 999987532111 11111100 0000 001122346
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 964 ILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 964 ~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
+.+++.+||+.+|++||++.|++++|+++.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.67 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=190.2
Q ss_pred ccccccceecccCceEEEEEEEc-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||+||+|.+. +|+ .||+|.+.... .....++..|+.++++++|||||++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999864 344 47888876433 2344678889999999999999999998864 45789
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|+||+++|+|.+++......+++..+..++.||+.||+|| |+.+++|++++ |++|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999987666789999999999999999999 56789999763 89999999876543
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
..........++..|+|||++....++.++|||||||++||++| |+.||.+... ....+++......
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcC----------
Confidence 32222234557789999999988899999999999999999998 9999875321 1111221110000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
. .+..+..++.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 231 --~------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 --A------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0 0001123578899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.16 Aligned_cols=246 Identities=18% Similarity=0.282 Sum_probs=193.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||.||+|+.. +++.||||.++.. ..+....+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999865 6899999987542 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 802 EYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 802 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
||+++|+|.+++.. ....++...+..++.|++.||+|| |+.+++|++++ +++|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 234578888999999999999999 67899999764 7999999987643
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.... ....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~---------~~~~ 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKI---------EQCD 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHH---------hcCC
Confidence 221 122346889999999998888999999999999999999999998643211 11111111 0000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
... ........++.+++.+||+.+|++||++.||++.+++++
T Consensus 225 ~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPP-----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC-----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 001123456899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.51 Aligned_cols=245 Identities=26% Similarity=0.431 Sum_probs=196.9
Q ss_pred HhcccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++..+|+..+.||+|+||.||+|...++..||+|++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999988899999999987665556788999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|+++|+|.+++.+. ...+++..+.+++.|++.|++|| |+.+|+|+++. |++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999763 34589999999999999999999 56789999764 8999999987643221
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......++..|+|||++....++.++|||||||++|||++ |+.||...... ...+.+.. ...
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~------------~~~- 222 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITA------------GYR- 222 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHh------------CCc-
Confidence 1123446778999999988889999999999999999998 89999753211 11111110 000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+.+...+.++.+++.+||+.||++|||++|+.+.|+.+
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 -----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000112245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.09 Aligned_cols=236 Identities=27% Similarity=0.407 Sum_probs=184.4
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999875 68999999886443 34457799999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccccc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
.+++......+++..+..++.|++.||+|| |+.+|+|+++. |++|||+++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999976655689999999999999999999 57789998753 899999998654221111111112
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 956 (1007)
++..|+|||.+....++.++|||||||++|||++ |..||....... ....++...... .
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~~~~~~~~------~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIEQGVRLP------C 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHHHcCCCCC------C
Confidence 3467999999988889999999999999999998 888886432110 111111100000 0
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 957 KEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 957 ~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
+...+.++.+++.+|++.+|++|||+.|+.++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122446899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=290.49 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=195.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
-|++.+++|+|+||.||+|.++ .|+.||||.+.-. ...+++..|+.++.+...|++|++||.|......|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4667789999999999999866 5999999998654 335778999999999999999999998888888999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
.|+..+.++-+...+.+.++..+..+.++||+||| ...-+|||+ +|++|||.|..+.+ .....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 99999999987778999999999999999999996 445578865 59999999987753 22233
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
..+.||+.|||||++..-.|+.++||||+|+...||..|++||.+......- .++ .......
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMI------------PT~PPPT 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMI------------PTKPPPT 248 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------Eec------------cCCCCCC
Confidence 5678999999999999999999999999999999999999999875322100 000 0111222
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+..++....++-++++.|+...|++|-|+.+++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 33456677889999999999999999999998876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=307.28 Aligned_cols=228 Identities=21% Similarity=0.258 Sum_probs=180.4
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++|||||++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 58899999997542 33456788999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccccc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99997654 488899999999999999999 57889999764 899999998643221 1223457
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... . ..+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~--------~--------~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP--------L--------RFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC--------C--------CCC
Confidence 99999999999988999999999999999999999999975321 11111111000 0 001
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRIN---AREIVTG 988 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt---~~evl~~ 988 (1007)
.....++.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 122346889999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.85 Aligned_cols=241 Identities=23% Similarity=0.361 Sum_probs=191.6
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56888999999999999999988888999999875432 34678999999999999999999999999999999999999
Q ss_pred CCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++++. ...+++..+..++.|++.|++|| |+.+++|+++. |++|||+++........ .
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 99999999754 34578889999999999999999 56789998763 79999999876532211 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||++....++.++|||||||++|||+| |+.||...... ....++....+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~--------------- 223 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRM--------------- 223 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC---------------
Confidence 223346778999999988889999999999999999998 99998653211 111111110000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
+.....+.++.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.06 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=193.0
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecC
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--------ERALKSFQDECEVMKRIR-HRNLVKIISACSND 794 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 794 (1007)
-+.|...+.+|.|..++|.++..+ +|++.|+|++.... ....++-.+|+.||+++. ||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346788899999999999999755 68999999986321 233466788999999995 99999999999999
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
.+.++|+|.|+.|.|+++|.+.. .+++....+|+.|+..|++|| |...|||||++ ||+|||+|+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999998654 478888889999999999999 78899999875 899999999
Q ss_pred ecCCCCcccccccccCCccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQ------GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
.+..+... +..+|||+|+|||.+.. ..|+..+|+||.|||+|.++.|.+||-... ++-
T Consensus 172 ~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qml----------- 235 (411)
T KOG0599|consen 172 QLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QML----------- 235 (411)
T ss_pred ccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHH-----------
Confidence 98765443 56799999999998753 358899999999999999999999985411 000
Q ss_pred cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 937 SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 937 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
++........+...+...+....+.+|+.+|++.||++|.|++|++++--
T Consensus 236 ----MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 236 ----MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ----HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 00001111112222223345667899999999999999999999998743
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.83 Aligned_cols=361 Identities=28% Similarity=0.470 Sum_probs=274.3
Q ss_pred CCeecccCcccC-CCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEc
Q 001838 142 MLGIDLSINRFS-GELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIIL 220 (1007)
Q Consensus 142 L~~LdLs~N~l~-~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1007)
.+..|+|.|.|+ +.+|.+. ..+++++.|.|...++. .+|+.++.+.+|++|.+++|+|. .+..++..|+.|+.+++
T Consensus 9 VrGvDfsgNDFsg~~FP~~v-~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDV-EQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eecccccCCcCCCCcCchhH-HHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 455678888888 4567766 47899999999999987 78999999999999999999998 56678889999999999
Q ss_pred ccCcCCC-CCCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCC
Q 001838 221 NDNELRG-EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS 299 (1007)
Q Consensus 221 ~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~ 299 (1007)
.+|++.. -+|..+..+..|..||||+|++.. .|..+...+++-.|+|++|+| .+||..++.++..|-+||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~I-etIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNI-ETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCcc-ccCCchHHHhhHhHhhhccccchhh
Confidence 9999863 478888899999999999999974 567777778888888888888 5788888878888888888888887
Q ss_pred CCCCccccccCCCCEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCC
Q 001838 300 GNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGIL 379 (1007)
Q Consensus 300 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~ 379 (1007)
.+|..+..+..|+.|+|++|.+...--.-+..+++|++|.+++.+=+- ..+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl----------------------------~N~ 214 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL----------------------------DNI 214 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh----------------------------hcC
Confidence 456667777777888888777654332333445555555555443221 124
Q ss_pred CCCccccccccceeeeccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcc
Q 001838 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHL 459 (1007)
Q Consensus 380 p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 459 (1007)
|.++.++. +|..++++.|.+. .+|+.+.++.+|+.|+||+|+|+ .+........+|++|+||.|+|+ .+|+.++.+
T Consensus 215 Ptsld~l~-NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 215 PTSLDDLH-NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCchhhhh-hhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 44454444 5555555555555 78889999999999999999998 56667778889999999999997 689999999
Q ss_pred cccceeeccccccc-CCCCCCCCCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEe
Q 001838 460 AKLDKLILHGNKFS-GAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELN 538 (1007)
Q Consensus 460 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~ 538 (1007)
++|+.|.+.+|++. .-+|+.++.+.+|+.+..++|.+. ..|..++.+..|+.|.|+.|++- .+|..+--++.|..||
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLD 368 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLD 368 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceee
Confidence 99999999999987 347888999999999999999886 56777776666666666666554 2344444444444444
Q ss_pred Cccc
Q 001838 539 LSRN 542 (1007)
Q Consensus 539 Ls~N 542 (1007)
|..|
T Consensus 369 lreN 372 (1255)
T KOG0444|consen 369 LREN 372 (1255)
T ss_pred ccCC
Confidence 4444
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.91 Aligned_cols=230 Identities=22% Similarity=0.285 Sum_probs=182.2
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||++++++|...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999997643 234456788999999999999999999999999999999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9999887654 488999999999999999999 57799999774 8999999986432211 1234
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 955 (1007)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+ . .......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~---~--------~~~~~~~-------- 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE---L--------ILMEEIR-------- 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHH---H--------HhcCCCC--------
Confidence 569999999999988899999999999999999999999997532111 000 0 0000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 956 AKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 956 ~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+||+.||++|| ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0011234688999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.26 Aligned_cols=240 Identities=22% Similarity=0.375 Sum_probs=189.0
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|...+.||+|+||+||+|...++..||||.+..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35778899999999999999987777899999875432 23678999999999999999999999999889999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++......+++..+..++.||+.|++|| |+.+++|+++ +|++|||.++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 9999999986555689999999999999999999 5778999865 48999999987643221 111
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....++..|+|||+.....++.++|||||||++|||++ |+.||...... .....+... .....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~------------~~~~~-- 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQG------------LRLYR-- 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcC------------CCCCC--
Confidence 23346678999999988889999999999999999999 99998753211 111111000 00000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
+......+.+++.+||+.+|++||++.++++.++
T Consensus 223 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 ----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011346899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.92 Aligned_cols=242 Identities=19% Similarity=0.288 Sum_probs=191.2
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechh--hHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E 802 (1007)
..|++.+.||+||.++||++...+.+.+|+|++... +.+....|.+|++.|.+++ |.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 358888999999999999999888888898877543 4566788999999999996 9999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccceeecceecCCCCccc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~DFGla~~~~~~~~~~ 871 (1007)
|-+ -+|.++|.++....+...++.|..|++.|+.++ |..+|||.|++ ||+|||+|..+..+....
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEeeeEEeeeechhcccCccccce
Confidence 865 499999988766555346778999999999999 67899998765 999999999998766555
Q ss_pred ccccccCCcccccccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 872 MQTQTLATIGYMAPEYGVQG-----------RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
.....+||+.||+||.+... +.+.++||||+|||||+|+.|++||..... .|.+ +..
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK------l~a 584 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK------LHA 584 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH------HHh
Confidence 55667899999999987542 256889999999999999999999975211 1211 122
Q ss_pred HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.|+.-.-... ..++ ..++.++|+.||+.||.+|||+.|+++.
T Consensus 585 I~~P~~~Iefp---~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFP---DIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCcccccc---CCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22221100000 0011 1238999999999999999999999875
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.57 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=189.6
Q ss_pred hcccccccceecccCceEEEEEEEcC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF 796 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 796 (1007)
++++|...+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 5679999886433 3344678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc---------------ccc
Q 001838 797 KALIMEYMPNGSLENRLYSGT------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV---------------AHI 855 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~---------------~kl 855 (1007)
.++||||+++|+|.+++.... ..+++.++.+++.||+.|++|| |+.+++|+++ +|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997542 2588999999999999999999 5678999854 479
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhc
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||+.....+ +..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~------ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VME------ 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH------
Confidence 99999987643222111122334568999999988889999999999999999997 999997532211 111
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.+....... .+...+.++.+++.+|++.+|++||++.||+++|+
T Consensus 233 ------~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ------FVTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------HHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100000 01122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=292.84 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=188.1
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHH--------------HHHHHHHHHHHHHhcCCCceeE
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYER--------------ALKSFQDECEVMKRIRHRNLVK 786 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~niv~ 786 (1007)
.+..++|...+.||+|.||+|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999965 6999999999754210 1247789999999999999999
Q ss_pred EEEEEecC--CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------
Q 001838 787 IISACSND--DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------- 853 (1007)
Q Consensus 787 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------- 853 (1007)
|+++..++ +..|||+|||..|.+...=.. ...+...++++|+.+++.||+|| |.++|||||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCc
Confidence 99999775 479999999999987643222 22388899999999999999999 67899999875
Q ss_pred -ccceeecceecCCCC---cccccccccCCcccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCccccCcch
Q 001838 854 -HISDFSIAKFLNGQD---QLSMQTQTLATIGYMAPEYGVQGR----VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELS 925 (1007)
Q Consensus 854 -kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~ 925 (1007)
||+|||.+....... ........+|||.|||||...++. .+.+.||||+||+||.|+.|+.||-+.+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---- 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---- 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence 999999998763211 111123478999999999887632 36688999999999999999999975321
Q ss_pred HHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 926 LSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 926 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.+..|+.....-. .+..++...++.+|+.++|+.||++|.+..||..+...
T Consensus 325 -------------~~l~~KIvn~pL~--fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 -------------LELFDKIVNDPLE--FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -------------HHHHHHHhcCccc--CCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 1222221111100 01112345678999999999999999999999877653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=314.83 Aligned_cols=241 Identities=21% Similarity=0.306 Sum_probs=186.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++++.++||||++++++|.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999976 58999999997643 234466889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|||++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997654 488899999999999999999 57789999774 8999999986532110
Q ss_pred cc------------------------------------ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 001838 870 LS------------------------------------MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913 (1007)
Q Consensus 870 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~ 913 (1007)
.. .....+||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246999999999998889999999999999999999999
Q ss_pred CCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHH
Q 001838 914 KPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN---AREIVTG 988 (1007)
Q Consensus 914 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt---~~evl~~ 988 (1007)
.||......+ ....+.... ....... ......++.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~~~--~~~~i~~~~---------~~~~~~~------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE--TYRKIINWK---------ETLQFPD------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH--HHHHHHcCC---------CccCCCC------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997532111 111000000 0000000 00113457888889986 8999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=301.51 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=191.7
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 797 (1007)
++|...+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888999999999999999742 35689999987543 34456789999999999 799999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec
Q 001838 798 ALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~ 864 (1007)
++||||+++|+|.+++++.. ..+++.++..++.|++.|++|| |+.+|+|++++ |++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997543 3489999999999999999999 56789999764 79999999876
Q ss_pred CCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.............++..|+|||++....++.++|||||||++|||++ |+.||......+ ...+.. +
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~------------~ 258 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLI------------K 258 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHH------------H
Confidence 43322212223356788999999988889999999999999999998 999987542211 111111 1
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
....... +.....++.+++.+|+..+|++|||+.|+++.|++.
T Consensus 259 ~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRMAQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1000000 001134689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.48 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=190.8
Q ss_pred cc-cccceecccCceEEEEEEE-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--Cee
Q 001838 727 RF-SKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFK 797 (1007)
Q Consensus 727 ~~-~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 797 (1007)
+| +..+.||+|+||+||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988653 357889999997543 33456788999999999999999999988754 368
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+++|+|.+++... .+++.++..++.|++.|++|| |+.+|+|++++ |++|||+++...
T Consensus 84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999999764 389999999999999999999 56789999764 899999998765
Q ss_pred CCCcc-cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-cCccHHHHhh
Q 001838 866 GQDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL-LPISVMEVID 943 (1007)
Q Consensus 866 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~d 943 (1007)
..... .......++..|+|||.+....++.++|||||||++|||+||+.|+............+.... ......+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 33221 111223456789999999888899999999999999999999999865322111111111000 0011111111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
..... +.+...+.++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 239 ~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRL------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCC------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11110 011123457999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=313.79 Aligned_cols=241 Identities=21% Similarity=0.301 Sum_probs=182.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999865 58899999997643 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc-
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ- 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~- 869 (1007)
||++|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997654 478888888999999999999 57899999764 8999999864311000
Q ss_pred --------------------------------------------ccccccccCCcccccccccccCCCCchhhHHHHHHH
Q 001838 870 --------------------------------------------LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIM 905 (1007)
Q Consensus 870 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvi 905 (1007)
........||+.|+|||++....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999988889999999999999
Q ss_pred HHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhh--cCCCCCCCCCCHH
Q 001838 906 LMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATE--CTIESPGKRINAR 983 (1007)
Q Consensus 906 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~~p~~Rpt~~ 983 (1007)
+|||+||+.||......+.. ...... ........ ......++.+++.+ |+..+|.+||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~~~----------~~~~~~~~------~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVINW----------ENTLHIPP------QVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHHcc----------ccccCCCC------CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999753221110 000000 00000000 00113356777777 5566777799999
Q ss_pred HHHHH
Q 001838 984 EIVTG 988 (1007)
Q Consensus 984 evl~~ 988 (1007)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=293.87 Aligned_cols=236 Identities=22% Similarity=0.305 Sum_probs=197.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.-|+..+.||+|-|++|-.|++- +|..||||++++.. ......+.+|++.|+-++|||||++|++.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999855 79999999998654 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~~~~ 869 (1007)
+-++|+|++|+.++...+.+....+++.||+.|+.|+|.. .+||||++ |+.|||++-...+...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999999999998888899999999999999999999654 48999764 8999999987655443
Q ss_pred ccccccccCCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVS-TRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
.+..+|+..|-|||++.+..|+ +++||||+|||||.|++|+.||+...+.+. +.-++|-..
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY-- 236 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY-- 236 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc--
Confidence 3567999999999999999886 579999999999999999999997654332 122233211
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.....++.+|+..|++.||++|.+..||+..
T Consensus 237 ------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 ------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2234456789999999999999999999998754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.42 Aligned_cols=244 Identities=22% Similarity=0.295 Sum_probs=190.9
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDD--- 795 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 795 (1007)
....++|...+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999854 6999999998653 2444567889999999999999999988775432
Q ss_pred -----eeEEEEEecCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cc
Q 001838 796 -----FKALIMEYMPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HI 855 (1007)
Q Consensus 796 -----~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl 855 (1007)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+|||++ ||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998643 24588889999999999999999 67899999764 89
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP 935 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 935 (1007)
+|||+++...............||+.|+|||++....++.++|||||||++|||++|+.||.... ...++...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~-- 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKT-- 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHH--
Confidence 99999987653322222345679999999999999899999999999999999999999997532 11111111
Q ss_pred ccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 936 ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 936 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...... +.+.....++.+++.+||+.||++||++.|++++
T Consensus 258 ----------~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 ----------LAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----------hcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 100000 0011224568899999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=310.23 Aligned_cols=190 Identities=22% Similarity=0.350 Sum_probs=162.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 58999999997543 233467888999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|||++|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997654 588999999999999999999 67899999774 8999999986532110
Q ss_pred c---------------------------------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001838 870 L---------------------------------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPT 916 (1007)
Q Consensus 870 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~ 916 (1007)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012357999999999999889999999999999999999999999
Q ss_pred Ccc
Q 001838 917 DEI 919 (1007)
Q Consensus 917 ~~~ 919 (1007)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=298.25 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=189.3
Q ss_pred hcccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF 796 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 796 (1007)
++++|+..+.||+|+||+||+|... ++..||||++.... .....++.+|+.++++++||||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 25679999986432 2344678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------ccc
Q 001838 797 KALIMEYMPNGSLENRLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHI 855 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl 855 (1007)
.++||||+++|+|.+++.+.. ...++..+..++.|++.|++|| |+.+++|+++ +|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 2357788899999999999999 5678999976 389
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhc
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
+|||+++...............+++.|+|||++....++.++|||||||++|||++ |+.||...... ...+++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~-- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME-- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 99999986643322222223356788999999988889999999999999999999 78888653211 11111100
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
..... .+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 237 ---------~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ---------GGLLD-------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---------CCcCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000 001123468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=298.29 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=192.3
Q ss_pred ccccccceecccCceEEEEEEEc-----CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-----DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKA 798 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 798 (1007)
.+|+..+.||+|+||+||+|..+ ++..||||++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999743 4789999999876666667899999999999999999999987543 4689
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
+||||+++|+|.+++.+....+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 99999999999999976655689999999999999999999 57799999764 8999999997754
Q ss_pred CCccc-ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc--------c
Q 001838 867 QDQLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI--------S 937 (1007)
Q Consensus 867 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--------~ 937 (1007)
..... ......++..|+|||+..+..++.++|||||||++|||++|..|+..... .|....... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhcccccccccchHH
Confidence 32211 11222345579999999888899999999999999999999877543211 111111110 0
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
..+.+..... .+.....+.++.+++.+||+.+|++||||.||++.|++++
T Consensus 235 ~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 235 LIELLKNNGR------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHhcCCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111111000 0011122456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=307.94 Aligned_cols=233 Identities=20% Similarity=0.258 Sum_probs=186.2
Q ss_pred ccccccceecccCceEEEEEEEcC--CceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD--GMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|...+.||+|+||+||+|..+. +..||+|++.... ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998653 3689999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
||||++|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999997654 488889999999999999999 57899999764 89999999876422
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... .... .+.......
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~-----------~i~~~~~~~ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQ-----------KILEGIIYF 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHH-----------HHhcCCCCC
Confidence 13457999999999998888999999999999999999999999753210 0000 000000000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
+......+.+++.+|++.||++|+ +++|++++
T Consensus 248 --------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 --------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011133578999999999999995 88888765
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=298.36 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=188.8
Q ss_pred ccccccceecccCceEEEEEEE-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||+||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999974 246789999997433 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------
Q 001838 800 IMEYMPNGSLENRLYSG----------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------- 853 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------- 853 (1007)
||||+++|+|.+++... ...+++.+...++.|++.||+|| |+++|+|++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence 99999999999998532 12478888999999999999999 56789999764
Q ss_pred --ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 001838 854 --HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWV 930 (1007)
Q Consensus 854 --kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~ 930 (1007)
|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 8999999987643332222334456778999999988889999999999999999999 9999864211 1111111
Q ss_pred HhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 931 NDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 931 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
...... +.+.....++.+++.+|++.||++||++.+|.++|..
T Consensus 240 ------------~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ------------RKRQLL------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HcCCcC------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 110000 0011123468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.92 Aligned_cols=239 Identities=21% Similarity=0.310 Sum_probs=186.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|+..+.||+|+||+||++... +++.||||++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777899999999999999865 68999999997543 2223567889999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|+++|+|.+++... ...+++..+..++.|++.|++|| |+.+|+|++++ +|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988653 34589999999999999999999 56789999763 7999999987643221
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....|++.|+|||++....++.++||||+||++|||++|+.||....... ....+ ...+....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~---------~~~~~~~~--- 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEV---------ERRVKEDQ--- 221 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHH---------HHHhhhcc---
Confidence 123468999999999988889999999999999999999999997532110 00000 01110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
. ..+......+.+++.+|++.||++|| ++.|++++
T Consensus 222 -~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -E---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -c---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 00112345688999999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=309.86 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=178.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
+|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|+|||++++++.+.+..++|||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999865 68999999986543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+.. ..++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++....... .
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 999987532 245677788999999999999 57789999764 8999999987643211 1
Q ss_pred cccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 873 QTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||....... |... +.....
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~---------~~~~~~ 290 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASL---------MCAICM 290 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHH---------HHHHhc
Confidence 234579999999998743 234568999999999999999999997322111 1110 000000
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... .........++.+++.+||+.||++|||+.|++++
T Consensus 291 ~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00011224568999999999999999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.59 Aligned_cols=230 Identities=23% Similarity=0.299 Sum_probs=183.0
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999997542 234567889999999999999999999999999999999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+|.+++.... .+++.++..++.||+.||+|| |+.+|+|||++ ||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887653 488999999999999999999 67899999774 899999998643221 11234
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 955 (1007)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------------~----~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------------I----K 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------------c----c
Confidence 57999999999998889999999999999999999999999753211 1111100000 0 0
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 956 AKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 956 ~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+|++.||++|| ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0111234688999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.47 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=192.9
Q ss_pred ccccccceecccCceEEEEEEEcC-Cc--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GM--EVAVKVFHQR-YERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||+||+|..++ +. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 33 4789888742 234456789999999999 799999999999999999999
Q ss_pred EEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 801 MEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
|||+++|+|.+++.... ..+++..+..++.|++.|++|| |+.+|+|+|++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 2478889999999999999999 56789999773
Q ss_pred ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 932 (1007)
||+|||++...... ........+..|+|||++....++.++|||||||++|||+| |+.||......+ +..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYE- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH-
Confidence 89999998743211 11111233567999999988889999999999999999998 999997532111 111
Q ss_pred hcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 001838 933 LLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKSV 1000 (1007)
Q Consensus 933 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~~~ 1000 (1007)
.+....... .+.....++.+++.+||+.+|.+|||+.+++++|+.+.+..+...
T Consensus 230 --------~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 230 --------KLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred --------HHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 111100000 011123468899999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=296.64 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=193.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCc----eEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||+||+|++. +|+ .||+|+++.. .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 56888899999999999999853 454 4899998753 234456788999999999999999999999764 4689
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~ 867 (1007)
+|||+++|+|.++++.....+++..+..++.|++.||+|| |+.+|+|||+ +||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999999999987666689999999999999999999 6788999966 389999999977533
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
..........+++.|+|||......++.++|||||||++|||++ |..||+.... ..+..++.......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~--------- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERLP--------- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCC---------
Confidence 22211222345678999999988889999999999999999998 8999875321 11222221110000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
.+...+.++.+++.+||+.||++||++.|+++.|+++....+.
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 0111244688999999999999999999999999888765543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.42 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=191.2
Q ss_pred cccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.++|+..+.||+|+||.||+|...+++.||||.++.... ..+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356888999999999999999987788999999875432 2466889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
++|+|.+++.... ..+++..+..++.|++.|+.|| |+.+|+|+|++ ||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997643 4589999999999999999999 56789999663 89999999987532111
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......++..|+|||+.....++.++|||||||++|||+| |+.||...... .... .++.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~------------~~~~~~~~-- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQ------------QVDQGYRM-- 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH------------HHHcCCCC--
Confidence 1112233468999999988889999999999999999999 99998753211 1111 11110000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
..+...+..+.+++.+|++.+|++||++.++.+.|++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011224568999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=296.80 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=194.9
Q ss_pred cccccccceecccCceEEEEEEEcC-----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEec-CCee
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSN-DDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 797 (1007)
.++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998765 6889999987542 3445778999999999999999999998776 4678
Q ss_pred EEEEEecCCCChhHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cccee
Q 001838 798 ALIMEYMPNGSLENRLYSGT-------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDF 858 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DF 858 (1007)
++++||+++|+|.+++.... ..+++..+..++.|++.||+|| |+.+++|+++. |++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 3588999999999999999999 57789999653 89999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCcc
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
|+++.+.............++..|+|||++....++.++|||||||++||+++ |+.||.... ...+..+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~- 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYRL- 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCCC-
Confidence 99987644332222223456778999999988889999999999999999999 999997532 11222222111000
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.....++.++.+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus 239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00011234688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.03 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=192.3
Q ss_pred hcccccccceecccCceEEEEEEEcC------CceEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQR-YERALKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
..++|+..+.||+|+||.||+|.... ...||+|++... ..+...++.+|+++++++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998642 367999998753 234456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 796 FKALIMEYMPNGSLENRLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
..++||||+++|+|.+++... ...+++..+++++.|++.|++|| |+.+|+|++++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEEc
Confidence 999999999999999998632 23588999999999999999999 57889999763
Q ss_pred -----ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~ 927 (1007)
|++|||+++...............++..|+|||++....++.++|||||||++|||++ |..||......+ ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence 8999999987654332222223345678999999888889999999999999999998 999987532111 11
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
+.+....... .+.....++.+++.+|+..+|++||||.|+++.|+++.
T Consensus 245 ------------~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 ------------KLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------------HHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111000000 01112346889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=309.10 Aligned_cols=252 Identities=19% Similarity=0.198 Sum_probs=186.1
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
..+|+..+.||+|+||.||+|... +++.||+|+... +.+.+|++++++++|||||+++++|...+..++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999865 689999997542 3467899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+. ++|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+|+....... .
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 95 68988886543 478999999999999999999 56799999874 8999999976432211 1
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc------CcchHHHHHHhhc------CccHH
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI------GELSLSRWVNDLL------PISVM 939 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~------~~~~l~~~~~~~~------~~~~~ 939 (1007)
......||+.|+|||++....++.++|||||||++|||+||+.|+..... ....+...+.... +....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345799999999999988999999999999999999999988653211 0111111111111 00000
Q ss_pred HHhhhhh-------c-c-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 EVIDTNL-------L-S-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 ~~~d~~~-------~-~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..++... . . ............+.++.+++.+||+.||++|||+.|+++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111000 0 0 0000111112335578999999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.81 Aligned_cols=241 Identities=22% Similarity=0.315 Sum_probs=188.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999865 68999999998653 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+....+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999987655689999999999999999999 57899999764 8999999987653322
Q ss_pred ccccccccCCcccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 870 LSMQTQTLATIGYMAPEYGV------QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..... +..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~--------i~~ 223 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNN--------IMN 223 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHH--------HHc
Confidence 1 223356899999999886 456789999999999999999999999753211 11111 000
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...... .+.......++.+++..|++ +|++|||+.+++++
T Consensus 224 ~~~~~~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 224 FQRFLK----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCccC----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000000 00001123468889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=298.03 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=190.3
Q ss_pred cccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
+|...+.||+|+||+||+|+.. ....||+|.+.... ....+++.+|+.++++++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23579999887543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc----
Q 001838 800 IMEYMPNGSLENRLYSG-----------------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV---- 852 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~---- 852 (1007)
||||+++|+|.+++... ...+++..+..++.|++.|++|| |+.+|+|+++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence 99999999999988642 12478889999999999999999 4678999976
Q ss_pred --------cccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCc
Q 001838 853 --------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGE 923 (1007)
Q Consensus 853 --------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~ 923 (1007)
+||+|||+++...............++..|+|||++....++.++|||||||++|||+| |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 48999999987643322222233456778999999888889999999999999999999 99998753211
Q ss_pred chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
.+..+.. ...... .+.....++.+++.+|++.+|++||+++|+++.|+++..
T Consensus 237 -~~~~~~~------------~~~~~~------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 -RLFNLLK------------TGYRME------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHh------------CCCCCC------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111111 100000 011223468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=313.20 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=186.7
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
..++|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999876 58899999997532 2233557889999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|||||++|+|.+++.... ++...+..++.|++.||+|| |+.+|+|||++ ||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999987643 67778888999999999999 56789999764 89999999876432
Q ss_pred CcccccccccCCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQG----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.. .......||+.|+|||++... .++.++|||||||++|||++|+.||....... .+ ..+.+
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~---------~~i~~ 261 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TY---------SKIMD 261 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HH---------HHHHc
Confidence 21 112345799999999988653 47899999999999999999999997532110 00 01110
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGK--RINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~evl~~ 988 (1007)
... ....+.....+.++.+++.+|++.+|++ |||+.|++++
T Consensus 262 ~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKN----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0000000012456889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=293.92 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=190.4
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
+|...+.||+|+||.||+|... +++.||+|++.... ...+++.+|++++++++||||+++++++..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4777899999999999999865 58899999987543 334678999999999999999999999999999999999999
Q ss_pred CCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++... ...+++..+..++.|+++||+|| |+.+++|++++ |++|||+++........ .
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence 99999999754 34589999999999999999999 57789999764 89999999876532211 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||++....++.++|||||||++|||++ |..||..... .++... +.......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~---------~~~~~~~~-- 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL---------LEKGYRME-- 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH---------HHCCCCCC--
Confidence 122334678999999988899999999999999999998 9999875321 111111 11100000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+...+.++.+++.+||+.+|++|||+.|++++|+++
T Consensus 226 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111245689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.13 Aligned_cols=233 Identities=25% Similarity=0.314 Sum_probs=188.3
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|...+.||.|+||.||-|+.. +...||||++... ..+...++..||..|++++|||+|.+.|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667788999999999999865 6788999999743 33455788999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||- |+-.+.+.-+..++....+..|..+.+.||+|| |+.+.||||++ |++|||.|....+.
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 996 588888876666788888899999999999999 67788999774 89999999876532
Q ss_pred cccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 871 SMQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.+.+|||+|||||++. .+.|+-|+||||+||+..||..+++|+..+... ..+...+..- .+.+.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNe---------sPtLq 246 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE---------SPTLQ 246 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcC---------CCCCC
Confidence 4578999999999875 478999999999999999999999998764210 1111111110 01111
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+....+..++..|++.-|.+|||..+++++
T Consensus 247 ---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22446679999999999999999999998876
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=287.74 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=192.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCc-eeEEEEEEecCC-----
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRN-LVKIISACSNDD----- 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~----- 795 (1007)
...|...++||+|+||+||+|+.+ +|+.||+|++.-..+ .......+|+.++++++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777788999999999999855 699999999975533 23345689999999999999 999999998877
Q ss_pred -eeEEEEEecCCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceee
Q 001838 796 -FKALIMEYMPNGSLENRLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFS 859 (1007)
Q Consensus 796 -~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFG 859 (1007)
..++||||++. +|.+++.... ..++...+..++.|+++||+|| |+++|+|||++ ||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccc
Confidence 78999999976 9999998654 3577788999999999999999 78899999875 999999
Q ss_pred cceecCCCCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C--
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P-- 935 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~-- 935 (1007)
+|+...-. ....+..++|.+|+|||++.+. .|+..+||||+|||++||+++++-|.+..+.+ .+.+..+... |
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCc
Confidence 99965422 1224567899999999999886 69999999999999999999998887643311 1111111111 1
Q ss_pred ccH---HHHhhhh--hccch--hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHH
Q 001838 936 ISV---MEVIDTN--LLSGE--ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKI 992 (1007)
Q Consensus 936 ~~~---~~~~d~~--~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~--L~~i 992 (1007)
..+ ....+.. ..... .......+....+..+++.+|++++|.+|.|+++++++ +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000 0000100 00000 00000011111368999999999999999999999987 4444
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.03 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=187.0
Q ss_pred ccccccceecccCceEEEEEEEcC---------------CceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD---------------GMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIIS 789 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~ 789 (1007)
++|+..+.||+|+||.||+|+... ...||||+++.. .....+.|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987542 235899998754 2344567999999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCChhHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----
Q 001838 790 ACSNDDFKALIMEYMPNGSLENRLYSGT-----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----- 853 (1007)
Q Consensus 790 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----- 853 (1007)
++...+..++||||+++++|.+++.... ..+++..+.+++.|++.|++|| |+.+++|++++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhEE
Confidence 9999999999999999999999986431 2367889999999999999999 57789999763
Q ss_pred -------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCcc
Q 001838 854 -------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT--GKKPTDEIFIGEL 924 (1007)
Q Consensus 854 -------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~~ 924 (1007)
|++|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 8999999987643322222233456788999999988889999999999999999998 566776432111
Q ss_pred hHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 925 SLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 925 ~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
........... .+...... .++..+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 -~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIENTGEFFRN-----QGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHhhhh-----ccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11110000000 00000000 00112346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=293.65 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=190.3
Q ss_pred HHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 721 LLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 721 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456777777889999999999999865 578899999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceec
Q 001838 800 IMEYMPNGSLENRLYSGTCML--DIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFL 864 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~ 864 (1007)
||||+++++|.+++......+ ++..+..++.|++.|++|| |+.+|+|+++ .||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654445 7788888999999999999 5789999865 379999999876
Q ss_pred CCCCcccccccccCCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHh
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 942 (1007)
..... ......|+..|+|||++.... ++.++|||||||++|||++|+.||....... ...|......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~------- 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFK------- 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhc-------
Confidence 43221 112345889999999986643 7899999999999999999999986421111 1111100000
Q ss_pred hhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ....+.....++.+++.+||+.+|++|||+.|++++
T Consensus 229 ------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ------I---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------c---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 000011223468899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=302.16 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=192.4
Q ss_pred ccccccceecccCceEEEEEEEc--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ--------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
++|...+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+++++++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999999753 23569999997542 34456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
..|+||||+++|+|.+++.... ..+++.++.+++.|++.||+|| |+.+++|++++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEEc
Confidence 9999999999999999997532 2478899999999999999999 56799999764
Q ss_pred -----ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~ 927 (1007)
|++|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----E 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H
Confidence 8999999986643222111222335578999999988889999999999999999998 8888864211 1
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
+... .+..... ...+.....++.+++.+|++.+|++||||.||++.|+++.+..
T Consensus 250 ~~~~---------~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELFK---------LLKEGHR------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH---------HHHcCCC------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 1110000 0011122457889999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=272.20 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=195.9
Q ss_pred cccccccceecccCceEEEEEE-EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKA 798 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 798 (1007)
..+|.+.+.+|+|||+.||.++ ..+++.+|+|++.....+..+..++|++..++++||||++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 5578999999998877777788999999999999999999999875433 589
Q ss_pred EEEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeeccee
Q 001838 799 LIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~ 863 (1007)
++++|...|+|.+.+.. ++..+++.+.+.|+.+|++||++||. ..+++.|||++ ++.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999998864 34578999999999999999999975 34579999875 7999999886
Q ss_pred cCCCCc-------ccccccccCCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 001838 864 LNGQDQ-------LSMQTQTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 864 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
..-.-. .+.......|..|+|||.+.- ...++++|||||||++|+|+.|..||+.....+.++.--+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~-- 256 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ-- 256 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee--
Confidence 542111 111123457899999998754 34689999999999999999999999976543332211000
Q ss_pred cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 934 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
...+.-... ...++.+.+++..|++.||.+||++.|++..++.+
T Consensus 257 ---------n~q~s~P~~------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 ---------NAQISIPNS------SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------ccccccCCC------CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 001100000 11355789999999999999999999999998764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=306.53 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=194.9
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.|.++..+|.|+||+||+|..++ +...|.|++....+...++|+-|++||....||+||++++.|..++..|+..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45556789999999999998764 66678899988888888999999999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
||..+..+-.-...+...++..+++|++.||.|| |+..|||||++ +++|||.+...... ....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhh
Confidence 9999998877667799999999999999999999 78999999875 89999988654321 1223
Q ss_pred ccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 874 TQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
.+..|||+|||||+.. ..+|+.++|||||||+|.||.-+.+|..+... +.++-....
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------------MRVllKiaK- 249 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------MRVLLKIAK- 249 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------------HHHHHHHhh-
Confidence 4678999999999864 46799999999999999999999999775321 112111111
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+....+......+.+++.+||..+|..||++++++++
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1112222344556789999999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=323.48 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=192.2
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....++|.+|++++++++|||||++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999876 58999999997432 334567999999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceee
Q 001838 802 EYMPNGSLENRLYSG----------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFS 859 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFG 859 (1007)
||++||+|.+++... ....++..+.+++.||++||+|| |+.+|+|||++ ||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988631 12356677889999999999999 56789999764 899999
Q ss_pred cceecCCCCc----------------ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCc
Q 001838 860 IAKFLNGQDQ----------------LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923 (1007)
Q Consensus 860 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~ 923 (1007)
+++....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001122469999999999998899999999999999999999999997522111
Q ss_pred chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHHHHhhh
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI-NAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-t~~evl~~L~~i~~~~~~ 998 (1007)
..... .. .++.. .......+..+.+++.+|++.||++|| +++++.+.|+.......+
T Consensus 239 i~~~~---~i--------~~P~~-------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYRD---VI--------LSPIE-------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhhh---hc--------cChhh-------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 10000 00 00000 000112244678999999999999996 677788888877654333
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.40 Aligned_cols=242 Identities=26% Similarity=0.420 Sum_probs=190.5
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
.+|+..+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35777899999999999999642 366899999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------c
Q 001838 800 IMEYMPNGSLENRLYSGT--------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------A 853 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~ 853 (1007)
||||+++|+|.+++.... ..+++..+..++.|++.|++|| |+.+++|+++ +
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence 999999999999997542 2478899999999999999999 5778999965 3
Q ss_pred ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 932 (1007)
||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |+.||......+ .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~-- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECI-- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHH--
Confidence 8999999987643322222223346788999999988889999999999999999998 999986532111 11111
Q ss_pred hcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 933 LLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 933 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
...... ..+...+..+.+++.+||+.||++||++.||.+.|+
T Consensus 238 ----------~~~~~~------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ----------TQGREL------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HcCccC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 000122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=313.52 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=183.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999865 68999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ |++|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997643 478888888999999999999 67899999874 8999999964321000
Q ss_pred c---------------------------------------------cccccccCCcccccccccccCCCCchhhHHHHHH
Q 001838 870 L---------------------------------------------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGI 904 (1007)
Q Consensus 870 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gv 904 (1007)
. ......+||+.|+|||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246999999999998889999999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCC---CC
Q 001838 905 MLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKR---IN 981 (1007)
Q Consensus 905 il~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---pt 981 (1007)
++|||+||+.||......+. ....... .. .+... .......++.+++.+|+. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~--~~--------~~~~p------~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-YRKIINW--RE--------TLYFP------DDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-HHHHHcc--CC--------ccCCC------CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999975321110 0000000 00 00000 000123467889999997 66664 69
Q ss_pred HHHHHHH
Q 001838 982 AREIVTG 988 (1007)
Q Consensus 982 ~~evl~~ 988 (1007)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=296.09 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=186.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
++|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999964 68899999997554444467889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++.... .+++..+..++.|++.|++|| |+.+|+|+++ .||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 9999999987543 578899999999999999999 5678999865 38999999987642211 1
Q ss_pred cccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 873 QTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||......+. ...+....... +..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-------~~~--- 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQP-------PKL--- 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCCC-------CCC---
Confidence 13346889999999874 34578899999999999999999999864321110 00000000000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
......+.++.+++.+||+.+|++|||++++++.+
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00011234688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=301.34 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=192.8
Q ss_pred cccccccceecccCceEEEEEEEc--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ--------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSND 794 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 794 (1007)
.++|...+.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 357888899999999999999742 24579999987542 34457789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------
Q 001838 795 DFKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------ 853 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------ 853 (1007)
+..|+||||+++|+|.+++.+.. ..+++..+.+++.|+++||+|| |+.+|+|+|++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEEE
Confidence 99999999999999999997531 2477888999999999999999 57799999764
Q ss_pred ------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchH
Q 001838 854 ------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSL 926 (1007)
Q Consensus 854 ------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l 926 (1007)
|++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence 8999999987754322222233456778999999988889999999999999999998 788886432 1
Q ss_pred HHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 927 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.++....... ... ..+..++.++.+++.+||+.+|++||||.|+++.|+++...
T Consensus 246 ~~~~~~~~~~---------~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEG---------HRM------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcC---------CcC------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111000 000 00112345688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=295.21 Aligned_cols=244 Identities=23% Similarity=0.427 Sum_probs=191.2
Q ss_pred ccccccceecccCceEEEEEEEc-CC---ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DG---MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||.||+|+.. ++ ..||+|.++... ....+.+..|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999875 33 379999987542 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++......+++.++..++.|++.|++|| |+.+++|++++ |++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999987666689999999999999999999 56789999764 899999998764322
Q ss_pred cccc-cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 869 QLSM-QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 869 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
.... ......+..|+|||++....++.++|||||||++|||++ |+.||...... ++... +....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~---------i~~~~ 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKA---------INDGF 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHH---------HhcCC
Confidence 2111 112234567999999988889999999999999999998 99998643211 11111 11000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.. +.....+.++.+++.+|++.+|++||++.||++.|+++
T Consensus 228 ~~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RL------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00112245689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=294.97 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=187.2
Q ss_pred cccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+|+..+.||+|+||.||+|..+++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777899999999999999988778899999865322 235688899999999999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~ 874 (1007)
++|.+++......+++..+..++.|++.|++|| |+.+++|+++ .|++|||+++........ ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 999999986555689999999999999999999 5678999965 389999999876432211 112
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
...++..|+|||++....++.++|||||||++|||++ |+.||...... .....+ .......
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~------------~~~~~~~---- 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESV------------SAGYRLY---- 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHH------------HcCCcCC----
Confidence 2234567999999988899999999999999999999 89998753211 111111 0000000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 222 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 --RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011245689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=314.97 Aligned_cols=253 Identities=22% Similarity=0.267 Sum_probs=182.0
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--------
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSND-------- 794 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 794 (1007)
...+|...+.||+|+||+||+|... +++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999875 58899999886432 2235799999999999999999887432
Q ss_pred CeeEEEEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------cccee
Q 001838 795 DFKALIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDF 858 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DF 858 (1007)
...++||||+++ ++.+++.. ....+++..+..++.|++.||+|| |+.+|+|||++ ||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 77776642 334688999999999999999999 57789999664 89999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCcc
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
|+|+....... .....||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.... ..+.+.+.......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99987643322 1345689999999988664 6899999999999999999999999753221 11111111111111
Q ss_pred H--HHHhhhhhc-------cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 V--MEVIDTNLL-------SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~--~~~~d~~~~-------~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .....+... .........+...+.++.+++.+||+.||++|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 000111000 00000011112234578999999999999999999999966
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=302.53 Aligned_cols=233 Identities=20% Similarity=0.312 Sum_probs=180.0
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHH---HhcCCCceeEEEEEEecCCeeEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVM---KRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
|+..+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++ ++++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999865 68999999997543 22345666776665 566799999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|..++.++ .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888654 489999999999999999999 57899999764 899999987543221
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... .......
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~--------i~~~~~~- 219 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDS--------IVNDEVR- 219 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHhCCCC-
Confidence 1223457999999999998889999999999999999999999999753211 11110 0000000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+||+.||++|| ++.|+++.
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011234678999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=299.53 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=190.8
Q ss_pred cccccccceecccCceEEEEEEEcC-----------------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD-----------------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 786 (1007)
.++|+..+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999997542 2468999987543 345578999999999999999999
Q ss_pred EEEEEecCCeeEEEEEecCCCChhHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---
Q 001838 787 IISACSNDDFKALIMEYMPNGSLENRLYSGT----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--- 853 (1007)
Q Consensus 787 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~--- 853 (1007)
++++|..++..++||||+++++|.+++.+.. ..+++..+..++.|++.||+|| |+.+|+|+|++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence 9999999999999999999999999997543 2588999999999999999999 56789999764
Q ss_pred ---------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccC
Q 001838 854 ---------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT--GKKPTDEIFIG 922 (1007)
Q Consensus 854 ---------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~ 922 (1007)
+++|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 7999999987644332222334457789999999988889999999999999999998 67787643211
Q ss_pred cchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 923 ELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 923 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.....+....... +... ....+...+.++.+++.+|++.||++|||+.||++.|+
T Consensus 241 --~~~~~~~~~~~~~-----~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 --QVIENAGHFFRDD-----GRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHhccccc-----cccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111100000 0000 00001122357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=294.10 Aligned_cols=227 Identities=23% Similarity=0.368 Sum_probs=177.2
Q ss_pred eecccCceEEEEEEEcC-------------------------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEE
Q 001838 733 LLGIGSFGSVYVARLQD-------------------------GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 787 (1007)
.||+|+||.||+|.... ...||+|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999986655555778999999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc--------------
Q 001838 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------- 853 (1007)
Q Consensus 788 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------- 853 (1007)
+++|.+....++||||+++|+|..++.+....+++..+.+++.|+++||+|| |+.+|+|||++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999976656689999999999999999999 57799998653
Q ss_pred -----ccceeecceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHH-HhCCCCCCccccCcchH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMET-FTGKKPTDEIFIGELSL 926 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~el-ltG~~p~~~~~~~~~~l 926 (1007)
|++|||++...... ....++..|+|||++.. ..++.++|||||||++||| ++|+.||......+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 67899987644221 12357788999998865 5689999999999999998 47999987532211 1
Q ss_pred HHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 927 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
..+. +...... +....++.+++.+||+.+|++||||.||++.|.
T Consensus 231 ~~~~------------~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFY------------EKKHRLP--------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH------------HhccCCC--------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 1000000 001235889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=302.89 Aligned_cols=230 Identities=23% Similarity=0.318 Sum_probs=180.6
Q ss_pred ceecccCceEEEEEEEc----CCceEEEEEechhh----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 732 NLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY----ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+.||+|+||+||+++.. +++.||||+++... ......+.+|++++++++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999853 57899999997542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|.+++.+.. .+.+..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999997654 467778888999999999999 57789999764 8999999986432221
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
......||+.|+|||++....++.++|||||||++|||++|+.||...... ..... .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~--------~~~~~~~---- 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDK--------ILKGKLN---- 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHH--------HHcCCCC----
Confidence 123457999999999998888999999999999999999999999753211 11111 1100000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+|++.+|++|| ++.++++.
T Consensus 219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0111234688999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=305.51 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=189.0
Q ss_pred cccccccceecccCceEEEEEEE------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC-C
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSND-D 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 795 (1007)
.++|+..+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|++++.++ +|||||+++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999973 247899999997532 33456788999999999 689999999988654 4
Q ss_pred eeEEEEEecCCCChhHhhhcCC----------------------------------------------------------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------------------------------------------------- 817 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 817 (1007)
..++|||||++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccccc
Q 001838 818 --------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 818 --------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
..+++.++.+++.|+++||+|| |+.+|+||+++ |++|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1367888899999999999999 57899999764 899999998764332222222334
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 956 (1007)
++..|+|||++....++.++|||||||++|||++ |..||........ .. ..+....... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~------------~~~~~~~~~~------~ 303 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC------------RRLKEGTRMR------A 303 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH------------HHHhccCCCC------C
Confidence 6678999999988889999999999999999997 9999875321110 00 0000000000 0
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 957 KEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 957 ~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
+.....++.+++..||+.+|++|||+.||+++|+.+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00113468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=295.02 Aligned_cols=233 Identities=20% Similarity=0.249 Sum_probs=180.6
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||+||+|... +|+.||||++..... ...+.+..|++++++++||||+++.+++..++..|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 689999999975432 2335678899999999999999999999999999999999999999
Q ss_pred hHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 810 ENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 810 ~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
.+++.. ....+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 234588999999999999999999 57799999763 8999999987643322 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~--------~~~~-------- 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRIL--------NDSV-------- 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhc--------ccCC--------
Confidence 4568999999999999999999999999999999999999997532111 0001110000 0000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
..++..+.++.+++.+|++.||++|| ++.|++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00112345688999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=309.55 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=185.1
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
..++|+..+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4568999999999999999999976 58899999997532 2234568899999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|||||++|+|.+++... .++...+..++.||+.||+|| |+.+|+|||++ ||+|||+|+.....
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999754 378888899999999999999 57899999774 89999999876432
Q ss_pred CcccccccccCCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQG----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.. .......||+.|+|||++... .++.++||||+||++|||++|+.||......+ ... .+++
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~------------~i~~ 261 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYS------------KIMD 261 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHH------------HHHh
Confidence 21 122345799999999998654 37899999999999999999999997532110 011 1111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGK--RINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~evl~~ 988 (1007)
.... ...+........+.+++..|++.++.+ ||++.|++++
T Consensus 262 ~~~~----~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS----LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc----cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 000000112345778888899865544 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=295.65 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=190.4
Q ss_pred cccccceecccCceEEEEEEEcC-C---ceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-G---MEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
+|+..+.||+|+||.||+|.... + ..||||+++.. .....++|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999998653 3 36999998754 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++......+++.++..++.|++.|++|| |+.+++|++++ |++|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999987666689999999999999999999 56799998764 7999999987643222
Q ss_pred cccccc---ccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhh
Q 001838 870 LSMQTQ---TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 870 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
...... ...+..|+|||++....++.++|||||||++||+++ |+.||..... .....++....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~~---------- 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDYR---------- 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCc----------
Confidence 111111 112457999999988899999999999999999886 9999875321 112222211000
Q ss_pred hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+.+...+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000112344688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=289.86 Aligned_cols=246 Identities=19% Similarity=0.301 Sum_probs=194.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999977 7999999988642 2334578899999999999999999999999999999999
Q ss_pred EecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 802 EYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 802 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
||+++|+|.+++.. ....+++.++.+++.|++.|+.|| |+.+|+|+++. +++|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 234578999999999999999999 57899999653 8999999987643
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ....++.... ....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~---------~~~~ 224 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI---------EKCD 224 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh---------hcCC
Confidence 221 1123468889999999988889999999999999999999999986432 1122211111 0000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
... ...+.....+.+++.+||..+|++|||+.+|+++|++++
T Consensus 225 ~~~-----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPP-----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC-----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 001123456889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.11 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=187.1
Q ss_pred ccccceecccCceEEEEEEEcC----CceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe-----
Q 001838 728 FSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF----- 796 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 796 (1007)
|...+.||+|+||.||+|.... +..||||+++... ....+.+.+|++.+++++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999987432 3445689999999999999999999998876554
Q ss_pred -eEEEEEecCCCChhHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cccee
Q 001838 797 -KALIMEYMPNGSLENRLYSG-----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDF 858 (1007)
Q Consensus 797 -~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DF 858 (1007)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+++|++++ ||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988532 23578899999999999999999 56789999764 89999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCcc
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||.+.... ...++.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGN--- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence 99987654332222222345678999999988889999999999999999999 88998653211 1111111100
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.. ..+...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 --------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 --------RL-------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CC-------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=312.14 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=189.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 68999999997643 134567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC-
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD- 868 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~- 868 (1007)
||+++|+|.+++.+. ..+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 4588899999999999999999 56899999774 899999998764322
Q ss_pred --------------------------cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC
Q 001838 869 --------------------------QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIG 922 (1007)
Q Consensus 869 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~ 922 (1007)
.........||+.|+|||++....++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123456999999999999999999999999999999999999999753211
Q ss_pred cchHHHHHHhhcCccHHHHhh--hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHHH
Q 001838 923 ELSLSRWVNDLLPISVMEVID--TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN-AREIVTG 988 (1007)
Q Consensus 923 ~~~l~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-~~evl~~ 988 (1007)
. .+. .+.. ........ .....++.+++.+|+. ||++||+ +.|++++
T Consensus 237 ~----~~~---------~i~~~~~~~~~p~~------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E----TYN---------KIINWKESLRFPPD------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHH---------HHhccCCcccCCCC------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 000 0000 00000000 0023468899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=299.88 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=188.0
Q ss_pred cccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
+|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999863 25789999997543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------
Q 001838 800 IMEYMPNGSLENRLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------- 853 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------- 853 (1007)
++||+++++|.+++... ...+++..+.+++.|++.||+|+ |+.+|+|||++
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCCc
Confidence 99999999999998521 12478888999999999999999 57789999764
Q ss_pred -ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 001838 854 -HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 854 -kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~ 931 (1007)
|++|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||..... .++..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 8999999987643332222233456789999999988889999999999999999998 8888865321 11111
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
..... ... ..+..++..+.+++..||+.+|++||+++||++.|+
T Consensus 238 ~i~~~--------~~~-------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 238 MIRNR--------QVL-------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHcC--------CcC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11100 000 001123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=296.68 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=182.3
Q ss_pred ccccccceecccCceEEEEEEEc--CCceEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeEEEEEEec-----
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ--DGMEVAVKVFHQRY--ERALKSFQDECEVMKRI---RHRNLVKIISACSN----- 793 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 793 (1007)
++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++++++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 47889999986432 12234566788777766 69999999999852
Q ss_pred CCeeEEEEEecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 794 DDFKALIMEYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 794 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
....++||||++ |+|.+++... ...+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999997 6899988753 23588999999999999999999 57889999764 8999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc---Ccc
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---PIS 937 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~ 937 (1007)
++..... .......||+.|+|||++....++.++|||||||++|||++|++||......+ .+...+.... +..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 9876432 12234568999999999988889999999999999999999999997642211 1111111110 000
Q ss_pred HHHH--hhhhhcc--chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 VMEV--IDTNLLS--GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~~~~--~d~~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... +...... ...............+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 0000000111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=288.56 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=189.5
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|...+.||+|++|.||+|+.. +|+.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999875 6899999998643 234557789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
+++++|.+++... ...+++..+.+++.|++.|+.|| |+.+++|+++. |++|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 34688999999999999999999 56799998663 89999999876543221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.....|++.|+|||+.....++.++|||||||++|||++|+.||..... ......+.. ... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-----------~~~-~-- 219 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIR-----------GVF-P-- 219 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc-----------CCC-C--
Confidence 2334688999999999988899999999999999999999999975321 111111100 000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........++.+++.+||+.+|++||+|.|+++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011224468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=291.65 Aligned_cols=236 Identities=24% Similarity=0.400 Sum_probs=183.2
Q ss_pred eecccCceEEEEEEEc---CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 733 LLGIGSFGSVYVARLQ---DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 35679999997653 3345679999999999999999999998864 46899999999999
Q ss_pred hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc-ccccc
Q 001838 809 LENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL-SMQTQ 875 (1007)
Q Consensus 809 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~-~~~~~ 875 (1007)
|.+++......+++..+.+++.|++.|++|| |+.+++|+|++ |++|||+++........ .....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999976556689999999999999999999 56789999763 89999999865433221 11122
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
..++..|+|||++....++.++|||||||++||+++ |+.||...... .....+....+ .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~------------------~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKR------------------L 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC------------------C
Confidence 334678999999888889999999999999999996 99999754221 11111111100 0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
..+.....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00112245688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=290.18 Aligned_cols=235 Identities=29% Similarity=0.405 Sum_probs=185.6
Q ss_pred ceecccCceEEEEEEEcCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChh
Q 001838 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLE 810 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 810 (1007)
++||+|+||.||+|...++..||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999987543 334457899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccC
Q 001838 811 NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLA 878 (1007)
Q Consensus 811 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~g 878 (1007)
+++......+++..+..++.|++.|+.|+ |+.+++|++++ |++|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99976655689999999999999999999 57899999764 8999999986532211 11122344
Q ss_pred CcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 879 t~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
+..|+|||++....++.++|||||||++||+++ |..||....... ....+.. ..... .+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~------------~~~~~------~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEK------------GYRMS------CP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc------------CCCCC------CC
Confidence 678999999988889999999999999999998 999987532111 1111100 00000 00
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
...+.++.+++.+|++.+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112356899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=302.66 Aligned_cols=229 Identities=21% Similarity=0.284 Sum_probs=177.0
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999997643 23345566777777755 799999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999987654 488888999999999999999 56899999764 899999998653222 1223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~~~---------i~~~~---~---- 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LFDS---------ILNDR---P---- 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HHHH---------HHcCC---C----
Confidence 4579999999999988889999999999999999999999997532111 1100 00000 0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAR-EIVT 987 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~-evl~ 987 (1007)
..+.....++.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00011234578999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=305.02 Aligned_cols=236 Identities=18% Similarity=0.287 Sum_probs=181.8
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||++++++|.+.+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 58899999998643 23446688999999998 699999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887543 589999999999999999999 67899999764 899999998532211 1123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCc---chHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE---LSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ....++.... .......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~---- 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-------ILEKQIR---- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-------HHcCCCC----
Confidence 4579999999999998899999999999999999999999997422111 1111111110 0000000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCC------HHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRIN------AREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt------~~evl~~ 988 (1007)
.+.....++.+++.+|++.||++||+ +.|++++
T Consensus 224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 01122346889999999999999998 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=293.92 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=191.5
Q ss_pred ccccccceecccCceEEEEEEEc----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||.||+|+.. .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999864 23479999987542 34457889999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++.+....+++.++.+++.|++.|++|| |+.+++|++++ |++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999987666689999999999999999999 57889999663 799999998765332
Q ss_pred ccc-ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 869 QLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 869 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
... ......++..|+|||++....++.++|||||||++||+++ |+.||...... ....++.....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~----------- 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR----------- 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc-----------
Confidence 211 1122234568999999988889999999999999999886 99998753211 11111111000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+.....+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=298.51 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=189.9
Q ss_pred cccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 797 (1007)
.++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999987543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---
Q 001838 798 ALIMEYMPNGSLENRLYSGT---------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--- 853 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~--- 853 (1007)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|| |+.+++|+++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence 99999999999999996421 2467888999999999999999 56799999763
Q ss_pred ---------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCc
Q 001838 854 ---------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGE 923 (1007)
Q Consensus 854 ---------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~ 923 (1007)
|++|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 8999999986543322222223345678999999988899999999999999999998 88888643211
Q ss_pred chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
++..... +.... ..++..+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 ----~~~~~~~--------~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ----EVIYYVR--------DGNVL-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHHh--------cCCCC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111110 00000 0011224568999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.64 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=193.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||.||+|+.. +|+.||||.+... .....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 7999999988643 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 802 EYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 802 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
||+++++|.+++.. ....+++..+..++.|++.|+.|| |+.+++|++++ +++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 234578999999999999999999 57899999764 8999999887643
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
... ......|+..|+|||++....++.++|||||||++|||++|..||.....+ ...+.... .....+..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-----~~~~~~~~ 228 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-----EQCDYPPL 228 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh-----hcCCCCCC
Confidence 221 112346889999999998888999999999999999999999998643211 11111110 00000000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.......++.+++.+||+.+|++||||.+|.+.++++.
T Consensus 229 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01123456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=311.11 Aligned_cols=189 Identities=22% Similarity=0.339 Sum_probs=159.3
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||+++++|.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999865 58899999997643 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC--
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD-- 868 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~-- 868 (1007)
||++|+|.+++.+.. .++......++.||+.||+|| |+.+|+|||++ ||+|||+|+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997653 478888888999999999999 57789999774 899999985321000
Q ss_pred -------------------------------------------cccccccccCCcccccccccccCCCCchhhHHHHHHH
Q 001838 869 -------------------------------------------QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIM 905 (1007)
Q Consensus 869 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvi 905 (1007)
........+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000123469999999999998899999999999999
Q ss_pred HHHHHhCCCCCCcc
Q 001838 906 LMETFTGKKPTDEI 919 (1007)
Q Consensus 906 l~elltG~~p~~~~ 919 (1007)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.50 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=180.5
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||+||+++.+ +|+.||+|++..... ...+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 589999999975321 2234566799999999999999999999999999999999999999
Q ss_pred hHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccc
Q 001838 810 ENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQT 876 (1007)
Q Consensus 810 ~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~ 876 (1007)
.+++... ...+++..+..++.|++.|++|| |+.+|+|++++ +|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 9888653 33588999999999999999999 57899999764 8999999987643221 1335
Q ss_pred cCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHH
Q 001838 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956 (1007)
Q Consensus 877 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 956 (1007)
.|+..|+|||++....++.++||||+||++|||++|+.||...... .....+.... +.......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~--------~~~~~~~~------- 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRT--------LEDEVKFE------- 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHh--------hccccccc-------
Confidence 6899999999998888999999999999999999999998753211 1111111110 00000000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 957 KEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 957 ~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
......++.+++.+||+.||++||+++|+++...
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0112346899999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.49 Aligned_cols=229 Identities=21% Similarity=0.300 Sum_probs=178.2
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999998653 23345667788888765 899999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999997643 478889999999999999999 57899999764 8999999986432211 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+... .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~---------~~~--------- 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD---------NPC--------- 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCC---------
Confidence 456999999999998889999999999999999999999999753211 111111000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAR-EIVT 987 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~-evl~ 987 (1007)
.+.....++.+++.+|++.||++||++. ++.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0011234578999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.47 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=188.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++..+...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46888899999999999999864 68999999997654444577899999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++... .+++.++..++.|++.|++|| |+.+|+|++++ ||+|||+++....... .
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~ 172 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence 999999998654 378889999999999999999 57789999764 8999999886543221 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|++.|+|||++....++.++|||||||++|||++|+.||........ +..+.....+ ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~---------~~------ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP---------EL------ 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC---------CC------
Confidence 1234688999999999888899999999999999999999999975322111 1111000000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+......+.+++.+||..+|++|||+.|+++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011223457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=296.73 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=188.8
Q ss_pred hcccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF 796 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 796 (1007)
..++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999754 25589999986443 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cc
Q 001838 797 KALIMEYMPNGSLENRLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HI 855 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl 855 (1007)
.++||||+++|+|.+++.... ...++..+..++.|++.||.|| |+++|+|++++ |+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996421 2346678889999999999999 57899999764 79
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhc
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||...... ++....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFV- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH-
Confidence 99999987643322222223345778999999988889999999999999999999 78888653211 111110
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+..... .+......+.+++.+|++.+|++|||+.|+++.+++.
T Consensus 235 -------~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 -------MDGGYLD-------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HcCCCCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0000000 0011234689999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=292.19 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=182.1
Q ss_pred ceecccCceEEEEEEEc----CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCeeEEEEEecC
Q 001838 732 NLLGIGSFGSVYVARLQ----DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACS-NDDFKALIMEYMP 805 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~E~~~ 805 (1007)
+.||+|+||+||+|... ++..||||++... .....+.+.+|+.++++++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999854 2457999998643 2344578889999999999999999999876 4556899999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc--c
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL--S 871 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~--~ 871 (1007)
+|+|.+++.+.....++..+..++.|++.|++|| |+.+++|++++ |++|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999987655577888899999999999999 56789999663 89999999865432111 1
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTG-KKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......++..|+|||++....++.++|||||||++|||++| .+||.... ...+..++.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~-----------~---- 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGR-----------R---- 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC-----------C----
Confidence 11234567789999999888899999999999999999995 55665321 111111111000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
...+...+..+.+++.+||+.+|++||++.|++++|+++..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=293.16 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=192.0
Q ss_pred ccccccceecccCceEEEEEEEcC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|...+.||+|+||.||+|...+ ...||||+..... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 357788999999999999998643 3469999987554 4556789999999999999999999999875 457899
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++......+++..+..++.|++.|++|| |+.+++|++++ |++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999999999987655689999999999999999999 57789998763 899999998775432
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
... .+...++..|+|||++....++.++|||||||++||+++ |+.||......+ ...+..... ..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~----------~~- 227 (270)
T cd05056 162 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE----------RL- 227 (270)
T ss_pred cee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC----------cC-
Confidence 221 123345678999999888889999999999999999996 999997542211 111111000 00
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
..++..+.++.+++.+|+..+|++|||+.|+++.|++++..
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112245688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=300.56 Aligned_cols=224 Identities=21% Similarity=0.285 Sum_probs=176.8
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|.+++... +||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999997542 23446678899999877 699999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 99999887654 488899999999999999999 57889999764 8999999986432211 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~--------~~~------- 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILND--------EVV------- 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcC--------CCC-------
Confidence 457999999999998888999999999999999999999999753211 111111000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
.+.....++.+++.+|++.||++||++
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 001123468899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=294.90 Aligned_cols=242 Identities=26% Similarity=0.377 Sum_probs=190.1
Q ss_pred ccccccceecccCceEEEEEEEcC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578889999999999999998642 4689999987543 344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccce
Q 001838 799 LIMEYMPNGSLENRLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISD 857 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~D 857 (1007)
+||||+++|+|.+++.... ..+++..+.+++.|++.|+.|| |+.+|+|+++ +||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999996421 2367889999999999999999 5788999976 38999
Q ss_pred eecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCc
Q 001838 858 FSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 858 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
||+++.+.............++..|+|||.+....++.++|||||||++||++| |+.||..... ....++...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~---- 236 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID---- 236 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhc----
Confidence 999987654332222234457889999999988889999999999999999998 9999864321 111111110
Q ss_pred cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 937 SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 937 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.... ..+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 237 -------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 -------GGHL-------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------CCCC-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 001112456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=292.43 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=187.6
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|+..+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999988888999999975432 2356899999999999999999999885 456899999999
Q ss_pred CCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++... ...+++..+.+++.|++.|++|| |+.+|+|+++. |++|||+++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999999754 33588999999999999999999 56789999663 79999999876432211 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||+.....++.++|||||||++|||++ |+.||.+.... ...++.. .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~------------~~~~~--- 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVE------------RGYRM--- 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH------------cCCCC---
Confidence 122345678999999888889999999999999999999 89998753211 1111111 00000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
+.+...+.++.+++.+|++.+|++|||++++.+.|++
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011223468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=299.52 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=190.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCc--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM--EVAVKVFHQR-YERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||+||+|..+ +|. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++.+++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999865 454 4688877643 234456788999999999 899999999999999999999
Q ss_pred EEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 801 MEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
|||+++|+|.++++... ..+++.++..++.|++.|++|| |+.+|+|++++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCcE
Confidence 99999999999997432 2478889999999999999999 57899999764
Q ss_pred ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHh
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 932 (1007)
||+|||+++..... .......++..|+|||++....++.++|||||||++|||+| |..||...... +....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK 235 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence 79999998743211 11112234678999999888889999999999999999998 99998643211 11111
Q ss_pred hcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 001838 933 LLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 933 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
. ....... .+.....++.+++.+||+.+|++||++.++++++.++.+.-..+
T Consensus 236 ~---------~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 236 L---------PQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred H---------hcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 0 0000000 00012346889999999999999999999999999887665444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=299.97 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=192.7
Q ss_pred ccccccceecccCceEEEEEEEc--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ--------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
++|...+.||+|+||.||+|+.. .+..||+|+++... ......+.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999742 24579999987542 34456788999999999 5999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc--------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------- 852 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------- 852 (1007)
..++||||+++|+|.+++.... ..+++.++.+++.|++.||+|| |+.+|+|+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEEc
Confidence 9999999999999999996531 3478899999999999999999 5789999976
Q ss_pred ----cccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHH
Q 001838 853 ----AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927 (1007)
Q Consensus 853 ----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~ 927 (1007)
.|++|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||...... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 48999999987643222211122335568999999988889999999999999999999 89998653211 111
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhh
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
.... ..... ..+...+.++.+++.+|++.+|++|||+.|+++.|+++.....+
T Consensus 247 ~~~~------------~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 247 KLLR------------EGHRM------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHH------------cCCCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 1110 00000 00112234688999999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=312.23 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=182.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
.+|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999865 58999999997543 233466889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC-
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD- 868 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~- 868 (1007)
|||++|+|.+++.+.. .++......++.||+.||+|| |+.+|+|||++ ||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999997654 478888888999999999999 57899999874 899999985321000
Q ss_pred ----------------------------------------cccccccccCCcccccccccccCCCCchhhHHHHHHHHHH
Q 001838 869 ----------------------------------------QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLME 908 (1007)
Q Consensus 869 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~e 908 (1007)
.........||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123479999999999998899999999999999999
Q ss_pred HHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC---CHHHH
Q 001838 909 TFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI---NAREI 985 (1007)
Q Consensus 909 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp---t~~ev 985 (1007)
|++|+.||......+. ........ ..... +.......++.+++.+|+ .+|++|+ ++.|+
T Consensus 237 ll~G~~Pf~~~~~~~~-----~~~i~~~~------~~~~~------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAET-----QLKVINWE------TTLHI------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHHH-----HHHHhccC------ccccC------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999975422111 00000000 00000 000011335667777765 4999999 89999
Q ss_pred HHH
Q 001838 986 VTG 988 (1007)
Q Consensus 986 l~~ 988 (1007)
+++
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=288.65 Aligned_cols=227 Identities=22% Similarity=0.354 Sum_probs=177.8
Q ss_pred ceecccCceEEEEEEEcC-------------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 001838 732 NLLGIGSFGSVYVARLQD-------------GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
+.||+|+||+||+|+..+ ...||+|.+..........|.+|+.+++.++|||||++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999987665555678899999999999999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------------ccceee
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------------HISDFS 859 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------------kl~DFG 859 (1007)
+||||+++|+|..++......+++..+.+++.||++|++|| |+.+|+|||++ |++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999887666689999999999999999999 67899999653 688999
Q ss_pred cceecCCCCcccccccccCCcccccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCccccCcchHHHHHHhhcCcc
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGV-QGRVSTRGDVYSYGIMLMETF-TGKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvil~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+......+. ...
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~-------- 221 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERF-------- 221 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHH--------
Confidence 88755321 2345788999999886 456899999999999999997 58888764321110 000
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
........ .....++.+++.+||+.||++||++.||++.+
T Consensus 222 ----~~~~~~~~--------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 ----YEGQCMLV--------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----HhcCccCC--------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 00124578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=307.01 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=187.9
Q ss_pred HHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Q 001838 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSND 794 (1007)
Q Consensus 719 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 794 (1007)
.++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999876 58899999987532 23345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
+..|+|||||++|+|.+++.... ++...+..++.|++.||+|| |+.+|+|||++ ||+|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999987643 77888888999999999999 67899999774 899999998
Q ss_pred ecCCCCcccccccccCCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQG----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
....... .......||+.|||||++... .++.++|||||||++|||++|+.||....... .....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i--------- 259 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKI--------- 259 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHH---------
Confidence 7643221 122345799999999998653 37899999999999999999999997532110 00000
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGK--RINAREIVTGL 989 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~evl~~L 989 (1007)
... ......+.......++.+++..|+..++.+ ||++.|++++.
T Consensus 260 ---~~~----~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 ---MNH----KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---HcC----CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 000000001122446788999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=300.62 Aligned_cols=230 Identities=22% Similarity=0.286 Sum_probs=180.6
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999876 58899999997643 23445678899999876 799999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|..++.... .+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 99999887654 478889999999999999999 57789999764 8999999986432221 223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++....++.++|||||||++|||++|+.||......+ ..+ ..... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~---~i~~~--------~~~------- 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE---SILHD--------DVL------- 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH---HHHcC--------CCC-------
Confidence 4569999999999988899999999999999999999999997532111 111 00000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC-------CHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRI-------NAREIVTG 988 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rp-------t~~evl~~ 988 (1007)
.+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0001134688999999999999999 77777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=292.74 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=182.7
Q ss_pred cccceecccCceEEEEEEEcC-Cc--eEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 001838 729 SKNNLLGIGSFGSVYVARLQD-GM--EVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSND------DFK 797 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 797 (1007)
...+.||+|+||.||+|+..+ +. .||||.++.. .....+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998764 33 5899988643 234457889999999999999999999987532 246
Q ss_pred EEEEEecCCCChhHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 798 ALIMEYMPNGSLENRLYS-----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
++||||+++|+|.+++.. ....+++.....++.|++.|++||| +++|+|||++ ||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 2235789999999999999999994 6789999764 8999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVM 939 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 939 (1007)
++...............+++.|+|||+.....++.++|||||||++|||++ |+.||...... .+.+.+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~~-- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ---GN-- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc---CC--
Confidence 997653322211223346778999999988889999999999999999999 88998653211 11111100 00
Q ss_pred HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 940 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
... .+...+..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 232 ------~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 ------RLK-------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------CCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0011234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=324.79 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=187.1
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--CCe
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSN--DDF 796 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~ 796 (1007)
....++|.+.+.||+|+||+||+|+.. ++..||+|++... .......|..|+.++++++|||||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999876 5788999998643 23445678999999999999999999998864 356
Q ss_pred eEEEEEecCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceeccc-----------------
Q 001838 797 KALIMEYMPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGH----STPIIHYMV----------------- 852 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~~~----------------- 852 (1007)
.|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+|||+|+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999642 245899999999999999999998532 256999854
Q ss_pred ------------cccceeecceecCCCCcccccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 853 ------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 853 ------------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 4789999998764322 1234579999999998854 4589999999999999999999999974
Q ss_pred cccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 919 IFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 919 ~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
.. ....++...... +.+. ....+.++.+|+..||+.+|.+||++.|+++
T Consensus 246 ~~----~~~qli~~lk~~-------p~lp---------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN----NFSQLISELKRG-------PDLP---------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC----cHHHHHHHHhcC-------CCCC---------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111111111000 0000 0011346889999999999999999999985
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=303.83 Aligned_cols=236 Identities=19% Similarity=0.293 Sum_probs=180.6
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.++.++ +|||||++++++...+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 58899999998642 23445678899998887 799999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|..++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99998886543 488999999999999999999 57799999774 8999999986432211 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCc---chHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE---LSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....++... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~~~~----- 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILEKQI----- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------HhcCCC-----
Confidence 4579999999999999999999999999999999999999996321111 1111111110 000000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINA------REIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~------~evl~~ 988 (1007)
..+.....++.+++.+||+.||++||++ .|++++
T Consensus 223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0011223467899999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=300.35 Aligned_cols=230 Identities=22% Similarity=0.282 Sum_probs=181.3
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999998653 23345678899999888 699999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.+.. .+++..+..++.|++.||.|| |+.+|+||+++ ||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999887653 489999999999999999999 67899999764 8999999976422211 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i--------~~~~~~------- 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSI--------LEDEVR------- 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHH--------HcCCCC-------
Confidence 356899999999999899999999999999999999999999753211 111100 000000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINA-----REIVTG 988 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~-----~evl~~ 988 (1007)
.+.....++.+++.+||+.||++||++ .++++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 001123468899999999999999999 777664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=295.51 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=194.7
Q ss_pred ccccccceecccCceEEEEEEEc-----CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEec--CCee
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-----DGMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSN--DDFK 797 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 797 (1007)
+.|...+.||+|+||.||+|++. ++..||||++...... ..+.|.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999854 3688999999765432 46789999999999999999999999987 5578
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+++|+|.+++......+++..+..++.|++.||+|| |+.+++|++++ |++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999999987665689999999999999999999 56789999764 899999998775
Q ss_pred CCCcc-cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 866 GQDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
..... .......++..|+|||......++.++|||||||++|||+||+.|+......... ++...........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 32221 1112234566799999998888999999999999999999999998653221111 1100000001111111
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.+..... ...+..++.++.+++.+||+.+|++||||.||+++|++|+
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCc--CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1110000 0111223457899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.83 Aligned_cols=256 Identities=19% Similarity=0.246 Sum_probs=187.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|...+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999876 58899999987443 22234577899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++ +|.+++......+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 985 89888876665688999999999999999999 57899999764 8999999986532221
Q ss_pred ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc--CccHHHHh------
Q 001838 872 MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--PISVMEVI------ 942 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~~~~~~------ 942 (1007)
......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +........ +......+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223467899999998765 4589999999999999999999999975432111 111111100 00000000
Q ss_pred -hhhhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 -DTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 -d~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+...... .............++.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 000000111234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=296.67 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=187.7
Q ss_pred ccccccceecccCceEEEEEEEc-----------------CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-----------------DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKI 787 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 787 (1007)
++|+..+.||+|+||+||++... ++..||+|++... .....+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 2346999999754 34445789999999999999999999
Q ss_pred EEEEecCCeeEEEEEecCCCChhHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----
Q 001838 788 ISACSNDDFKALIMEYMPNGSLENRLYSGT----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---- 853 (1007)
Q Consensus 788 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---- 853 (1007)
++++...+..++||||+++|+|.+++.... ..+++..+.+++.|++.|++|| |+.+++|++++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheE
Confidence 999999999999999999999999987532 2367788999999999999999 56789999764
Q ss_pred --------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCc
Q 001838 854 --------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT--GKKPTDEIFIGE 923 (1007)
Q Consensus 854 --------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt--G~~p~~~~~~~~ 923 (1007)
+++|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 8999999987643322222223345678999999888889999999999999999998 678876432111
Q ss_pred chHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
++... .+.......... .+.+..++..+.+++.+||+.||++||++.||.+.|++
T Consensus 242 -----~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 -----VIENT-----GEFFRDQGRQVY---LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -----HHHHH-----HHHHhhcccccc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100 000000000000 00011123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=301.52 Aligned_cols=240 Identities=24% Similarity=0.298 Sum_probs=183.9
Q ss_pred cccccceecccCceEEEEEEEc----CCceEEEEEechhh----HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCee
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY----ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFK 797 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 797 (1007)
+|+..+.||+|+||+||+++.. +|+.||+|++.... ....+.+..|+.++++++ ||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 58899999997542 233456888999999994 99999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+++|+|.+++..+. .+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 488899999999999999999 57789999764 899999998653
Q ss_pred CCCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 866 GQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ .......... .++
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------~~~ 228 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------CDP 228 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc------CCC
Confidence 32211 12345799999999998765 478999999999999999999999974321111 1111110000 000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.. +......+.+++.+|++.||++|| ++.|++++
T Consensus 229 ~~----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PF----------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 011234678999999999999999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.79 Aligned_cols=240 Identities=21% Similarity=0.302 Sum_probs=176.5
Q ss_pred ceecccCceEEEEEEEcC---CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 732 NLLGIGSFGSVYVARLQD---GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998653 4579999987543 233457889999999999999999999999999999999999999
Q ss_pred ChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 808 SLENRLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 808 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+|.+++.... ...++..+.+++.|++.|++|| |+.+++|+++ +|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 2456777888999999999999 5778999976 4899999998654332222
Q ss_pred ccccccCCcccccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 872 MQTQTLATIGYMAPEYGVQG-------RVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
......|+..|+|||++... .++.++|||||||++|||++ |+.||......+. ..+... .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~---~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVR---EQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhh---cccCCCCC
Confidence 22334578899999987542 35889999999999999996 9999975322111 111000 00000000
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
+... ......+.+++.+|+ .+|++|||++||++.|+
T Consensus 233 ~~~~----------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK----------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC----------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1000 011235778889999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=292.12 Aligned_cols=238 Identities=21% Similarity=0.290 Sum_probs=184.5
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|+..+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 68999999987543 22234578899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
+++|+|.+++... ...+++..+..++.|++.||.|| |+.+|+||+++ ||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999888653 33589999999999999999999 57889999764 8999999986543221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+ +.......
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~-------------~~~~~~~~ 221 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEV-------------DRRVLETE 221 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-------------HHhhhccc
Confidence 1345689999999999888899999999999999999999999975321110 0111 11000000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
.. .......++.+++.+|++.||++||+ +.|+++.
T Consensus 222 ~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00 01112346789999999999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=303.76 Aligned_cols=231 Identities=21% Similarity=0.266 Sum_probs=181.9
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999997643 233466788999999999999999999999999999999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+|.+++.... .+++..+..++.|++.||+||| ...+|+|||++ ||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH--~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 9999887654 4889999999999999999995 23789999764 8999999986432211 1234
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 955 (1007)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+.+. .....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i~-----------~~~~~-------- 214 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELIL-----------MEEIR-------- 214 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHHh-----------cCCCC--------
Confidence 569999999999988899999999999999999999999997532110 111000 00000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 956 AKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 956 ~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+.....++.+++.+|++.||++|+ ++.|++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0011234688999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=294.37 Aligned_cols=241 Identities=20% Similarity=0.280 Sum_probs=184.4
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC------
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSND------ 794 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 794 (1007)
.+++.|+..+.||+|+||+||+|... +++.||+|++.... .....+..|+.+++++ +||||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678888999999999999999865 58899999986543 2235678899999998 699999999998753
Q ss_pred CeeEEEEEecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecc
Q 001838 795 DFKALIMEYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIA 861 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla 861 (1007)
...|+||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+|+++ +||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999864 345889999999999999999995 678999966 389999999
Q ss_pred eecCCCCcccccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
+...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .+.... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~~-~~ 231 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLIP-RN 231 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHh-cC
Confidence 8764321 1123456899999999876 3458889999999999999999999986432111 110000 00
Q ss_pred cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 937 SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..... .....+.++.+++.+||+.+|.+|||+.|+++.
T Consensus 232 -----~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 -----PAPRL---------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----CCCCC---------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 001123468899999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.72 Aligned_cols=241 Identities=24% Similarity=0.413 Sum_probs=188.6
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|...+.||+|+||+||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 56888999999999999999987777899999975332 23578899999999999999999998754 55799999999
Q ss_pred CCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++.+. ...+++..+..++.|++.||+|+ |+.+++|+++ +||+|||.++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 99999999764 34578999999999999999999 5788999976 389999999876433221 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||+.....++.++|||||||++|||+| |+.||......+ . .+.+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~------------~~~~~~~~~---- 221 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V------------LDQVERGYR---- 221 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--H------------HHHHhcCCC----
Confidence 123346778999999988889999999999999999999 888887532111 0 000100000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.......+.++.+++.+|++.+|++||++.++.+.|++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000112345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=275.89 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=198.4
Q ss_pred cHHHHHHhcccccccceecccCceEEEEEE-EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecC
Q 001838 717 SYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSND 794 (1007)
Q Consensus 717 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 794 (1007)
.+.|+-+.| .+.+|+|+||.|--|. ..+|.++|||++.+.....+.+..+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666665 3789999999999987 6789999999999886666788999999999996 99999999999999
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceee
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFS 859 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFG 859 (1007)
..+|||||-|.||+|..++.++. .+.+.++.++..+||.||+|| |.++|.|||++ |||||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999998765 488889999999999999999 78999999875 899999
Q ss_pred cceecCCCCc-----ccccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHH
Q 001838 860 IAKFLNGQDQ-----LSMQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW 929 (1007)
Q Consensus 860 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~ 929 (1007)
++.-+..... .....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+....+ .-|
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGW 301 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGW 301 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCc
Confidence 9865432111 11123567999999999753 2468999999999999999999999998754422 122
Q ss_pred HHhhcCccHHHHhhhhhccchh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 930 VNDLLPISVMEVIDTNLLSGEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 930 ~~~~~~~~~~~~~d~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
-+.-.-..-.+.+-..+..+.. .+.......+.+..+++...+..|+.+|.++.+++++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2111111111111111222211 1112233456678889999999999999999999883
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.92 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=186.1
Q ss_pred ceecccCceEEEEEEEcC--C--ceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQD--G--MEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|||||++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998653 3 3699999986654 566789999999999999999999999988 889999999999
Q ss_pred CChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc-ccc
Q 001838 807 GSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ-LSM 872 (1007)
Q Consensus 807 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~-~~~ 872 (1007)
|+|.+++.+.. ..+++.....++.|++.||+|| |+.+++|+++ .|++|||+++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 4689999999999999999999 5779999976 48999999987754222 112
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||++....++.++|||||||++|||++ |+.||......+ ..+...... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~---------~~~----- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG---------ERL----- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC---------CcC-----
Confidence 223457889999999988899999999999999999999 999986432111 111111000 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.90 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=190.8
Q ss_pred ccccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++||||+++++++.++...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999999764 88999999976533 578999999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++++|.+++......+++..+..++.|++.|+.|| |..+++|+++ .|++|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 99999999976666789999999999999999999 5678999866 48999999987653321 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .+..... .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~----~ 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------------MIPNKPP----P 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------------hhccCCC----C
Confidence 233458889999999988889999999999999999999999987532211000 0000000 0
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+.....++.+++.+|++.+|++|||+.||++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 000111223468899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=300.43 Aligned_cols=228 Identities=21% Similarity=0.278 Sum_probs=177.6
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999998643 22345667788888765 899999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++..+. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 99999987643 478889999999999999999 57799999764 8999999985422111 223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.+... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~---------~~~~-------- 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVD---------TPHY-------- 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCCC--------
Confidence 457999999999999889999999999999999999999999753211 111100000 0000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAR-EIV 986 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~-evl 986 (1007)
+.....++.+++.+|++.||++||++. ++.
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 001234678999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=301.10 Aligned_cols=229 Identities=21% Similarity=0.256 Sum_probs=179.4
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH-RNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 801 (1007)
+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 57899999997642 2345678889999999975 56889999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999999987654 478889999999999999999 56799999764 8999999975422111
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+. .....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~-----------~~~~~-- 219 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIM-----------EHNVS-- 219 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH-----------cCCCC--
Confidence 123457999999999999889999999999999999999999999753211 1111110 00000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
.+.....++.+++.+|++.||++||++
T Consensus 220 ------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 001123467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=294.52 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=190.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|+||.||+|... +|..||+|.++.. .....+++.+|++++++++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 5888999998654 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|.+++... ..+++..+..++.|+++||.|||. ..+++|++++ |++|||+++.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 9999999999765 347888899999999999999962 3589999763 89999998765322
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC----------------
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP---------------- 935 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---------------- 935 (1007)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .....+......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCCC
Confidence 12345689999999998888899999999999999999999999864321 111111111000
Q ss_pred -----ccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 936 -----ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 936 -----~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
....+..+........ .. .......++.+++.+|+..+|++|||+.||++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPP-KL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCc-cC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0001111110000000 00 00012346899999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=307.10 Aligned_cols=254 Identities=18% Similarity=0.195 Sum_probs=186.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
..+|...+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|||||++++++..++..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346889999999999999999976 488999996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+. |+|.+++......+++.++.+++.|+++||+|| |+.+|+|||++ ||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 799998876555689999999999999999999 57799999874 899999998764332222
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC------cchHHHHHHhhc------Cc---
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIG------ELSLSRWVNDLL------PI--- 936 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~------~~~l~~~~~~~~------~~--- 936 (1007)
......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...+.+.+.... +.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223457999999999999889999999999999999999988765432111 011222221110 00
Q ss_pred -cHHHHhhhhh----ccchhh-hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 937 -SVMEVIDTNL----LSGEER-YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 -~~~~~~d~~~----~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......... ...... ..........++.+++.+||+.||++|||+.|++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 000000 000001122368899999999999999999999875
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=291.43 Aligned_cols=227 Identities=24% Similarity=0.370 Sum_probs=177.3
Q ss_pred ceecccCceEEEEEEEcC--------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 732 NLLGIGSFGSVYVARLQD--------GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999997642 235888988765555567889999999999999999999999998999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc--------------------ccceeeccee
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------------HISDFSIAKF 863 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~--------------------kl~DFGla~~ 863 (1007)
+++|+|.+++......+++..+..++.||+.|++|| |+.+|+|||++ |++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999987666689999999999999999999 67899998652 6888888765
Q ss_pred cCCCCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCccccCcchHHHHHHhhcCccHHHH
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGK-KPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
.... ....+++.|+|||++... .++.++|||||||++|||++|. .|+....... .....
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~----------- 218 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFY----------- 218 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHH-----------
Confidence 4321 234578899999998764 5799999999999999999995 5554321100 00000
Q ss_pred hhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 942 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.... ..+.....++.+++.+||+.+|++|||++|+++.|
T Consensus 219 -~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 -EDRH--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -Hccc--------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 00001124688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=286.31 Aligned_cols=234 Identities=22% Similarity=0.354 Sum_probs=182.0
Q ss_pred eecccCceEEEEEEEc---CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 733 LLGIGSFGSVYVARLQ---DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
.||+|+||+||+|.++ ++..||+|+++... ....+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 57889999986443 3445789999999999999999999998864 4678999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc-ccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS-MQT 874 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~-~~~ 874 (1007)
+|.+++.... .+++..+.+++.|++.|++|| |+++|+|++++ ||+|||+++......... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997543 488999999999999999999 57789999764 899999998765332211 112
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
...++..|+|||.+....++.++|||||||++|||++ |+.||..... ....+.+.. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~------------~~~------ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES------------GER------ 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC------------CCC------
Confidence 2345678999999888889999999999999999998 9999975321 111111111 000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.+.+...+.++.+++.+||+.||++||++.+|.++|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 00011234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=302.66 Aligned_cols=226 Identities=24% Similarity=0.330 Sum_probs=178.2
Q ss_pred ceecccCceEEEEEEE----cCCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 732 NLLGIGSFGSVYVARL----QDGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
+.||+|+||+||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3588999999986532 234567789999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999999997643 488999999999999999999 57789999763 8999999986543211 12
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
....||+.|+|||++....++.++|||||||++|||++|+.||...... ...... ..... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i--------~~~~~----~-- 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMI--------LKAKL----G-- 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHH--------HcCCC----C--
Confidence 3457999999999998888999999999999999999999999753211 001000 00000 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINARE 984 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 984 (1007)
.+.....++.+++.+||+.||++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00112346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.68 Aligned_cols=229 Identities=21% Similarity=0.277 Sum_probs=180.0
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
+|...+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 57899999997643 22345577788888887 5899999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 9999999999987654 488899999999999999999 56789999764 8999999986432211
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
......||+.|+|||++....++.++|||||||++|||+||+.||...... .+...+ ......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i-----------~~~~~~-- 219 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSI-----------MEHNVA-- 219 (323)
T ss_pred --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHH-----------HhCCCC--
Confidence 123457999999999999999999999999999999999999999753211 111111 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
.+.....++.+++.+|++.+|++|+++
T Consensus 220 ------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001123468899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=288.03 Aligned_cols=235 Identities=25% Similarity=0.350 Sum_probs=188.0
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4777889999999999999875 58899999987543 344578899999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++..+ .+++.+...++.|++.|++|| |+.+++|+++ .+++|||++........ .
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence 999999998754 478889999999999999999 5778999865 47999999987643321 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....++..|+|||++.+..++.++|||||||++|||+||+.||........ . ..+....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~---------~~~~~~~------ 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L---------FLIPKNN------ 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h---------hhhhcCC------
Confidence 2234688899999999888899999999999999999999999875321110 0 0000000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........+..+.+++.+||+.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000112234568899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=289.96 Aligned_cols=240 Identities=23% Similarity=0.274 Sum_probs=185.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999865 58999999987655444566889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++.... .+++.+...++.|++.|+.|| |+.+++|++++ ||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999987544 588999999999999999999 56689998763 899999998664221 11
Q ss_pred cccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-cCccHHHHhhhhhcc
Q 001838 873 QTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL-LPISVMEVIDTNLLS 948 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~d~~~~~ 948 (1007)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||........ ........ .+....
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~--------- 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQPPKLK--------- 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCCCccc---------
Confidence 23456899999999874 45688999999999999999999999864321110 00000000 000000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........+.+++.+|++.+|++|||+.|++++
T Consensus 233 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 -------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000112357899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.46 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=191.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778899999999999999865 58899999886543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|.+++.+.. .+++..+..++.+++.|+.||| +..+++|+++. +|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999887643 4889999999999999999997 34579999663 899999987653211
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....|+..|+|||++....++.++|||||||++||++||+.||+.....+.. ...+....+.+.........
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhccCC
Confidence 12356899999999998888999999999999999999999999854321110 00000111111111100000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.. .....+.++.+++.+|++.||++|||+.|++++..-
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 232 RL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00 011134568899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=292.80 Aligned_cols=238 Identities=22% Similarity=0.304 Sum_probs=186.4
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
|+..+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999976 4788999999766656667899999999999999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|..++.+....+++..+..++.|++.||.|| |+.+++|+++. |++|||+++...... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 999998876555689999999999999999999 56789999663 899999997653221 1123
Q ss_pred cccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 875 QTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
...|+..|+|||++. ...++.++|||||||++|||++|+.||......+ .......... +..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~--- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEP---------PTL--- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCC---------CCC---
Confidence 346899999999874 3457889999999999999999999987532111 0111110000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.....++.+++.+||+.+|.+||++.+++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123468899999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=291.83 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=190.5
Q ss_pred cccccceecccCceEEEEEEEc-----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 798 (1007)
-|...+.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3677899999999999999742 47889999987543 34456799999999999999999999998875 5689
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
+||||+++|+|.+++.+....+++..+..++.|++.||+|| |+.+++|+|++ |++|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 99999999999999976655689999999999999999999 57899999764 8999999987653
Q ss_pred CCcc-cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh-cCccHHHHhhh
Q 001838 867 QDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL-LPISVMEVIDT 944 (1007)
Q Consensus 867 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~d~ 944 (1007)
.... .......++..|+|||++.+..++.++|||||||++|||+||+.|........ .+..... ........+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccccccccHHHHHHH
Confidence 3221 11223456778999999888889999999999999999999887754321100 0000000 00000000000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
+.... ..+.+...+.++.+++.+|++.+|++|||+.|+++.++++
T Consensus 239 -~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 0000112345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=291.90 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=188.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
+.|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999876 48999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|..++.+....+++..+..++.|++.|++|| |+.+++|+++. ||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 99999998876555689999999999999999999 67899999663 899999987643221 11
Q ss_pred cccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 873 QTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+..... +
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~---------~--- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEP---------P--- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCC---------c---
Confidence 13346888999999875 345788999999999999999999998653211 00111110000 0
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+.....++.+++.+||+.+|++||++.|+++.
T Consensus 234 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 -----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000011223468899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=299.65 Aligned_cols=225 Identities=24% Similarity=0.300 Sum_probs=174.5
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECE-VMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999997543 222344555554 56789999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.+.. .+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999987644 478888999999999999999 57789999764 899999998643221 1223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i--------~~~~~----~~-- 215 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNI--------LNKPL----RL-- 215 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHH--------HcCCC----CC--
Confidence 45799999999999988999999999999999999999999975321 1111110 00000 00
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAR 983 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 983 (1007)
......++.+++.+|++.||++||+++
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011234688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=293.22 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=190.5
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
.++|+..+.||+|+||+||+|... ++..||+|+++.......+.+.+|++++++++||||+++++++..++..|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888999999999999999875 6899999999866666667899999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|.+++......+++..+.+++.|++.|+.|| |+.+|+|+++. +|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999987655689999999999999999999 56789999763 7999999876532211
Q ss_pred ccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 872 MQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
......|++.|+|||++. ...++.++|||||||++|||++|+.||....... ....+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------------- 224 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSE------------- 224 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCC-------------
Confidence 123356899999999874 3457889999999999999999999987532110 111111000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......+.....++.+++.+||+.+|++||++.++++.
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ----PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000111223468899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=288.31 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=192.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||+||+|..+ +|. .||+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999865 333 58999887543 3445778999999999999999999999987 77899
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
||||+++|+|.+++......+++..+.+++.|++.|++|| |+.+++|+++. |++|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999987666689999999999999999999 56899999663 89999999876533
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
..........++..|+|||.+....++.++|||||||++||+++ |+.||+..... .+...+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE------------ 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence 22211122334678999999888889999999999999999999 99999753211 1111111100
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.. +.+..+..++.+++.+||..+|.+||++.++++.|.++...
T Consensus 229 ~~------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 RL------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CC------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 00011234578999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=285.37 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=187.8
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|...+.||+|+||.||+|....+..||+|++..... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 56888899999999999999988777899998865432 2356889999999999999999999875 456899999999
Q ss_pred CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.++++... ..+++..+..++.|++.|++|| |+.+++|+|+. ||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999997543 3578999999999999999999 56789999763 8999999987643221 11
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||+.....++.++|||||||++|||+| |+.||.+.... ...++.....+.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~--------------- 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRM--------------- 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC---------------
Confidence 123346778999999988889999999999999999999 89998753211 111111110000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
..+...+..+.+++.+||+.+|++||++++|.+.|++
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=293.28 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=191.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||.||+|... +|. .||+|++.... .....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999864 444 47899887543 33345788999999999999999999998765 4679
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|+||+++|+|.+++......+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 9999999999999987666688999999999999999999 57889999763 89999999876533
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
..........++..|+|||++....++.++|||||||++|||++ |+.||..... ....+++....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~------------ 228 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE------------ 228 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC------------
Confidence 22212223446778999999988889999999999999999997 9999875321 11122221100
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~ 997 (1007)
... .+..+..++.+++.+||..+|++||+++|+++.++++.+...
T Consensus 229 ~~~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 229 RLP------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 000 001123468899999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=303.91 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=185.5
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 798 (1007)
+|+..+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999865 68999999986532 234467889999999999999999999998776 789
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
+||||+. ++|.+++.... .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 58888876543 588999999999999999999 57799999764 8999999987643
Q ss_pred CCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH-----
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME----- 940 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~----- 940 (1007)
... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.............+
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhh
Confidence 221 122345688999999998764 47999999999999999999999997532211 1111111111000000
Q ss_pred -----Hhhhhhccchh--hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 -----VIDTNLLSGEE--RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 -----~~d~~~~~~~~--~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+......... ...........++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 0000011124568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=283.90 Aligned_cols=237 Identities=28% Similarity=0.451 Sum_probs=190.5
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|+..+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46888899999999999999875 88999999986544 45789999999999999999999999999899999999999
Q ss_pred CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++.... ..+++..+..++.|++.|+.|| |+.+++|+++ .||+|||.++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999997643 3589999999999999999999 5788999865 3899999998763221
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
....++..|+|||++....++.++|||||||++|||++ |+.||......+ +...+. .....
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~------------~~~~~--- 218 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVE------------KGYRM--- 218 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHh------------cCCCC---
Confidence 12335678999999988889999999999999999997 999987532111 111111 00000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
..+...+.++.+++.+||..+|++|||+.|++++|+.+
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00112245688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=290.57 Aligned_cols=238 Identities=21% Similarity=0.308 Sum_probs=185.7
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 68999999987542 22335677899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
+++|+|.+++... ...+++..+..++.|++.|+.|| |+.+|+|++++ +++|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988643 23588899999999999999999 57899999764 7999999987643221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+ ....+... .
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~---------~~~~~~~~-~-- 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV---------ERLVKEVQ-E-- 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH---------Hhhhhhhh-h--
Confidence 123468999999999998899999999999999999999999997532111 00000 00000000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
..+.....++.+++.+||+.||++||| +.|++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001112346789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=319.71 Aligned_cols=245 Identities=28% Similarity=0.404 Sum_probs=196.1
Q ss_pred ccccccceecccCceEEEEEEEc----C----CceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ----D----GMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~----~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
++....+.+|+|+||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|||||.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455569999999999999743 1 3579999998543 35568899999999999 5999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
..++|+||++.|+|.++++..+ ..+...+.+.++.|||.||+|| ++.++||||+|
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEEec
Confidence 9999999999999999998765 3488889999999999999999 78889999875
Q ss_pred -----ccceeecceecCCCCccccccccc--CCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcch
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTL--ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELS 925 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~ 925 (1007)
||+|||+|+.....+.+... ... -...|||||.+....|+.|+|||||||++||++| |..||.+.... ..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~ 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EE 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HH
Confidence 89999999977655444322 122 2456999999999999999999999999999998 89999763211 11
Q ss_pred HHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 926 LSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 926 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
+.++.+. ..+...+..+..+++++|..||+.+|++||++.|+++.++...
T Consensus 531 l~~~l~~------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLEFLKE------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhc------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1222211 1122334455778999999999999999999999999999854
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=299.74 Aligned_cols=183 Identities=26% Similarity=0.321 Sum_probs=160.1
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-C-----CceeEEEEEEecCCeeEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-H-----RNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 799 (1007)
+|.+.+.||+|+||.|.||... +++.||||+++... ....+...|+.+|..++ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999865 69999999998653 34466788999999997 5 389999999999999999
Q ss_pred EEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc--------------ccceeecceec
Q 001838 800 IMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------HISDFSIAKFL 864 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~--------------kl~DFGla~~~ 864 (1007)
|+|.++. +|+++++... ..++...+..++.||+.||.+| |..+|||+|++ ||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999965 9999998654 4688999999999999999999 68899999875 99999999976
Q ss_pred CCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEI 919 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~ 919 (1007)
... ....+-++.|+|||++.+.+|+.+.||||||||++||++|.+-|.+.
T Consensus 342 ~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 432 12456788999999999999999999999999999999998877653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.04 Aligned_cols=236 Identities=25% Similarity=0.411 Sum_probs=181.2
Q ss_pred ceecccCceEEEEEEEcC-Cc--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQD-GM--EVAVKVFHQR-YERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||.||+|+.++ |. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 5788988743 234456789999999999 799999999999999999999999999
Q ss_pred CChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceee
Q 001838 807 GSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFS 859 (1007)
Q Consensus 807 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFG 859 (1007)
|+|.+++.... ..+++.++..++.|++.|++|| |+.+++|+|++ |++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997432 2478899999999999999999 56899999764 799999
Q ss_pred cceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccH
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
+++..... ........+..|+|||++....++.++|||||||++|||++ |..||...... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~------ 223 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK------ 223 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHH------
Confidence 98643211 11112234667999999988889999999999999999997 99998653211 11111
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
+....... .+.....++.+++.+|++.+|.+|||+.|+++.|.++.
T Consensus 224 ---~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ---LPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---HhCCCCCC------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11100000 00112346889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=285.28 Aligned_cols=236 Identities=29% Similarity=0.473 Sum_probs=189.6
Q ss_pred ceecccCceEEEEEEEcC----CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQD----GMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||.||+|.... +..||||+++..... ..+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998763 788999999865432 367889999999999999999999999999999999999999
Q ss_pred CChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCC
Q 001838 807 GSLENRLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNG 866 (1007)
Q Consensus 807 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~ 866 (1007)
|+|.+++... ...+++..+.+++.|++.|++|| |+.+++|+++ .|++|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 35689999999999999999999 6789999976 38999999998764
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
...........++..|+|||.+....++.++||||+||++|||++ |+.||..... ....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~-----------~~ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK-----------GY 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc-----------CC
Confidence 432222344567889999999888889999999999999999999 6999976411 111111110 00
Q ss_pred hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
....+...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00011122457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=299.76 Aligned_cols=231 Identities=23% Similarity=0.303 Sum_probs=176.9
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECE-VMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 68999999997542 223345556655 46778999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|..++.... .+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 99999887544 488899999999999999999 57899999774 899999998543221 1223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... ...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~--------~~~~~~----~-- 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNI--------LHKPLV----L-- 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHH--------HcCCcc----C--
Confidence 457999999999999989999999999999999999999999753211 111110 000000 0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.+....++.+++.+|++.+|++||++++.++.+
T Consensus 216 --~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 216 --RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred --CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 001234578999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=288.20 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=188.8
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|...++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 56888999999999999999988899999999875432 2357889999999999999999999874 456899999999
Q ss_pred CCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++... ...+++.++..++.|++.||+|| |+.+++|+++. +++|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence 99999998753 34688999999999999999999 57889999763 8999999987652221 11
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||++....++.++|||||||++||+++ |+.||...... ......... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~------------~~~--- 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERG------------YRM--- 222 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcC------------CCC---
Confidence 223346778999999988889999999999999999999 99999753211 111111100 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
+.+...+.++.+++.+|+..+|++|||+.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011123468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=306.73 Aligned_cols=254 Identities=20% Similarity=0.185 Sum_probs=186.7
Q ss_pred cccccccceecccCceEEEEEEEc---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ---DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
..+|...+.||+|+||.||+|... .+..||||.+... +.+.+|++++++++|||||++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3678999988653 23567999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+. ++|.+++.. ...+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 688888844 34589999999999999999999 56789999864 8999999987654332
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCc--chHHHHHHhhc------Cc----c
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE--LSLSRWVNDLL------PI----S 937 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~--~~l~~~~~~~~------~~----~ 937 (1007)
........||+.|+|||++....|+.++|||||||++|||++|+.||....... ..+...+.... +. .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 222234579999999999998899999999999999999999999997543221 11111111111 00 0
Q ss_pred HHHHhhhhhc---cchhh-hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 VMEVIDTNLL---SGEER-YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~~~~~d~~~~---~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.+..... ..... ..-.......++.+++.+|++.||++|||+.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001100000 00000 000001123467889999999999999999999986
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.71 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=190.8
Q ss_pred ccccccceecccCceEEEEEEEc--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ--------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
.+|...+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999742 12369999887532 34457889999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 796 FKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
..++||||+++|+|.+++.+.. ..+++.++..++.|++.||+|| |+.+|+|++++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEc
Confidence 9999999999999999987431 2478889999999999999999 57899999763
Q ss_pred -----ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLS 927 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~ 927 (1007)
||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 8999999987643322222223345678999999988889999999999999999998 888886532 11
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
++....... .... .+...+.++.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 244 ~~~~~~~~~---------~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ELFKLLKEG---------HRMD------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHcC---------CCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111000 0000 011123468899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=291.67 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=188.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||++++++|..++..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888999999999999999864 69999999997654444567889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++.+. .+++.++..++.|++.||.|| |+.+++|+++ ++++|||++.........
T Consensus 99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999998654 378889999999999999999 5678999965 389999999876433211
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|++.|+|||...+..++.++|||||||++|||++|+.||............+... .+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~----------------- 233 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP----------------- 233 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CC-----------------
Confidence 133468899999999988889999999999999999999999997532111100000000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+......+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011223457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=283.94 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=187.3
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-----ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999865 68999999886432 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~ 867 (1007)
||||+++++|.+++.... .+++..+.+++.|++.|+.|| |+.+|+|+++ .+|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987654 478888899999999999999 5779999976 389999999876432
Q ss_pred Cccc-ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 868 DQLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
.... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-----------~~~ 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIAT-----------QPT 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHHHhc-----------cCC
Confidence 1111 112346788999999999888999999999999999999999998653110 00000000 000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ...+......+.+++.+||..+|++|||+.|+++.
T Consensus 225 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ---N---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---C---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 00011223468899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=297.01 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=183.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 58999999997532 233466889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+....+++..+..++.||+.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999976555688889999999999999999 67899999764 8999999987643221
Q ss_pred ccccccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 870 LSMQTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+......... .
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~------~ 225 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHK------E 225 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC------C
Confidence 1 1123469999999999863 4578899999999999999999999975321 11111100000 0
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCC--CCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESP--GKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p--~~Rpt~~evl~~ 988 (1007)
... ........+.++.+++.+|+..++ ..||++.+++++
T Consensus 226 ~~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 000001123457778877765433 348899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=287.41 Aligned_cols=238 Identities=23% Similarity=0.255 Sum_probs=184.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|+||+||+|... +++.||+|++... .....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 6889999998643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|..+. .+++..+..++.|++.|++|| |+.+|+|+++. ||+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997643 367888889999999999999 57899999763 899999998764321
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcch--HHHHHHhhcCccHHHHhhhhhccc
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELS--LSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......... ...+. +.+.......
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL---------QCIVDEDPPV 219 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH---------HHHhccCCCC
Confidence 23457899999999999888999999999999999999999999753221110 01111 0100000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
. .......++.+++.+|++.+|++||++.|+++.-
T Consensus 220 ~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 L-----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C-----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 0011234688999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=284.08 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=191.7
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
.++|...+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999875 5788999999866555567899999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
+++++|.+++......++...+..++.|++.|++|| |+.+|+|+++. |++|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999999987645688999999999999999999 56789999663 899999998764321 1
Q ss_pred ccccccCCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 872 MQTQTLATIGYMAPEYGVQG---RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......++..|+|||.+... .++.++|||||||++|||+||+.||......... ...... ...+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~--------~~~~---- 223 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKS--------NFPP---- 223 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc--------cCCC----
Confidence 12335688899999998776 7899999999999999999999999753211110 000000 0000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.........+.++.+++.+||+.+|.+|||+.||+.+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 ---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000112234568999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.17 Aligned_cols=190 Identities=23% Similarity=0.358 Sum_probs=161.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999876 58999999997543 234567888999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|||++|+|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997654 478888999999999999999 57899999764 8999999875432110
Q ss_pred c---------------------------------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001838 870 L---------------------------------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPT 916 (1007)
Q Consensus 870 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~ 916 (1007)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred Ccc
Q 001838 917 DEI 919 (1007)
Q Consensus 917 ~~~ 919 (1007)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=307.65 Aligned_cols=260 Identities=21% Similarity=0.213 Sum_probs=183.7
Q ss_pred HHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCC------CceeEEEEEE
Q 001838 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRH------RNLVKIISAC 791 (1007)
Q Consensus 719 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~ 791 (1007)
+++...+++|...+.||+|+||+||+|... +++.||||+++... ...+.+..|++++++++| +++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999865 58899999996432 223455667777777754 4589999998
Q ss_pred ecC-CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------------
Q 001838 792 SND-DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------------ 852 (1007)
Q Consensus 792 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------------ 852 (1007)
... ++.|+|||++ +++|.+++.+.. .+++..+..|+.||+.||+||| +..+|||||+
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHEEEecCCccccccc
Confidence 764 5789999998 678998887653 5889999999999999999996 2368999963
Q ss_pred ----------cccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC
Q 001838 853 ----------AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIG 922 (1007)
Q Consensus 853 ----------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~ 922 (1007)
.||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 47899998864321 123467999999999999999999999999999999999999999753211
Q ss_pred c-chHH---------HHHHhhcCccHHHHhhhhhc--cc-hhh--------hHHHHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001838 923 E-LSLS---------RWVNDLLPISVMEVIDTNLL--SG-EER--------YFAAKEQSLLSILNLATECTIESPGKRIN 981 (1007)
Q Consensus 923 ~-~~l~---------~~~~~~~~~~~~~~~d~~~~--~~-~~~--------~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 981 (1007)
+ .... .|..........+.++.... .. ... ...........+.+|+.+||++||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1 0000 11111000011111111000 00 000 00000011245789999999999999999
Q ss_pred HHHHHHH
Q 001838 982 AREIVTG 988 (1007)
Q Consensus 982 ~~evl~~ 988 (1007)
++|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.46 Aligned_cols=236 Identities=31% Similarity=0.433 Sum_probs=185.5
Q ss_pred ceecccCceEEEEEEEcCCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChh
Q 001838 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLE 810 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 810 (1007)
+.||+|+||.||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999875432 34578999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccccccccC
Q 001838 811 NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLA 878 (1007)
Q Consensus 811 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~~~~g 878 (1007)
+++.+....+++..+..++.+++.|++|| |+.+++|+++ .|++|||+++...............+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99976555688999999999999999999 6778999975 38999999986542211111112234
Q ss_pred CcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 879 t~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
+..|+|||++.++.++.++|||||||++|||+| |..||...... ..... +...... ..+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~------------~~~~~~~------~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER------------IESGYRM------PAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH------------HhcCCCC------CCC
Confidence 667999999988889999999999999999999 88888653211 11111 1100000 001
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=284.40 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=187.8
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.+|+..+.||+|+||.||+|...++..+|+|++..... ...+|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999887788999999875422 12568899999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++......+++..+..++.|++.|++|| |+.+++|+++ .||+|||+++...... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence 9999999987655688999999999999999999 5678999865 3899999998654221 1111
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....++.+|+|||++....++.++|||||||++|||++ |+.||...... ...... .........
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~---------~~~~~~~~~- 223 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI---------NAGFRLYKP- 223 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH---------hCCCCCCCC-
Confidence 23345678999999988889999999999999999998 99998753211 111111 000000000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
...+.++.+++.+||+.+|++|||+.|++++|
T Consensus 224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 01134689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=290.67 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=187.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|+||+||+|... +|+.||+|.++.. .....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 6899999988753 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 804 MPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
+++++|.+++... ...+++..+..++.|++.|+.||| ++.+|+|++++ |++|||+++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 235899999999999999999996 34689999764 899999998653221
Q ss_pred ccccccccCCcccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 870 LSMQTQTLATIGYMAPEYGVQG------RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.....|++.|+|||++... .++.++|||||||++|||++|+.||....... +... .....+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~-----~~~~~~ 224 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQ-----LSAIVD 224 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHH-----HHHHhh
Confidence 1234688899999987543 35889999999999999999999997532111 0000 000111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... ...+.....++.+++.+|++.+|++||++.|+++.
T Consensus 225 ~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 GDP-------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cCC-------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000 00111234568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.80 Aligned_cols=231 Identities=20% Similarity=0.277 Sum_probs=178.2
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999998643 23456688999999998 599999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+++..+..++.|++.|++|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99999887543 489999999999999999999 56799999764 899999998642211 1123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCc-chHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE-LSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....+... .+.. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~~----~~~-- 220 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ--------VILE----KPI-- 220 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH--------HHHh----CCC--
Confidence 4579999999999998899999999999999999999999997432211 111111111 0000 000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAR 983 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 983 (1007)
..+.....++.+++.+|++.||++||++.
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00111234578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=290.58 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=190.3
Q ss_pred cccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q 001838 715 RFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACS 792 (1007)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 792 (1007)
.+.++++..++++|+..+.||+|+||+||+|... +++.||+|+++... ....++.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3566778888999999999999999999999875 58899999886532 2235678899999999 6999999999884
Q ss_pred -----cCCeeEEEEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------
Q 001838 793 -----NDDFKALIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------ 852 (1007)
Q Consensus 793 -----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------ 852 (1007)
.++..++||||+++|+|.+++.. ....+++..+..++.|+++|+.|| |+.+|+|+++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCC
Confidence 34568999999999999998753 234578888999999999999999 5778999965
Q ss_pred cccceeecceecCCCCcccccccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHH
Q 001838 853 AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLS 927 (1007)
Q Consensus 853 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~ 927 (1007)
+|++|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~ 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----R 236 (286)
T ss_pred EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----H
Confidence 37999999987643221 1233468999999998753 44789999999999999999999998753211 1
Q ss_pred HHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 928 RWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 928 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.+.. ..... .+... .+.....++.+++.+||+.||++|||+.|+++..
T Consensus 237 ~~~~-~~~~~-----~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFK-IPRNP-----PPTLH--------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhh-ccccC-----CCccc--------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1100 00000 00000 0001123588999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=290.35 Aligned_cols=235 Identities=24% Similarity=0.323 Sum_probs=186.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999865 58899999987443 344567899999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++..+ .+++..+..++.|+++|+.|| |+.+++|+++ .+++|||+++....... .
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 999999988653 478899999999999999999 5788999865 48999999987643221 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+....... ...+..... .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~--------~~~------- 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNS--------PPT------- 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCC--------CCC-------
Confidence 123468889999999988889999999999999999999999987532111 111110000 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.....+.++.+++.+|++.+|++||+|.|++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 ---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011223468899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=290.93 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=188.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.+|+..+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...+..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 36888999999999999999864 68999999987554444567889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++... .+++.++..++.|++.|++|| |+.+++|++++ ||+|||+++........
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 999999988754 489999999999999999999 57789999764 89999998876433211
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|+..|+|||.+....++.++|||||||++|||++|+.||......+. ..+....... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~~~--------~~------ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGTP--------EL------ 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCc--------cc------
Confidence 1234688999999999888899999999999999999999999975321110 0000000000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+......+.+++.+||+.||++|||+.++++.
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0011223468889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=284.09 Aligned_cols=239 Identities=22% Similarity=0.344 Sum_probs=185.5
Q ss_pred cccccceecccCceEEEEEEEcCCceEEEEEechhh------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
+|...+.||+|+||+||+|...+|+.||||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886321 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||+++|+|.+++.+.. .+++..+..++.|++.|++|| |+.+|+|+++ .|++|||+++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997643 478888999999999999999 5678999865 3899999998653211
Q ss_pred ----cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 869 ----QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 869 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------~~~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRG-------LMP 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccC-------CCC
Confidence 1111233568999999999988889999999999999999999999997431110 0000000000 000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
. .+.....++.+++.+||+.+|++||++.|+++
T Consensus 229 ~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R----------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C----------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01112346889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=281.68 Aligned_cols=238 Identities=21% Similarity=0.311 Sum_probs=189.6
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||.|+||.||.++.. +++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999999854 58899999986442 44556789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++|+|.+++.+. ...+++..+..++.|++.|+.|| |+.+++|+++ .||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 34588999999999999999999 5678999865 38999999987644321
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......|++.|+|||+..+..++.++|||||||++|||++|+.||+.... .+........ ... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~--------~~~-~- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQG--------NYT-P- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcC--------CCC-C-
Confidence 22345689999999998888899999999999999999999999875221 1111110000 000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.......++.+++.+||+.+|++||++.|+++++
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0012245688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=283.01 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=184.1
Q ss_pred ceecccCceEEEEEEEcC----CceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQD----GMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||.||+|.... +..||+|.+..... ...+++.+|+.+++++.|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997542 36899999875542 34567899999999999999999999876 4467999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc-cc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS-MQ 873 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~-~~ 873 (1007)
|+|.+++.... .+++..+..++.|++.|++|| |..+++|++++ |++|||+++......... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998655 588999999999999999999 56789999764 899999998764332211 11
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....++..|+|||......++.++|||||||++|||++ |+.||..... .....++....+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~---------------- 217 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL---------------- 217 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC----------------
Confidence 22234568999999988889999999999999999998 9999975321 1222222111000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
+.+...+.++.+++.+||..+|++||++.|+++.|+++.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001112346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=297.59 Aligned_cols=255 Identities=21% Similarity=0.207 Sum_probs=184.6
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDD----- 795 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 795 (1007)
..++|...+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999865 5899999999643 2334567889999999999999999999986543
Q ss_pred -eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 796 -FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 796 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999975 56666643 377888889999999999999 67899999764 899999998
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc--cHH-
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI--SVM- 939 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~- 939 (1007)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......... ...
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHH
Confidence 653221 223457899999999999889999999999999999999999999753211 1111111111100 000
Q ss_pred -------HHhhhhhccch-h-----------hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 940 -------EVIDTNLLSGE-E-----------RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 940 -------~~~d~~~~~~~-~-----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
........... . ...........++.+++.+|++.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000 0 00000011134688999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.78 Aligned_cols=237 Identities=30% Similarity=0.468 Sum_probs=183.1
Q ss_pred ceecccCceEEEEEEEcC-------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 732 NLLGIGSFGSVYVARLQD-------GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+.||+|+||.||+|+..+ ++.||||.+.... ......+.+|+.++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 3579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecc-----------------ccccceeec
Q 001838 804 MPNGSLENRLYSG------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM-----------------VAHISDFSI 860 (1007)
Q Consensus 804 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~-----------------~~kl~DFGl 860 (1007)
+++|+|.+++.+. ...+++.++..++.|++.|++|| |+.+++|++ ..|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 23478899999999999999999 567899974 358999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVM 939 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 939 (1007)
++...............++..|+|||++....++.++|||||||++|||+| |+.||..... ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~-------- 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVT-------- 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHh--------
Confidence 987643322222223346788999999998899999999999999999998 9999864321 11111110
Q ss_pred HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 940 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
... ....+...+.++.+++.+||+.+|++||++.++.+.|++
T Consensus 228 ----~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 ----AGG------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----cCC------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 000111234568899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=296.57 Aligned_cols=230 Identities=23% Similarity=0.261 Sum_probs=175.2
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHH-HHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDEC-EVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999997543 12223444444 456788999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+.......++.||+.||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 99999997654 367778888999999999999 57899999874 8999999986432211 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+ ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i-----------~~~~~~------- 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNI-----------LNKPLQ------- 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHH-----------HhCCcC-------
Confidence 457999999999999889999999999999999999999999753211 111111 000000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.....+.+++.+|++.||++||++.+.+.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 001123468899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=297.35 Aligned_cols=243 Identities=16% Similarity=0.239 Sum_probs=184.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999876 58899999997532 233456888999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+....+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987555688889999999999999999 57899999764 8999999987653322
Q ss_pred ccccccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 870 LSMQTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
. ......||+.|+|||++.. +.++.++|||||||++|||++|+.||...... +..... ...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i--------~~~ 223 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKI--------MNH 223 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHH--------HcC
Confidence 1 1123569999999998865 46889999999999999999999999743211 111000 000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGK--RINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~evl~~ 988 (1007)
.. ...........+.++.+++.+|+..++++ |+++++++++
T Consensus 224 ~~---~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 EE---RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CC---cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 00000000112446888899988866544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=292.54 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=187.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|...+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999876 58899999986432 22234677899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
++ ++|.+++......+++..+..++.|+++||+|| |+.+|+|+|++ ||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 97 599998877655688999999999999999999 67899999663 8999999986532211
Q ss_pred ccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC----ccHHHHhhhhh
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP----ISVMEVIDTNL 946 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----~~~~~~~d~~~ 946 (1007)
......+++.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+..... ......++...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcccc
Confidence 12234578899999987654 5789999999999999999999999753221 11111111110 00001110000
Q ss_pred c-----cc-hhh-hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 L-----SG-EER-YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~-----~~-~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .. ... ..........++.+++.+|++.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00 000 000011223467899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=285.66 Aligned_cols=239 Identities=21% Similarity=0.281 Sum_probs=174.2
Q ss_pred eecccCceEEEEEEEcC---CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 733 LLGIGSFGSVYVARLQD---GMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
.||+|+||+||+|...+ ...||+|.+.... ......+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4568888876432 3445678899999999999999999999999999999999999999
Q ss_pred hhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 809 LENRLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 809 L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
|.+++.... ...++....+++.|++.|++|| |+.+|+|||++ ||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 2346777889999999999999 57789999764 8999999976533222222
Q ss_pred cccccCCccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 873 QTQTLATIGYMAPEYGVQ-------GRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||......+ .+......... ...++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~----~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDI----KLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCc----cCCCC
Confidence 233456778999998643 356889999999999999999 788886532111 11111100000 00000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
. ........+.+++..|+ .||++|||++||++.|.
T Consensus 234 ~----------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 Q----------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c----------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 01112345677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=298.74 Aligned_cols=180 Identities=23% Similarity=0.273 Sum_probs=153.4
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
...+|...+.||+|+||+||+|+.. +++.||+|+.... ....|+.++++++|||||++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999876 4788999986432 23569999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|+. |+|.+++......+++..+.+++.||+.||.|| |+.+|+|||++ ||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 689998877666789999999999999999999 56789999774 899999998643221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPT 916 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~ 916 (1007)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456899999999999989999999999999999999866554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=293.71 Aligned_cols=229 Identities=21% Similarity=0.266 Sum_probs=179.4
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 801 (1007)
+|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|.+++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999865 68999999997543 233456788999998885 678889999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+.. .+++.++..++.|++.||+|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999987644 488999999999999999999 57799999764 8999999986432211
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+ ......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i-----------~~~~~~-- 219 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSI-----------MEHNVS-- 219 (323)
T ss_pred --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH-----------HhCCCC--
Confidence 123456999999999998888999999999999999999999999753211 111110 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
.+.....++.+++.+|++.+|++|++.
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 001123467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.08 Aligned_cols=236 Identities=26% Similarity=0.397 Sum_probs=185.6
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS-NDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~E~~ 804 (1007)
++|...+.||+|+||.||+|..+ |..||+|.++... ..+.+.+|+.++++++|+||+++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999875 7889999987543 2357889999999999999999999764 456789999999
Q ss_pred CCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
++|+|.+++.... ..+++..+.+++.|++.||+|| |+.+++|+++ +|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999997643 3478999999999999999999 5778999965 3899999998654221
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
....++..|+|||++....++.++|||||||++|||++ |+.||..... .....++....+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~-------------- 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM-------------- 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC--------------
Confidence 22345678999999988889999999999999999998 9999864211 0111111110000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
......+..+.+++.+|++.+|++|||+.+++++|+++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00112245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=295.91 Aligned_cols=243 Identities=16% Similarity=0.229 Sum_probs=183.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||+||+++.+ +++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999976 47889999997532 223455888999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.+....+++..+..++.|++.|++|| |+.+|+|||++ ||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999987555688989999999999999999 57889999764 8999999986543222
Q ss_pred ccccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 870 LSMQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~-------- 223 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNH-------- 223 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCC--------
Confidence 1123357999999999886 34689999999999999999999999975311 1111111000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGK--RINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~evl~~ 988 (1007)
.. .............++.+++.+|+..++++ |+++.|++++
T Consensus 224 ~~---~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KE---RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cc---cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00000001122446788888888654444 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=284.79 Aligned_cols=237 Identities=26% Similarity=0.338 Sum_probs=188.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||.|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999876 58899999987543 33446788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+++|+|.+++... .+++..+..++.|++.|+.|| |+.+++|+++ .+++|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999999865 589999999999999999999 5678999865 3799999998875331 1
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
......|++.|+|||++.+..++.++|||||||++|||+||+.||....... ...-+.... .+....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~--------~~~~~~--- 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNN--------PPSLEG--- 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcC--------CCCCcc---
Confidence 1234568889999999988889999999999999999999999997532111 000000000 000000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.....++.+++.+||..+|++|||+++++++
T Consensus 221 ------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ------NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0023468899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=286.05 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=190.9
Q ss_pred cccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.++|...+.||+|+||+||+|..++++.||||.+..... ..+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 367888999999999999999988888999999975432 2367889999999999999999999999988999999999
Q ss_pred CCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
++++|.+++.... ..+++..+..++.|++.|+.|| |+.+++|+++. |++|||+++...... ..
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence 9999999997643 4689999999999999999999 56789998663 899999998764321 11
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......++..|+|||.+.+..++.++|||||||++||++| |+.||...... .....+... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~------------~~~~- 224 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERG------------YRMP- 224 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------CCCC-
Confidence 1122335678999999988889999999999999999999 99998653211 111111000 0000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
.+...+.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001113468999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=282.00 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=190.0
Q ss_pred cccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35788899999999999999998778889999987543 334678999999999999999999999887 7789999999
Q ss_pred CCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
++|+|.+++.+. ....++..+..++.|++.|++|| |+.+++|+++ .|++|||.++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 999999999763 34578889999999999999999 5678999975 48999999987643221 1
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......++..|+|||++....++.++|||||||++||++| |+.||..... .....+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM-------------- 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC--------------
Confidence 1223346678999999988889999999999999999999 9999875321 1111111111000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011224468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=285.11 Aligned_cols=237 Identities=19% Similarity=0.282 Sum_probs=186.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
+|+..+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999865 6889999998643 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~ 871 (1007)
++|+|.+++... ...++......++.|++.|+.|| |+.+|+|++++ +++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988653 34578889999999999999999 67899998663 7999999987643221
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
......|++.|+|||+.....++.++||||||+++|+|++|+.||...... .......... ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~---- 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGS--------YK---- 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCC--------CC----
Confidence 123356889999999998888999999999999999999999999753111 1110000000 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.+.....++.+++.+||+.||++|||+.|++.+
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=294.98 Aligned_cols=225 Identities=22% Similarity=0.291 Sum_probs=173.1
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECE-VMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++|||||++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999997543 222344555554 67889999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .++...+..++.||+.||+|| |+.+|+|||++ ||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99998887543 477888888999999999999 57789999774 899999998642221 1223
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...||+.|+|||++....++.++|||||||++|||++|+.||..... ....... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i--------~~~~~~------- 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNI--------LHKPLQ------- 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHH--------hcCCCC-------
Confidence 45799999999999888899999999999999999999999975321 1111111 000000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAR 983 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 983 (1007)
.+.....++.+++.+|++.||++||++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 -LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0011234688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=299.29 Aligned_cols=255 Identities=20% Similarity=0.214 Sum_probs=185.0
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC-----
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND----- 794 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 794 (1007)
...++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999865 58899999997532 33456788999999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecc
Q 001838 795 -DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIA 861 (1007)
Q Consensus 795 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla 861 (1007)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 247999999975 67766653 378888999999999999999 67899999764 89999999
Q ss_pred eecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC------
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP------ 935 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 935 (1007)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+.....
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 8654321 1234578999999999988889999999999999999999999997532111 00000111000
Q ss_pred ----ccHHHHhhhhhc----------cch--hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 936 ----ISVMEVIDTNLL----------SGE--ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 936 ----~~~~~~~d~~~~----------~~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......++.... ... ............++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 001111110000 000 00000011123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=296.33 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=185.0
Q ss_pred HHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC----
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND---- 794 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---- 794 (1007)
.+..++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999864 68899999987542 23345678899999999999999999988643
Q ss_pred --CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 795 --DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 795 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
...|+++|++ +++|.+++..+ .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999998 77998887643 488999999999999999999 57799999764 8999999
Q ss_pred ceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc--c
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI--S 937 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~ 937 (1007)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+....... .
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9876432 134568999999999876 46899999999999999999999999753211 1111111111100 0
Q ss_pred HHHHhhh--------hhcc-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 VMEVIDT--------NLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~~~~~d~--------~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+.. .+.. ...............+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000 0000000000112357899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=285.28 Aligned_cols=241 Identities=27% Similarity=0.416 Sum_probs=185.1
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhhHHH--HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERA--LKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
|+..+.||+|+||+||+|... +++.||+|++....... .....+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999977 46789999998665332 234456999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~ 872 (1007)
++++|.+++... ..+++..+..++.|+++||+||| +.+|+|+|++ +|+|||.+...... ...
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc--ccc
Confidence 999999999832 34799999999999999999995 5799999774 89999999864211 122
Q ss_pred cccccCCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGV-QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||++. ...++.++||||+|+++|+|++|+.||..... ......... ...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~--------~~~~~~----~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEK--------ILKRPL----P 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHH--------HHHTHH----H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhh--------cccccc----c
Confidence 34567899999999988 77899999999999999999999999986410 000000000 000000 0
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...........++.+++.+||+.||++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000012579999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=289.82 Aligned_cols=182 Identities=20% Similarity=0.280 Sum_probs=147.3
Q ss_pred cceecccCceEEEEEEEc---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEEecC
Q 001838 731 NNLLGIGSFGSVYVARLQ---DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN--DDFKALIMEYMP 805 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~~ 805 (1007)
.+.||+|+||+||+|+.. +++.||+|++..... ...+.+|++++++++|||||++++++.. +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 467899999875421 2456789999999999999999999864 456899999996
Q ss_pred CCChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc----------------cccceeecc
Q 001838 806 NGSLENRLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV----------------AHISDFSIA 861 (1007)
Q Consensus 806 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~----------------~kl~DFGla 861 (1007)
++|.+++... ...+++..+..++.|++.||+|| |+.+|+|||+ +||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888877532 12478888999999999999999 6788999965 389999999
Q ss_pred eecCCCCc-ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 862 KFLNGQDQ-LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 862 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
+....... ........||+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643221 1122346789999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=274.21 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=189.7
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|+..+.||.|.-|+||++++++ +..+|+|++.+.. .+...+.+.|-+||+.+.||.++.||+.|+.+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567889999999999999874 6899999998764 3455678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC--
Q 001838 803 YMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ-- 867 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~-- 867 (1007)
||+||+|....+++. ..++...+.-+|.+|+-||+|| |-.|||.||++ .++||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999887653 4688888888999999999999 78999999886 58999887543100
Q ss_pred -------------------------------Cc---------------------ccccccccCCcccccccccccCCCCc
Q 001838 868 -------------------------------DQ---------------------LSMQTQTLATIGYMAPEYGVQGRVST 895 (1007)
Q Consensus 868 -------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 895 (1007)
.. .......+||-.|+|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 00 00112347999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCC
Q 001838 896 RGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIES 975 (1007)
Q Consensus 896 ~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 975 (1007)
++|+|+|||++|||+.|+.||.+....+ .+..++...+.-.. .+..+.++.||+++.|..|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~Fp~------~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLKFPE------EPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCcCCC------CCcchhHHHHHHHHHhccC
Confidence 9999999999999999999998643222 12222222221111 1133567899999999999
Q ss_pred CCCCCC----HHHHHHH
Q 001838 976 PGKRIN----AREIVTG 988 (1007)
Q Consensus 976 p~~Rpt----~~evl~~ 988 (1007)
|++|.. |.||-++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 7776543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=292.21 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=181.0
Q ss_pred ccceeccc--CceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 730 KNNLLGIG--SFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 730 ~~~~ig~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
..++||+| +||+||+++.+ +|+.||||+++... ....+.+.+|+++++.++|||||+++++|..++..++|||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999865 68999999997542 334467788999999999999999999999999999999999
Q ss_pred CCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc-c
Q 001838 805 PNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ-L 870 (1007)
Q Consensus 805 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~-~ 870 (1007)
++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+|||++ +++|||.+........ .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999653 23588999999999999999999 57789999874 6788876544321111 0
Q ss_pred ----cccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCcc-------
Q 001838 871 ----SMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS------- 937 (1007)
Q Consensus 871 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------- 937 (1007)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||.......... .......+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccchh
Confidence 01122356788999999876 458999999999999999999999997543221111 1111000000
Q ss_pred HHHH--------hhhhhcc---------ch--hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 VMEV--------IDTNLLS---------GE--ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~~~~--------~d~~~~~---------~~--~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+. .+..... .. ....+.......++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 0000000 00 00000111224578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.60 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=185.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF 796 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 796 (1007)
+|.....||+|+||.||+|... +++.||+|.+.... .+..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999865 58899999885321 1234678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~ 864 (1007)
.++||||+++++|.+++.... .+++..+..++.|++.|++|| |+.+++|+++. ||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997653 478888999999999999999 56789999764 89999999877
Q ss_pred CCCCccc----ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 865 NGQDQLS----MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 865 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
....... ......|+..|+|||++....++.++|||||||++|||++|+.||....... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~------------~ 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIF------------K 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHH------------H
Confidence 5321110 1123458889999999988889999999999999999999999997532110 000 0
Q ss_pred HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... .. ...+......+.+++.+||+.||++||++.||++.
T Consensus 224 ~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 IGEN-AS------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred Hhcc-CC------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 00 00011224568899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.91 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=186.5
Q ss_pred cccccceecccCceEEEEEEEcC--CceEEEEEechh----------hHHHHHHHHHHHHHHHh-cCCCceeEEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD--GMEVAVKVFHQR----------YERALKSFQDECEVMKR-IRHRNLVKIISACSN 793 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 793 (1007)
+|+..+.||+|+||.||+|.... ++.||+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999999764 688999987532 22344567889998876 689999999999999
Q ss_pred CCeeEEEEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------ccccee
Q 001838 794 DDFKALIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDF 858 (1007)
Q Consensus 794 ~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DF 858 (1007)
.+..++||||+++++|.+++.. ....+++..+++++.|++.|+.||| ...+++|+++ +|++||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 3345888999999999999999995 3468999976 489999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccH
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
|.+....... ......|+..|+|||+.....++.++|||||||++|||++|+.||..... .......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~----- 225 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKI----- 225 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHH-----
Confidence 9998765332 22345689999999999888899999999999999999999999864211 1111110
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.+....... ......++.+++.+||+.||++||++.||.++++
T Consensus 226 ---~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 ---VEAVYEPLP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---hhccCCcCC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000000 0012346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=279.83 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=180.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--CCee
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-----YERALKSFQDECEVMKRIRHRNLVKIISACSN--DDFK 797 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 797 (1007)
.+|...+.||+|+||.||+|... +|..||+|++... ..+..+.+.+|+.++++++||||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999865 5899999988633 12345678899999999999999999998875 3578
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+++++|.+++.... .+++.....++.|++.||+|| |+.+|+|++++ ||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999997654 478888999999999999999 57789999653 899999998654
Q ss_pred CCCc-ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 866 GQDQ-LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. +... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~-~~~~--------~-- 222 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AA-IFKI--------A-- 222 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HH-HHHH--------h--
Confidence 2111 11112345889999999998888999999999999999999999999753110 00 0000 0
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..... ...+......+.+++ .||..+|++||+|+||+++
T Consensus 223 -~~~~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 -TQPTN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -cCCCC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00000 000111223455565 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=288.68 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=180.4
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeEEEEEEec-----CC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRI---RHRNLVKIISACSN-----DD 795 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~ 795 (1007)
+|...+.||+|+||+||+|+.. +|+.||+|.++... ......+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 68999999987432 11123456677777665 69999999998864 24
Q ss_pred eeEEEEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 796 FKALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|| |+.+|+|+|++ ||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999984 8988887543 3488999999999999999999 57789999764 899999998
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-Cc--cHH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-PI--SVM 939 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~~--~~~ 939 (1007)
...... ......||..|+|||++.+..++.++||||+||++|||++|++||...... ..+.+...... +. ...
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 764321 123456899999999998888999999999999999999999998653221 11111111110 00 000
Q ss_pred HHhh---hhhcc-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 EVID---TNLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 ~~~d---~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... ..... .........+....++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000 0000001111234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=284.67 Aligned_cols=255 Identities=23% Similarity=0.248 Sum_probs=184.3
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||+||+|+.. +|..||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999875 68999999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 804 MPNGSLENRLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
++ |+|.+++.... ..+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988886432 4588999999999999999999 57899999763 899999998654221
Q ss_pred ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC--cc----HH--H
Q 001838 870 LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP--IS----VM--E 940 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~----~~--~ 940 (1007)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.||....... ........... .. .. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence 112334678899999987654 57899999999999999999999997532111 11111111000 00 00 0
Q ss_pred Hhhhhhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......... .............++.+++.+|++.||++|||+.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 000000011234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=280.34 Aligned_cols=236 Identities=25% Similarity=0.324 Sum_probs=186.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-----ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
+|+..+.||+|+||+||+|... +++.||+|.+.... .+..+.+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999886432 23457789999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||+++++|.+++.+.. .+++..+..++.|++.|++|| |+.+|+|+++ .||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 478899999999999999999 5678999865 3899999998764332
Q ss_pred cccccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
......|+..|+|||.+.... ++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~-----------~- 220 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKE-----------L- 220 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHHHHHHhccc-----------C-
Confidence 123456889999999987766 89999999999999999999999875321 000111100000 0
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+.....++.+++.+||+.+|++||++.|+++.
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00011123467889999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=288.74 Aligned_cols=256 Identities=20% Similarity=0.221 Sum_probs=184.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 68999999986432 22235677899999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
++ |+|.+++......+++..+..++.||++||.|| |+.+|+|+++ +||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 97 588888876555689999999999999999999 5678999976 38999999986532211
Q ss_pred ccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCcc------HHHHhhh
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS------VMEVIDT 944 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------~~~~~d~ 944 (1007)
......+++.|+|||++.+. .++.++|||||||++|||+||+.|+.........+........... ..+..+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12334678899999987664 4799999999999999999999986532221111111111110000 0000000
Q ss_pred hhccchh---hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEE---RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....... ...........++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 0000111234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.91 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=187.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58999999986432 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++++.+..++.... .+++..+..++.|++.||+|| |+.+++|+++ +||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999998888775443 489999999999999999999 5688999865 38999999997754321
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC--ccHHHHhhhhh-
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP--ISVMEVIDTNL- 946 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~d~~~- 946 (1007)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ....+...... ....+..+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999998766 457899999999999999999999997533211 11111111000 00001110000
Q ss_pred -----ccch---hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 -----LSGE---ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 -----~~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... .............+.+++.+||+.+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 00000011224568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.78 Aligned_cols=238 Identities=24% Similarity=0.313 Sum_probs=188.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
++|...+.||+|+||+||+|... +++.||+|.+........+.+.+|+.++++++||||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999864 68899999987554444577899999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++|+|.+++.+. .+++..+..++.|++.|+.|| |+.+++|+++ .||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 999999999764 378889999999999999999 5778999965 38999999886643322 1
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
.....|++.|+|||.+....++.++|||||||++||+++|+.||............+... ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~------------------~~ 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG------------------TP 233 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC------------------CC
Confidence 123468899999999888889999999999999999999999997532211100000000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...........+.+++.+||+.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111223468899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=294.63 Aligned_cols=254 Identities=20% Similarity=0.218 Sum_probs=185.0
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC------
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND------ 794 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 794 (1007)
..++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999865 58899999997532 33446788999999999999999999988643
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999975 77777753 378888999999999999999 67899999764 899999998
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC--ccHHH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP--ISVME 940 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~ 940 (1007)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+..... .....
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 754321 1234568999999999999899999999999999999999999997532111 11111111110 01111
Q ss_pred Hhhhhhcc------ch-----hh---------hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLS------GE-----ER---------YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~------~~-----~~---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+.+.... .. .. ..........++.+++.+|++.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11100000 00 00 000000112468899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=281.48 Aligned_cols=237 Identities=21% Similarity=0.344 Sum_probs=187.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||+++.. +|+.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999865 6899999998743 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
+++++|.+++.... ..+++.++.+++.|++.|+.|| |+.+++|+++ ++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999987543 3578899999999999999999 5678999855 489999999876432211
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
.....|++.|+|||+..+..++.++|||||||++|||++|+.||..... ...+ +.......
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~------------~~~~~~~~ 218 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLV------------LKIIRGSY 218 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHH------------HHHhcCCC
Confidence 1234588899999999888899999999999999999999999864211 1111 11110000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. +.+.....++.+++.+||+.+|++||+|.||+++
T Consensus 219 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 P---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 0111224568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.93 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=190.0
Q ss_pred ccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec
Q 001838 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN 793 (1007)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 793 (1007)
+.++++..++++|...+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677778999999999999999999999875 688999999865422 235677899999999 79999999999875
Q ss_pred C-----CeeEEEEEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------c
Q 001838 794 D-----DFKALIMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------A 853 (1007)
Q Consensus 794 ~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~ 853 (1007)
. +..++||||+++|+|.++++. ....+++..+..++.|++.||+|| |+.+++|+++ +
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998863 234588999999999999999999 5679999865 3
Q ss_pred ccceeecceecCCCCcccccccccCCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHH
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG-----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR 928 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~ 928 (1007)
||+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+.+
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK 244 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH
Confidence 89999999876432211 1234688999999987543 3689999999999999999999998753211 11111
Q ss_pred HHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 929 WVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 929 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.... +.. . ..++.....+.+++.+|++.+|++||++.|++++
T Consensus 245 ~~~~~-~~~--------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNP-PPT--------L--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCC-CCC--------C--------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11000 000 0 0011223468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=278.15 Aligned_cols=240 Identities=20% Similarity=0.281 Sum_probs=188.6
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSN--DDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 801 (1007)
+|+..+.+|.|+||.||+|... +|+.||+|++... .....+++..|++++++++||||+++++++.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 6889999998643 23445678899999999999999999998864 44689999
Q ss_pred EecCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceeccc------------cccceeecceec
Q 001838 802 EYMPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGH--STPIIHYMV------------AHISDFSIAKFL 864 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~~~------------~kl~DFGla~~~ 864 (1007)
||+++|+|.+++... ...+++..+..++.|++.|++|||..+ +.+++|+++ .|++|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999653 346899999999999999999996443 889999865 389999999977
Q ss_pred CCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
...... .....|++.|+|||++....++.++|||||||++|+|++|+.||.... .....+.+...
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~----------- 225 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEG----------- 225 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcC-----------
Confidence 543221 233468999999999988889999999999999999999999997532 11111111110
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... ..+.....++.+++.+|++.+|++|||+.||+++
T Consensus 226 -~~~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -KFR------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0111234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.71 Aligned_cols=226 Identities=25% Similarity=0.417 Sum_probs=176.9
Q ss_pred ceecccCceEEEEEEEcC-C----------ceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 732 NLLGIGSFGSVYVARLQD-G----------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
+.||+|+||.||+|...+ + ..||+|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998764 3 25788887654433 5788999999999999999999999988 778999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------------cccceeecc
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------------AHISDFSIA 861 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------------~kl~DFGla 861 (1007)
|||+++|+|.+++......+++..+..++.|++.||+|| |+.+|+|+|+ .|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999987665689999999999999999999 5789999843 479999999
Q ss_pred eecCCCCcccccccccCCcccccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccH
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQG--RVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
+..... ....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~------ 221 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD------ 221 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc------
Confidence 875431 223467789999998776 78999999999999999999 57777653211 11111110
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
....... ...++.+++.+||..+|++|||+.||++.|.
T Consensus 222 -----~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 -----QHRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----CCCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0146889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.32 Aligned_cols=236 Identities=23% Similarity=0.367 Sum_probs=187.6
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999865 68899999986542 33457889999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCCCCc
Q 001838 804 MPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~~~~ 869 (1007)
+++++|.+++.... ..+++..+.+++.|+++|++|| |+.+++|+++ +|++|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 3578999999999999999999 5779999854 37999999987653321
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....|+..|+|||.+....++.++|||||||++|||++|+.||+..... ........ ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~-----------~~~~-- 219 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMS-----------GTFA-- 219 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHh-----------cCCC--
Confidence 12346889999999998888999999999999999999999998753211 11111100 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.+.....++.+++.+||+.+|++|||+.|++++
T Consensus 220 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=280.48 Aligned_cols=245 Identities=23% Similarity=0.256 Sum_probs=187.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 801 (1007)
++|...+.||.|++|.||+|... +++.||+|++.... .....++.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 58899999987543 24457789999999999999999999998654 4689999
Q ss_pred EecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCC
Q 001838 802 EYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNG 866 (1007)
Q Consensus 802 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~ 866 (1007)
||+++|+|.+++.. ....++......++.|++.||.|| |+.+++|+++ ++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 234578888999999999999999 5788999865 38999999876542
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---CcchHHHHHHhhcCccHHHHhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI---GELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~---~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
... ....++..|+|||.+.+..++.++||||+||++|||++|+.||+.... .......|..........+..
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP- 232 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC-
Confidence 211 234578899999999888999999999999999999999999985422 111222222211000000000
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
........++.+++.+||+.+|++|||+.|+++.-
T Consensus 233 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 233 -----------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -----------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 00001234688999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.11 Aligned_cols=242 Identities=24% Similarity=0.277 Sum_probs=190.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999876 58999999987553 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecccc------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
+++++|.+++......++.....+++.|++.|++|| |+ .+++|+++. ||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999987645688899999999999999999 56 899999763 8999999876632211
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
....++..|+|||++.+..++.++|||||||++|+|++|+.||.............+... .....
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~ 221 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI------------VNEPP 221 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH------------hcCCC
Confidence 125688899999999888999999999999999999999999975422111111111111 00000
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... ......++.+++.+||..+|++|||+.|++.+
T Consensus 222 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 00134568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=281.15 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=184.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh----------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY----------ERALKSFQDECEVMKRIRHRNLVKIISACSNDD 795 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 795 (1007)
+|...+.||+|+||.||+|... +|+.||||.++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 68999999885321 112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeeccee
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~ 863 (1007)
..++||||+++|+|.+++.+.. .+++..+..++.|++.|+.|| |+.+++|+++. +++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999997653 588889999999999999999 56789999763 8999999986
Q ss_pred cCCCCcccccccccCCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHH
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
..............|+..|+|||++.... ++.++|||||||++||+++|+.||..... ...+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLG-NKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhh-ccccCCc
Confidence 54322111223456889999999887654 89999999999999999999999864211 11111100 0000000
Q ss_pred hhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
++. ......+.++.+++.+|+..+|++|||+.||+++
T Consensus 233 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0011224578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.39 Aligned_cols=239 Identities=18% Similarity=0.298 Sum_probs=172.3
Q ss_pred eecccCceEEEEEEEcCC---ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 733 LLGIGSFGSVYVARLQDG---MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
.||+|+||+||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||++++++|.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975543 346677665432 3445789999999999999999999999999999999999999999
Q ss_pred hhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 809 LENRLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 809 L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
|.+++.+.. ...++.....++.||++||+|| |+.+++|+|++ |++|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997532 2456677788999999999999 46789999764 89999998754322211122
Q ss_pred ccccCCccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhh
Q 001838 874 TQTLATIGYMAPEYGVQ-------GRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||...... +..............++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhhcccccCCCc
Confidence 34568889999998743 245789999999999999997 56787643211 111111000001111111
Q ss_pred hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
+.. .....+.+++..|| .+|++||+|+||++.|.
T Consensus 234 ~~~----------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL----------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC----------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 110 11235777888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=279.35 Aligned_cols=237 Identities=23% Similarity=0.364 Sum_probs=186.1
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSN-DDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E 802 (1007)
+|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|||++++++.+.. ....|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999865 57899999986542 3445678899999999999999999998764 446899999
Q ss_pred ecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|+++++|.+++... ...+++.++..++.|++.|++|| |+.+++|+++. +|+|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999764 33589999999999999999999 57789999764 7999999987643221
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
......|++.|+|||+.....++.++|||||||++|||++|+.||+.... ..+....... .. .
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~--------~~-~- 220 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEG--------KL-P- 220 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhc--------CC-C-
Confidence 22345688999999999888899999999999999999999999874321 1111110000 00 0
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+.....++.+++.+|++.+|++|||+.|++++
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=288.06 Aligned_cols=236 Identities=22% Similarity=0.305 Sum_probs=184.7
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++++..++..|+||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344567999999999999865 5889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
++|.+++... .+++..+..++.||+.|++|| |+.+|+|++++ ||+|||++........ ...
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9999988654 378899999999999999999 56789999764 8999999976543221 123
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...|+..|+|||+.....++.++|||||||++|||++|+.||...... ....-+. ..+.....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~--------~~~~~~~~------- 239 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIR--------DNLPPRVK------- 239 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH--------hcCCCccc-------
Confidence 356899999999998888999999999999999999999998742110 0000000 00000000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........+.+++.+|+..||++|||+.|+++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001123457889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=283.99 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=189.0
Q ss_pred ccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec
Q 001838 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN 793 (1007)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 793 (1007)
.++.++..+.+.|+..+.||+|+||.||+|+.. +++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456677777889999999999999999999875 58899999986543 2335688899999998 69999999999853
Q ss_pred ------CCeeEEEEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------c
Q 001838 794 ------DDFKALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------H 854 (1007)
Q Consensus 794 ------~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------k 854 (1007)
.+..|+||||+++|+|.+++.... ..+++..+..++.|++.|++|| |+.+|+|+++. +
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEE
Confidence 457899999999999999987532 3478888889999999999999 56789999663 8
Q ss_pred cceeecceecCCCCcccccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHH
Q 001838 855 ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW 929 (1007)
Q Consensus 855 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~ 929 (1007)
|+|||+++....... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 999999886532211 123356899999999875 3458889999999999999999999986532110000
Q ss_pred HHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 930 VNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 930 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. +....... ......+.++.+++.+||+.||++|||+.|+++.
T Consensus 237 ----------~-~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 ----------L-IPRNPPPK-----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------h-HhhCCCCC-----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 00000000 0011224568999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.52 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=188.9
Q ss_pred ccccccceecccCceEEEEEEEc------CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888999999999999999864 2467999998765433 5678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cccee
Q 001838 799 LIMEYMPNGSLENRLYSGT--------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDF 858 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DF 858 (1007)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|| |+.+|+|+|++ +++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 1589999999999999999999 67789999764 79999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCcc
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
|+++....... .......++..|+|||.+....++.++|||||||++|||++ |..||...... ........
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~----- 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA----- 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc-----
Confidence 99876532221 12233456788999999888889999999999999999999 78888643211 11111110
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
...... .....+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 234 ------~~~~~~------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 ------GKLELP------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------CCcCCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000 00112346899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=280.61 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=190.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||.|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 58899999986432 23557789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 804 MPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
+++++|.+++... ...+++.....++.|++.|++|| |+.+++|+++. |++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 24588999999999999999999 57889999653 8999999987654322
Q ss_pred cc--ccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 870 LS--MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 870 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||......+ ...+...... . ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~--------~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDP-P--------SL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCC-C--------Cc
Confidence 21 12334688999999998777 78999999999999999999999997532211 1111111100 0 00
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... .....+.++.+++.+|++.||++||++.|+++.
T Consensus 228 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGA-----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcc-----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 011224568899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.28 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=187.2
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999976 58999999986542 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++++++.++..... .+++..+..++.|+++|++||| +.+++|+++ .+++|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999999988776543 4899999999999999999994 678999865 48999999987643321
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcc--hHHHHHHhhcCccHHHHhhhh--
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL--SLSRWVNDLLPISVMEVIDTN-- 945 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~-- 945 (1007)
......++..|+|||+..+ ..++.++|||||||++|||++|++||......+. .+..+... ......+..+..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN-LIPRHQEIFQKNPL 233 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC-CchhhHHHhccchH
Confidence 1233568899999998865 4478899999999999999999999864321100 01111110 011111111100
Q ss_pred ----hccch---hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 946 ----LLSGE---ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 946 ----~~~~~---~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..... .......+..+..+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 00000111234579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=288.05 Aligned_cols=237 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.+..|.....||+|.|++|..|+.. +|..||||.+++.. ....+.+.+|+++|+.++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567899999999999999999865 69999999998764 33345588999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+.+|.+++++.++....+ ..+..++.|+.+|++|+ |++.|||||++ ||+|||++.++....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 999999999999998876555 77778999999999999 78999999764 899999999886432
Q ss_pred cccccccccCCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
...+.+|++.|.|||+..+.+| ++++|+||+||++|.|+.|..||++....+. -+..+.
T Consensus 210 ---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl~ 269 (596)
T KOG0586|consen 210 ---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVLR 269 (596)
T ss_pred ---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchhee
Confidence 3356789999999999998876 6799999999999999999999996322111 011111
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+ .+.-...++.+++++++..+|.+|++++++.+.
T Consensus 270 gk~r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYR----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeec----ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 011123468899999999999999999999876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=279.06 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=187.1
Q ss_pred cccccceecccCceEEEEEEE-cCCceEEEEEechhh------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
+|+..+.||+|+||.||+|.. .+++.||+|++.... .+..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 468999999986432 2345788999999999999999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNG 866 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~ 866 (1007)
||||+++++|.+++.+.. .+++..+..++.|++.|++|| |+.+++|+++ .|++|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997643 578899999999999999999 5679999865 38999999987653
Q ss_pred CCcc--cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 867 QDQL--SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 867 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.... .......|+..|+|||++....++.++||||+||++|||++|+.||....... ........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~--------~~~ 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKI--------ASA 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHH--------hcc
Confidence 2111 11123468899999999888889999999999999999999999986422111 11111000 000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... ...+.....++.+++.+|++.+|++|||+.|+++.
T Consensus 227 -~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 -TTA-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -CCC-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000 00112234568899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=284.90 Aligned_cols=243 Identities=20% Similarity=0.260 Sum_probs=184.5
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999876 57899999987553 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .+++..+..++.|++.|++|| |+.+++|++++ |++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 478888899999999999999 56789999663 8999999874211000
Q ss_pred -------------ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc
Q 001838 870 -------------LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 870 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
........|+..|+|||++....++.++|||||||++|||++|+.||.+.... ++....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~--- 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQV--- 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH---
Confidence 00111235788999999998888999999999999999999999998743211 111110
Q ss_pred cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 937 SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 937 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
......... .....+.++.+++.+||+.+|++||++.++.+.|+
T Consensus 229 -----~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 -----ISDDIEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -----HhcccCCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 000000000 00012346899999999999999999655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=285.27 Aligned_cols=182 Identities=20% Similarity=0.287 Sum_probs=146.5
Q ss_pred cceecccCceEEEEEEEc---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEEecC
Q 001838 731 NNLLGIGSFGSVYVARLQ---DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN--DDFKALIMEYMP 805 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E~~~ 805 (1007)
...||+|+||+||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999865 357899999875421 2457789999999999999999999854 457899999997
Q ss_pred CCChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc----------------cccceeecc
Q 001838 806 NGSLENRLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV----------------AHISDFSIA 861 (1007)
Q Consensus 806 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~----------------~kl~DFGla 861 (1007)
+ +|.+++... ...+++..+..++.|++.||+|| |+.+|+|||+ .||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 787776421 12478888999999999999999 5778999965 379999999
Q ss_pred eecCCCCc-ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 862 KFLNGQDQ-LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 862 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
+....... ........||+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 87643321 1122345689999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=276.71 Aligned_cols=234 Identities=26% Similarity=0.354 Sum_probs=185.7
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999865 68899999986432 3445678899999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++... .+++..+..++.|++.|+.|| |+.+++|+++ .+++|||+++....... ..
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 99999998754 478999999999999999999 6789999865 37999999987643221 12
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
....|+..|+|||+.....++.++|||||||++|||++|+.||...... .....+....+..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~---------------- 220 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPPT---------------- 220 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCCC----------------
Confidence 2346888999999998888999999999999999999999998642211 0111110000000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......++.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011123468899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=283.43 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=184.5
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|+||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 5678999999999999999999865 688999999865432 22245678999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+. +++.+++......+.+..+..++.|++.||.|| |+.+|+|+++ .||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 678777765545578888889999999999999 5678999976 48999999986532211
Q ss_pred ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHH-HHHhhcCccHH-HHh---h
Q 001838 870 LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR-WVNDLLPISVM-EVI---D 943 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~-~~~~~~~~~~~-~~~---d 943 (1007)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||+........+.+ |.....+.... ..+ .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 11234578899999988754 5789999999999999999999999754321111111 11000110000 000 0
Q ss_pred ---hhhccc-hhhhHH---HHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 944 ---TNLLSG-EERYFA---AKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 944 ---~~~~~~-~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
+..... ...... .......++.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000000 00001346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=276.85 Aligned_cols=237 Identities=29% Similarity=0.499 Sum_probs=187.0
Q ss_pred cccceecccCceEEEEEEEcC-----CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 729 SKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
...+.||.|+||.||+|+..+ +..||+|++...... ..+.+..|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999998764 388999999755432 56789999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
|+++++|.+++...... +++..+..++.|++.|++|| |+.+++|+++ .+++|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999765443 89999999999999999999 6779999976 48999999987754422
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
... ....+++.|+|||.+....++.++||||+||++|||++ |+.||.... .....+.+.... ..
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~------------~~ 223 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGY------------RL 223 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC------------CC
Confidence 221 12347789999999988889999999999999999998 788886521 111111111100 00
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
..+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111345688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=278.04 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=182.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--Cee
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-----YERALKSFQDECEVMKRIRHRNLVKIISACSND--DFK 797 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 797 (1007)
.+|...+.||+|+||+||+|... +|..||||.+... ..+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999865 5899999988532 123456788999999999999999999998764 468
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+++|+|.+++.+.. .+++....+++.|++.||+|| |+.+++|++++ ||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987653 378888899999999999999 57789998663 899999998654
Q ss_pred CCCcc-cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 866 GQDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
..... .......|+..|+|||++....++.++|||||||++|||++|+.||...... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~---------~~-- 222 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFK---------IA-- 222 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHH---------Hh--
Confidence 22111 1122346889999999998888999999999999999999999998742110 00000 00
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... ....+......+.+++.+|+. +|++||++.|+++.
T Consensus 223 --~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 --TQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --cCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 000112234467888899985 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=285.07 Aligned_cols=234 Identities=24% Similarity=0.299 Sum_probs=183.3
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
.+|+..+.||+|+||+||+|+.. +|+.||+|++... ..+..+.+.+|++++++++||||++++++|.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999875 6899999998643 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||++ |++.+++......+++..+..++.|++.||.|| |+.+|+|+++ .||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 578777765555689999999999999999999 5778999865 389999999865422
Q ss_pred ccccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 870 LSMQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
....|++.|+|||++. ...++.++|||||||++|||+||+.||....... .........+ +..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~--------~~~ 234 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS--------PTL 234 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC--------CCC
Confidence 2346788999999874 3568899999999999999999999987532110 0000000000 000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......++.+++.+||+.+|++||++.+|+.+
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 ---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011234568999999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=295.89 Aligned_cols=184 Identities=30% Similarity=0.462 Sum_probs=160.7
Q ss_pred ccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------eeEEEE
Q 001838 730 KNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDD------FKALIM 801 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 801 (1007)
..+.+|+|+||.||+|+.+ +|+.||||.+.... ....+...+|++++++++|||||++++.-.+.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3577999999999999955 79999999997643 234567889999999999999999999876543 578999
Q ss_pred EecCCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------------ccceeeccee
Q 001838 802 EYMPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------------HISDFSIAKF 863 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------------kl~DFGla~~ 863 (1007)
|||.+|||+..|.+. ...++..+.+.+..+++.||.|| |+++|+|||++ ||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999864 45799999999999999999999 68899999886 8999999999
Q ss_pred cCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEI 919 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~ 919 (1007)
+.++. ..++.+||..|.+||.... +.|+..+|.|||||++||.+||..||..-
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 87554 3467899999999999885 78999999999999999999999999753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=281.76 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=184.9
Q ss_pred ccccceecccCceEEEEEEEc----CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
|...+.||+|+||+||+|... +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999854 3688999998753 2344577899999999999999999999886532
Q ss_pred eeEEEEEecCCCChhHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cccee
Q 001838 796 FKALIMEYMPNGSLENRLYSG-----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDF 858 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DF 858 (1007)
..++++||+++|+|.+++... ...+++....+++.|++.|++|| |+.+|+|++++ |++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 22478888999999999999999 56789999764 89999
Q ss_pred ecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCcc
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 859 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
|+++...............+++.|++||.+....++.++|||||||++|||++ |+.||..... ..+..+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~-- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNR-- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCc--
Confidence 99987643322222223446678999999988889999999999999999999 8899864321 112222111000
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.. .....+.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 234 --------~~--------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 --------LK--------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------CC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0011234689999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=286.69 Aligned_cols=235 Identities=24% Similarity=0.321 Sum_probs=184.2
Q ss_pred cccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 729 SKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+....||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++..++..|+||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999865 68999999987554444567889999999999999999999999999999999999999
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccc
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQ 875 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~ 875 (1007)
+|.+++... .+++..+..++.|++.|++|| |+.+++|+++. ||+|||+++....... ....
T Consensus 104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 104 ALTDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 999987653 478999999999999999999 57789999764 8999999976543221 1234
Q ss_pred ccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHH
Q 001838 876 TLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955 (1007)
Q Consensus 876 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 955 (1007)
..|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+....+.. ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~--------~~-------- 238 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK--------LK-------- 238 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCC--------cc--------
Confidence 5689999999999888899999999999999999999999874211 11111111100000 00
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 956 AKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 956 ~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......++.+++.+|++.+|++||++.|+++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=281.56 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=184.6
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.++|+..+.||+|+||+||+|+.+ +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999876 689999999865421 122456789999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|+++ +|.+++.+....+++.....++.|++.||.|| |+.+|+|+++ +|++|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9985 99999877655788999999999999999999 5778999966 48999999875432111
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc---CccHHHHhhh--
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---PISVMEVIDT-- 944 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~~~~~d~-- 944 (1007)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||.........+........ +.......+.
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1123356889999998765 45899999999999999999999999754311111111100000 0000000000
Q ss_pred ----hhcc-chhhhHHHHHHH--HHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 945 ----NLLS-GEERYFAAKEQS--LLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 945 ----~~~~-~~~~~~~~~~~~--~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
.... ............ ..++.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 000000000001 146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=278.46 Aligned_cols=234 Identities=27% Similarity=0.465 Sum_probs=183.5
Q ss_pred ccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
++|...+.||+|+||.||+|.. +++.||+|+++... ..+.+.+|+.++++++||||+++++++...+ .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4588889999999999999975 57889999987543 2357889999999999999999999987654 799999999
Q ss_pred CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 806 NGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 806 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
+|+|.+++.... ..+++..+..++.|++.|+.|| |+.+++|+|+ +||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997543 3578999999999999999999 5789999865 3899999998653211
Q ss_pred cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....+..|+|||++....++.++|||||||++|||++ |+.||...... .+. +.+......
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~---------~~~~~~~~~--- 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVK---------ECVEKGYRM--- 216 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHH---------HHHhCCCCC---
Confidence 12234578999999988889999999999999999998 99998753211 111 111110000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
..+...+.++.+++.+||+.+|++||+++|+++.|++
T Consensus 217 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 ---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011224568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=279.86 Aligned_cols=238 Identities=25% Similarity=0.280 Sum_probs=178.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHH-HHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEV-MKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||.||+|+.. +|+.||||+++... .....++..|+.+ ++..+|||||++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999876 69999999987542 2223455566665 566789999999999999999999999
Q ss_pred ecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-Cceeccc------------cccceeecceecCC
Q 001838 803 YMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHYMV------------AHISDFSIAKFLNG 866 (1007)
Q Consensus 803 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~~~------------~kl~DFGla~~~~~ 866 (1007)
|++ |+|.+++.. ....+++..+..++.|++.|++||| +. +++|+++ .||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 688877753 2346899999999999999999995 44 8999865 38999999987642
Q ss_pred CCcccccccccCCccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQ----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 942 (1007)
.. ..+...|+..|+|||++.. ..++.++|||||||++|||++|+.||.........+........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-------- 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--------
Confidence 21 1123468889999998764 45789999999999999999999998642211111111110000
Q ss_pred hhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.. . ....+.++.+++.+||..+|++||++.|+++.
T Consensus 226 -~~~---~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 -PQL---P------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CCC---C------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 01124568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=280.08 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=186.2
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC-----
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSNDD----- 795 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~----- 795 (1007)
.++++|+..+.||+|+||.||+|... +++.||+|++..... ..+++.+|+++++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35789999999999999999999975 578999999876543 336789999999999 6999999999997644
Q ss_pred -eeEEEEEecCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceee
Q 001838 796 -FKALIMEYMPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFS 859 (1007)
Q Consensus 796 -~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFG 859 (1007)
..++||||+++++|.+++... ...+++..+..++.|++.||.|| |+.+++|+++ .|++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 34688999999999999999999 6788999865 3899999
Q ss_pred cceecCCCCcccccccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL 934 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 934 (1007)
++....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+.....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~- 234 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNP- 234 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccC-
Confidence 998764321 11234568999999998753 34788999999999999999999999743211 1111100000
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+. ...+.....++.+++.+||..||++|||+.|++++
T Consensus 235 --------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 --------PPT--------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --------CCC--------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 00111234568899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=278.66 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=188.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999875 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+ +++|.+++......+++.++..++.||++||+|| |+.+++|+++ .+++|||+++....... .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 9999999976556689999999999999999999 5678999976 37999999987654322 1
Q ss_pred ccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc----cHHHHh----
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI----SVMEVI---- 942 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----~~~~~~---- 942 (1007)
......|+.+|+|||.+... .++.++||||+||++|||+||++||..... .....++...... ...+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 12345689999999987654 468999999999999999999888764321 1111111111000 000000
Q ss_pred -hhhhcc-chh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 -DTNLLS-GEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 -d~~~~~-~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+..... ... ......++...++.+++.+|++.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000 0000111224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=281.84 Aligned_cols=257 Identities=24% Similarity=0.270 Sum_probs=187.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 58899999987542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++++.+..+.... ..+++..+..++.||+.|++|| |..+++|+++ +||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987776655443 3488999999999999999999 5678999865 389999999887544321
Q ss_pred cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHh--hcCccHHHHhh--hh
Q 001838 871 SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVND--LLPISVMEVID--TN 945 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~--~~~~~~~~~~d--~~ 945 (1007)
......++..|+|||++... .++.++|||||||++|||++|+.||......+ .+..-... ..+........ ..
T Consensus 157 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 -PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcc
Confidence 12335678999999999887 78999999999999999999999987532111 01000000 00000000000 00
Q ss_pred hc--------cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 946 LL--------SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 946 ~~--------~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.. .........+...+.++.+++.+||..+|++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000111225679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=291.19 Aligned_cols=228 Identities=20% Similarity=0.229 Sum_probs=172.4
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc---CCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI---RHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
||+|+||+||+|+.. +|+.||||++.... ......+..|..++.+. +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 58999999997542 22334456677777765 699999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.+.. .+++..+..++.||++||+|| |+.+|+|||++ ||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 99999987644 488899999999999999999 57789999864 8999999986432211 123
Q ss_pred cccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 875 QTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
...||+.|+|||++.+. .++.++|||||||++|||+||+.||...... +........ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~--------~~~~~---- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFG--------KVRFP---- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcC--------CCCCC----
Confidence 45799999999998764 4899999999999999999999999753211 111110000 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRIN----AREIVT 987 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt----~~evl~ 987 (1007)
......++.+++.+||+.||++||+ +.|+++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0011345789999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=280.65 Aligned_cols=255 Identities=21% Similarity=0.250 Sum_probs=183.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|++|.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 68999999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
+. ++|.+++... ...+++..+..++.|++.|++|| |+.+++|+++ .|++|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 96 6898888653 34588999999999999999999 5678999865 4899999998654221
Q ss_pred cccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc--cHHHHhhh---
Q 001838 871 SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI--SVMEVIDT--- 944 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~d~--- 944 (1007)
.......+++.|+|||++.+.. ++.++|||||||++|||+||+.||...... ....+........ .....+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1123345788999999876644 688999999999999999999999753211 1111211111110 00000000
Q ss_pred ---hhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 ---NLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ---~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..... ........+....++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 000000011223467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=273.27 Aligned_cols=239 Identities=26% Similarity=0.304 Sum_probs=191.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
++|+..+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++.+.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999977 499999999876543 4457899999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceeccc------------cccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
+++++|.+++... ..+++..+..++.|+++|++|| |+ .+++|+++ .+++|||.++........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999765 4588999999999999999999 66 89999865 389999999876533221
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-CcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI-GELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....++..|+|||.+....++.++||||||+++|||+||+.||..... .......++... ....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~- 222 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-----------PPPS- 222 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----------CCCC-
Confidence 1234578899999999888899999999999999999999999976432 111111111100 0000
Q ss_pred hhhhHHHHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQ-SLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... .+..+.+++.+|+..+|++||++.|++++
T Consensus 223 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 ------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011 24568999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=277.76 Aligned_cols=237 Identities=23% Similarity=0.346 Sum_probs=186.9
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999876 58899999987542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCCCCc
Q 001838 804 MPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~~~~ 869 (1007)
+++++|.+++.+.. ..+++..+..++.|++.|+.|| |+.+++|+++ .|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997643 3578999999999999999999 5678999855 37999999987643322
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
. .....|++.|+|||+.....++.++|||||||++|||++|+.||.... ..+++....... ....
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~~~~ 222 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY--------FAPI 222 (257)
T ss_pred c--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc--------CCCC
Confidence 1 123458899999999888889999999999999999999999987432 112221111110 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......++.+++.+|++.+|++|||+.|++++
T Consensus 223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00113468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=275.39 Aligned_cols=240 Identities=28% Similarity=0.386 Sum_probs=187.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 689999999875543 3567899999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+++++|.+++..+. .+++..+..++.|+++|+.|| |+.+|+|+++ +||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999997653 478888999999999999999 5678999976 4899999998765432211
Q ss_pred c--cccccCCcccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 872 M--QTQTLATIGYMAPEYGVQGR---VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 872 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
. .....++..|+|||++.... ++.++|||||||++||+++|+.||..... ............ .+..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~--------~~~~ 227 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGAGH--------KPPI 227 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhcCC--------CCCC
Confidence 1 11346788999999988766 89999999999999999999999975321 111111111000 0000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
+........+.+++.+||+.+|++|||+.|++.
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 --------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111345789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=278.20 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=191.8
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
..++.|+..+.||+|+||.||+|..+ ++..||+|+++.... ..+.+.+|++++++++|+||+++++++...+..|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35667888899999999999999977 688999999976544 4567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+++++|.+++......+++..+..++.|++.|+.|| |..+++|+++ .+|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999987654689999999999999999999 5689999865 47999999876543211
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
......++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.....+
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------------- 234 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKGIP-------------- 234 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC--------------
Confidence 1123457889999999988889999999999999999999999986421110 00111000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
..........++.+++.+|++.+|.+|||+.|+++.-
T Consensus 235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 235 ---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ---CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0000111244688999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=262.35 Aligned_cols=240 Identities=22% Similarity=0.251 Sum_probs=188.5
Q ss_pred hccccccc-ceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec----CCe
Q 001838 724 ATDRFSKN-NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN----DDF 796 (1007)
Q Consensus 724 ~~~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 796 (1007)
.|++|++. ++||-|-.|+|..|..+ +|+.+|+|++... ...++|+++.-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566654 67899999999999865 6899999998654 3456899887766 49999999999864 346
Q ss_pred eEEEEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeec
Q 001838 797 KALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSI 860 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGl 860 (1007)
..+|||.|+||.|+..+.+++ ..+++.++-.|+.||+.|+.|| |+..|.|||++ |++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999997653 4689999999999999999999 78899999885 8999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
||..... ....+.+-|++|.|||++...+|+..+|+||+||++|-|+.|.+||...... .+ +..
T Consensus 211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--ai--------spg--- 274 (400)
T KOG0604|consen 211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AI--------SPG--- 274 (400)
T ss_pred ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cC--------Chh---
Confidence 9976432 2234567899999999999999999999999999999999999999764321 11 111
Q ss_pred Hhhhhhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+..++..+ .....+...+.+++..++++..|..+|++|.|+.|++++
T Consensus 275 -Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 275 -MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111111 111222344567789999999999999999999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=281.40 Aligned_cols=233 Identities=25% Similarity=0.321 Sum_probs=182.5
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|+..+.||+|+||.||+|+.. +|..||+|++... ..+..+.+.+|++++++++|||+|++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999865 6889999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
++ |++.+.+......+++.++..++.|++.|+.|| |+.+|+|+++ .|++|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 97 588888866556689999999999999999999 5778999865 389999998765322
Q ss_pred ccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 872 MQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...... ..+..+.....+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~------------ 243 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPT------------ 243 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCC------------
Confidence 2346888999999874 456899999999999999999999998653110 1111111110000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.........+.+++.+|++.+|.+||++.|+++..
T Consensus 244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00112234688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=278.23 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=184.8
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIR---HRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 801 (1007)
.|+..+.||+|+||.||+|... +++.||||.++.. .....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999964 6899999998654 2344567889999999997 999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+++++|.+++..+ .+++.....++.|++.|+.|| |+.+|+|+++ .+++|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998764 588999999999999999999 5778999865 38999999987754321
Q ss_pred ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......|+..|+|||++..+ .++.++|||||||++|||++|+.||..... ..+....... ..+.+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~ 224 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS-----KPPRLED 224 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC-----CCCCCCc
Confidence 12334689999999987654 478999999999999999999999975321 1111100000 0000000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.....++.+++.+||+.||++||++.|++++
T Consensus 225 ---------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ---------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0123468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=280.94 Aligned_cols=254 Identities=21% Similarity=0.251 Sum_probs=186.1
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhH-----HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-----RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
+|+..+.||+|+||.||+|... +|+.||||+++.... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999875 689999999975432 2335677899999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||+ +|+|.+++......+++..+..++.||++||.|| |+.+|+|+++ +||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8999999977554689999999999999999999 6778999865 3899999998765332
Q ss_pred cccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc---cHH-----
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI---SVM----- 939 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~----- 939 (1007)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.+........ ...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 1 1123456888999998754 45789999999999999999998877643211 1111111111000 000
Q ss_pred -HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 -EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 -~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........... ...........++.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPT-PLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCc-chhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0000111224578999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=278.66 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=185.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.|...+.||+|++|.||+|... +++.||+|+++.......+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455679999999999999864 688999999875554455678899999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
+++|.+++... .+++..+..++.|++.|++|| |+.+++|+++. +++|||.+........ ..
T Consensus 100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 99999999773 478899999999999999999 57789999753 7999998876543211 11
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
....|++.|+|||+..+..++.++|||||||++|||++|+.||..... .......... ..+...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~------ 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDN-----LPPKLK------ 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhc-----CCCCCc------
Confidence 234689999999999888899999999999999999999999864211 1111110000 000000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......++.+++.+||+.+|++|||+.|+++.
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 001123468999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=276.76 Aligned_cols=252 Identities=18% Similarity=0.229 Sum_probs=183.9
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecC--CeeEEEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSND--DFKALIME 802 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~E 802 (1007)
|+..+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999865 68999999987542 112234457899999995 99999999999887 88999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccceeecceecCCCCccc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~DFGla~~~~~~~~~~ 871 (1007)
|++ |++.+.+......+++.++..++.|++.||+|| |+.+++|+++. ||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcCCCeEEEecccccccccCCCc-
Confidence 997 588888876555689999999999999999999 56789999764 89999999876433221
Q ss_pred ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc---cHHHHhhhhhc
Q 001838 872 MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI---SVMEVIDTNLL 947 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~~~~d~~~~ 947 (1007)
....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .....+....... .+.+.......
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 23457889999997654 4578999999999999999999999975321 2222222221111 11111110000
Q ss_pred cc-------hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SG-------EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~-------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.. ...........+.++.+++.+||+++|++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 000011122345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=273.16 Aligned_cols=238 Identities=22% Similarity=0.229 Sum_probs=181.8
Q ss_pred HHHHHHhccccccccee--cccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec
Q 001838 718 YHELLQATDRFSKNNLL--GIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN 793 (1007)
Q Consensus 718 ~~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 793 (1007)
..+.....++|+..+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +||||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34555556677777776 99999999999865 68899999987542111 123222223 69999999999999
Q ss_pred CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeec
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSI 860 (1007)
Q Consensus 794 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGl 860 (1007)
.+..|+||||+++|+|.+++.... .+++..+..++.|+++|+.|| |+.+++|+++ .+++|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999997754 689999999999999999999 5678999854 47999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
++..... ....|+..|+|||++....++.++|||||||++|||++|+.||............|..... .
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---- 225 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K---- 225 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c----
Confidence 9876422 2245889999999998888999999999999999999999999854433333333322210 0
Q ss_pred HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 001838 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN-AREIVT 987 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-~~evl~ 987 (1007)
.. .........+.+++.+|++.+|.+||+ +.|+++
T Consensus 226 ----~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KL--------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cC--------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 001123456899999999999999996 588875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=278.51 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=183.5
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
|+..+.||+|++|.||+|... +|..||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999865 69999999987443 223356888999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++|+++ .+++|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68999887644 35899999999999999999995 678999865 38999999986532211
Q ss_pred ccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-Ccc-H-------HHH
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-PIS-V-------MEV 941 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~~~-~-------~~~ 941 (1007)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+...... +.. . .+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11233568899999987664 5789999999999999999999999753211 11111111110 000 0 000
Q ss_pred hhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
................+....++.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000111223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.34 Aligned_cols=241 Identities=26% Similarity=0.281 Sum_probs=180.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|...+.||+|+||+||++... +|+.||||++.... ......+.+|+.++.++. |||||++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999865 58999999987543 334567889999999996 99999999999999999999999
Q ss_pred cCCCChhHhh---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 804 MPNGSLENRL---YS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 804 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
+.. ++.++. .. ....+++..+..++.|++.||+||| +..+++|+|++ ||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554433 22 2345889999999999999999997 45689999764 89999999865432
Q ss_pred CcccccccccCCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQG---RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.. .....|++.|+|||++... .++.++|||||||++|||++|+.||.... ....-+....... .+
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-----~~ 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-----PP 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-----CC
Confidence 11 1234688999999998766 68999999999999999999999987532 1111011000000 00
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+... .....+.++.+++.+|++.+|++|||+.||++.
T Consensus 230 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNS------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCc------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 001234568999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=284.90 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=185.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----ee
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FK 797 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 797 (1007)
+++|...+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 68999999986432 234466888999999999999999999876543 57
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
|+|+||+++ ++.+++..+ .+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999974 888877653 488999999999999999999 57789999764 899999998764
Q ss_pred CCCccc-ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC----ccHH
Q 001838 866 GQDQLS-MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP----ISVM 939 (1007)
Q Consensus 866 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----~~~~ 939 (1007)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .....++..... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence 322111 1123468999999998755 4689999999999999999999999965321 111111111111 1111
Q ss_pred HHhhhhhc-------cchh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 EVIDTNLL-------SGEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 ~~~d~~~~-------~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+.... .... ......+....++.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 0000 0000111234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=269.55 Aligned_cols=238 Identities=27% Similarity=0.356 Sum_probs=190.4
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
+|...+.||+|++|.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999976 688999999987655556789999999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+++|.+++......+++..+..++.|++.|+.|| |..+++|+++ ++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999987655689999999999999999999 5688999976 48999999987754321 2
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
....|+..|+|||++....++.++||||||+++|+|++|+.||....... ........ .....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~------------~~~~~--- 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIATN------------GPPGL--- 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhc------------CCCCc---
Confidence 34568889999999988889999999999999999999999987532110 00000000 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.........+.+++.+|++.||++|||+.|+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000113468899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=314.42 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=188.4
Q ss_pred hcccccccceecccCceEEEEEEE-cCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.+-++.....||.|.||.||-|.. .+|...|+|-++-.. .+..+...+|+.++..++|||+|+++|+-.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 455777789999999999999984 569999999776432 33345678999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
||||++|+|.+.+..++. .++.-...+..|++.|+.|| |+.+|||||++ |.+|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999976542 45555556889999999999 68899999875 899999999886542
Q ss_pred ccc--ccccccCCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 869 QLS--MQTQTLATIGYMAPEYGVQG---RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 869 ~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
+.. ......||+.|||||++.+. ....+.||||+|||+.||+||+.||.... .+..+..-|..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V~~----------- 1456 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHVAA----------- 1456 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHHhc-----------
Confidence 211 12356799999999999764 35678999999999999999999997532 22222211111
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...++.++....+-.+++.+|++.||++|.++.|+++.
T Consensus 1457 -------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11122333456678899999999999999888876654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=276.87 Aligned_cols=233 Identities=25% Similarity=0.339 Sum_probs=186.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|...+.||+|+||.||+|... +++.||+|++.... .+..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999876 58999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+++|+|.+++.... .++...+..++.|++.||+|| |+.+|+|+++ .||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999997653 588899999999999999999 5689999966 389999999876433
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
.....|++.|+|||.+....++.++|||||||++|||++|+.||..... ....+ ........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~-----------~~~~~~~~-- 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYE-----------KILEGKVR-- 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH-----------HHhcCCcc--
Confidence 2334688999999998888889999999999999999999999875321 00000 00000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+......+.+++.+||+.+|++|| +++|+++.
T Consensus 217 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 ------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0011134678999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=284.76 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=186.1
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC--Cee
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRI-RHRNLVKIISACSND--DFK 797 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 797 (1007)
..++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999876 5889999988542 223345677899999999 999999999998654 368
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
|+||||++ ++|.+++..+ .+++..+..++.|++.||+|| |+.+|+|++++ ||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988765 578889999999999999999 56799999663 899999998765
Q ss_pred CCCcc---cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh--cCc---
Q 001838 866 GQDQL---SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL--LPI--- 936 (1007)
Q Consensus 866 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~--~~~--- 936 (1007)
..... .......|+..|+|||++.. ..++.++|||||||++|||+||+.||......+ ...+..... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence 33221 12233568999999998765 457899999999999999999999997532211 011111000 000
Q ss_pred ------cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 937 ------SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 ------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+.++...................++.+++.+|++.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0011111000000000011111234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=279.16 Aligned_cols=258 Identities=19% Similarity=0.240 Sum_probs=183.5
Q ss_pred cccccceecccCceEEEEEEEc---CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ---DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 798 (1007)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999865 47899999997632 23345678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc----------------ccccee
Q 001838 799 LIMEYMPNGSLENRLYSG----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV----------------AHISDF 858 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~----------------~kl~DF 858 (1007)
+||||+++ ++.+.+... ...++...+..++.|++.|++|| |+.+|+|+++ .|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677666432 22578889999999999999999 5778999854 479999
Q ss_pred ecceecCCCCc-ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCc--------chHHH
Q 001838 859 SIAKFLNGQDQ-LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE--------LSLSR 928 (1007)
Q Consensus 859 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~--------~~l~~ 928 (1007)
|+++....... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122345688999999987664 58999999999999999999999997543322 01111
Q ss_pred HHHhhcCccH------------HHHhhhhh---ccchhhhHHHHH--HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 929 WVNDLLPISV------------MEVIDTNL---LSGEERYFAAKE--QSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 929 ~~~~~~~~~~------------~~~~d~~~---~~~~~~~~~~~~--~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
++........ ....+... ............ ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111110000 00000000 000000000000 234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=274.35 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=185.0
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
+|+..+.||+|++|+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999976 589999999875432 22356778999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 805 PNGSLENRLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 805 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
++ +|.+++.... ..+++..+..++.|++.||+|| |+.+++|+++. |++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8988886543 4589999999999999999999 56789999663 8999999986532211
Q ss_pred cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C--ccHHHHhh---
Q 001838 871 SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P--ISVMEVID--- 943 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~--~~~~~~~d--- 943 (1007)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......+ ...+...... + .......+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence 11234578899999987654 57899999999999999999999997543211 1111111100 0 00000000
Q ss_pred --hhhcc-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 944 --TNLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 944 --~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
..... .........+....++.+++.+|++.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000001111223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=278.83 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=182.1
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999875 58999999986432 122345678999999999999999999987654
Q ss_pred --eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecc
Q 001838 796 --FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIA 861 (1007)
Q Consensus 796 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla 861 (1007)
..++||||+.+ ++.+++......+++.++..++.|++.||+||| +.+++|+++ +||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999974 888888766556899999999999999999994 668999865 389999999
Q ss_pred eecCCCCcc--cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCc-chHHHHHHhhcCcc
Q 001838 862 KFLNGQDQL--SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE-LSLSRWVNDLLPIS 937 (1007)
Q Consensus 862 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~ 937 (1007)
......... .......++..|+|||++.+. .++.++|||||||++|||+||+.||....... ......+....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876432211 111234578899999987654 37899999999999999999999987532111 00011110000100
Q ss_pred H------HHHhhhhhccchhh-hHH---HHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 938 V------MEVIDTNLLSGEER-YFA---AKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ~------~~~~d~~~~~~~~~-~~~---~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .+..+......... ... ........+.+++.+||..||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00000000000000 000 000012357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=272.79 Aligned_cols=230 Identities=20% Similarity=0.263 Sum_probs=172.4
Q ss_pred eecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHh---cCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 733 LLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKR---IRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.||+|+||.||+|... +|+.||||.+.... ......+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58999999886532 1222334455544443 469999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++.... .+++..+..++.|++.||+|| |+.+|+|+|++ +++|||++....... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999987654 489999999999999999999 56789999764 799999997653221 1
Q ss_pred ccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....|+..|+|||.... ..++.++|||||||++|||++|+.||......... ....... ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~-----~~~~-------- 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-----TVNV-------- 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh-----cCCc--------
Confidence 23468999999998864 55899999999999999999999999753221111 0100000 0000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
..++....++.+++.+|++.||++|| |++|++++
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 --ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00112245688999999999999999 59988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=264.50 Aligned_cols=257 Identities=22% Similarity=0.262 Sum_probs=204.3
Q ss_pred HHHHhcccccccceecccCceEEEEEEEc------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Q 001838 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACS 792 (1007)
Q Consensus 720 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 792 (1007)
++.....+++....+-+|.||.||+|.+. +.+.|-||.++... +-....+..|...+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444556777788999999999999654 34567788887653 344577899999999999999999999886
Q ss_pred c-CCeeEEEEEecCCCChhHhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------
Q 001838 793 N-DDFKALIMEYMPNGSLENRLYS-------GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------- 853 (1007)
Q Consensus 793 ~-~~~~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------- 853 (1007)
+ .+..+..|.++.-|+|..+|.. ....+...+...++.|++.|++|| |+.+|||.|++
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhee
Confidence 5 4578899999999999999972 123466678888999999999999 78899999875
Q ss_pred -ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 001838 854 -HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 854 -kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~ 931 (1007)
|++|=.++|.+.+.+.............||+||.+....|+.++|||||||++|||.| |+.||.+....+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------- 506 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------- 506 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence 8999999998877666554445556788999999999999999999999999999998 999987642211
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
+...+ . ++.+..++-.++.+++.+|.-||...|++||++++++..|.+....+.++
T Consensus 507 ------m~~yl----k--dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y 562 (563)
T KOG1024|consen 507 ------MEHYL----K--DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY 562 (563)
T ss_pred ------HHHHH----h--ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence 11111 1 12223345567889999999999999999999999999999988776654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=277.02 Aligned_cols=256 Identities=22% Similarity=0.225 Sum_probs=184.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 800 (1007)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999976 58899999997443 22234577899999999999999999998877 789999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||++ ++|.+++......+++..+..++.|++.||+|| |+.+++|+++ +|++|||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 499998876655689999999999999999999 5678999865 4899999998765332
Q ss_pred cccccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C-ccHHHHh-h-
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P-ISVMEVI-D- 943 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~-~~~~~~~-d- 943 (1007)
. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... ...+...... + ....... +
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhcc
Confidence 1 123345788999999886544 6899999999999999999999997532111 1111111000 0 0000000 0
Q ss_pred -----hhhccc-h-hhhHHHHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 -----TNLLSG-E-ERYFAAKEQ-SLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 -----~~~~~~-~-~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...... . ......+.. ....+.+++.+|++.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 0 000000000 24568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=268.50 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=190.3
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKALIM 801 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 801 (1007)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 68999999987654 24567889999999999999999999999988 8899999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+++++|.+++.... .+++..+..++.|+++|++||| +.+++|+++ .+|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998655 6899999999999999999994 688999866 38999999998764432
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
........++..|+|||......++.++||||||+++|+|++|+.||..... ........ ...
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~--------~~~----- 219 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKI--------GSS----- 219 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhc--------ccc-----
Confidence 1112345688899999999888899999999999999999999999975320 00000000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......+.....++.+++.+|++.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00000111224568999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=276.58 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=182.8
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|++|+||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999876 68999999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCCCC
Q 001838 803 YMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~~~ 868 (1007)
|++ +++.+++.... ...++.....++.||+.||+|| |+.+++|+++ .|++|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888775433 2357788889999999999999 5678999854 3799999998653221
Q ss_pred cccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-C-ccH-------
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-P-ISV------- 938 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~-~~~------- 938 (1007)
...+...+++.|+|||++.+. .++.++|||||||++|||+||+.||......+ .+.+...... + ...
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhccccccc
Confidence 111334578899999988664 57899999999999999999999997532111 1111000000 0 000
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+.................+....++.+++.+|++.+|++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000011224568899999999999999999999874
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=279.65 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=186.5
Q ss_pred HHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEec-CC
Q 001838 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSN-DD 795 (1007)
Q Consensus 720 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 795 (1007)
++...+++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 45567889999999999999999999865 69999999886422 2234667889999999999999999999875 55
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeeccee
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~ 863 (1007)
..|+||||+ +++|.+++... .+++.....++.|++.||+|| |+.+|+|+++ .|++|||.++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999999 56899888653 367888888999999999999 5778999965 38999999986
Q ss_pred cCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHH-----------HHHH
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLS-----------RWVN 931 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~-----------~~~~ 931 (1007)
.... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ..... +|..
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 5321 123457889999998766 5689999999999999999999999964321 00111 1111
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........+.+....................++.+++.+|++.+|++|||+.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111111111000000000000011224578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=276.28 Aligned_cols=256 Identities=20% Similarity=0.214 Sum_probs=181.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCe-----
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIR-HRNLVKIISACSNDDF----- 796 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 796 (1007)
++|+..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 689999999865432 22356888999999995 6999999999987665
Q ss_pred eEEEEEecCCCChhHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceee
Q 001838 797 KALIMEYMPNGSLENRLYSG----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFS 859 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFG 859 (1007)
.|+||||+++ ++.+++... ...+++..+..++.||+.||.|| |+.+|+|+++ +|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888643 23578999999999999999999 5778999865 3899999
Q ss_pred cceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-Cc-
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-PI- 936 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-~~- 936 (1007)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.+...... +.
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 9986532211 1123357889999998765 457999999999999999999999987532111 0111111000 00
Q ss_pred c----HHHHhhhhhccc--hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 937 S----VMEVIDTNLLSG--EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 ~----~~~~~d~~~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ..+..+...... ........+....++.+++.+|++++|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000000 000000112234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=283.86 Aligned_cols=258 Identities=20% Similarity=0.227 Sum_probs=186.8
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEec----CCee
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSN----DDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 797 (1007)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999865 69999999987542 2334667889999999999999999998763 3468
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~ 865 (1007)
++||||+. |+|.+++.... .+++..+..++.|++.||.|| |+.+|+|++++ ||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 68999887554 489999999999999999999 56789999764 899999998764
Q ss_pred CCCcc--cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc------
Q 001838 866 GQDQL--SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI------ 936 (1007)
Q Consensus 866 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------ 936 (1007)
..... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence 32211 11123468899999998765 45899999999999999999999999753211 111111111110
Q ss_pred ------cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 937 ------SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 937 ------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
...+..+..-...........+..+.++.+++.+|++.+|++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 11111110000000000001122356799999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=274.81 Aligned_cols=235 Identities=23% Similarity=0.347 Sum_probs=186.8
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
+|+..+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 58999999997543 2445788999999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
|+++++|.+++... ..+++..+..++.|+++|+.|| |+.+++|+++. +++|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999765 3588999999999999999999 56789998653 899999998764332
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
......|+..|+|||++....++.++||||||+++|+|++|+.||...... ...+.... ... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~--------~~~----~- 217 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAK--------QET----A- 217 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHH--------hcc----c-
Confidence 123456888999999998888999999999999999999999999854221 11111110 000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH--HHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINA--REIV 986 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~--~evl 986 (1007)
....+...+.++.+++.+||+.||.+||++ +|++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 000111224578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=278.57 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=186.1
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999876 48999999997543 134567899999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 802 EYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
||+++++|.+++... ...+++..+..++.|++.||+|| |+.+++|++++ +++|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 24588999999999999999999 57789999764 799999987653211
Q ss_pred cc---------------------------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 001838 869 QL---------------------------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI 921 (1007)
Q Consensus 869 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~ 921 (1007)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 001123688899999999888899999999999999999999999975321
Q ss_pred CcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 001838 922 GELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN----AREIVT 987 (1007)
Q Consensus 922 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt----~~evl~ 987 (1007)
.. .+ .+..+....... ......++.+++.+|++.+|++||| +.|+++
T Consensus 238 ~~----~~---------~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE----TF---------SNILKKEVTFPG------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH----HH---------HHHhcCCccCCC------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11 111111100000 0012457899999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=278.63 Aligned_cols=257 Identities=25% Similarity=0.236 Sum_probs=184.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSND--DFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 799 (1007)
.++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999975 589999999864321 1223466899999999999999999998765 46899
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
||||+++ +|.+++......+++.++..++.|++.|++|| |+.+++|++++ ||+|||+++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999974 89888876556689999999999999999999 56789999763 89999999876533
Q ss_pred CcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc--CccHHHHhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--PISVMEVIDT 944 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~~~~~~d~ 944 (1007)
.. ..+...+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+........ .......++.
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhc
Confidence 21 1223346788999998865 457999999999999999999999997532211 1111111000 0000000000
Q ss_pred ------hhcc--chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 ------NLLS--GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ------~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... ..............++.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000000001124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=275.99 Aligned_cols=241 Identities=24% Similarity=0.268 Sum_probs=182.1
Q ss_pred ccccccceecccCceEEEEEEEcC-CceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++|+..+.||+|+||+||+|...+ ++.||||+++... ......+..|++++.+.. ||||++++++|.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999875 8999999997542 233456777888777775 9999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|++ +++.+++......+++..+.+++.|++.|++|||. ..+|+|+++ .||+|||++........
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 985 47777776544568999999999999999999962 358999965 38999999986643221
Q ss_pred cccccccCCcccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 871 SMQTQTLATIGYMAPEYGVQGR----VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
.....++..|+|||++.... ++.++|||||||++|||++|+.||.........+..+.....+ ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~ 239 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP---------SL 239 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC---------CC
Confidence 12345788999999987553 7899999999999999999999997532111111111111000 00
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.. ......++.+++.+||+.||++||++.|++++-
T Consensus 240 -~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 -PP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -CC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 001234689999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=276.12 Aligned_cols=233 Identities=24% Similarity=0.318 Sum_probs=182.6
Q ss_pred cceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 731 NNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
...||+|+||.||+|... +|..||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 6899999998755445557789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccccccc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
.+++... .+++.....++.|++.|++|| |+.+++|++++ +++|||++........ ......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 9988654 378889999999999999999 56789999653 7999999886643221 113356
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
|+++|+|||++....++.++|||||||++|||++|+.||..... ...........+.. ... .
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~--------~~~--------~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK--------LKN--------L 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc--------cCC--------c
Confidence 88999999998888899999999999999999999999864211 11111111111100 000 0
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.....++.+++.+||+.+|.+||++.|++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1123357889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=273.16 Aligned_cols=255 Identities=25% Similarity=0.286 Sum_probs=185.4
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND--DFKALIME 802 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 802 (1007)
|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999876 48999999998653 33446788999999999999999999999887 78999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~ 870 (1007)
|+++ +|.+++......+++..+..++.|+++|++||| ..+++|+++ .|++|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899988766556899999999999999999995 578999865 48999999987754321
Q ss_pred cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC---ccH---HHH-h
Q 001838 871 SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP---ISV---MEV-I 942 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~---~~~-~ 942 (1007)
...+...++..|+|||.+.+ ..++.++|||||||++|||+||+.||+...... ........... ... .+. .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence 11233457889999997765 457999999999999999999999997532111 11111110000 000 000 0
Q ss_pred hhhhc--cc-hhhhHHHHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLL--SG-EERYFAAKEQ-SLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~--~~-~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..... .. .......... +..++.+++.+|++.+|++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 00 0000001111 25678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=282.19 Aligned_cols=254 Identities=20% Similarity=0.209 Sum_probs=185.2
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC------
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSND------ 794 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 794 (1007)
..++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 6899999998643 233445678899999999999999999998643
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
...|+||||+. |+|.+.+... ++...+..++.|++.||+|| |+.+|+|+|++ |++|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999996 5888887643 78888999999999999999 56799999763 899999998
Q ss_pred ecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc--CccHHH
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--PISVME 940 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~~~~ 940 (1007)
....... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........... +....+
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 7643211 23346889999999999889999999999999999999999999743210 00111111110 111111
Q ss_pred Hhhhhhcc--------chhh-------------hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLS--------GEER-------------YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~--------~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.++..... .... ..........++.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 0000 000011224568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=282.30 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=189.1
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC-----Ce
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND-----DF 796 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 796 (1007)
.++|...+.||+|+||+||+|+.. +|+.||||.++... ......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999865 68999999987532 23345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~ 864 (1007)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|| |+.+++|++++ ||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68998887543 588999999999999999999 57789999663 89999999876
Q ss_pred CCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc---C-----
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---P----- 935 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---~----- 935 (1007)
..... ......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .......... +
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhh
Confidence 43221 1233467889999998765 468999999999999999999999997532110 0100110000 0
Q ss_pred ---ccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHHHHH
Q 001838 936 ---ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIRDT 995 (1007)
Q Consensus 936 ---~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~--L~~i~~~ 995 (1007)
....+.++..............+....++.+++.+|++.+|++|||+.|+++. +..+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00011110000000000001112345678999999999999999999999988 6555443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=268.49 Aligned_cols=231 Identities=22% Similarity=0.265 Sum_probs=173.6
Q ss_pred ceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHH-HhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVM-KRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
+.||+|+||.||+|... +|+.||||++.... ......+..|..++ ...+||||+++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 58999999986542 12223445555554 445899999999999999999999999999
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~ 874 (1007)
|+|.+++.... .+++..+.+++.|++.||.|| |+.+++|+++ +|++|||+++.... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997643 478889999999999999999 5678999965 37999999986532 12
Q ss_pred cccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhH
Q 001838 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 954 (1007)
...|++.|+|||...+..++.++|||||||++|||++|..||....... .... +........ .
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~---------~~~~~~~~~---~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFDN---------ILSRRINWP---E 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH---------HHhcccCCC---C
Confidence 3458889999999888889999999999999999999999997532111 1100 000000000 0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 955 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
........++.+++.+||+.+|++||++.++.+.|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00112345789999999999999999876555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=274.97 Aligned_cols=236 Identities=25% Similarity=0.313 Sum_probs=182.6
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
+.|+..+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|++++++++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999975 5888999998632 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~ 869 (1007)
||+. |++.+.+......+++..+..++.|++.|+.|| |+.+++|+++ .|++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 688887765555688999999999999999999 5678999965 489999999876432
Q ss_pred ccccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 870 LSMQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
....|++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....+. .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~---------~ 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPA---------L 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCCC---------c
Confidence 2346888999999874 356888999999999999999999998642110 0011111100000 0
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
........+.+++.+||+.+|++||++.|+++...
T Consensus 235 ---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 ---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01122346889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=266.87 Aligned_cols=236 Identities=22% Similarity=0.318 Sum_probs=191.6
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.+.|+.-++||+||||.||-++.+ +|+.+|.|.+.+..- +...-..+|-.++.+++.+.||.+-.+|++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 345777899999999999999866 699999999876542 2234568899999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 801 MEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
+..|.||+|.-+|...+ ..+++.++.-+|.+|+.||++| |+.+||.||++ +|+|.|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999997643 4689999999999999999999 78899999875 89999999988755
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
... ++.+||.+|||||++....|+...|+||+||++|||+.|+.||...... .-.+.+|....
T Consensus 341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEvdrr~~ 403 (591)
T KOG0986|consen 341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEVDRRTL 403 (591)
T ss_pred Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHHHHHHh
Confidence 433 4558999999999999999999999999999999999999999742111 11223444333
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 983 (1007)
...... ++..++++.++.+..|+.||++|.-.+
T Consensus 404 ~~~~ey---~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 EDPEEY---SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cchhhc---ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 322221 233456788889999999999998554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=258.63 Aligned_cols=237 Identities=22% Similarity=0.274 Sum_probs=188.0
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.++|+..+++|+|.||+|-.++-+ +|+.+|+|++++.. ......-..|-++|+..+||.+..+-..|...++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 567888999999999999999855 69999999998753 33445667899999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
|||+.||.|+-+|.+.. .++..+..-+-..|+.||.|| |+.+||.||++ ||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-- 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-- 320 (516)
T ss_pred EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence 99999999999997755 466766777999999999999 67899999875 8999999986422
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
........+|||.|+|||++....|+..+|+|.+|||+|||++|+.||.....+ .+.+.+-..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------------kLFeLIl~e--- 383 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------------KLFELILME--- 383 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------------HHHHHHHhh---
Confidence 123346789999999999999999999999999999999999999999753211 111111100
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.- ..+.....+...|+...+..||.+|. .++||.++
T Consensus 384 -d~---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -DL---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -hc---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 00 01122244677888899999999997 36666554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=271.86 Aligned_cols=231 Identities=22% Similarity=0.274 Sum_probs=177.2
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||+||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 58999999987542 22345677899999999999999999999999999999999999999
Q ss_pred hHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccccccc
Q 001838 810 ENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQT 876 (1007)
Q Consensus 810 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~~~ 876 (1007)
.+++.+.. ..+++..+..++.|++.|+.|| |+.+++|+++ .|++|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99997643 3588999999999999999999 5778999975 3899999998664321 11234
Q ss_pred cCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHH
Q 001838 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956 (1007)
Q Consensus 877 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 956 (1007)
.++..|+|||++.+..++.++|||||||++|||++|+.||....... ........ ..... ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-------------~~~~~---~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRR-------------TLEMA---VEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhc-------------ccccc---ccC
Confidence 67889999999888889999999999999999999999997532210 00000000 00000 000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001838 957 KEQSLLSILNLATECTIESPGKRI-----NAREIVT 987 (1007)
Q Consensus 957 ~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~ 987 (1007)
+.....++.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 111244688999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=276.69 Aligned_cols=259 Identities=24% Similarity=0.289 Sum_probs=186.1
Q ss_pred HhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC----
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD---- 795 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 795 (1007)
.+.++|+..+.||+|+||.||+|..+ +|+.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999976 58999999997542 222356778999999999999999999987654
Q ss_pred ------eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccce
Q 001838 796 ------FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISD 857 (1007)
Q Consensus 796 ------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~D 857 (1007)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|| |+.+|+|+++ +||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 77777776555689999999999999999999 5679999865 48999
Q ss_pred eecceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc--
Q 001838 858 FSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-- 934 (1007)
Q Consensus 858 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-- 934 (1007)
||+++....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ...+........
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999987653322 11122346788999998765 3578999999999999999999999975321 111111111110
Q ss_pred -CccHHHHh--------hhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 935 -PISVMEVI--------DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 935 -~~~~~~~~--------d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+....+.. +...... ..........+.++.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYR-RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred Chhhcccccccccccccccccccc-cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0000000 00000111124578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=277.65 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=185.2
Q ss_pred HHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--
Q 001838 721 LLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDD-- 795 (1007)
Q Consensus 721 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 795 (1007)
+....++|+..+.||+|+||.||+|... +|..||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3345678999999999999999999854 6899999998643 2334457889999999999999999999987653
Q ss_pred ----eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceee
Q 001838 796 ----FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFS 859 (1007)
Q Consensus 796 ----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFG 859 (1007)
..++||||+ +++|.+++... .+++..+..++.|+++|++|| |+.+|+|++++ |++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 77999888653 488999999999999999999 57889999763 899999
Q ss_pred cceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHH----------
Q 001838 860 IAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR---------- 928 (1007)
Q Consensus 860 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~---------- 928 (1007)
+++..... .....+++.|+|||++.. ..++.++||||+||++|++++|+.||....... ....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence 99865422 123457889999998876 458899999999999999999999997532111 0111
Q ss_pred -HHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 929 -WVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 929 -~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
|............+...............+....++.+++.+|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111000001000000000000001112234468899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=270.64 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=188.8
Q ss_pred ccccccceecccCceEEEEEEE-cCCceEEEEEechh-------hHHHHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCe
Q 001838 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQR-------YERALKSFQDECEVMKRIRHRNLVKIISACS-NDDF 796 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~ 796 (1007)
++|-..+.+|+|||++||+|.+ ...+.||||+-... .+...+...+|.+|.+.+.||.||++|+||. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5677789999999999999984 45889999986421 1223456789999999999999999999997 4567
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeecc
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIA 861 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGla 861 (1007)
+|-|+|||+|.+|+-||+.+. .+++.++..|+.||+.||.||.+ -+++|||.|++ ||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 899999999999999998765 47888899999999999999965 57899998664 89999999
Q ss_pred eecCCCCcc-----cccccccCCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHh
Q 001838 862 KFLNGQDQL-----SMQTQTLATIGYMAPEYGVQG----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 862 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~ 932 (1007)
+.+.++... ..++...||.+|++||.+.-+ +.+.|+||||.|||+|..+.|+.||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 998755332 233567899999999976543 47899999999999999999999997532111
Q ss_pred hcCccHHHHhh-hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 933 LLPISVMEVID-TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 933 ~~~~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+++. ..+....+..++..+....+..+++++|+++.-++|....+++..
T Consensus 692 -------dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 692 -------DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred -------HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1111 111111122222233445678899999999999999988877654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=276.57 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=179.1
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
.+.+|.|+++.||++.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555554 6899999998754 34455789999999999999999999999999999999999999999
Q ss_pred hhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc-----
Q 001838 809 LENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL----- 870 (1007)
Q Consensus 809 L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~----- 870 (1007)
|.+++... ...+++.....++.|++.||+|| |+.+|+|+|++ |++|||.+.........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999754 34578888999999999999999 56789999764 89999998765432211
Q ss_pred cccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCc------------
Q 001838 871 SMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI------------ 936 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------------ 936 (1007)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||............ .....+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcC
Confidence 11123457788999999866 35889999999999999999999999754222111111 1100000
Q ss_pred cHHH----HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 937 SVME----VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 937 ~~~~----~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
...+ ..+... ..............++.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNN--RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccch--hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000 000000 00001111222345788999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=268.54 Aligned_cols=235 Identities=23% Similarity=0.307 Sum_probs=187.7
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||++... +++.+|+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999755 68899999987542 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 804 MPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 804 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
+++++|.+++.+. ...+++..+..++.|++.|++|| |+.+++|+++ .|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 24578899999999999999999 6788999865 389999999877543
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
......|+..|+|||...+..++.++||||+|+++|||++|+.||...... .+... +.....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~------------~~~~~~- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK------------VQRGKY- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH------------HhcCCC-
Confidence 112345888999999998888999999999999999999999999753211 11111 000000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+.+.....++.+++.+|++.+|++|||+.|+++.
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111334578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=279.32 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=183.3
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999865 68999999986432 223456889999999999999999999987543
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeeccee
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~ 863 (1007)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|| |+.+|+||++ +|++|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46999999974 7776653 2478889999999999999999 5678999976 48999999986
Q ss_pred cCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHh--hcCccHHH
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVND--LLPISVME 940 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~--~~~~~~~~ 940 (1007)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...... .......+
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 5321 123467889999998876 458999999999999999999999997532111 11111110 00011111
Q ss_pred Hhhhhh---------ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHHHH
Q 001838 941 VIDTNL---------LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIRD 994 (1007)
Q Consensus 941 ~~d~~~---------~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~--L~~i~~ 994 (1007)
..+... ...........+....++.+++.+||+.||++||++.|++.+ ++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 111000 000000000011223468899999999999999999999965 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=277.95 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=187.9
Q ss_pred ccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Q 001838 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACS 792 (1007)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 792 (1007)
....++..++++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 334567778899999999999999999999854 68999999997532 233466888999999999999999999886
Q ss_pred cC------CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------c
Q 001838 793 ND------DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------H 854 (1007)
Q Consensus 793 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------k 854 (1007)
.. ...|+|+|++ +++|.+++..+ .+++..+..++.|+++|++|| |+.+|+|++++ |
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEE
Confidence 43 3468888887 78998888654 388999999999999999999 56789999663 8
Q ss_pred cceeecceecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 001838 855 ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 855 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
|+|||+++..... .....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999999865321 123468899999998766 468899999999999999999999996432111 111111100
Q ss_pred --cCccHHHHhhh--------hhccchh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 934 --LPISVMEVIDT--------NLLSGEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 934 --~~~~~~~~~d~--------~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+......+.. .+..... ...........++.+++.+|++.||++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 01111100000 0000000 0000000123468899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=275.42 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=181.2
Q ss_pred ceeccc--CceEEEEEEEc-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCC
Q 001838 732 NLLGIG--SFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~ig~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
..||+| +||+||+|+.. +|+.||||++... ..+..+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999875 6999999998743 234457889999999999999999999999999999999999999
Q ss_pred CChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc---
Q 001838 807 GSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL--- 870 (1007)
Q Consensus 807 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~--- 870 (1007)
|++.+++.+. ...+++..+..++.|++.||+|| |+.+|+|||++ |++|||.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 23588889999999999999999 57899999875 67888755332211100
Q ss_pred --cccccccCCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh---------cCcc
Q 001838 871 --SMQTQTLATIGYMAPEYGVQG--RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL---------LPIS 937 (1007)
Q Consensus 871 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~---------~~~~ 937 (1007)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........ .+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 001112356679999998763 478999999999999999999999975422111 11110000 0000
Q ss_pred HHHH----------hhhhh--------ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHHHH
Q 001838 938 VMEV----------IDTNL--------LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIRD 994 (1007)
Q Consensus 938 ~~~~----------~d~~~--------~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~--L~~i~~ 994 (1007)
.... ++... ........+.......++.+++.+||+.||++|||+.|+++. +..+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000 00000 000001111223445679999999999999999999999865 344444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=250.58 Aligned_cols=236 Identities=22% Similarity=0.243 Sum_probs=185.0
Q ss_pred ccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEecCC
Q 001838 730 KNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~~ 806 (1007)
....+|+|+.|+|++++.+ +|..+|||.+.... .+..+++...++++.+-+ .|.||+.+|||......++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3567999999999999976 58999999997653 455678888898888776 89999999999999989999999954
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQT 874 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~ 874 (1007)
.++.++++-...+++...=++...++.||.||. ..++|+|||++ |+||||++..+.+... .+
T Consensus 176 -C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---ht 249 (391)
T KOG0983|consen 176 -CAEKLLKRIKGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HT 249 (391)
T ss_pred -HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCCEEeecccccceeecccc---cc
Confidence 567777766666888878888999999999997 45589999875 9999999988764432 24
Q ss_pred cccCCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 875 QTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 875 ~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
...|.+.|||||.+.- .+|+.++|||||||.++||+||+.||.....+-..+.+...... +.+..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---------P~L~~--- 317 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---------PLLPG--- 317 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---------CCCCc---
Confidence 5679999999998864 46999999999999999999999999875433322222222111 11110
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+..+.+++..||+.|+.+||.-.+++++
T Consensus 318 -----~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 -----HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11124578999999999999999999988875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.69 Aligned_cols=237 Identities=24% Similarity=0.383 Sum_probs=189.1
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 58999999997543 34557789999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 804 MPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 804 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
+++++|.+++.+. ...+++..+..++.+++.|+.|| |+.+++|+++ .+++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764 35689999999999999999999 5669999865 3899999998764432
Q ss_pred cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
. ......|++.|+|||......++.++||||+|+++|+|++|+.||+.... .+...... .....
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~--------~~~~~- 221 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKIL--------KGQYP- 221 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHh--------cCCCC-
Confidence 1 12334688899999998888899999999999999999999999875321 11111100 00000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .+.....++.+++.+||..+|++|||+.|+++.
T Consensus 222 ~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 P------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 001223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=264.78 Aligned_cols=230 Identities=25% Similarity=0.340 Sum_probs=180.1
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||.|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999976 48999999997542 23446789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccccccc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
.+++.+.. .+++..+..++.|++.||+|| |+.+++|+++ +|++|||+++...... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997654 478889999999999999999 5789999865 4899999998775432 112346
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
|+..|+|||++....++.++|||||||++|||++|+.||.....+. .++... ..+... . ...+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~~~~~~----~--~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND--------ILKGNG----K--LEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------HhccCC----C--CCCC
Confidence 8889999999888889999999999999999999999997543211 111111 110000 0 0001
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRIN-----AREIVT 987 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~ 987 (1007)
.....++.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112457899999999999999999 566655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=291.25 Aligned_cols=260 Identities=17% Similarity=0.185 Sum_probs=176.8
Q ss_pred hcccccccceecccCceEEEEEEEcC--CceEEEEEe--------------ch---hhHHHHHHHHHHHHHHHhcCCCce
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQD--GMEVAVKVF--------------HQ---RYERALKSFQDECEVMKRIRHRNL 784 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~ni 784 (1007)
..++|...+.||+|+||+||+|..+. +..+++|.+ .+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987542 222332211 11 012234568899999999999999
Q ss_pred eEEEEEEecCCeeEEEEEecCCCChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 785 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
|++++++.+.+..|+|+|++. +++.+++.... ......+..+++.|++.||+|| |+.+|||||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEC
Confidence 999999999999999999995 57777775432 1223456778999999999999 57799999875
Q ss_pred -----ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCccccC-cchH
Q 001838 854 -----HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP-TDEIFIG-ELSL 926 (1007)
Q Consensus 854 -----kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p-~~~~~~~-~~~l 926 (1007)
||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|..+ +...... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 89999999877533221 22345799999999999998999999999999999999998754 4322111 1112
Q ss_pred HHHHHhh------cCcc---HHHHhhhhhccch-hh--hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 927 SRWVNDL------LPIS---VMEVIDTNLLSGE-ER--YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 927 ~~~~~~~------~~~~---~~~~~d~~~~~~~-~~--~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+.+... .+.. ..+.++....... .. ..-.......++.+++.+|++.||++|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2211111 1111 1111111100000 00 000000123457788999999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=280.09 Aligned_cols=256 Identities=22% Similarity=0.260 Sum_probs=182.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC----------
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSND---------- 794 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------- 794 (1007)
.+|...+.||+|+||+||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999875 5899999998765545557788999999999999999999876543
Q ss_pred ----CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccce
Q 001838 795 ----DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISD 857 (1007)
Q Consensus 795 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~D 857 (1007)
...|+||||++ ++|.+++..+ .+++..+..++.||+.||+|| |+.+|+|+++ .|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 5898888654 478899999999999999999 5678999865 38999
Q ss_pred eecceecCCCCccc-ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC
Q 001838 858 FSIAKFLNGQDQLS-MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP 935 (1007)
Q Consensus 858 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 935 (1007)
||.++......... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 99998764321111 1123357889999997654 458899999999999999999999997532211 01111111000
Q ss_pred c---cHHH---Hhhhhhc----cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 936 I---SVME---VIDTNLL----SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 936 ~---~~~~---~~d~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ...+ .+..... ..........+....++.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0000 0000000 00000000111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=268.74 Aligned_cols=253 Identities=24% Similarity=0.271 Sum_probs=183.4
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCceeEEEEEEecCCe-----
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRI---RHRNLVKIISACSNDDF----- 796 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 796 (1007)
|+..+.||+|+||.||+|+.+ +++.||||+++... ......+.+|+++++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999987 48999999997432 22234567788887776 59999999999988776
Q ss_pred eEEEEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeeccee
Q 001838 797 KALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKF 863 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~ 863 (1007)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++||.|| |+.+++|+++ +|++|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999974 8998887643 3589999999999999999999 5678999865 48999999987
Q ss_pred cCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHh-
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI- 942 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~- 942 (1007)
....... ....++..|+|||++....++.++|||||||++|||++|++||..... ...+.++.............
T Consensus 157 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence 6433211 233578899999999888899999999999999999999999875322 11222222211100000000
Q ss_pred h----hh-hcc-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 D----TN-LLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d----~~-~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. .. ... ...............+.+++.+||+.||++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00 000 0000011112334678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=271.06 Aligned_cols=232 Identities=24% Similarity=0.294 Sum_probs=179.6
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|...+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|++++++++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999865 5889999998643 233446788999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+. |++.+++......+++.++..++.|++.|+.|| |+.+++|+++ .|++|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 96 588888876555689999999999999999999 4678999865 389999998653221
Q ss_pred ccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhcc
Q 001838 872 MQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 948 (1007)
....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ............ +...
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~- 241 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDS--------PTLQ- 241 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCC--------CCCC-
Confidence 2346889999999874 35688999999999999999999999875321 111111100000 0000
Q ss_pred chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......+.+++.+||+.+|.+||++.|++..
T Consensus 242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112357889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=277.93 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=193.2
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 798 (1007)
+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999976 48999999987643 344567899999999999999999999998775 789
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~ 866 (1007)
+||||++ ++|.+++.+.. .+++..+..++.|++.||+|| |+.+|+|++++ +++|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 48999887654 689999999999999999999 57789999763 8999999998754
Q ss_pred CCcc-cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc----------
Q 001838 867 QDQL-SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---------- 934 (1007)
Q Consensus 867 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---------- 934 (1007)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||......+ ..+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHhhh
Confidence 3211 112345688999999999887 78999999999999999999999997543211 111111100
Q ss_pred --CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHHHHH
Q 001838 935 --PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIRDT 995 (1007)
Q Consensus 935 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~--L~~i~~~ 995 (1007)
.....+.+...............+....++.+++.+||+.+|++|||+.+++++ ++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 001111111000000000000111234578999999999999999999999986 5555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=258.00 Aligned_cols=191 Identities=22% Similarity=0.299 Sum_probs=155.4
Q ss_pred hcccccccceecccCceEEEEEEEc---C--CceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEec-CC
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ---D--GMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSN-DD 795 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 795 (1007)
....|+....||+|.||.||+|.-. + .+++|||+++...+ ..-....+|+.+++.++|||||.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456889999999999999999532 2 34799999975531 223567899999999999999999999877 77
Q ss_pred eeEEEEEecCCCChhHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------------cc
Q 001838 796 FKALIMEYMPNGSLENRLYSG----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------------HI 855 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------------kl 855 (1007)
..++++||++. +|.+.++-+ ...++...+..|+.||+.|+.|| |++=|+|||++ ||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEe
Confidence 89999999987 899988643 24678888999999999999999 78889999763 99
Q ss_pred ceeecceecCCCCcc-cccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 856 SDFSIAKFLNGQDQL-SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
+|||+|+.....-.. .....++-|.+|+|||.+.+.+ |+.+.||||.|||+.||+|-++-|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999987643221 1224556799999999988865 89999999999999999997776653
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=262.37 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=187.8
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999866 588999999976542 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+++++|.+++... ..+++..+..++.|++.|+.|| |+.+|+|+++ .+|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999765 4589999999999999999999 6779999966 489999999977543221
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
.....++..|+|||+.....++.++||||+|+++|||++|+.||..... ......... . ..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~------------~~- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-D------------DH- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-c------------CC-
Confidence 2334688899999998877789999999999999999999999875321 111000000 0 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
...+......+.+++.+|+..+|++|||+.|++.
T Consensus 217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0001112346889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=264.44 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=182.7
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--Cee
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-----YERALKSFQDECEVMKRIRHRNLVKIISACSND--DFK 797 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 797 (1007)
.+|+..+.||+|+||.||+|+.. +|..||+|++... ..+..+.+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999865 5899999987532 234456789999999999999999999998764 468
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~ 865 (1007)
++||||+++++|.+++.... .+++....+++.|++.|+.|| |+.+++|+++ ++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987644 378888999999999999999 5778999865 3899999998653
Q ss_pred CCCc-ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhh
Q 001838 866 GQDQ-LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 944 (1007)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~ 221 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----------------AIFKI 221 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----------------HHHHH
Confidence 2111 111123468899999999988889999999999999999999999987531110 00000
Q ss_pred hhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...... ...+.....++.+++.+|++ +|.+||++.+++.+
T Consensus 222 ~~~~~~---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQPTK---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCCCC---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 000000 00111234568999999999 47999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=268.21 Aligned_cols=254 Identities=22% Similarity=0.254 Sum_probs=187.9
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
|+..+.||+|++|.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999875 688999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
++ ++.+++......+++..+..++.|++.|+.|| |..+|+|+++ .||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 89888877555689999999999999999999 5678999865 3899999998775432 11
Q ss_pred cccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc---CccHHHHhh---h-
Q 001838 873 QTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL---PISVMEVID---T- 944 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~~~~~d---~- 944 (1007)
.....++..|+|||.+... .++.++||||+||++|+|+||+.||......+ .+........ +.......+ .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234578899999998776 68999999999999999999999986532111 0111111000 000000000 0
Q ss_pred --hhcc-chhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 945 --NLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 --~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.... .........+....++.+++.+||+.||.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0000111223346689999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=266.05 Aligned_cols=230 Identities=20% Similarity=0.257 Sum_probs=172.5
Q ss_pred eecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHH---HHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 733 LLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEV---MKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.||+|+||.||+|... +|+.||+|.+.... ......+..|..+ ++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 58899999986532 1112234444443 444579999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|+|.+++.... .+++..+..++.|+++|++|| |+.+|+|++++ |++|||+++...... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887543 589999999999999999999 56789999763 799999998653221 1
Q ss_pred ccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhh
Q 001838 874 TQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 952 (1007)
....|+..|+|||++..+ .++.++||||+||++|||++|+.||................. ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~-------- 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAV-------- 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------cCC--------
Confidence 234689999999998754 589999999999999999999999975322111100000000 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
..+.....++.+++.+|+..+|++|| ++.|++++
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00111245688999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=268.99 Aligned_cols=234 Identities=24% Similarity=0.336 Sum_probs=181.2
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++.+..++..|+||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 499999999975432 4456789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc------cc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ------LS 871 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~------~~ 871 (1007)
.+++.+.. .+++..+..++.|+++||+|| |..+++|+++. |++|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 589999999999999999999 56789999663 8999999886543211 11
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
......++..|+|||......++.++||||||+++||+++|+.||...... ....... .... .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~--------~~~~-~--- 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNIL--------NGKI-E--- 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHh--------cCCc-C---
Confidence 223346788999999988888999999999999999999999999753211 1111100 0000 0
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.+........+.+++.+|++.+|++|||+.++.+.|+
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000001456899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=272.96 Aligned_cols=232 Identities=20% Similarity=0.313 Sum_probs=185.5
Q ss_pred cceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCC
Q 001838 731 NNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
.+++|+|-||+||-|.++ +|+.||||++++-. .+...+.++|+.||.+++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 478999999999999865 79999999997543 23447889999999999999999999999999999999999965
Q ss_pred ChhHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeecceecCCCCccc
Q 001838 808 SLENR-LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 808 sL~~~-l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGla~~~~~~~~~~ 871 (1007)
+..++ |....+.++......++.||+.||+|| |-++|||+|++ |+||||+|+.+.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 55554 455566788888888999999999999 67899999875 999999999986442
Q ss_pred ccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchh
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 951 (1007)
-..+++||+.|+|||++..+.|...-|+||.|||+|.-++|..||.+.. ++.+.+......
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----------------dIndQIQNAaFM--- 782 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----------------DINDQIQNAAFM--- 782 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----------------chhHHhhccccc---
Confidence 2356889999999999999999999999999999999999999997521 111222111100
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.......+.....++++...++..-++|.|....+.+
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 0011123445578899999999999999998877654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=279.78 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=184.8
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCe----
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDF---- 796 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 796 (1007)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999976 58899999986432 2334667889999999999999999998876554
Q ss_pred --eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 797 --KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 797 --~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|| |+.+|+|+++. ||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 56999988763 489999999999999999999 56789999663 899999998
Q ss_pred ecCCCCcccccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHH----------
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN---------- 931 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~---------- 931 (1007)
..... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ .+.....
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHH
Confidence 76432 233467889999998765 367899999999999999999999997432110 0111111
Q ss_pred -hhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 932 -DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 932 -~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..........+....................++.+++.+|++.+|++|||+.||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 111011111111100000000001111224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=268.82 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=181.6
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY-----ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
+|...+.||+|+||+||++.... +..+++|+++... .....++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 4556666665321 22334577899999999999999999999998899999
Q ss_pred EEecCCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-----------cccceeecceecCC
Q 001838 801 MEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-----------AHISDFSIAKFLNG 866 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-----------~kl~DFGla~~~~~ 866 (1007)
|||+++++|.+++.. ....+++..+..++.|++.|+.|| |+.+++|+++ .|++|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeecCCEeecccCceeecCC
Confidence 999999999998863 234689999999999999999999 5789999865 38999999987643
Q ss_pred CCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
... ......|++.|+|||+.....++.++||||||+++|+|++|+.||.... ........ .....
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~--------~~~~~ 222 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI--------VEGPT 222 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH--------HcCCC
Confidence 322 1233468889999999888889999999999999999999999986421 11111110 00000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
...+.....++.+++.+||..+|++||++.|+++.
T Consensus 223 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 -------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00011234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=275.13 Aligned_cols=257 Identities=21% Similarity=0.215 Sum_probs=181.6
Q ss_pred ccccc-cceecccCceEEEEEEEc-CCceEEEEEechhhHHH--------------HHHHHHHHHHHHhcCCCceeEEEE
Q 001838 726 DRFSK-NNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERA--------------LKSFQDECEVMKRIRHRNLVKIIS 789 (1007)
Q Consensus 726 ~~~~~-~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 789 (1007)
++|.. .+.||+|+||+||+|... +++.||||+++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999865 68999999986432111 124778999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccce
Q 001838 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISD 857 (1007)
Q Consensus 790 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~D 857 (1007)
++..++..++||||++ |+|.+++.... .+++.....++.|++.||+|| |+.+|+|+++. |++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 69999886543 478889999999999999999 57889999663 8999
Q ss_pred eecceecCCCCc------------ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcc
Q 001838 858 FSIAKFLNGQDQ------------LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL 924 (1007)
Q Consensus 858 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~ 924 (1007)
||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999987641110 0111233568899999988764 47999999999999999999999997532211
Q ss_pred hHHHHHHhhc---CccHHHHhh-----hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 925 SLSRWVNDLL---PISVMEVID-----TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 925 ~l~~~~~~~~---~~~~~~~~d-----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+........ +....+..+ +..................++.+++.+|++.+|++|||+.|++..
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111000 000000000 000000000001111224568899999999999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=268.63 Aligned_cols=252 Identities=20% Similarity=0.238 Sum_probs=182.3
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEec
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-RALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
|+..+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999976 488999999875432 12234567999999999 999999999999999999999999
Q ss_pred CCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccc
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~ 871 (1007)
+|+|.+++.... ..+++..+..++.|++.||.|| |+.+++|+++ .+|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 4689999999999999999999 5678999865 38999999987643222
Q ss_pred ccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC----ccHH------H
Q 001838 872 MQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP----ISVM------E 940 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----~~~~------~ 940 (1007)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||......+ .......... .... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 123468889999998754 457999999999999999999999986532111 1111100000 0000 0
Q ss_pred Hhhhhhccchhh-hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 941 VIDTNLLSGEER-YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 941 ~~d~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.++......... .....+....++.+++.+|++.+|++|||+.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 000011113568999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=260.10 Aligned_cols=263 Identities=20% Similarity=0.268 Sum_probs=196.6
Q ss_pred ccccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-C-C----ceeE
Q 001838 714 RRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-H-R----NLVK 786 (1007)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~ 786 (1007)
..+...|.. +++|.+...+|+|.||+|-.+... .+..||||+++.. .+..++.+-|++++.++. + | -+|+
T Consensus 79 ~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 344444544 678999999999999999999865 4789999999865 345577888999999994 2 3 3889
Q ss_pred EEEEEecCCeeEEEEEecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 787 IISACSNDDFKALIMEYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 787 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
+.+||.-.++.++|+|.+ |-|++++|..+ -..++...+..|+.|++++++|| |+.+++|-|++
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceE
Confidence 999999999999999998 45999999874 35688999999999999999999 78889997543
Q ss_pred --------------------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 001838 854 --------------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913 (1007)
Q Consensus 854 --------------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~ 913 (1007)
||+|||-|.+..... +..+.|..|+|||++.+-.++.++||||+||||+|+.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 689999999865432 4567899999999999999999999999999999999999
Q ss_pred CCCCcccc-CcchHHHHHHhhcCccHHHHh------hhh---------------h---ccchhhhHHHHHHHHHHHHHHH
Q 001838 914 KPTDEIFI-GELSLSRWVNDLLPISVMEVI------DTN---------------L---LSGEERYFAAKEQSLLSILNLA 968 (1007)
Q Consensus 914 ~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~------d~~---------------~---~~~~~~~~~~~~~~~~~~~~l~ 968 (1007)
.-|+.-.. +...+.+-+-.-.|..+.... ... . .......+.....+..++++|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 98874221 111122211111111111111 000 0 0001111122334456799999
Q ss_pred hhcCCCCCCCCCCHHHHHHH
Q 001838 969 TECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 969 ~~cl~~~p~~Rpt~~evl~~ 988 (1007)
++|+.+||.+|+|++|++.+
T Consensus 387 ~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHccCccccccHHHHhcC
Confidence 99999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=272.87 Aligned_cols=259 Identities=22% Similarity=0.231 Sum_probs=182.2
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 589999999864321 12245678999999999999999999875433
Q ss_pred --eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecc
Q 001838 796 --FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIA 861 (1007)
Q Consensus 796 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla 861 (1007)
..++||||+++ ++.+.+......+++..+..++.|+++||+|| |+.+|+|+++ .|++|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999975 78777766555689999999999999999999 5778999976 389999999
Q ss_pred eecCCCCcc---------cccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 001838 862 KFLNGQDQL---------SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 862 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~ 931 (1007)
+........ ...+...|++.|+|||++.+. .++.++|||||||++|||++|++||.+..... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 865432111 111234578899999987654 58999999999999999999999997532211 1111111
Q ss_pred hhc--CccHH-------HHhhhhhccc-hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 932 DLL--PISVM-------EVIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 932 ~~~--~~~~~-------~~~d~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
... +.... ...+...... ..............+.+++.+|++.||++|||+.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000 00000 0000000000 000000111123568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=291.65 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=174.8
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSND-------- 794 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 794 (1007)
..+|+..+.+|+||||.||+++.+ ||+.+|||++.... .+......+|+.++++++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356777889999999999999977 89999999997543 34456688999999999999999976544110
Q ss_pred --------------------------------------------------------------------------------
Q 001838 795 -------------------------------------------------------------------------------- 794 (1007)
Q Consensus 795 -------------------------------------------------------------------------------- 794 (1007)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 001838 795 -------------------------------DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843 (1007)
Q Consensus 795 -------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~ 843 (1007)
...||-||||+.-.+++++++....-.....++++.+|+.||.|+ |
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI---H 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI---H 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH---H
Confidence 013788999999888888876553224667889999999999999 7
Q ss_pred CCCceecccc------------ccceeecceecC----------------CCCcccccccccCCcccccccccccC---C
Q 001838 844 STPIIHYMVA------------HISDFSIAKFLN----------------GQDQLSMQTQTLATIGYMAPEYGVQG---R 892 (1007)
Q Consensus 844 ~~~ivH~~~~------------kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~ 892 (1007)
+.+|||||++ ||+|||+|+... ........++.+||.-|+|||++.+. +
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 8889999875 999999998721 01111234667899999999998764 4
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcC
Q 001838 893 VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECT 972 (1007)
Q Consensus 893 ~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 972 (1007)
|+.|+|+||+|||++||+. ||... +..+....... +..+... ..........-..++.+++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR--------~g~iP~~----~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLR--------KGSIPEP----ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcc--------cCCCCCC----cccccccchHHHHHHHHHh
Confidence 9999999999999999984 55431 11111111111 1111000 0001111234567889999
Q ss_pred CCCCCCCCCHHHHHH
Q 001838 973 IESPGKRINAREIVT 987 (1007)
Q Consensus 973 ~~~p~~Rpt~~evl~ 987 (1007)
+.||.+||||.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=269.83 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=183.9
Q ss_pred cccccceecccCceEEEEEEEc----CCceEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY----ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 797 (1007)
+|+..+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++.++ +||||+++++++..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999999743 57889999987532 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~ 865 (1007)
++||||+++|+|.+++.... .+++.....++.|+++||+|| |..+++|+++ .+++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987643 478888999999999999999 4678999965 3899999998764
Q ss_pred CCCcccccccccCCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 866 GQDQLSMQTQTLATIGYMAPEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 866 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
..... ......|+..|+|||...+.. ++.++||||||+++|||++|+.||..... ......+.... ..
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~--------~~ 226 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRI--------LK 226 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHH--------Hc
Confidence 33211 112346889999999887654 78899999999999999999999863211 10111111110 00
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~ 991 (1007)
. . . +.+......+.+++.+||+.+|++|||+++|.+.|.-
T Consensus 227 ~-~----~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 S-K----P---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred c-C----C---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 0 0 0011123467899999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=267.29 Aligned_cols=246 Identities=18% Similarity=0.175 Sum_probs=170.4
Q ss_pred ccccccceecccCceEEEEEEEcC----CceEEEEEechhhHHH-----------HHHHHHHHHHHHhcCCCceeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRYERA-----------LKSFQDECEVMKRIRHRNLVKIISA 790 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~~ 790 (1007)
++|...+.||+|+||+||+|...+ +..+|+|+........ ......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998754 4466777543221100 0112233445566789999999998
Q ss_pred EecCC----eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------c
Q 001838 791 CSNDD----FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------H 854 (1007)
Q Consensus 791 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------k 854 (1007)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|| |+.+|+|||++ +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcEE
Confidence 76543 45788888753 6666665432 356778889999999999999 57799999874 8
Q ss_pred cceeecceecCCCCcc-----cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHH
Q 001838 855 ISDFSIAKFLNGQDQL-----SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW 929 (1007)
Q Consensus 855 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~ 929 (1007)
|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||........ ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHH
Confidence 9999999876422111 111234699999999999988999999999999999999999999986422111 1110
Q ss_pred HHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 930 VNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 930 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.. .+.+.. +..... ....++.++.+++..|+..+|++||++.++.+.+
T Consensus 246 ~~-------~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AK-------CDFIKR-LHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hH-------HHHHHH-hhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00 001000 000000 0112245689999999999999999999999876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=264.70 Aligned_cols=240 Identities=24% Similarity=0.309 Sum_probs=181.7
Q ss_pred cccccceecccCceEEEEEEE----cCCceEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 001838 727 RFSKNNLLGIGSFGSVYVARL----QDGMEVAVKVFHQRY----ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 797 (1007)
+|+..+.||+|+||.||+|+. .+|..||+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367789999999999999986 368899999997532 22346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecC
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~ 865 (1007)
|+||||+++|+|.+++.... .+++.....++.|+++||.|| |+.+++|+++ .||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999997653 478888888999999999999 5788999966 3899999998764
Q ss_pred CCCcccccccccCCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 866 GQDQLSMQTQTLATIGYMAPEYGVQG--RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 866 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.... .......|+..|+|||++... .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~------- 227 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKS------- 227 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhcc-------
Confidence 3221 112235688999999998753 478899999999999999999999863211 11111111111000
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.. +.+......+.+++.+|++.+|++|| ++.++++.
T Consensus 228 -----~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 00111234678999999999999997 66777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=277.61 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=196.0
Q ss_pred ccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec
Q 001838 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN 793 (1007)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 793 (1007)
..++-+...++-|.+.++||.|.||.||+++.. +|+.+|||+...... ..++...|.++++.. .|||++.++|+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555566788999999999999999999854 689999999876543 235677889999988 59999999999863
Q ss_pred -----CCeeEEEEEecCCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------cc
Q 001838 794 -----DDFKALIMEYMPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HI 855 (1007)
Q Consensus 794 -----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl 855 (1007)
++..|||||||.+||..++++.- +..++|..+..|.+.+++|+.+| |...++|||++ |+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEE
Confidence 56899999999999999999742 34688999999999999999999 78889999875 89
Q ss_pred ceeecceecCCCCcccccccccCCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 001838 856 SDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG-----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWV 930 (1007)
Q Consensus 856 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~ 930 (1007)
+|||.+..+... .....+.+||+.|||||++... .|+.++|+||+|++..||.-|.+|+.++....
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 999999877432 2223456899999999998643 47889999999999999999999987643211
Q ss_pred HhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 931 NDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 931 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+-... +........++...+++.+++..|+..|-++||++.+++++
T Consensus 236 ----------aLF~Ip-RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ----------ALFLIP-RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------hhccCC-CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 000000 11111222345667889999999999999999999998865
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=269.00 Aligned_cols=256 Identities=21% Similarity=0.224 Sum_probs=179.8
Q ss_pred cccccceecccCceEEEEEEEc-C--CceEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC----Ce
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-D--GMEVAVKVFHQRY--ERALKSFQDECEVMKRI-RHRNLVKIISACSND----DF 796 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 796 (1007)
+|...+.||+|+||.||+|+.. + +..||||++.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999865 3 7789999987432 22346788899999999 499999999875432 45
Q ss_pred eEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceec
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~ 864 (1007)
.|+++||+. ++|.+++.... .+++..+..++.|++.||+|| |+.+|+|+|+ +||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 789999986 68999886543 588999999999999999999 5778999975 389999999876
Q ss_pred CCCCcc--cccccccCCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh--cCcc-H
Q 001838 865 NGQDQL--SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL--LPIS-V 938 (1007)
Q Consensus 865 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~--~~~~-~ 938 (1007)
...... .......||..|+|||+..+ ..++.++||||+||++|||++|+.||....... .+...+... .+.. .
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 432211 11233568999999998765 468999999999999999999999987532110 011111100 0000 0
Q ss_pred HHHhhhh-------hccch-hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 939 MEVIDTN-------LLSGE-ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 ~~~~d~~-------~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....++. ..... .......+.....+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000 00000011123568999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=267.81 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=187.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 800 (1007)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999876 69999999997532 234467889999999998 99999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~ 868 (1007)
|||+++++|.+++.+.. .+++..+..++.|++.||.|| |+.+++|+++ .+++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999997654 589999999999999999999 5678999866 3899999998764322
Q ss_pred cc------------------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 001838 869 QL------------------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWV 930 (1007)
Q Consensus 869 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~ 930 (1007)
.. .......|+..|+|||+.....++.++||||||++++|+++|+.||..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~--- 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTF--- 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHH---
Confidence 10 111234578899999998888899999999999999999999999975321 0000
Q ss_pred HhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCH----HHHHH
Q 001838 931 NDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINA----REIVT 987 (1007)
Q Consensus 931 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~----~evl~ 987 (1007)
....+... ..+......+.+++.+||+.+|++||++ .|+++
T Consensus 232 --------~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --------QKILKLEY--------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------HHHHhcCC--------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000000 0011123468899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=291.01 Aligned_cols=134 Identities=26% Similarity=0.401 Sum_probs=117.8
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.++|...+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357889999999999999999976 68999999997542 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
|||+++|+|.+++.... .+++..+.+|+.||+.||+||| ..+|+|||++ ||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997543 4788889999999999999995 5689999764 899999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=265.07 Aligned_cols=253 Identities=24% Similarity=0.257 Sum_probs=185.4
Q ss_pred ccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 728 FSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999876 48999999997653 333467788999999999999999999999999999999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccc
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~ 872 (1007)
+ ++|.+++.+....+++..+.+++.|++.|++||| +.+|+|+++ +||+|||.++....... .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 8 5999999876456899999999999999999994 678999865 48999999987643221 1
Q ss_pred cccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcC---ccHHHHh------
Q 001838 873 QTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP---ISVMEVI------ 942 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~~~~~------ 942 (1007)
.....++..|+|||.+... .++.++|||||||++|||++|+.||..... ......+..... ......+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 2234567889999998776 789999999999999999999999865321 111111111100 0000000
Q ss_pred hhhhccchh-hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLLSGEE-RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+........ ......+....++.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0000111124578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-29 Score=256.21 Aligned_cols=236 Identities=23% Similarity=0.291 Sum_probs=181.8
Q ss_pred HHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q 001838 718 YHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACS 792 (1007)
Q Consensus 718 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 792 (1007)
-.+..+++ +|....+||+|+||+|..|.-+ +.+.+|||++++.. ....+--+.|-++|.-- +-|.+|++..+|.
T Consensus 342 ~~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 342 KRDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred cccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 33444444 6888999999999999999765 46789999997653 22234445677777765 5789999999999
Q ss_pred cCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 793 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
.-+..|.||||+.||+|--++.+-+ .+.+..+.-+|.+||-||-|| |+++|+.||++ ||+|||+
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeeccc
Confidence 9999999999999999988887543 366777888999999999999 89999999774 8999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHH
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 940 (1007)
++.---+. .++.+.+||+.|+|||.+...+|+..+|+|||||+||||+.|++||++...++ +-+ .
T Consensus 497 cKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~-----------a 561 (683)
T KOG0696|consen 497 CKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ-----------A 561 (683)
T ss_pred ccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH-----------H
Confidence 98643222 23456799999999999999999999999999999999999999999743221 111 1
Q ss_pred HhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001838 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN 981 (1007)
Q Consensus 941 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 981 (1007)
+.+... ..+...+.++.++....+...|.+|..
T Consensus 562 I~ehnv--------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEHNV--------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHccC--------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111111 112223556788888889999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=232.95 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=194.9
Q ss_pred hcccccccceecccCceEEEEEE-EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC--eeEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDD--FKAL 799 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~l 799 (1007)
..++|++.+.+|+|.|++||.|. ..+.+.++||++++... +.+.+|+.+|..++ |||||++++...++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35689999999999999999997 44678899999987654 55788999999998 999999999988754 5789
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNG 866 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~ 866 (1007)
|+||+.+-+....... +...++..++.+++.||.|+ |+.||+|||++ +++|+|+|.+..+
T Consensus 113 iFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999877665532 66677888999999999999 89999999986 6999999999877
Q ss_pred CCcccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhh
Q 001838 867 QDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 867 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
..++. ..+.+..|.-||.+... .|+..-|+|||||++.+|+..+.||.........+++.++-....++...+++.
T Consensus 186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 65553 24567889999988764 589999999999999999999999987655555566555544433333333221
Q ss_pred hcc---------------chhhhHHH--HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 946 LLS---------------GEERYFAA--KEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 946 ~~~---------------~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
-.. ........ ..-...++++++.+.+.+|..+||||+|++.+
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111 00000000 00112578999999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=249.62 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=182.8
Q ss_pred cccccHHHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEE
Q 001838 713 IRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIIS 789 (1007)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~ 789 (1007)
...|+-++++. ...||.|+||+|+|-.++ .|+..|||+++... ++..+++..|.++..+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 44566555543 577999999999999866 69999999998654 46668899999877666 5999999999
Q ss_pred EEecCCeeEEEEEecCCCChhHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------
Q 001838 790 ACSNDDFKALIMEYMPNGSLENRLYS----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 790 ~~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------ 853 (1007)
++..++..|+.||.|+- |++.+.+. ....+++.-.-.|+.-.+.||+||. ....|||||++
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCE
Confidence 99999999999999964 77654432 2345777777778888899999996 45679999885
Q ss_pred ccceeecceecCCCCcccccccccCCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ--GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN 931 (1007)
Q Consensus 854 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~ 931 (1007)
|+||||++..+.+. ...+..+|...|||||.+.. ..|+.++||||+|++|||++||+.||.....
T Consensus 208 KLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------- 274 (361)
T KOG1006|consen 208 KLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------- 274 (361)
T ss_pred eeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------
Confidence 99999999876432 22355679999999998864 3599999999999999999999999985311
Q ss_pred hhcCccHHHHhhhhhccchhhhHHHH---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 932 DLLPISVMEVIDTNLLSGEERYFAAK---EQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 932 ~~~~~~~~~~~d~~~~~~~~~~~~~~---~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+.+.+......... ....+ -+....+.+++..|+..|-++||...++.+.
T Consensus 275 ------vfeql~~Vv~gdpp-~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 ------VFEQLCQVVIGDPP-ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------HHHHHHHHHcCCCC-eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111111110000 00000 1124568899999999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=223.61 Aligned_cols=257 Identities=19% Similarity=0.218 Sum_probs=185.0
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.+|+..++||+|.||+||+|+.. +++.||+|+++-.. +.......+|+.+++.++|+|||+++++...+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777889999999999999865 58899999987443 3334678899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||.. +|..+...-.+.++......++.|+.+|+.|+ |+..+.|||++ |++|||+|+...-. .
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgip--v 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence 9965 88888887777799999999999999999999 67789999775 89999999976422 1
Q ss_pred cccccccCCcccccccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCccccCc-chHHHHHHhhcCc----cHHHHhh
Q 001838 871 SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFT-GKKPTDEIFIGE-LSLSRWVNDLLPI----SVMEVID 943 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~-~~l~~~~~~~~~~----~~~~~~d 943 (1007)
...+..+-|.+|.+|.++.+.+ |++..|+||-|||+.|+.. |++-|.+...++ .....|.-....+ .+...-|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2224456789999999988865 8999999999999999986 666665432221 1111122111111 0111111
Q ss_pred hhhccchhhh---HHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERY---FAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
-......... ....+.....-.+++.+.+.-+|.+|.++.++++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111000000 00111112234677778888899999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=284.98 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=190.5
Q ss_pred HHHHHhcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Q 001838 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSND 794 (1007)
Q Consensus 719 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 794 (1007)
.++....++|.+.++||+|+||.|..++++ +++.+|.|++.+.. ......|..|-++|..-..+=||.++.+|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455556788999999999999999999876 58899999998743 23346789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
.+.|+|||||+||+|-.++.+.. .++...+..|+..|+-||+-+ |+.|+||||++ |++|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999998776 688887888999999999999 78999999886 899999998
Q ss_pred ecCCCCcccccccccCCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCcc
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQ-----GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS 937 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 937 (1007)
.+..+.. ......+|||-|++||++.. +.|++.+|+||+||++|||+.|..||... .++.-.....
T Consensus 224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm--- 294 (1317)
T KOG0612|consen 224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM--- 294 (1317)
T ss_pred hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh---
Confidence 7764332 33456789999999998752 57999999999999999999999999742 1221111111
Q ss_pred HHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHH
Q 001838 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN---AREIVTG 988 (1007)
Q Consensus 938 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt---~~evl~~ 988 (1007)
+ ......++.....+.+..+|+.+.+. +|+.|.. +.|+-.+
T Consensus 295 -----~----hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 -----N----HKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -----c----hhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 0 00000111112234567777776654 4777776 7777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=265.62 Aligned_cols=228 Identities=23% Similarity=0.272 Sum_probs=182.1
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++.|.....+|.|+|+.|-++... +++..|||++.+.. .+..+|+.++... +||||+++.+.|.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777788999999999999855 68899999998662 3345788777777 59999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceecCCCCc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~~~~~~ 869 (1007)
++.||-+.+.+..... .. ..+..|+.+++.|+.|| |+++|||||++ +|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999998888876543 22 56777999999999999 56899999764 79999999987643
Q ss_pred ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccc
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 949 (1007)
..+.+-|..|.|||+.....|++++||||+||+||||++|+.||.....+ . +..........
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~---ei~~~i~~~~~----------- 531 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I---EIHTRIQMPKF----------- 531 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H---HHHHhhcCCcc-----------
Confidence 12346688999999999899999999999999999999999999854322 1 11111111110
Q ss_pred hhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
....+..+.+|+.+||+.||.+||+|.|+...
T Consensus 532 -------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 -------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12345678999999999999999999999765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=252.77 Aligned_cols=224 Identities=27% Similarity=0.342 Sum_probs=177.2
Q ss_pred ecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCCh
Q 001838 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
||+|+||.||++... +++.||+|++.... ....+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 58999999987543 22456789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccccccc
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
.+++.... .+++.....++.|++.|+.|+| +.+++|+++ ++++|||.+........ ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 99997654 4889999999999999999994 688999865 37999999987643321 123456
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
++..|+|||...+..++.++|+||||+++||+++|+.||..... ....+.+. .... ..+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~-----------~~~~--------~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKIL-----------KDPL--------RFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHh-----------cCCC--------CCC
Confidence 88899999998888889999999999999999999999965321 11111110 0000 000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRINARE 984 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt~~e 984 (1007)
.....++.+++.+|+..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-29 Score=240.96 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=182.9
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--------
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSND-------- 794 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 794 (1007)
..|.....||+|.||+||+|+.+ +|+.||+|++-... +..-....+|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999865 58889998764322 22334568999999999999999999888542
Q ss_pred CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecce
Q 001838 795 DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 795 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~ 862 (1007)
...|+||++|+. +|...|......++..++.+++.++..||.|+ |+..|+|||++ |++|||+|+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 358999999987 89988887766788999999999999999999 78899999764 899999998
Q ss_pred ecCCCCc--ccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh------
Q 001838 863 FLNGQDQ--LSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL------ 933 (1007)
Q Consensus 863 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~------ 933 (1007)
.....+. ....+..+-|.+|++||.+.+. .|+++.|||+-|||+.||.||.+-+++..... ....+...
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq--ql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ--QLHLISQLCGSITK 250 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH--HHHHHHHHhccCCc
Confidence 7643222 1223444569999999998875 59999999999999999999998776532211 11111111
Q ss_pred --cCc----cHHHHhhhh-hccchhhhHHHHHHHH------HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 934 --LPI----SVMEVIDTN-LLSGEERYFAAKEQSL------LSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 934 --~~~----~~~~~~d~~-~~~~~~~~~~~~~~~~------~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.|+ .+.+.+... +..+. ....++.. .+.++++..++..||.+|+++.+++.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~---~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQ---KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcch---hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111 111222100 00000 00111112 268899999999999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=247.60 Aligned_cols=209 Identities=18% Similarity=0.118 Sum_probs=162.8
Q ss_pred cCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhhhc
Q 001838 737 GSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS 815 (1007)
Q Consensus 737 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 815 (1007)
|.||+||+++.. +|+.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 68999999997643 233455555666799999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccCCcccc
Q 001838 816 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYM 883 (1007)
Q Consensus 816 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 883 (1007)
.. .+++..+..++.|++.||+|| |+.+|+|+|++ +++|||.+...... .....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 54 488999999999999999999 57889999774 89999988765422 12334677899
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHH
Q 001838 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLS 963 (1007)
Q Consensus 884 aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 963 (1007)
|||......++.++||||+||++|||++|+.|++....... ...... .+.....+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~~~----------~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTTLN----------IPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccccC----------CcccCCHH
Confidence 99998888899999999999999999999988753211000 000000 00112346
Q ss_pred HHHHHhhcCCCCCCCCCCHHH
Q 001838 964 ILNLATECTIESPGKRINARE 984 (1007)
Q Consensus 964 ~~~l~~~cl~~~p~~Rpt~~e 984 (1007)
+.+++.+|++.||++||++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 889999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=253.67 Aligned_cols=290 Identities=20% Similarity=0.204 Sum_probs=181.7
Q ss_pred cEEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccC-cccCCcchhhhhhcCCCCeecc
Q 001838 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD-NQLFGSLSSFIFNMSSMLGIDL 147 (1007)
Q Consensus 69 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~LdL 147 (1007)
..+.++|..|+|+.+.+.+|..+++|+.||||+|+|+.+-|.+|.+|++|..|-+.+ |+|+......|.+|++|+-|++
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456666666666665556666666666666666666666666666666665555444 6666666666666666666666
Q ss_pred cCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCC
Q 001838 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG 227 (1007)
Q Consensus 148 s~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1007)
.-|++. -++...|..+++|..|.|..|.+..+--.+|..+..++.+.+..|.+- ...+++.+... ..
T Consensus 148 Nan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-------~a 214 (498)
T KOG4237|consen 148 NANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-------LA 214 (498)
T ss_pred Chhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-------Hh
Confidence 666665 555555566666666666666665333335666666666666655432 11222222111 11
Q ss_pred CCCcccCCccccceeeccCccccccccccccCC-CCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccc
Q 001838 228 EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNM-STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI 306 (1007)
Q Consensus 228 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 306 (1007)
..|.+++...-..-..+.++++..+.+..|..- .++..=..++....+..|..-|..+++|+.|+|++|+|+++-+.+|
T Consensus 215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 233345555555555566666655555444321 1221111122223356677777788888888888888888888888
Q ss_pred cccCCCCEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCC
Q 001838 307 TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376 (1007)
Q Consensus 307 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~ 376 (1007)
..+.+++.|.|..|+|..+....|.++..|+.|+|.+|+|+...|. .|..+..|.+|.|-.|++.
T Consensus 295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~-----aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG-----AFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc-----cccccceeeeeehccCccc
Confidence 8888888888888888877777788888888888888888876654 4666677777777777664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=271.05 Aligned_cols=248 Identities=22% Similarity=0.238 Sum_probs=159.6
Q ss_pred hcccccccceecccCceEEEEEEEc-C----CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEE------Ee
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-D----GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISA------CS 792 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 792 (1007)
..++|...+.||+|+||+||+|++. + +..||||++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999875 4 689999998643221 111111 1222223333322221 24
Q ss_pred cCCeeEEEEEecCCCChhHhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc
Q 001838 793 NDDFKALIMEYMPNGSLENRLYSGTCM-------------------LDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA 853 (1007)
Q Consensus 793 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~ 853 (1007)
.+...++||||+++|+|.+++...... .....+..++.|++.||+|| |+.+|+|||++
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence 556789999999999999998754211 11233557899999999999 56799999764
Q ss_pred -------------ccceeecceecCCCCcccccccccCCcccccccccccC----------------------CCCchhh
Q 001838 854 -------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG----------------------RVSTRGD 898 (1007)
Q Consensus 854 -------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 898 (1007)
||+|||+|+.+...... ......|++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 89999999876433222 22345789999999965322 2455779
Q ss_pred HHHHHHHHHHHHhCCCCCCcccc--------CcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhh
Q 001838 899 VYSYGIMLMETFTGKKPTDEIFI--------GELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATE 970 (1007)
Q Consensus 899 vwS~Gvil~elltG~~p~~~~~~--------~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~ 970 (1007)
||||||++|||+++..|++.... .+.....|.....+. ....................+|+.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR---------ASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc---------cchhhhhhhhhccccchHHHHHHHH
Confidence 99999999999998877653210 011122232211110 0000000000001112245689999
Q ss_pred cCCCCCCCCCCHHHHHHH
Q 001838 971 CTIESPGKRINAREIVTG 988 (1007)
Q Consensus 971 cl~~~p~~Rpt~~evl~~ 988 (1007)
|++.||++|||++|++++
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=261.93 Aligned_cols=246 Identities=19% Similarity=0.208 Sum_probs=168.0
Q ss_pred hcccccccceecccCceEEEEEEE-----------------cCCceEEEEEechhhHHHHH--------------HHHHH
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARL-----------------QDGMEVAVKVFHQRYERALK--------------SFQDE 772 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~--------------~~~~E 772 (1007)
..++|+..++||+|+||+||+|.. ..++.||||++........+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 23568999998643322222 23457
Q ss_pred HHHHHhcCCCce-----eEEEEEEec--------CCeeEEEEEecCCCChhHhhhcCC----------------------
Q 001838 773 CEVMKRIRHRNL-----VKIISACSN--------DDFKALIMEYMPNGSLENRLYSGT---------------------- 817 (1007)
Q Consensus 773 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------- 817 (1007)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 677888753 346899999999999999986421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccCCccccc
Q 001838 818 -CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884 (1007)
Q Consensus 818 -~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 884 (1007)
..+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+++........ ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 1245677888999999999999 56789999764 89999999765432211 1122345889999
Q ss_pred ccccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCccccCc-------chHHHHHHhhc
Q 001838 885 PEYGVQGR--------------------V--STRGDVYSYGIMLMETFTGKK-PTDEIFIGE-------LSLSRWVNDLL 934 (1007)
Q Consensus 885 PE~~~~~~--------------------~--~~~~DvwS~Gvil~elltG~~-p~~~~~~~~-------~~l~~~~~~~~ 934 (1007)
||.+.... | ..+.||||+||++|||++|.. |+.....-. ..+..|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 235799999999999999975 665321111 11112211000
Q ss_pred CccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCC---CCCCCHHHHHHH
Q 001838 935 PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESP---GKRINAREIVTG 988 (1007)
Q Consensus 935 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p---~~Rpt~~evl~~ 988 (1007)
....+...........+++.+++..+| .+|+|++|++++
T Consensus 459 ---------------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 ---------------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---------------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000011111224568899999999766 689999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=234.93 Aligned_cols=236 Identities=19% Similarity=0.292 Sum_probs=184.7
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 799 (1007)
.++|+..++||+|+|++|..++++ +.+.+|+|++++.- .+..+..+.|-.+..+. +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999865 67889999998653 34456677888888877 59999999999999999999
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
|.||++||+|--++.+++ .++++.+..+..+|.-||.|| |+.+|+.||++ |++|+|.++.--.+
T Consensus 329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999988887654 488888888999999999999 78999999775 89999999864322
Q ss_pred CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--CcchHHHHHHhhcCccHHHHhhhh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFI--GELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~d~~ 945 (1007)
...+++.+||+.|+|||.+.+..|...+|+|++||+++||+.|+.||+-... .+.+..++.-+. ++..+
T Consensus 405 --gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------ilekq 475 (593)
T KOG0695|consen 405 --GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------ILEKQ 475 (593)
T ss_pred --CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-------Hhhhc
Confidence 2334678999999999999999999999999999999999999999984321 222222222111 11111
Q ss_pred hccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN 981 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 981 (1007)
+. .+...+.+...+++.-+..||.+|..
T Consensus 476 ir--------iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 IR--------IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cc--------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 12223445677788889999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=266.88 Aligned_cols=233 Identities=24% Similarity=0.365 Sum_probs=178.5
Q ss_pred ccccceecccCce-EEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEecC
Q 001838 728 FSKNNLLGIGSFG-SVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 728 ~~~~~~ig~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
|...+++|.|+-| .||+|.+. |++||||++-... .....+|+..|+.-+ |||||++++.-.++.+.||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4556788999888 57999986 8999999986543 345678999999884 9999999999999999999999997
Q ss_pred CCChhHhhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------------ccceeecceecC
Q 001838 806 NGSLENRLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------------HISDFSIAKFLN 865 (1007)
Q Consensus 806 ~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------------kl~DFGla~~~~ 865 (1007)
. +|++++..... .......+.+..|++.||++| |+-+|||||++ +|+|||++|.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999986411 111134567889999999999 67899999763 799999999987
Q ss_pred CCCc-ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCcchHHHHHHhhcCccHHHHhh
Q 001838 866 GQDQ-LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTG-KKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 866 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d 943 (1007)
.+.. ........||-||+|||.+....-+.++||+|+|||+|+.++| ..||.+....+.++.. .. ..+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~~--~~L~---- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---GN--YTLV---- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---Cc--ccee----
Confidence 5433 2334567899999999999988888899999999999999986 9999864332222111 00 0000
Q ss_pred hhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+ ...+++ ++.+|+.+|+.++|..||+|.+|+.+
T Consensus 734 -~L--------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 -HL--------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -ee--------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00 000111 68899999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=238.55 Aligned_cols=226 Identities=29% Similarity=0.379 Sum_probs=177.9
Q ss_pred CceEEEEEEEc-CCceEEEEEechhhHHH-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhhhc
Q 001838 738 SFGSVYVARLQ-DGMEVAVKVFHQRYERA-LKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS 815 (1007)
Q Consensus 738 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 815 (1007)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654333 57899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCcccccccccCCcccc
Q 001838 816 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883 (1007)
Q Consensus 816 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 883 (1007)
... +++..+..++.++++++.||| ..+++|+++ .+++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 543 788999999999999999994 568999865 4799999999875432 123456888999
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHH
Q 001838 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLS 963 (1007)
Q Consensus 884 aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 963 (1007)
|||......++.++||||||+++||+++|..||.... ......++....... ... .......+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~------------~~~----~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP------------FPP----PEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC------------Ccc----ccccCCHH
Confidence 9999888889999999999999999999999987521 111111111110000 000 00002346
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHH
Q 001838 964 ILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 964 ~~~l~~~cl~~~p~~Rpt~~evl~ 987 (1007)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=246.65 Aligned_cols=435 Identities=22% Similarity=0.275 Sum_probs=265.4
Q ss_pred CCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCee-cccCcccCCCCc
Q 001838 79 NLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLSINRFSGELP 157 (1007)
Q Consensus 79 ~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-dLs~N~l~~~ip 157 (1007)
+++ .+|..+. ..-..++|..|.|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++.+|..| ++++|+|+ .+|
T Consensus 57 GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~ 132 (498)
T KOG4237|consen 57 GLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLP 132 (498)
T ss_pred Ccc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhh
Confidence 344 4565554 256789999999999999999999999999999999999999999999998777 45559998 899
Q ss_pred hhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCcc
Q 001838 158 ANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLP 237 (1007)
Q Consensus 158 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 237 (1007)
.+.|.+|..|+.|.+.-|++.-+..++|..+++|..|.|..|.+..+--.+|..+..++++.+..|.+- ..++++
T Consensus 133 k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~ 207 (498)
T KOG4237|consen 133 KGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLP 207 (498)
T ss_pred hhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccc
Confidence 999999999999999999999888889999999999999999998544458888999999998888754 245555
Q ss_pred ccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCc-cccccCCCCEEE
Q 001838 238 YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS-SITNASKLTVFQ 316 (1007)
Q Consensus 238 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 316 (1007)
.+... +.. .|..++......-..+.++++...-+..+...+..+..-..+....-+.-|. .|..+++|+.|+
T Consensus 208 wla~~-~a~------~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln 280 (498)
T KOG4237|consen 208 WLADD-LAM------NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN 280 (498)
T ss_pred hhhhH-Hhh------chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence 55432 222 2333444444444555555552222222222222221111222222233333 256666777777
Q ss_pred ecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceeeec
Q 001838 317 LRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMF 396 (1007)
Q Consensus 317 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~ 396 (1007)
|++|+++++-+.+|.++..+++|+|..|+|....
T Consensus 281 lsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~---------------------------------------------- 314 (498)
T KOG4237|consen 281 LSNNKITRIEDGAFEGAAELQELYLTRNKLEFVS---------------------------------------------- 314 (498)
T ss_pred cCCCccchhhhhhhcchhhhhhhhcCcchHHHHH----------------------------------------------
Confidence 7777777666666666666666666666654311
Q ss_pred cccccccCChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCc-hhhhcccccceeecccccccCC
Q 001838 397 NCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP-DEICHLAKLDKLILHGNKFSGA 475 (1007)
Q Consensus 397 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 475 (1007)
...|.+++.|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+---.- .++.. .|..+.-. .
T Consensus 315 --------~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~-~ 378 (498)
T KOG4237|consen 315 --------SGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVV-G 378 (498)
T ss_pred --------HHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCC-C
Confidence 1245667777778888888887778888888888888877776631100 11111 12223311 2
Q ss_pred CCCCCCCcccCceeecCCcccc---cCCCcccccccccccccCCCCCcCCCCccccccccccce-EeCccccCCCCcccc
Q 001838 476 IPSCSGNLTSLRALYLGSNRFT---SALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE-LNLSRNNLSGDIPIT 551 (1007)
Q Consensus 476 ~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~ 551 (1007)
.|.+- .-..++.+.++.+.+. ...|+...-. -++.-|... +.+.+ ...|++.++ .+|..
T Consensus 379 ~~~Cq-~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~cP~~c---~c~~tVvRcSnk~lk-~lp~~ 441 (498)
T KOG4237|consen 379 NPRCQ-SPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPCPPPC---TCLDTVVRCSNKLLK-LLPRG 441 (498)
T ss_pred CCCCC-CCchhccccchhccccccccCCccccCCC------------CCCCCCCCc---chhhhhHhhcccchh-hcCCC
Confidence 22221 1112333444443332 1122211100 011112111 11111 223344443 34433
Q ss_pred ccCCCCccEEeccccccccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCC
Q 001838 552 IGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614 (1007)
Q Consensus 552 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N 614 (1007)
+. ..-+.|+|.+|.++ .+|.. .+.+| .+|+|+|+|+..--..|.++++|.+|-+|+|
T Consensus 442 iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 442 IP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 32 23456677777776 45555 45566 7777777777666667777777777777776
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=247.83 Aligned_cols=236 Identities=20% Similarity=0.300 Sum_probs=186.2
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
++..+..+|-||||.|=...... ...+|+|++++.. .+..+....|-.+|...+.|.||++|-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 34556779999999999888654 3358999887653 3455778899999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
-|-||.++..|++++ .++......++..+.+|++|| |+++||.||++ |+.|||+||.+......
T Consensus 501 aClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 999999999998765 477777778899999999999 78899999875 99999999998654332
Q ss_pred cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccch
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 950 (1007)
-+.+||+.|.|||++....++..+|.||+|+++|||++|.+||..... +..... +..-+|.
T Consensus 577 ---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~--------ILkGid~------ 637 (732)
T KOG0614|consen 577 ---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNL--------ILKGIDK------ 637 (732)
T ss_pred ---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHH--------HHhhhhh------
Confidence 357899999999999999999999999999999999999999986321 111110 0111111
Q ss_pred hhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt-----~~evl~~ 988 (1007)
...+........+++++.+..+|.+|.- +.||-++
T Consensus 638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 ---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1122334556788999999999999985 5555443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=233.25 Aligned_cols=122 Identities=22% Similarity=0.339 Sum_probs=102.2
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-----C---CceeEEEEEEecC-
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-----H---RNLVKIISACSND- 794 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~- 794 (1007)
..+|...++||-|-|++||+|.+. +.+.||+|+.+.. ....+....||++|++++ | .+||+|+++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 468999999999999999999865 5789999999864 344577889999999985 3 3699999999764
Q ss_pred ---CeeEEEEEecCCCChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 001838 795 ---DFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY 850 (1007)
Q Consensus 795 ---~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 850 (1007)
.+.+||+|+. |-+|..++.. ....++...+.+|+.||+.||.||| ...+|||.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHT 212 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHT 212 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCcccc
Confidence 4899999998 5588888864 3456899999999999999999999 55688995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=212.27 Aligned_cols=189 Identities=26% Similarity=0.270 Sum_probs=154.4
Q ss_pred ccccccceecccCceEEEEEEEc-CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEE
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
+.......||+|+||.|-+-++. +|+..|||++.... .+..++..+|+++..+. ..|.+|+++|.+.+....++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 44455678999999999888754 69999999997553 45557788899887665 69999999999999999999999
Q ss_pred ecCCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCC
Q 001838 803 YMPNGSLENRLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 803 ~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~ 867 (1007)
.|+. ||+.+.+ ..+..+++.-.=+||..|.+||.||| ....++|||++ |+||||++..+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9975 7776654 23456888888899999999999998 56689999885 99999999987543
Q ss_pred CcccccccccCCccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQ----GRVSTRGDVYSYGIMLMETFTGKKPTDEIF 920 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvil~elltG~~p~~~~~ 920 (1007)
- ..+-..|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+...
T Consensus 203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2 1233468889999998753 369999999999999999999999998743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=226.59 Aligned_cols=259 Identities=21% Similarity=0.275 Sum_probs=184.0
Q ss_pred cccceecccCceEEEEEEEc-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeEEE
Q 001838 729 SKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE--RALKSFQDECEVMKRIRHRNLVKIISACSNDD-----FKALI 800 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv 800 (1007)
+..+.||-|+||+||-.++. +|+.||.|++..... ...+++.+|++++.-++|.|+...++...... +.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999865 799999999875543 34578899999999999999999988776543 57889
Q ss_pred EEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCC
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~ 868 (1007)
.|.|.. +|...+.... .++...+.-+..||++||.|| |+.+|.|||++ ||||||+|+....++
T Consensus 136 TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999965 8888776544 467777777899999999999 78899999875 999999999765443
Q ss_pred cccccccccCCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh-
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL- 946 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~- 946 (1007)
. ...+..+-|.+|+|||.+.+. .|+.++||||.|||+.|++-++.-|+... .....+.+.+......+|.+....
T Consensus 211 ~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 R-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred h-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 3 233556678899999998875 49999999999999999998887776421 111222222222211112211111
Q ss_pred ------ccchhhhH--------HHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 947 ------LSGEERYF--------AAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 947 ------~~~~~~~~--------~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.+...+.+ ..+...-.+...+...++..||++|.+..+.+..+..=+.+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 00000000 00001122466777889999999999999998876543333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-26 Score=248.18 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=187.1
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
..++|.....+|+|.||.||||+.. .++..|||+++-.......-.+.|+-+++..+|||||.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3467888999999999999999965 689999999987655555667889999999999999999999999999999999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcc
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~ 870 (1007)
||.+|+|++..+- ...+++.++-.+.+...+|++|| |+.+-+|||++ |++|||.+..+... .
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence 9999999986654 34588888888999999999999 78888999875 89999998776432 1
Q ss_pred cccccccCCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhc
Q 001838 871 SMQTQTLATIGYMAPEYGV---QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 947 (1007)
.......||++|||||+.. .+.|..++|||+.|+...|+-.-++|-.+...... +. .+.. ...++.-.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l~-LmTk-------S~~qpp~l 237 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-LF-LMTK-------SGFQPPTL 237 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-HH-Hhhc-------cCCCCCcc
Confidence 2234578999999999753 46799999999999999999887877543211100 00 0000 00111000
Q ss_pred cchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..+......+.++++.|+..+|++|||+...+++
T Consensus 238 -------kDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 -------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred -------cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0111224568899999999999999999887653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=229.02 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=191.1
Q ss_pred HhcccccccceecccCceEEEEEEEc----CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCee
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFK 797 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 797 (1007)
...+.|..+++||+|.|++||+|.+. ..+.||+|.+.... ...+..+|+++|..+. |.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34557888999999999999999754 36789999987543 2356889999999996 99999999999999999
Q ss_pred EEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecceec
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFL 864 (1007)
Q Consensus 798 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~~~ 864 (1007)
.+|+||++.-...+++.. ++..++..+...+..||.|+ |..+|||||++ .|.|||+|...
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999988888865 66788888999999999999 78999999997 59999999721
Q ss_pred CCC-------C-------c-------------------c---------cccccccCCcccccccccccCC-CCchhhHHH
Q 001838 865 NGQ-------D-------Q-------------------L---------SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYS 901 (1007)
Q Consensus 865 ~~~-------~-------~-------------------~---------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS 901 (1007)
... . . + .......||+||.|||++...+ -++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 100 0 0 0 0001236999999999987754 688999999
Q ss_pred HHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHH---------------------hhh-------hhccchh--
Q 001838 902 YGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV---------------------IDT-------NLLSGEE-- 951 (1007)
Q Consensus 902 ~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---------------------~d~-------~~~~~~~-- 951 (1007)
.|||++-+++++.||.....+-..+.+.+....+..+... ... .+....+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999998766665555554433222111110 000 0000000
Q ss_pred -hhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 952 -RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 952 -~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
......+..+..+++++.+|+..||.+|.|++|++++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011111223368999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=220.35 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=185.2
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
..+|.....+|.|+- .|..|.+. .++.||+|++.... ....++..+|..++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999988 66666544 58999999886543 233467789999999999999999999997543
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeeccee
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~ 863 (1007)
..|+|||||. ++|.+.+.- .++-.....|..|++.|++|| |+.+|+|||++ ||.|||+|+.
T Consensus 95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcc
Confidence 5799999996 489888873 367778888999999999999 78999999764 9999999986
Q ss_pred cCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhc-----CccH
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-----PISV 938 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~-----~~~~ 938 (1007)
.... -+.+..+.|..|.|||++.+..|.+.+||||.||++.||++|+.-|. ++..+.+|.+... ..+.
T Consensus 168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHH
Confidence 5322 24567789999999999999889999999999999999999998776 3455566643221 1122
Q ss_pred HHHhhhhhcc-----------chhh---------hHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 939 MEVIDTNLLS-----------GEER---------YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 ~~~~d~~~~~-----------~~~~---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
++.+.+.... ...+ .....+-....+.+++.+||..+|++|.++++++++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 2222211100 0000 000011123457899999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=233.09 Aligned_cols=211 Identities=21% Similarity=0.343 Sum_probs=167.8
Q ss_pred ccHHHHHHh---cccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEE
Q 001838 716 FSYHELLQA---TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKII 788 (1007)
Q Consensus 716 ~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~ 788 (1007)
-.|-++++| ..-|..++.||-|+||+|.+++.. +...+|.|.+++.+ .........|-+||.....+=||+||
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 445555554 234777899999999999999744 57789999998765 23445677899999999999999999
Q ss_pred EEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccc
Q 001838 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HIS 856 (1007)
Q Consensus 789 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~ 856 (1007)
..|.+.+.+|+||||++||++-.+|-+-+ .+++..+..++.++..|+++. |..++||||++ |++
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeee
Confidence 99999999999999999999999886643 477777777888999999999 79999999886 899
Q ss_pred eeecceecC---------CCC---cc----------------------------cccccccCCcccccccccccCCCCch
Q 001838 857 DFSIAKFLN---------GQD---QL----------------------------SMQTQTLATIGYMAPEYGVQGRVSTR 896 (1007)
Q Consensus 857 DFGla~~~~---------~~~---~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 896 (1007)
|||++.-+. ..+ +. ......+||+.|+|||++....|+.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999985321 000 00 00113479999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCccccCc--chHHHHH
Q 001838 897 GDVYSYGIMLMETFTGKKPTDEIFIGE--LSLSRWV 930 (1007)
Q Consensus 897 ~DvwS~Gvil~elltG~~p~~~~~~~~--~~l~~~~ 930 (1007)
+|+||.|||||||+.|++||......+ ..+..|.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence 999999999999999999998655443 2334453
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=260.88 Aligned_cols=325 Identities=22% Similarity=0.274 Sum_probs=178.7
Q ss_pred CCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccC
Q 001838 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG 234 (1007)
Q Consensus 155 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 234 (1007)
.+|.++..-.++|+.|++.+|.++ .+|..| ...+|++|+|.+|++. .+|..+..+++|+.|+|+++.....+|. ++
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls 654 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS 654 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence 455554322235777777777775 566666 4577777777777776 4666677777777777777654445553 67
Q ss_pred CccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCCCccccccCCCCE
Q 001838 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTV 314 (1007)
Q Consensus 235 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 314 (1007)
.+++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|...+.+|.. ..+|+.
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~ 729 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISW 729 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence 77777888887776666677777777777777777765556666654 5677777777777655555532 346777
Q ss_pred EEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCCCCCCCccccccccceee
Q 001838 315 FQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQ 394 (1007)
Q Consensus 315 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~ 394 (1007)
|++++|.+.. +|..+ .+++|+.|++.++....... .+.. ++........+|+.|+
T Consensus 730 L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~----------------------~~~~-l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 730 LDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWE----------------------RVQP-LTPLMTMLSPSLTRLF 784 (1153)
T ss_pred eecCCCcccc-ccccc-cccccccccccccchhhccc----------------------cccc-cchhhhhccccchhee
Confidence 7777777763 44443 45666666665433211100 0000 0000001112344444
Q ss_pred eccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccC
Q 001838 395 MFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474 (1007)
Q Consensus 395 l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 474 (1007)
+++|...+.+|..++++++|+.|+|++|..-+.+|..+ . +++|+.|+|++|....
T Consensus 785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~------------------------L~sL~~L~Ls~c~~L~ 839 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-N------------------------LESLESLDLSGCSRLR 839 (1153)
T ss_pred CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-C------------------------ccccCEEECCCCCccc
Confidence 44444444455555555555555555443222333332 3 4444444444443322
Q ss_pred CCCCCCCCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccc
Q 001838 475 AIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRN 542 (1007)
Q Consensus 475 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N 542 (1007)
.+|.. .++|+.|+|++|.++ .+|..+..+++|++|++++++--..+|..+..++.|+.++++++
T Consensus 840 ~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 840 TFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 33321 234455555555554 24445555555555555542222224445555566666666554
|
syringae 6; Provisional |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=233.02 Aligned_cols=185 Identities=22% Similarity=0.331 Sum_probs=155.4
Q ss_pred ccccccceecccCceEEEEEEEcC-CceEEEEEechhhH--------HHHHHHHHHHHHHHhcC---CCceeEEEEEEec
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYE--------RALKSFQDECEVMKRIR---HRNLVKIISACSN 793 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 793 (1007)
.+|...+.+|+|+||.|+.|.++. ..+|+||.+.+..- +..-..-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999774 67899998876531 11112456999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeec
Q 001838 794 DDFKALIMEYM-PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSI 860 (1007)
Q Consensus 794 ~~~~~lv~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGl 860 (1007)
++.+||+||-- ++-+|++++..+.. +++..+.-|++||+.|+++| |+.+|||||++ |++|||-
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999975 56789999987654 78888889999999999999 89999999875 8999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
|.......- ...+||..|.|||++.+.+| ...-|||++||+||.++..+.||..
T Consensus 717 aa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 987654322 34679999999999998887 5668999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=211.69 Aligned_cols=244 Identities=18% Similarity=0.249 Sum_probs=184.7
Q ss_pred cccccccceecccCceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEE-EEecCCeeEEEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIIS-ACSNDDFKALIM 801 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~-~~~~~~~~~lv~ 801 (1007)
.+.|.+.+.+|+|.||.+-.|+++ ..+.+|+|.+..... ..++|.+|..---.+ .|.||+.-++ .|...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 457889999999999999999987 477899999876532 347788888766566 4999998876 577788889999
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc--------------ccceeecceecCCC
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~--------------kl~DFGla~~~~~~ 867 (1007)
||++.|+|.+-+... .+.+....+++.|++.|++|| |++.+||||++ |+||||..+.....
T Consensus 102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999999887653 367778889999999999999 79999999875 89999998864311
Q ss_pred CcccccccccCCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHh
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQG-----RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 942 (1007)
....--+..|.|||..... ...+.+|||.||+++|..+||+.||+.....+....+|.........
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---- 247 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence 1122245568999976532 35778999999999999999999999877777777777654332211
Q ss_pred hhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.+.... . .....++++-++-+.++|++|.-..++.++-...
T Consensus 248 --~~P~~F-~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 --ALPKKF-N------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred --cCchhh-c------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 000000 0 1134577888899999999998777777665443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=209.80 Aligned_cols=198 Identities=32% Similarity=0.541 Sum_probs=168.4
Q ss_pred ecccCceEEEEEEEcC-CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhH
Q 001838 734 LGIGSFGSVYVARLQD-GMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLEN 811 (1007)
Q Consensus 734 ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 811 (1007)
||+|++|.||++...+ |+.+++|++...... ..+.+.+|++.+++++|++|+++++++......++||||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999865432 34678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCCCCcccccccccC
Q 001838 812 RLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNGQDQLSMQTQTLA 878 (1007)
Q Consensus 812 ~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~~~~~~~~~~~~g 878 (1007)
++......+++..+..++.++++++.|| |+.+++|+++ .+++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 9986534588999999999999999999 5668999854 37899999987653321 1223457
Q ss_pred CcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHH
Q 001838 879 TIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAK 957 (1007)
Q Consensus 879 t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 957 (1007)
...|++||..... .++.+.|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999998777 788999999999999999
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 958 EQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 958 ~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.++.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 147788899999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=256.18 Aligned_cols=312 Identities=24% Similarity=0.263 Sum_probs=151.0
Q ss_pred cceEEcccCcCCCCCCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEecc
Q 001838 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLG 294 (1007)
Q Consensus 215 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls 294 (1007)
|+.|.+.+|.++ .+|..| ...+|+.|+|++|++.. ++..+..+++|+.|+|+++...+.+|. ...+++|+.|+|+
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~ 665 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLS 665 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEec
Confidence 455555555444 334433 23455555555555442 333444555555555555443344543 2245667777777
Q ss_pred CCCCCCCCCccccccCCCCEEEecCCCcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCC
Q 001838 295 TNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNP 374 (1007)
Q Consensus 295 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~ 374 (1007)
+|.....+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|++++|......|. ...+|++|++++|.
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~--------~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD--------ISTNISWLDLDETA 736 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc--------ccCCcCeeecCCCc
Confidence 666555677777777777777777754333455433 456666666655532211111 01233344444443
Q ss_pred CCCCCCCCccccccccceeeeccccccccCChhhhccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCch
Q 001838 375 LDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPD 454 (1007)
Q Consensus 375 l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 454 (1007)
+. .+|..+ .+++|+.|++.++.... ++. .+....|.
T Consensus 737 i~--------------------------~lP~~~-~l~~L~~L~l~~~~~~~-l~~----------------~~~~l~~~ 772 (1153)
T PLN03210 737 IE--------------------------EFPSNL-RLENLDELILCEMKSEK-LWE----------------RVQPLTPL 772 (1153)
T ss_pred cc--------------------------cccccc-cccccccccccccchhh-ccc----------------cccccchh
Confidence 32 122211 23444444444322110 000 00011111
Q ss_pred hhhcccccceeecccccccCCCCCCCCCcccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCcccccccccc
Q 001838 455 EICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVV 534 (1007)
Q Consensus 455 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L 534 (1007)
.+...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|.....+|.. .++|
T Consensus 773 ~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL 848 (1153)
T PLN03210 773 MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNI 848 (1153)
T ss_pred hhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---cccc
Confidence 12223455555555555555555555555555555555543333344333 3444555555544332222221 2345
Q ss_pred ceEeCccccCCCCccccccCCCCccEEeccc-cccccccCccCcCCCCCCEEECCCC
Q 001838 535 IELNLSRNNLSGDIPITIGGLKNLQKLFLAN-NRLEGPIPESFSGLSSLEILDLSKN 590 (1007)
Q Consensus 535 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~LdLs~N 590 (1007)
+.|+|++|.|+ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|+++++
T Consensus 849 ~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 849 SDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 56666666665 4566666666666666665 4444 34555556666666666554
|
syringae 6; Provisional |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-24 Score=232.39 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=198.0
Q ss_pred ccccccccHHHHHHhcccccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcC------CC
Q 001838 710 PQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIR------HR 782 (1007)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~ 782 (1007)
.++...+.+.|+.. .+|.+....|+|-|++|.+|.... |..||||++.... -..+.=+.|+++|+++. -.
T Consensus 418 aEGYYrv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 418 AEGYYRVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred ccceEEEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhh
Confidence 35556666777654 689999999999999999998764 8899999998653 22345578999999995 35
Q ss_pred ceeEEEEEEecCCeeEEEEEecCCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------
Q 001838 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------- 853 (1007)
Q Consensus 783 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------- 853 (1007)
|+++++-.|...+++|||||-.. -+|.+.|++- ...+....+..|+.|+.-||..| ...+|+|.|++
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEec
Confidence 89999999999999999999885 4899999753 34678888999999999999999 78899998775
Q ss_pred ------ccceeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHH
Q 001838 854 ------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLS 927 (1007)
Q Consensus 854 ------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~ 927 (1007)
||||||-|......+. +.+.-+..|.|||++.+..|+...|+||.||.||||+||+.-|.+.....+- .
T Consensus 571 E~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-r 645 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-R 645 (752)
T ss_pred cCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-H
Confidence 8999999998764432 3344567899999999999999999999999999999999988764332211 0
Q ss_pred HHHH--hhcCc---------------------------------cHHHHhhh------hhccchhhhHHHHHHHHHHHHH
Q 001838 928 RWVN--DLLPI---------------------------------SVMEVIDT------NLLSGEERYFAAKEQSLLSILN 966 (1007)
Q Consensus 928 ~~~~--~~~~~---------------------------------~~~~~~d~------~~~~~~~~~~~~~~~~~~~~~~ 966 (1007)
-++. .-.|. .++..+.| .+.. .+..+........++.+
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~-~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA-VQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc-cCCCCchhHHHHHHHHH
Confidence 0000 00000 00111111 0000 01111122345678999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHH
Q 001838 967 LATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 967 l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
|+..|+..||++|.|..+++++
T Consensus 725 LLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=211.71 Aligned_cols=187 Identities=29% Similarity=0.433 Sum_probs=158.4
Q ss_pred ccccceecccCceEEEEEEEcC-CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecC
Q 001838 728 FSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYER-ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 889999999865443 56788999999999999999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+++|.+++......+++.....++.+++.++.||| ..+++|+++ .+++|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999999765433788999999999999999994 569999865 489999999887543211 11
Q ss_pred ccccCCccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 874 TQTLATIGYMAPEYG-VQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
....++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578889999988 566788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=238.42 Aligned_cols=154 Identities=26% Similarity=0.334 Sum_probs=99.4
Q ss_pred EEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccC
Q 001838 70 VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSI 149 (1007)
Q Consensus 70 v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~ 149 (1007)
-..|||++++|+ .+|+.+. ++|+.|++++|+|+. +|. .+++|++|+|++|+|+..+ . ..++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP-~---lp~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLP-V---LPPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCccc-C---cccccceeeccC
Confidence 346788888888 5777775 478889999998884 554 2578888888888887543 2 235777777877
Q ss_pred cccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCC
Q 001838 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEI 229 (1007)
Q Consensus 150 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 229 (1007)
|.++ .+|. ..++|+.|+|++|+|+. +|.. +++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +
T Consensus 272 N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 272 NPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-L 337 (788)
T ss_pred Cchh-hhhh----chhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-c
Confidence 7776 4554 23457777777777763 4432 3567777777777764 34322 345566666666663 3
Q ss_pred CcccCCccccceeeccCccccc
Q 001838 230 PQEMGNLPYLVRLTLATNNLVG 251 (1007)
Q Consensus 230 p~~~~~l~~L~~L~Ls~N~l~~ 251 (1007)
|.. ..+|+.|+|++|+|++
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLAS 356 (788)
T ss_pred ccc---ccccceEecCCCccCC
Confidence 321 1345566666665554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=239.22 Aligned_cols=162 Identities=28% Similarity=0.382 Sum_probs=83.2
Q ss_pred CCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCcccCceeec
Q 001838 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYL 491 (1007)
Q Consensus 412 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 491 (1007)
++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++
T Consensus 302 ~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~L 369 (788)
T PRK15387 302 PGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWA 369 (788)
T ss_pred cccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehh
Confidence 456666666666654 2321 1234555555555543 3321 1345555555555553 3322 123444555
Q ss_pred CCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEeccccccccc
Q 001838 492 GSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGP 571 (1007)
Q Consensus 492 s~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 571 (1007)
++|++++ +|.. ...|+.|+|++|+|++ +|... ++|+.|++++|+|++
T Consensus 370 s~N~L~~-LP~l---------------------------~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss- 416 (788)
T PRK15387 370 YNNRLTS-LPAL---------------------------PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS- 416 (788)
T ss_pred hcccccc-Cccc---------------------------ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-
Confidence 5555543 2321 1235555666666552 44322 356666666666653
Q ss_pred cCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccccccCC
Q 001838 572 IPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622 (1007)
Q Consensus 572 ~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ip~ 622 (1007)
+|..+ .+|+.|++++|+|+ .+|..+.+++.|+.|+|++|+|+|.+|.
T Consensus 417 IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 44332 34556666666666 4566666666666666666666665543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=233.43 Aligned_cols=271 Identities=19% Similarity=0.331 Sum_probs=143.0
Q ss_pred CcchHHHHHHHHHhcccCCCCccc---cCCCCCCCCccccc----------------eEeCCCCCcEEEEEeCCCCCccc
Q 001838 23 ITTDQQSLLALKAHISYDPTNLFA---KNWTSSTSVCSWIG----------------ITCGVNSHKVIVLNISGFNLQGT 83 (1007)
Q Consensus 23 ~~~~~~~ll~~k~~~~~~~~~~~~---~~w~~~~~~C~w~g----------------v~c~~~~~~v~~L~L~~~~l~~~ 83 (1007)
..++.+.+++..+.+.+.+ ... ..|...++.|-=.. |.|. ++.|+.+...+......
T Consensus 61 ~~~~~~~~~~~~~~l~~p~--~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPA--YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQASS 136 (754)
T ss_pred CHHHHHHHHHHHHHhcCCc--hhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccccc
Confidence 3467788999999886443 222 23998899995433 6674 35677776655322211
Q ss_pred Cc--ccc-------------------------------cCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCC
Q 001838 84 IP--PQL-------------------------------GNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFG 130 (1007)
Q Consensus 84 ~~--~~l-------------------------------~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 130 (1007)
.. .+. +-..+...|++++++++. +|..+. +.|+.|+|++|+|+.
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts 213 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS 213 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc
Confidence 10 000 111345666666666663 454442 356666666666664
Q ss_pred cchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccc
Q 001838 131 SLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIG 210 (1007)
Q Consensus 131 ~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 210 (1007)
.++..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+.
T Consensus 214 LP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~ 282 (754)
T PRK15370 214 LPENLQ---GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP 282 (754)
T ss_pred CChhhc---cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC
Confidence 433222 35666666666665 4555432 24566666666665 4444433 35566666666655 3444332
Q ss_pred cccccceEEcccCcCCCCCCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcE
Q 001838 211 NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEF 290 (1007)
Q Consensus 211 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~ 290 (1007)
.+|+.|+|++|+|++ +|..+. ++|+.|++++|+++. +|..+ .++|+.
T Consensus 283 --~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-------------------------LP~~l---~~sL~~ 329 (754)
T PRK15370 283 --EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-------------------------LPETL---PPGLKT 329 (754)
T ss_pred --CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-------------------------CCccc---ccccee
Confidence 355555555555552 333221 244555555555543 33222 134555
Q ss_pred EeccCCCCCCCCCccccccCCCCEEEecCCCcCCCCCcccccccccccccccccccccCC
Q 001838 291 LNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSST 350 (1007)
Q Consensus 291 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 350 (1007)
|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+. ++|+.|+|++|+|+.++
T Consensus 330 L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~LP 383 (754)
T PRK15370 330 LEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNLP 383 (754)
T ss_pred ccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCCC
Confidence 6666666654 344332 466666666666653 444332 45666666666655443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-23 Score=204.75 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=172.0
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCC
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGS 808 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gs 808 (1007)
..+|.+...|+.|+|+++ |..+++|++.-+. ....++|.+|.-.++-+.||||..++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345778889999999997 6677788876442 3445789999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc---c-ccceeecc-eecCCCCcccc-cccccCCcc
Q 001838 809 LENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV---A-HISDFSIA-KFLNGQDQLSM-QTQTLATIG 881 (1007)
Q Consensus 809 L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~---~-kl~DFGla-~~~~~~~~~~~-~~~~~gt~~ 881 (1007)
|+..++++.. ..+..++.++|.++|+|++|||.. .+++-|.- . ...|-.+. +.-..+...+. ..+..-.+.
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pa 351 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPA 351 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeeeccccccCcc
Confidence 9999997653 467789999999999999999843 23333211 0 11222211 11111111110 112335788
Q ss_pred cccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHH
Q 001838 882 YMAPEYGVQGRVS---TRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKE 958 (1007)
Q Consensus 882 y~aPE~~~~~~~~---~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 958 (1007)
||+||.+...+-+ ..+|+|||.|++||+.|++.||.+....+.....- .+ ..+...++
T Consensus 352 wmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------le----------glrv~ipp 412 (448)
T KOG0195|consen 352 WMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------LE----------GLRVHIPP 412 (448)
T ss_pred cCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------hc----------cccccCCC
Confidence 9999998876643 46899999999999999999998753322111100 00 11111223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 959 QSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 959 ~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.....+.+++.-|..+||.+||.+..|+-.|++++
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34556889999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=194.57 Aligned_cols=168 Identities=20% Similarity=0.152 Sum_probs=120.7
Q ss_pred CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceec--cccccceeecceecCCCCcccccccccCCcccc
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHY--MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~--~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 883 (1007)
|+|.+++......+++.++..++.|+++||+|||..+. .+|.-. ..+|+ ||.++..... ...||+.||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeeccc-------cCCCccccc
Confidence 78999998766679999999999999999999986442 233332 23455 9999876432 125889999
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHH--
Q 001838 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSL-- 961 (1007)
Q Consensus 884 aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-- 961 (1007)
|||++.+..++.++|||||||++|||+||+.||.........+..+.....+... ... .......
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~ 138 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP-----------RDR--SNLESVSAA 138 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----------ccc--ccHHHHHhh
Confidence 9999999999999999999999999999999997532222222222221111100 000 0011112
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001838 962 LSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 962 ~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
.++.+++.+||+.+|++||++.|+++++..+....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 26899999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-21 Score=228.58 Aligned_cols=234 Identities=24% Similarity=0.384 Sum_probs=164.9
Q ss_pred ccccceEeCCCCCcEEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhh
Q 001838 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSF 135 (1007)
Q Consensus 56 C~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 135 (1007)
+.|.-..|-. ...+.|++++++++ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+.. |..
T Consensus 168 a~~r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsL-P~~ 238 (754)
T PRK15370 168 AVQRMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSI-PAT 238 (754)
T ss_pred HHHHHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccC-Chh
Confidence 3455556754 35789999999998 4676664 589999999999994 666554 5899999999999865 443
Q ss_pred hhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCccccccccc
Q 001838 136 IFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKL 215 (1007)
Q Consensus 136 ~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 215 (1007)
+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|+.+. ++|+.|+|++|+|++ +|..+. ++|
T Consensus 239 l~--~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL 306 (754)
T PRK15370 239 LP--DTIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGI 306 (754)
T ss_pred hh--ccccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhH
Confidence 32 47999999999998 8888764 57999999999999 5777664 589999999999995 565553 479
Q ss_pred ceEEcccCcCCCCCCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccC
Q 001838 216 KDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGT 295 (1007)
Q Consensus 216 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~ 295 (1007)
+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|++. .+|..+ .++|+.|+|++
T Consensus 307 ~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l---p~~L~~LdLs~ 376 (754)
T PRK15370 307 THLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL---PPTITTLDVSR 376 (754)
T ss_pred HHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh---cCCcCEEECCC
Confidence 999999999995 555443 688889999988876 444332 45666666666553 344332 13455555555
Q ss_pred CCCCCCCCccccccCCCCEEEecCCCcC
Q 001838 296 NRFSGNIPSSITNASKLTVFQLRGNSFS 323 (1007)
Q Consensus 296 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 323 (1007)
|+++. +|..+. ..|+.|++++|+|+
T Consensus 377 N~Lt~-LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 377 NALTN-LPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CcCCC-CCHhHH--HHHHHHhhccCCcc
Confidence 55542 233222 13444444444444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-21 Score=239.83 Aligned_cols=184 Identities=16% Similarity=0.168 Sum_probs=130.5
Q ss_pred cCC-CceeEEEEEE-------ecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 001838 779 IRH-RNLVKIISAC-------SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY 850 (1007)
Q Consensus 779 l~H-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 850 (1007)
++| +||++++++| .+.+.++.+|||+ +++|.+++......+++.++..++.||++||+|| |+.+|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence 455 6888888887 2334577889988 5699999986656689999999999999999999 67899999
Q ss_pred ccc-------------------------------ccceeecceecCCCCc--------------ccccccccCCcccccc
Q 001838 851 MVA-------------------------------HISDFSIAKFLNGQDQ--------------LSMQTQTLATIGYMAP 885 (1007)
Q Consensus 851 ~~~-------------------------------kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aP 885 (1007)
|++ |++|||+++....... ........||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 764 4667777764321000 0001124589999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHH
Q 001838 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSIL 965 (1007)
Q Consensus 886 E~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~ 965 (1007)
|++.+..|+.++|||||||++|||++|..|+.... .....+.... ..+ .......+..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~--------~~~-----------~~~~~~~~~~ 242 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRV--------LPP-----------QILLNWPKEA 242 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhh--------cCh-----------hhhhcCHHHH
Confidence 99999999999999999999999999998865311 0011110000 000 0001123456
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHH
Q 001838 966 NLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 966 ~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
+++.+||+++|.+||+|.||+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78889999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=189.88 Aligned_cols=155 Identities=18% Similarity=0.173 Sum_probs=118.1
Q ss_pred HHHhcccccccceecccCceEEEEEEEc--CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCceeE-EEEEEe
Q 001838 721 LLQATDRFSKNNLLGIGSFGSVYVARLQ--DGMEVAVKVFHQR-----YERALKSFQDECEVMKRIRHRNLVK-IISACS 792 (1007)
Q Consensus 721 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~ 792 (1007)
+....++|...+.||+|+||+||+|+.+ +++.||||++... .....+.|.+|++++++++|+|||. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999865 4778899987532 2234567999999999999999995 4432
Q ss_pred cCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-c------------ccceee
Q 001838 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-A------------HISDFS 859 (1007)
Q Consensus 793 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-~------------kl~DFG 859 (1007)
+..|+|||||+|++|... ... . ...++.++++||.|| |+.+|+|||+ + ||+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999732 111 1 145788999999999 6789999999 4 799999
Q ss_pred cceecCCCCcc------cccccccCCccccccccccc
Q 001838 860 IAKFLNGQDQL------SMQTQTLATIGYMAPEYGVQ 890 (1007)
Q Consensus 860 la~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~ 890 (1007)
+|+........ ...+...+++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99977543211 11235578899999998754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-19 Score=203.23 Aligned_cols=250 Identities=24% Similarity=0.257 Sum_probs=126.1
Q ss_pred EEeCCCCCc-ccCcccccCCCCCCEEEcCCCCCCCC----CCccccCcccCcEEeccCcccCC------cchhhhhhcCC
Q 001838 73 LNISGFNLQ-GTIPPQLGNLSSLETLDLSHNKLSGN----IPSSIFNMHTLKLLDFRDNQLFG------SLSSFIFNMSS 141 (1007)
Q Consensus 73 L~L~~~~l~-~~~~~~l~~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~ 141 (1007)
|+|.+++++ +.....+..++.|+.|+++++.++.. ++..+...++|++|++++|.+.+ .++..+.++++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666665 23344455556667777776666432 44445555666666666666652 22344555666
Q ss_pred CCeecccCcccCCCCchhHhhcCCC---CcEEEccCccccc----cCCccccCC-CCCcEEEcccccCCCC----CCccc
Q 001838 142 MLGIDLSINRFSGELPANICKNLPN---LKKLLLGRNMFHG----KIPSTLSKC-KQLEGLYLRFNNLSGA----IPKEI 209 (1007)
Q Consensus 142 L~~LdLs~N~l~~~ip~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~ 209 (1007)
|+.|++++|.+.+..+..+. .+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 83 L~~L~l~~~~~~~~~~~~~~-~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLE-SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred eeEEEccCCCCChhHHHHHH-HHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 66666666666543333322 2333 6666666666652 222334445 6666666666666532 22234
Q ss_pred ccccccceEEcccCcCCCC----CCcccCCccccceeeccCccccccc----cccccCCCCCCeEEcccccccCcCCchh
Q 001838 210 GNLTKLKDIILNDNELRGE----IPQEMGNLPYLVRLTLATNNLVGVV----PFTIFNMSTLKKLSLLENTLWGSLPSRI 281 (1007)
Q Consensus 210 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~lp~~~ 281 (1007)
..+++|++|++++|.+++. ++..+..+++|+.|+|++|.+.+.. +..+..+++|++|++++|.+.+.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 4455666666666666532 2223344456666666666655332 2223344555555555555432111111
Q ss_pred hc----CCCCCcEEeccCCCCCC----CCCccccccCCCCEEEecCCCcC
Q 001838 282 DL----SLPNVEFLNLGTNRFSG----NIPSSITNASKLTVFQLRGNSFS 323 (1007)
Q Consensus 282 ~~----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 323 (1007)
.. ..+.|+.|++++|.++. .+...+...++|+.+++++|.++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 11 12455555555555541 11222233344555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-19 Score=206.61 Aligned_cols=243 Identities=20% Similarity=0.196 Sum_probs=174.7
Q ss_pred cccceecccCceEEEEEEEc-CCceEEEEEec----hhh--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 729 SKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFH----QRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~----~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
...+++|.|++|.|+.+... .....+.|... ... .+....+..|..+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877543 33334444332 111 122233677888888999999988877777666555569
Q ss_pred EecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCc
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~ 869 (1007)
|||++ +|..++.+.. .+...++..++.|+..|++|+ |..+|.|||++ ||+|||.+....-..+
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 9999998752 367778888999999999999 78899999764 8999999987654433
Q ss_pred c--cccccccCCcccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhh
Q 001838 870 L--SMQTQTLATIGYMAPEYGVQGRVSTR-GDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 870 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 946 (1007)
. ......+|+..|+|||++....|+++ +||||.||++..|++|+.||......+.... .......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~~~--------- 543 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYSDQ--------- 543 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccccc---------
Confidence 3 45567889999999999999999875 7999999999999999999976543332210 0000000
Q ss_pred ccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..............+.+...++.++++.+|.+|.|+.+|++.
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000011112223345567889999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-16 Score=177.72 Aligned_cols=246 Identities=30% Similarity=0.399 Sum_probs=183.3
Q ss_pred ccccceecccCceEEEEEEEcCCceEEEEEechhhHH---HHHHHHHHHHHHHhcCCC-ceeEEEEEEecCCeeEEEEEe
Q 001838 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYER---ALKSFQDECEVMKRIRHR-NLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~E~ 803 (1007)
|...+.+|.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 78999999765432 467899999999999988 799999999887778999999
Q ss_pred cCCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecCCCC
Q 001838 804 MPNGSLENRLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLNGQD 868 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~~~~ 868 (1007)
+.++++.+++.... ..+.......++.|++.++.|+ |+.+++|||+ ++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776553 2578889999999999999999 6677999965 3889999998665432
Q ss_pred ccc----ccccccCCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccC--cchHHHHHHhhcCccHH
Q 001838 869 QLS----MQTQTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIG--ELSLSRWVNDLLPISVM 939 (1007)
Q Consensus 869 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 939 (1007)
... ......||..|+|||.+.. ..++...|+||+|++++++++|..|+...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 211 2355679999999999887 57899999999999999999999997653221 11111111111000
Q ss_pred HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 940 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
........... ......+.+++..|+..+|..|.++.+....
T Consensus 234 -----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1122467888899999999999999887765
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-19 Score=199.77 Aligned_cols=109 Identities=26% Similarity=0.270 Sum_probs=60.4
Q ss_pred cccccccCCCCCcCCC----CccccccccccceEeCccccCCCCcccccc-----CCCCccEEeccccccc----cccCc
Q 001838 508 KDILFFDVSSNSLDGP----LSLDIGNLKVVIELNLSRNNLSGDIPITIG-----GLKNLQKLFLANNRLE----GPIPE 574 (1007)
Q Consensus 508 ~~L~~Ldls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~----~~~p~ 574 (1007)
++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++ ..++.
T Consensus 193 ~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~ 272 (319)
T cd00116 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAE 272 (319)
T ss_pred CCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHH
Confidence 3444444444444322 122334456666777777766643332222 1357777777777775 12334
Q ss_pred cCcCCCCCCEEECCCCccccc----CCcchhhh-cCCCeeeCcCCcc
Q 001838 575 SFSGLSSLEILDLSKNKISGV----IPTSLEKL-LYLKKLNLSFNKL 616 (1007)
Q Consensus 575 ~~~~l~~L~~LdLs~N~l~~~----~p~~l~~l-~~L~~L~ls~N~l 616 (1007)
.+..+++|+.+|+++|.++.. ....+... +.|+.+++.+|++
T Consensus 273 ~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 273 VLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 455557777777777777744 33333334 5677777777654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=176.93 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=181.3
Q ss_pred cccccceecccCceEEEEEEEcCC--ceEEEEEechhhHHHHHHHHHHHHHHHhcCC----CceeEEEEEE-ecCCeeEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQDG--MEVAVKVFHQRYERALKSFQDECEVMKRIRH----RNLVKIISAC-SNDDFKAL 799 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 799 (1007)
+|...+.||+|+||.||+|..... ..+|+|.-..........+..|+.++..+.+ +++.++++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788888765432222267789999998873 6899999998 57788999
Q ss_pred EEEecCCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------------ccceeecc
Q 001838 800 IMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------------HISDFSIA 861 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------------kl~DFGla 861 (1007)
||+.+ |.+|.++..... ..++.....+|+.|++.+|+++ |+.+++|||++ .+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 679999875443 5789999999999999999999 78999999774 57999999
Q ss_pred e--ecCCCCc----cc-c-cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhh
Q 001838 862 K--FLNGQDQ----LS-M-QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 862 ~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
+ ....... .. . .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ..+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3322111 11 1 1234599999999999999999999999999999999999999975432111 11100000
Q ss_pred cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001838 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 934 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
....... .....+.++.+++..+-..+..++|....+...++.....
T Consensus 254 ----~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 ----RKLLTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----hhhcccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0000000 0001123455566566668899999999999998776654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-19 Score=163.26 Aligned_cols=156 Identities=35% Similarity=0.598 Sum_probs=117.1
Q ss_pred ccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCC
Q 001838 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNL 167 (1007)
Q Consensus 88 l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L 167 (1007)
+..+++.+.|.||+|+++ .+|+.+..|.+|+.|++++|+| + .+|..+. .+++|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqi------------------------e-~lp~~is-sl~kl 81 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQI------------------------E-ELPTSIS-SLPKL 81 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchh------------------------h-hcChhhh-hchhh
Confidence 344556666666666666 4555566666666666555555 3 6777775 68888
Q ss_pred cEEEccCccccccCCccccCCCCCcEEEcccccCC-CCCCcccccccccceEEcccCcCCCCCCcccCCccccceeeccC
Q 001838 168 KKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS-GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLAT 246 (1007)
Q Consensus 168 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 246 (1007)
+.|+++-|++. +.|..|+.++.|+.|||++|+++ ..+|..|..++.|+.|+|++|.++ .+|..++++++|+.|.+.+
T Consensus 82 r~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 82 RILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred hheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 88888888887 78888999999999999999885 467888888888888888888888 7788888888888888888
Q ss_pred ccccccccccccCCCCCCeEEcccccc
Q 001838 247 NNLVGVVPFTIFNMSTLKKLSLLENTL 273 (1007)
Q Consensus 247 N~l~~~~p~~~~~l~~L~~L~L~~N~l 273 (1007)
|.+. ..|..++.+..|++|.+.+|.+
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhccccee
Confidence 8876 3566666666666666666665
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-19 Score=165.82 Aligned_cols=162 Identities=33% Similarity=0.574 Sum_probs=132.1
Q ss_pred CcEEEEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecc
Q 001838 68 HKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147 (1007)
Q Consensus 68 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL 147 (1007)
..++.|.||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++++++|++|+++-|++. ..|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 47899999999998 78999999999999999999999 78999999999999999999984 67888888888888888
Q ss_pred cCcccCC-CCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCC
Q 001838 148 SINRFSG-ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELR 226 (1007)
Q Consensus 148 s~N~l~~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 226 (1007)
++|+++. .+|.++| .++.|+.|.|+.|.|. .+|..++++++|+.|.+..|.+- .+|.+++.+++|+.|.+.+|+++
T Consensus 110 tynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred cccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 8888874 4566666 5777777777777776 67777777777777777777776 57777777777777777777777
Q ss_pred CCCCcccCCc
Q 001838 227 GEIPQEMGNL 236 (1007)
Q Consensus 227 ~~~p~~~~~l 236 (1007)
.+|.+++++
T Consensus 187 -vlppel~~l 195 (264)
T KOG0617|consen 187 -VLPPELANL 195 (264)
T ss_pred -ecChhhhhh
Confidence 455555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.9e-17 Score=181.30 Aligned_cols=205 Identities=26% Similarity=0.342 Sum_probs=148.6
Q ss_pred HHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec-----
Q 001838 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY----- 850 (1007)
Q Consensus 776 l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~----- 850 (1007)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..+...++|.-...++.+|+.||+|+| +++.-.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence 35678999999999999999999999999999999999987777999999999999999999996 44433664
Q ss_pred -------cccccceeecceecCCCCcccccccccCCcccccccccccCC-------CCchhhHHHHHHHHHHHHhCCCCC
Q 001838 851 -------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR-------VSTRGDVYSYGIMLMETFTGKKPT 916 (1007)
Q Consensus 851 -------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwS~Gvil~elltG~~p~ 916 (1007)
.+.|++|||+.................-..-|.|||.+.... .+.+.||||||++++|+++++.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 345999999998774311111111222344699999877631 467899999999999999999999
Q ss_pred CccccCcc--hHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001838 917 DEIFIGEL--SLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 917 ~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
+....... .+..++......... +.+ ....+...++..++..||.++|++||++++|-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~r----P~i--------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFR----PSI--------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcC----cch--------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 87443332 222222221100000 000 0001223468999999999999999999999888876655
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-16 Score=187.48 Aligned_cols=154 Identities=25% Similarity=0.435 Sum_probs=124.8
Q ss_pred hhcCCcchHHHHHHHHHhcccCCCCccccCCCCCCCCc----cccceEeCC--CC--CcEEEEEeCCCCCcccCcccccC
Q 001838 19 AASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVC----SWIGITCGV--NS--HKVIVLNISGFNLQGTIPPQLGN 90 (1007)
Q Consensus 19 ~~~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~C----~w~gv~c~~--~~--~~v~~L~L~~~~l~~~~~~~l~~ 90 (1007)
...+.+.|.+||+++|+.+. ++.. . +|.. ..|| .|.||.|+. .. ..|+.|+|++|+++|.+|++++.
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~-~~~~--~-~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLG-LPLR--F-GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccccCchHHHHHHHHHHhcC-Cccc--C-CCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 34567789999999999975 4432 2 7964 3332 799999953 22 25999999999999999999999
Q ss_pred CCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEE
Q 001838 91 LSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKL 170 (1007)
Q Consensus 91 l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L 170 (1007)
+++|+.|+|++|.|+|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|||++|+++|.+|..+...+.++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 99999999999999999999999999999999999999988888888888888888888888888888775434456666
Q ss_pred EccCccc
Q 001838 171 LLGRNMF 177 (1007)
Q Consensus 171 ~Ls~N~l 177 (1007)
++++|..
T Consensus 521 ~~~~N~~ 527 (623)
T PLN03150 521 NFTDNAG 527 (623)
T ss_pred EecCCcc
Confidence 6666654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=150.38 Aligned_cols=196 Identities=22% Similarity=0.297 Sum_probs=158.7
Q ss_pred HHHHHHhcccccccceecccCceEEEEEE-EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCC
Q 001838 718 YHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH-RNLVKIISACSNDD 795 (1007)
Q Consensus 718 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~ 795 (1007)
.+++.. ..+|...+.||+|+||.+|.|. ..+|.+||||.=..... ..++..|..+.+.++| ..|..+..|..+++
T Consensus 8 ~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 8 LEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 344443 3679999999999999999997 55799999998654322 2457789999999974 67778888888899
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeec
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSI 860 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGl 860 (1007)
.-.+|||.. |.+|++...-....++....+-.|-|++.-++|+ |..+.||||++ .++|||+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccc
Confidence 999999998 7799998876556688899999999999999999 67789999886 5899999
Q ss_pred ceecCCCCc-----ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 001838 861 AKFLNGQDQ-----LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIF 920 (1007)
Q Consensus 861 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~ 920 (1007)
|+...+... +...+...||..|.+--...+..-+.+-|+=|+|.++...-.|..||++..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 997643211 122245579999998877666677889999999999999999999999754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.9e-15 Score=149.37 Aligned_cols=188 Identities=20% Similarity=0.305 Sum_probs=157.1
Q ss_pred cccccceecccCceEEEEEE-EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEec
Q 001838 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.|.+.++||+|+||+.+.|+ +-++++||||.=....+ ..++..|.+..+.+. .+.|...+.+..++-+-.||+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999997 44799999997543321 245677888888775 789999998888888889999998
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------------ccceeecceecCCC
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------------kl~DFGla~~~~~~ 867 (1007)
|.||+++..-.++.++...+..||.|+..-++|+ |++.+|.||++ +++|||+||...+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 7799999887777799999999999999999999 56778888875 69999999987644
Q ss_pred Cc-----ccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 001838 868 DQ-----LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIF 920 (1007)
Q Consensus 868 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~ 920 (1007)
.. +....+..||..||+--...+.+-+.+-|+=|+|-+++..+.|..||++..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 32 222345679999999998888889999999999999999999999998743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=153.32 Aligned_cols=129 Identities=17% Similarity=0.181 Sum_probs=97.8
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhHH--H------------------------HHHHHHHHHHHHhcCCCce
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYER--A------------------------LKSFQDECEVMKRIRHRNL 784 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 784 (1007)
.+.||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754210 0 1123459999999987776
Q ss_pred eEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------
Q 001838 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------- 853 (1007)
Q Consensus 785 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~----------- 853 (1007)
.....+... ..++||||++++++....... ..++.....+++.|++.+|.|+| |+.+|+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~~~~v 156 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYHDGKL 156 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEECCcE
Confidence 433332222 238999999998776543322 35788899999999999999997 67789999874
Q ss_pred ccceeecceec
Q 001838 854 HISDFSIAKFL 864 (1007)
Q Consensus 854 kl~DFGla~~~ 864 (1007)
+++|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 89999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-15 Score=154.22 Aligned_cols=159 Identities=14% Similarity=0.159 Sum_probs=119.3
Q ss_pred cccccccceecccCceEEEEEEEcCCceEEEEEechhhH---HHHHH------HHHHHHHHHhcCCCceeEEEEEEecC-
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE---RALKS------FQDECEVMKRIRHRNLVKIISACSND- 794 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~~~~~~~- 794 (1007)
.++|...+++|.|+||.||.+.. ++..+|||.+..... ..... +.+|+..+.+++||+|....+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999765 577899999975432 22222 68999999999999999999886533
Q ss_pred -------CeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccc
Q 001838 795 -------DFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HIS 856 (1007)
Q Consensus 795 -------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~ 856 (1007)
+..++||||++|.+|.++.. ++. ....+++.++..+ |..+++|+|+. +++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~gi~li 176 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNGLRII 176 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCCEEEE
Confidence 35789999999999988632 222 2456899999999 67899999763 789
Q ss_pred eeecceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHH
Q 001838 857 DFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETF 910 (1007)
Q Consensus 857 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ell 910 (1007)
|||..+....+... ..+.....|+.++|+|||||.+.-..
T Consensus 177 Dfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987755321110 11334445778999999999876654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-15 Score=177.72 Aligned_cols=234 Identities=22% Similarity=0.294 Sum_probs=162.9
Q ss_pred cccccceecccCceEEEEEEEcCCceEEEEEechhhH-HHHHHH---HHHHHHHHhcCCCceeEEEEEEecCCeeEEEEE
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-RALKSF---QDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 802 (1007)
.|...+.+|++.|=+|.+|+.+.|. |+||++-++.+ -..+.| .+|++ ..-.+|||++.+.-+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999998886 99999865542 122333 34444 455689999999888777778889999
Q ss_pred ecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec--CCCC
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL--NGQD 868 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~--~~~~ 868 (1007)
|..+ +|+|.+..+. .+...+.+=||.|+..|+.-+ |..+|.|+|++ .++||.--|.. +.+.
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9865 8999987654 355566666999999999999 78899999997 58999765532 2221
Q ss_pred ccccc---ccccCCcccccccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhh
Q 001838 869 QLSMQ---TQTLATIGYMAPEYGVQG----------R-VSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDL 933 (1007)
Q Consensus 869 ~~~~~---~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~ 933 (1007)
..... .+...-.+|+|||.+... . .+++-||||.||+++|+++ |++||+-. .+..+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 11100 011122379999976541 2 5788999999999999987 78888631 111111110
Q ss_pred --cCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001838 934 --LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989 (1007)
Q Consensus 934 --~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L 989 (1007)
.++...+.+. ...+..++..|++.||++|.+|.+.++.-
T Consensus 252 ~~~~e~~Le~Ie-----------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 252 ADDPEQLLEKIE-----------------DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCHHHHHHhCc-----------------CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0011111110 12478899999999999999999999883
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5e-15 Score=154.66 Aligned_cols=186 Identities=20% Similarity=0.185 Sum_probs=126.4
Q ss_pred CCCceeEEEEEEec---------------------------CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHH
Q 001838 780 RHRNLVKIISACSN---------------------------DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDV 832 (1007)
Q Consensus 780 ~H~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 832 (1007)
+|||||++.++|.+ +...|+||.-++. +|.+++..+. .+...+.-|..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999998754 1246899988865 8999997654 3444555588999
Q ss_pred HHHHHHHHhcCCCCceecccc----------------ccceeecceecCCC-Ccc---cccccccCCcccccccccccCC
Q 001838 833 ALALEYLHFGHSTPIIHYMVA----------------HISDFSIAKFLNGQ-DQL---SMQTQTLATIGYMAPEYGVQGR 892 (1007)
Q Consensus 833 a~~l~yLH~~~~~~ivH~~~~----------------kl~DFGla~~~~~~-~~~---~~~~~~~gt~~y~aPE~~~~~~ 892 (1007)
++|+.|| |.++|.|||++ .|+|||.+--.... -+. +..-..-|...-||||+....+
T Consensus 351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999 78899999875 58999987533210 000 1111223666789999865422
Q ss_pred -----C-CchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHH
Q 001838 893 -----V-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILN 966 (1007)
Q Consensus 893 -----~-~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 966 (1007)
. -.|+|.|+.|.+.||+++...||......-.+...+.+.-. +..++.++..+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL-------------------Palp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL-------------------PALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-------------------CCCcccCChHHHH
Confidence 1 35899999999999999999999762211111111111110 1112233456888
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHH
Q 001838 967 LATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 967 l~~~cl~~~p~~Rpt~~evl~~L~ 990 (1007)
++...++.||++|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999877666654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-16 Score=173.42 Aligned_cols=213 Identities=25% Similarity=0.325 Sum_probs=159.7
Q ss_pred eecccCceEEEEEE----EcCCceEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEecC
Q 001838 733 LLGIGSFGSVYVAR----LQDGMEVAVKVFHQRYE--RALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~----~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.+|+|+||.|+.++ .+.|+.+|.|+.++... +.......|..++..++ ||.+|++..++..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999764 33477889998865432 11225567888999997 9999999999999999999999999
Q ss_pred CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecceecCCCCccccc
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla~~~~~~~~~~~~ 873 (1007)
+|.+...+.... .++......+...+|-|++++ |..+|+||+. .|+.|||+++...+..
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 999998887654 355555556777888999999 7888999876 4899999999765332
Q ss_pred ccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhh
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 953 (1007)
..+||..|||||++. .+...+|.|||||+.+||+||..||... . +..|-. ..
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------~------------~~~Il~---~~---- 203 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------T------------MKRILK---AE---- 203 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------H------------HHHHhh---hc----
Confidence 228999999999987 6788999999999999999999999751 0 011100 00
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001838 954 FAAKEQSLLSILNLATECTIESPGKRINA 982 (1007)
Q Consensus 954 ~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 982 (1007)
...+.+....+.++...+...+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 01122334456677777788888888654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.8e-15 Score=177.61 Aligned_cols=118 Identities=39% Similarity=0.622 Sum_probs=97.3
Q ss_pred ccceEeCccccCCCCccccccCCCCccEEeccccccccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCc
Q 001838 533 VVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLS 612 (1007)
Q Consensus 533 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls 612 (1007)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36678888888888888888888899999999999988888888888899999999999998889888888999999999
Q ss_pred CCccccccCCCC--cCCCCcccccccccccCCCCCCCCCCCC
Q 001838 613 FNKLEGEIPRGG--PFANLTAKSFLGNELLCGLPDLHNSPCK 652 (1007)
Q Consensus 613 ~N~l~~~ip~~~--~~~~~~~~~~~~n~~lc~~p~~~~~~c~ 652 (1007)
+|+++|.+|..- .+..+....+.+|+.+|+.|.. ..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence 999998888642 1233455678899999997643 4674
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=140.78 Aligned_cols=129 Identities=22% Similarity=0.238 Sum_probs=98.8
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhH--------------------------HHHHHHHHHHHHHHhcCCCce
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE--------------------------RALKSFQDECEVMKRIRHRNL 784 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~ni 784 (1007)
.+.||+|+||+||+|+..+|+.||||+++.... .....+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999987899999999875321 002234679999999999987
Q ss_pred eEEEEEEecCCeeEEEEEecCCCChhHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------
Q 001838 785 VKIISACSNDDFKALIMEYMPNGSLENR-LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------- 853 (1007)
Q Consensus 785 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------- 853 (1007)
.....+.... .++||||++++++... +.. ..++..+..+++.|++.++.|+| +..+|+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~NIll~~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYNILYHDGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhhEEEECCC
Confidence 5544443332 4899999998865443 332 24677788899999999999996 33799999874
Q ss_pred -ccceeecceecC
Q 001838 854 -HISDFSIAKFLN 865 (1007)
Q Consensus 854 -kl~DFGla~~~~ 865 (1007)
+++|||+|+...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.8e-13 Score=135.45 Aligned_cols=174 Identities=16% Similarity=0.111 Sum_probs=125.8
Q ss_pred cccceecccCceEEEEEEEcCCceEEEEEechhhH----HHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEEe
Q 001838 729 SKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE----RALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 729 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
.....+++|+||+||.+.- ++..++.+.+..... -....|.+|+++|+++. |++|++++++ +..++||||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 577888777764432 11235789999999995 5889999886 346999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-c------------ccceeecceecCCCCcc
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-A------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-~------------kl~DFGla~~~~~~~~~ 870 (1007)
++|.+|.+.+.. ....++.|++++++|+ |..+|+|||+ + +|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764421 1134778999999999 6789999988 3 69999999865432210
Q ss_pred ------cc-----cccccCCcccccccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCc
Q 001838 871 ------SM-----QTQTLATIGYMAPEYGVQG-RVS-TRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 871 ------~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
.. ..-...++.|++|+...-. ..+ .+.+.++-|.-+|.++||..|.-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 0112367788888743221 233 567899999999999999998643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-14 Score=157.76 Aligned_cols=162 Identities=23% Similarity=0.296 Sum_probs=116.2
Q ss_pred eeEEEEEecCCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc------------cccceeecc
Q 001838 796 FKALIMEYMPNGSLENRLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV------------AHISDFSIA 861 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~------------~kl~DFGla 861 (1007)
..|+.|++|+..+|.+|+.+. ....++.....++.|++.|++| ++.+|++. .||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 3456788889999999999998 56788765 489999999
Q ss_pred eecCCCC----cccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCcchHHHHHHhhcCc
Q 001838 862 KFLNGQD----QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 862 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
....... .....+...||..||+||.+.+..|+.|+||||+|++++|+++ =..+++...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------
Confidence 8776443 2234466789999999999999999999999999999999997 233332210
Q ss_pred cHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001838 937 SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986 (1007)
Q Consensus 937 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl 986 (1007)
...++-|..+ ... .-...++-..++.+++.+.|.+||++.++.
T Consensus 468 t~~d~r~g~i-p~~------~~~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 468 TLTDIRDGII-PPE------FLQDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhhhhcCCC-ChH------HhhcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 0011111111 000 000112346788899999999999655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.5e-13 Score=137.09 Aligned_cols=117 Identities=15% Similarity=0.233 Sum_probs=90.0
Q ss_pred ccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhc-----CCCceeEEEEEEecCC---e-eE
Q 001838 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-----RHRNLVKIISACSNDD---F-KA 798 (1007)
Q Consensus 728 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~ 798 (1007)
+...+.||+|+||.||. +++....+||++........+.+.+|+.+++++ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 443333479988765333456789999999999 5799999999998863 3 34
Q ss_pred EEEEe--cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecccc
Q 001838 799 LIMEY--MPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHYMVA 853 (1007)
Q Consensus 799 lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~~~~ 853 (1007)
+|+|| +++|+|.+++.+.. ++.. ..++.+++.++ +|| |+.+|+|||++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlK 132 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYL---LDNRIVTMELK 132 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHH---HHCCEeecCCC
Confidence 78999 66899999997642 5554 35677888787 899 67889999874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-15 Score=161.43 Aligned_cols=175 Identities=34% Similarity=0.549 Sum_probs=102.3
Q ss_pred ccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCcccCcee
Q 001838 410 NLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRAL 489 (1007)
Q Consensus 410 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 489 (1007)
.++--...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++++..|.+|||+.|+++ .+|..+..++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445566777777776 56767777777777777777764 46666677777777777777776 4444444443 6666
Q ss_pred ecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEeccccccc
Q 001838 490 YLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE 569 (1007)
Q Consensus 490 ~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 569 (1007)
.+++|+++ .+|..++.+..|..||. |.|.|. .+|..++++.+|+.|++..|++.
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~------------------------s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDV------------------------SKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhh------------------------hhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 66666665 34444444444444444 455444 45555555555555555555554
Q ss_pred cccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccc
Q 001838 570 GPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617 (1007)
Q Consensus 570 ~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 617 (1007)
..|+.+..|+ |..||+|.|+++ .||-.|.+|..|++|-|.+|+|.
T Consensus 203 -~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 203 -DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred -hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 3344444433 555555555555 45555555555555555555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6e-14 Score=164.04 Aligned_cols=198 Identities=23% Similarity=0.296 Sum_probs=128.7
Q ss_pred cccccccceecccCceEEEEEEEcC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
.++|..++.|..|+||.||..+++. .+.+|.|+ .++.- ..+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence 3578889999999999999998774 67788843 32211 0000 33333344443
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC-----
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG----- 866 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~----- 866 (1007)
|+-...++.-+ .++. +.+.+++|+ |+.+|+||+.+ |+.|||+++..-.
T Consensus 136 ---gDc~tllk~~g-~lPv--------dmvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-PLPV--------DMVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCC-CCcc--------hhhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444443321 1222 127899999 88999999764 8999999986411
Q ss_pred ---CC-c---c-cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccH
Q 001838 867 ---QD-Q---L-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 867 ---~~-~---~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
.. . . -...+++||+.|+|||++....|...+|+|++|+|+||.+.|+.||++...++. +...+...
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~----- 274 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDD----- 274 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhh-----
Confidence 00 0 0 011456899999999999999999999999999999999999999987533221 11111110
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN 981 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 981 (1007)
+ ... +..+....++.+++.+.++.+|..|--
T Consensus 275 -------i-~wp----E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 275 -------I-EWP----EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -------c-ccc----ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0 000 001122446888889999999999853
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.3e-15 Score=159.54 Aligned_cols=193 Identities=29% Similarity=0.469 Sum_probs=167.4
Q ss_pred EEEeCCCCCccc-CcccccCCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCc
Q 001838 72 VLNISGFNLQGT-IPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150 (1007)
Q Consensus 72 ~L~L~~~~l~~~-~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N 150 (1007)
.|.|++..+... .+..=-.|..-...||+.|++. .+|..+..+..|+.|.|++|.+. .+|..+.++..|++||||.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 456777666521 1112245677788999999998 79999999999999999999984 67888999999999999999
Q ss_pred ccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCC
Q 001838 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIP 230 (1007)
Q Consensus 151 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 230 (1007)
+++ .+|..++ .|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|.+..|++. .+|
T Consensus 132 qlS-~lp~~lC-~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 132 QLS-HLPDGLC-DLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred hhh-cCChhhh-cCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 999 8999998 454 999999999998 78999999999999999999998 78899999999999999999999 778
Q ss_pred cccCCccccceeeccCccccccccccccCCCCCCeEEccccccc
Q 001838 231 QEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274 (1007)
Q Consensus 231 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 274 (1007)
.+++.| .|..||+|.|+++ .+|..|.+|+.|++|-|.+|.+.
T Consensus 206 ~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 888855 5899999999998 68999999999999999999884
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.1e-13 Score=160.15 Aligned_cols=186 Identities=23% Similarity=0.235 Sum_probs=144.0
Q ss_pred HhcccccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeEE
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR---HRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 723 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 799 (1007)
.--+.|.+.+.||+|+||+||+|...+|+.||+|+=++.... +|.-=.+++.+++ -+-|..+..++.-.+.-++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 334578888999999999999999888999999997765422 1111122333333 2345555555556667789
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------------ccceeec
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------------HISDFSI 860 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------------kl~DFGl 860 (1007)
|+||.+.|+|.+++. ....++|.-.+.++.|+++-+++| |..+|||.|++ +|+|||-
T Consensus 772 v~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999998 444689999999999999999999 78899999875 7999999
Q ss_pred ceecCCCCcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 001838 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915 (1007)
Q Consensus 861 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p 915 (1007)
+-.+.--.....-...++|-++-.+|...+..++..+|-|.+..+++-|+.|+.-
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9765321111222456788889999999999999999999999999999999853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.5e-12 Score=134.17 Aligned_cols=123 Identities=20% Similarity=0.323 Sum_probs=99.8
Q ss_pred ceecccCceEEEEEEEcCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
+.||+|++|.||+|.. +|..|+||+..... ......+.+|++++.+++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 57789999765321 11235688999999999999998877777777788999999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccceeeccee
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDFSIAKF 863 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~DFGla~~ 863 (1007)
++|++|.+++.... + .+..++.+++.++.++ |..+++|+|+. +++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 99999999986532 2 7788999999999999 57789999763 5788887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-12 Score=138.66 Aligned_cols=219 Identities=19% Similarity=0.224 Sum_probs=133.3
Q ss_pred cccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCC-----------CceeEEEEE-
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH-----------RNLVKIISA- 790 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-----------~niv~l~~~- 790 (1007)
.+...+.||.|+++.||.+++. +|+++|||++.... ....+++.+|.-....+.+ +-++.+--.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999987 48999999885322 2345667776655544332 112211111
Q ss_pred -------EecC---C-----eeEEEEEecCCCChhHhhh---cCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 001838 791 -------CSND---D-----FKALIMEYMPNGSLENRLY---SGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849 (1007)
Q Consensus 791 -------~~~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 849 (1007)
+... . ..+++|+-+. ++|.+++. .... .+....+..+..|+++.+++| |..++||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEe
Confidence 1111 1 1357788774 58888764 2211 234456677789999999999 6788999
Q ss_pred cccc------------ccceeecceecCCCCcccccccccCCccccccccccc--------CCCCchhhHHHHHHHHHHH
Q 001838 850 YMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ--------GRVSTRGDVYSYGIMLMET 909 (1007)
Q Consensus 850 ~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~el 909 (1007)
.++. +++||+....... .. .....+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--RY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE--EE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc--ee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 8764 7999987765432 11 11234578999997543 2478999999999999999
Q ss_pred HhCCCCCCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 001838 910 FTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKR 979 (1007)
Q Consensus 910 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 979 (1007)
.+|+.||+.......... +-. ... +.++.+.+|+..+|+++|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~---------------~f~---------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---------------DFS---------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---------------GGT---------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---------------cch---------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999985432211100 000 001 235578999999999999988
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.8e-12 Score=149.78 Aligned_cols=130 Identities=16% Similarity=0.232 Sum_probs=102.5
Q ss_pred HHhcccccccceecccCceEEEEEEEcCCceEEEEEe-chh-------hHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Q 001838 722 LQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVF-HQR-------YERALKSFQDECEVMKRIRHRNLVKIISACSN 793 (1007)
Q Consensus 722 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 793 (1007)
......|...+.||+|+||+||+|.+.+. .+++|+. .+. .....+++.+|++++++++|++|+....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445567789999999999999987644 4444432 211 11223568899999999999999988888887
Q ss_pred CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccceeecce
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDFSIAK 862 (1007)
Q Consensus 794 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~DFGla~ 862 (1007)
.+..++||||+++++|.+++. ....++.++++++.|| |+.+++|||++ +++|||+++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl~~~~~~liDFGla~ 475 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIVRDDRLYLIDFGLGK 475 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEEECCcEEEEeCcccc
Confidence 778899999999999998875 3567899999999999 57899999874 789999998
Q ss_pred ec
Q 001838 863 FL 864 (1007)
Q Consensus 863 ~~ 864 (1007)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-12 Score=148.51 Aligned_cols=214 Identities=29% Similarity=0.445 Sum_probs=148.8
Q ss_pred ccccceEeCCCCCcEE---EEEeCCCCCcccCcccccCCCCCCEEEcCCCCCCCCCCccccCcc-cCcEEeccCcccCCc
Q 001838 56 CSWIGITCGVNSHKVI---VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMH-TLKLLDFRDNQLFGS 131 (1007)
Q Consensus 56 C~w~gv~c~~~~~~v~---~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ 131 (1007)
+.+.+..+... ... .++++.+.+... ...+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++...
T Consensus 80 ~~~l~~~~~~~--~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l 155 (394)
T COG4886 80 ISSLDGSENLL--NLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESL 155 (394)
T ss_pred ccccccccccc--CCCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhh
Confidence 45555555432 222 467777766433 233445577888888888887 5666666674 888888888887533
Q ss_pred chhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCccccc
Q 001838 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGN 211 (1007)
Q Consensus 132 ~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 211 (1007)
|..+.++++|+.|++++|+++ .+|.... .+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+.+
T Consensus 156 -~~~~~~l~~L~~L~l~~N~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~ 230 (394)
T COG4886 156 -PSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230 (394)
T ss_pred -hhhhhccccccccccCCchhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhh
Confidence 356777888888888888887 6776553 5778888888888887 56666566666888888888543 45666777
Q ss_pred ccccceEEcccCcCCCCCCcccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchh
Q 001838 212 LTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI 281 (1007)
Q Consensus 212 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~ 281 (1007)
+.++..+.+.+|++. .++..++.+++++.|++++|.++.+.+ +..+.+++.|++++|.+...+|...
T Consensus 231 ~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 788888888888877 346667777778888888888876554 6777777777777777765555443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.8e-12 Score=129.06 Aligned_cols=120 Identities=18% Similarity=0.334 Sum_probs=94.4
Q ss_pred eecccCceEEEEEEEcCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEec
Q 001838 733 LLGIGSFGSVYVARLQDGMEVAVKVFHQRY--------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 733 ~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~ 804 (1007)
.||+|+||+||+|.+ +|..|++|+..... ....+++.+|++++.+++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999864321 122466789999999999887665555556666779999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-----------cccceeecceec
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-----------AHISDFSIAKFL 864 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-----------~kl~DFGla~~~ 864 (1007)
+|++|.+.+..... .++.++++++.++ |+.+++|+|+ +++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 99999988754321 7899999999999 6789999876 378999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=129.80 Aligned_cols=131 Identities=18% Similarity=0.142 Sum_probs=97.8
Q ss_pred ccccccceecccCceEEEEEE--EcCCceEEEEEechhhH------------------------HHHHHHHHHHHHHHhc
Q 001838 726 DRFSKNNLLGIGSFGSVYVAR--LQDGMEVAVKVFHQRYE------------------------RALKSFQDECEVMKRI 779 (1007)
Q Consensus 726 ~~~~~~~~ig~G~~g~Vy~~~--~~~g~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 779 (1007)
..|+..+.||+|+||.||+|. ..+|+.||||+++.... .....+..|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347778999999999999998 55799999999874310 0123467899999999
Q ss_pred CCC--ceeEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecccc---
Q 001838 780 RHR--NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP-IIHYMVA--- 853 (1007)
Q Consensus 780 ~H~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~~~~--- 853 (1007)
.+. .+.+++++ ...++||||++++++........ ..+......++.|++.++.|| |..+ |+|+|++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhh
Confidence 753 34444543 23589999999988876653322 345556678999999999999 5677 9999763
Q ss_pred --------ccceeecceec
Q 001838 854 --------HISDFSIAKFL 864 (1007)
Q Consensus 854 --------kl~DFGla~~~ 864 (1007)
+++|||.|...
T Consensus 180 Ili~~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVHDGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEECCCEEEEEChhhhcc
Confidence 78999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-13 Score=160.61 Aligned_cols=246 Identities=21% Similarity=0.231 Sum_probs=181.6
Q ss_pred cccccccceecccCceEEEEEEEc--CCceEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEE
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ--DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 799 (1007)
...|...+.||+|+|+.|-..... ....+|+|.+.... ....++...|..+=+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346777888999999999888754 24557777665432 233344556777777776 9999999999999999999
Q ss_pred EEEecCCCChhHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-------------cccceeecceecC
Q 001838 800 IMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-------------AHISDFSIAKFLN 865 (1007)
Q Consensus 800 v~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-------------~kl~DFGla~~~~ 865 (1007)
++||..+|++.+-+ .......+.....++..|+..++.|+|. ..++.|+++ .|++|||+|....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5544345666777899999999999941 777888755 3799999998876
Q ss_pred C-CCcccccccccC-CcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHHh
Q 001838 866 G-QDQLSMQTQTLA-TIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 866 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 942 (1007)
. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|........
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 5 333333445678 9999999998874 4577899999999999999999999876555554555543321000
Q ss_pred hhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
. ...........++..+++..+|+.|.+.+++...
T Consensus 252 ---~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 ---Q--------LPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---c--------CccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 0011112356788888999999999998887654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.3e-11 Score=124.05 Aligned_cols=133 Identities=22% Similarity=0.184 Sum_probs=98.4
Q ss_pred HHHHHhcccccccceecccCceEEEEEEEcCCceEEEEEechhhH----------------------HHHHHHHHHHHHH
Q 001838 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE----------------------RALKSFQDECEVM 776 (1007)
Q Consensus 719 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l 776 (1007)
.++.+.-..|...+.||+|+||.||+|..++|+.||||++..... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444444778899999999999999988899999998753210 0112367899999
Q ss_pred HhcCCCc--eeEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc--
Q 001838 777 KRIRHRN--LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMV-- 852 (1007)
Q Consensus 777 ~~l~H~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~-- 852 (1007)
.++.|++ +.+.++. ...++||||+++++|.+.... ....+++.+++.++.++| ..+|+|+|+
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence 9998874 4444442 345899999999999765431 234568899999999995 588999976
Q ss_pred ----------cccceeecceecC
Q 001838 853 ----------AHISDFSIAKFLN 865 (1007)
Q Consensus 853 ----------~kl~DFGla~~~~ 865 (1007)
++|+|||.+....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 3899999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.4e-12 Score=143.10 Aligned_cols=182 Identities=40% Similarity=0.569 Sum_probs=96.9
Q ss_pred hccCCCcEEEccCCeeccccchhhhhcc-ccCccccCCCccCCCCchhhhcccccceeecccccccCCCCCCCCCcccCc
Q 001838 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLL-NLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLR 487 (1007)
Q Consensus 409 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 487 (1007)
..++.++.|++.+|.++ .+|.....+. +|+.|++++|++.. +|..+..+++|+.|++++|+++ .+|...+.+++|+
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 33455666666666665 3344444442 55556666665542 3334455555555555555555 2333333445555
Q ss_pred eeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEeccccc
Q 001838 488 ALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNR 567 (1007)
Q Consensus 488 ~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 567 (1007)
.|++++|+++. +|..+ +.+..|++|++++|++. .++..+..++++..|.+++|+
T Consensus 190 ~L~ls~N~i~~-l~~~~------------------------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 190 NLDLSGNKISD-LPPEI------------------------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred heeccCCcccc-Cchhh------------------------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence 55555555542 33332 33334555555555432 445555666666666666666
Q ss_pred cccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccccccCC
Q 001838 568 LEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622 (1007)
Q Consensus 568 l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ip~ 622 (1007)
+. .+|..++.+++|+.|++++|+++... . +..+.+++.|++++|.+....|.
T Consensus 244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~i~-~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 244 LE-DLPESIGNLSNLETLDLSNNQISSIS-S-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ee-eccchhccccccceeccccccccccc-c-ccccCccCEEeccCccccccchh
Confidence 65 23555566666666666666666332 2 55666666666666666654443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.3e-11 Score=115.68 Aligned_cols=124 Identities=19% Similarity=0.224 Sum_probs=102.1
Q ss_pred ccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCC--CceeEEEEEEecCCeeEEEEEecCCC
Q 001838 730 KNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH--RNLVKIISACSNDDFKALIMEYMPNG 807 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~E~~~~g 807 (1007)
+.+.||+|.++.||++...+ ..++||....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999864 7899999876543 4578899999999976 59999999988888899999999998
Q ss_pred ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceec
Q 001838 808 SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 808 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~ 864 (1007)
.+..+ +......++.+++++++++|..+..+++|+|+. ++.|||.++..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77654 456677789999999999987666789998753 67888877643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=131.90 Aligned_cols=214 Identities=21% Similarity=0.303 Sum_probs=131.3
Q ss_pred CCCCCCEEEcCCCCCCCCCC--ccccCcccCcEEeccCcccCCcch--hhhhhcCCCCeecccCcccCCCCchhHhhcCC
Q 001838 90 NLSSLETLDLSHNKLSGNIP--SSIFNMHTLKLLDFRDNQLFGSLS--SFIFNMSSMLGIDLSINRFSGELPANICKNLP 165 (1007)
Q Consensus 90 ~l~~L~~LdLs~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~ 165 (1007)
++++|+...|.+..+. ..+ +....+++++.||||+|-+....+ .....|++|+.|+||.|++.-......-..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4667888888777665 222 356678888888888888876544 34567888888888888887555555545677
Q ss_pred CCcEEEccCcccccc-CCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCC--cccCCcccccee
Q 001838 166 NLKKLLLGRNMFHGK-IPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIP--QEMGNLPYLVRL 242 (1007)
Q Consensus 166 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L 242 (1007)
.|+.|.|+.|.|+.. +-.....+++|+.|+|.+|..-.........+..|+.|+|++|++- ..+ ...+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence 788888888887732 1122456778888888888533333344556677888888888776 333 335667777777
Q ss_pred eccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCC-CccccccCCCCEEEecCCC
Q 001838 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI-PSSITNASKLTVFQLRGNS 321 (1007)
Q Consensus 243 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~ 321 (1007)
.++.+.+..+--... .++ .....+++|++|+++.|++...- -..+..+.+|+.|....|.
T Consensus 277 nls~tgi~si~~~d~---~s~----------------~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ 337 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDV---ESL----------------DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNY 337 (505)
T ss_pred hccccCcchhcCCCc---cch----------------hhhcccccceeeecccCccccccccchhhccchhhhhhccccc
Confidence 777776654321111 000 00123566666666666664210 1123334556666666666
Q ss_pred cCC
Q 001838 322 FSG 324 (1007)
Q Consensus 322 l~~ 324 (1007)
++.
T Consensus 338 ln~ 340 (505)
T KOG3207|consen 338 LNK 340 (505)
T ss_pred ccc
Confidence 653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-11 Score=129.61 Aligned_cols=188 Identities=29% Similarity=0.361 Sum_probs=98.3
Q ss_pred hcCCCCcEEEccCccccccCC--ccccCCCCCcEEEcccccCCCCCCccc-ccccccceEEcccCcCCCC-CCcccCCcc
Q 001838 162 KNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGE-IPQEMGNLP 237 (1007)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~p~~~~~l~ 237 (1007)
..+++++.||||+|-|+...| .....|++|+.|+|+.|.+........ ..+++|+.|.|+.+.|+.. +-.....+|
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 345555555555555442111 123345555555555555542211111 1345666667766666521 122234567
Q ss_pred ccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCCCCcEEeccCCCCCCCC-Ccc-----ccccCC
Q 001838 238 YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI-PSS-----ITNASK 311 (1007)
Q Consensus 238 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~ 311 (1007)
+|+.|+|..|............++.|+.|||++|++...-.-.....+|.|+.|+++.+.++..- |+. ...+++
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 77777777775444444445556667777777776632211112235677777777777666432 221 234567
Q ss_pred CCEEEecCCCcCCCC-CcccccccccccccccccccccC
Q 001838 312 LTVFQLRGNSFSGFI-PNTIGNLRNLEFLNIADNYLTSS 349 (1007)
Q Consensus 312 L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ 349 (1007)
|++|+++.|++.... -..+..+++|+.|.+..|.++..
T Consensus 303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred ceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 777777777774221 12334455666666666666653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-10 Score=113.95 Aligned_cols=110 Identities=29% Similarity=0.351 Sum_probs=28.4
Q ss_pred ccCCCCCCEEEcCCCCCCCCCCcccc-CcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCC
Q 001838 88 LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPN 166 (1007)
Q Consensus 88 l~~l~~L~~LdLs~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~ 166 (1007)
+.+...+++|+|++|.|+.+ +.++ .+.+|+.|||++|+|+... .+..++.|++|++++|+|+ .+++.+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 33444567777777777632 2344 4566677777777665432 2444555666666666665 454444345666
Q ss_pred CcEEEccCccccccCC-ccccCCCCCcEEEcccccCC
Q 001838 167 LKKLLLGRNMFHGKIP-STLSKCKQLEGLYLRFNNLS 202 (1007)
Q Consensus 167 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 202 (1007)
|++|+|++|+|...-. ..++.+++|++|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 6666666666653211 23444555555555555544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-10 Score=118.01 Aligned_cols=189 Identities=24% Similarity=0.264 Sum_probs=124.2
Q ss_pred HHHhcCCCceeEEEEEEecC-----CeeEEEEEecCCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001838 775 VMKRIRHRNLVKIISACSND-----DFKALIMEYMPNGSLENRLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTP 846 (1007)
Q Consensus 775 ~l~~l~H~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 846 (1007)
-+-.+.|.|||+++.|+.+. .+..++.|||+.|++.++|++- ...+......+++-||..||.|||. +.++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 34456799999999998653 3578899999999999999752 2346666777899999999999986 7889
Q ss_pred ceecccc----ccceeecceecCC--CCcc--------cccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhC
Q 001838 847 IIHYMVA----HISDFSIAKFLNG--QDQL--------SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTG 912 (1007)
Q Consensus 847 ivH~~~~----kl~DFGla~~~~~--~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG 912 (1007)
|+|.... -+.-=|+.+.-.. +... .......|-++|.|||+-.....+..+|||+||....||..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9997432 2222233332110 0000 001123467899999998888888999999999999999988
Q ss_pred CCC-CCccccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 913 KKP-TDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 913 ~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
..- ...... . ...+.+...+...... .=.+++.+|++..|..||+|++.+.+
T Consensus 279 Eiq~tnseS~---~-----------~~ee~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESK---V-----------EVEENIANVIIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcce---e-----------ehhhhhhhheeeccCc----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 653 221100 0 0111111111111100 01346678999999999999998765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-10 Score=111.15 Aligned_cols=123 Identities=28% Similarity=0.314 Sum_probs=52.6
Q ss_pred cEEEEEeCCCCCcccCccccc-CCCCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecc
Q 001838 69 KVIVLNISGFNLQGTIPPQLG-NLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147 (1007)
Q Consensus 69 ~v~~L~L~~~~l~~~~~~~l~-~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL 147 (1007)
+.+.|+|++|.|+.. +.++ .+.+|+.||||+|.|+.. + .+..++.|+.|++++|+|+...+.....+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 578899999999843 4566 588999999999999954 3 5888999999999999998775544467999999999
Q ss_pred cCcccCCCCchhHhhcCCCCcEEEccCccccccCCc----cccCCCCCcEEEc
Q 001838 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS----TLSKCKQLEGLYL 196 (1007)
Q Consensus 148 s~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L 196 (1007)
++|+|...-.-.....+++|++|+|.+|.++.. +. .+..+|+|+.||-
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 999997422223345799999999999999843 33 2566778887774
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.1e-11 Score=121.20 Aligned_cols=128 Identities=29% Similarity=0.289 Sum_probs=69.4
Q ss_pred CCCCEEEcCCCCCCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEE
Q 001838 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLL 171 (1007)
Q Consensus 92 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~ 171 (1007)
+.|++||||+|.|+ .+.++..-++.++.|++|+|.|...-. +..|++|+.||||+|.++ .+.. +-..|-|.+.|.
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~G-wh~KLGNIKtL~ 358 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVG-WHLKLGNIKTLK 358 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhh-hHhhhcCEeeee
Confidence 46777777777777 566666667777777777777753322 555666666666666665 2222 222455566666
Q ss_pred ccCccccccCCccccCCCCCcEEEcccccCCCCC-CcccccccccceEEcccCcCC
Q 001838 172 LGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAI-PKEIGNLTKLKDIILNDNELR 226 (1007)
Q Consensus 172 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 226 (1007)
|+.|.|... +.+.++-+|+.||+++|++.... -..+++++-|+++.|.+|.+.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 666655421 23344445555555555554211 123444444444444444444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.4e-09 Score=110.88 Aligned_cols=126 Identities=21% Similarity=0.254 Sum_probs=86.0
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhH--HHHHH----------------------HHHHHHHHHhcCCCc--e
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE--RALKS----------------------FQDECEVMKRIRHRN--L 784 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~----------------------~~~E~~~l~~l~H~n--i 784 (1007)
.+.||+|+||+||+|...+|+.||||++..... ..... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999864321 11111 135666677765433 4
Q ss_pred eEEEEEEecCCeeEEEEEecCCCChhHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc----------
Q 001838 785 VKIISACSNDDFKALIMEYMPNGSLENR-LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------- 853 (1007)
Q Consensus 785 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------- 853 (1007)
.+.+++ ...++||||+++|.+... +.... .. .+...++.+++.++.++| .+.+|+|+|+.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh--~~~~ivH~Dl~p~Nili~~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY--REAGLVHGDLSEYNILVDDGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh--hccCcCcCCCChhhEEEECCc
Confidence 445543 235899999999654321 11111 11 456789999999999995 23899999763
Q ss_pred -ccceeecceecC
Q 001838 854 -HISDFSIAKFLN 865 (1007)
Q Consensus 854 -kl~DFGla~~~~ 865 (1007)
+++|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 899999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-10 Score=133.19 Aligned_cols=173 Identities=34% Similarity=0.401 Sum_probs=80.0
Q ss_pred hccCCCcEEEccCCeeccccchhhhhccccCccccCCCccCCCCchhhhcccccceeecccccccCCCC-CCCCCcccCc
Q 001838 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIP-SCSGNLTSLR 487 (1007)
Q Consensus 409 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 487 (1007)
..+.+|++|||++|+|+...+ +..+..|+.|++++|.++.. ..+..+.+|+.+++++|++...-+ . ...+.+++
T Consensus 115 ~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~ 189 (414)
T KOG0531|consen 115 SSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLE 189 (414)
T ss_pred hhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchH
Confidence 345555566666666554332 23333455555555555432 223334555555555555543222 1 23444555
Q ss_pred eeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCC--CccEEeccc
Q 001838 488 ALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLK--NLQKLFLAN 565 (1007)
Q Consensus 488 ~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~ 565 (1007)
.+++++|.+... ..+..+..+..+ ++..|.++-.-+ +..+. .|+.+++++
T Consensus 190 ~l~l~~n~i~~i--~~~~~~~~l~~~------------------------~l~~n~i~~~~~--l~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 190 ELDLGGNSIREI--EGLDLLKKLVLL------------------------SLLDNKISKLEG--LNELVMLHLRELYLSG 241 (414)
T ss_pred HHhccCCchhcc--cchHHHHHHHHh------------------------hcccccceeccC--cccchhHHHHHHhccc
Confidence 555555554321 112222223333 444444431111 11111 255666666
Q ss_pred cccccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCccc
Q 001838 566 NRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617 (1007)
Q Consensus 566 N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 617 (1007)
|++. .++..+..+..+..||+++|+++.. ..+.....+..+.++.|++.
T Consensus 242 n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 242 NRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred Cccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 6665 3334455556666666666666643 22334445555566666654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-10 Score=132.83 Aligned_cols=200 Identities=27% Similarity=0.232 Sum_probs=89.3
Q ss_pred CCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCC-cccCCcccccee
Q 001838 164 LPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIP-QEMGNLPYLVRL 242 (1007)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 242 (1007)
+++|++|+|++|+|+.+. .+..++.|+.|++++|.++.. ..+..+.+|+.+++++|++....+ . ...+.+++.+
T Consensus 117 ~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l 191 (414)
T KOG0531|consen 117 LVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEEL 191 (414)
T ss_pred hhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHH
Confidence 444555555555544321 233334455555555554421 223334455555555555543222 1 3444555555
Q ss_pred eccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCCC--CCcEEeccCCCCCCCCCccccccCCCCEEEecCC
Q 001838 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLP--NVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGN 320 (1007)
Q Consensus 243 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 320 (1007)
+++.|.+..+.. +..+..+..+++..|.+...-+.. .++ .|+.+++++|.+.. .+..+..+..+..|++++|
T Consensus 192 ~l~~n~i~~i~~--~~~~~~l~~~~l~~n~i~~~~~l~---~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n 265 (414)
T KOG0531|consen 192 DLGGNSIREIEG--LDLLKKLVLLSLLDNKISKLEGLN---ELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSN 265 (414)
T ss_pred hccCCchhcccc--hHHHHHHHHhhcccccceeccCcc---cchhHHHHHHhcccCcccc-ccccccccccccccchhhc
Confidence 555555443221 122223333344444442111100 111 25566666666653 2234555666677777777
Q ss_pred CcCCCCCcccccccccccccccccccccCCCCccccccccccccccEEEccCCCCCC
Q 001838 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDG 377 (1007)
Q Consensus 321 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~ 377 (1007)
++... ..+.....+..+....|.+....... ..........++.+.+..|+...
T Consensus 266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 266 RISNL--EGLERLPKLSELWLNDNKLALSEAIS-QEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred ccccc--ccccccchHHHhccCcchhcchhhhh-ccccccccccccccccccCcccc
Confidence 66543 22444555666666666655321110 00112333445555566665544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-10 Score=116.68 Aligned_cols=132 Identities=27% Similarity=0.269 Sum_probs=88.3
Q ss_pred cccCceeecCCcccccCCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccEEe
Q 001838 483 LTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562 (1007)
Q Consensus 483 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 562 (1007)
...|+.+|||+|.|+ .+.....-++.++.|++|+|.+...- .+..+.+|+.||||+|.++ .+..+-..|.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344555666666554 24444444556666666666654322 2455677777888888776 4555556677888888
Q ss_pred ccccccccccCccCcCCCCCCEEECCCCcccccC-CcchhhhcCCCeeeCcCCcccccc
Q 001838 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVI-PTSLEKLLYLKKLNLSFNKLEGEI 620 (1007)
Q Consensus 563 Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~-p~~l~~l~~L~~L~ls~N~l~~~i 620 (1007)
|+.|.|... ..+..+-+|..||+++|+|.... -..+++||-|+.+.|.+|++.+.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 888888633 34566778888999999887432 245778888899999999988643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-09 Score=123.52 Aligned_cols=237 Identities=22% Similarity=0.208 Sum_probs=165.1
Q ss_pred cccccceecc--cCceEEEEEEE--c-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeE
Q 001838 727 RFSKNNLLGI--GSFGSVYVARL--Q-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 727 ~~~~~~~ig~--G~~g~Vy~~~~--~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 798 (1007)
.|.....+|+ |.+|.||.+.. . ++..+|+|+-+... ......=.+|....++++ |+|.|+.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555678999 99999999986 3 58889999844322 122233356777777885 999999999999999999
Q ss_pred EEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceeccc-------------cccceeecc
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL----ALEYLHFGHSTPIIHYMV-------------AHISDFSIA 861 (1007)
Q Consensus 799 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~~~-------------~kl~DFGla 861 (1007)
+-.|+|. .++.++.+.....++......+..+..+ |+.++ |+..++|.++ .+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCccee
Confidence 9999996 6888888766556777778888888888 99988 7888999644 378999999
Q ss_pred eecCCCCcccc---cccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccH
Q 001838 862 KFLNGQDQLSM---QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 862 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
..+....-... .....|...|++||.. .+-++.+.|+||+|.+..|..+|..+....... .|.....-.-.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~~r~~~ip 344 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQLRQGYIP 344 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----CccccccccCc
Confidence 98865432211 1223567789999974 456789999999999999999987654321111 12111000000
Q ss_pred HHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001838 939 MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~ 988 (1007)
.+..+. ...++......+++++|..|++++++...
T Consensus 345 ~e~~~~---------------~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 345 LEFCEG---------------GSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhhcC---------------cchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 011100 01223347778999999999998876653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.1e-08 Score=107.89 Aligned_cols=124 Identities=12% Similarity=0.162 Sum_probs=92.0
Q ss_pred cceec-ccCceEEEEEEEcCCceEEEEEechhh-------------HHHHHHHHHHHHHHHhcCCCce--eEEEEEEecC
Q 001838 731 NNLLG-IGSFGSVYVARLQDGMEVAVKVFHQRY-------------ERALKSFQDECEVMKRIRHRNL--VKIISACSND 794 (1007)
Q Consensus 731 ~~~ig-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 794 (1007)
...|| .||.|+||++... +..+|||++.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999875 7789999885311 1223567889999999998875 6777765432
Q ss_pred C----eeEEEEEecCC-CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccce
Q 001838 795 D----FKALIMEYMPN-GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISD 857 (1007)
Q Consensus 795 ~----~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~D 857 (1007)
. ..++||||++| .+|.+++... .++.. .+.+++.++.+| |..+|+|+|++ +++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6999888653 24432 356899999999 67899999764 6889
Q ss_pred eecceec
Q 001838 858 FSIAKFL 864 (1007)
Q Consensus 858 FGla~~~ 864 (1007)
||.++..
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9987753
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-09 Score=79.83 Aligned_cols=40 Identities=40% Similarity=0.959 Sum_probs=30.6
Q ss_pred cchHHHHHHHHHhcccCCCCccccCCCCC--CCCccccceEeC
Q 001838 24 TTDQQSLLALKAHISYDPTNLFAKNWTSS--TSVCSWIGITCG 64 (1007)
Q Consensus 24 ~~~~~~ll~~k~~~~~~~~~~~~~~w~~~--~~~C~w~gv~c~ 64 (1007)
+.|++||++||+++..+|.+.+. +|..+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~-~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLS-SWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCT-T--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccc-cCCCcCCCCCeeeccEEeC
Confidence 47999999999999877877777 99987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-09 Score=86.69 Aligned_cols=60 Identities=45% Similarity=0.649 Sum_probs=37.1
Q ss_pred CccEEeccccccccccCccCcCCCCCCEEECCCCcccccCCcchhhhcCCCeeeCcCCcc
Q 001838 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616 (1007)
Q Consensus 557 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ls~N~l 616 (1007)
+|++|++++|+|+...++.|.++++|++||+++|+|+...|..|..+++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666655555666666666666666666666666666666666666666654
|
... |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-08 Score=117.51 Aligned_cols=129 Identities=23% Similarity=0.226 Sum_probs=86.2
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhHHH----------------------------------------HHHHH
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERA----------------------------------------LKSFQ 770 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~ 770 (1007)
.+.||+|++|.||+|++++|+.||||+.++...+. .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986431100 00255
Q ss_pred HHHHHHHhcC----CCceeEEEEEEe-cCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 001838 771 DECEVMKRIR----HRNLVKIISACS-NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALA-LEYLHFGHS 844 (1007)
Q Consensus 771 ~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~-l~yLH~~~~ 844 (1007)
+|++.+.+++ |.+-|.+-.++. .....+|||||++|++|.++........ .+.+++..++++ +..+ |.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---Hh
Confidence 5666666653 333333333332 2345799999999999988765322122 234566666653 4555 67
Q ss_pred CCceeccc------------cccceeecceecC
Q 001838 845 TPIIHYMV------------AHISDFSIAKFLN 865 (1007)
Q Consensus 845 ~~ivH~~~------------~kl~DFGla~~~~ 865 (1007)
.+++|+|. .++.|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 78999865 3799999998775
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.5e-10 Score=116.98 Aligned_cols=217 Identities=27% Similarity=0.359 Sum_probs=115.4
Q ss_pred ccccCCCCCCEEEcCCCCCCCC----CCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhH-
Q 001838 86 PQLGNLSSLETLDLSHNKLSGN----IPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANI- 160 (1007)
Q Consensus 86 ~~l~~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~- 160 (1007)
+.+.....++.++||+|.|... +...+.+.++|+.-++|+= ++|.+- ..+|+.+
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~--------------------~Ei~e~L~ 82 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLK--------------------DEIPEALK 82 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcH--------------------HHHHHHHH
Confidence 3455566777888888877532 3445556666776666542 222111 1122211
Q ss_pred -----hhcCCCCcEEEccCccccccCCcc----ccCCCCCcEEEcccccCCCCC-------------CcccccccccceE
Q 001838 161 -----CKNLPNLKKLLLGRNMFHGKIPST----LSKCKQLEGLYLRFNNLSGAI-------------PKEIGNLTKLKDI 218 (1007)
Q Consensus 161 -----~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L 218 (1007)
....+.|++||||.|-|.-.-+.. +.++..|++|+|.+|.+.-.- -.-.++-++|+++
T Consensus 83 ~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~ 162 (382)
T KOG1909|consen 83 MLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVF 162 (382)
T ss_pred HHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEE
Confidence 113445555555555554222222 334556666666666554110 1112334578888
Q ss_pred EcccCcCCCC----CCcccCCccccceeeccCccccc----cccccccCCCCCCeEEcccccccCcCCc---hhhcCCCC
Q 001838 219 ILNDNELRGE----IPQEMGNLPYLVRLTLATNNLVG----VVPFTIFNMSTLKKLSLLENTLWGSLPS---RIDLSLPN 287 (1007)
Q Consensus 219 ~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~lp~---~~~~~l~~ 287 (1007)
+..+|++... +...|...+.|+.+.++.|.|.. .....|..+++|+.|||.+|.++..-.. .....++.
T Consensus 163 i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~ 242 (382)
T KOG1909|consen 163 ICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPH 242 (382)
T ss_pred EeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccch
Confidence 8888887642 22345666778888888887642 1234456777777777777776422111 11224556
Q ss_pred CcEEeccCCCCCCCCCcccc-----ccCCCCEEEecCCCcC
Q 001838 288 VEFLNLGTNRFSGNIPSSIT-----NASKLTVFQLRGNSFS 323 (1007)
Q Consensus 288 L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~ 323 (1007)
|+.|+++++.+...-..+|. ..++|++|.+.+|.++
T Consensus 243 L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 243 LRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred heeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 66777766666543222221 2345566666666554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.2e-08 Score=112.40 Aligned_cols=155 Identities=17% Similarity=0.222 Sum_probs=111.5
Q ss_pred EcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEecCCCChhHhhhcCCCCCCHHHHH
Q 001838 747 LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL 826 (1007)
Q Consensus 747 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~ 826 (1007)
..++.+|.|...+.......+...+-++.++.+|||||++++..++.++..|+|+|-+. .|..++.+.. .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 45788999998876655444556778899999999999999999999999999999985 5777776532 34445
Q ss_pred HHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCCCCcccccccccCCcccccccccccCCCC
Q 001838 827 NIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894 (1007)
Q Consensus 827 ~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 894 (1007)
-.+.||+.||.||| +...++|..+. ||++|-++.....-.. ......---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 57899999999998 67889998664 6777776654322111 001111122366676543322
Q ss_pred chhhHHHHHHHHHHHHhCC
Q 001838 895 TRGDVYSYGIMLMETFTGK 913 (1007)
Q Consensus 895 ~~~DvwS~Gvil~elltG~ 913 (1007)
-..|.|-|||+++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=6e-09 Score=84.18 Aligned_cols=59 Identities=34% Similarity=0.436 Sum_probs=27.1
Q ss_pred CCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCc
Q 001838 166 NLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNE 224 (1007)
Q Consensus 166 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 224 (1007)
+|++|++++|+|+...++.|.++++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444433444444444444444444444444444444444444444443
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-09 Score=113.28 Aligned_cols=230 Identities=21% Similarity=0.297 Sum_probs=161.4
Q ss_pred CcEEEEEeCCCCCcc----cCcccccCCCCCCEEEcCCCCCCC----CCCc-------cccCcccCcEEeccCcccCCcc
Q 001838 68 HKVIVLNISGFNLQG----TIPPQLGNLSSLETLDLSHNKLSG----NIPS-------SIFNMHTLKLLDFRDNQLFGSL 132 (1007)
Q Consensus 68 ~~v~~L~L~~~~l~~----~~~~~l~~l~~L~~LdLs~N~l~~----~~p~-------~~~~l~~L~~L~Ls~N~l~~~~ 132 (1007)
..++.|+||||.|.- .+.+.+.+.++|+.-++|. -++| .+|+ ++-..++|++||||+|.|.-..
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 368999999998853 3556677788888888874 3343 3443 3445568999999999886544
Q ss_pred hh----hhhhcCCCCeecccCcccCCCCchhH-------------hhcCCCCcEEEccCcccccc----CCccccCCCCC
Q 001838 133 SS----FIFNMSSMLGIDLSINRFSGELPANI-------------CKNLPNLKKLLLGRNMFHGK----IPSTLSKCKQL 191 (1007)
Q Consensus 133 ~~----~~~~l~~L~~LdLs~N~l~~~ip~~~-------------~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 191 (1007)
+. .+....+|++|.|.+|.+. ..-... ...-+.|+++..++|++..- +...|...+.|
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 43 3455678889999999885 222111 12457799999999998632 22346677899
Q ss_pred cEEEcccccCCC----CCCcccccccccceEEcccCcCCCC----CCcccCCccccceeeccCcccccccccccc-----
Q 001838 192 EGLYLRFNNLSG----AIPKEIGNLTKLKDIILNDNELRGE----IPQEMGNLPYLVRLTLATNNLVGVVPFTIF----- 258 (1007)
Q Consensus 192 ~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----- 258 (1007)
+.+.++.|.+.. .+...|..+++|++|+|.+|-++.. +...+..+++|+.|+++++.+...-...|.
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~ 267 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKE 267 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhc
Confidence 999999998842 1234577889999999999988743 345677788999999999988754433332
Q ss_pred CCCCCCeEEcccccccCcCCch---hhcCCCCCcEEeccCCCCC
Q 001838 259 NMSTLKKLSLLENTLWGSLPSR---IDLSLPNVEFLNLGTNRFS 299 (1007)
Q Consensus 259 ~l~~L~~L~L~~N~l~~~lp~~---~~~~l~~L~~L~Ls~N~l~ 299 (1007)
..++|+.|.+.+|.+...--.. .....|.|+.|+|++|++.
T Consensus 268 ~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 268 SAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 3678999999999875321111 1124788999999999994
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.9e-08 Score=118.07 Aligned_cols=128 Identities=25% Similarity=0.217 Sum_probs=77.7
Q ss_pred cEEEEEeCCCCCcccCcccccCCCCCCEEEcCCCC--CCCCCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeec
Q 001838 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNK--LSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGID 146 (1007)
Q Consensus 69 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~LdLs~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ld 146 (1007)
.+....+-+|++. .++.+.. .+.|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++||
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 3444445555544 2222222 2256677676665 4433334456677777777776665566677777777777777
Q ss_pred ccCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEccccc
Q 001838 147 LSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNN 200 (1007)
Q Consensus 147 Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 200 (1007)
|++..++ .+|.++. +|..|.+|++..+.-...+|.....+.+|++|.+..-.
T Consensus 602 L~~t~I~-~LP~~l~-~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLG-NLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccCCCcc-ccchHHH-HHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 7777776 6777664 57777777777666555556666667777777766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.5e-09 Score=121.74 Aligned_cols=238 Identities=21% Similarity=0.269 Sum_probs=153.6
Q ss_pred hcccccccceecccCceEEEEEEEc-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 724 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
..+.+.+.+-+-+|+++.++-+.-. .|...++|...... ....+....+-.+.-..+||-+++...-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666777888999999987643 35445555443221 1112333444444444567878877666666778899
Q ss_pred EEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc------------ccceeecceecCC-
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG- 866 (1007)
Q Consensus 800 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~------------kl~DFGla~~~~~- 866 (1007)
|++|..+|+|...++...+ .+..........+.++.+|| |+..++|++.+ +++|||..+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999999987553 33333344566788999999 56668888654 6888884332110
Q ss_pred -----C-----------------------CcccccccccCCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 001838 867 -----Q-----------------------DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918 (1007)
Q Consensus 867 -----~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~ 918 (1007)
. +.........||+.|.|||...+......+|+|+.|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 000112345789999999999999999999999999999999999999986
Q ss_pred cccCcchHHHHHHhhcCccHHHHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001838 919 IFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983 (1007)
Q Consensus 919 ~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 983 (1007)
...... ++..+. ........+.+...++.+++...+..+|.+|-.|.
T Consensus 1038 ~tpq~~-----------------f~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI-----------------FENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh-----------------hhcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 433221 111000 00000011222334567777778888888887665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-06 Score=100.11 Aligned_cols=133 Identities=20% Similarity=0.179 Sum_probs=80.1
Q ss_pred cccccceecccCceEEEEEEEcC-CceEEEEEechhhH----------------------------------HHHH----
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYE----------------------------------RALK---- 767 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----------------------------------~~~~---- 767 (1007)
.|+. +.||+|++|.||+|++++ |+.||||+.++... +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999987 99999999974321 0011
Q ss_pred --HHHHHHHHHHhcC----CCceeEEEEEEec-CCeeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001838 768 --SFQDECEVMKRIR----HRNLVKIISACSN-DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840 (1007)
Q Consensus 768 --~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH 840 (1007)
+|.+|+..+.+++ +...|.+-.++.+ ....+|||||++|+.+.+.-.-.....+. ..++...++. |++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~--~~~ 274 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEV--FFT 274 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHH--HHH
Confidence 2344555555542 4444444444433 34578999999999998743211111221 1222222221 222
Q ss_pred hcCCCCceeccc----------------cccceeecceecC
Q 001838 841 FGHSTPIIHYMV----------------AHISDFSIAKFLN 865 (1007)
Q Consensus 841 ~~~~~~ivH~~~----------------~kl~DFGla~~~~ 865 (1007)
.....+++|+|. .++.|||++..+.
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 224567888753 3678999988764
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.5e-08 Score=121.14 Aligned_cols=127 Identities=24% Similarity=0.262 Sum_probs=61.8
Q ss_pred ccCcEEeccCcccCCcchhhhhhcCCCCeecccCccc-CCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEE
Q 001838 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF-SGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGL 194 (1007)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l-~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 194 (1007)
...+...+-+|.+...... . .-+.|++|-+..|.. ...++...|..++.|++|||++|.=-+.+|+.++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~~~~-~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGS-S-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhccCC-C-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 4556666666655322111 1 111344555555541 124555555555555555555544334555555555555555
Q ss_pred EcccccCCCCCCcccccccccceEEcccCcCCCCCCcccCCccccceeecc
Q 001838 195 YLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245 (1007)
Q Consensus 195 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 245 (1007)
+|++..++ .+|..+++|.+|.+|++..+.-...+|.....+++|++|.+-
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEee
Confidence 55555554 455555555555555555544333334444445555555443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.8e-08 Score=112.07 Aligned_cols=241 Identities=18% Similarity=0.090 Sum_probs=163.0
Q ss_pred HHHhcccccccceecccCceEEEEEEEc--CCceEEEEEechhhHHH--HHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 001838 721 LLQATDRFSKNNLLGIGSFGSVYVARLQ--DGMEVAVKVFHQRYERA--LKSFQDECEVMKRI-RHRNLVKIISACSNDD 795 (1007)
Q Consensus 721 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 795 (1007)
....+.+|..+..||.|.|+.|++...+ ++..+|+|.+....... ...-..|+-+...+ .|.++++++..+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445667888999999999999998754 57789999876543221 12234577776666 4999999988888877
Q ss_pred eeEEEEEecCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-------------ccceeecce
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAK 862 (1007)
Q Consensus 796 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-------------kl~DFGla~ 862 (1007)
..|+--|||++++......- ...++...++++..|++.++.++ |++.++|+|++ ++.|||.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhcccccccc
Confidence 88899999999998766632 22467778889999999999999 68889998553 678888876
Q ss_pred ecCCCCcccccccccCCccc-ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCcchHHHHHHhhcCccHHHH
Q 001838 863 FLNGQDQLSMQTQTLATIGY-MAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
.+.-... ....++..| .+|+......+..+.|++|||.-+.|.++|..--+. ...|.....
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~i~~------- 477 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLTIRS------- 477 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccceeeec-------
Confidence 4321100 111123334 355555667789999999999999999998753221 011111000
Q ss_pred hhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 942 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.... .......++..++..+..+++..||.+.+...+.+-.+
T Consensus 478 --~~~p--------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 478 --GDTP--------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --cccc--------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 00011234667777888999999999988877665443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.1e-09 Score=118.79 Aligned_cols=180 Identities=29% Similarity=0.311 Sum_probs=109.5
Q ss_pred chhhhhccccCccccCCCccCCCCchhhhc-ccccceeeccccccc---CCCCCCCC------CcccCceeecCCccccc
Q 001838 429 PVTFSRLLNLQGLGLAFNKLARSIPDEICH-LAKLDKLILHGNKFS---GAIPSCSG------NLTSLRALYLGSNRFTS 498 (1007)
Q Consensus 429 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~---~~~p~~~~------~l~~L~~L~Ls~N~l~~ 498 (1007)
|-.+..+.+|+.|.|.+..|+.. ..+.. -..|++|.-+ |.+. ..+..+.+ ....|...+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 55677788888888888887531 11111 1234444322 2221 01111111 1235667777778776
Q ss_pred CCCcccccccccccccCCCCCcCCCCccccccccccceEeCccccCCCCcc-ccccCCCCccEEeccccccccccCccCc
Q 001838 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP-ITIGGLKNLQKLFLANNRLEGPIPESFS 577 (1007)
Q Consensus 499 ~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 577 (1007)
.....+.-++.++.||||+|+++..- .+..++.|.+|||+.|.+. .+| ....++. |+.|+|++|.++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 34455666777788888888887533 4566777778888888887 343 2333343 88888888877643 2456
Q ss_pred CCCCCCEEECCCCcccccCC-cchhhhcCCCeeeCcCCcccc
Q 001838 578 GLSSLEILDLSKNKISGVIP-TSLEKLLYLKKLNLSFNKLEG 618 (1007)
Q Consensus 578 ~l~~L~~LdLs~N~l~~~~p-~~l~~l~~L~~L~ls~N~l~~ 618 (1007)
+|.+|+-||||+|-|++.-- ..+..|..|+.|+|.+|++.+
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 77778888888887776421 223456677778888888764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-08 Score=114.79 Aligned_cols=180 Identities=27% Similarity=0.298 Sum_probs=118.5
Q ss_pred cccccCCCCCCEEEcCCCCCCCCCCccccCc-ccCcEEeccCcccCC---cchhhhhhc------CCCCeecccCcccCC
Q 001838 85 PPQLGNLSSLETLDLSHNKLSGNIPSSIFNM-HTLKLLDFRDNQLFG---SLSSFIFNM------SSMLGIDLSINRFSG 154 (1007)
Q Consensus 85 ~~~l~~l~~L~~LdLs~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~---~~~~~~~~l------~~L~~LdLs~N~l~~ 154 (1007)
|-++..+.+|+.|.|.+..|.. -..+..+ ..|+.|. -+|.+.. .+.+-.+.. ..|...+.|+|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4467777888888888877763 1111111 2233333 2222211 000000111 24677889999987
Q ss_pred CCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCCcccC
Q 001838 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG 234 (1007)
Q Consensus 155 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 234 (1007)
.+...+ .-++.|+.|||++|+++.. +.+..++.|++|||++|.|. .+|.-=..-.+|..|.+++|.++.. ..+.
T Consensus 178 ~mD~SL-qll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESL-QLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHH-HHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHH
Confidence 444444 4688999999999999844 37888999999999999998 4444222223499999999998843 3478
Q ss_pred CccccceeeccCcccccccccc-ccCCCCCCeEEccccccc
Q 001838 235 NLPYLVRLTLATNNLVGVVPFT-IFNMSTLKKLSLLENTLW 274 (1007)
Q Consensus 235 ~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~ 274 (1007)
+|.+|+.|||++|-|.+.-... +..+..|+.|+|.+|.+.
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8999999999999987654322 345678888999988874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.34 E-value=9e-07 Score=88.56 Aligned_cols=119 Identities=18% Similarity=0.125 Sum_probs=82.0
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEEecCCCCh
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV-KIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~E~~~~gsL 809 (1007)
.+.++.|.++.||+++.. |..|++|+...... ....+..|+++++.+.+.+++ +++++.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999875 77899999865432 123467899999998765554 4444433 345899999999887
Q ss_pred hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecccc-----------ccceeecce
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH--STPIIHYMVA-----------HISDFSIAK 862 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~~~~-----------kl~DFGla~ 862 (1007)
.+.- . ....++.+++++++.||... ...++|+|+. +++|||.+.
T Consensus 79 ~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred cccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 6430 1 11235678999999997432 2346998753 567776655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.6e-08 Score=87.87 Aligned_cols=78 Identities=32% Similarity=0.451 Sum_probs=39.7
Q ss_pred cccCcccCCCCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcC
Q 001838 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNEL 225 (1007)
Q Consensus 146 dLs~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 225 (1007)
+||+|.|. .+|+.+....+-++.|+|++|+|+ .+|..++.++.|+.|+++.|.+. ..|..+..|.+|..|+..+|.+
T Consensus 59 ~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 59 SLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred ecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 44444444 444444433444555555555554 34444555555555555555554 3444444455555555555555
Q ss_pred C
Q 001838 226 R 226 (1007)
Q Consensus 226 ~ 226 (1007)
.
T Consensus 136 ~ 136 (177)
T KOG4579|consen 136 A 136 (177)
T ss_pred c
Confidence 4
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-08 Score=88.49 Aligned_cols=131 Identities=21% Similarity=0.269 Sum_probs=77.5
Q ss_pred CEEEcCCCCCCCCCCccccCc---ccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcEEE
Q 001838 95 ETLDLSHNKLSGNIPSSIFNM---HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLL 171 (1007)
Q Consensus 95 ~~LdLs~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~L~ 171 (1007)
..+||+++.+- -++.....+ ..|+..+|++|.+...++.+-...+.++.|+|++|.|+ .+|.++ ..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~-Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEEL-AAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHH-hhhHHhhhcc
Confidence 34455555443 233333332 33444566666666555555566667777777777777 677774 4678888888
Q ss_pred ccCccccccCCccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCCC
Q 001838 172 LGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIP 230 (1007)
Q Consensus 172 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 230 (1007)
++.|.|. ..|..+..|.+|..||..+|.+. .+|..+-.-++.-...+.++.+.+.-+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 8888877 56667777888888888887776 444433222222233344455554433
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.6e-07 Score=93.27 Aligned_cols=178 Identities=25% Similarity=0.313 Sum_probs=83.9
Q ss_pred CCCCeecccCcccCC-CCchhHhhcCCCCcEEEccCccccccCCccccCCCCCcEEEcccccCCCC-CCcccccccccce
Q 001838 140 SSMLGIDLSINRFSG-ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA-IPKEIGNLTKLKD 217 (1007)
Q Consensus 140 ~~L~~LdLs~N~l~~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~ 217 (1007)
+.++++||.+|.|+. +--..+.+++|.|++|+|+.|++...|-..=..+.+|+.|-|.+..+.-. ....+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 344455555555541 00123445666666666666666533221113455666666666555422 2233445555555
Q ss_pred EEcccCcCCC----------CCCc--ccCCccccceeeccCccccccccccccCCCCCCeEEcccccccCcCCchhhcCC
Q 001838 218 IILNDNELRG----------EIPQ--EMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSL 285 (1007)
Q Consensus 218 L~L~~N~l~~----------~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~lp~~~~~~l 285 (1007)
|.++.|.+.. .-|. .+..++.+..+.++-|++....| ++..+-+.+|.+...-...-+..+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~e~PlK~~s~ek~se~~ 223 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVCEGPLKTESSEKGSEPF 223 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeeecCcccchhhcccCCCC
Confidence 5555553321 1111 12233444455555555554433 344455555544322222222345
Q ss_pred CCCcEEeccCCCCCCCC-CccccccCCCCEEEecCCCcCC
Q 001838 286 PNVEFLNLGTNRFSGNI-PSSITNASKLTVFQLRGNSFSG 324 (1007)
Q Consensus 286 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 324 (1007)
|.+-.|+|+.|+|..-. -+++..+++|..|.+++|.+..
T Consensus 224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred CcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 55666677766665321 1234455666666666666543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.1e-05 Score=79.17 Aligned_cols=125 Identities=17% Similarity=0.150 Sum_probs=86.5
Q ss_pred ceecccCceEEEEEEEcC-------CceEEEEEechhh-------------H-------------HHHHHHHHHHHHHHh
Q 001838 732 NLLGIGSFGSVYVARLQD-------GMEVAVKVFHQRY-------------E-------------RALKSFQDECEVMKR 778 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~ 778 (1007)
..||.|--+.||.|...+ +..+|||+.+... . .......+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999997553 4799999874210 0 011223489999999
Q ss_pred cC--CCceeEEEEEEecCCeeEEEEEecCCCChhH-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc--
Q 001838 779 IR--HRNLVKIISACSNDDFKALIMEYMPNGSLEN-RLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-- 853 (1007)
Q Consensus 779 l~--H~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-- 853 (1007)
+. .-++.+.+++ ..-++||||+.++.+.. .++.. .++..+...+..+++.+|.+++ |..+|||+|+.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCHH
Confidence 85 3455666654 34689999997754422 22221 2444456678899999999996 67799998763
Q ss_pred ---------ccceeecceec
Q 001838 854 ---------HISDFSIAKFL 864 (1007)
Q Consensus 854 ---------kl~DFGla~~~ 864 (1007)
.++|||.|-..
T Consensus 155 NIL~~~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWHDGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEECCcEEEEECCCceeC
Confidence 69999988755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-07 Score=105.19 Aligned_cols=180 Identities=16% Similarity=0.138 Sum_probs=129.2
Q ss_pred cccccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCc-eeEEEEEEecCCeeEEEEEecC
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN-LVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 727 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~E~~~ 805 (1007)
.+..-+-.++|+++++||.+-...+....+.+... ....-++++|.+++||| .|+.++-+..++..+++++|+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33334557899999999988554445556766544 33456899999999999 7777777777888999999999
Q ss_pred CC-ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecc-------ccccceeecceecCCCCccccccccc
Q 001838 806 NG-SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYM-------VAHISDFSIAKFLNGQDQLSMQTQTL 877 (1007)
Q Consensus 806 ~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~-------~~kl~DFGla~~~~~~~~~~~~~~~~ 877 (1007)
+| +-..-.......+...+...+...-.++++|+| +..-+|+| ..|..||+.+..+.... ..+...
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRDNILGSEEEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcccccccccccccccccCCcccCccc---ccccCC
Confidence 87 222212111112334444455666678888884 44456775 35889999888765432 234567
Q ss_pred CCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001838 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTD 917 (1007)
Q Consensus 878 gt~~y~aPE~~~~~~~~~~~DvwS~Gvil~elltG~~p~~ 917 (1007)
+|+.|+|||+.....+..+.|+|+.|+--.+|.-|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999999998888888877754
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.6e-07 Score=92.46 Aligned_cols=179 Identities=23% Similarity=0.298 Sum_probs=88.0
Q ss_pred CCCCEEEcCCCCCCC--CCCccccCcccCcEEeccCcccCCcchhhhhhcCCCCeecccCcccCCCCchhHhhcCCCCcE
Q 001838 92 SSLETLDLSHNKLSG--NIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKK 169 (1007)
Q Consensus 92 ~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ip~~~~~~l~~L~~ 169 (1007)
+.++.|||.+|.|+. .+-.-+.+|+.|+.|+|++|.|...+...-..+.+|+.|-|.+..+.=.--......+|.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 445555555555542 122333455555555555555544333332334444444444444432222233344555555
Q ss_pred EEccCccccc----------cCC--ccccCCCCCcEEEcccccCCCCCCcccccccccceEEcccCcCCCCC-CcccCCc
Q 001838 170 LLLGRNMFHG----------KIP--STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEI-PQEMGNL 236 (1007)
Q Consensus 170 L~Ls~N~l~~----------~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l 236 (1007)
|++|.|.+.- ..| .++..++.++.+.++-|++...+| ++..+.+..|.+...- ...+..+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~e~PlK~~s~ek~se~~ 223 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVCEGPLKTESSEKGSEPF 223 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeeecCcccchhhcccCCCC
Confidence 5555553221 000 012333444445555555554333 4555666666555322 2345556
Q ss_pred cccceeeccCcccccccc-ccccCCCCCCeEEcccccccCcC
Q 001838 237 PYLVRLTLATNNLVGVVP-FTIFNMSTLKKLSLLENTLWGSL 277 (1007)
Q Consensus 237 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~l 277 (1007)
+.+.-|+|+.|+|-..-. ..+..+++|..|.+++|.++..+
T Consensus 224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred CcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence 666677777777754322 33556677777777777765444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.6e-05 Score=75.69 Aligned_cols=121 Identities=21% Similarity=0.364 Sum_probs=86.9
Q ss_pred ceecccCceEEEEEEEcCCceEEEEE-echhh-------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEEe
Q 001838 732 NLLGIGSFGSVYVARLQDGMEVAVKV-FHQRY-------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 732 ~~ig~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~E~ 803 (1007)
..+++|+-+.+|.+.+. |.++++|. +.+.. .-..++-.+|+.++++++--.|-.-+=+..+++...|||||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 44566664 22211 11235678899999998754444444455666777899999
Q ss_pred cCCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc-----------ccceeecceec
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDFSIAKFL 864 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~-----------kl~DFGla~~~ 864 (1007)
++|-.|.+.+... +..++..|-+-+.-| |..+|+|.|+. .++|||+++.-
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGRIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCcEEEEECCccccc
Confidence 9999999888764 244666777777888 78899998763 68999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.7e-05 Score=83.70 Aligned_cols=162 Identities=17% Similarity=0.187 Sum_probs=101.5
Q ss_pred ceEEEEEEEc-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEEEEecCC-CChhHh
Q 001838 739 FGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN----DDFKALIMEYMPN-GSLENR 812 (1007)
Q Consensus 739 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~ 812 (1007)
-.+.||++.. ||..|+.|+++.........-..-++.++++.|+|||++.++|.. +...++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999754 899999999943322111122345788999999999999998873 3468999999986 677765
Q ss_pred hhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec--cccccceeecceecCCCCcccccccc
Q 001838 813 LYS--------------GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY--MVAHISDFSIAKFLNGQDQLSMQTQT 876 (1007)
Q Consensus 813 l~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~--~~~kl~DFGla~~~~~~~~~~~~~~~ 876 (1007)
... .....++...+.++.|+..||.++| +.|..-+ +..||.-.|--|..- ..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIri---------S~ 436 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRI---------SG 436 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEE---------ec
Confidence 431 1224677889999999999999996 3343332 222333333211110 00
Q ss_pred cCCcccc--cc-cccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 001838 877 LATIGYM--AP-EYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915 (1007)
Q Consensus 877 ~gt~~y~--aP-E~~~~~~~~~~~DvwS~Gvil~elltG~~p 915 (1007)
+|-..-. .| |-+.. -.+-|.=.||.+++.|.||..-
T Consensus 437 C~i~Dvl~~d~~~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 437 CGIMDVLQEDPTEPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ccceeeecCCCCcchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 1100000 11 11111 2367999999999999999653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.8e-05 Score=83.00 Aligned_cols=109 Identities=17% Similarity=0.184 Sum_probs=85.3
Q ss_pred cceecccCceEEEEEEEcCCceEEEEEechhhH-HHHHHHHHHHHHHHhcCC--CceeEEEEEEecC---CeeEEEEEec
Q 001838 731 NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYE-RALKSFQDECEVMKRIRH--RNLVKIISACSND---DFKALIMEYM 804 (1007)
Q Consensus 731 ~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~---~~~~lv~E~~ 804 (1007)
.+.++.|..+.||+++..+|+.+++|+...... .....+..|+++++.+++ ..+.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999999765322 123567899999999975 4457777777654 2568999999
Q ss_pred CCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 841 (1007)
+|+++.+.+.. ..++..++..++.++++++.+||.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 99988876542 246778888999999999999974
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.4e-06 Score=86.29 Aligned_cols=41 Identities=27% Similarity=0.384 Sum_probs=19.9
Q ss_pred ccCCCCCCEEEcCCCCCCCCCCcccc----CcccCcEEeccCccc
Q 001838 88 LGNLSSLETLDLSHNKLSGNIPSSIF----NMHTLKLLDFRDNQL 128 (1007)
Q Consensus 88 l~~l~~L~~LdLs~N~l~~~~p~~~~----~l~~L~~L~Ls~N~l 128 (1007)
+..+++|+..|||.|.|....|..++ .-..|++|.|++|.+
T Consensus 88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGl 132 (388)
T COG5238 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGL 132 (388)
T ss_pred HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCC
Confidence 34445555555555555544443322 234455555555554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.6e-05 Score=71.96 Aligned_cols=130 Identities=16% Similarity=0.192 Sum_probs=90.6
Q ss_pred ccceecccCceEEEEEEEcCCceEEEE-Eechhh-------HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 001838 730 KNNLLGIGSFGSVYVARLQDGMEVAVK-VFHQRY-------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~~g~~vavK-~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
....+-+|+-+.|+++.+. |+...|| ++.+.. .-..++..+|++++.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678889999999999986 6666666 333221 123466788999999987545544444555556667999
Q ss_pred EecCC-CChhHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccc---------------ccceeeccee
Q 001838 802 EYMPN-GSLENRLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIAKF 863 (1007)
Q Consensus 802 E~~~~-gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~~~~---------------kl~DFGla~~ 863 (1007)
||.+| -++.+++..... ..+.......+..|-+.+.-| |...|+|.|+. .++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477888765432 222223356888899999999 78889998652 5789998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00019 Score=77.55 Aligned_cols=261 Identities=14% Similarity=0.104 Sum_probs=146.1
Q ss_pred ccceecccCceEEEEEEEcCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCceeEEEEEE------ecCC-eeEEEE
Q 001838 730 KNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISAC------SNDD-FKALIM 801 (1007)
Q Consensus 730 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~------~~~~-~~~lv~ 801 (1007)
..+.+|+|+-+.+|----- +. -+.|++......... ..++.|.+. .||-+-.=+.|= -+++ ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3577999999999943211 22 344777644322111 123334444 466443311111 1122 256777
Q ss_pred EecCCCC-hhHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceeccccccceeecceecCCCCcc----
Q 001838 802 EYMPNGS-LENRLY-----SGTCMLDIFQRLNIMIDVALALEYLHF-GHSTPIIHYMVAHISDFSIAKFLNGQDQL---- 870 (1007)
Q Consensus 802 E~~~~gs-L~~~l~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~~~~kl~DFGla~~~~~~~~~---- 870 (1007)
..+++.. ...++. +.-...+|.-.++++..+|.+.+-||. +|..+=|.-...-++|=|..+.+..++..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC
Confidence 7776642 222222 112357899999999999999999973 44444333333457777777666543221
Q ss_pred -cccccccCCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCcc---hHH-HHHHhhcCccHH
Q 001838 871 -SMQTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTG-KKPTDEIFIGEL---SLS-RWVNDLLPISVM 939 (1007)
Q Consensus 871 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~elltG-~~p~~~~~~~~~---~l~-~~~~~~~~~~~~ 939 (1007)
......+|...|.+||.-. +-.-+...|-|.+||++++++.| +.||.+...... ... +...........
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 1123356888999999643 23457789999999999999886 999986532110 010 111000000000
Q ss_pred HHhhhhhccchhhhHHHHHHHHHHHHHHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHhhhc
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIES--PGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 940 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~--p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
. ..-++... .....+-.+.++..+-.+|.... +.-|||++.-+..|.+++..+.++
T Consensus 250 ~--~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 250 Q--RRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred c--cCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0 00000000 00011122345666667787654 568999999999999999988876
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.9e-06 Score=86.92 Aligned_cols=197 Identities=18% Similarity=0.244 Sum_probs=120.6
Q ss_pred cccccccccccEEEccCCCCCCCCCCCcccc---ccccceeeeccccccccCCh----hh---------hccCCCcEEEc
Q 001838 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNL---SISLERFQMFNCRISGKIPQ----VI---------SNLSNLLLLDL 419 (1007)
Q Consensus 356 l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~~l~~L~l~~n~l~~~~p~----~~---------~~l~~L~~L~L 419 (1007)
++.+..|++|+.++||.|.|....|+.+..+ ...+.+|.+++|.+...--. ++ .+-+.|++.+.
T Consensus 85 l~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vic 164 (388)
T COG5238 85 LKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVIC 164 (388)
T ss_pred HHHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEe
Confidence 3466778888888888888877766665543 23578888888877532211 11 23468999999
Q ss_pred cCCeeccccc----hhhhhccccCccccCCCccCCC-----CchhhhcccccceeecccccccCC----CCCCCCCcccC
Q 001838 420 GGNKLTGSIP----VTFSRLLNLQGLGLAFNKLARS-----IPDEICHLAKLDKLILHGNKFSGA----IPSCSGNLTSL 486 (1007)
Q Consensus 420 s~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 486 (1007)
..|++..-.- ..+..-.+|+.+.+.+|-+.-. +-..+..+.+|+.|||..|-|+-. +...+..++.|
T Consensus 165 grNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~l 244 (388)
T COG5238 165 GRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLL 244 (388)
T ss_pred ccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchh
Confidence 9999964322 1233345889999999976421 111234578899999999988732 22334456668
Q ss_pred ceeecCCcccccCCCcccc------cccccccccCCCCCcCCCCccccccccccceEeCccccCCCCccccccCCCCccE
Q 001838 487 RALYLGSNRFTSALPSTIW------NLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQK 560 (1007)
Q Consensus 487 ~~L~Ls~N~l~~~~p~~~~------~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 560 (1007)
+.|.+..|-++..-...+. ..++|..|-..+|...+.+- ++.+-|.+. =..++-|..
T Consensus 245 rEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i-----------~~~~l~~~e------~~~~p~L~~ 307 (388)
T COG5238 245 RELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGII-----------LDISLNEFE------QDAVPLLVD 307 (388)
T ss_pred hhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCcee-----------eeechhhhh------hcccHHHHH
Confidence 8888888877654333221 13455555556665544321 222222221 134556777
Q ss_pred Eeccccccc
Q 001838 561 LFLANNRLE 569 (1007)
Q Consensus 561 L~Ls~N~l~ 569 (1007)
|-+.+|+|+
T Consensus 308 le~ngNr~~ 316 (388)
T COG5238 308 LERNGNRIK 316 (388)
T ss_pred HHHccCcch
Confidence 777788876
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.6e-05 Score=58.77 Aligned_cols=36 Identities=47% Similarity=0.704 Sum_probs=17.8
Q ss_pred CccEEeccccccccccCccCcCCCCCCEEECCCCccc
Q 001838 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKIS 593 (1007)
Q Consensus 557 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 593 (1007)
+|++|++++|+|+ .+|..+++|++|+.||+++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 33444555555555555555554
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1007 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-42 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-41 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 1e-07 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 7e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-06 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 4e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 4e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 5e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1007 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-176 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-158 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-104 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-101 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-81 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-25 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-07 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-100 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-23 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-94 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-72 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-32 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-83 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-64 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-60 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-82 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-72 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-68 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-27 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-78 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-60 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-23 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-68 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-65 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-60 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-58 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 8e-58 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-23 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-49 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-48 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-23 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 9e-51 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-47 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-42 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-26 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-43 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-30 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-22 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-40 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-36 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-30 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-18 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-45 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-44 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-44 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-44 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-43 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-43 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-42 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-42 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-40 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-33 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-10 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-32 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-25 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-25 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-16 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-30 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-30 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-22 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-38 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-30 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-30 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-29 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-35 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-33 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-30 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-15 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-15 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-31 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-31 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-31 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-31 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-13 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-30 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-30 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-30 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-30 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-26 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-30 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-30 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-30 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-29 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-29 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-29 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-29 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-29 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-29 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-29 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-29 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-29 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-29 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-28 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-28 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-21 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-28 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-09 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-28 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-28 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-28 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-28 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-10 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-27 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-27 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-27 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-27 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-25 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-25 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-25 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-25 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-24 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-24 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-24 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-24 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-24 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-24 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-24 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-24 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-24 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-19 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-05 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-23 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-23 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-23 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-22 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-22 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-22 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-22 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-22 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-07 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-16 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-16 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-09 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-22 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-21 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-21 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-20 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-20 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-19 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-10 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-11 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-19 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-19 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-19 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-13 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-10 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-18 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-18 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-18 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-18 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-11 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-17 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-17 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-17 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-17 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-17 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-17 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-17 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-17 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-17 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-08 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-17 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-17 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 9e-17 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-17 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-16 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-16 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-16 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-16 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-16 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-15 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-07 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-15 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-15 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-15 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-15 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-15 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-15 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-15 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-15 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-15 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-14 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-14 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-11 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-14 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-14 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-14 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-14 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-04 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-13 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-13 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-13 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-13 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-13 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 8e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-11 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-12 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-12 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-12 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-12 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-11 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-04 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-11 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-07 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-10 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-10 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-10 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-05 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-09 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-07 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-09 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 7e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-05 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-08 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-08 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-06 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-06 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-06 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-06 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-06 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 9e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-05 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-05 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-05 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-05 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 9e-05 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-04 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-04 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-04 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-04 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 8e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 532 bits (1372), Expect = e-176
Identities = 182/610 (29%), Positives = 274/610 (44%), Gaps = 22/610 (3%)
Query: 61 ITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKL 120
++ L ISG + G + + +LE LD+S N S IP + + L+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227
Query: 121 LDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGK 180
LD N+L G S I + + +++S N+F G +P L +L+ L L N F G+
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGE 284
Query: 181 IPSTLS-KCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPY 238
IP LS C L GL L N+ GA+P G+ + L+ + L+ N GE+P + +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 239 LVRLTLATNNLVGVVPFTIFNMST-LKKLSLLENTLWGSLPSRI-DLSLPNVEFLNLGTN 296
L L L+ N G +P ++ N+S L L L N G + + ++ L L N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 297 RFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFL 356
F+G IP +++N S+L L N SG IP+++G+L L L + N L P
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP----- 459
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
L + + LIL N L G +PS + N + +L + N R++G+IP+ I L NL +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
L L N +G+IP +L L L N +IP + + + N +G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKR 574
Query: 477 PSCSGNLTSLRALYLGSN--RFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVV 534
N + + N F + L +++S G S N +
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634
Query: 535 IELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISG 594
+ L++S N LSG IP IG + L L L +N + G IP+ L L ILDLS NK+ G
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 595 VIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLN 654
IP ++ L L +++LS N L G IP G F FL N LCG P P +
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNAD 754
Query: 655 KPKTHHKSRK 664
H +S
Sbjct: 755 GYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-158
Identities = 166/643 (25%), Positives = 284/643 (44%), Gaps = 34/643 (5%)
Query: 17 AAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNIS 76
A+ + ++ + L++ K + D L +W+S+ + C++ G+TC KV +++S
Sbjct: 4 ASPSQSLYREIHQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTC--RDDKVTSIDLS 58
Query: 77 GFNLQ---GTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLS 133
L + L +L+ LE+L LS++ ++G++ +L LD N L G ++
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT 117
Query: 134 SF--IFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL---SKC 188
+ + + S + +++S N + L +L+ L L N G C
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+L+ L + N +SG + + L+ + ++ N IP +G+ L L ++ N
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSIT- 307
L G I + LK L++ N G +P L L ++++L+L N+F+G IP ++
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 308 NASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRV 367
LT L GN F G +P G+ LE L ++ N + P +L + ++V
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM----DTLLKMRGLKV 347
Query: 368 LILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISN--LSNLLLLDLGGNKLT 425
L L+ N G LP S+ NLS SL + + SG I + + L L L N T
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 426 GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTS 485
G IP T S L L L+FN L+ +IP + L+KL L L N G IP + +
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 486 LRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLS 545
L L L N T +PS + N ++ + +S+N L G + IG L+ + L LS N+ S
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 546 GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605
G+IP +G ++L L L N G IP + S ++ N I+G ++
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGM 583
Query: 606 LKKLNLSFN--KLEGEIPRG-GPFANLTAKSFLGNELLCGLPD 645
K+ + + N + +G + +
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-104
Identities = 130/605 (21%), Positives = 239/605 (39%), Gaps = 29/605 (4%)
Query: 70 VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLF 129
+ VLN++ L+ S L +LD+ N +S P + LK+L+ + N+L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
+++ + L N + N NL L L N T + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 190 QLEGLYLRFNNLSGAIPKEIG--NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
L+ L L N + +E+ + LK + L+ N+++ P + L L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 248 NLVGVVPFTIF---NMSTLKKLSLLENTLWGSLPSRID-LSLPNVEFLNLGTNRFSGNIP 303
L + + ++++ LSL + L + + L N+ L+L N +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 304 SSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF----LSSL 359
S +L F L N+ +++ L N+ +LN+ ++ S S S
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 360 TNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK--IPQVISNLSNLLL- 416
+ + L + N + GI + L +L+ + N S + + +L++ L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 417 -LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP-DEICHLAKLDKLILHGNKFSG 474
L+L NK++ FS L +L+ L L N++ + + E L + ++ L NK+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 475 AIPSCSGNLTSLRALYLGSNRFTS--ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLK 532
+ + SL+ L L + + PS L+++ D+S+N++ + L+
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 533 VVIELNLSRNNLS--------GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEI 584
+ L+L NNL+ G + GL +L L L +N + E F L L+I
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 585 LDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR--GGPFANLTAKSFLGNELLCG 642
+DL N ++ + + + LK LNL N + + G F NLT N C
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 643 LPDLH 647
+
Sbjct: 625 CESIA 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-101
Identities = 124/616 (20%), Positives = 216/616 (35%), Gaps = 44/616 (7%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
L++ + P L L+ L+L HN+LS + L L N +
Sbjct: 53 SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLS--KCK 189
++ +++ +DLS N S L NL++LLL N L
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 190 QLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG---NLPYLVRLTLAT 246
L+ L L N + P + +L + LN+ +L + +++ + L+L+
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 247 NNLVGVVPFTIFNM--STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS 304
+ L T + + L L L N L LP +E+ L N
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSH 290
Query: 305 SITNASKLTVFQLRGN---------SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
S+ + L+ + S + L+ LE LN+ DN +
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS---- 346
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSS---IGNLSISLERFQMFNCRISGKIPQVISNLS 412
+ T ++ L L+ + ++ + L + +IS S L
Sbjct: 347 -NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 413 NLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
+L +LDLG N++ + + L N+ + L++NK + + + L +L+L
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 472 FSG--AIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSL--------D 521
+ PS L +L L L +N + + L+ + D+ N+L
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS 581
G + L + LNL N L L+ + L N L F+ S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 582 LEILDLSKNKISGVIPTSLEKLLY-LKKLNLSFNKLEGEIPRGGPFANLTAKS-----FL 635
L+ L+L KN I+ V L +L++ FN + F N ++ L
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 636 GNELLCGLP-DLHNSP 650
+ LC P H P
Sbjct: 646 SSHYLCNTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 4e-81
Identities = 108/557 (19%), Positives = 180/557 (32%), Gaps = 76/557 (13%)
Query: 93 SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF 152
S E D SH KL+ +P + + +L+ NQL
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRR---------------------- 39
Query: 153 SGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNL 212
LPA L L +G N P K L+ L L+ N LS K
Sbjct: 40 ---LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 213 TKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENT 272
T L ++ L N ++ L+ L L+ N L T
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ------------- 143
Query: 273 LWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNA--SKLTVFQLRGNSFSGFIPNTI 330
L N++ L L N+ + S L +L N F P
Sbjct: 144 ------------LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 331 GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI-S 389
+ L L + + L S E L IR L L+ + L ++ L +
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLEL--ANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 390 LERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA----- 444
L + ++ + L L L N + + L N++ L L
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 445 ----FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNR--FTS 498
L + L L+ L + N G + L +L+ L L ++ +
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 499 ALPSTIWNL--KDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPI-TIGGL 555
T +L + +++ N + S L + L+L N + ++ GL
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 556 KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV--IPTSLEKLLYLKKLNLSF 613
+N+ +++L+ N+ SF+ + SL+ L L + + V P+ + L L L+LS
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 614 NKLEGEIPRGGPFANLT 630
N + L
Sbjct: 490 NNIANIND--DMLEGLE 504
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-47
Identities = 74/400 (18%), Positives = 124/400 (31%), Gaps = 65/400 (16%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHN---------KLSGNIPSSIFNMH 116
++ + N+Q L L ++ L+L + L S +
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 117 TLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFS-GELPANICKNLPN--LKKLLLG 173
L+ L+ DN + G S+ + ++ + LS + S L +L + L L L
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 174 RNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIP-KEIGNLTKLKDIILNDNELRGEIPQE 232
+N S LE L L N + + +E L + +I L+ N+
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 233 MGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLN 292
+P L RL L L V
Sbjct: 450 FALVPSLQRLMLRRVALKNV---------------------------------------- 469
Query: 293 LGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPE 352
+ PS LT+ L N+ + + + L LE L++ N L
Sbjct: 470 -------DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522
Query: 353 L---SFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVIS 409
+ L + +L L N D I +L L+ + ++ V +
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF-ELKIIDLGLNNLNTLPASVFN 581
Query: 410 NLSNLLLLDLGGNKLTGSIPVTFSRLL-NLQGLGLAFNKL 448
N +L L+L N +T F NL L + FN
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-46
Identities = 70/372 (18%), Positives = 132/372 (35%), Gaps = 27/372 (7%)
Query: 67 SHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDN 126
+IS +L L LE L++ N + G + + LK L ++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 127 QL-FGSLSSFIF---NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP 182
+L++ F S + ++L+ N+ S + ++ L +L+ L LG N ++
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 183 -STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG--EIPQEMGNLPYL 239
+ + +YL +N + L+ ++L L+ P L L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 240 VRLTLATNNLVGVVPFTIFNMSTLKKLSL-------LENTLWGSLPSRIDLSLPNVEFLN 292
L L+ NN+ + + + L+ L L L P L ++ LN
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 293 LGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPE 352
L +N F + +L + L N+ + + N +L+ LN+ N +T S +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT-SVEK 601
Query: 353 LSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLS 412
F + N + L + NP D S+ F + IP++ S+
Sbjct: 602 KVFGPAFRN---LTELDMRFNPFDCTCE--------SIAWFVNWINETHTNIPELSSHYL 650
Query: 413 NLLLLDLGGNKL 424
G +
Sbjct: 651 CNTPPHYHGFPV 662
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-38
Identities = 56/248 (22%), Positives = 104/248 (41%), Gaps = 10/248 (4%)
Query: 387 SISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
++S E + +++ ++P + +N+ +L+L N+L F+R L L + FN
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 447 KLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWN 506
+++ P+ L L L L N+ S T+L L+L SN +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 507 LKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKN--LQKLFLA 564
K+++ D+S N L L+ + EL LS N + + N L+KL L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 565 NNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSL---EKLLYLKKLNLSFNKLEGEIP 621
+N+++ P F + L L L+ ++ + L ++ L+LS ++L
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 622 RGGPFANL 629
F L
Sbjct: 240 --TTFLGL 245
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-25
Identities = 37/196 (18%), Positives = 61/196 (31%), Gaps = 10/196 (5%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSG--NIPSSIFNMHTLKLLDF 123
+ + +S + SL+ L L L + PS + L +LD
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 124 RDNQLFGSLSSFIFNMSSMLGIDLSINRFS-------GELPANICKNLPNLKKLLLGRNM 176
+N + + + + +DL N + P K L +L L L N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 177 FHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG-N 235
F +L+ + L NNL+ N LK + L N + + G
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 236 LPYLVRLTLATNNLVG 251
L L + N
Sbjct: 608 FRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 4/108 (3%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFR 124
+ ++ ++++ NL N SL++L+L N ++ L LD R
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617
Query: 125 DNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLL 172
N + S + ++ + +I S +C P+ +
Sbjct: 618 FNPFDCTCESIAWFVNWINETHTNIPELSSHY---LCNTPPHYHGFPV 662
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-100
Identities = 93/620 (15%), Positives = 198/620 (31%), Gaps = 82/620 (13%)
Query: 48 NWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGN 107
NW + + W G GV L + + L L SG
Sbjct: 59 NWNFNKELDMW-GAQPGV---------------------SLNSNGRVTGLSLEGFGASGR 96
Query: 108 IPSSIFNMHTLKLLDFRDNQLFGSLSSFIF----NMSSMLGIDLSINRFSGELPANICK- 162
+P +I + L++L + + F S + +
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 163 NLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILND 222
+ +L K + + I + + + NN++ + K + LTKL+ + +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215
Query: 223 NELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID 282
+ E E N+ L + + LP+ +
Sbjct: 216 SPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL- 269
Query: 283 LSLPNVEFLNLGTNRF--------SGNIPSSITNASKLTVFQLRGNSF-SGFIPNTIGNL 333
+LP ++ +N+ NR + K+ + + N+ + + ++ +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERF 393
+ L L N L P L L LA N + I + G +E
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSEIKLA------SLNLAYNQITEIPANFCGFTE-QVENL 382
Query: 394 QMFNCRISGKIPQV--ISNLSNLLLLDLGGNKLTG-------SIPVTFSRLLNLQGLGLA 444
+ ++ IP + ++S + +D N++ + T + +N+ + L+
Sbjct: 383 SFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 445 FNKLARSIPDEICHLAKLDKLILHGNKFSG-------AIPSCSGNLTSLRALYLGSNRFT 497
N++++ + + L + L GN + N L ++ L N+ T
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 498 SALPSTI--WNLKDILFFDVSSNSLDGPLSLDIGNLKVVIEL------NLSRNNLSGDIP 549
L L ++ D+S NS N + + N + P
Sbjct: 502 K-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 550 ITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKL 609
I +L +L + +N + + E ++ +LD+ N + + + +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 610 NLSFNKLEGEIPRGGPFANL 629
L ++K + +I RG ++
Sbjct: 617 MLFYDKTQ-DI-RGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-54
Identities = 56/345 (16%), Positives = 115/345 (33%), Gaps = 19/345 (5%)
Query: 296 NRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
+ + S+ + ++T L G SG +P+ IG L LE L + + + L
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-LFG 125
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS-LERFQMFNCRISGKIPQVISNLSNL 414
++ S L + + + I +
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 415 LLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
+ N +T + RL L+ + + E + +
Sbjct: 186 TQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT---- 240
Query: 475 AIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSL-------- 526
NL L + + + + LP+ + L ++ +V+ N L
Sbjct: 241 -EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 527 DIGNLKVVIELNLSRNNL-SGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEIL 585
D + + + + NNL + + ++ +K L L N+LEG +P F L L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASL 358
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+L+ N+I+ + ++ L+ + NKL+ IP +++
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 34/255 (13%), Positives = 68/255 (26%), Gaps = 39/255 (15%)
Query: 397 NCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEI 456
N G Q +N + LD+ G V+ + + GL L + +PD I
Sbjct: 46 NWSQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 457 CHLAKLDKLILHGNKFSG----AIPSCSGNLTSLRALYLGSNRFTSALPSTI--WNLKDI 510
L +L+ L L + P S + + D+
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG 570
+ ++S+ + ++ NN++ + + L L++ ++ N+
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA 220
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+ E K + L L + +
Sbjct: 221 ENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVY------------------ 257
Query: 631 AKSFLGNELLCGLPD 645
L LP
Sbjct: 258 -----NCPNLTKLPT 267
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 3e-94
Identities = 115/570 (20%), Positives = 201/570 (35%), Gaps = 38/570 (6%)
Query: 71 IVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFG 130
I N IP L S + LDLS N L S F+ L++LD ++
Sbjct: 10 ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 131 SLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQ 190
++S + + L+ N L L +L+KL+ + K
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 191 LEGLYLRFNNL-SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL----VRLTLA 245
L+ L + N + S +P+ NLT L+ + L+ N+++ ++ L + + L L+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGN---- 301
N + + P F L KL+L N ++ L +E L F
Sbjct: 186 LNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 302 --IPSSITNASKLTVFQLRGNSFSGF---IPNTIGNLRNLEFLNIADNYLTSSTPELSFL 356
S++ LT+ + R + I + L N+ ++ + S+
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-FSYN 303
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
+ L L + +L ++ G +L +L
Sbjct: 304 FGWQH------LELVNCKFGQFPTLKLKSLK------RLTFTSNKGGNAFSEVDLPSLEF 351
Query: 417 LDLGGNKLT--GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
LDL N L+ G + +L+ L L+FN + ++ L +L+ L +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 475 AIP-SCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDI-GNLK 532
S +L +L L + A L + ++ NS DI L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 533 VVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+ L+LS+ L P L +LQ L +++N + L+SL++LD S N I
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 593 SGVIPTSLEKLLY-LKKLNLSFNKLEGEIP 621
L+ L LNL+ N
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 9e-72
Identities = 97/488 (19%), Positives = 186/488 (38%), Gaps = 26/488 (5%)
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
++P N+ + K L L N + +L+ L L + +L+
Sbjct: 21 KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
L +IL N ++ L L +L NL + F I ++ TLK+L++ N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 275 GSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQ----LRGNSFSGFIPNTI 330
+L N+E L+L +N+ + + ++ + L N + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 331 GNLRNLEFLNIADNYLTSSTPELSF--LSSLTNCQKIRVLILAGNPLDGILPSSIGNL-S 387
+ L L + +N+ + + + L+ L + + L+ S++ L +
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 388 ISLERFQM-FNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
+++E F++ + I + + L+N+ L + FS Q L L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNC 314
Query: 447 KLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNR--FTSALPSTI 504
K + ++ L +L G +L SL L L N F +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 505 WNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFL 563
+ + + D+S N + +S + L+ + L+ +NL ++ L+NL L +
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVI-PTSLEKLLYLKKLNLSFNKLEGEIPR 622
++ F+GLSSLE+L ++ N P +L L L+LS +LE P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP- 487
Query: 623 GGPFANLT 630
F +L+
Sbjct: 488 -TAFNSLS 494
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 4e-88
Identities = 98/666 (14%), Positives = 191/666 (28%), Gaps = 110/666 (16%)
Query: 25 TDQQSLLALKAHISYDP---------TNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNI 75
D ++L A+ + + + NW + + W
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV----------- 317
Query: 76 SGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSF 135
L N + L L+ G +P +I + LK+L F + S F
Sbjct: 318 -----------DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 136 IFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGK---IPSTLSKCKQLE 192
+ + +R L L ++ + P L+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426
Query: 193 GLYL-RFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
+ N I K I LTKL+ I ++ +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYE 481
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSG---------NI 302
+ N+ L + L LP + LP ++ LN+ NR +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFL-YDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPN-TIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
K+ +F + N+ F + ++ + L L+ N + L +
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-------LEAFGT 593
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQV--ISNLSNLLLLDL 419
K+ L L N ++ I P + +E + ++ IP + ++ + +D
Sbjct: 594 NVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDF 651
Query: 420 GGNKLTGSIPVTFS-----RLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFS- 473
NK+ + +N + L++N++ + + + + +IL N +
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
Query: 474 ------GAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
N L + L N+ TS L
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR---------------------- 748
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKL------FLANNRLEGPIPESFSGLSS 581
L + +++S N S P L+ NR+ P + S
Sbjct: 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
Query: 582 LEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL-EGEIPRGGPFANLTAKSFLGN--E 638
L L + N I V + L L+++ N ++ P+ L + +
Sbjct: 808 LIQLQIGSNDIRKVDEKLTPQ---LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
Query: 639 LLCGLP 644
+ G
Sbjct: 865 DIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-32
Identities = 70/444 (15%), Positives = 136/444 (30%), Gaps = 61/444 (13%)
Query: 210 GNLTKLKDIILNDNELRGEIPQEMG-NLPYLVRLTLATNNLVG-------VVPFTIFNMS 261
T+LK + + E E N Y+ ++ V VV +T ++ S
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQS 227
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
+K+ L ++ G + ID L + + + I + +
Sbjct: 228 GIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWR 287
Query: 322 FSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPS 381
+ N + N F D + L N ++ L LAG G +P
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPG------VDLDNNGRVTGLSLAGFGAKGRVPD 341
Query: 382 SIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGL 441
+IG L+ L +L G + T S + L
Sbjct: 342 AIGQLT-------------------------ELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 442 GLAFNKLARSIP----DEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLG--SNR 495
+++ D L D L N+ P + SL+ +G +NR
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 496 FTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGL 555
T + I L + +++ ++ + + N + ++ L
Sbjct: 437 ITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWE----DANSDYAKQYENEELSWSNL 490
Query: 556 KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV---------IPTSLEKLLYL 606
K+L + L N +P+ L L+ L+++ N+ + + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 607 KKLNLSFNKLEGEIPRGGPFANLT 630
+ + +N LE E P +
Sbjct: 551 QIFYMGYNNLE-EFPASASLQKMV 573
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 4e-83
Identities = 93/349 (26%), Positives = 144/349 (41%), Gaps = 60/349 (17%)
Query: 302 IPSSITNASKL----TVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
I + N + L ++ G + +T + L+++ L P
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP------ 67
Query: 358 SLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFN-CRISGKIPQVISNLSNLLL 416
+PSS+ NL L + + G IP I+ L+ L
Sbjct: 68 ---------------------IPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
L + ++G+IP S++ L L ++N L+ ++P I L L + GN+ SGAI
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 477 PSCSGNLTSL-RALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVI 535
P G+ + L ++ + NR T +P T NL +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------------------LA 200
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
++LSRN L GD + G KN QK+ LA N L + +L LDL N+I G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLP 644
+P L +L +L LN+SFN L GEIP+GG ++ N+ LCG P
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 3e-64
Identities = 84/359 (23%), Positives = 134/359 (37%), Gaps = 88/359 (24%)
Query: 25 TDQQSLLALKAHISYDPTNLFAKNWTSSTSVC--SWIGITCGV--NSHKVIVLNISGFNL 80
D+Q+LL +K + +PT L +W +T C +W+G+ C +++V L++SG NL
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 81 QGT---------------------------IPPQLGNLSSLETLDLSHNKLSGNIPSSIF 113
IPP + L+ L L ++H +SG IP +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 114 NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLG 173
+ L L
Sbjct: 123 -------------------------------------------------QIKTLVTLDFS 133
Query: 174 RNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKL-KDIILNDNELRGEIPQE 232
N G +P ++S L G+ N +SGAIP G+ +KL + ++ N L G+IP
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 233 MGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLN 292
NL L + L+ N L G + +K+ L +N+L L N+ L+
Sbjct: 194 FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG--LSKNLNGLD 250
Query: 293 LGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP 351
L NR G +P +T L + N+ G IP GNL+ + A+N +P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 1e-60
Identities = 71/330 (21%), Positives = 114/330 (34%), Gaps = 42/330 (12%)
Query: 180 KIPSTLSKCKQL----EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGE--IPQEM 233
+I L L G + ++ ++ L+ L IP +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 234 GNLPYLVRLTLA-TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLN 292
NLPYL L + NNLVG +P I L + +L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAK-------------------------LTQLHYLY 107
Query: 293 LGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP- 351
+ SG IP ++ L N+ SG +P +I +L NL + N ++ + P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNL 411
S L + ++ N L G +P + NL +L + + G + +
Sbjct: 168 SYGSFSKL-----FTSMTISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSD 220
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
N + L N L + NL GL L N++ ++P + L L L + N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 472 FSGAIPSCSGNLTSLRALYLGSNRFTSALP 501
G IP GNL +N+ P
Sbjct: 280 LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-82
Identities = 111/584 (19%), Positives = 199/584 (34%), Gaps = 52/584 (8%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
N L IP L +S E L+ S N L ++ + L LD Q++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ + + L+ N + LK L + L K L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA-TNNLV 250
E LYL N++S + KLK + +N + ++M +L L+L N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 251 GVVPFTIFNMSTLKKLSLLENTLWGSLPSRID-LSLPNVEFLNLGTNRFSGNIPSSITNA 309
+ F+ + + L+ + + ++ ++ P+
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 310 SKLTVFQLR--GNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRV 367
+++V + + F NT L+ L++ +L+ L LS+L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTL------KK 305
Query: 368 LILAGNPLDGILPSSIGNLSISLERFQM-FNCRISGKIPQVISNLSNLLLLDLGGNKLTG 426
L+L+ N + + S N SL + N + + NL NL LDL + +
Sbjct: 306 LVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 427 S--IPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIP-SCSGNL 483
S + L +LQ L L++N+ + +L+ L L + S NL
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
L+ L L + + L L+ LNL N+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLP---------------------ALQH---LNLQGNH 460
Query: 544 LSGDIPITIG---GLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSL 600
L L+ L L+ L +F+ L + +DLS N+++ +L
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
Query: 601 EKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL---GNELLC 641
L + LNL+ N + +P L+ + + N L C
Sbjct: 521 SHLKGI-YLNLASNHISIILP--SLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-72
Identities = 106/546 (19%), Positives = 179/546 (32%), Gaps = 46/546 (8%)
Query: 95 ETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSG 154
+T + + L+ IP ++ N + + L+F N L
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVL-------------------------P 46
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
+ L NL L L R + T +L+ L L N L +
Sbjct: 47 TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
LK + + + N L L L +N++ + F LK L N +
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
Query: 275 GSLPSRID-LSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN- 332
+ L LNL N +G I +++ G I + N
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 333 -LRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLE 391
+++L D +P + + + + L + I ++ S L+
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMS---VESINLQKHYFFNISSNTFHCFS-GLQ 281
Query: 392 RFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARS 451
+ +S ++P + LS L L L NK ++ S +L L + N
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 452 IPDE-ICHLAKLDKLILHGNK--FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLK 508
+ + +L L +L L + S NL+ L++L L N S
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400
Query: 509 DILFFDVSSNSLDGPLSLDI-GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNR 567
+ D++ L + NL ++ LNLS + L GL LQ L L N
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460
Query: 568 LEGPI---PESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGG 624
S L LEIL LS +S + + L + ++LS N+L
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--E 518
Query: 625 PFANLT 630
++L
Sbjct: 519 ALSHLK 524
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 9e-68
Identities = 100/562 (17%), Positives = 174/562 (30%), Gaps = 88/562 (15%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
+ H++ L ++ L L +L+ L +S + N TL+ L
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
N + + LK L N H +
Sbjct: 139 NHI-------------------------SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 186 SKCKQLEGLYLRFNNLS-GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGN--LPYLVRL 242
S +Q L L N I + + + + I + + N + L
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
T + + P + + +VE +NL + F
Sbjct: 234 TFEDMDDEDISPAVFEGLCEM-----------------------SVESINLQKHYFFNIS 270
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNC 362
++ S L L S +P+ + L L+ L ++ N + S +N
Sbjct: 271 SNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQ-----ISASNF 324
Query: 363 QKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGN 422
+ L + GN L + NL NL LDL +
Sbjct: 325 PSLTHLSIKGNTKRLELG------------------------TGCLENLENLRELDLSHD 360
Query: 423 KLTGS--IPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIP-SC 479
+ S + L +LQ L L++N+ + +L+ L L + S
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
Query: 480 SGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIG---NLKVVIE 536
NL L+ L L + + L + ++ N L +
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L LS +LS LK + + L++NRL E+ S L + L+L+ N IS ++
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 597 PTSLEKLLYLKKLNLSFNKLEG 618
P+ L L + +NL N L+
Sbjct: 540 PSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-46
Identities = 74/379 (19%), Positives = 137/379 (36%), Gaps = 20/379 (5%)
Query: 72 VLNISGFNLQGTIPPQLGN--LSSLETLDLSHNKLSGNIPSSIFNMHTLKL--LDFRDNQ 127
LN G I L N + SL P+ + + + ++ + +
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 128 LFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSK 187
F S+ S + +DL+ S ELP+ + L LKKL+L N F + S
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV-GLSTLKKLVLSANKFENLCQISASN 323
Query: 188 CKQLEGLYLRFNNLSGAIPKE-IGNLTKLKDIILNDNELR--GEIPQEMGNLPYLVRLTL 244
L L ++ N + + NL L+++ L+ +++ ++ NL +L L L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 245 ATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS 304
+ N + + L+ L L L +L ++ LNL + +
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 305 SITNASKLTVFQLRGNSFSGFI---PNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
L L+GN F N++ L LE L ++ L+S + T+
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH-----AFTS 498
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421
+ + + L+ N L ++ +L + + IS +P ++ LS ++L
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHL--KGIYLNLASNHISIILPSLLPILSQQRTINLRQ 556
Query: 422 NKLTGSIPVT-FSRLLNLQ 439
N L + F
Sbjct: 557 NPLDCTCSNIYFLEWYKEN 575
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-27
Identities = 43/231 (18%), Positives = 69/231 (29%), Gaps = 29/231 (12%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
+ L IP T + + L +FN L L L L L +
Sbjct: 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
+ L L L +N + + K LK
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPK---------------------ALK---H 109
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L + +S I + K L+ L+L +N + L++LD N I +
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 597 PTSLEKL--LYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPD 645
+ L LNL+ N + G P A + +F G + L +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-78
Identities = 108/564 (19%), Positives = 186/564 (32%), Gaps = 38/564 (6%)
Query: 71 IVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFG 130
I L +P + SS + +DLS N L S N L+ LD ++
Sbjct: 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 131 SLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQ 190
+ + + L+ N L +L+ L+ + +
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 191 LEGLYLRFNNLSGA-IPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL----VRLTLA 245
L+ L + N + +P NLT L + L+ N ++ ++ L + L ++
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS 305
N + + F L +L+L N ++ +L + L F
Sbjct: 190 LNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 306 ITNAS--------KLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
I S + F+L + L N+ +++A + L
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-------LE 301
Query: 358 SLTNCQKIRVLILAGNPLDGILPSSIGNL-SISLERFQMFNCRISGKIPQVISNLSNLLL 416
+ K + L + L + L S++L + G I L +L
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNK-------GSISFKKVALPSLSY 354
Query: 417 LDLGGNKLTGSIPVTFSRL--LNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
LDL N L+ S ++S L +L+ L L+FN + L +L L +
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKR 413
Query: 475 AIP-SCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSL-DGPLSLDIGNLK 532
S +L L L + L + ++ NS D LS N
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473
Query: 533 VVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+ L+LS+ L L LQ L +++N L ++ L SL LD S N+I
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 593 SGVIPTSLEKLLYLKKLNLSFNKL 616
L NL+ N +
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-60
Identities = 96/497 (19%), Positives = 169/497 (34%), Gaps = 26/497 (5%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ S ++P +I + K + L N + S +L+ L L +
Sbjct: 16 YQCMDQKLS-KVPDDI---PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 205 IPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLK 264
K L L ++IL N ++ P L L L L + F I + TLK
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 265 KLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQ----LRGN 320
KL++ N + +L N+ ++L N + + + + N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF--LSSLTNCQKIRVLILAGNPLDGI 378
+ L L + N+ +S+ + L+ L + I L+
Sbjct: 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 379 LPSSIGNL-SISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLN 437
PS + L ++++ F++ L+N+ + L G + V
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFK 308
Query: 438 LQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFT 497
Q L + +L + P L L L L NK S I L SL L L N +
Sbjct: 309 WQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS 363
Query: 498 SALPSTIWNLK--DILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPI-TIGG 554
+ + +L + D+S N +S + L+ + L+ + L
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 555 LKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTS-LEKLLYLKKLNLSF 613
L+ L L ++ + F GL+SL L ++ N ++ L L+LS
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 614 NKLEGEIPRGGPFANLT 630
+LE G F L
Sbjct: 483 CQLEQISW--GVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-23
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 474 GAIPSCSGNLTSLRALYLGSNRFTS---ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGN 530
G++ C + ++ + + +PS+ N+ D+S N L S N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPSSTKNI------DLSFNPLKILKSYSFSN 54
Query: 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
+ L+LSR + GL +L L L N ++ P SFSGL+SLE L +
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 591 KISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
K++ + + +L+ LKKLN++ N + F+NLT
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-68
Identities = 90/320 (28%), Positives = 151/320 (47%), Gaps = 29/320 (9%)
Query: 698 SITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKV 757
SI + + P R +L +AT+ F L+G G FG VY L+DG +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 758 FHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY--- 814
+ ++ F+ E E + RH +LV +I C + LI +YM NG+L+ LY
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 815 SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAK 862
T + QRL I I A L YLH IIH V I+DF I+K
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIF-I 921
DQ + T T+GY+ PEY ++GR++ + DVYS+G++L E + +
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 922 GELSLSRWVNDLLPIS-VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI 980
++L+ W + + +++D NL ++ + +SL + A +C S R
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNL---ADKI---RPESLRKFGDTAVKCLALSSEDRP 301
Query: 981 NAREIVTGL---LKIRDTLV 997
+ +++ L L+++++++
Sbjct: 302 SMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-65
Identities = 99/300 (33%), Positives = 141/300 (47%), Gaps = 33/300 (11%)
Query: 713 IRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVF----HQRYERALKS 768
++RFS EL A+D FS N+LG G FG VY RL DG VAVK Q E
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ--- 73
Query: 769 FQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY---SGTCMLDIFQR 825
FQ E E++ HRNL+++ C + L+ YM NGS+ + L LD +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 826 LNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQ 873
I + A L YLH IIH A + DF +AK L +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVT 192
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE---LSLSRWV 930
T TIG++APEY G+ S + DV+ YG+ML+E TG++ D + + L WV
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 931 NDLLPI-SVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
LL + ++D +L + Y K++ + ++ +A CT SP +R E+V L
Sbjct: 253 KGLLKEKKLEALVDVDL---QGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-60
Identities = 111/568 (19%), Positives = 205/568 (36%), Gaps = 45/568 (7%)
Query: 71 IVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFG 130
I N IP L S + LDLS N L S F+ L++LD ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-Q 65
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
++ + ++S + + L+ N L L +L+KL+ + K
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 190 QLEGLYLRFNNL-SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL----VRLTL 244
L+ L + N + S +P+ NLT L+ + L+ N+++ ++ L + + L L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 245 ATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS 304
+ N + + F L KL+L N ++ L +E L F
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--- 240
Query: 305 SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQK 364
+ F + + L NL YL ++ L +
Sbjct: 241 ---------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTN 283
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
+ L ++ + S LE + L +L L NK
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKG 337
Query: 425 TGSIPVTFSRLLNLQGLGLAFNKLARS--IPDEICHLAKLDKLILHGNKFSGAIPSCSGN 482
+ + L +L+ L L+ N L+ L L L N + S
Sbjct: 338 GNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 483 LTSLRALYLGSNRFTSALPSTIW-NLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSR 541
L L L + +++ +L+++++ D+S + L + L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 542 NNLSGDI-PITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSL 600
N+ + P L+NL L L+ +LE P +F+ LSSL++L+++ N++ V
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 601 EKLLYLKKLNLSFNKLEGEIPRGGPFAN 628
++L L+K+ L N + PR +
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 9e-55
Identities = 118/567 (20%), Positives = 198/567 (34%), Gaps = 56/567 (9%)
Query: 96 TLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGE 155
T IP ++ + K LD N L
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPL-------------------------RH 42
Query: 156 LPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKL 215
L + + P L+ L L R L L L N + L+ L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 216 KDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSLLENTLW 274
+ ++ + L +G+L L L +A N + F N++ L+ L L N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 275 GSLPSRIDLSLPNVEF----LNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP-NT 329
S+ L + L+L N + I +L LR N S +
Sbjct: 163 -SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 330 IGNLRNLEFLNIADNYLTSSTPELSF-LSSLTNCQKIRVLILAGNPLDGILPSSIGNLS- 387
I L LE + + F S+L + + LD L I +
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 388 -ISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
++ F + + I ++ S L+L K +L +L+ L N
Sbjct: 281 LTNVSSFSLVSVTIE-RVKDF-SYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSN 335
Query: 447 KLARSIPDEICHLAKLDKLILHGNK--FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTI 504
K + + L L+ L L N F G TSL+ L L N + + S
Sbjct: 336 KGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 505 WNLKDILFFDVSSNSLDGPLSLDI-GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563
L+ + D ++L + +L+ +I L++S + GL +L+ L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 564 ANNRL-EGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622
A N E +P+ F+ L +L LDLS+ ++ + PT+ L L+ LN++ N+L+ +P
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD 511
Query: 623 GGPFANLTAKSFL---GNELLCGLPDL 646
G F LT+ + N C P +
Sbjct: 512 -GIFDRLTSLQKIWLHTNPWDCSCPRI 537
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 59/294 (20%), Positives = 100/294 (34%), Gaps = 25/294 (8%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA 444
NL S + + + + L +LDL ++ + L +L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 445 FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTS-ALPST 503
N + L+ L KL+ + G+L +L+ L + N S LP
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLK----VVIELNLSRNNLSGDIPITIGGLKNLQ 559
NL ++ D+SSN + D+ L + + L+LS N ++ I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 560 KLFLANNRLEGPIPE-SFSGLSSLEILDLSK------NKISGVIPTSLEKLLYLKKLNLS 612
KL L NN + + GL+ LE+ L + ++LE L L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 613 FNKLEGEIPRG----GPFANLTAKSFLGNEL--------LCGLPDLHNSPCKLN 654
L+ + N+++ S + + G L CK
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 50/300 (16%), Positives = 111/300 (37%), Gaps = 17/300 (5%)
Query: 64 GVNSHKVIVLNISGFNLQGTIPPQL-GNLSSLETLDLSHNKLSGNIPSSIF--NMHTLKL 120
G+ + + ++ + L L+++ + L + + + L+L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL 311
Query: 121 LDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFH-- 178
++ + Q + S+ + + N+ + + +LP+L+ L L RN
Sbjct: 312 VNCKFGQFPT------LKLKSLKRLTFTSNKGG-NAFSEV--DLPSLEFLDLSRNGLSFK 362
Query: 179 GKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLP 237
G + L+ L L FN + + L +L+ + + L+ + +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 238 YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNR 297
L+ L ++ + +S+L+ L + N+ + I L N+ FL+L +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 298 FSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
P++ + S L V + N L +L+ + + N S P + +LS
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-17
Identities = 43/189 (22%), Positives = 72/189 (38%), Gaps = 21/189 (11%)
Query: 479 CSGNLTSLRALYLGSNRFTS---ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVI 535
C + ++ F LP + NL D+S N L S + +
Sbjct: 3 CVEVVPNITY-QCMELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQ 55
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
L+LSR + L +L L L N ++ +FSGLSSL+ L + ++ +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL---GNEL-------LCGLPD 645
+ L LK+LN++ N ++ F+NLT L N++ L L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 646 LHNSPCKLN 654
+ L+
Sbjct: 175 MPLLNLSLD 183
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-58
Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 39/302 (12%)
Query: 714 RRFSYHELLQATDRFSK------NNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERA-- 765
FS++EL T+ F + N +G G FG VY + + VAVK +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 766 --LKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY--SGTCMLD 821
+ F E +VM + +H NLV+++ S+ D L+ YMPNGSL +RL GT L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 822 IFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQ 869
R I A + +L H IH A ISDF +A+ Q
Sbjct: 132 WHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW 929
M ++ + T YMAPE ++G ++ + D+YS+G++L+E TG DE L
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDI 246
Query: 930 VNDLL--PISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987
++ ++ + ID + S+ ++ ++A++C E KR + +++
Sbjct: 247 KEEIEDEEKTIEDYIDKKM----NDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 988 GL 989
L
Sbjct: 300 LL 301
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 8e-58
Identities = 112/569 (19%), Positives = 207/569 (36%), Gaps = 46/569 (8%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDL 147
L++ E L LS N + + +S F + L+LL+ ++ F N+ ++ +DL
Sbjct: 22 VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKI--PSTLSKCKQLEGLYLRFNNLSG-A 204
++ L + + L +L +L L + K L L L N +
Sbjct: 81 GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 205 IPKEIGNLTKLKDIILNDNELRGEIPQEMGNL--PYLVRLTLATNNLVGVVPFTIFN-MS 261
+ G L LK I + N++ E+ L L +LA N+L V M+
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
+ + L + G+ + +N S + S+ A + ++
Sbjct: 200 PFRNMVLEILDVSGNGWTVDIT--------GNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 322 FSGFIPNTIGNLR--NLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGIL 379
NT L ++ L+++ ++ S + ++VL LA N ++ I
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLKDLKVLNLAYNKINKIA 306
Query: 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ 439
+ L +L+ + + L + +DL N + TF L LQ
Sbjct: 307 DEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA 499
L L N L I + + + L GNK + + ++L NR +
Sbjct: 366 TLDLRDNALT-----TIHFIPSIPDIFLSGNKLV----TLPKINLTANLIHLSENRLENL 416
Query: 500 LP-STIWNLKDILFFDVSSNSLDG-PLSLDIGNLKVVIELNLSRNNLSGDIPITI----- 552
+ + + ++ N + +L L N L +
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 553 GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLS 612
GL +LQ L+L +N L P FS L++L L L+ N+++ + L L+ L++S
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDIS 534
Query: 613 FNKLEGEIPRGGPFANLTAKSFLGNELLC 641
N+L P F +L+ N+ +C
Sbjct: 535 RNQL--LAPNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-38
Identities = 78/400 (19%), Positives = 136/400 (34%), Gaps = 52/400 (13%)
Query: 228 EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPN 287
++PQ L RL L+ N + V + + L+ L L ++ +LPN
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 288 VEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFI--PNTIGNLRNLEFLNIADNY 345
+ L+LG+++ P + L +L S + NL+ L L+++ N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 346 LTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIP 405
+ S SF ++ + + N + + + L
Sbjct: 135 IRSLYLHPSF----GKLNSLKSIDFSSNQIFLVCEHELEPLQ------------------ 172
Query: 406 QVISNLSNLLLLDLGGNKLTGSIPVTFSRLLN------LQGLGLAFNKLARSIPDEICHL 459
L L N L + V + + +N L+ L ++ N I
Sbjct: 173 -----GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS-- 225
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKD--ILFFDVSS 517
N S + + G + +T L + D+S
Sbjct: 226 ----------NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 518 NSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFS 577
+ S LK + LNL+ N ++ GL NLQ L L+ N L +F
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335
Query: 578 GLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
GL + +DL KN I+ + + + L L+ L+L N L
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-28
Identities = 71/345 (20%), Positives = 122/345 (35%), Gaps = 49/345 (14%)
Query: 64 GVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLD 122
G+ V L++S + L L+ L+L++NK++ I F + L++L+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLN 320
Query: 123 FRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP 182
N L GEL ++ LP + + L +N
Sbjct: 321 LSYNLL-------------------------GELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
T ++L+ L LR N L+ I + + DI L+ N+L +P+ +
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLI 406
Query: 243 TLATNNLVGVVPFTIF-NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGN 301
L+ N L + + L+ L L +N + P++E L LG N
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 302 IPSSI-----TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFL 356
+ + S L V L N + P +L L L++ N LT
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL-SHNDLP 525
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
++L +L ++ N L P +LS+ F C
Sbjct: 526 ANL------EILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-23
Identities = 69/362 (19%), Positives = 125/362 (34%), Gaps = 28/362 (7%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
+ VLN++ + L +L+ L+LS+N L S+ + + + +D +
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
N + + + +DL N + +P++ + L N K+ +
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTT------IHFIPSIPDIFLSGN----KLVTLP 397
Query: 186 SKCKQLEGLYLRFNNLSG-AIPKEIGNLTKLKDIILNDNELRGEIPQEM--GNLPYLVRL 242
++L N L I + + L+ +ILN N + P L +L
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQL 456
Query: 243 TLATNNLVGVVPFTI-----FNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNR 297
L N L + +S L+ L L N L SLP + L + L+L +NR
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL-NSLPPGVFSHLTALRGLSLNSNR 515
Query: 298 FSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
+ + + + L + + N P+ +L L+I N +F++
Sbjct: 516 LT-VLSHN-DLPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFIN 570
Query: 358 SLTNCQKIRVLILAGNPLDGILPSSIGN--LSISLERFQMFNCRISGKIPQVISNLSNLL 415
L N + + + S G S+S E S K I L
Sbjct: 571 WL-NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
Query: 416 LL 417
L
Sbjct: 630 LF 631
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-53
Identities = 90/537 (16%), Positives = 190/537 (35%), Gaps = 40/537 (7%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSI 149
+ + D + +IPS + +K LD N++ + +++ + L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSG-AIPKE 208
+R + + + +L +L+ L L N S L+ L L N +
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 209 IGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
NLT L+ + + + E EI + L L L + +L ++ ++ + L+
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP 327
L + L L +V +L L + S + + +
Sbjct: 179 LHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL--------- 228
Query: 328 NTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT--NCQKIRVLILAGNPLDGILPSSIGN 385
R + + N L + LS + +C + + D +
Sbjct: 229 ----AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 386 LSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAF 445
+++ R + + + V S L + + + +K+ L +L+ L L+
Sbjct: 285 T-VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 446 NKLARSIPDE---ICHLAKLDKLILHGNKFSGAIPSCSG---NLTSLRALYLGSNRFTSA 499
N + L L+L N ++ L +L +L + N F
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHP- 401
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
+P + + + F ++SS + + + + L++S NNL + L LQ
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQ 454
Query: 560 KLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
+L+++ N+L+ S L ++ +S+N++ V ++L L+K+ L N
Sbjct: 455 ELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-49
Identities = 93/529 (17%), Positives = 177/529 (33%), Gaps = 57/529 (10%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
L++S + L ++L+ L L ++++ I F ++ +L+ LD DN L
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL-S 87
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP-STLSKC 188
SLSS F +SS+ ++L N + ++ NL NL+ L +G +I +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L L ++ +L + + ++ + + L+ +E + L + L L N
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
L + + L L L + L + +
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRG-SVLTDESFNELLKLLRYILELSEV------EFDD 260
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
+ + + + L+I YL + + +K++ +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS-----TVYSLLEKVKRI 315
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKI---PQVISNLSNLLLLDLGGNKLT 425
+ + + + S +L SLE + + + +L L L N L
Sbjct: 316 TVENSKVFLVPCSFSQHLK-SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 426 --GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNL 483
L NL L ++ N +PD K+ L L + +C
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTC--IP 430
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
+L L + +N S SL + L+ EL +SRN
Sbjct: 431 QTLEVLDVSNNNLDS-------------------------FSLFLPRLQ---ELYISRNK 462
Query: 544 LSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
L +P L + ++ N+L+ F L+SL+ + L N
Sbjct: 463 LK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-48
Identities = 99/504 (19%), Positives = 181/504 (35%), Gaps = 36/504 (7%)
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAI 205
D F+ +P+ + +K L L N L C L+ L L+ + ++
Sbjct: 11 DGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF-NMSTLK 264
+L L+ + L+DN L G L L L L N + ++F N++ L+
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 265 KLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSG 324
L + + + L ++ L + S+ + + L + +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 325 FIPNTIGNLRNLEFLNIADNYLTS---STPELSFLSSLTNCQKIRVLILAGNPLDGILPS 381
+ L ++ +L + D L S + +SS R +L + +L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 382 SIGNLSISLERFQMFNCRISGKIPQVISN---------LSNLLLLDLGGNKLTGSIPVTF 432
L +S F G S+ + L + L + +
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 433 SRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAI---PSCSGNLTSLRA 488
S L ++ + + +K+ +P HL L+ L L N +C G SL+
Sbjct: 307 SLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 489 LYLGSNRFTS--ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSG 546
L L N S + LK++ D+S N+ P+ + + LNLS +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV 424
Query: 547 DIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYL 606
+ + L+ L ++NN L+ L L+ L +S+NK+ + SL L
Sbjct: 425 ---VKTCIPQTLEVLDVSNNNLD----SFSLFLPRLQELYISRNKLKTLPDASL--FPVL 475
Query: 607 KKLNLSFNKLEGEIPRGGPFANLT 630
+ +S N+L+ +P G F LT
Sbjct: 476 LVMKISRNQLK-SVPD-GIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 75/472 (15%), Positives = 159/472 (33%), Gaps = 37/472 (7%)
Query: 72 VLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLF 129
VL + + TI +L SLE LDLS N LS ++ SS F + +LK L+ N
Sbjct: 54 VLILKS-SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 130 G-SLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
++S N++++ + + E+ L +L +L + +L
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+ + L L + + + L+ ++ + L D L + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 249 LVGVVPFTIFNMS-----------------TLKKLSLLENTLWGSLPSRIDLSLPNVEFL 291
+ + + TL L + + + + L
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 292 NLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP 351
++ ++ + + K+ + + + +L++LEFL++++N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDGI--LPSSIGNLSISLERFQMFNCRISGKIPQVIS 409
+ S + ++ L+L+ N L + + L +L + +P
Sbjct: 352 KNS--ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK-NLTSLDISRNTFH-PMPDSCQ 407
Query: 410 NLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHG 469
+ L+L + V L+ L ++ N L S L +L +L +
Sbjct: 408 WPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISR 460
Query: 470 NKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
NK +P S L + + N+ S L + + +N D
Sbjct: 461 NKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 58/293 (19%), Positives = 108/293 (36%), Gaps = 27/293 (9%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMH--------TLKLLDFRDNQLFGSLSS 134
+ + LS +E D + N L PS + T++ L LF LS+
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 135 FIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPST---LSKCKQL 191
+ + I + ++ +P + ++L +L+ L L N+ + L
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 192 EGLYLRFNNLSGAIPKEIG---NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+ L L N+L ++ K L L + ++ N +P + L L++
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
+ VV I TL+ L + N L L LP ++ L + N+ +P + +
Sbjct: 422 IR-VVKTCIP--QTLEVLDVSNNNL-----DSFSLFLPRLQELYISRNKLK-TLPDA-SL 471
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
L V ++ N L +L+ + + N S P + +LS N
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 524
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 9e-51
Identities = 65/309 (21%), Positives = 109/309 (35%), Gaps = 38/309 (12%)
Query: 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEV 775
L + + G FG V+ A+L VAVK+F + ++ S+Q+E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ---SWQNEYEV 69
Query: 776 --MKRIRHRNLVKIISACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIM 829
+ ++H N+++ I A LI + GSL + L + + + +I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIA 127
Query: 830 IDVALALEYLH------FGHSTP-IIH------------YMVAHISDFSIAKFLNGQDQL 870
+A L YLH P I H + A I+DF +A
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 871 SMQTQTLATIGYMAPEY-----GVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIG-EL 924
+ T YMAPE Q R D+Y+ G++L E + D L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 925 SLSRWVNDLLPISVM-EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983
+ + M EV+ R + K + + EC R++A
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 984 EIVTGLLKI 992
+ + ++
Sbjct: 308 CVGERITQM 316
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-50
Identities = 95/456 (20%), Positives = 178/456 (39%), Gaps = 42/456 (9%)
Query: 162 KNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILN 221
L K +LG+ + + Q+ L + + L L I +
Sbjct: 21 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFS 76
Query: 222 DNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI 281
+N+L P + NL LV + + N + + P N++ L L+L N + P +
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDPLK- 131
Query: 282 DLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNI 341
+L N+ L L +N S S+++ + L GN + P + NL LE L+I
Sbjct: 132 --NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDI 184
Query: 342 ADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
+ N ++ +S L + LI N + I + +G L+ +L+ + ++
Sbjct: 185 SSNKVSD-------ISVLAKLTNLESLIATNNQISDI--TPLGILT-NLDELSLNGNQLK 234
Query: 402 GKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAK 461
+++L+NL LDL N+++ P S L L L L N+++ P + L
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 288
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
L L L+ N+ P NL +L L L N + P + +L + +N +
Sbjct: 289 LTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS 581
SL NL + L+ N +S P+ L + +L L + + +S
Sbjct: 345 DVSSL--ANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSI 400
Query: 582 LEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
+ + + P ++ + ++++N
Sbjct: 401 PNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-50
Identities = 107/509 (21%), Positives = 190/509 (37%), Gaps = 45/509 (8%)
Query: 70 VIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLF 129
+ I+ I L+ L ++ + ++ + L +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
S+ + ++++ I+ S N+ + P KNL L +L+ N P L+
Sbjct: 59 KSIDG-VEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 190 QLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL 249
L GL L N ++ P + NLT L + L+ N + + L L +L+ N +
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQV 167
Query: 250 VGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNA 309
+ P N++TL++L + N + S S + L N+E L N+ S P +
Sbjct: 168 TDLKPLA--NLTTLERLDISSNKV--SDISVLA-KLTNLESLIATNNQISDITP--LGIL 220
Query: 310 SKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLI 369
+ L L GN T+ +L NL L++A+N +++ L+ L+ K+ L
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-------LAPLSGLTKLTELK 271
Query: 370 LAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIP 429
L N + I S + L+ +L ++ ++ P ISNL NL L L N ++ P
Sbjct: 272 LGANQISNI--SPLAGLT-ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 430 VTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRAL 489
S L LQ L NK+ S + +L ++ L N+ S P NLT + L
Sbjct: 327 --VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 490 YLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP 549
L +T+ P I + + I + E +++ N S
Sbjct: 381 GLNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPA-TISDGGSYTEPDITWNLPS-YTN 437
Query: 550 ITIGGLKNLQKLFLANNRLEGPIPESFSG 578
+ G + +
Sbjct: 438 EVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-49
Identities = 94/458 (20%), Positives = 174/458 (37%), Gaps = 64/458 (13%)
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
T + + L N++ + +L ++ + + + + + L L ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+ N L + P +L + + + N+ +
Sbjct: 74 NFSNNQLTDITPLK---------------------------NLTKLVDILMNNNQIAD-- 104
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNC 362
+ + N + LT L N + P + NL NL L ++ N ++ +S+L+
Sbjct: 105 ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-------ISALSGL 155
Query: 363 QKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGN 422
++ L D + NL+ +LER + + ++S V++ L+NL L N
Sbjct: 156 TSLQQLSFGNQVTD---LKPLANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209
Query: 423 KLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGN 482
+++ P L NL L L N+L + L L L L N+ S P
Sbjct: 210 QISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPL--SG 263
Query: 483 LTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRN 542
LT L L LG+N+ ++ S + L + +++ N L+ I NLK + L L N
Sbjct: 264 LTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 319
Query: 543 NLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEK 602
N+S P+ L LQ+LF NN++ S + L+++ L N+IS + P L
Sbjct: 320 NISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LAN 373
Query: 603 LLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELL 640
L + +L L+ ++ L
Sbjct: 374 LTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-45
Identities = 96/481 (19%), Positives = 185/481 (38%), Gaps = 66/481 (13%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
+V L L + L++L ++ S+N+L+ P + N+ L + +NQ+
Sbjct: 47 QVTTLQAD--RLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 129 FGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
+ + + N++++ G+ L N+ + P KNL NL +L L N S LS
Sbjct: 103 --ADITPLANLTNLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISD--ISALSGL 155
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L+ L N ++ P + NLT L+ + ++ N++ + L L L N
Sbjct: 156 TSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ 210
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
+ + P L N++ L+L N+ ++ +
Sbjct: 211 ISDITPLG---------------------------ILTNLDELSLNGNQLKD--IGTLAS 241
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
+ LT L N S P + L L L + N +++ +S L + L
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-------ISPLAGLTALTNL 292
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSI 428
L N L+ I S I NL +L ++ IS P +S+L+ L L NK++
Sbjct: 293 ELNENQLEDI--SPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVS 347
Query: 429 PVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRA 488
+ L N+ L N+++ P + +L ++ +L L+ ++ A + N++
Sbjct: 348 S--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 489 LYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDI 548
+ + + P+TI + D++ N + + + SG +
Sbjct: 404 VKNVTGALIA--PATISDGGSYTEPDITWNLPSYTNEV-SYTFSQPVTIGKGTTTFSGTV 460
Query: 549 P 549
Sbjct: 461 T 461
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-47
Identities = 100/533 (18%), Positives = 181/533 (33%), Gaps = 83/533 (15%)
Query: 84 IPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSML 143
I P+ + + L+ + L+ +P N+ + ++ + M
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 144 GIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSG 203
L +L L +P LE L N+L+
Sbjct: 62 VSRLRDCL------------DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT- 104
Query: 204 AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTL 263
+P+ +L L N L P L L ++ N L +P + N S L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 264 KKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFS 323
K + + N+L LP P++EF+ G N+ +P + N LT NS
Sbjct: 156 KIIDVDNNSL-KKLPD----LPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK 208
Query: 324 GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSI 383
+LE + +N L L L N + + N L LP
Sbjct: 209 KLPDL----PLSLESIVAGNNILEE-------LPELQNLPFLTTIYADNNLL-KTLPDLP 256
Query: 384 GNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
+L E + + ++ +P++ +L+ L + + + L+ P NL L
Sbjct: 257 PSL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNA 304
Query: 444 AFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPST 503
+ N++ RS+ D L +L+ + NK +P+ L L N +P
Sbjct: 305 SSNEI-RSLCDLPPSLEELN---VSNNKLI-ELPALPPRLERL---IASFNHLAE-VPEL 355
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563
NLK + V N L +++ +L N+ ++P NL++L +
Sbjct: 356 PQNLKQL---HVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQ---NLKQLHV 403
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
N L P+ S+E L ++ ++ + E L+ +
Sbjct: 404 ETNPLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-44
Identities = 89/511 (17%), Positives = 174/511 (34%), Gaps = 82/511 (16%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSM 142
+P + N+ S + ++ N P + + RD +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE--------- 75
Query: 143 LGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
++L+ S LP P+L+ L+ N ++P K L LS
Sbjct: 76 --LELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
P L+ + +++N+L ++P E+ N +L + + N+L +P +
Sbjct: 128 DLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS--- 174
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
L+ ++ N L LP +LP + + N +P + L N
Sbjct: 175 LEFIAAGNNQL-EELPELQ--NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNIL 227
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSS 382
+ NL L + +N L + L +L + N L LP
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALN---------VRDNYLTD-LPEL 275
Query: 383 IGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLG 442
+ L + S + ++ NL L+ N++ S+ +L+ L
Sbjct: 276 PQS----LTFLDVSENIFS-GLSELPPNLYY---LNASSNEIR-SLC---DLPPSLEELN 323
Query: 443 LAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPS 502
++ NKL +P L +L N + +P +L+ L++ N P
Sbjct: 324 VSNNKL-IELPALPPRLERLI---ASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPD 374
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
+++D+ NS + NLK +L++ N L + P +++L+
Sbjct: 375 IPESVEDL-----RMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPESVEDLR--- 422
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKIS 593
+ + R+ P + LE +
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-42
Identities = 93/429 (21%), Positives = 155/429 (36%), Gaps = 69/429 (16%)
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L+ +NL+ +P E N+ + +E P G + L
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
+L L L SLP P++E L N + +P +
Sbjct: 70 D-----------RQAHELELNNLGL-SSLPE----LPPHLESLVASCNSLT-ELPELPQS 112
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
L V + S P LE+L +++N L L L N ++++
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPELQNSSFLKII 158
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSI 428
+ N L LP + LE N ++ ++P+ + NL L + N L +
Sbjct: 159 DVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KL 210
Query: 429 PVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRA 488
P L+L+ + N L E+ +L L + N +P +L +
Sbjct: 211 P---DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA--- 261
Query: 489 LYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDI 548
L + N T LP +L + DVS N G LS NL LN S N + +
Sbjct: 262 LNVRDNYLTD-LPELPQSLTFL---DVSENIFSG-LSELPPNLY---YLNASSNEIR-SL 312
Query: 549 PITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKK 608
+L++L ++NN+L +P LE L S N ++ +P + LK+
Sbjct: 313 C---DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPELPQN---LKQ 361
Query: 609 LNLSFNKLE 617
L++ +N L
Sbjct: 362 LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 54/310 (17%), Positives = 98/310 (31%), Gaps = 47/310 (15%)
Query: 325 FIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIG 384
FI + L+ + LT E + S T A + + P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTE------YYNAWSEWERNAPPGNG 55
Query: 385 NLSISLERFQMFNCRISG------------KIPQVISNLSNLLLLDLGGNKLTGSIPVTF 432
+ ++ +C +P++ +L + L N LT +P
Sbjct: 56 EQ-REMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLT-ELPELP 110
Query: 433 SRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLG 492
L +L L+ P L+ L + N+ +P N + L+ + +
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPEL-QNSSFLKIIDVD 161
Query: 493 SNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSL-DIGNLKVVIELNLSRNNLSGDIPIT 551
+N LP +L+ I +N L+ L ++ NL + + N+L +P
Sbjct: 162 NNSLKK-LPDLPPSLEFI---AAGNNQLE---ELPELQNLPFLTAIYADNNSLK-KLP-- 211
Query: 552 IGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNL 611
+L+ + NN LE L L + N + +P L L +
Sbjct: 212 -DLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDN 267
Query: 612 SFNKLEGEIP 621
L
Sbjct: 268 YLTDLPELPQ 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-47
Identities = 90/404 (22%), Positives = 164/404 (40%), Gaps = 60/404 (14%)
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
+ + P +L +R L ++ VV + ++ KL + +
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKV- 56
Query: 275 GSLPSRIDLS-LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNL 333
S+ + L N+E+LNL N+ + P ++N KLT + N + + NL
Sbjct: 57 ASIQ---GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNL 109
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERF 393
NL L + ++ ++ +S L N K+ L L N S + N++ L
Sbjct: 110 TNLRELYLNEDNISD-------ISPLANLTKMYSLNLGANHNLSD-LSPLSNMT-GLNYL 160
Query: 394 QMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP 453
+ ++ P I+NL++L L L N++ P + L +L N++ P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 454 DEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFF 513
+ ++ +L+ L + NK + P NL+ L L +G+N+ + + + +L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLT----- 265
Query: 514 DVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573
LK LN+ N +S DI + + L L LFL NN+L
Sbjct: 266 ----------------KLK---MLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDM 304
Query: 574 ESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
E GL++L L LS+N I+ + P L L + + + ++
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-46
Identities = 84/368 (22%), Positives = 143/368 (38%), Gaps = 36/368 (9%)
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
L+ L + P D L L + + +T + G
Sbjct: 2 AATLATLPAPINQIFP---DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV 56
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSS 382
+ I L NLE+LN+ N +T +S L+N K+ L + N + I S+
Sbjct: 57 ASIQG--IEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITDI--SA 105
Query: 383 IGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLG 442
+ NL+ +L + IS P ++NL+ + L+LG N + S + L L
Sbjct: 106 LQNLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLT 161
Query: 443 LAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPS 502
+ +K+ P I +L L L L+ N+ P +LTSL N+ T +
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITD--IT 215
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
+ N+ + + +N + L NL + L + N +S DI + L L+ L
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLN 271
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622
+ +N++ + LS L L L+ N++ + L L L LS N +
Sbjct: 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR-- 327
Query: 623 GGPFANLT 630
P A+L+
Sbjct: 328 --PLASLS 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-43
Identities = 78/361 (21%), Positives = 150/361 (41%), Gaps = 33/361 (9%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+L+ L ++ + + ++ L ++ S+ I ++++ ++L
Sbjct: 18 DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNL 73
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPK 207
+ N+ + P NL L L +G N S L L LYL +N+S P
Sbjct: 74 NGNQITDISPL---SNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP- 127
Query: 208 EIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
+ NLTK+ + L N ++ + N+ L LT+ + + V P N++ L LS
Sbjct: 128 -LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLS 183
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP 327
L N + P SL ++ + N+ + P + N ++L ++ N + P
Sbjct: 184 LNYNQIEDISPLA---SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 328 NTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLS 387
+ NL L +L I N ++ ++++ + K+++L + N + I S + NLS
Sbjct: 239 --LANLSQLTWLEIGTNQISD-------INAVKDLTKLKMLNVGSNQISDI--SVLNNLS 287
Query: 388 ISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNK 447
L + N ++ + +VI L+NL L L N +T P + L + A
Sbjct: 288 -QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
Query: 448 L 448
+
Sbjct: 345 I 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-30
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSM 142
T L NL++L L L+ + +S S + N+ + L+ N LS
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPL------- 151
Query: 143 LGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
N+ L L + + P ++ L L L +N +
Sbjct: 152 -------------------SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
P + +LT L N++ P + N+ L L + N + + P N+S
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA--NLSQ 244
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
L L + N + S + + L ++ LN+G+N+ S S + N S+L L N
Sbjct: 245 LTWLEIGTNQI--SDINAVK-DLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL 375
IG L NL L ++ N++T + L + K+ A +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITD-------IRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-22
Identities = 46/282 (16%), Positives = 91/282 (32%), Gaps = 65/282 (23%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
N K+ LN+ N + L N++ L L ++ +K+ P I N+ L L
Sbjct: 130 NLTKMYSLNLG-ANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
NQ+ +S +L +L N P +
Sbjct: 187 NQI-EDISPL--------------------------ASLTSLHYFTAYVNQITDITP--V 217
Query: 186 SKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245
+ +L L + N ++ P + NL++L + + N++ + +L L L +
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS 305
+N + + +L + L L N+
Sbjct: 274 SNQISDISVLN---------------------------NLSQLNSLFLNNNQLGNEDMEV 306
Query: 306 ITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
I + LT L N + P + +L ++ + A+ +
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 58/324 (17%), Positives = 117/324 (36%), Gaps = 27/324 (8%)
Query: 305 SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQK 364
++S +G++ + + + + N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN---------RWHSAWRQANSNN 57
Query: 365 IRVLILAGNPLDGILPSSIGNL-SISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNK 423
++ G L + + ++ + + + P LS+L + +
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 424 LTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGN- 482
L +P T + L+ L LA N L R++P I L +L +L + +P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 483 --------LTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVV 534
L +L++L L S LP++I NL+++ + ++ L L I +L +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 535 IELNLSRNNLSGDIPITIGGLKNLQKLFLAN-NRLEGPIPESFSGLSSLEILDLSKNKIS 593
EL+L + P GG L++L L + + L +P L+ LE LDL
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNL 290
Query: 594 GVIPTSLEKLLYLKKLNLSFNKLE 617
+P+ + +L + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-40
Identities = 55/345 (15%), Positives = 109/345 (31%), Gaps = 33/345 (9%)
Query: 82 GTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSS 141
G+ + S E L + + D ++ S+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SN 56
Query: 142 MLGIDLSINRFSGELPANICK-NLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNN 200
I+ R + P L L + P + L+ + +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 201 LSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNM 260
L +P + L+ + L N LR +P + +L L L++ + +P + +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 261 STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGN 320
+ L N++ L L ++P+SI N L ++R +
Sbjct: 174 DASGEHQ----------------GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILP 380
S + I +L LE L++ + P ++ LIL LP
Sbjct: 217 PLSA-LGPAIHHLPKLEELDLRGCTALRNYPP-----IFGGRAPLKRLILKDCSNLLTLP 270
Query: 381 SSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
I L+ LE+ + C ++P +I+ L ++ + +
Sbjct: 271 LDIHRLT-QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 59/313 (18%), Positives = 103/313 (32%), Gaps = 18/313 (5%)
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
E LY + + + + + N N T
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 248 NLVGVVP-FTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI 306
L L L L P + L +++ + + +P ++
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPL-PQFPDQAF-RLSHLQHMTIDAAGLM-ELPDTM 123
Query: 307 TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPE----LSFLSSLTNC 362
+ L L N +P +I +L L L+I + PE
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 363 QKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGN 422
++ L L + LP+SI NL +L+ ++ N +S + I +L L LDL G
Sbjct: 183 VNLQSLRLEWTGIRS-LPASIANLQ-NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239
Query: 423 KLTGSIPVTFSRLLNLQGLGLA-FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG 481
+ P F L+ L L + L ++P +I L +L+KL L G +PS
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 482 NLTSLRALYLGSN 494
L + + + +
Sbjct: 299 QLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 47/288 (16%), Positives = 90/288 (31%), Gaps = 46/288 (15%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
+ L + L P Q LS L+ + + L +P ++ L+ L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
N L +L + I +++ + + + ELP +
Sbjct: 137 NPL-RALPASIASLNRLRELSIRACPELTELPEPLAST----------------DASGEH 179
Query: 186 SKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245
L+ L L + + ++P I NL LK + + ++ L + + +LP L L L
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS 305
+ P + LK+L L + + +P
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDC------------------------SNLL-TLPLD 272
Query: 306 ITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPEL 353
I ++L LRG +P+ I L + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 17/225 (7%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+ I L +P + + LETL L+ N L +P+SI +++ L+ L R
Sbjct: 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165
Query: 132 LSSFIFNMSSMLGI---------DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP 182
L + + + L LPA+I NL NLK L + + +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLS-ALG 222
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILND-NELRGEIPQEMGNLPYLVR 241
+ +LE L LR P G LK +IL D + L +P ++ L L +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281
Query: 242 LTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLP 286
L L + +P I + + L+ L L ++ P
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCII-LVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 33/204 (16%), Positives = 60/204 (29%), Gaps = 12/204 (5%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
S H + + L G+ N +
Sbjct: 3 SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNP 58
Query: 511 LFFDVSSNSL-DGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE 569
+ +L L+ + L L L P L +LQ + + L
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 570 GPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANL 629
+P++ + LE L L++N + +P S+ L L++L++ E+P A+
Sbjct: 118 E-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP--LAST 173
Query: 630 TAKSFLGNELLCGLPDLHNSPCKL 653
A L L L +
Sbjct: 174 DASGEHQG--LVNLQSLRLEWTGI 195
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 69/286 (24%), Positives = 106/286 (37%), Gaps = 59/286 (20%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G+FG V A+ + +VA+K E K+F E + R+ H N+VK+ AC N
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 794 DDFKALIMEYMPNGSLENRLYS--GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-- 849
L+MEY GSL N L+ ++ + + + YLH +IH
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGD 898
V I DF A + + T + +MAPE S + D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQ-----THMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 899 VYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKE 958
V+S+GI+L E T +KP DEI +M + R
Sbjct: 186 VFSWGIILWEVITRRKPFDEI------------GGPAFRIMWAVHNGT-----R------ 222
Query: 959 QSLLSI--------LNLATECTIESPGKRINAREIVTGLLKIRDTL 996
+ +L T C + P +R + EIV + +
Sbjct: 223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQR-------YERALKSFQDECEVMKRIRHRNLV 785
+G G FG V+ RL D VA+K + FQ E +M + H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
K+ N ++ME++P G L +RL + +L +M+D+AL +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 846 PIIH-----------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-- 886
PI+H + A ++DF +++ + L +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETI 198
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEI 919
+ + + D YS+ ++L TG+ P DE
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISAC 791
+G GSFG+VY + +VAVK+ + + L++F++E V+++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-- 849
+ A++ ++ SL + L++ ++ + ++I A ++YL H+ IIH
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 145
Query: 850 ----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE---YGVQGRVSTR 896
I DF +A + Q +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 897 GDVYSYGIMLMETFTGKKP 915
DVY++GI+L E TG+ P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISAC 791
+G GSFG+V+ A G +VAVK+ ++ + F E +MKR+RH N+V + A
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTC--MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
+ +++ EY+ GSL L+ LD +RL++ DVA + YLH + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 850 ------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRG 897
+ DF +++ LS ++ T +MAPE + +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAA-GTPEWMAPEVLRDEPSNEKS 220
Query: 898 DVYSYGIMLMETFTGKKPTDEI 919
DVYS+G++L E T ++P +
Sbjct: 221 DVYSFGVILWELATLQQPWGNL 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 49/324 (15%)
Query: 716 FSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEV 775
+ E D L+G G +G+VY L D VAVKVF + +F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 776 MK--RIRHRNLVKIISACSNDDFKA-----LIMEYMPNGSLENRLYSGTCMLDIFQRLNI 828
+ + H N+ + I L+MEY PNGSL L T D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 829 MIDVALALEYLH-----FGHSTP-IIH------------YMVAHISDFSIAKFLNGQDQL 870
V L YLH H P I H ISDF ++ L G +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 871 SMQTQTLA------TIGYMAPEY-------GVQGRVSTRGDVYSYGIMLMETFTGKK--- 914
+ A TI YMAPE + D+Y+ G++ E F
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 915 PTDEIFIGELSLSRWVNDLLPISVME--VIDTNLLSGEERYFAAKEQSLLSILNLATECT 972
P + + +++ V + M+ V + ++ S+ +C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 973 IESPGKRINAREIVTGLLKIRDTL 996
+ R+ A+ + ++
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIW 320
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 29/206 (14%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISAC 791
L G ++ R Q G ++ VKV R R + F +EC ++ H N++ ++ AC
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 792 SN--DDFKALIMEYMPNGSLENRLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPII 848
+ LI +MP GSL N L+ GT +D Q + +D+A + +LH I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 849 HY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE---YGVQGRV 893
+ M A IS + + ++APE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEI 919
D++S+ ++L E T + P ++
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 31/210 (14%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFH----QRYERALKSFQDECEVMKRIRHRNLVKIIS 789
+GIG FG VY A G EVAVK + + +++ + E ++ ++H N++ +
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
C + L+ME+ G L L + +N + +A + YLH PIIH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 850 --------------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
+ I+DF +A+ + + + +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAPEVIR 187
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEI 919
S DV+SYG++L E TG+ P I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 30/209 (14%)
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIIS 789
L+G G FG VY R EVA+++ E LK+F+ E ++ RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 849
AC + A+I +L + + +LD+ + I ++ + YL H+ I+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLA---TIGYMAPE--------- 886
I+DF + + + + ++APE
Sbjct: 154 KDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ S DV++ G + E + P
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-40
Identities = 68/402 (16%), Positives = 133/402 (33%), Gaps = 28/402 (6%)
Query: 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKL 312
+ + + + T D++L N + + + + + + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQ-DVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 313 TVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAG 372
+ L ++ L + N + P + N + VL+L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLER 126
Query: 373 NPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTF 432
N L + N L M N + ++L L L N+LT V
Sbjct: 127 NDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDL 182
Query: 433 SRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLG 492
S + +L +++N L + +++L N + + L L L
Sbjct: 183 SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVR--GPVNVELTILKLQ 234
Query: 493 SNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI 552
N T + + N ++ D+S N L+ + ++ + L +S N L + +
Sbjct: 235 HNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291
Query: 553 GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLS 612
+ L+ L L++N L + + LE L L N I + ++ LK L LS
Sbjct: 292 QPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHT---LKNLTLS 347
Query: 613 FNKLEGEIPRGGPFANLTAKSFLGNELLCGLPD--LHNSPCK 652
N + F N+ + + C + H CK
Sbjct: 348 HNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCK 388
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 72/394 (18%), Positives = 139/394 (35%), Gaps = 56/394 (14%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSM 142
I L + + ++ K++ F+++ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-------------- 57
Query: 143 LGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
+LPA + + ++ L L + ++ LY+ FN +
Sbjct: 58 -----------RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 203 GAIPKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNM 260
+P + N+ L ++L N+L +P+ + N P L L+++ NNL + T
Sbjct: 107 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164
Query: 261 STLKKLSLLENTLWGSLPSRIDLS-LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRG 319
++L+ L L N L + +DLS +P++ N+ N S++ +
Sbjct: 165 TSLQNLQLSSNRL-----THVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 214
Query: 320 NSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGIL 379
NS + + L L + N LT + L N + + L+ N L+ I+
Sbjct: 215 NSIN-VVRG--PVNVELTILKLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIM 264
Query: 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ 439
+ LER + N R+ + + L +LDL N L + + L+
Sbjct: 265 YHPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 321
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFS 473
L L N + ++ L L L N +
Sbjct: 322 NLYLDHNSI-VTLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 58/319 (18%), Positives = 109/319 (34%), Gaps = 28/319 (8%)
Query: 72 VLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLF 129
++ ++ +P L + +E L+L+ ++ I + F HT++ L N +
Sbjct: 49 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI- 105
Query: 130 GSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
L +F N+ + + L N S LP I N P L L + N T
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L+ L L N L+ + + + L ++ N L + + L + N+
Sbjct: 165 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
+ VV + L L L N L ++ P + ++L N +
Sbjct: 217 IN-VVRGPVN--VELTILKLQHNNL-TDTAWLLN--YPGLVEVDLSYNELEKIMYHPFVK 270
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
+L + N + + L+ L+++ N+L L L
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRL------ENL 323
Query: 369 ILAGNPLDGILPSSIGNLS 387
L N + + S+ L
Sbjct: 324 YLDHNSIVTLKLSTHHTLK 342
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 36/155 (23%), Positives = 56/155 (36%), Gaps = 34/155 (21%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGS 131
L + NL T L N L +DLS+N+L I F M L+ L +N+L
Sbjct: 231 LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL--- 284
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
L + +P LK L L N + + +L
Sbjct: 285 ----------------------VALNLYG-QPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELR 226
E LYL N++ + + LK++ L+ N+
Sbjct: 321 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 7e-40
Identities = 72/441 (16%), Positives = 147/441 (33%), Gaps = 50/441 (11%)
Query: 228 EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPN 287
I + + + F ++ K ++ +T+ LP+ + S
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 76
Query: 288 VEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
VE LNL + + A + + N+ P+ N+ L L + N L+
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 348 SSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQV 407
S + N K+ L ++ N L+ I + + SL+ Q+ + R++ +
Sbjct: 137 SLPRGI-----FHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLT-HVD-- 187
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+S + +L ++ N L+ T + + ++ L + N + + + +L L L
Sbjct: 188 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPVN--VELTILKL 239
Query: 468 HGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
N + N L + L N + ++
Sbjct: 240 QHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQ------------------- 278
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDL 587
L+ L +S N L + + + L+ L L++N L + + LE L L
Sbjct: 279 --RLE---RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 331
Query: 588 SKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLH 647
N I + ++ LK L LS N + F N+ + + C +
Sbjct: 332 DHNSIVTLKLSTHHT---LKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQL 387
Query: 648 NSPCKLNKPKTHHKSRKMMLL 668
+ + R + +
Sbjct: 388 EHGLCCKESDKPYLDRLLQYI 408
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 87/537 (16%), Positives = 175/537 (32%), Gaps = 70/537 (13%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSM 142
I L + + ++ K++ F+++ +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-------------- 63
Query: 143 LGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
+LPA + + ++ L L + ++ LY+ FN +
Sbjct: 64 -----------RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 203 GAIPKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNM 260
+P + N+ L ++L N+L +P+ + N P L L+++ NNL + T
Sbjct: 113 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170
Query: 261 STLKKLSLLENTLWGSLPSRIDLS-LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRG 319
++L+ L L N L + +DLS +P++ N+ N S++ +
Sbjct: 171 TSLQNLQLSSNRL-----THVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 220
Query: 320 NSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGIL 379
NS + L L + N LT + L N + + L+ N L+ I+
Sbjct: 221 NSINVVRGPV---NVELTILKLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIM 270
Query: 380 PSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ 439
+ LER + N R+ + + L +LDL N L + + L+
Sbjct: 271 YHPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 327
Query: 440 GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA 499
L L N + ++ L L L N + C+ R + +
Sbjct: 328 NLYLDHNSI-VTLKLST--HHTLKNLTLSHNDW-----DCNSLRALFRNVARPAVDDADQ 379
Query: 500 LPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
+ L+ L S L I VV ++ ++ S +
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS--------ATDTIN 431
Query: 560 KLFLANNRLEGPIPESFSGLSSLEILDLSKNK-ISGVIPTSLEKLLYLKKLNLSFNK 615
+ ++ + G LE + + +++ L+ L+ +
Sbjct: 432 SVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 65/357 (18%), Positives = 126/357 (35%), Gaps = 56/357 (15%)
Query: 72 VLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLF 129
++ ++ +P L + +E L+L+ ++ I + F HT++ L N +
Sbjct: 55 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI- 111
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
LP ++ +N+P L L+L RN
Sbjct: 112 ------------------------RYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 147
Query: 190 QLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+L L + NNL I + T L+++ L+ N L + + +P L ++ N
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 203
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
L T+ +++L N++ + + + L L N + + + N
Sbjct: 204 LS-----TLAIPIAVEELDASHNSI-NVVRGPV---NVELTILKLQHNNLTD--TAWLLN 252
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
L L N + + ++ LE L I++N L + + +L +VL
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTL------KVL 306
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
L+ N L + + LE + + I + +S L L L N
Sbjct: 307 DLSHNHLLHV-ERNQPQFD-RLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 2e-16
Identities = 24/190 (12%), Positives = 60/190 (31%), Gaps = 2/190 (1%)
Query: 450 RSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKD 509
+ I + + + + L + + + ++ + + + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 510 ILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE 569
+ +++ ++ + + +L + N + P + L L L N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 570 GPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANL 629
F L L +S N + + + + L+ L LS N+L + +L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-IPSL 194
Query: 630 TAKSFLGNEL 639
+ N L
Sbjct: 195 FHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 7e-10
Identities = 52/367 (14%), Positives = 107/367 (29%), Gaps = 30/367 (8%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSS 141
T L N L +DLS+N+L I F M L+ L +N+L +L+ + + +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPT 302
Query: 142 MLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL 201
+ +DLS N + N L+ L L N + LS L+ L L N+
Sbjct: 303 LKVLDLSHNHLL-HVERNQ-PQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
Query: 202 SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMS 261
+ + + ++D + +I ++ + P+ +
Sbjct: 358 DCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESD---------KPYLDRLLQ 406
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLR-GN 320
+ S++E + + + ++ + + +L
Sbjct: 407 YIALTSVVEKV---QRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRA 463
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILP 380
I + L+ L+ + L R +
Sbjct: 464 EVQQLTNEQIQQEQLLQGLHAEIDTNLRR-------YRLPKDGLARSSDNLNKVFTHLKE 516
Query: 381 SSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQG 440
L + R + + N++ LD K T + ++
Sbjct: 517 RQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
Query: 441 LGLAFNK 447
L N+
Sbjct: 577 LEAKKNR 583
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-39
Identities = 78/345 (22%), Positives = 127/345 (36%), Gaps = 41/345 (11%)
Query: 302 IPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
+P I ++ + L N + + +LE L + +N +++ P + N
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-----AFNN 78
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421
+R L L N L I LS +L + + +I + + +L NL L++G
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLS-NLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 422 NKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKFSGAIPSC 479
N L I FS L +L+ L L L SIP E HL L L L + AI
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNIN-AIRDY 194
Query: 480 S-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELN 538
S L L+ L + + + NL L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGL---------------------NLT---SLS 230
Query: 539 LSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPT 598
++ NL+ + + L L+ L L+ N + L L+ + L +++ V P
Sbjct: 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290
Query: 599 SLEKLLYLKKLNLSFNKLEGEIPRG--GPFANLTAKSFLGNELLC 641
+ L YL+ LN+S N+L + NL N L C
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 15/308 (4%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
+L++ ++ + + LE L+L+ N +S + F N+ L+ L R N+L
Sbjct: 36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL-K 93
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
+ +F +S++ +D+S N+ L + ++L NLK L +G N S
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152
Query: 190 QLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
LE L L NL+ +IP E +L L + L + L L L ++
Sbjct: 153 SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-T 307
+ + L LS+ L ++P L + FLNL N S I S+
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLH 269
Query: 308 NASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRV 367
+L QL G + P L L LN++ N LT+ + S+ N +
Sbjct: 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV--FHSVGN---LET 324
Query: 368 LILAGNPL 375
LIL NPL
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-32
Identities = 61/344 (17%), Positives = 119/344 (34%), Gaps = 38/344 (11%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSS 141
+P + + LDL N++ + F + L+ L+ +N +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV------------- 68
Query: 142 MLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL 201
+ NL NL+ L L N + L L + N +
Sbjct: 69 ------------SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
Query: 202 SGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNM 260
+ +L LK + + DN+L I L L +LTL NL + + ++
Sbjct: 117 VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175
Query: 261 STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGN 320
L L L + ++ L ++ L + + + + LT +
Sbjct: 176 HGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILP 380
+ + + +L L FLN++ N +++ S L +++ + L G L + P
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEG-----SMLHELLRLQEIQLVGGQLAVVEP 289
Query: 381 SSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
+ L+ L + +++ V ++ NL L L N L
Sbjct: 290 YAFRGLN-YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-22
Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 12/232 (5%)
Query: 73 LNISGFNLQGTIPPQL-GNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
L+IS N + + +L +L++L++ N L I F +++L+ L L
Sbjct: 109 LDISE-NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL-T 165
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
S+ + ++ ++ + L + + K L LK L + + +
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 190 QLEGLYLRFNNLSGAIPKE-IGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATN 247
L L + NL+ A+P + +L L+ + L+ N + I M L L + L
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGG 282
Query: 248 NLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS 299
L V P+ ++ L+ L++ N L +L + S+ N+E L L +N +
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPLA 333
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 99/464 (21%), Positives = 173/464 (37%), Gaps = 31/464 (6%)
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAI 205
++S N S EL + +L L+ L++ N S ++LE L L N L I
Sbjct: 27 NISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KI 84
Query: 206 PKEIGNLTKLKDIILNDNELRG-EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLK 264
LK + L+ N I +E GN+ L L L+T +L I +++ K
Sbjct: 85 S--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142
Query: 265 KLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLR------ 318
L +L T L + +L + I + S TV L
Sbjct: 143 VLLVLGETYGEKEDP---EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 319 ---GNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL 375
N S F+ N + N+ N + ++ + L + ++ L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 376 DGILPSSIGNLSI----SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVT 431
G L + S +L Q+ + + SN+ + + + +
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 432 FSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG---NLTSLRA 488
S++ L + N L ++ + HL +L+ LIL N+ + + + SL+
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378
Query: 489 LYLGSNRFTSALPSTIW-NLKDILFFDVSSNSL-DGPLSLDIGNLKVVIELNLSRNNLSG 546
L + N + K +L ++SSN L D +KV L+L N +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKV---LDLHSNKIK- 434
Query: 547 DIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
IP + L+ LQ+L +A+N+L+ F L+SL+ + L N
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 76/450 (16%), Positives = 145/450 (32%), Gaps = 47/450 (10%)
Query: 180 KIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL 239
+P LS+ + L + N +S +I +L+KL+ +I++ N ++ L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 240 VRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS-LPNVEFLNLGTNRF 298
L L+ N LV + LK L L N + +LP + + ++FL L T
Sbjct: 72 EYLDLSHNKLVKI-SCH--PTVNLKHLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHL 127
Query: 299 SGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS 358
+ I + + V + G ++ L++ ++ + T+ S
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 359 LTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLD 418
+ + + + D + L+ ++ N L+N+
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN-----------LTLNNIETTW 234
Query: 419 LGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPS 478
++ + T ++ + L R L L + + F
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 479 CSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELN 538
+++ + V L+
Sbjct: 295 IYEIFSNMNIKNFTVSGTRM----------------VHMLCPSKISPFL--------HLD 330
Query: 539 LSRNNLSGDIPITIGGLKNLQKLFLANNRLE--GPIPESFSGLSSLEILDLSKNKISGVI 596
S N L+ + G L L+ L L N+L+ I E + + SL+ LD+S+N +S
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 597 PTSL-EKLLYLKKLNLSFNKLEGEIPRGGP 625
L LN+S N L I R P
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 83/408 (20%), Positives = 149/408 (36%), Gaps = 30/408 (7%)
Query: 73 LNISGFNLQG-TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL--F 129
L++S I + GN+S L+ L LS L + I +++ K+L
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
+ L I N+ + K + NL+ + + K LS
Sbjct: 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS--- 211
Query: 190 QLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL 249
L+ + L +I N I Q + + + +++ L
Sbjct: 212 ----------ILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHTT-VWYFSISNVKL 259
Query: 250 VGVVPFTIFNMST--LKKLSL--LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS 305
G + F F+ S LK LS+ + + ++G S I N+ N +
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 306 ITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKI 365
+ S N + + G+L LE L + N L + + + + +
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS---L 376
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
+ L ++ N + + + SL M + ++ I + + + +LDL NK+
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
Query: 426 GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICH-LAKLDKLILHGNKF 472
SIP +L LQ L +A N+L +S+PD I L L K+ LH N +
Sbjct: 435 -SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 64/363 (17%), Positives = 115/363 (31%), Gaps = 27/363 (7%)
Query: 286 PNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNY 345
LN+ N S S I + SKL + + N + + LE+L+++ N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 346 LTSSTPELSFLSSLTNCQKIRVLILAGNPLDGI-LPSSIGNLSISLERFQMFNCRISGKI 404
L +S N ++ L L+ N D + + GN+S L+ + +
Sbjct: 81 LVK----ISC-HPTVN---LKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEKSS 131
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDK 464
I++L+ +L + G + N + L + F + +
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 465 LILHGNKFSGAIPSCSGNLTSL---------RALYLGSNRFTSALPSTIWNLKD---ILF 512
L L K CS L+ L L L + T I L + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 513 FDVSSNSLDGPLSLDIG-----NLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNR 567
F +S+ L G L +LK + + + N+ +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 568 LEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFA 627
S +S LD S N ++ + + L L+ L L N+L+
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 628 NLT 630
+
Sbjct: 372 QMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 40/181 (22%), Positives = 78/181 (43%), Gaps = 7/181 (3%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL--F 129
+ N + + +S LD S+N L+ + + ++ L+ L + NQL
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
++ M S+ +D+S N S + C +L L + N+ I L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421
Query: 190 QLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNN 248
+++ L L N + +IPK++ L L+++ + N+L+ +P + L L ++ L TN
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479
Query: 249 L 249
Sbjct: 480 W 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 61/342 (17%), Positives = 124/342 (36%), Gaps = 23/342 (6%)
Query: 28 QSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQ 87
Q HI + F S + + + S+ VL + + +I +
Sbjct: 161 QDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL-----SNIKCVLEDNKCSYFLSILAK 215
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNM---HTLKLLDFRDNQLFGSLSSFIFNMS--SM 142
L L L L++ + + N I + T+ + +L G L F+ S S+
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 143 LGI---DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFN 199
+ + + F + I + N+ + SK L N
Sbjct: 276 KALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 200 NLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG---NLPYLVRLTLATNNLVGVVPFT 256
L+ + + G+LT+L+ +IL N+L+ E+ + + L +L ++ N++
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 257 IF-NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVF 315
+L L++ N L ++ + P ++ L+L +N+ +IP + L
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL---PPRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 316 QLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
+ N L +L+ + + N S P + +LS
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-38
Identities = 60/420 (14%), Positives = 123/420 (29%), Gaps = 31/420 (7%)
Query: 204 AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTL 263
AI + N + K + D+ L+ + + + L L+ N L + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 264 KKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFS 323
+ L+L N L+ +L SL + L+L N + + N+ S
Sbjct: 61 ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 324 GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSI 383
+ + + + +A+N +T +++ L L N +D + + +
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 384 GNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
S +LE + I + + + L LDL NKL + F + + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 444 AFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPST 503
NKL I + L+ L GN F + R +
Sbjct: 222 RNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLR-DFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRN-------NLSGDIPITIGGLK 556
+ + L +I L + + + +
Sbjct: 280 EEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
+++ + I + + L+ K + + L
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-38
Identities = 62/463 (13%), Positives = 124/463 (26%), Gaps = 52/463 (11%)
Query: 160 ICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDII 219
I +N K + + + S ++ L L N LS ++ TKL+ +
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 220 LNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPS 279
L+ N L ++ +L L L L N + + +++ L N + +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSC 116
Query: 280 RIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGF-IPNTIGNLRNLEF 338
+ + L N+ + S++ L+ N + LE
Sbjct: 117 SR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 339 LNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNC 398
LN+ N++ + K++ L L+ N L
Sbjct: 174 LNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLA---------------------- 204
Query: 399 RISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICH 458
+ + + + + L NKL I NL+ L N
Sbjct: 205 ----FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFF 258
Query: 459 LAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSN 518
+ T + G+ L + + +
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 519 SLDG----PLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE 574
S G L + N E++ + I + L L+ +
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 575 SFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
+ L+ + + E+ L+ L + E
Sbjct: 379 GRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-38
Identities = 70/525 (13%), Positives = 158/525 (30%), Gaps = 52/525 (9%)
Query: 89 GNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLS 148
N + + ++ + L + S + +K LD N L ++ + + + ++LS
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKE 208
N E ++L L+ L L N L +E L+ NN+S +
Sbjct: 67 SNVLY-ETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS 117
Query: 209 IGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLS 267
K+I L +N++ + G + L L N + V + + TL+ L+
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP 327
L N ++ + + ++ L+L +N+ + + +A+ +T LR N I
Sbjct: 176 LQYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 328 NTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLS 387
+ +NLE ++ N T F + RV +A + +
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ------RVQTVAKQTVKKL--------- 275
Query: 388 ISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNK 447
Q + L G RL+ L+ A
Sbjct: 276 ----------------TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
Query: 448 LA----RSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPST 503
+ E + A+ ++ ++ I + + L + +
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563
++ + + + + + + ++ +
Sbjct: 380 RRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKK 608
++ E+ DL+ + + + + L
Sbjct: 440 YQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-35
Identities = 55/344 (15%), Positives = 112/344 (32%), Gaps = 22/344 (6%)
Query: 281 IDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLN 340
I + + + + + S +A + L GN S + LE LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 341 IADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRI 400
++ N L + +L LS+L R L L N + + S+E N I
Sbjct: 65 LSSNVLYET-LDLESLSTL------RTLDLNNNYV-----QELLVGP-SIETLHAANNNI 111
Query: 401 SGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLAR-SIPDEICHL 459
S ++ S + L NK+T + +Q L L N++ + +
Sbjct: 112 S-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNS 519
L+ L L N + L+ L L SN+ + + + + + +N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 520 LDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGL 579
L + + + + +L N + KN + +A ++ ++
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCG-TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 580 SSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
+ + + ++L+ LK+ + +G
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 72/497 (14%), Positives = 147/497 (29%), Gaps = 46/497 (9%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
++ V L++SG L L + LE L+LS N L + ++ TL+ LD +
Sbjct: 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNN 89
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
N + + S+ + + N S + + K + L N
Sbjct: 90 NYV-----QELLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRDLDE 140
Query: 186 SKCKQLEGLYLRFNNLSG-AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTL 244
+++ L L+ N + + + L+ + L N + ++ ++ L L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198
Query: 245 ATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS 304
++N L + S V +++L N+ I
Sbjct: 199 SSNKLA-------------------------FMGPEFQ-SAAGVTWISLRNNKLV-LIEK 231
Query: 305 SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQK 364
++ + L F LRGN F +N +A + T + T
Sbjct: 232 ALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQN--EEECTVPTL 288
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
L + L + ++ N + +D +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 425 TGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLT 484
I R L L + + A+LD + + + +
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQS 407
Query: 485 SLRALYLGSNRFTSAL-PSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
L+ L R+ I +D+ + + K+ E +L+ +
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALAS 467
Query: 544 LSGDIPITIGGLKNLQK 560
+ + + +NL
Sbjct: 468 ANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 16/228 (7%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLD 463
I ++ N + + + + L ++ N++ L L+ N L++ ++ KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 464 KLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGP 523
L L N + +L++LR L L +N + I ++N++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-- 112
Query: 524 LSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG-PIPESFSGLSSL 582
+ + + L+ N ++ + G +Q L L N ++ E + +L
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 583 EILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
E L+L N I V + LK L+LS NKL + F +
Sbjct: 172 EHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPE--FQSAA 214
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 28/180 (15%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
+I + + + + + A+ S + +++ L L N + + + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG 570
++SSN L LD+ +L + L+L+ N + + +++ L ANN +
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+ + L+ NKI+ + ++ L+L N+++ + A+
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 69/295 (23%), Positives = 107/295 (36%), Gaps = 42/295 (14%)
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEV--MKRIRHRNLVKIIS 789
+G G +G V+ Q G VAVK+F R E+ S+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 790 ACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH----- 840
+ + LI Y GSL + L T LD L I++ +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA--TIGYMAPE 886
I H I+D +A + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940
R D++++G++L E + + V + M
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 941 --VIDTNL-LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
V + R+F + +L S+ L EC ++P R+ A I L KI
Sbjct: 248 KVVCVDQQRPNIPNRWF--SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 65/299 (21%), Positives = 105/299 (35%), Gaps = 42/299 (14%)
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEV--MKRIRHRNLVKIIS 789
+G G +G V++ + + G +VAVKVF E S+ E E+ +RH N++ I+
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 790 ACSNDDFK----ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH----- 840
A LI +Y NGSL + L S T LD L + L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA--TIGYMAPE 886
I H I+D +A T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940
+ D+YS+G++L E + +L V S +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP--SDPSYED 274
Query: 941 VIDTNLLSG---EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996
+ + + + ++ L + L TEC +P R+ A + L K+ ++
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 28/207 (13%)
Query: 734 LGIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACS 792
LG G FG + G + +K + E ++F E +VM+ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 793 NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH--- 849
D I EY+ G+L + S QR++ D+A + YL HS IIH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDL 134
Query: 850 ---------YMVAHISDFSIAKFLNGQDQLSMQTQTLA------------TIGYMAPEYG 888
++DF +A+ + + ++L +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ DV+S+GI+L E
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 50/295 (16%), Positives = 104/295 (35%), Gaps = 17/295 (5%)
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
N + ++ + + L L S + +++ + +S ++ + L LL+L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 421 GNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCS 480
N L L L+ L L N + E+ ++ L N S +
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC-- 116
Query: 481 GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDG-PLSLDIGNLKVVIELNL 539
+ +YL +N+ T + + D+ N +D + + + LNL
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 540 SRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTS 599
N + D+ + L+ L L++N+L + F + + + L NK+ +I +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 600 LEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLN 654
L L+ +L N R F+ + + + L + C +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 57/332 (17%), Positives = 101/332 (30%), Gaps = 46/332 (13%)
Query: 281 IDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLN 340
I + + + + + S +A + L GN S + LE LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 341 IADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRI 400
++ N L + +L LS+L R L L N + + S+E N I
Sbjct: 65 LSSNVLYET-LDLESLSTL------RTLDLNNNYV-----QELLVGP-SIETLHAANNNI 111
Query: 401 SGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLAR-SIPDEICHL 459
S ++ S + L NK+T + +Q L L N++ + +
Sbjct: 112 S-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNS 519
L+ L L N + L+ L L SN+ + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAA----------- 214
Query: 520 LDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE-GPIPESFSG 578
+ ++L N L I + +NL+ L N G + + FS
Sbjct: 215 ----------GVT---WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 579 LSSLEILDLSKNKISGVIPTSLEKLLYLKKLN 610
++ + K + L
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 53/305 (17%), Positives = 104/305 (34%), Gaps = 23/305 (7%)
Query: 163 NLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILND 222
N K + + + S ++ L L N LS ++ TKL+ + L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 223 NELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID 282
N L E ++ +L L L L N + + +++ L N + +
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR- 118
Query: 283 LSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGF-IPNTIGNLRNLEFLNI 341
+ + L N+ + S++ L+ N + LE LN+
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 342 ADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
N++ + K++ L L+ N L + + + + + N ++
Sbjct: 177 QYNFIYD-------VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKLV 227
Query: 402 GKIPQVISNLSNLLLLDLGGNKLT-GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLA 460
I + + NL DL GN G++ FS+ +Q + K +E C +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 461 KLDKL 465
L
Sbjct: 287 TLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 45/228 (19%), Positives = 87/228 (38%), Gaps = 16/228 (7%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLD 463
I ++ N + + + + L ++ N++ L L+ N L++ ++ KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 464 KLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGP 523
L L N + +L++LR L L +N + I ++N++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-- 112
Query: 524 LSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG-PIPESFSGLSSL 582
+ + + L+ N ++ + G +Q L L N ++ E + +L
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 583 EILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
E L+L N I V LK L+LS NKL + F +
Sbjct: 172 EHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPE--FQSAA 214
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 55/266 (20%), Positives = 99/266 (37%), Gaps = 17/266 (6%)
Query: 379 LPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNL 438
+ N + + ++ + + + + + N+ LDL GN L+ + L
Sbjct: 2 IHEIKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 439 QGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTS 498
+ L L+ N L D + L+ L L L+ N + S+ L+ +N +
Sbjct: 61 ELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISR 113
Query: 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSG-DIPITIGGLKN 557
S K+I +++N + LD G V L+L N + +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 558 LQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
L+ L L N + + + L+ LDLS NK++ + + + ++L NKL
Sbjct: 171 LEHLNLQYNFIYD-VKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 618 GEIPRG-GPFANLTAKSFLGNELLCG 642
I + NL GN CG
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCG 252
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 54/295 (18%), Positives = 107/295 (36%), Gaps = 41/295 (13%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRD 125
N ++ + ++ +L+ + + +++ LDLS N LS + + L+LL+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 126 NQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL 185
N L ++L L+ L L N L
Sbjct: 68 NVL-YETLDL--------------------------ESLSTLRTLDLNNNYV-----QEL 95
Query: 186 SKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245
+E L+ NN+S + K+I L +N++ + G + L L
Sbjct: 96 LVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 246 TNNLVGVVPFTIF-NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPS 304
N + V + + TL+ L+L N ++ + + ++ L+L +N+ + +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGP 208
Query: 305 SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSL 359
+A+ +T LR N I + +NLE ++ N T F +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 54/331 (16%), Positives = 109/331 (32%), Gaps = 22/331 (6%)
Query: 204 AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTL 263
AI + N + K + D+ L+ + + + L L+ N L + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 264 KKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFS 323
+ L+L N L L + L+L N + + N+ S
Sbjct: 61 ELLNLSSNVL-YETLDLES--LSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 324 GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSI 383
+ + + + +A+N +T +++ L L N +D + + +
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 384 GNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
S +LE + I + + + L LDL NKL + F + + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 444 AFNKLARSIPDEICHLAKLDKLILHGNKFS-GAIPSCSGNLTSLRALYLGSNRFTSALPS 502
NKL I + L+ L GN F G + ++ + + + +
Sbjct: 222 RNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 503 TIWNLKDILFFD-VSSNSLDGPLSLDIGNLK 532
+ + + L P + + L
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 77/373 (20%), Positives = 143/373 (38%), Gaps = 53/373 (14%)
Query: 261 STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGN 320
+ L++ E+ L +LP + ++ L + N + ++P+ L ++ GN
Sbjct: 40 NGNAVLNVGESGL-TTLPDCL---PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILP 380
+ +P L L + +L + S L L + GN L LP
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPAL------PSGLCK------LWIFGNQLTS-LP 137
Query: 381 SSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQG 440
L + + + +++ +P + S L L + N+LT S+P+ S LQ
Sbjct: 138 VLPPGL----QELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPS---GLQE 185
Query: 441 LGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSAL 500
L ++ N+L S+P L KL + N+ + ++P+ + L+ L + NR TS L
Sbjct: 186 LSVSDNQL-ASLPTLPSELYKLW---AYNNRLT-SLPA---LPSGLKELIVSGNRLTS-L 236
Query: 501 PSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQK 560
P LK++ VS N L L + L L++ RN L+ +P ++ L +
Sbjct: 237 PVLPSELKEL---MVSGNRLTS-LPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETT 288
Query: 561 LFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIP--TSLEKLLYLKKLNLSFNKLEG 618
+ L N L ++ ++S + + L+L + EG
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
Query: 619 EIPRGGPFANLTA 631
E +
Sbjct: 349 EPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 74/413 (17%), Positives = 140/413 (33%), Gaps = 82/413 (19%)
Query: 91 LSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
+ L++ + L+ +P + + L DN L
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL---------------------- 73
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIG 210
LPA P L+ L + N +P +L +L P
Sbjct: 74 ---TSLPALP----PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPS 121
Query: 211 NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLE 270
L KL + N+L +P L L+++ N L +P L KL
Sbjct: 122 GLCKLW---IFGNQLT-SLPVLPPG---LQELSVSDNQL-ASLPALPSE---LCKLWAYN 170
Query: 271 NTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTI 330
N L + + + ++ L++ N+ + ++P+ + KL + R S +P
Sbjct: 171 NQL-----TSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS----LPALP 220
Query: 331 GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISL 390
L+ L ++ N LTS S L + L+++GN L LP L
Sbjct: 221 SGLKE---LIVSGNRLTSLPVLPSEL---------KELMVSGNRLT-SLPMLPSG----L 263
Query: 391 ERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLG---LAFNK 447
++ +++ ++P+ + +LS+ ++L GN L+ + + G + F+
Sbjct: 264 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 448 LARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSAL 500
S P E L L + P+ + ++ F+ L
Sbjct: 323 AGASAPRETRALHLAAADWLVPAREGE--PAPADRWHMFGQE-DNADAFSLFL 372
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 66/351 (18%), Positives = 126/351 (35%), Gaps = 54/351 (15%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
L I NL ++P L TL++S N+L+ ++P + L + L
Sbjct: 65 TLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL 119
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
S + + N+ + LP P L++L + N +P+ S +L
Sbjct: 120 PSGLCK-------LWIFGNQLT-SLPVLP----PGLQELSVSDNQL-ASLPALPS---EL 163
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
L+ N L+ ++P L +L ++DN+L +P L L NN +
Sbjct: 164 CKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAY----NNRLT 214
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+P LK+L + N L SLP ++ L + NR + ++P +
Sbjct: 215 SLPALPSG---LKELIVSGNRL-TSLPV----LPSELKELMVSGNRLT-SLPMLPSG--- 262
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILA 371
L + N + +P ++ +L + +N+ N L+ T + ++I
Sbjct: 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ--------ALREITSAPGY 313
Query: 372 GNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGN 422
P+ + + S E + +P + + G
Sbjct: 314 SGPI---IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 65/305 (21%), Positives = 110/305 (36%), Gaps = 44/305 (14%)
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEV--MKRIRHRNLVKIIS 789
+G G FG V+ + + G EVAVK+F R ER S+ E E+ +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 790 ACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH----- 840
A + D+ L+ +Y +GSL + L T + + + + + A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA--TIGYMAPE 886
I H I+D +A + T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940
R D+Y+ G++ E +L V + M
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 941 --VIDTNL-LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997
V + L + R+ ++L + + EC + R+ A I L ++
Sbjct: 282 KVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ-- 337
Query: 998 KSVGM 1002
+ + M
Sbjct: 338 EGIKM 342
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 734 LGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISAC 791
+G G+FG V+ RL+ D VAVK + F E ++K+ H N+V++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-- 849
+ ++ME + G L + L + L ++ D A +EYL S IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 850 ----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDV 899
V ISDF +++ + + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 900 YSYGIMLMETFT-GKKP 915
+S+GI+L ETF+ G P
Sbjct: 299 WSFGILLWETFSLGASP 315
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 79/432 (18%), Positives = 147/432 (34%), Gaps = 69/432 (15%)
Query: 237 PYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
++ + L+ N++ + + + L+ L + + T + + L ++ L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 297 RFSGNIPSSI-TNASKLTVFQLRGNSF-SGFIPNTI-GNLRNLEFLNIADNYLTSSTPEL 353
+F + + + L V L + + L +LE L + DN + P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 354 SFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSN 413
F ++ VL L N + I + N + LS+
Sbjct: 149 FF-LNMRR---FHVLDLTFNKVKSICEEDLLNFQ---------------GKHFTLLRLSS 189
Query: 414 LLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLI-LHGNKF 472
+ L D+ L + ++ L L+ N S+ K+ L +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 473 SGAIPSCSGN--------------LTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSN 518
S + ++ L ++ + L ++++
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFS------------ 296
Query: 519 SLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFS 577
+ + +L L++N ++ I GL +L KL L+ N L F
Sbjct: 297 -----------HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE 344
Query: 578 GLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL-- 635
L LE+LDLS N I + S L LK+L L N+L+ +P G F LT+ +
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPD-GIFDRLTSLQKIWL 402
Query: 636 -GNELLCGLPDL 646
N C P +
Sbjct: 403 HTNPWDCSCPRI 414
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 78/397 (19%), Positives = 148/397 (37%), Gaps = 35/397 (8%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLSIN 150
+ + +DLS N ++ +S + L+ L + + F S L I L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKI--PSTLSKCKQLEGLYLRFNNLSGAIPKE 208
+F +L L NL+ L L + G + + LE L LR NN+ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 209 I-GNLTKLKDIILNDNELR----------GEIPQEMGNLPYLVRLTLATNNLVGVVPFTI 257
N+ + + L N+++ + L + + L
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 258 FNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQL 317
F +++ L L N S+ R ++ + +L + S K
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK----DP 264
Query: 318 RGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDG 377
+F G + ++ +++ + + + + F ++ + L LA N ++
Sbjct: 265 DNFTFKGLEAS------GVKTCDLSKSKIF-ALLKSVF----SHFTDLEQLTLAQNEINK 313
Query: 378 ILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLL 436
I ++ L+ L + + + ++ NL L +LDL N + ++ +F L
Sbjct: 314 IDDNAFWGLT-HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP 371
Query: 437 NLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKF 472
NL+ L L N+L +S+PD I L L K+ LH N +
Sbjct: 372 NLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 50/266 (18%), Positives = 80/266 (30%), Gaps = 27/266 (10%)
Query: 381 SSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQ 439
+ L + + I+ S L +L L + I TF L +L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 440 GLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKF-SGAIPSCS-GNLTSLRALYLGSNRF 496
L L +N+ + LA L+ L L + LTSL L L N
Sbjct: 83 ILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 497 TSALPSTIW-NLKDILFFDVSSNSLDG--PLSLDIGNLKVVIELNLSRNNLSGDIPITIG 553
P++ + N++ D++ N + L K L LS L
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL--------- 192
Query: 554 GLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIP---TSLEKLLYLKKLN 610
+ L + +S+ LDLS N + ++ L
Sbjct: 193 -------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 611 LSFNKLEGEIPRGGPFANLTAKSFLG 636
LS + G F + +F G
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 31/284 (10%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIF-----------NMHTLKLLDFRDNQLFGSLSSFIFN 138
N+ LDL+ NK+ +I + ++ L D + L F
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 139 MSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRF 198
+S+ +DLS N F + + K L + + S
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS------------FGH 258
Query: 199 NNLSGAIPKEIGNL--TKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPF 255
N L + +K L+ +++ + + + + L +LTLA N + +
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDN 317
Query: 256 TIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASKLTV 314
+ ++ L KL+L +N L GS+ SR+ +L +E L+L N + L
Sbjct: 318 AFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKE 375
Query: 315 FQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS 358
L N L +L+ + + N S P + +LS
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 48/264 (18%), Positives = 80/264 (30%), Gaps = 63/264 (23%)
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGN 470
+++ +DL N + +FSRL +LQ L + I + L+ L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 471 KFSGAIPSCS-GNLTSLRALYLGSNRFTSA-LPSTIWNLKDILFFDVSSNSLDGPLSLDI 528
+F + + + L +L L L A L F
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF--------FK-------------- 126
Query: 529 GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES-FSGLSSLEILDL 587
L +L+ L L +N ++ P S F + +LDL
Sbjct: 127 -------------------------PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161
Query: 588 SKNKISGVIPTSLEKL--LYLKKLNLSFNKL------EGEIPRGGPFANLTAKSFL---G 636
+ NK+ + L + L LS L + G T+ + L G
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221
Query: 637 NELLCGLPDLHNSPCKLNKPKTHH 660
N + K ++
Sbjct: 222 NGFKESMAKRFFDAIAGTKIQSLI 245
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFN-MHTLKLLDFRDNQLFGS 131
+++ + L +S+ TLDLS N ++ F+ + K+ + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 132 LSSFIFN--------------MSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMF 177
SSF S + DLS ++ L ++ + +L++L L +N
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 178 HGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEM-G 234
+ KI L L L N L +I + NL KL+ + L+ N +R + +
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLEN 271
LP L L L TN L V +++L+K+ L N
Sbjct: 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 85/529 (16%), Positives = 165/529 (31%), Gaps = 79/529 (14%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
+ L LS N +S + + + L++L N++
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRI---------------------- 88
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL-SGAIPKEI 209
L ++ +L+ L + N I L L L FN+ + KE
Sbjct: 89 ---RSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEF 142
Query: 210 GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
GNLTKL + L+ + R + +L L + + + L L+
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 270 ENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNT 329
+ ++++S+ + L L +L + +
Sbjct: 203 FHP-NSLFSVQVNMSVNALGHLQLSNI-------------------KLNDENCQRLMTFL 242
Query: 330 IGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI- 388
R LN+ ++ ++ L + + L + + + S
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET 302
Query: 389 ---SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAF 445
SL + N + S + + + L + V + L
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362
Query: 446 NKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIW 505
N S+ L +L LIL N + ++ +L S L S
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS-LNS--- 417
Query: 506 NLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLAN 565
+ S+ + LNLS N L+G + + ++ L L N
Sbjct: 418 --------HAYDRTCAWAESILV--------LNLSSNMLTGSVFRCL--PPKVKVLDLHN 459
Query: 566 NRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
NR+ IP+ + L +L+ L+++ N++ V ++L L+ + L N
Sbjct: 460 NRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 89/487 (18%), Positives = 170/487 (34%), Gaps = 49/487 (10%)
Query: 157 PANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTKL 215
P ++ P K L L +N +S +L L L N + ++ + L
Sbjct: 47 PKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 216 KDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSLLENTLW 274
+ + ++ N L+ I + L L L+ N+ + F N++ L L L
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 275 GSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSIT--NASKLTVFQLRGNSFSGFIPNTIGN 332
+ + L+L + G S+ N + L + + FS + ++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 333 LRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS-LE 391
L +L+ NI N + V + +E
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 392 RFQMFNCRISGKIPQVI-----SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
++N I+ +I + + L +L++ + S +S + L+ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 447 KLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWN 506
I C + +S L N FT ++
Sbjct: 340 DT-PFIH-----------------------MVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 507 LKDILFFDVSSNSLD--GPLSLDIGNLKVVIELNLSRNNL-SGDIPITIGGLKNLQKLFL 563
LK + + N L ++L N+ + L++S N+L S T +++ L L
Sbjct: 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
++N L G + +++LDL N+I IP + L L++LN++ N+L+ +P
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD- 490
Query: 624 GPFANLT 630
G F LT
Sbjct: 491 GVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 86/447 (19%), Positives = 172/447 (38%), Gaps = 39/447 (8%)
Query: 72 VLNISGFNLQGTIPPQL-GNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFG 130
VL +S ++ ++ + LE LD+SHN+L NI +L+ LD N
Sbjct: 80 VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMA--SLRHLDLSFNDFDV 135
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
F N++ + + LS +F +L +L LL + + +
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194
Query: 190 QLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG-------EIPQEMGNLPYLVRL 242
L+L F+ S + ++ L + L++ +L E+ P L+ +
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254
Query: 243 TLATNNLVGVVPFTIFN---MSTLKKLSLLENTLWGSLPSRI----DLSLPNVEFLNLGT 295
TL +F ++ L++ T+ + + +L ++ ++
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 296 NRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
F + + + +++ + L + + + FLN N T S +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC- 373
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRI----SGKIPQVISNL 411
S+L ++ LIL N L ++ + + + S + +
Sbjct: 374 -STLKR---LQTLILQRNGLK-NFFKVALMTK-NMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRL-LNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGN 470
++L+L+L N LTGS+ F L ++ L L N++ SIP ++ HL L +L + N
Sbjct: 428 ESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASN 483
Query: 471 KFSGAIPSCS-GNLTSLRALYLGSNRF 496
+ ++P LTSL+ ++L N +
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 63/397 (15%), Positives = 130/397 (32%), Gaps = 34/397 (8%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
+P + P + L+L N S I+ S+L V +L N + ++
Sbjct: 45 HVPKDL---PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD 101
Query: 336 LEFLNIADNYLTSSTPELSF--LSSLTNCQKIRVLILAGNPLDGI-LPSSIGNLSISLER 392
LE+L+++ N L + +S ++SL + L L+ N D + + GNL+ L
Sbjct: 102 LEYLDVSHNRLQN----ISCCPMASLRH------LDLSFNDFDVLPVCKEFGNLT-KLTF 150
Query: 393 FQMFNCRISGKIPQVISNLS-NLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARS 451
+ + +++L + +LLDL + G + ++ N L L F+ +
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLVFHPNSLF 209
Query: 452 IPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWN----- 506
+ L L L K + S T T W
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269
Query: 507 -----LKDILFFDVSSNSLDGPLSLDIGN-----LKVVIELNLSRNNLSGDIPITIGGLK 556
+ + + ++ + ++ + + LK ++ ++
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
+ L+ + SS L+ ++N + + L L+ L L N L
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 617 EGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKL 653
+ N+++ L L ++ C
Sbjct: 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGME-----VAVKVFHQRY-ERALKSFQDECEVMKRI 779
F K +LG G+FG+VY E VA+K + +A K DE VM +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+ ++ +++ C + LI + MP G L + + + LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 840 ---HFGH----------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
H TP I+DF +AK L +++ I +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ + + DV+SYG+ + E T G KP
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 29/240 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRYERALKSFQDECEVMKRIR 780
+ LG G+FGSV + R G VAVK + FQ E +++K +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 781 HRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+VK ++ L+MEY+P+G L + L LD + L + +EY
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAP 885
L S +H I+DF +AK L +D ++ + I + AP
Sbjct: 143 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLP-ISVMEVID 943
E S + DV+S+G++L E FT K R + ++ +++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLE 255
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRYERALKSFQDECEVMKRIR 780
LG G+FGSV + R G VAVK E L+ F+ E E++K ++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 781 HRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
H N+VK C + + LIMEY+P GSL + L +D + L + +EY
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAP 885
L + IH I DF + K L ++ ++ + I + AP
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFT 911
E + + S DV+S+G++L E FT
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRYERALKSFQDECEVMKRIR 780
LG G+FGSV + R G VAVK E L+ F+ E E++K ++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 781 HRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
H N+VK C + + LIMEY+P GSL + L +D + L + +EY
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAP 885
L + IH I DF + K L ++ ++ + I + AP
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFT 911
E + + S DV+S+G++L E FT
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 24/198 (12%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G FG V++ + +VA+K + + + F +E EVM ++ H LV++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIH- 849
L+ E+M +G L + L + + L + +DV + YL IH
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGD 898
V +SDF + +F+ DQ + T T + + +PE R S++ D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 899 VYSYGIMLMETFT-GKKP 915
V+S+G+++ E F+ GK P
Sbjct: 188 VWSFGVLMWEVFSEGKIP 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 51/240 (21%), Positives = 99/240 (41%), Gaps = 28/240 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-----QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRI 779
+ LG G FG V + R G +VAVK + + E E+++ +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 780 RHRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
H N+VK C+ D LIME++P+GSL+ L +++ Q+L + + ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 838 YLHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMA 884
YL S +H I DF + K + ++ +++ + + + A
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
PE +Q + DV+S+G+ L E T + + + + ++V +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ---MTVTRLVN 254
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 65/351 (18%), Positives = 120/351 (34%), Gaps = 76/351 (21%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
+P + P+ L+L N+ + N L L N S P L
Sbjct: 45 KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 336 LEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
LE L ++ N L ++ +L L + N + + S F
Sbjct: 102 LERLYLSKNQLKELPEKM--PKTLQE------LRVHENEITKVRKSV----------F-- 141
Query: 396 FNCRISGKIPQVISNLSNLLLLDLGGNKLTGSI--PVTFSRLLNLQGLGLAFNKLARSIP 453
+ L+ +++++LG N L S F + L + +A + +IP
Sbjct: 142 -------------NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIP 187
Query: 454 DEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILF 512
+ L +L L GNK + + + S L +L L L N ++ ++ N
Sbjct: 188 QGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP---- 240
Query: 513 FDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG-- 570
+L+ EL+L+ N L +P + K +Q ++L NN +
Sbjct: 241 -----------------HLR---ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 279
Query: 571 ----PIPESFSGLSSLEILDLSKNKI--SGVIPTSLEKLLYLKKLNLSFNK 615
P + +S + L N + + P++ + + L K
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 56/264 (21%), Positives = 107/264 (40%), Gaps = 19/264 (7%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA 444
+L + N +I+ NL NL L L NK++ P F+ L+ L+ L L+
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 445 FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSAL--PS 502
N+L + +P+++ L +L +H N+ + S L + + LG+N S+
Sbjct: 109 KNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
+K + + ++ ++ ++ G + EL+L N ++ ++ GL NL KL
Sbjct: 166 AFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPR 622
L+ N + S + L L L+ NK+ +P L Y++ + L N +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----- 276
Query: 623 GGPFANLTAKSFLGNELLCGLPDL 646
+ + F
Sbjct: 277 -----AIGSNDFCPPGYNTKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 55/278 (19%), Positives = 106/278 (38%), Gaps = 22/278 (7%)
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
+L L N + I NL +L + N +IS P + L L L L N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 425 TGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKF-SGAIPSCS- 480
+P LQ L + N++ + + L ++ + L N S I + +
Sbjct: 113 K-ELPEKMPK---TLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 481 GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLS 540
+ L + + T+ +L ++ + N + + + L + +L LS
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 541 RNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV----- 595
N++S ++ +L++L L NN+L +P + ++++ L N IS +
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 596 -IPTSLEKLLYLKKLNLSFNKLE-GEIPRGGPFANLTA 631
P K ++L N ++ EI F +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPST-FRCVYV 320
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 55/276 (19%), Positives = 107/276 (38%), Gaps = 26/276 (9%)
Query: 83 TIPP-QLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMS 140
I NL +L TL L +NK+S I F + L+ L NQL L +
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL-KELPEKMP--K 121
Query: 141 SMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKI--PSTLSKCKQLEGLYLRF 198
++ + + N + ++ ++ L + + LG N K+L + +
Sbjct: 122 TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 199 NNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTI 257
N++ IP+ G L ++ L+ N++ ++ L L +L L+ N++ V ++
Sbjct: 181 TNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 258 FNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSS-------ITNAS 310
N L++L L N L +P + ++ + L N S I S+ T +
Sbjct: 237 ANTPHLRELHLNNNKL-VKVPGGLA-DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA 293
Query: 311 KLTVFQLRGN--SFSGFIPNTIGNLRNLEFLNIADN 344
+ L N + P+T + + + +
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 24/292 (8%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSI 149
LDL +NK++ I F N+ L L +N++ +S F + + + LS
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSK 109
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNL-SGAIPKE 208
N+ ELP + L++L + N S + Q+ + L N L S I
Sbjct: 110 NQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 209 I-GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
+ KL I + D + IPQ G P L L L N + V ++ ++ L KL
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP 327
L N++ ++ + + P++ L+L N+ +P + + + V L N+ S
Sbjct: 223 LSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 328 NTIG------NLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGN 373
N + +++ N + + S + + L
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV---RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 35/150 (23%), Positives = 59/150 (39%), Gaps = 12/150 (8%)
Query: 485 SLRALYLGSNRFTS---ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSR 541
LR + LP L D+ +N + D NLK + L L
Sbjct: 32 HLRVVQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 542 NNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLE 601
N +S P L L++L+L+ N+L+ +PE +L+ L + +N+I+ V +
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFN 142
Query: 602 KLLYLKKLNLSFNKLEGEIPRGGPFANLTA 631
L + + L N L+ G F +
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 28/212 (13%)
Query: 725 TDRFSK-NNLLGIGSFGSVYVAR-LQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIR 780
RF K + +G GSF +VY + +EVA + + + F++E E++K ++
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 781 HRNLVKIISACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
H N+V+ + + L+ E M +G+L ++ I + + L
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGL 142
Query: 837 EYLHFGHSTPIIH-------YMVAH------ISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
++LH + PIIH + I D +A ++ T +M
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFM 197
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
APE + DVY++G+ ++E T + P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 24/198 (12%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V + + +VA+K+ + + F +E +VM + H LV++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIH- 849
+I EYM NG L N L Q L + DV A+EYL F +H
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGD 898
V +SDF +++++ D+ + + + + PE + + S++ D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 899 VYSYGIMLMETFT-GKKP 915
++++G+++ E ++ GK P
Sbjct: 204 IWAFGVLMWEIYSLGKMP 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
LG G FG V + + + +VAVK+ + + F E + M ++ H LVK CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIH- 849
+ ++ EY+ NG L N L S L+ Q L + DV + +L F IH
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128
Query: 850 -----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGD 898
+ +SDF + +++ DQ T + + APE + S++ D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 899 VYSYGIMLMETFT-GKKP 915
V+++GI++ E F+ GK P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 734 LGIGSFGSVYVARLQDG----MEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKI 787
LG G FGSV L+ ++VAVK +R ++ F E MK H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 788 ISACSNDDFKA-----LIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIMIDVALALE 837
+ C + +I+ +M G L +RL +G + + L M+D+AL +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 838 YL---HFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGY 882
YL +F +H M+ ++DF ++K + D + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+A E +++ DV+++G+ + E T G P
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGME-----VAVKVFHQRY-ERALKSFQDECEVMKRI 779
K +LG G FG+V+ E V +KV + ++ ++ D + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
H ++V+++ C + L+ +Y+P GSL + + L LN + +A + YL
Sbjct: 73 DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 840 ---HFGH----------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
H +P ++DF +A L D+ + ++ I +MA E
Sbjct: 132 EEHGMVHRNLAARNVLLKSP----SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
G+ + + DV+SYG+ + E T G +P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-30
Identities = 73/463 (15%), Positives = 156/463 (33%), Gaps = 57/463 (12%)
Query: 165 PNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNE 224
N + + + L L ++++ I LT L +I N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 225 LRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS 284
+ + + L L +N L + ++ L L+ N L +++D+S
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL-----TKLDVS 124
Query: 285 -LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIAD 343
P + +LN N + I +++ ++LT N + + L L+ +
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 344 NYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK 403
N +T ++ + + L N + + + L + +++ +
Sbjct: 180 NKITE--------LDVSQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLT-E 226
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLD 463
I ++ L+ L D N LT + S L L L L I + H +L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL-LEID--LTHNTQLI 278
Query: 464 KLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGP 523
G + + + T L L + T L + +++ +++ L
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE-LD--LSQNPKLVYLYLNNTELT-- 331
Query: 524 LSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLS--- 580
LD+ + + L+ ++ D ++G + L F A + E+ + S
Sbjct: 332 -ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
Query: 581 --SLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621
S ++LD N ++ I + +++ L + P
Sbjct: 389 AVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-29
Identities = 87/483 (18%), Positives = 156/483 (32%), Gaps = 82/483 (16%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSL 132
+ F +Q T L++L +LD ++ ++ + I + L L N +
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI---- 76
Query: 133 SSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLE 192
+DLS NL L N + ++ +L
Sbjct: 77 ----------TTLDLS--------------QNTNLTYLACDSNKLT-NLD--VTPLTKLT 109
Query: 193 GLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGV 252
L N L+ ++ L + N L EI + + L L N +
Sbjct: 110 YLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163
Query: 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS-LPNVEFLNLGTNRFSGNIPSSITNASK 311
+ T + L L N + + +D+S + LN TN + + + +
Sbjct: 164 LDVT--PQTQLTTLDCSFNKI-----TELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQ 213
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILA 371
LT N + + L L + + + N LT ++ K+ L
Sbjct: 214 LTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTE--------LDVSTLSKLTTLHCI 262
Query: 372 GNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVT 431
L I + + + L FQ CR ++ +++ + L LLD +T +
Sbjct: 263 QTDLLEI---DLTHNT-QLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 432 FSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYL 491
S+ L L L +L + + H KL L S G + +L +
Sbjct: 314 LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFE 368
Query: 492 GSNRFTSALPSTIWNLKDILFFDVSSNSLDG-----PLSLDIGNLKVVIELNLSRNNLSG 546
+ + T+ N L VS + LD + G + ++ NLS
Sbjct: 369 AEGQTITMPKETLTNNS--LTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
Query: 547 DIP 549
D P
Sbjct: 427 DNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 63/362 (17%), Positives = 116/362 (32%), Gaps = 45/362 (12%)
Query: 256 TIFNMSTLKKLSLLENTLWGSLPSRIDLS-LPNVEFLNLGTNRFSGNIPSSITNASKLTV 314
F + + I L + L+ + + + I + LT
Sbjct: 13 DWFPDDNFASEVAAAFEMQATDT--ISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTK 68
Query: 315 FQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNP 374
N+ + + NL +L N LT+ +T K+ L N
Sbjct: 69 LICTSNNITTL---DLSQNTNLTYLACDSNKLTNL--------DVTPLTKLTYLNCDTNK 117
Query: 375 LDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSR 434
L + + L ++ +I +S+ + L LD NK + +
Sbjct: 118 LTKL---DVSQNP-LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTP 168
Query: 435 LLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSN 494
L L +FNK+ + + L++L N + + L L SN
Sbjct: 169 QTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNIT-KLDL--NQNIQLTFLDCSSN 222
Query: 495 RFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGG 554
+ T + + L + +FD S N L LD+ L + L+ + +L I +
Sbjct: 223 KLTE-ID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLE---IDLTH 273
Query: 555 LKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
L R + + + L +LD I+ + L + L L L+
Sbjct: 274 NTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNT 328
Query: 615 KL 616
+L
Sbjct: 329 EL 330
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 33/209 (15%)
Query: 734 LGIGSFGSVYVARLQD--------GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
LG G+F ++ ++ EV +KV + + +SF + +M ++ H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFG 842
C D L+ E++ GSL+ L ++I +L + +A A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135
Query: 843 H--------------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
H + +SD I+ + +D I ++ PE
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECI 189
Query: 889 VQGRV-STRGDVYSYGIMLMETFT-GKKP 915
+ + D +S+G L E + G KP
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 53/214 (24%), Positives = 74/214 (34%), Gaps = 31/214 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY---ERALKSFQDECEVMKR 778
LG GSFG V + VAVK A+ F E M
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+ HRNL+++ K ++ E P GSL +RL + + VA + Y
Sbjct: 78 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 839 L---HFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGY 882
L F IH + I DF + + L D MQ +
Sbjct: 137 LESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
APE S D + +G+ L E FT G++P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGME-----VAVKVFHQRY-ERALKSFQDECEVMKRI 779
F K +LG G+FG+VY E VA+K + +A K DE VM +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+ ++ +++ C + LI + MP G L + + + LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 840 ---HFGH----------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
H TP I+DF +AK L +++ I +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ + + DV+SYG+ + E T G KP
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRY-ERALKSFQDECEVMKRI 779
K LG G FG V + G VAVK + ++ E ++++ +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 780 RHRNLVKIISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
H +++K C + + L+MEY+P GSL + L + + + Q L + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMA 148
Query: 838 YLHFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMA 884
YL H+ IH + I DF +AK + G + ++ + + + A
Sbjct: 149 YL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
PE + + DV+S+G+ L E T
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++ VA+K + ++F E +VMK++RH LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 242
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHS 844
++ + S + ++ EYM GSL + L L + Q +++ +A + Y+
Sbjct: 243 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +V ++DF +A+ + + + Q I + APE + GR
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGR 357
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
+ + DV+S+GI+L E T G+ P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 732 NLLGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
++G G FG VY D ++ A+K + + +++F E +M+ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 787 IISACSNDD-FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFG 842
+I + +++ YM +G L + S + ++ + VA +EYL F
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF- 145
Query: 843 HSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLAT--IGYMAPEYG 888
+H M+ ++DF +A+ + ++ S+Q A + + A E
Sbjct: 146 -----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKP 915
R +T+ DV+S+G++L E T G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+ + LG G +G VY + + VAVK + ++ F E VMK I+H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 278
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 843
V+++ C+ + +I E+M G+L + L + L + ++ A+EYL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
IH + ++DF +++ + G D + I + APE
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 394
Query: 892 RVSTRGDVYSYGIMLMETFT-GKKP 915
+ S + DV+++G++L E T G P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 734 LGIGSFGSVYVARLQDG----MEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKI 787
LG G FGSV A+L+ ++VAVK+ ++ F E MK H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 788 ISACSNDDFKA------LIMEYMPNGSL-----ENRLYSGTCMLDIFQRLNIMIDVALAL 836
+ K +I+ +M +G L +R+ L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 837 EYL---HFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIG 881
EYL +F IH M+A ++DF +++ + D + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++A E + DV+++G+ + E T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 732 NLLGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
++G G FG VY L D + AVK ++ + F E +MK H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 787 IISACSNDDFKAL-IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFG 842
++ C + L ++ YM +G L N + + T + + + VA ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 843 HSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLAT--IGYMAPEYG 888
+H M+ ++DF +A+ + ++ S+ +T A + +MA E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ +T+ DV+S+G++L E T G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++ VA+K + ++F E +VMK++RH LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 325
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHS 844
++ + S + ++ EYM GSL + L L + Q +++ +A + Y+
Sbjct: 326 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +V ++DF +A+ + + + Q I + APE + GR
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGR 440
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
+ + DV+S+GI+L E T G+ P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP 464
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 12/243 (4%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKL 462
+PQ I SN L+L N + TF L +L+ L L N + R I LA L
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASL 125
Query: 463 DKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
+ L L N + IPS + L+ LR L+L +N S + ++ D+
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 522 GPLSLDI-GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLS 580
+S L + LNL N+ D+P + L L++L ++ N P SF GLS
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 581 SLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG--GPFANLTAKSFLGNE 638
SL+ L + +++S + + + L L +LNL+ N L +P P L N
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301
Query: 639 LLC 641
C
Sbjct: 302 WNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 32/253 (12%)
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
R L L N + I + +L LE Q+ I + L++L L+L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 425 TGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKFSGAIPSCS-G 481
T IP F L L+ L L N + SIP + L +L L K I +
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 482 NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSR 541
L +L+ L LG +P ++ L + EL +S
Sbjct: 194 GLFNLKYLNLGMCNIKD-MP-------------------------NLTPLVGLEELEMSG 227
Query: 542 NNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLE 601
N+ P + GL +L+KL++ N+++ +F GL+SL L+L+ N +S +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 602 KLLYLKKLNLSFN 614
L YL +L+L N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 67/288 (23%), Positives = 107/288 (37%), Gaps = 39/288 (13%)
Query: 161 CKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIIL 220
C K++ R ++P + L L NN+ +L L+ + L
Sbjct: 50 CSCSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQL 106
Query: 221 NDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPS 279
N +R +I L L L L N L + +S L++L L N + S+PS
Sbjct: 107 GRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPS 164
Query: 280 RIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFL 339
+P++ L+LG L NL++L
Sbjct: 165 YAFNRVPSLMRLDLG-----------------------ELKKLEYISEGAFEGLFNLKYL 201
Query: 340 NIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCR 399
N+ + P L+ L L L ++GN I P S LS SL++ + N +
Sbjct: 202 NLGMCNIKD-MPNLTPLVGL------EELEMSGNHFPEIRPGSFHGLS-SLKKLWVMNSQ 253
Query: 400 ISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFN 446
+S L++L+ L+L N L+ S+P F+ L L L L N
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 64/288 (22%), Positives = 106/288 (36%), Gaps = 41/288 (14%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINR 151
+ + + LS +P I + L+ +N +
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNI----------------------- 87
Query: 152 FSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-G 210
+ A+ ++L +L+ L LGRN + L L L N L+ IP
Sbjct: 88 --QMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
Query: 211 NLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSL 268
L+KL+++ L +N + IP +P L+RL L + + F + LK L+L
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 269 LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPN 328
+ +P+ L +E L + N F P S S L + + S N
Sbjct: 204 GMCNI-KDMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 329 TIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
L +L LN+A N L+S +L + L + L L NP +
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDL--FTPLRY---LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 13/230 (5%)
Query: 72 VLNISGFNLQGTIPP-QLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLF 129
LN+ N+Q I +L LE L L N + I F + +L L+ DN L
Sbjct: 79 YLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL- 135
Query: 130 GSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSK 187
+ S F +S + + L N +P+ +P+L +L LG I
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLAT 246
L+ L L N+ +P + L L+++ ++ N EI L L +L +
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMN 251
Query: 247 NNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
+ + + +++L +L+L N L SLP + L + L+L N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGS 131
LN+ N+ P L L LE L++S N I F + +LK L ++Q+
Sbjct: 201 LNLGMCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV-SL 256
Query: 132 LSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFH 178
+ F ++S++ ++L+ N S LP ++ L L +L L N ++
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDG-MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+ + LG G +G VY + + VAVK + ++ F E VMK I+H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 71
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
V+++ C+ + +I E+M G+L + L + L + ++ A+EYL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
IH + ++DF +++ + G D + I + APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 892 RVSTRGDVYSYGIMLMETFT-GKKP 915
+ S + DV+++G++L E T G P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 37/231 (16%)
Query: 716 FSYHELLQATDRFSK---------NNLLGIGSFGSVYVARLQDG----MEVAVKVFHQRY 762
+Y E +A F++ ++G G G V RL+ + VA+K Y
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 763 -ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLD 821
ER + F E +M + H N++++ + ++ EYM NGSL+ L +
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 822 IFQRLNIMIDVALALEYL---HFGHSTPIIH------------YMVAHISDFSIAKFL-N 865
I Q + ++ V + YL + +H +V +SDF +++ L +
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
D T I + APE S+ DV+S+G+++ E G++P
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 734 LGIGSFGSVYVARLQDG---MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIIS 789
LG G+FGSV + ++VA+KV Q + + E ++M ++ + +V++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTP 846
C + L+ME G L L + + ++ V++ ++YL +F
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131
Query: 847 IIH------------YMVAHISDFSIAKFLNGQDQL-SMQTQTLATIGYMAPEYGVQGRV 893
+H A ISDF ++K L D + ++ + + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
S+R DV+SYG+ + E + G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++A +VAVK ++++F E VMK ++H LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLV 246
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHS 844
K+ + + + +I E+M GSL + L S + + ++ +A + ++
Sbjct: 247 KLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
IH +V I+DF +A+ + ++ + + I + APE G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGS 361
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
+ + DV+S+GI+LME T G+ P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 734 LGIGSFGSVYVARL------QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG V++A +D M VAVK A K FQ E E++ ++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 788 ISACSNDDFKALIMEYMPNGSL---------------ENRLYSGTCMLDIFQRLNIMIDV 832
C + D ++ EYM +G L + + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 833 ALALEYL---HFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL 877
A + YL HF +H ++ I DF +++ + D + T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
I +M PE + + +T DV+S+G++L E FT GK+P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 732 NLLGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
++G G FG VY L D + AVK ++ + F E +MK H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 787 IISACSNDDFKAL-IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFG 842
++ C + L ++ YM +G L N + + T + + + VA +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 843 HSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLAT--IGYMAPEYG 888
+H M+ ++DF +A+ + ++ S+ +T A + +MA E
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ +T+ DV+S+G++L E T G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
LG G+FG VY ++ ++VAVK + E+ F E ++ + H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 787 IISACSNDDFKALIMEYMPNGSL-----ENRLYSGT-CMLDIFQRLNIMIDVALALEYL- 839
I + ++ME M G L E R L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 840 --HFGHS---------TPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
HF H T VA I DF +A+ + + + +M PE
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++G +++ D +S+G++L E F+ G P
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++ +VAVK Q + +F E +MK+++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHS 844
++ + + + +I EYM NGSL + L + + L I + L++ +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
IH + I+DF +A+ + ++ + + I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
+ + DV+S+GI+L E T G+ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 734 LGIGSFGSVYVARLQ----DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKII 788
+G G FG V RL+ + VA+K Y E+ + F E +M + H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 845
+ ++ EYM NGSL++ L + Q + ++ +A ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 846 PIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +V +SDF + + L + + I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
++ DV+SYGI+L E + G++P
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/265 (19%), Positives = 100/265 (37%), Gaps = 35/265 (13%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT--GSIPVTFSRLLNLQGLG 442
+ S R ++ + ++ V L+ L L L N L+ G + +L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 443 LAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCS--GNLTSLRALYLGSNRFTSAL 500
L+FN + ++ L +L+ L + + S +L +L L +
Sbjct: 85 LSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-- 140
Query: 501 PSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQ 559
+ +G SL+ L ++ N+ + I L+NL
Sbjct: 141 --------------AFNGIFNGLSSLE--------VLKMAGNSFQENFLPDIFTELRNLT 178
Query: 560 KLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGE 619
L L+ +LE P +F+ LSSL++L++S N + + L L+ L+ S N +
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237
Query: 620 IPRG---GPFANLTAKSFLGNELLC 641
+ ++L + N+ C
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/289 (18%), Positives = 101/289 (34%), Gaps = 40/289 (13%)
Query: 93 SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSINR 151
S + + L+ ++P+ I + L+ N+L SL +F ++ + + LS N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNG 63
Query: 152 FS-GELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI- 209
S + +LK L L N + S +QLE L + +NL +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 210 GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
+L L + ++ R + L L L +A N+ IF
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT--------- 172
Query: 269 LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASKLTVFQLRGNSFSGFIP 327
L N+ FL+L + + + + S L V + N+F
Sbjct: 173 ---------------ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDT 216
Query: 328 NTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
L +L+ L+ + N++ +S + ++ + L L N
Sbjct: 217 FPYKCLNSLQVLDYSLNHIMTS-KKQELQHFPSS---LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 53/257 (20%), Positives = 86/257 (33%), Gaps = 15/257 (5%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS-- 202
I + + +P I + +L L N K QL L L N LS
Sbjct: 12 IRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF-NMS 261
G + T LK + L+ N + + L L L +NL + F++F ++
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 262 TLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASKLTVFQLRGN 320
L L + + I L ++E L + N F N I T LT L
Sbjct: 127 NLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILP 380
P +L +L+ LN++ N S ++VL + N +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT-----FPYKCLNSLQVLDYSLNHIMTSKK 240
Query: 381 SSIGNLSISLERFQMFN 397
+ + SL +
Sbjct: 241 QELQHFPSSLAFLNLTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 8/233 (3%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLS-GNIPSSIF-NMHTLKLLDFRDNQLF 129
L + LQ L+ L L LS N LS S +LK LD N +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV- 90
Query: 130 GSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
++SS + + +D + ++ +L NL L + +
Sbjct: 91 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150
Query: 190 QLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATN 247
LE L + N+ +I L L + L+ +L ++ +L L L ++ N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 248 NLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLP-NVEFLNLGTNRFS 299
N + F +++L+ L N + + + P ++ FLNL N F+
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 64/326 (19%), Positives = 116/326 (35%), Gaps = 39/326 (11%)
Query: 620 IPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVI-------- 671
IP G F L GL C + + L
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282
Query: 672 -ALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELLQATDRFSK 730
L++ R T + P+ ++ L+ +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF--LKRDNLLIA 340
Query: 731 NNLLGIGSFGSVYVARLQDG---MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
+ LG G+FGSV + ++VA+KV Q + + E ++M ++ + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH 843
+I C + L+ME G L L + + ++ V++ ++YL +F
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 457
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQL-SMQTQTLATIGYMAPEYGVQ 890
+H A ISDF ++K L D + ++ + + APE
Sbjct: 458 ----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 891 GRVSTRGDVYSYGIMLMETFT-GKKP 915
+ S+R DV+SYG+ + E + G+KP
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 734 LGIGSFGSVYVARLQDG-----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKI 787
+G G FG VY L+ + VA+K Y E+ F E +M + H N++++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 788 ISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHS 844
S +I EYM NG+L+ L + Q + ++ +A ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQ-TLATIGYMAPEYGVQG 891
+H +V +SDF +++ L + + T I + APE
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 892 RVSTRGDVYSYGIMLMETFT-GKKP 915
+ ++ DV+S+GI++ E T G++P
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 734 LGIGSFGSVYVARLQDG---MEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKII 788
LG G+FG+V Q VAVK+ E VM+++ + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 845
C + + L+ME G L L + + ++ V++ ++YL +F
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 846 PIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H A ISDF ++K L ++ QT + + APE +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 893 VSTRGDVYSYGIMLMETFT-GKKP 915
S++ DV+S+G+++ E F+ G+KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 16/245 (6%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKL 462
+P IS +N LL+L N++ +F L +L+ L L+ N + R+I LA L
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANL 114
Query: 463 DKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSS-NSLD 521
+ L L N+ + L+ L+ L+L +N S + + D+ L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 522 GPLSLDIG---NLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSG 578
+ G L + LNL+ NL +IP + L L +L L+ N L P SF G
Sbjct: 175 ---YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 579 LSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG--GPFANLTAKSFLG 636
L L+ L + +++I + + + L L ++NL+ N L +P P +L
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 637 NELLC 641
N C
Sbjct: 289 NPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 9/234 (3%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSI 149
++ L+L N++ I + F ++ L++L N + ++ F ++++ ++L
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI 209
NR + +P L LK+L L N ++ L L L I +
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 210 -GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
L+ L+ + L LR EIP + L L L L+ N+L + P + + L+KL +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 269 LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
+++ + + +L ++ +NL N + T L L N +
Sbjct: 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 64/288 (22%), Positives = 105/288 (36%), Gaps = 41/288 (14%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINR 151
+ + L +P I +LL+ +NQ+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQI----------------------- 76
Query: 152 FSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-G 210
+ N K+L +L+ L L RN + L L L N L+ IP
Sbjct: 77 --QIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
Query: 211 NLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSL 268
L+KLK++ L +N + IP +P L RL L + + F +S L+ L+L
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 269 LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPN 328
L +P+ L ++ L+L N S P S L + + N
Sbjct: 193 AMCNL-REIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 329 TIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
NL++L +N+A N LT +L + L + + + L NP +
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDL--FTPLHH---LERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 11/229 (4%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
+LN+ +Q +L LE L LS N + I F + L L+ DN+L
Sbjct: 68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL-T 125
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKC 188
++ + F +S + + L N +P+ +P+L++L LG I
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATN 247
L L L NL IP + L KL ++ L+ N L I L +L +L + +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS 241
Query: 248 NLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
+ + N+ +L +++L N L LP + L ++E ++L N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 63/249 (25%), Positives = 91/249 (36%), Gaps = 16/249 (6%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
+P I N LNL N+ +S + L + QL N L N
Sbjct: 57 EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 336 LEFLNIADNYLTSSTPE-LSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQ 394
L L + DN LT+ +LS L + L L NP++ I + + SL R
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKL------KELWLRNNPIESIPSYAFNRIP-SLRRLD 166
Query: 395 MFNC-RISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP 453
+ R+S LSNL L+L L IP + L+ L L L+ N L+ P
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224
Query: 454 DEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILF 512
L L KL + ++ I + NL SL + L N T L +
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283
Query: 513 FDVSSNSLD 521
+ N +
Sbjct: 284 IHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 7/108 (6%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGS 131
LN++ NL P L L L+ LDLS N LS I F + L+ L +Q+
Sbjct: 190 LNLAMCNL--REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQI-QV 245
Query: 132 LSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFH 178
+ F N+ S++ I+L+ N + LP ++ L +L+++ L N ++
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
LG G+FG VY ++ ++VAVK + E+ F E ++ + H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 787 IISACSNDDFKALIMEYMPNGSL-----ENRLYSGT-CMLDIFQRLNIMIDVALALEYL- 839
I + +++E M G L E R L + L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 840 --HFGHS---------TPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
HF H T VA I DF +A+ + + + +M PE
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258
Query: 889 VQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++G +++ D +S+G++L E F+ G P
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+G G FG V + + G +VAVK ++F E VM ++RH NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 786 KIISACSNDDFKA-LIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 843
+++ + ++ EYM GSL + L S G +L L +DV A+EYL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
+H VA +SDF + K + S Q + + APE +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 361
Query: 892 RVSTRGDVYSYGIMLMETFT-GKKP 915
+ ST+ DV+S+GI+L E ++ G+ P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+G G FG V + + G +VAVK ++F E VM ++RH NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 786 KIISACSNDDFKALI-MEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 843
+++ + I EYM GSL + L S G +L L +DV A+EYL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 134
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
+H VA +SDF + K + S Q + + APE +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 189
Query: 892 RVSTRGDVYSYGIMLMETFT-GKKP 915
+ ST+ DV+S+GI+L E ++ G+ P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 29/203 (14%)
Query: 734 LGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKII 788
+G G FG V+ + VA+K + + F E M++ H ++VK+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 845
+ + +IME G L + L LD+ + ++ AL YL F
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137
Query: 846 PIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+H +V+ + DF +++++ ++ I +MAPE R
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 194
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
++ DV+ +G+ + E G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 29/203 (14%)
Query: 734 LGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKII 788
LG G FG VY + + VAVK + + F E +MK + H ++VK+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 845
+ +IME P G L + L L + + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 846 PIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+H +VA + DF +++++ +D + T I +M+PE R
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF 191
Query: 894 STRGDVYSYGIMLMETFT-GKKP 915
+T DV+ + + + E + GK+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 72/350 (20%), Positives = 110/350 (31%), Gaps = 75/350 (21%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
++P I P+ L+L N S L L N S LR
Sbjct: 47 AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 336 LEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
L+ L I+ N+L P L SSL L + N + +
Sbjct: 104 LQKLYISKNHLVEIPPNL--PSSLVE------LRIHDNRIRKVPKGV------------- 142
Query: 396 FNCRISGKIPQVISNLSNLLLLDLGGNKLT-GSIPVTFSRLLNLQGLGLAFNKLARSIPD 454
S L N+ +++GGN L L L L ++ KL IP
Sbjct: 143 ------------FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPK 189
Query: 455 EICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFF 513
++ L++L L NK AI + L L LG N+ ++ L
Sbjct: 190 DL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP----- 241
Query: 514 DVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573
L+ EL+L N LS +P + LK LQ ++L N +
Sbjct: 242 ----------------TLR---ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGV 281
Query: 574 ESFSGL------SSLEILDLSKNKIS--GVIPTSLEKLLYLKKLNLSFNK 615
F + + + L N + V P + + + K
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 54/254 (21%), Positives = 94/254 (37%), Gaps = 10/254 (3%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA 444
+S + N IS L +L L L NK++ FS L LQ L ++
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 445 FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFT-SALPST 503
N L IP + + L +L +H N+ L ++ + +G N S
Sbjct: 111 KNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFL 563
++ + + +S L + + + EL+L N + + L +L L
Sbjct: 168 AFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGL 224
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
+N++ S S L +L L L NK+S +P L L L+ + L N + ++
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282
Query: 624 GPFANLTAKSFLGN 637
F +
Sbjct: 283 D-FCPVGFGVKRAY 295
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 62/337 (18%), Positives = 116/337 (34%), Gaps = 72/337 (21%)
Query: 302 IPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
+P I+ T+ L+ N S + L++L L + +N ++ + + +
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK-----AFSP 100
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421
+K++ L ++ N L I P+ S+L+ L +
Sbjct: 101 LRKLQKLYISKNHLVEIPPNL----------------------------PSSLVELRIHD 132
Query: 422 NKLTGSIPV-TFSRLLNLQGLGLAFNKLARS-IPDEICHLAKLDKLILHGNKFSGAIPSC 479
N++ +P FS L N+ + + N L S KL+ L + K + IP
Sbjct: 133 NRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK- 189
Query: 480 SGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNL 539
+L L+L N+ + + L + L L
Sbjct: 190 -DLPETLNELHLDHNKIQA----------------IELEDLLR--------YSKLYRLGL 224
Query: 540 SRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTS 599
N + ++ L L++L L NN+L +P L L+++ L N I+ V
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 600 ------LEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
K Y ++L N + + F +T
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 68/349 (19%), Positives = 112/349 (32%), Gaps = 72/349 (20%)
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
+P I P+ L L N + L L L N +S K L K
Sbjct: 47 AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
L+ + ++ N L EIP + LV L + N +
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR------------------------ 136
Query: 275 GSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLR 334
+P + L N+ + +G N L +F G
Sbjct: 137 -KVPKGVFSGLRNMNCIEMGGNP--------------LENSGFEPGAFDG---------L 172
Query: 335 NLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQ 394
L +L I++ LT +L +L L L N + I + S L R
Sbjct: 173 KLNYLRISEAKLTGIPKDL--PETLNE------LHLDHNKIQAIELEDLLRYS-KLYRLG 223
Query: 395 MFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPD 454
+ + +I +S L L L L NKL+ +P L LQ + L N + + +
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282
Query: 455 EICHL------AKLDKLILHGNKFS-GAIPSCS-GNLTSLRALYLGSNR 495
+ C + A + + L N + + +T A+ G+ +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 25/275 (9%)
Query: 83 TIPP-QLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMS 140
+ L L L L +NK+S I F + L+ L N L + + S
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL-VEIPPNLP--S 123
Query: 141 SMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN-MFHGKIPSTLSKCKQLEGLYLRFN 199
S++ + + NR ++P + L N+ + +G N + + +L L +
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 200 NLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF 258
L+ IPK L ++ L+ N+++ I E L RL L N + + ++
Sbjct: 183 KLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 259 NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-------TNASK 311
+ TL++L L N L +P+ + L ++ + L TN + + + +
Sbjct: 239 FLPTLRELHLDNNKL-SRVPAGLP-DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295
Query: 312 LTVFQLRGN--SFSGFIPNTIGNLRNLEFLNIADN 344
L N + P T + + + +
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 53/311 (17%), Positives = 116/311 (37%), Gaps = 26/311 (8%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
V+ S L+ +P ++ LDL +N +S + F + L L +N++
Sbjct: 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI-S 91
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCK 189
+ F + + + +S N E+P N+ +L +L + N S +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 190 QLEGLYLRFNNL-SGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+ + + N L + + KL + +++ +L IP+++ L L L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
+ + + S L +L L N + + + LP + L+L N+ S +P+ + +
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLR------NLEFLNIADNYLTSSTPELSFLSSLTNC 362
L V L N+ + N + +++ +N + + + +T+
Sbjct: 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD- 321
Query: 363 QKIRVLILAGN 373
+
Sbjct: 322 --RLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 29/95 (30%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
+ S L +P I + L L NN + + F GL L L L NKIS +
Sbjct: 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKI 93
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+ L L+KL +S N L EIP ++L
Sbjct: 94 HEKAFSPLRKLQKLYISKNHLV-EIPPNL-PSSLV 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 54/232 (23%), Positives = 82/232 (35%), Gaps = 27/232 (11%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA 444
+ + +R + RIS NL +L L N L F+ L L+ L L+
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 445 FNKLARSIPDEI-CHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPS 502
N RS+ L +L L L + L +L+ LYL N +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA---- 143
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
+ ++ +L L L N +S GL +L +L
Sbjct: 144 ------------LPDDTFRDLGNLT--------HLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
L NR+ P +F L L L L N +S + +L L L+ L L+ N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/244 (25%), Positives = 88/244 (36%), Gaps = 36/244 (14%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKL 462
+P I + + L GN+++ +F NL L L N L I LA L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALL 82
Query: 463 DKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
++L L N ++ + L L L+L +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE----------------LGPGLFR 126
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLS 580
G +L L L N L +P L NL LFL NR+ +F GL
Sbjct: 127 GLAALQ--------YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 581 SLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL---GN 637
SL+ L L +N+++ V P + L L L L N L +P A L A +L N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA-LAPLRALQYLRLNDN 235
Query: 638 ELLC 641
+C
Sbjct: 236 PWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 50/223 (22%), Positives = 80/223 (35%), Gaps = 10/223 (4%)
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
+P I +++ L N ++ C+ L L+L N L+ L
Sbjct: 25 AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 215 LKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTL 273
L+ + L+DN + L L L L L + P ++ L+ L L +N L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 274 WGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNL 333
+LP L N+ L L NR S + L L N + P+ +L
Sbjct: 142 -QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
L L + N L++ E L + ++ L L NP
Sbjct: 201 GRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 12/206 (5%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
+ + G + +L L L N L+ I ++ F + L+ LD DN
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKC 188
S+ F + + + L EL + + L L+ L L N +P T
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 189 KQLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLAT 246
L L+L N +S ++P+ L L ++L+ N + + +L L+ L L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 247 NNLVGVVPFTIF-NMSTLKKLSLLEN 271
NNL +P + L+ L L +N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSI 149
++ + + L N++S ++P++ F L +L N L + + F ++ + +DLS
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKE 208
N + L L L L R ++ L+ LYL+ N L A+P +
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDD 147
Query: 209 I-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKL 266
+L L + L+ N + +P+ L L RL L N + V P ++ L L
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 267 SLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
L N L +LP+ L +++L L N
Sbjct: 207 YLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 15/229 (6%)
Query: 221 NDNELRGEIPQEMGNLP-YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPS 279
L+ +P +P R+ L N + V + L L L N L + +
Sbjct: 19 PQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDA 73
Query: 280 RIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEF 338
L +E L+L N ++ + +L L P L L++
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 339 LNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNC 398
L + DN L + + + + L L GN + + + L SL+R +
Sbjct: 134 LYLQDNALQALPDDT-----FRDLGNLTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQN 187
Query: 399 RISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFN 446
R++ P +L L+ L L N L+ ++P + L LQ L L N
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 44/184 (23%), Positives = 69/184 (37%), Gaps = 10/184 (5%)
Query: 72 VLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLF 129
+L + L I L+ LE LDLS N ++ + F + L L L
Sbjct: 60 ILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 130 GSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
L +F ++++ + L N LP + ++L NL L L N
Sbjct: 119 -ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 189 KQLEGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQE-MGNLPYLVRLTLAT 246
L+ L L N ++ + +L +L + L N L +P E + L L L L
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
Query: 247 NNLV 250
N V
Sbjct: 235 NPWV 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 42/218 (19%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKI 787
LG G+FG V++A + M VAVK + E A + FQ E E++ ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 788 ISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCM---------LDIFQRLNIMIDVA 833
C+ ++ EYM +G L + + L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 834 LALEYL---HFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLA 878
+ YL HF +H +V I DF +++ + D + +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
I +M PE + + +T DV+S+G++L E FT GK+P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
LG GSFG VY + VA+K ++ R F +E VMK ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 787 IISACSNDDFKALIMEYMPNGSLENRL---------YSGTCMLDIFQRLNIMIDVALALE 837
++ S +IME M G L++ L + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 838 YLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
YL ++ +H MVA I DF + + + D + L + +M+P
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
E G +T DV+S+G++L E T ++P
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
LG FG VY L VA+K + + F+ E + R++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 787 IISACSNDDFKALIMEYMPNGSL-----ENRLYSGTCM----------LDIFQRLNIMID 831
++ + D ++I Y +G L +S L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 832 VALALEYL---HFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQT 876
+A +EYL H +H +V ISD + + + D + +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
L I +MAPE + G+ S D++SYG++L E F+ G +P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 25/201 (12%)
Query: 734 LGIGSFGSVYVARLQDG----MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKII 788
+G G FG V+ M VA+K + + F E M++ H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH-- 843
+ + +IME G L + L LD+ + ++ AL YL F H
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRD 516
Query: 844 --------STPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVST 895
S+ + DF +++++ ++ I +MAPE R ++
Sbjct: 517 IAARNVLVSSN----DCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTS 571
Query: 896 RGDVYSYGIMLMETFT-GKKP 915
DV+ +G+ + E G KP
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
+R+ + LG G +VY+A ++VA+K E LK F+ E ++ H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+N+V +I DD L+MEY+ +L + S L + +N + +++ H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD 129
Query: 842 GHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIG---YMAPE 886
I+H ++ I DF IAK L+ + TQT +G Y +PE
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE----TSLTQTNHVLGTVQYFSPE 182
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
D+YS GI+L E G+ P F GE
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 52/228 (22%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
+G G+FG V+ AR VAVK+ + FQ E +M + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 787 IISACSNDDFKALIMEYMPNGSLENRL-----------------------YSGTCMLDIF 823
++ C+ L+ EYM G L L G L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 824 QRLNIMIDVALALEYL---HFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQD 868
++L I VA + YL F +H +V I+DF +++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
I +M PE R +T DV++YG++L E F+ G +P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 734 LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVK 786
LG G FG V A VAVK+ + L+ E V+K++ H +++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 787 IISACSNDDFKALIMEYMPNGSL-----------------------ENRLYSGTCMLDIF 823
+ ACS D LI+EY GSL + + L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 824 QRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLS 871
++ ++ ++YL ++H ISDF +++ + +D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++Q + +MA E +T+ DV+S+G++L E T G P
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 29/232 (12%)
Query: 702 SSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQ 760
N+G+ + ++ Y E + + +G GSFG V+ + Q G + AVK
Sbjct: 35 EDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---- 89
Query: 761 RYERALKSF-QDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCM 819
+ L+ F +E + +V + A + + ME + GSL + C+
Sbjct: 90 --KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 820 LDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH------ISDFSIAKFLNG 866
+ L + LEYL H+ I+H +++ + DF A L
Sbjct: 148 -PEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 867 QDQLSMQTQTLATIG---YMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
G +MAPE + + D++S M++ G P
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 41/228 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
+R S LG G+FG V A M VAVK+ ++ E +V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 779 I-RHRNLVKIISACSNDDFKALIMEYMPNGSL-----------------ENRLYSGTCML 820
+ H N+V ++ AC+ +I EY G L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 821 DIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQD 868
D+ L+ VA + +L S IH ++ H I DF +A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++ + +MAPE + DV+SYGI L E F+ G P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 76/443 (17%), Positives = 134/443 (30%), Gaps = 47/443 (10%)
Query: 205 IPKEIGNLTKLKDIILNDN--ELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
I I N L + + N V ++ + N
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--Q 60
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
+L L L SLP + P + L + N ++P + L N
Sbjct: 61 FSELQLNRLNL-SSLPDNL---PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSS 382
S +P +L++L ++ +N LT + L + N L LP
Sbjct: 113 S-TLPELPASLKHL---DVDNNQLTMLPELPALL---------EYINADNNQLTM-LPEL 158
Query: 383 IGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQ--- 439
+L E + N +++ +P++ +L L D+ N L S+P R + +
Sbjct: 159 PTSL----EVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 440 -GLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTS 498
N++ IP+ I L +IL N S + S + + + Y G + S
Sbjct: 210 IFFRCRENRI-THIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFS 267
Query: 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNL 558
N D + D+ + E N S + +
Sbjct: 268 MSDGQ-QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 559 QKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEG 618
+ + + LS+ L ++ S E + L NL L
Sbjct: 326 RNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVH 381
Query: 619 EIPRGGPFANLTAKSFLGNELLC 641
+ G + A LG E+
Sbjct: 382 QASEGLFDNDTGALLSLGREMFR 404
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 29/248 (11%)
Query: 411 LSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGN 470
++ L L L+ S+P + L + N L S+P+ L LD N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL-ISLPELPASLEYLD---ACDN 110
Query: 471 KFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGN 530
+ S +P SL+ L + +N+ T LP L+ I + +N L L +
Sbjct: 111 RLS-TLPE---LPASLKHLDVDNNQLTM-LPELPALLEYI---NADNNQLTM-LPELPTS 161
Query: 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLE----ILD 586
L+ L++ N L+ +P ++L+ L ++ N LE +P E
Sbjct: 162 LE---VLSVRNNQLT-FLP---ELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 587 LSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDL 646
+N+I+ IP ++ L + L N L I
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 647 HNSPCKLN 654
N+ +
Sbjct: 273 QNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 50/276 (18%), Positives = 95/276 (34%), Gaps = 48/276 (17%)
Query: 73 LNISGFNL-QGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+ G N + + ++ L L+ LS ++P ++ + +L+ N L S
Sbjct: 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL-IS 94
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
L ++ + D NR S LP +LK L + N +P + L
Sbjct: 95 LPELPASLEYL---DACDNRLS-TLPELP----ASLKHLDVDNNQLT-MLPELPA---LL 142
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
E + N L+ +P+ +L L + +N+L +P+ + L L ++TN L
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELPES---LEALDVSTNLLES 194
Query: 252 VVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+P ++ + F NR + +IP +I +
Sbjct: 195 -LPAVPVRNHHSEETEI---------------------FFRCRENRIT-HIPENILSLDP 231
Query: 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
L N S I ++ + Y +
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 54/227 (23%), Positives = 88/227 (38%), Gaps = 42/227 (18%)
Query: 728 FSKNNL-----LGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEV 775
F +NNL LG G+FG V A ++VAVK+ ++ E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 776 MKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSL-------------ENRLYSGTCMLD 821
M + +H N+V ++ AC++ +I EY G L +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 822 IFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQ 869
L+ VA + +L + IH VA I DF +A+ +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
++ + +MAPE + + DV+SYGI+L E F+ G P
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD--------GMEVAVKVFHQRY-ERALKSFQDECEVM 776
D+ + LG G+FG V +A + VAVK+ E+ L E E+M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 777 KRI-RHRNLVKIISACSNDDFKALIMEYMPNGSL---------------ENRLYSGTCML 820
K I +H+N++ ++ AC+ D +I+EY G+L + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 821 DIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQD 868
++ +A +EYL IH +V I+DF +A+ +N D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
T + +MAPE + + DV+S+G+++ E FT G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 734 LGIGSFGSVYVARLQD--------GMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRN 783
LG G+FG V +A +VAVK+ E+ L E E+MK I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 784 LVKIISACSNDDFKALIMEYMPNGSL---------------ENRLYSGTCMLDIFQRLNI 828
++ ++ AC+ D +I+EY G+L N ++ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 829 MIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQT 876
VA +EYL IH +V I+DF +A+ ++ D T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ +MAPE + + DV+S+G++L E FT G P
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
D +LG G++G VY R L + + +A+K +R R + +E + K ++H+N
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLEN--RLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+V+ + + S + F + ME +P GSL R G + + L+YL
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL-- 138
Query: 842 GHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPE- 886
H I+H V ISDF +K L G ++ T+T T+ YMAPE
Sbjct: 139 -HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEI 194
Query: 887 --YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
G +G D++S G ++E TGK P
Sbjct: 195 IDKGPRGY-GKAADIWSLGCTIIEMATGKPP 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 42/241 (17%), Positives = 86/241 (35%), Gaps = 39/241 (16%)
Query: 697 KSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVK 756
S+ D S + + S+ ++LG G+ G++ + D +VAVK
Sbjct: 5 PSLEQDDGDEETSVVIVGKISF----------CPKDVLGHGAEGTIVYRGMFDNRDVAVK 54
Query: 757 VFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS 815
E ++++ H N+++ + F+ + +E +L+ +
Sbjct: 55 RILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ 110
Query: 816 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-----------------YMVAHISDF 858
+ + ++ L +L HS I+H + A ISDF
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 859 SIAKFL-NGQDQLSMQTQTLATIGYMAPEY---GVQGRVSTRGDVYSYGIMLMETFTGKK 914
+ K L G+ S ++ T G++APE + + D++S G + +
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227
Query: 915 P 915
Sbjct: 228 H 228
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 40/227 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
DR LG G+FG V A VAVK+ + ++ E +++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 779 I-RHRNLVKIISACSNDDFKA-LIMEYMPNGSL---------------ENRLYSGTCMLD 821
I H N+V ++ AC+ +I+E+ G+L L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 822 IFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQ 869
+ + VA +E+L IH +++ I DF +A+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ + +MAPE + + DV+S+G++L E F+ G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 734 LGIGSFGSVYVARLQD--------GMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRN 783
LG G FG V +A + VAVK+ E+ L E E+MK I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 784 LVKIISACSNDDFKALIMEYMPNGSL---------------ENRLYSGTCMLDIFQRLNI 828
++ ++ AC+ D +I+EY G+L + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 829 MIDVALALEYL---HFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQ 873
+A +EYL IH V I+DF +A+ +N D
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
T + +MAPE + + DV+S+G+++ E FT G P
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 732 NLLGIGSFGSVYVARLQDG---MEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVK 786
+++G G+FG V AR++ M+ A+K + + + F E EV+ ++ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 787 IISACSNDDFKALIMEYMPNGSL---------------ENRLYSGTCMLDIFQRLNIMID 831
++ AC + + L +EY P+G+L S L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 832 VALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLAT 879
VA ++YL IH VA I+DF +++ GQ+ +T
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 880 IGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ +MA E +T DV+SYG++L E + G P
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 51/236 (21%)
Query: 728 FSKNNL-----LGIGSFGSVYVARLQDG------MEVAVKVFHQRY-ERALKSFQDECEV 775
F + NL LG G+FG V A ++VAVK+ ++ ++ E ++
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 776 MKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL--------------------- 813
M ++ H N+V ++ AC+ LI EY G L N L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 814 -YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSI 860
+L L VA +E+L F +H +V H I DF +
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 861 AKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
A+ + ++ + +MAPE +G + + DV+SYGI+L E F+ G P
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-24
Identities = 38/214 (17%), Positives = 74/214 (34%), Gaps = 44/214 (20%)
Query: 733 LLGIGSFGSVYVA---RLQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKII 788
+ G G +Y+A + +G V +K A E + + + H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 789 SACSNDDFKA-----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+ + D ++MEY+ SL+ L + + + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 844 STPIIH-------YMVAH----ISDFSIAKFLNGQDQLSMQTQT---LATIGYMAPEYGV 889
S +++ M+ + D + T G+ APE V
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI---------NSFGYLYGTPGFQAPEI-V 249
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ + D+Y+ G L G
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 32/312 (10%)
Query: 283 LSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIA 342
LS + + +IPS +T + L N + + + NL+ L +
Sbjct: 28 LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84
Query: 343 DNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISG 402
N + + E SF SSL + + L L+ N L + S LS SL +
Sbjct: 85 SNGINT-IEEDSF-SSLGS---LEHLDLSYNYLSNLSSSWFKPLS-SLTFLNLLGNPYKT 138
Query: 403 KIPQ-VISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHL 459
+ S+L+ L +L +G I F+ L L+ L + + L +S + +
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSI 197
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNS 519
+ LILH + + +S+ L L + S + +NS
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL--------STGETNS 249
Query: 520 LDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPES-FSG 578
L + + ++ +L + + + L +L + N+L+ +P+ F
Sbjct: 250 LIKKFTFR--------NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDR 299
Query: 579 LSSLEILDLSKN 590
L+SL+ + L N
Sbjct: 300 LTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 50/264 (18%), Positives = 102/264 (38%), Gaps = 16/264 (6%)
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
++ L L+ N + I S + +L+ + + I+ S+L +L LDL N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 425 TGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC--HLAKLDKLILHGNKFSGAIPSCS- 480
+ ++ F L +L L L N +++ + HL KL L + I
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 481 GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLS 540
LT L L + ++ S P ++ +++++ + L + + V L L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 541 RNNLSGDIPITI--------GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+L + + + + + L + + + +S L L+ S+N++
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 593 SGVIPTSLEKLLYLKKLNLSFNKL 616
V ++L L+K+ L N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 47/277 (16%), Positives = 98/277 (35%), Gaps = 15/277 (5%)
Query: 156 LPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTK 214
+P+ + +K L L N S L +C L+ L L N ++ I ++ +L
Sbjct: 46 IPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 215 LKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSLLENT 272
L+ + L+ N L + L L L L N + ++F +++ L+ L +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 273 LWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN 332
+ + + L +E L + + P S+ + ++ L + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 333 LRNLEFLNIADNYLT----SSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI 388
++E L + D L S +SL R + + L + + +S
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGET-NSLIKKFTFRNVKITDESLFQV-MKLLNQIS- 277
Query: 389 SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
L + ++ + L++L + L N
Sbjct: 278 GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 52/296 (17%), Positives = 100/296 (33%), Gaps = 44/296 (14%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
++++LDLS+N+++ I +S L+ L N +
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGI---------------------- 88
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI- 209
+ + +L +L+ L L N S L L L N +
Sbjct: 89 ---NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF 145
Query: 210 GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
+LTKL+ + + + + +I ++ L +L L + ++L P ++ ++ + L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 269 LENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI--------TNASKLTVFQLRGN 320
L +VE L L S + ++
Sbjct: 206 HMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
S + + + L L + N L S P+ F LT+ ++ + L NP D
Sbjct: 265 SLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIF-DRLTS---LQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 50/263 (19%), Positives = 93/263 (35%), Gaps = 39/263 (14%)
Query: 398 CRISGK----IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP 453
C+ S IP ++ + LDL N++T R +NLQ L L N + +I
Sbjct: 36 CKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIE 92
Query: 454 DEI-CHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDIL 511
++ L L+ L L N S + S L+SL L L N + + L +
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT--------LGETS 143
Query: 512 FFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPI-TIGGLKNLQKLFLANNRLEG 570
F +L + L + + I GL L++L + + L+
Sbjct: 144 LFS---------------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
P+S + ++ L L + ++ ++ ++ L L L+ F+ L+
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF-----HFSELS 243
Query: 631 AKSFLGNELLCGLPDLHNSPCKL 653
++ + L
Sbjct: 244 TGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 54/289 (18%), Positives = 106/289 (36%), Gaps = 23/289 (7%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
L++S + L +L+ L L+ N ++ I F ++ +L+ LD N L
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-S 113
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKC 188
+LSS F +SS+ ++L N + ++ +L L+ L +G KI +
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
LE L + ++L PK + ++ + +IL+ + + + + L L +
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
L F+ S L + N+L + + + +
Sbjct: 234 L------DTFHFSELS--TGETNSLIK---------KFTFRNVKITDESLF-QVMKLLNQ 275
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLS 357
S L + N L +L+ + + N S P + +LS
Sbjct: 276 ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 324
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
DR+ +LG G V++AR L+D +VAVKV F+ E + + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 782 RNLVKIISACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
+V + + ++MEY+ +L + +++ + + + ++ D AL
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALN 130
Query: 838 YLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIG---Y 882
+ H IIH M++ + DF IA+ + D + TQT A IG Y
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQY 185
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
++PE V R DVYS G +L E TG+ P F G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 36/234 (15%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKL 462
IP + + LDL N L +F LQ L L+ ++ ++I D L+ L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHL 78
Query: 463 DKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDG 522
LIL GN L+SL+ L S + + +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS----------------LENFPIGH 122
Query: 523 PLSLDIGNLKVVIELNLSRNNL-SGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS 581
+L ELN++ N + S +P L NL+ L L++N+++ L
Sbjct: 123 LKTLK--------ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 582 LEI----LDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTA 631
+ + LDLS N ++ I K + LK+L L N+L+ +P G F LT+
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI-FDRLTS 225
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 16/204 (7%)
Query: 78 FNLQGTIPP-QLGNLSSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSF 135
FN + + L+ LDLS ++ I + + L L N + SL+
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLALG 94
Query: 136 IF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHG-KIPSTLSKCKQLEG 193
F +SS+ + + L +L LK+L + N+ K+P S LE
Sbjct: 95 AFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 194 LYLRFNNLSGAIPKEI-GNLTKLKDII----LNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L L N + +I L ++ + L+ N + I L L L TN
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211
Query: 249 LVGVVPFTIF-NMSTLKKLSLLEN 271
L VP IF +++L+K+ L N
Sbjct: 212 LK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 16/214 (7%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLSI 149
S + LDLS N L ++ S F + L++LD ++ ++ + S L L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKE 208
N L L +L+KL+ + + + K L+ L + N + E
Sbjct: 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 209 I-GNLTKLKDIILNDNELRGEIPQEM----GNLPYL-VRLTLATNNLVGVVPFTIFNMST 262
NLT L+ + L+ N+++ I +P L + L L+ N + + F
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIR 201
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
LK+L+L N L S+P I L +++ + L TN
Sbjct: 202 LKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 33/233 (14%)
Query: 241 RLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSG 300
L L+ N L + ++ F+ L+ L L + ++ SL ++ L L N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 301 NIPSSI-TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSL 359
++ + S L + + IG+L+ L+ LN+A N + S + S+L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
Query: 360 TNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL-LD 418
TN + L L+ N + I + + L + L L LD
Sbjct: 149 TN---LEHLDLSSNKIQSIYCTDLRVL----------------------HQMPLLNLSLD 183
Query: 419 LGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGN 470
L N + I + + L+ L L N+L +S+PD I L L K+ LH N
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 8/94 (8%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIF-NMHTLKL----LDFRDNQLFGSLSSFIFNMSSMLG 144
NL++LE LDLS NK+ +I + +H + L LD N + + F +
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKE 204
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFH 178
+ L N+ +P I L +L+K+ L N +
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 48/210 (22%), Positives = 74/210 (35%), Gaps = 31/210 (14%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKII 788
L+G G G VY A VA+K+ + Q E R++ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
D + M + L L L + + I+ + AL+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAG---AT 156
Query: 849 H-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIG---YMAPEYGVQGRV 893
H +V+ + DF IA TQ T+G YMAPE +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTD----EKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ R D+Y+ +L E TG P + G+
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 47/233 (20%), Positives = 85/233 (36%), Gaps = 35/233 (15%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G F V + L DG A+K ++ + Q E ++ + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 786 KIISACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALEY 838
++++ C + L++ + G+L N + + Q L +++ + LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-------T 879
+ H+ H + D + S Q TL T
Sbjct: 150 I---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 880 IGYMAPEYGVQGR----VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR 928
I Y APE + + R DV+S G +L G+ P D +F S++
Sbjct: 207 ISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 44/208 (21%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHR 782
+++ + +G GSFG V +DG + +K + + + + E V+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHF 841
N+V+ + + ++M+Y G L R+ + Q L+ + + LAL+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV-- 141
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYG 888
H I+H + DF IA+ LN +L + T Y++PE
Sbjct: 142 -HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEI- 196
Query: 889 VQGR-VSTRGDVYSYGIMLMETFTGKKP 915
+ + + + D+++ G +L E T K
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 51/315 (16%), Positives = 111/315 (35%), Gaps = 49/315 (15%)
Query: 697 KSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVK 756
+ S + G + + + +S +G G V+ + A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 757 V--FHQRYERALKSFQDECEVMKRIRHRNL--VKIISACSNDDFKALIMEYMPNGSLENR 812
+ + L S+++E + +++ + +++ D + ++ME N L +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 813 LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-----------YMVAHISDFSIA 861
L +D ++R + ++ A+ + H I+H + + DF IA
Sbjct: 146 LKKKKS-IDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVDGMLKLIDFGIA 201
Query: 862 KFLNGQDQLSMQTQTLATIGYMAPE-----------YGVQGRVSTRGDVYSYGIMLMETF 910
+ ++ + + YM PE + ++S + DV+S G +L
Sbjct: 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
Query: 911 TGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATE 970
GK P +I L ++ I ++ + +L Q +L
Sbjct: 262 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL------------QDVLK------C 303
Query: 971 CTIESPGKRINAREI 985
C P +RI+ E+
Sbjct: 304 CLKRDPKQRISIPEL 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 28/214 (13%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHR 782
+ + +G GS+G + R DG + K + E + E +++ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 783 NLVKIISACSNDDFKAL--IMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALE 837
N+V+ + L +MEY G L + + GT L +M + LAL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 838 YLHFGHSTP--IIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGY 882
H ++H + DF +A+ LN +T T Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFVGTPYY 182
Query: 883 MAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKP 915
M+PE + + + D++S G +L E P
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 50/285 (17%), Positives = 105/285 (36%), Gaps = 49/285 (17%)
Query: 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRNL 784
+S +G G V+ + A+K + + L S+++E + +++ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 785 --VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+++ D + ++ME N L + L +D ++R + ++ A+ +
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI--- 124
Query: 843 HSTPIIH-----------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE----- 886
H I+H + + DF IA + ++ + T+ YM PE
Sbjct: 125 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940
+ ++S + DV+S G +L GK P +I L ++ I +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ + +L Q +L C P +RI+ E+
Sbjct: 245 IPEKDL------------QDVLK------CCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 39/215 (18%), Positives = 83/215 (38%), Gaps = 31/215 (14%)
Query: 727 RFSKNNLLGIGSFGSVYVARLQDGMEVAVKV--FHQRYERALKSFQDECEVMKRIRHRNL 784
+S +G G V+ + A+K + + L S+++E + +++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 785 --VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+++ D + ++ME N L + L +D ++R + ++ A+ +
Sbjct: 89 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI--- 143
Query: 843 HSTPIIHY-----------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE----- 886
H I+H + + DF IA + ++ + T+ YM PE
Sbjct: 144 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 887 ------YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ ++S + DV+S G +L GK P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
+ +++LG G+ +V+ R + G A+KVF+ + R + E EV+K++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 784 LVKIISA--CSNDDFKALIMEYMPNGSLENRLYS--GTCMLDIFQRLNIMIDVALALEYL 839
+VK+ + + K LIME+ P GSL L L + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 840 HFGHSTPIIH----------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
I+H V ++DF A+ L +Q T Y+
Sbjct: 129 ---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL 182
Query: 884 APEYGVQGRVSTRG---------DVYSYGIMLMETFTGKKP 915
P+ + V + D++S G+ TG P
Sbjct: 183 HPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 24/209 (11%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVK---VFHQRYERALKSFQDECEVMKRIRH 781
F +G G F VY A L DG+ VA+K +F +A E +++K++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALEY 838
N++K ++ D+ +++E G L + + + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+ HS ++H V + D + +F + + + T YM+PE
Sbjct: 152 M---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLV-GTPYYMSPE 206
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + + D++S G +L E + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 51/266 (19%), Positives = 102/266 (38%), Gaps = 24/266 (9%)
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNL 411
+ +L N K + + + + +L + F ++ I + L
Sbjct: 11 VIFPDPALANAIK---IAAGKSNVTDT--VTQADLD-GITTLSAFGTGVT-TIE-GVQYL 62
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
+NL+ L+L N++T + L + L L+ N L I L + L L +
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQ 118
Query: 472 FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD-IGN 530
+ + + L++L+ LYL N+ T+ S + L ++ + + + + L + N
Sbjct: 119 ITD-VTPLA-GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS---DLTPLAN 171
Query: 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
L + L N +S DI + L NL ++ L NN++ + S+L I+ L+
Sbjct: 172 LSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQ 227
Query: 591 KISGVIPTSLEKLLYLKKLNLSFNKL 616
I+ L+ +
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 58/324 (17%), Positives = 112/324 (34%), Gaps = 53/324 (16%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
L+N + + G + +T VT + L + L + +I + +L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLEL 70
Query: 468 HGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
N+ + + NLT + L L N +
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNVSA-------------------------- 102
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDL 587
I L+ + L+L+ ++ P+ GL NLQ L+L N++ +GL++L+ L +
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTPL--AGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSI 158
Query: 588 SKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNEL-------- 639
++S + P L L L L NK+ +I NL N++
Sbjct: 159 GNAQVSDLTP--LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSPLAN 215
Query: 640 LCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIAL------PLSTAALIIVVTLTLKWKLI 693
L + + + + + ++ +V P + + + L W L
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
Query: 694 RCWKSITGSSNDGINSPQAIRRFS 717
+++ + N + FS
Sbjct: 276 SFINNVSYTFNQSVTFKNTTVPFS 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 31/291 (10%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
I + N+ T+ +L + TL ++ I + ++ L L+ +DNQ+
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75
Query: 129 FGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKC 188
+ + + N++ + ++LS N + A L ++K L L P L+
Sbjct: 76 --TDLAPLKNLTKITELELSGNPLK-NVSAI--AGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
L+ LYL N ++ P + LT L+ + + + ++ P + NL L L N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS----LPNVEFLNLGTNRFSGNIPS 304
+ + P ++ L ++ L N + D+S N+ + L +
Sbjct: 185 ISDISPLA--SLPNLIEVHLKNNQI-------SDVSPLANTSNLFIVTLTNQTITNQPVF 235
Query: 305 SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
N V ++G S + P TI + N+ N LTS +S+
Sbjct: 236 YNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWN-LTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 50/258 (19%), Positives = 99/258 (38%), Gaps = 29/258 (11%)
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
+ +N++ + +L + + + I + L L+ L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID--LSLPNVEFLNLGTNRFSG 300
L N + + P N++ + +L L N L + L +++ L+L + + +
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
P + S L V L N + P + L NL++L+I + ++ L+ L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-------LTPLA 170
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
N K+ L N + I S + +L +L + N +IS P ++N SNL ++ L
Sbjct: 171 NLSKLTTLKADDNKISDI--SPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
Query: 421 GNKLTGSIPVTFSRLLNL 438
+T + L+
Sbjct: 226 NQTITNQPVFYNNNLVVP 243
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 46/278 (16%), Positives = 93/278 (33%), Gaps = 52/278 (18%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
L++ + + ++ + ++ + L + +++ G+
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-----------TTIEGVQ- 60
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKI--PSTLSKCKQLEGLYLRFNNLSGAI 205
L NL L L N +I + L ++ L L N L
Sbjct: 61 ---------------YLNNLIGLELKDN----QITDLAPLKNLTKITELELSGNPLK--N 99
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
I L +K + L ++ P + L L L L N + + P ++ L+
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQY 155
Query: 266 LSLLENTLWGSLPSRIDL--SLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFS 323
LS+ + S + +L + L N+ S +I S + + L L+ N S
Sbjct: 156 LSIGNAQV-----SDLTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQIS 208
Query: 324 GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
P + N NL + + + +T+ + + N
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN 244
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 42/217 (19%), Positives = 73/217 (33%), Gaps = 37/217 (17%)
Query: 86 PQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI 145
L LS+L+ L L N+++ NI S + + L+ L + Q+ L+
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQV-SDLTPL---------- 169
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAI 205
NL L L N I L+ L ++L+ N +S
Sbjct: 170 ----------------ANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVS 211
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
P + N + L + L + + + NL + + + P TI + T
Sbjct: 212 P--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
Query: 266 LSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+L N S + + + T FSG +
Sbjct: 268 PNLTWNLT--SFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 52/251 (20%), Positives = 98/251 (39%), Gaps = 23/251 (9%)
Query: 368 LILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGS 427
I P+ I P + + + ++ + Q + L+++ + + + S
Sbjct: 4 TITVSTPIKQIFP--DDAFA-ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-S 57
Query: 428 IPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG--NLTS 485
+ L N+ L L NKL I + +L L L L NK I S +L
Sbjct: 58 VQG-IQYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENK----IKDLSSLKDLKK 110
Query: 486 LRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLS 545
L++L L N + + + +L + + +N + L L + L+L N +S
Sbjct: 111 LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 166
Query: 546 GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605
DI + GL LQ L+L+ N + + +GL +L++L+L + L+
Sbjct: 167 -DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 606 LKKLNLSFNKL 616
+ + L
Sbjct: 223 PNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 51/290 (17%), Positives = 103/290 (35%), Gaps = 53/290 (18%)
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
+ L+ +++ A+ L + II N+++++ + Q + LP + +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID--LSLPNVEFLNLGTNRFSG 300
L N L + P T N+ L L L EN + + L ++ L+L N S
Sbjct: 71 FLNGNKLTDIKPLT--NLKNLGWLFLDENKI-----KDLSSLKDLKKLKSLSLEHNGIS- 122
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
+I + + + +L L N + + L L+ L++ DN ++ + L
Sbjct: 123 DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-------IVPLA 172
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
K++ L L+ N + + ++ L NL +L+L
Sbjct: 173 GLTKLQNLYLSKNHISDLRA---------------------------LAGLKNLDVLELF 205
Query: 421 GNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGN 470
+ S L+ + L P+ I +K + +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 4e-16
Identities = 49/267 (18%), Positives = 101/267 (37%), Gaps = 32/267 (11%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+ +L ++ + + ++++ + ++ + I + ++ + L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFL 72
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSGAI 205
+ N+ + P NL NL L L N KI S+L K+L+ L L N +S
Sbjct: 73 NGNKLTDIKPL---TNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGISDIN 125
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
+ +L +L+ + L +N++ + L L L+L N + +VP ++ L+
Sbjct: 126 G--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQN 179
Query: 266 LSLLENTLWGSLPSRIDLS----LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
L L +N + DL L N++ L L + + +N + S
Sbjct: 180 LYLSKNHI-------SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232
Query: 322 FSGFIPNTIGNLRNLEFLNIADNYLTS 348
P I + + E N+ +
Sbjct: 233 L--VTPEIISDDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 55/309 (17%), Positives = 101/309 (32%), Gaps = 53/309 (17%)
Query: 310 SKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLI 369
++ L+ S + + L +++ + ++ + S + + + L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 71
Query: 370 LAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIP 429
L GN L I + NL +L + +I + + +L L L L N ++ I
Sbjct: 72 LNGNKLTDI--KPLTNLK-NLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 125
Query: 430 VTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRAL 489
L L+ L L NK+ + + L KLD L L N+ S I + LT L+ L
Sbjct: 126 G-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVPLA-GLTKLQNL 180
Query: 490 YLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP 549
YL N + + L LK + L L
Sbjct: 181 YLSKNHISD-----LRALA---------------------GLKNLDVLELFSQECLNKPI 214
Query: 550 ITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKL 609
L + + L P S + D K + +P ++ ++
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQ 267
Query: 610 NLSFNKLEG 618
++ K +
Sbjct: 268 PVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 2e-14
Identities = 55/251 (21%), Positives = 102/251 (40%), Gaps = 20/251 (7%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+ L ++ L L+ NKL+ +I + N+ L L +N++ S + ++ + + L
Sbjct: 61 IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSL 116
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKI--PSTLSKCKQLEGLYLRFNNLSGAI 205
N S ++ +LP L+ L LG N KI + LS+ +L+ L L N +S +
Sbjct: 117 EHNGIS-DING--LVHLPQLESLYLGNN----KITDITVLSRLTKLDTLSLEDNQISDIV 169
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
P + LTKL+++ L+ N + + + L L L L + + N+
Sbjct: 170 P--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 266 LSLLENTL--WGSLPSRIDLSLPNVEF-LNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
+ + +L + D PNV++ L TN S +T F R
Sbjct: 226 VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQP 285
Query: 323 SGFIPNTIGNL 333
+ ++
Sbjct: 286 LKEVYTVSYDV 296
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 38/226 (16%), Positives = 78/226 (34%), Gaps = 13/226 (5%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
L +L L++L L HN +S +I + + ++ L+ L +N++ + + + ++ + + L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSGAI 205
N+ S ++ L L+ L L +N I L+ K L+ L L
Sbjct: 161 EDNQIS-DIVP--LAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKP 213
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
NL + D L + V F + T+ K
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
Query: 266 LSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+ + +V+ + T +G ++ +K
Sbjct: 274 AKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTK 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 723 QATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR-YERALKSFQDECEVMKRIR 780
Q + LG G FG V G +VA+K Q + + + E ++MK++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 781 HRNLVKII------SACSNDDFKALIMEYMPNGSLENRL--YSGTCMLDIFQRLNIMIDV 832
H N+V + +D L MEY G L L + C L ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 833 ALALEYLHFGHSTPIIH---------------YMVAHISDFSIAKFLNGQDQLSMQTQTL 877
+ AL YLH IIH ++ I D AK L+ + T+ +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV 184
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
T+ Y+APE Q + + D +S+G + E TG +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-21
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
+ +++LG G+ +V+ R + G A+KVF+ + R + E EV+K++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 784 LVKI--ISACSNDDFKALIMEYMPNGSLENRLYS--GTCMLDIFQRLNIMIDVALALEYL 839
+VK+ I + K LIME+ P GSL L L + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 840 HFGHSTPIIH----------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
I+H V ++DF A+ L +Q T Y+
Sbjct: 129 ---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL 182
Query: 884 APEYGVQGRVSTRG---------DVYSYGIMLMETFTGKKP 915
P+ + V + D++S G+ TG P
Sbjct: 183 HPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/307 (18%), Positives = 98/307 (31%), Gaps = 76/307 (24%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
F + +LG G+FG V AR D A+K E L + E ++ + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63
Query: 784 LVKIISACSNDDFKA-------------LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI 830
+V+ +A + MEY NG+L + ++S + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 831 DVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA 878
+ AL Y+ HS IIH I DF +AK ++ +
Sbjct: 124 QILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 879 T---------IG---YMAPEYGVQGRVSTRG---DVYSYGIMLME----TFTGKKPTDEI 919
IG Y+A E V D+YS GI+ E TG
Sbjct: 181 PGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM------ 232
Query: 920 FIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLS-ILNLATECTIESPGK 978
+ + + + + E+ ++ +++ P K
Sbjct: 233 -----------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-------DPNK 274
Query: 979 RINAREI 985
R AR +
Sbjct: 275 RPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 44/221 (19%), Positives = 79/221 (35%), Gaps = 42/221 (19%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
F + L+G G FG V+ DG +K E+A + E + + ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66
Query: 785 VKIISACSNDDFKA----------------LIMEYMPNGSLENRL-YSGTCMLDIFQRLN 827
V D+ + ME+ G+LE + LD L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 828 IMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQ 875
+ + ++Y+ HS +I+ I DF + L + T+
Sbjct: 127 LFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 876 TLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKP 915
+ T+ YM+PE + + D+Y+ G++L E
Sbjct: 181 SKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 54/301 (17%), Positives = 98/301 (32%), Gaps = 43/301 (14%)
Query: 331 GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL-DGILPSSIGNLSIS 389
G R+LE+L + + SL+ ++ L + + IL ++ L IS
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLS----LKRLTVRAARIPSRILFGALRVLGIS 95
Query: 390 -LERFQMFNCRISGKIPQVISNLS--NLLLLDLGGNKLTGSIP----VTFSRLLNLQGLG 442
L+ + N ++G P + + +L +L+L + L+ L
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 443 LAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIP----SCSGNLTSLRALYLGSNRFTS 498
+A +++ L L L N G C +L+ L L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-- 213
Query: 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIP-ITIGGLKN 557
+ G S + L+LS N+L +
Sbjct: 214 -------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 558 LQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
L L L+ L+ + L +LDLS N++ S ++L + L+L N
Sbjct: 255 LNSLNLSFTGLKQVPKGLPA---KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFL 309
Query: 618 G 618
Sbjct: 310 D 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 46/240 (19%), Positives = 75/240 (31%), Gaps = 21/240 (8%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLN---LQGLGLAFNKLARSIPDEI--CHLAKL 462
I +L L + ++ I R+L LQ L L ++ + P + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 463 DKLILHGNKFSGAIPSCSG----NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSN 518
+ L L ++ + L+ L + + + + D+S N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 519 SLDGPLSLDI----GNLKVVIELNLSRNN---LSGDIPITIGGLKNLQKLFLANNRLEG- 570
G L + L L SG LQ L L++N L
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
S S L L+LS + V K L L+LS+N+L+ P +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK---LSVLDLSYNRLD-RNPSPDELPQVG 299
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 42/286 (14%), Positives = 77/286 (26%), Gaps = 26/286 (9%)
Query: 290 FLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNT---IGNLRNLEFLNIADNYL 346
L + I + L +R I + + L+ L + + +
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 347 TSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQ 406
T + P ++ + + + ++ D L L L+ + +
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 407 VISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLI 466
+ L LDL N G + + P + L L
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISA-----------------LCPLKFPTLQVLALRN 210
Query: 467 LHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTI-WNLKDILFFDVSSNSLDGPLS 525
SG + + L+ L L N A + + ++S L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---Q 267
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGP 571
+ G + L+LS N L P L + L L N
Sbjct: 268 VPKGLPAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 47/250 (18%), Positives = 82/250 (32%), Gaps = 18/250 (7%)
Query: 391 ERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLAR 450
+ FNC + + S LL + + L+L+ L + ++
Sbjct: 23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPS 82
Query: 451 SIPDEICHL---AKLDKLILHGNKFSGAIPS--CSGNLTSLRALYLGSNRFTSALPST-- 503
I + + L +L L + +G P L L L + + +
Sbjct: 83 RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAE 142
Query: 504 --IWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI----GGLKN 557
W + ++ + + L+LS N G+ +
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 558 LQKLFLANNRLE---GPIPESFSGLSSLEILDLSKNKISGVIP-TSLEKLLYLKKLNLSF 613
LQ L L N +E G + L+ LDLS N + S + L LNLSF
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 614 NKLEGEIPRG 623
L+ ++P+G
Sbjct: 263 TGLK-QVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 50/285 (17%), Positives = 91/285 (31%), Gaps = 34/285 (11%)
Query: 163 NLPNLKKLLLGRNMFHGKIP-STLSKCKQLEGLYLRFNNLSGAIPK---EIGNLTKLKDI 218
+L+ LL + + + K L+ L +R + I + ++ L+++
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 219 ILNDNELRGEIPQEMGNL--PYLVRLTLATNNLVGVVPFT----IFNMSTLKKLSLLENT 272
L + E+ G P + P L L L + + + LK LS+ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 273 LWGSLPSRIDLSLPNVEFLNLGTNRFSGNI-------PSSITNASKLTVFQLRGNSFSGF 325
+ P + L+L N G P L + + SG
Sbjct: 161 S-LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 326 IPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGI---LPSS 382
L+ L+++ N L + S ++ L L+ L + LP+
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCD----WPSQLNSLNLSFTGLKQVPKGLPAK 275
Query: 383 IGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGS 427
+ L +S R+ P L + L L GN S
Sbjct: 276 LSVLDLS-------YNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 38/163 (23%), Positives = 56/163 (34%), Gaps = 12/163 (7%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNI-------PSSIFNMHTLKLLDFR 124
VL+I+ + Q+ +L TLDLS N G P + L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 125 DNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPST 184
G S+ + G+DLS N A C L L L ++P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 185 LSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG 227
L +L L L +N L P L ++ ++ L N
Sbjct: 272 LP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 40/267 (14%), Positives = 70/267 (26%), Gaps = 49/267 (18%)
Query: 87 QLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGID 146
++ +S L+ L L + +++G P + L +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR-------------------N 130
Query: 147 LSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIP 206
+S L P LK L + + + L L L N G
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 207 KEI----GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
L+ + L + + GV
Sbjct: 191 LISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQ 229
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
L+ L L N+L + + + LNL +P + +KL+V L N
Sbjct: 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRL 286
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSS 349
L + L++ N S
Sbjct: 287 DRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 35/194 (18%), Positives = 60/194 (30%), Gaps = 16/194 (8%)
Query: 69 KVIVLNISGFNLQG--TIPPQLGNLS--SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFR 124
+ +LN+ + +L L+ L ++ + L LD
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 125 DNQLFGSL----SSFIFNMSSMLGIDLSINRFS--GELPANICKNLPNLKKLLLGRNMFH 178
DN G + ++ + L + + + L+ L L N
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 179 GKIP-STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLP 237
+ QL L L F L +PK + KL + L+ N L P LP
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSP-DELP 296
Query: 238 YLVRLTLATNNLVG 251
+ L+L N +
Sbjct: 297 QVGNLSLKGNPFLD 310
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 35/187 (18%), Positives = 65/187 (34%), Gaps = 10/187 (5%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
S L LG + +T +++ +L + LA + + I + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTIN 74
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDI 528
+ P L++L L + TS + L + D+S ++ D + I
Sbjct: 75 NIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 529 GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLS 588
L V ++LS N DI + L L+ L + + + L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 589 KNKISGV 595
I G
Sbjct: 190 SQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 31/166 (18%), Positives = 64/166 (38%), Gaps = 10/166 (6%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
+IPD +L + + + + SL + L + T + I +I
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL--TGIEYAHNI 68
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG 570
+++ + L + L + +++ D + GL +L L ++++ +
Sbjct: 69 KDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
I + L + +DLS N I L+ L LK LN+ F+ +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 31/149 (20%), Positives = 62/149 (41%), Gaps = 10/149 (6%)
Query: 482 NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSR 541
+ LG + + + + +L I +++ L G I + +L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 542 NNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLE 601
+ + + I GL NL++L + + + SGL+SL +LD+S + I T +
Sbjct: 76 IHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 602 KLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
L + ++LS+N +I P L
Sbjct: 134 TLPKVNSIDLSYNGAITDIM---PLKTLP 159
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 23/161 (14%), Positives = 66/161 (40%), Gaps = 8/161 (4%)
Query: 89 GNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLS 148
++SL + L++ ++ ++ + I H +K L + + + I +S++ + +
Sbjct: 41 AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIM 96
Query: 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKE 208
+ + N+ L +L L + + I + ++ ++ + L +N I
Sbjct: 97 GKDVTSDKIPNL-SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 209 IGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL 249
+ L +LK + + + + + + P L +L + +
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 30/187 (16%), Positives = 67/187 (35%), Gaps = 11/187 (5%)
Query: 162 KNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILN 221
LLG++ T ++ L + L N++ I +KD+ +N
Sbjct: 20 STFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTIN 74
Query: 222 DNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI 281
+ P + L L RL + ++ + +++L L + + S+ ++I
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 282 DLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNI 341
+ +LP V ++L N +I + +L ++ + + I + L L
Sbjct: 133 N-TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 342 ADNYLTS 348
+
Sbjct: 189 FSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 22/141 (15%), Positives = 54/141 (38%), Gaps = 6/141 (4%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+ +++ L +++ + N + I + L+ L + + ++S+ +D+
Sbjct: 62 IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPK 207
S + + I LP + + L N I L +L+ L ++F+ +
Sbjct: 120 SHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG- 176
Query: 208 EIGNLTKLKDIILNDNELRGE 228
I + KL + + G+
Sbjct: 177 -IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 35/190 (18%), Positives = 62/190 (32%), Gaps = 37/190 (19%)
Query: 329 TIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSI 388
T + +L ++ +A+ +T L+ + N I+ L + P
Sbjct: 39 TEAQMNSLTYITLANINVTD----LTGIEYAHN---IKDLTINNIHATNYNP-------- 83
Query: 389 SLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKL 448
IS LSNL L + G +T S L +L L ++ +
Sbjct: 84 -------------------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 449 ARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLK 508
SI +I L K++ + L N I L L++L + + I +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMPLK-TLPELKSLNIQFDGVHDYRG--IEDFP 181
Query: 509 DILFFDVSSN 518
+ S
Sbjct: 182 KLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 26/190 (13%), Positives = 60/190 (31%), Gaps = 13/190 (6%)
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+ S + L I L + + ++ + + LT+ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITN 308
P + +S L++L ++ + + L ++ L++ + +I + I
Sbjct: 78 ATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINT 134
Query: 309 ASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
K+ L N I + L L+ LNI + + + + K+ L
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-------YRGIEDFPKLNQL 186
Query: 369 ILAGNPLDGI 378
+ G
Sbjct: 187 YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 28/215 (13%), Positives = 68/215 (31%), Gaps = 44/215 (20%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSI 149
+ L + + + M++L + + + + + GI+
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----------TDLTGIE--- 63
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI 209
N+K L + H + +S LE L + +++ +
Sbjct: 64 -------------YAHNIKDLTINNI--HATNYNPISGLSNLERLRIMGKDVTSDKIPNL 108
Query: 210 GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
LT L + ++ + I ++ LP + + L+ N + + + + LK L++
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQ 167
Query: 270 ENTLWGSLPSRIDLS----LPNVEFLNLGTNRFSG 300
+ + D P + L + G
Sbjct: 168 FDGV-------HDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 26/196 (13%), Positives = 67/196 (34%), Gaps = 25/196 (12%)
Query: 211 NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLE 270
+ +L + I + + L +TLA N+ + +K L++
Sbjct: 21 TFKAYLNGLLGQSST-ANITEA--QMNSLTYITLANINVTDLTGIE--YAHNIKDLTINN 75
Query: 271 NTLWGSLPSRIDLS----LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFI 326
+ + L N+E L + + + +++ + LT+ + ++ I
Sbjct: 76 IHA-------TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 327 PNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNL 386
I L + ++++ N + + L +++ L + + + I +
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQFDGVHDY--RGIEDF 180
Query: 387 SISLERFQMFNCRISG 402
L + F+ I G
Sbjct: 181 P-KLNQLYAFSQTIGG 195
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 41/222 (18%), Positives = 81/222 (36%), Gaps = 43/222 (19%)
Query: 726 DRFSKNNLLGIGSFGSVY-VARLQDGMEVAVK-VFHQRYERALKSFQDECEVMKRIRHRN 783
F LG G FG V+ D A+K + E A + E + + ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 784 LVKIISACSNDDFKA------------LIMEYMPNGSLENRL--YSGTCMLDIFQRLNIM 829
+V+ +A + + M+ +L++ + + L+I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 830 IDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL 877
+ +A A+E+L HS ++H V + DF + ++ ++ +
Sbjct: 125 LQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 878 ATIG----------YMAPEYGVQGRV-STRGDVYSYGIMLME 908
YM+PE + G S + D++S G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFE 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 48/207 (23%), Positives = 75/207 (36%), Gaps = 26/207 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV--FHQRYERALKSFQDECEVMKRI-RH 781
F + + LG GS+G V+ R +DG AVK R + E +++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
V++ A L E SL+ + L Q + D LAL +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL-- 173
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYG 888
HS ++H + DF + L + YMAPE
Sbjct: 174 -HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPEL- 227
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKP 915
+QG T DV+S G+ ++E +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICH-LAKL 462
IP I ++ LDL NKL+ F RL L+ L L NKL +++P I L L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87
Query: 463 DKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
+ L + NK A+P L +L L L N+ S LP + FD
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRV--------FD------- 130
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLS 580
+ L L+L N L +P + L +L++L L NN+L+ +F L+
Sbjct: 131 -----SLTKLT---YLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 581 SLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
L+ L L N++ V + + L LK L L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 37/221 (16%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
++PS I + + L+L +N+ S + +KL + L N L+N
Sbjct: 30 AIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 336 LEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
LE L + DN L + + L N + L L N L SL
Sbjct: 87 LETLWVTDNKLQALPIGV--FDQLVNLAE---LRLDRNQLK------------SLP---- 125
Query: 396 FNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPD 454
P+V +L+ L L LG N+L S+P F +L +L+ L L N+L + +P+
Sbjct: 126 ---------PRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPE 174
Query: 455 EICH-LAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSN 494
L +L L L N+ +L L+ L L N
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
+IP I A KL L NK S LT LR LYL N+ + LP+ I
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGI------ 80
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLE 569
F ++ NL+ L ++ N L +PI + L NL +L L N+L+
Sbjct: 81 --FK------------ELKNLE---TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
Query: 570 GPIPES-FSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 628
+P F L+ L L L N++ + +KL LK+L L N+L+ +P G F
Sbjct: 123 S-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGA-FDK 179
Query: 629 LTAKSFL 635
LT L
Sbjct: 180 LTELKTL 186
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 53/223 (23%), Positives = 81/223 (36%), Gaps = 38/223 (17%)
Query: 302 IPSSI-TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
IPS+I + KL L+ N S L L L + DN L +
Sbjct: 31 IPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT------------ 75
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
LP+ I +LE + + ++ V L NL L L
Sbjct: 76 ------------------LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117
Query: 421 GNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAIPS 478
N+L S+P F L L L L +N+L +S+P + L L +L L+ N+
Sbjct: 118 RNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175
Query: 479 CSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
LT L+ L L +N+ +L+ + + N D
Sbjct: 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLG-IDLSI 149
+ + LDL NKLS ++PS F + L+LL DN+L +L + IF L + ++
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTD 94
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL-SKCKQLEGLYLRFNNLSGAIPKE 208
N+ LP + L NL +L L RN +P + +L L L +N L ++PK
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151
Query: 209 I-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKL 266
+ LT LK++ L +N+L+ +P+ L L L L N L V ++ LK L
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 267 SLLEN 271
L EN
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 478 SCSGNLTSLRALYLGSNRFTS---ALPSTIWNLKDILFFDVSSNSLDGPLSLDIG---NL 531
SC+ N S+ S + T+ +P+ L D+ SN L SL L
Sbjct: 13 SCNNNKNSV---DCSSKKLTAIPSNIPADTKKL------DLQSNKLS---SLPSKAFHRL 60
Query: 532 KVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
+ L L+ N L +P I LKNL+ L++ +N+L+ F L +L L L +N
Sbjct: 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119
Query: 591 KISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTA 631
++ + P + L L L+L +N+L+ +P+G F LT+
Sbjct: 120 QLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKLTS 158
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 10/205 (4%)
Query: 156 LPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTK 214
+P+NI + KKL L N + +L LYL N L +P I L
Sbjct: 31 IPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 215 LKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKKLSLLENT 272
L+ + + DN+L+ +P + L L L L N L + P +F +++ L LSL N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNE 144
Query: 273 LWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN 332
L SLP + L +++ L L N+ + ++L +L N +
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 333 LRNLEFLNIADNYLTSSTPELSFLS 357
L L+ L + +N + + +++
Sbjct: 204 LEKLKMLQLQENPWDCTCNGIIYMA 228
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 52/219 (23%), Positives = 81/219 (36%), Gaps = 39/219 (17%)
Query: 409 SNLSNLLLLDLGGNKLT---GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKL 465
S +++ L ++ LT +P + L L+ N L + +L +L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPK------DTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 466 ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
L + + + G L L L L N+ S LP L
Sbjct: 61 NLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQS-LPLLGQTL------------------ 99
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEI 584
L L++S N L+ +P+ GL LQ+L+L N L+ P + LE
Sbjct: 100 ---PALT---VLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 585 LDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG 623
L L+ N ++ + L L L L L N L IP+G
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 30/207 (14%)
Query: 385 NLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLA 444
+L + + + + L L+L +LT + V L L L L+
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85
Query: 445 FNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTI 504
N+L +S+P L L L + N+ + L L+ LYL N + LP +
Sbjct: 86 HNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGL 143
Query: 505 WNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFL 563
P L+ +L+L+ NNL+ ++P + GL+NL L L
Sbjct: 144 --------LT--------PTP----KLE---KLSLANNNLT-ELPAGLLNGLENLDTLLL 179
Query: 564 ANNRLEGPIPESFSGLSSLEILDLSKN 590
N L IP+ F G L L N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 43/196 (21%), Positives = 65/196 (33%), Gaps = 37/196 (18%)
Query: 436 LNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNR 495
+N L ++P ++ L L N + T L L L
Sbjct: 15 VNCDKRNLT------ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 496 FTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGL 555
T + L V+ L+LS N L +P+ L
Sbjct: 67 LTK-----------LQVDG---------------TLPVLGTLDLSHNQLQ-SLPLLGQTL 99
Query: 556 KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNK 615
L L ++ NRL + GL L+ L L N++ + P L L+KL+L+ N
Sbjct: 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159
Query: 616 LEGEIPRGGPFANLTA 631
L E+P G L
Sbjct: 160 LT-ELPAGL-LNGLEN 173
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 50/221 (22%), Positives = 78/221 (35%), Gaps = 46/221 (20%)
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
++P T+ L N F T+ L LN+ LT L L
Sbjct: 28 DLPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLG 80
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
L L+ N L +P + L L +LD+
Sbjct: 81 T------LDLSHNQLQ--------------------------SLPLLGQTLPALTVLDVS 108
Query: 421 GNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAIPS 478
N+LT S+P+ L LQ L L N+L +++P + KL+KL L N + +P+
Sbjct: 109 FNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPA 165
Query: 479 CS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSN 518
L +L L L N + +P + + F + N
Sbjct: 166 GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 47/184 (25%), Positives = 69/184 (37%), Gaps = 13/184 (7%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
L LS N L + L L+ +L L + + +DLS N
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHN 87
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKEI 209
+ LP + LP L L + N +P L +L+ LYL+ N L +P +
Sbjct: 88 QLQ-SLPLLG-QTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 210 -GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
KL+ + L +N L E+P + L L L L N+L +P F L
Sbjct: 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 268 LLEN 271
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 17/211 (8%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLS 148
++S ++ L+ +P + +L +N L + S + L +L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLD 63
Query: 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKE 208
+ +L + LP L L L N +P L L + FN L+ ++P
Sbjct: 64 RAELT-KLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 209 I-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIF-NMSTLKK 265
L +L+++ L NEL+ +P + P L +L+LA NNL +P + + L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176
Query: 266 LSLLENTLWGSLPSRIDLSLPNVEFLNLGTN 296
L L EN+L ++P + F L N
Sbjct: 177 LLLQENSL-YTIPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 7/177 (3%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
+L++S L L + L L+L +L+ + + L LD NQL S
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL-QS 91
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
L + ++ +D+S NR + LP + L L++L L N P L+ +L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 192 EGLYLRFNNLSGAIPKEI-GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
E L L NNL+ +P + L L ++L +N L IP+ L L N
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 54/262 (20%), Positives = 84/262 (32%), Gaps = 66/262 (25%)
Query: 211 NLTKLKDIILNDNELRGEIPQEMGNLP-YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
+ ++ + L +P +LP L L+ N L T+ + L +L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 270 ENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNT 329
L L +D +LP + L+L N+ ++P LTV + N +
Sbjct: 64 RAEL-TKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 330 IGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS 389
+ L L+ L + N L + LP
Sbjct: 120 LRGLGELQELYLKGNELKT------------------------------LP--------- 140
Query: 390 LERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKL 448
P +++ L L L N LT +P + L NL L L N L
Sbjct: 141 ---------------PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 449 ARSIPDEICHLAKLDKLILHGN 470
+IP L LHGN
Sbjct: 185 -YTIPKGFFGSHLLPFAFLHGN 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 41/240 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
+ F LG G FG+VY+AR Q +A+KV + + E E+ +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
N++++ + LI+EY P G++ L + + + ++A AL Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYC-- 125
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYG 888
HS +IH I+DF + + L T+ Y+ PE
Sbjct: 126 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEM- 178
Query: 889 VQGRV-STRGDVYSYGIMLMETFTGKKPTDE---------IFIGELSLSRWVN----DLL 934
++GR+ + D++S G++ E GK P + I E + +V DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 50/232 (21%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFH-QRYERALKSFQDECEVMKRI-RHRN 783
+ +LG GS G+V G VAVK + AL E +++ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPN 70
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------NIMIDVALALE 837
+++ + + D F + +E N +L++ + S + + +++ +A +
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 838 YLHFGHSTPIIH-------------------------YMVAHISDFSIAKFL-NGQDQLS 871
+L HS IIH + ISDF + K L +GQ
Sbjct: 130 HL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 872 MQTQTLA-TIGYMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ T G+ APE + R++ D++S G + + K
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
+G GS G V +AR G +VAVK+ R ++ + +E +M+ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+V++ + + ++ME++ G+L + + L+ Q + V AL YL H
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYL---H 158
Query: 844 STPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPEY 887
+ +IH + + SDF Q+S + +G +MAPE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QISKDVPKRKSLVGTPYWMAPEV 212
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ +T D++S GIM++E G+ P
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 43/236 (18%), Positives = 77/236 (32%), Gaps = 9/236 (3%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
+K+T IP R N L KL L+K+ + N I
Sbjct: 14 FLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 477 PSCS-GNLTSLRALYL-GSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVV 534
+ NL L + + +N P NL ++ + +S+ + + +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 535 IELNLSRNNLSGDIPI-TIGGL-KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+ L++ N I + GL L+L N ++ +F+G E+ N +
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNL 190
Query: 593 SGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHN 648
+ L++S ++ +P G NL L LP L
Sbjct: 191 EELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNLKKLPTLEK 244
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 17/259 (6%)
Query: 93 SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSINR 151
S +K++ IPS + L F +L + F + I++S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQND 65
Query: 152 FSGELPANICKNLPNLKKL-LLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI- 209
+ A++ NLP L ++ + N P L+ L + + +P
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124
Query: 210 GNLTKLKDIILNDNELRGEIPQEM--GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
+ + + + DN I + G V L L N + + + FN + L +L+
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASKLTVFQLRGNSFSGFI 326
L +N LP+ + L++ R ++PS N KL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KL 239
Query: 327 PNTIGNLRNLEFLNIADNY 345
P T+ L L ++
Sbjct: 240 P-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 44/279 (15%), Positives = 90/279 (32%), Gaps = 17/279 (6%)
Query: 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNASK 311
+P + +L + L + ++E + + N I + + +N K
Sbjct: 24 IPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 312 LTVFQL-RGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLIL 370
L ++ + N+ P NL NL++L I++ + P++ + SL + +L +
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL----QKVLLDI 135
Query: 371 AGNP-LDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIP 429
N + I +S LS + I + L N L
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN 195
Query: 430 VTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAIPSCSGNLTSLRA 488
F L ++ ++ S+P +L KL + K +P+ L +L
Sbjct: 196 DVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALME 250
Query: 489 LYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
L A + + ++ S +
Sbjct: 251 ASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMT 289
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 53/271 (19%), Positives = 81/271 (29%), Gaps = 42/271 (15%)
Query: 302 IPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
IPS + + +LE + I+ N + F S+L
Sbjct: 24 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF-SNLPK 80
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421
+IR I N L I P + NL NL L +
Sbjct: 81 LHEIR--IEKANNLLYINP-------------------------EAFQNLPNLQYLLISN 113
Query: 422 NKLTGSIP-VTFSRLLNLQGLGLAFNKLARSIPDE-ICHL-AKLDKLILHGNKFSGAIPS 478
+ +P V L L + N +I L + L L+ N I +
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN 171
Query: 479 CSGNLTSLRALYL-GSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIEL 537
+ N T L L L +N + D+S + SL L+ + +L
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH---SLPSYGLENLKKL 228
Query: 538 N-LSRNNLSGDIPITIGGLKNLQKLFLANNR 567
S NL +P T+ L L + L
Sbjct: 229 RARSTYNLK-KLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 39/231 (16%), Positives = 79/231 (34%), Gaps = 14/231 (6%)
Query: 73 LNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFG 130
L L+ I LE +++S N + I + +F N+ L +
Sbjct: 35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93
Query: 131 SLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSK-- 187
++ F N+ ++ + +S LP + L + N+ I
Sbjct: 94 YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLAT 246
+ L+L N + I N T+L ++ L+DN E+P ++ V L ++
Sbjct: 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211
Query: 247 NNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNR 297
+ + + + N+ L+ S +L L + +L
Sbjct: 212 TRIHSLPSYGLENLKKLRARSTYNLKKLPTL-----EKLVALMEASLTYPS 257
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
++++ +G G+ G+VY A + G EVA++ + + + + +E VM+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+V + + D ++MEY+ GSL + + +D Q + + ALE+L H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFL---H 133
Query: 844 STPIIH----------YMVAHI--SDFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPEY 887
S +IH M + +DF Q++ + +T +G +MAPE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEV 187
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + D++S GIM +E G+ P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 28/208 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
+ F LG GS+GSVY A + G VA+K E L+ E +M++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+VK + + ++MEY GS+ + + L + I+ LEYL H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---H 142
Query: 844 STPIIH----------YMVAHI--SDFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPEY 887
IH H +DF +A QL+ T IG +MAPE
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG------QLTDTMAKRNTVIGTPFWMAPEV 196
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + D++S GI +E GK P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/251 (19%), Positives = 97/251 (38%), Gaps = 23/251 (9%)
Query: 368 LILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGS 427
I P+ I + + + ++ + Q + L+++ + + + S
Sbjct: 7 TITVPTPIKQIFS--DDAFA-ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-S 60
Query: 428 IPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG--NLTS 485
+ L N+ L L NKL I + +L L L L NK + S +L
Sbjct: 61 VQ-GIQYLPNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENK----VKDLSSLKDLKK 113
Query: 486 LRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLS 545
L++L L N + + + +L + + +N + L L + L+L N +S
Sbjct: 114 LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 169
Query: 546 GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605
DI + GL LQ L+L+ N + + +GL +L++L+L + L+
Sbjct: 170 -DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 606 LKKLNLSFNKL 616
+ + L
Sbjct: 226 PNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 21/263 (7%)
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLL 415
+ S + L + + L+ S+++ N I + Q I L N+
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDA--VTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 416 LLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGA 475
L L GNKLT I + L NL L L NK+ + + + L KL L L N S
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV-KDL-SSLKDLKKLKSLSLEHNGIS-D 126
Query: 476 IPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD-IGNLKVV 534
I +L L +LYLG+N+ T + + L + + N + + + L +
Sbjct: 127 INGLV-HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS---DIVPLAGLTKL 180
Query: 535 IELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISG 594
L LS+N++S D+ + GLKNL L L + S L + + +
Sbjct: 181 QNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 236
Query: 595 VIPTSLEKLLYLKKLNLSFNKLE 617
V P + +K N+ ++ E
Sbjct: 237 VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 50/287 (17%), Positives = 102/287 (35%), Gaps = 53/287 (18%)
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
+ + L+ +++ A+ L + II N+++++ + Q + LP + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID--LSLPNVEFLNLGTNRFSG 300
L N L + P N+ L L L EN + + L ++ L+L N S
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEHNGIS- 125
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
+I + + + +L L N + + L L+ L++ DN ++ + L
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-------IVPLA 175
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
K++ L L+ N + + ++ L NL +L+L
Sbjct: 176 GLTKLQNLYLSKNHISDLRA---------------------------LAGLKNLDVLELF 208
Query: 421 GNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+ S L+ + L P+ I +K +
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNV 253
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 53/274 (19%), Positives = 107/274 (39%), Gaps = 33/274 (12%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+ +L ++ + + ++++ + ++ + I + ++ + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFL 75
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSGAI 205
+ N+ + P NL NL L L N K+ S+L K+L+ L L N +S
Sbjct: 76 NGNKLTDIKP---LANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
+ +L +L+ + L +N++ + L L L+L N + +VP ++ L+
Sbjct: 129 G--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQN 182
Query: 266 LSLLENTLWGSLPSRIDLS----LPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNS 321
L L +N + DL L N++ L L + + +N + S
Sbjct: 183 LYLSKNHI-------SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235
Query: 322 FSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
P I + + E N+ + L T E+SF
Sbjct: 236 LVT--PEIISDDGDYEKPNVKWH-LPEFTNEVSF 266
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/290 (18%), Positives = 93/290 (32%), Gaps = 48/290 (16%)
Query: 304 SSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQ 363
S ++ L+ S + + L +++ + ++ + S + +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLP 68
Query: 364 KIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNK 423
+ L L GN L I + NL +L + ++ + + +L L L L N
Sbjct: 69 NVTKLFLNGNKLTDI--KPLANLK-NLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNG 123
Query: 424 LTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNL 483
++ I L L+ L L NK+ + + L KLD L L N+ S I + L
Sbjct: 124 IS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVPLA-GL 177
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
T L+ LYL N + + L LK + L L
Sbjct: 178 TKLQNLYLSKNHISD-----LRALA---------------------GLKNLDVLELFSQE 211
Query: 544 LSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKIS 593
L + + L PE S E ++ +
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 23/219 (10%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
L NL +L L L NK+ ++ SS+ ++ LK L N + S + + ++ + + L
Sbjct: 86 LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYL 141
Query: 148 SINRFSGELPANIC--KNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSG 203
N+ + +I L L L L N +I L+ +L+ LYL N++S
Sbjct: 142 GNNKIT-----DITVLSRLTKLDTLSLEDN----QISDIVPLAGLTKLQNLYLSKNHISD 192
Query: 204 AIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTL 263
+ + L L + L E + NL + +L V P I +
Sbjct: 193 L--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 248
Query: 264 KKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+K ++ + + + + RF G +
Sbjct: 249 EKPNVKWHLPE--FTNEVSFIFYQPVTIGKAKARFHGRV 285
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 39/231 (16%), Positives = 81/231 (35%), Gaps = 50/231 (21%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV--FHQRYERALKSFQDECEVMKRI-R 780
T F + +G G FGSV+ DG A+K ++ E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALE 837
H ++V+ SA + DD + EY GSL + + ++ F + ++++ V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 838 YLHFGHSTPIIH-------------------------------YMVAHISDFSIAKFLNG 866
Y+ HS ++H ++ I D ++
Sbjct: 130 YI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 867 QDQLSMQTQTLATIGYMAPEYGVQGRVS--TRGDVYSYGIMLMETFTGKKP 915
S Q + ++A E +Q + + D+++ + ++ +
Sbjct: 186 ----SPQVEE-GDSRFLANEV-LQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
+ + LG G+FG VY A+ + G A KV + E L+ + E E++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+VK++ A +D +++E+ P G+++ + L Q + + AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 844 STPIIH----------YMVAHI--SDFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPE- 886
IIH + I +DF ++ + Q + IG +MAPE
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSA------KNLKTLQKRDSFIGTPYWMAPEV 188
Query: 887 ----YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ D++S GI L+E + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 33/230 (14%), Positives = 70/230 (30%), Gaps = 48/230 (20%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR------LQDGMEVAVKVFHQRYERALKSFQDECEVMKR 778
+ ++LLG G+F VY A ++ + +KV E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRL----YSGTCMLDIFQRLNIMIDVAL 834
+K SA + L+ E G+L N + + ++ ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 835 ALEYLHFGHSTPIIH-------YMVAH----------------ISDFSIAKFLNGQDQLS 871
+E + H IIH +++ + + D + + + +
Sbjct: 184 MIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 872 MQTQTLATIGYMAPE------YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ T T G+ E + Q D + + G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYM 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 49/231 (21%), Positives = 80/231 (34%), Gaps = 43/231 (18%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNL 784
R +L G F VY A+ + G E A+K E ++ E MK++ H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 785 VKIISACS-------NDDFKALIMEYMPNGSL----ENRLYSGTCMLDIFQRLNIMIDVA 833
V+ SA S + L++ + G L + G L L I
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTC 146
Query: 834 LALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA--- 878
A++++H PIIH + DF A ++ S Q A
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 879 -------TIGYMAPE----YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918
T Y PE Y + + D+++ G +L + P ++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-18
Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 47/227 (20%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRH 781
++ + + LG G++G V + R +E A+K+ + + +E V+K + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIMIDVA 833
N++K+ + L+ME G L + I R I+ V
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDE---------IIHRMKFNEVDAAVIIKQVL 146
Query: 834 LALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLA 878
+ YLH + I+H ++ I DF ++ Q ++ + L
Sbjct: 147 SGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLG 200
Query: 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE ++ + + DV+S G++L G P EI
Sbjct: 201 TAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-18
Identities = 81/462 (17%), Positives = 152/462 (32%), Gaps = 76/462 (16%)
Query: 92 SSLETLDLSHNKLSGN-IPSSIFNMHTLKLLDFRDNQL----FGSLSSFIFNMSSMLGID 146
+++LD+ +LS + + +++ D L +SS + ++ ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 147 LSINRFSGELPANICKNL----PNLKKLLLGRNMFHGK----IPSTLSKCKQLEGLYLRF 198
L N + + L ++KL L G + STL L+ L+L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 199 NNLSGAIPKEIG-----NLTKLKDIILNDNELRGEIPQEMG----NLPYLVRLTLATNNL 249
N L A + + +L+ + L L + + P LT++ N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 250 --VGVVPFT---IFNMSTLKKLSLLENTL----WGSLPSRIDLSLPNVEFLNLGTNRFSG 300
GV + L+ L L + L I S ++ L LG+N+
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL-CGIVASKASLRELALGSNKLGD 241
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS-L 359
++L L + L L I + +T+ L L
Sbjct: 242 ------VGMAELCPGLLHPS-------------SRLRTLWIWECGITAKG--CGDLCRVL 280
Query: 360 TNCQKIRVLILAGNPLDG----ILPSSIGNLSISLERFQMFNCRISGK----IPQVISNL 411
+ ++ L LAGN L +L ++ LE + +C + V++
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLL-----NLQGLGLAFNKL----ARSIPDEICHLAKL 462
LL L + N+L + + L L+ L LA + S+ + L
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400
Query: 463 DKLILHGNKF--SGAIPSCSG---NLTSLRALYLGSNRFTSA 499
+L L N +G + L L L ++
Sbjct: 401 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-16
Identities = 89/516 (17%), Positives = 152/516 (29%), Gaps = 112/516 (21%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGK----IPSTLSKCKQLEGLYLRFNN 200
+D+ S A + L + + L I S L L L LR N
Sbjct: 8 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 67
Query: 201 LSGAIPKEIGNL-----TKLKDIILNDNELRGE----IPQEMGNLPYLVRLTLATNNLVG 251
L + K++ + L + L G + + LP L L L+ N L
Sbjct: 68 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 127
Query: 252 VVPFTIFNM-----STLKKLSLLENTL----WGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+ L+KL L +L L S + + P+ + L + N +
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR-AKPDFKELTVSNNDINEAG 186
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNC 362
+ K + LE L + +TS + +
Sbjct: 187 VRVLCQGLK-------------------DSPCQLEALKLESCGVTSDNCR-DLCGIVASK 226
Query: 363 QKIRVLILAGNPL--DGI--LPSSIGNLSISLERFQMFNCRISGK----IPQVISNLSNL 414
+R L L N L G+ L + + S L ++ C I+ K + +V+ +L
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 415 LLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
L L GN+L L ++ + C L L + F+
Sbjct: 287 KELSLAGNELGDE----------------GARLLCETLLEPGCQLESLW---VKSCSFTA 327
Query: 475 ----AIPSCSGNLTSLRALYLGSNRFT--------SALPSTIWNLKDILFFDVSSNSLD- 521
S L L + +NR L L+ + ++ +
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL---WLADCDVSD 384
Query: 522 ---GPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSG 578
L+ + + EL+LS N L G+ L +
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDA------GILQLVESVRQPG------------ 426
Query: 579 LSSLEILDLSKNKISGVIPTSLEKLL----YLKKLN 610
LE L L S + L+ L L+ ++
Sbjct: 427 -CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 63/355 (17%), Positives = 118/355 (33%), Gaps = 46/355 (12%)
Query: 310 SKLTVFQLRGNSFS-GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVL 368
+ ++ S + L+ + + + D LT + + S+L + L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAEL 61
Query: 369 ILAGNPLDG----ILPSSIGNLSISLERFQMFNCRISGK----IPQVISNLSNLLLLDLG 420
L N L + + S +++ + NC ++G + + L L L L
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 421 GNKLTGSIPVTFSRLL-----NLQGLGLAFNKL----ARSIPDEICHLAKLDKLILHGNK 471
N L + L L+ L L + L + + +L + N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 472 FS--GAIPSCSG---NLTSLRALYLGSNRFT----SALPSTIWNLKDILFFDVSSNSL-- 520
+ G C G + L AL L S T L + + + + SN L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 521 DGPLSLDIGNLKV---VIELNLSRNNLSGD----IPITIGGLKNLQKLFLANNRLEGP-- 571
G L G L + L + ++ + + ++L++L LA N L
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301
Query: 572 --IPESF-SGLSSLEILDLSKNKISGV----IPTSLEKLLYLKKLNLSFNKLEGE 619
+ E+ LE L + + + L + +L +L +S N+LE
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 74/411 (18%), Positives = 141/411 (34%), Gaps = 56/411 (13%)
Query: 261 STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS----GNIPSSITNASKLTVFQ 316
++ L + L + + + L + + L + +I S++ L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 317 LRGNSFSGFIPNTIGNL-----RNLEFLNIADNYLTSSTPELSFLSS-LTNCQKIRVLIL 370
LR N + + ++ L++ + LT + LSS L ++ L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA--GCGVLSSTLRTLPTLQELHL 120
Query: 371 AGNPLDG----ILPSSIGNLSISLERFQMFNCRISGK----IPQVISNLSNLLLLDLGGN 422
+ N L +L + + LE+ Q+ C +S + V+ + L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 423 KLTGSIPVTFSRLL-----NLQGLGLAFNKL----ARSIPDEICHLAKLDKLILHGNKF- 472
+ + + L L+ L L + R + + A L +L L NK
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 473 -SGAIPSCSGNL---TSLRALYLGSNRFT----SALPSTIWNLKDILFFDVSSNSL--DG 522
G C G L + LR L++ T L + + + ++ N L +G
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 523 PLSLDIG---NLKVVIELNLSRNNLSGD----IPITIGGLKNLQKLFLANNRLEGPIPES 575
L + L + + + + + L +L ++NNRLE
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360
Query: 576 FS-----GLSSLEILDLSKNKISGV----IPTSLEKLLYLKKLNLSFNKLE 617
S L +L L+ +S + +L L++L+LS N L
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 65/410 (15%), Positives = 132/410 (32%), Gaps = 71/410 (17%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNM-----HTLKLLDFRDNQL----FGSLSSFIFN 138
L +L L+L N+L + ++ L ++ L G LSS +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 139 MSSMLGIDLSINRFSGELPANICKNL----PNLKKLLLGRNMFHGK----IPSTLSKCKQ 190
+ ++ + LS N +C+ L L+KL L + S L
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 191 LEGLYLRFNNLSGAIPKEIG-----NLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLA 245
+ L + N+++ A + + + +L+ + L + + +++ + +A
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI-------VA 224
Query: 246 TNNLVGVVPFTIFNMSTLKKLSLLENTLWGS----LPSRIDLSLPNVEFLNLGTNRFS-- 299
+ ++L++L+L N L L + + L + +
Sbjct: 225 SK-------------ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271
Query: 300 --GNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNL-----RNLEFLNIADNYLTS-STP 351
G++ + L L GN + LE L + T+
Sbjct: 272 GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS 331
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDG----ILPSSIGNLSISLERFQMFNCRISGK---- 403
S S L + + L ++ N L+ L +G L + +C +S
Sbjct: 332 HFS--SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS 389
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL-----NLQGLGLAFNKL 448
+ + +L LDL N L + + + L+ L L
Sbjct: 390 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 56/232 (24%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR---YERALKSFQDECEVMKRIR 780
+DR+ +LG GSFG V + + G E AVKV +R + +S E +++K++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------------NI 828
H N++K+ + + L+ E G L F + I
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARI 131
Query: 829 MIDVALALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQ 873
+ V + Y+H I+H ++ I DF ++ ++
Sbjct: 132 IRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--- 185
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP-----TDEIF 920
+ T Y+APE + G + DV+S G++L +G P +I
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 43/204 (21%), Positives = 73/204 (35%), Gaps = 26/204 (12%)
Query: 735 GIGSFGSVYVAR-LQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIRHRNLVKIISAC 791
G +V +AR G V V+ + Q E V K H N+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 792 SNDDFKALIMEYMPNGSLENRL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY 850
D+ ++ +M GS ++ + ++ I+ V AL+Y+H +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152
Query: 851 MV--AHI----------SDFSIAKFL--NGQDQLSMQTQTLATIG---YMAPEYGVQGRV 893
V +HI S + +GQ Q + ++ +++PE Q
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 894 --STRGDVYSYGIMLMETFTGKKP 915
+ D+YS GI E G P
Sbjct: 213 GYDAKSDIYSVGITACELANGHVP 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHR 782
+ F+K +G GSFG V+ + VA+K+ + E ++ Q E V+ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+ K + D +IMEY+ GS + L G LD Q I+ ++ L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 136
Query: 843 HSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPE 886
S IH + ++DF +A QL+ T +G +MAPE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QLTDTQIKRNTFVGTPFWMAPE 189
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
Q ++ D++S GI +E G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
F +LG G+F V++ + G A+K + S ++E V+K+I+H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIMIDVALA 835
+V + + L+M+ + G L +R I +R ++ V A
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDR---------ILERGVYTEKDASLVIQQVLSA 118
Query: 836 LEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLATI 880
++YL H I+H + I+DF ++K M T T
Sbjct: 119 VKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMST-ACGTP 171
Query: 881 GYMAPEYGVQGRVSTRGDVYSYGIML 906
GY+APE Q S D +S G++
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 21/197 (10%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
D + LG G+FG V+ G K + Y + ++E +M ++ H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
L+ + A + LI+E++ G L +R+ + + + +N M L+++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 844 STPIIH-------YMVAH-------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
I+H M I DF +A LN + + T AT + APE
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVD 223
Query: 890 QGRVSTRGDVYSYGIML 906
+ V D+++ G++
Sbjct: 224 REPVGFYTDMWAIGVLG 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 41/240 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
D F LG G FG+VY+AR Q+ +A+KV + E + E E+ +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
N++++ + + L++E+ P G L L + M ++A AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHE 132
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYG 888
+IH I+DF + + +T+ T+ Y+ PE
Sbjct: 133 RK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEM- 183
Query: 889 VQGRV-STRGDVYSYGIMLMETFTGKKPTDE---------IFIGELSLSRWVN----DLL 934
++G+ + D++ G++ E G P D I +L +++ DL+
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 4e-17
Identities = 35/270 (12%), Positives = 74/270 (27%), Gaps = 66/270 (24%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYE---RALKSFQDECEVMKRIR-- 780
+ +LG + A + G V V + A+K ++E ++ +R
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 781 --------------------HRNLVKIISACSNDDFKALIMEYM----PNGSLEN----- 811
K+I ++ ++ + +L+
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 812 -RLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDF 858
S L RL + + V L L H ++H ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 859 SIAKFLNGQDQLSMQTQTLATIGYMAPE-----YGVQGRVSTRGDVYSYGIMLMETFTGK 913
G +S + A A ++ D ++ G+ + +
Sbjct: 256 EHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 914 KP---------TDEIFIGELSLSRWVNDLL 934
P ++ IF ++ + V LL
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQPVRALL 344
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 45/194 (23%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 728 FSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVK 786
SK +LG G FG V+ G+++A K+ R + + ++E VM ++ H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 846
+ A + + L+MEY+ G L +R+ + L + M + + ++ H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMY 207
Query: 847 IIH-------YMVAH-------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
I+H + + I DF +A+ +++L T ++APE
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDF 264
Query: 893 VSTRGDVYSYGIML 906
VS D++S G++
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 51/295 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
D + ++G G+ V A +VA+K + ++ + ++ E + M + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 784 LVKIISACSNDDFKALIMEYMPNGSL----ENRLYSGTCMLDIFQRLNIMI---DVALAL 836
+V ++ D L+M+ + GS+ ++ + G + I +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 837 EYLHFGHSTPIIHYMV------------AHISDFSIAKFLNGQDQLSMQTQTLATIG--- 881
EYL H IH V I+DF ++ FL ++ +G
Sbjct: 135 EYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 882 YMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME 940
+MAPE Q R + D++S+GI +E TG P + P+ V+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--------------YHKYPPMKVLM 237
Query: 941 VIDTN----LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLK 991
+ N L +G + K+ S + + C + P KR A E LL+
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYG-KSFRKMISLCLQKDPEKRPTAAE----LLR 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 44/209 (21%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRH 781
+R++ +LG GSFG V + E AVKV ++ + + E E++K++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIMIDVA 833
N++K+ + ++ E G L + I +R I+ V
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE---------IIKRKRFSEHDAARIIKQVF 131
Query: 834 LALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLA 878
+ Y+ H I+H ++ I DF ++ ++ +
Sbjct: 132 SGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIG 185
Query: 879 TIGYMAPEYGV-QGRVSTRGDVYSYGIML 906
T Y+APE V +G + DV+S G++L
Sbjct: 186 TAYYIAPE--VLRGTYDEKCDVWSAGVIL 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 21/204 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
D F K + LG G+ G V+ G+ +A K+ H + E +V+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+V A +D ++ ME+M GSL+ ++ + + I V L YL H
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 844 STPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
I+H +V + DF ++ GQ SM + T YM+PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGT 205
Query: 892 RVSTRGDVYSYGIMLMETFTGKKP 915
S + D++S G+ L+E G+ P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 11/224 (4%)
Query: 397 NCRISGKIPQVISNL-SNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPD 454
+ R++ K Q I +L + L L L +IP FS L N+ + ++ + + +
Sbjct: 15 DFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLES 73
Query: 455 EI-CHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILF 512
+L+K+ + + + I + L L+ L + + T DI F
Sbjct: 74 HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFF 133
Query: 513 -FDVSSNSLDGPLSLDI--GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLA-NNRL 568
+++ N + ++ G + L L N + + L ++L N L
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192
Query: 569 EGPIPESFSGL-SSLEILDLSKNKISGVIPTSLEKLLYLKKLNL 611
++F G+ S +LD+S+ ++ + LE L L N
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 47/229 (20%), Positives = 80/229 (34%), Gaps = 16/229 (6%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGS 131
++ ++Q IP S +TL L L IPS F N+ + + +
Sbjct: 16 FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 132 LSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKC 188
L S F N+S + I++ R + + K LP LK L + P + +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 189 KQLEGLYLRFNNLSGAIPKEI-GNLTK-LKDIILNDNELRGEIPQEMGNLPYLVRLTLAT 246
L + N +IP L + L +N + N L + L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 247 NNLVGVVPFTIFN--MSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL 293
N + V+ F S L + + ++ +LPS+ L + N
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 33/224 (14%), Positives = 64/224 (28%), Gaps = 35/224 (15%)
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
+ + IP S + Q L L L +L + ++ + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 472 FSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGN 530
+ S S NL+ + + + + R + +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA--------LK---------------E 103
Query: 531 LKVVIELNLSRNNLSGDIP--ITIGGLKNLQKLFLANNRLEGPIPE-SFSGLSS-LEILD 586
L ++ L + L P + L + +N IP +F GL + L
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 587 LSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
L N + + L + L+ NK I + F +
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA-FGGVY 204
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 38/237 (16%), Positives = 76/237 (32%), Gaps = 32/237 (13%)
Query: 236 LPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGT 295
P L L +L + N+ + ++ + + L S +L V + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 296 NRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
R I P+ + L L+FL I + L P+L+
Sbjct: 90 TRNLTYID-----------------------PDALKELPLLKFLGIFNTGLKMF-PDLTK 125
Query: 356 LSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLL 415
+ S + I + I ++ L +++N + + N + L
Sbjct: 126 VYSTDI--FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 416 LLDLGGNKLTGSIPV-TFSRLLN-LQGLGLAFNKLARSIPDEICHLAKLDKLILHGN 470
+ L NK I F + + L ++ + ++P + L L +LI
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 21/115 (18%), Positives = 46/115 (40%), Gaps = 6/115 (5%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLA-NNRLEGPIPESFSGLSSLEILDLSKNK-IS 593
L L +L L N+ +++++ + L+ SF LS + +++ + ++
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 594 GVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL---GNELLCGLPD 645
+ P +L++L LK L + L+ P + L N + +P
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-17
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 47/227 (20%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRH 781
+R++ +LG GSFG V + E AVKV ++ + + E E++K++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIMIDVA 833
N++K+ + ++ E G L + I +R I+ V
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE---------IIKRKRFSEHDAARIIKQVF 131
Query: 834 LALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLA 878
+ Y+H + I+H ++ I DF ++ ++ +
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIG 185
Query: 879 TIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE ++G + DV+S G++L +G P +I
Sbjct: 186 TAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 25/196 (12%), Positives = 52/196 (26%), Gaps = 39/196 (19%)
Query: 733 LLGIGSFGSVYVARLQD---GMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVK 786
G + A D +VA+ + + L+ + RI + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 846
++ ++ E++ GSL+ + + M +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAG 149
Query: 847 IIHYMV----AHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSY 902
+ + +S LA M + + D+
Sbjct: 150 VALSIDHPSRVRVSIDGDVV--------------LAYPATMPD-------ANPQDDIRGI 188
Query: 903 GIMLMETFTGKKPTDE 918
G L + P E
Sbjct: 189 GASLYALLVNRWPLPE 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 46/302 (15%), Positives = 91/302 (30%), Gaps = 70/302 (23%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQD-----------------ECEVM 776
L G F + + +D A+K + + + F E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 777 KRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL-------NIM 829
I++ + +N D +I EYM N S+ + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 830 IDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL 877
V + Y+H + I H +SDF ++++ + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210
Query: 878 A-TIGYMAPEYGVQGRVSTRG---DVYSYGIMLMETFTGKKPTDE----------IFIGE 923
T +M PE+ S G D++S GI L F P I
Sbjct: 211 RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269
Query: 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983
+ L + + + + + ++ L + L P +RI +
Sbjct: 270 IEY-----PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-LRKN-----PAERITSE 318
Query: 984 EI 985
+
Sbjct: 319 DA 320
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 29/210 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV---FHQRYERALKSFQDECEVMKRIR 780
FS +G GSFG+VY AR +++ VA+K ++ + E ++++R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H N ++ + L+MEY GS + L L + + L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 841 FGHSTPIIH----------YMVAHI--SDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-- 886
S +IH + DF A ++ + T +MAPE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVI 222
Query: 887 -YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+G+ + DV+S GI +E K P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 42/197 (21%), Positives = 76/197 (38%), Gaps = 21/197 (10%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
D + + LG G+FG V+ G A K +E ++ + E + M +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
LV + A +D+ +I E+M G L ++ + + + M V L ++H +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 844 STPIIH-------YMVAH-------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
+H M + DF + L+ + + T T + APE
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 890 QGRVSTRGDVYSYGIML 906
V D++S G++
Sbjct: 330 GKPVGYYTDMWSVGVLS 346
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 27/202 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHR 782
D F LG G+FG V++ G+E +K + R + ++ + E EV+K + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALALEYL 839
N++KI + ++ME G L R+ S +M + AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 840 HFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
H H ++H + I DF +A+ + T T YMA
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMA 194
Query: 885 PEYGVQGRVSTRGDVYSYGIML 906
PE + V+ + D++S G+++
Sbjct: 195 PEV-FKRDVTFKCDIWSAGVVM 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 48/240 (20%), Positives = 95/240 (39%), Gaps = 65/240 (27%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV-------------FHQRYERALKSFQ 770
+ + K LG G++G V + + E A+KV ++ E+ +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 771 DECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL---- 826
+E ++K + H N++K+ + + L+ E+ G L F+++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRH 141
Query: 827 --------NIMIDVALALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKF 863
NIM + + YLH + I+H ++ + I DF ++ F
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ +L L T Y+APE ++ + + + DV+S G+++ G P F G+
Sbjct: 199 FSKDYKL---RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 34/234 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
+ F NLLG GSF VY A + G+EVA+K+ ++ ++ Q+E ++ +++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+++++ + + ++ L++E NG + L + + + M + + YL
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL-- 128
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTL-ATIGYMAPEYG 888
HS I+H M I+DF +A L + TL T Y++PE
Sbjct: 129 -HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPEI- 183
Query: 889 VQGRV-STRGDVYSYGIMLMETFTGKKPTDE---------IFIGELSLSRWVND 932
DV+S G M G+ P D + + + + +++
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 41/206 (19%), Positives = 79/206 (38%), Gaps = 40/206 (19%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
++ N +G GS+G V +A + A K + + + F+ E E+MK + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIMIDVALA 835
++++ ++ L+ME G L R + + IM DV A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFER---------VVHKRVFRESDAARIMKDVLSA 118
Query: 836 LEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLATI 880
+ Y H + + H ++ + DF +A + + T
Sbjct: 119 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTP 172
Query: 881 GYMAPEYGVQGRVSTRGDVYSYGIML 906
Y++P+ ++G D +S G+M+
Sbjct: 173 YYVSPQV-LEGLYGPECDEWSAGVMM 197
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 19/211 (9%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
L+N + +LG +T V+ L +Q + + +S+ + L +L L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI-QSL-AGMQFFTNLKELHL 70
Query: 468 HGNKFSGAIPSCSG--NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
N+ I S +LT L L + NR + L + + +N L S
Sbjct: 71 SHNQ----ISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDS 123
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEIL 585
L +LK + L++ N L I + +G L L+ L L N + + L + +
Sbjct: 124 LI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWI 177
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
DL+ K +L + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/263 (18%), Positives = 90/263 (34%), Gaps = 24/263 (9%)
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDV 515
LA K L + L+ ++ ++ S + + ++ +
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 516 SSNSLDGPLSLD-IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE 574
S N + L + +L + EL+++RN L + L +LFL NN L +
Sbjct: 71 SHNQIS---DLSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDT--D 122
Query: 575 SFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSF 634
S L +LEIL + NK+ + L L L+ L+L N++ +
Sbjct: 123 SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDL 179
Query: 635 LGNELLCGLPDLHNSPCKLNKPKTHHKSRKMMLLLVIALPLSTAALIIVVTLTLKWKLIR 694
G + N P K + K I+ P + V + W+L
Sbjct: 180 TGQK-------CVNEPVKYQPELYITNTVKDPDGRWIS-PYYISNGGSYVDGCVLWELPV 231
Query: 695 CWKSITGSSNDGINSPQAIRRFS 717
++ ++ IN + F
Sbjct: 232 YTDEVSYKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 40/220 (18%), Positives = 77/220 (35%), Gaps = 27/220 (12%)
Query: 209 IGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
L L + + Q+ L + +N+ + + + LK+L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 269 LENTLWGSLPSRID--LSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFI 326
N + S + L +E L++ NR N+ + ++ L+ L N
Sbjct: 71 SHNQI-----SDLSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRDTD 122
Query: 327 PNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNL 386
+ +L+NLE L+I +N L S + L K+ VL L GN + + L
Sbjct: 123 S--LIHLKNLEILSIRNNKLKS-------IVMLGFLSKLEVLDLHGNEITNT--GGLTRL 171
Query: 387 SISLERFQMFNCRISGKIPQVISNLSNL-LLLDLGGNKLT 425
+ + + + + L + D G ++
Sbjct: 172 K-KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 35/206 (16%), Positives = 77/206 (37%), Gaps = 18/206 (8%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
+ N+ ++ + LS ++ + ++ + ++ + + LK L NQ+
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQI 75
Query: 129 FGSLSSFIFNMSSMLGIDLSINRFSGELPANICK-NLPNLKKLLLGRNMFHGKIPSTLSK 187
S S + +++ + + ++ NR N+ L +L L N + +L
Sbjct: 76 --SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNEL--RDTDSLIH 126
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
K LE L +R N L + +G L+KL+ + L+ NE+ + L + + L
Sbjct: 127 LKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182
Query: 248 NLVGVVPFTIFNMSTLKKLSLLENTL 273
V + + +
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 48/273 (17%), Positives = 86/273 (31%), Gaps = 54/273 (19%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
L++ +L ++ S + ++ + ++ + S+ G+
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI-----------QSLAGMQ- 60
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEGLYLRFNNLSGAI 205
NLK+L L N +I S L +LE L + N L
Sbjct: 61 ---------------FFTNLKELHLSHN----QISDLSPLKDLTKLEELSVNRNRLKNL- 100
Query: 206 PKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKK 265
L + L++NEL + +L L L++ N L +V +S L+
Sbjct: 101 --NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEV 154
Query: 266 LSLLENTLWGSLPSRID--LSLPNVEFLNLGTNRFSGNIPSSITNASKL-TVFQLRGNSF 322
L L N + + L V +++L + TV G
Sbjct: 155 LDLHGNEI-----TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF 355
S P I N + + T E+S+
Sbjct: 210 S---PYYISNGGSYVDGCVLWELPV-YTDEVSY 238
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 41/236 (17%), Positives = 83/236 (35%), Gaps = 22/236 (9%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
V N + ++ + ++L+ L LSHN++S ++ S + ++ L+ L N+L
Sbjct: 42 GVQNFNGD-NSNIQSLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL 97
Query: 129 FGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLS 186
+L+ + + + L N ++ +L NL+ L + N K+ L
Sbjct: 98 -KNLNG--IPSACLSRLFLDNNELRD--TDSL-IHLKNLEILSIRNN----KLKSIVMLG 147
Query: 187 KCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLAT 246
+LE L L N ++ + L K+ I L + E + L +
Sbjct: 148 FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPD 205
Query: 247 NNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+ P+ I N + +L + + F G +
Sbjct: 206 GRW--ISPYYISNGGSYVDGCVLWELP--VYTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 46/211 (21%), Positives = 73/211 (34%), Gaps = 69/211 (32%)
Query: 724 ATDRFSKN---------NLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDEC 773
+TD FS ++LG G+ V L E AVK+ ++ E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 774 EVMKRIR-HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------ 826
E++ + + HRN++++I +D L+ E M GS+ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108
Query: 827 ------NIMIDVALALEYLHFGHSTPIIHYMVAH--------------------ISDFSI 860
++ DVA AL++LH +AH I DF +
Sbjct: 109 NELEASVVVQDVASALDFLHNKG--------IAHRDLKPENILCEHPNQVSPVKICDFDL 160
Query: 861 AKFLN-GQDQLSMQTQTLATI----GYMAPE 886
+ D + T L T YMAPE
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 43/237 (18%), Positives = 81/237 (34%), Gaps = 41/237 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
R+ + LG G F + A K+ + + E + + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+++V ++DF +++E SL + + R + + L +YL
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYL-- 131
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATI-G---YMAP 885
H +IH + I DF +A + + + G Y+AP
Sbjct: 132 -HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTPNYIAP 184
Query: 886 EYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDE---------IFIGELSLSRWVND 932
E + + S DV+S G ++ GK P + I E S+ + +N
Sbjct: 185 EV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 44/241 (18%), Positives = 82/241 (34%), Gaps = 49/241 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
R+ + LG G F + A K+ + + E + + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+++V ++DF +++E SL + + R + + L +YL
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYL-- 157
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATI-G---YMAP 885
H +IH + I DF +A + + + G Y+AP
Sbjct: 158 -HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTPNYIAP 210
Query: 886 EYGVQGRVSTRG-----DVYSYGIMLMETFTGKKPTDE---------IFIGELSLSRWVN 931
E +S +G DV+S G ++ GK P + I E S+ + +N
Sbjct: 211 EV-----LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 265
Query: 932 D 932
Sbjct: 266 P 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 42/215 (19%), Positives = 84/215 (39%), Gaps = 55/215 (25%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRH 781
+D + LG G+F V G+E A K+ + + R + + E + ++++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRL-----YS----GTCMLDIFQRLNIMIDV 832
N+V++ + + F L+ + + G L + YS C+ I +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 833 ALALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTL 877
++ Y HS I+H ++A ++DF +A +N +
Sbjct: 117 --SIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA 168
Query: 878 ATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
T GY++PE Y D+++ G++L
Sbjct: 169 GTPGYLSPEVLKKDPYS------KPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 42/215 (19%), Positives = 84/215 (39%), Gaps = 55/215 (25%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRH 781
+D + LG G+F V G+E A K+ + + R + + E + ++++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRL-----YS----GTCMLDIFQRLNIMIDV 832
N+V++ + + F L+ + + G L + YS C+ I +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 139
Query: 833 ALALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTL 877
++ Y HS I+H ++A ++DF +A +N +
Sbjct: 140 --SIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA 191
Query: 878 ATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
T GY++PE Y D+++ G++L
Sbjct: 192 GTPGYLSPEVLKKDPYS------KPVDIWACGVIL 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 16/216 (7%)
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSI---PDEICHLAK 461
+ + L +L K T + LQ L +I + L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
+ + + + P + L LR+ +L N D+ ++ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKDLT 454
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSS 581
L+ L +V L+LS N L +P + L+ L+ L ++N LE + + L
Sbjct: 455 VLCHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPR 509
Query: 582 LEILDLSKNKISGV-IPTSLEKLLYLKKLNLSFNKL 616
L+ L L N++ L L LNL N L
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 8e-14
Identities = 50/326 (15%), Positives = 100/326 (30%), Gaps = 19/326 (5%)
Query: 330 IGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS 389
+G + L + + F LT ++ L+L + + +
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295
Query: 390 LERFQMFNCRISGKIPQVISNLSNLLLLDLGG-------NKLTGSIPVTFSRLLNLQGLG 442
+ + + Q+ + ++ + L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCE 355
Query: 443 LAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPS 502
L+ K + E+ +L +L I L L F++
Sbjct: 356 LSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---L 411
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
+ + D + S+ V L+L+ +L+ + + L + L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLD 469
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEG--EI 620
L++NRL +P + + L LE+L S N + V + L L++L L N+L+ I
Sbjct: 470 LSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAI 526
Query: 621 PRGGPFANLTAKSFLGNELLCGLPDL 646
L + GN LC +
Sbjct: 527 QPLVSCPRLVLLNLQGNS-LCQEEGI 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 41/274 (14%), Positives = 77/274 (28%), Gaps = 40/274 (14%)
Query: 336 LEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLS--ISLERF 393
+ + + +++ L+ +L S + + LE
Sbjct: 322 WTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPE 380
Query: 394 QMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP 453
+ + + + L + L P + L +K
Sbjct: 381 NKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP------MRAAYLDDLRSKFLLENS 434
Query: 454 DEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFF 513
A + L L + + L + L L NR + LP + L+
Sbjct: 435 VLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALR----- 486
Query: 514 DVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG-PI 572
L+ L S N L ++ + L LQ+L L NNRL+
Sbjct: 487 ----------------CLE---VLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAA 525
Query: 573 PESFSGLSSLEILDLSKNKISGVIPTSLEKLLYL 606
+ L +L+L N + E+L +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 43/251 (17%), Positives = 79/251 (31%), Gaps = 53/251 (21%)
Query: 182 PSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVR 241
+ +QL L + + E+ + +L+++ + I M L L+
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 242 LTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI-------DLSLPNVEFLNLG 294
STLK + + L S+ + +V L+L
Sbjct: 401 EKETLQYF-----------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 295 TNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELS 354
+ + + +T L N +P + LR LE L +DN L +
Sbjct: 450 HKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN------ 500
Query: 355 FLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNL 414
+ + N +++ L+L N L Q + + L
Sbjct: 501 -VDGVANLPRLQELLLCNNRLQQS------------------------AAIQPLVSCPRL 535
Query: 415 LLLDLGGNKLT 425
+LL+L GN L
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 3e-09
Identities = 38/279 (13%), Positives = 85/279 (30%), Gaps = 58/279 (20%)
Query: 81 QGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMS 140
L +LS K + + S + + L+ L+ + ++ + +
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALD 396
Query: 141 SMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNN 200
+L ++ FS + + R+ F + + + L+L +
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDL----RSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 201 LSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNM 260
L+ + + L + + L+ N LR +P + L L L + N L
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL----------- 498
Query: 261 STLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGN 320
+ ++ +LP ++ L L NR + ++ +
Sbjct: 499 ENVDGVA----------------NLPRLQELLLCNNR--------LQQSAAI-------- 526
Query: 321 SFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSL 359
+ + L LN+ N L L+ +
Sbjct: 527 -------QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 42/213 (19%), Positives = 76/213 (35%), Gaps = 42/213 (19%)
Query: 8 HCLLLSLAIAAAASNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNS 67
CLL + + A + ++++L + DP + S + +
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442
Query: 68 HKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQ 127
+V+ L + T+ L L + LDLSHN+L +P ++ + L++L DN
Sbjct: 443 VRVLHLA----HKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497
Query: 128 LFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPS---- 183
L ++ NLP L++LLL N ++
Sbjct: 498 LE-NVDGV--------------------------ANLPRLQELLLCNN----RLQQSAAI 526
Query: 184 -TLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKL 215
L C +L L L+ N+L L ++
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 7e-09
Identities = 39/226 (17%), Positives = 75/226 (33%), Gaps = 29/226 (12%)
Query: 66 NSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHN-------------KLSGNIPSSI 112
++ +S + +L + L+ L+ + ++
Sbjct: 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405
Query: 113 FNMHTLKLLDFRDNQLFGSLSSF--------IFNMSSMLGIDLSINRFSGELPANICKNL 164
TLK +D L S + + + L+ + L + L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHL--EQL 462
Query: 165 PNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNE 224
+ L L N +P L+ + LE L N L + + NL +L++++L +N
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 519
Query: 225 LRG-EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
L+ Q + + P LV L L N+L L +S +
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 9e-07
Identities = 24/103 (23%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSL 132
L++S L+ +PP L L LE L S N L N+ + N+ L+ L +N+L
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL-QQS 523
Query: 133 SSF--IFNMSSMLGIDLSINRFSG--ELPANICKNLPNLKKLL 171
++ + + ++ ++L N + + + LP++ +L
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 41/217 (18%), Positives = 71/217 (32%), Gaps = 54/217 (24%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD------ECEVMK 777
D + LG G F V R G+E A K +R RA + E +++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL----------- 826
++ H N++ + N LI+E + G L F L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117
Query: 827 -NIMIDVALALEYLHFGHSTPIIH-------YMVAH---------ISDFSIAKFLNGQDQ 869
+ + + + YLH I H M+ + DF +A + +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T ++APE + D++S G++
Sbjct: 175 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 42/218 (19%), Positives = 78/218 (35%), Gaps = 64/218 (29%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKR-IRHR 782
TD + +G+GS+ ME AVK+ + +E E++ R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHP 76
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------------NIMI 830
N++ + + + ++ E M G L ++ ++
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLF 123
Query: 831 DVALALEYLHFGHSTPIIH---------YMVAH-------ISDFSIAKFLNGQDQLSMQT 874
+ +EYL H+ ++H Y+ I DF AK L ++ L + T
Sbjct: 124 TITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMT 179
Query: 875 QTLATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
T ++APE Y D++S G++L
Sbjct: 180 -PCYTANFVAPEVLERQGYD------AACDIWSLGVLL 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 40/213 (18%), Positives = 71/213 (33%), Gaps = 46/213 (21%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD------ECEVMK 777
D + LG G F V R G E A K +R + + E +++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIM 829
IRH N++ + N LI+E + G L + + ++ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDF---------LAEKESLTEDEATQFL 114
Query: 830 IDVALALEYLHFGHSTPIIH-------YMVAH---------ISDFSIAKFLNGQDQLSMQ 873
+ + YLH I H M+ + DF IA + ++
Sbjct: 115 KQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 168
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T ++APE + D++S G++
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 36/342 (10%), Positives = 77/342 (22%), Gaps = 77/342 (22%)
Query: 697 KSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAV 755
+ + S L Q + L +G V++ R ++ + A+
Sbjct: 35 AMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92
Query: 756 KVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISAC--------------------- 791
KVF L+ + R+ + +
Sbjct: 93 KVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152
Query: 792 -SNDDFKA----LIMEYM-----PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
DD+ L+M S + +Y I + + L
Sbjct: 153 PGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ- 211
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
S ++H + D S ++ + + AP +
Sbjct: 212 --SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW------KVGTRGPASSVPVTYAPREFL 263
Query: 890 QGR---VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946
+ + + G+ + + P F + + V
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDSLAF 319
Query: 947 LSGEERYFAAKE--QSLLSILNLATECTIESPGKRINAREIV 986
S K L+ +R+ E +
Sbjct: 320 GSCTPLPDFVKTLIGRFLNF----------DRRRRLLPLEAM 351
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 42/215 (19%), Positives = 83/215 (38%), Gaps = 54/215 (25%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRH 781
T+ + LG G+F V + G E A + + + R + + E + + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRL-----YS----GTCMLDIFQRLNIMIDV 832
N+V++ + S + LI + + G L + YS C+ I +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 121
Query: 833 ALALEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTL 877
A+ + H ++H ++A ++DF +A + G+ Q
Sbjct: 122 --AVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFG-FA 174
Query: 878 ATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
T GY++PE YG D+++ G++L
Sbjct: 175 GTPGYLSPEVLRKDPYG------KPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 41/217 (18%), Positives = 71/217 (32%), Gaps = 54/217 (24%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD------ECEVMK 777
D + LG G F V R G+E A K +R RA + E +++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL----------- 826
++ H N++ + N LI+E + G L F L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117
Query: 827 -NIMIDVALALEYLHFGHSTPIIH-------YMVAH---------ISDFSIAKFLNGQDQ 869
+ + + + YLH I H M+ + DF +A + +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T ++APE + D++S G++
Sbjct: 175 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 44/208 (21%), Positives = 73/208 (35%), Gaps = 62/208 (29%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISAC 791
LG GSF + AVK+ +R + Q E +K H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------------NIMIDVALALEYL 839
+ L+ME + G L F+R+ IM + A+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 840 HFGHSTPIIH---------YMVAH------ISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
H ++H + + I DF A+ +Q ++T T+ Y A
Sbjct: 123 ---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKT-PCFTLHYAA 177
Query: 885 PE------YGVQGRVSTRGDVYSYGIML 906
PE Y D++S G++L
Sbjct: 178 PELLNQNGYD------ESCDLWSLGVIL 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 51/245 (20%)
Query: 702 SSNDGIN-SPQAIRRFSYHELLQA---------TDRFSKNNLLGIGSFGSVYVAR-LQDG 750
++N I S + F + +L D + + LG G+ G V +A +
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 751 MEVAVKVFHQR--------YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802
+VA+++ +R + + E E++K++ H ++KI + +D+ +++E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLE 219
Query: 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------- 849
M G L +++ + + + + LA++YL H IIH
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQ 275
Query: 850 --YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYGVQGRVSTRG-----DVYS 901
+ I+DF +K L + TL T Y+APE V V T G D +S
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMR----TLCGTPTYLAPE--VLVSVGTAGYNRAVDCWS 329
Query: 902 YGIML 906
G++L
Sbjct: 330 LGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 63/223 (28%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR--------YERALKSFQDECEV 775
D + + LG G+ G V +A + +VA+K+ +R + + E E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL--------- 826
+K++ H ++KI + +D+ +++E M G L F ++
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 114
Query: 827 ---NIMIDVALALEYLHFGHSTPIIH---------------YMVAHISDFSIAKFLNGQD 868
+ LA++YL H IIH + I+DF +K L
Sbjct: 115 TCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRG-----DVYSYGIML 906
+ T Y+APE V V T G D +S G++L
Sbjct: 172 LM---RTLCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 50/233 (21%), Positives = 87/233 (37%), Gaps = 41/233 (17%)
Query: 698 SITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK 756
S+T S+ G S +D F + LG G+ VY + A+K
Sbjct: 25 SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 757 VFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSG 816
V + ++ K + E V+ R+ H N++K+ +L++E + G L +R
Sbjct: 85 VLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR---- 138
Query: 817 TCMLDIFQR--------LNIMIDVALALEYLHFGHSTPIIH-------YMVAH------- 854
I ++ + + + A+ YL H I+H + A
Sbjct: 139 -----IVEKGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPL 190
Query: 855 -ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
I+DF ++K + Q + T GY APE D++S GI+
Sbjct: 191 KIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 41/212 (19%), Positives = 78/212 (36%), Gaps = 41/212 (19%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV-----FHQRYERALKSFQDECEVMKR 778
D + ++G G F V + G + AVK+ F + + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF---QRLNIMIDVALA 835
++H ++V+++ S+D ++ E+M L + ++ + M + A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 836 LEYLHFGHSTPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLATI 880
L Y H IIH ++A + F +A L ++ + T
Sbjct: 143 LRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTP 197
Query: 881 GYMAPE------YGVQGRVSTRGDVYSYGIML 906
+MAPE YG DV+ G++L
Sbjct: 198 HFMAPEVVKREPYG------KPVDVWGCGVIL 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 40/210 (19%), Positives = 71/210 (33%), Gaps = 48/210 (22%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
+++ LG G FG V+ K + + E ++ RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRN 62
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL-------------NIMI 830
++ + + + + +I E++ DIF+R+ + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVH 109
Query: 831 DVALALEYLHFGHSTPIIH-------YMVAH-------ISDFSIAKFLNGQDQLSMQTQT 876
V AL++LH + I H + I +F A+ L D
Sbjct: 110 QVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLL 163
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
Y APE VST D++S G ++
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 45/245 (18%), Positives = 82/245 (33%), Gaps = 66/245 (26%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVF-----HQRYERALKSFQDECEVMKR 778
++ +G GS+G V VA Q A+K+ Q + ++ + E +MK+
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------------ 826
+ H N+ ++ ++ + L+ME G L ++L +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 827 ---------------------------NIMIDVALALEYLHFGHSTPIIH-------YMV 852
NIM + AL YLH I H ++
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201
Query: 853 AH-------ISDFSIAKFLNGQDQLSMQT-QTLA-TIGYMAPE--YGVQGRVSTRGDVYS 901
+ + DF ++K + T A T ++APE + D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 902 YGIML 906
G++L
Sbjct: 262 AGVLL 266
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 39/213 (18%), Positives = 74/213 (34%), Gaps = 46/213 (21%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD------ECEVMK 777
D + LG G F V R G++ A K +R ++ + E ++K
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQR--------LNIM 829
I+H N++ + N LI+E + G L + + ++ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDF---------LAEKESLTEEEATEFL 120
Query: 830 IDVALALEYLHFGHSTPIIH-------YMVAH---------ISDFSIAKFLNGQDQLSMQ 873
+ + YLH I H M+ I DF +A ++ ++
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T ++APE + D++S G++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 47/201 (23%), Positives = 73/201 (36%), Gaps = 37/201 (18%)
Query: 450 RSIPDEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLK 508
++P + + L L N S + LT+L +L L N
Sbjct: 31 PNVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF---------- 78
Query: 509 DILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRL 568
+SS + + + L+LS N+L L+ L+ L L NN +
Sbjct: 79 ------ISSEAFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 569 EGPIPESFSGLSSLEILDLSKNKISGVIP---TSLEKLLYLKKLNLSFNKLEGEIPRGGP 625
+F ++ L+ L LS+N+IS KL L L+LS NKL+ ++P
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL-TD 182
Query: 626 FANLTAKSFL-----GNELLC 641
L A N L C
Sbjct: 183 LQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 43/163 (26%), Positives = 65/163 (39%), Gaps = 19/163 (11%)
Query: 478 SCSGNLTSLRALYLGSNRFTS---ALPSTIWNLKDILFFDVSSNSLDG-PLSLDIGNLKV 533
C+ N+ L + + +LPS L D+S N+L L
Sbjct: 17 LCASNI-----LSCSKQQLPNVPQSLPSYTALL------DLSHNNLSRLRAEWTPTRLTN 65
Query: 534 VIELNLSRNNLSGDIPI-TIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592
+ L LS N+L+ I + NL+ L L++N L FS L +LE+L L N I
Sbjct: 66 LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 593 SGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL 635
V + E + L+KL LS N++ P + L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL-IKDGNKLPKL 165
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 14/171 (8%)
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERF 393
L+++ N L+ E + + LTN L+L+ N L+ I + + +L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTP-TRLTNLHS---LLLSHNHLNFISSEAFVPVP-NLRYL 93
Query: 394 QMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSI 452
+ + + + S+L L +L L N + + F + LQ L L+ N++
Sbjct: 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRF 151
Query: 453 PDEI----CHLAKLDKLILHGNKFSGAIPSCSGNLTSL--RALYLGSNRFT 497
P E+ L KL L L NK + L + LYL +N
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 48/167 (28%), Positives = 69/167 (41%), Gaps = 17/167 (10%)
Query: 92 SSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMSSMLGIDLSI 149
S LDLSHN LS + L L N L +SS F + ++ +DLS
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSS 97
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKI----PSTLSKCKQLEGLYLRFNNLSGAI 205
N L + +L L+ LLL N I + QL+ LYL N +S
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNN----HIVVVDRNAFEDMAQLQKLYLSQNQIS-RF 151
Query: 206 PKEI----GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
P E+ L KL + L+ N+L+ ++ LP V+ L +N
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 13/161 (8%)
Query: 72 VLNISGFNLQGTIPPQ--LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQL 128
+L++S NL + + L++L +L LSHN L+ I S F + L+ LD N L
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL 100
Query: 129 FGSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN---MFHGKIPST 184
+L F+F ++ ++ + L N + N +++ L+KL L +N F ++
Sbjct: 101 -HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158
Query: 185 LSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK--DIILNDN 223
+K +L L L N L ++ L + L++N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 46/213 (21%), Positives = 75/213 (35%), Gaps = 37/213 (17%)
Query: 93 SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF 152
+ L S +L N+P S+ + LLD N L + +
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTP--------------- 60
Query: 153 SGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKEI-G 210
L NL LLL N + I S L L L N+L + + +
Sbjct: 61 ---------TRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFS 109
Query: 211 NLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
+L L+ ++L +N + + + ++ L +L L+ N + I + + L KL LL
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLL 168
Query: 270 E--NTLWGSLPSRIDLSLPN--VEFLNLGTNRF 298
+ + LP LP L L N
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 35/177 (19%), Positives = 71/177 (40%), Gaps = 17/177 (9%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSIT--NASKLTVFQLRGNSFSGFIPNTIGNL 333
++P + L+L N S + + T + L L N + +
Sbjct: 32 NVPQSLP---SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV 87
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERF 393
NL +L+++ N+L + ++ Q + VL+L N + + ++ +++ L++
Sbjct: 88 PNLRYLDLSSNHLHTLDEF-----LFSDLQALEVLLLYNNHIVVVDRNAFEDMA-QLQKL 141
Query: 394 QMFNCRISGKIP----QVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
+ +IS + P + + L L+LLDL NKL +L GL +
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 34/225 (15%), Positives = 73/225 (32%), Gaps = 64/225 (28%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVF---------HQRYERALKSFQDECE 774
+ + +LG G V E AVK+ + + ++ E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 775 VMKRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRL-----YS----GTCMLDIFQ 824
+++++ H N++++ + F L+ + M G L + L S M + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 825 RLNIMIDVALALEYLHFGHSTPIIHYMVAH-----------------ISDFSIAKFLNGQ 867
+ LH + H ++DF + L+
Sbjct: 136 ----------VICALHK--------LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 868 DQLSMQTQTLATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
++L + T Y+APE D++S G+++
Sbjct: 178 EKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 60/248 (24%)
Query: 708 NSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERAL 766
+ +++ L F L+G G++G VY R ++ G A+KV +
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-E 64
Query: 767 KSFQDECEVMKRI-RHRNLVKII------SACSNDDFKALIMEYMPNGSLENRLYSGTCM 819
+ + E ++K+ HRN+ + DD L+ME+ GS+
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV---------- 114
Query: 820 LDIFQRLN-----------IMIDVALALEYLHFGHSTPIIH----------YMVAHI--S 856
D+ + I ++ L +L H +IH A +
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLV 171
Query: 857 DFSIAKFLNGQDQLSMQTQTLAT-IG---YMAPE-----YGVQGRVSTRGDVYSYGIMLM 907
DF ++ QL T IG +MAPE + D++S GI +
Sbjct: 172 DFGVSA------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 908 ETFTGKKP 915
E G P
Sbjct: 226 EMAEGAPP 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 49/208 (23%), Positives = 80/208 (38%), Gaps = 36/208 (17%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERA-LKSFQDECEV-MKRIRHRNLVKIISA 790
LG G++G V R + G +AVK K + ++ M+ + V A
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHS 844
+ + ME M + SL+ + Y ++D Q + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELM-DTSLD-KFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPE----Y 887
+IH + DF I+ +L + A YMAPE
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPE 184
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
Q S + D++S GI ++E + P
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 38/224 (16%), Positives = 78/224 (34%), Gaps = 63/224 (28%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQR--------YERALKSFQDECEV 775
++ +++G G V G E AVK+ E ++ + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 776 MKRIR-HRNLVKIISACSNDDFKALIMEYMPNGSLENRL-----YS----GTCMLDIFQR 825
++++ H +++ +I + + F L+ + M G L + L S + M + +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE- 211
Query: 826 LNIMIDVALALEYLHFGHSTPIIHYMVAH-----------------ISDFSIAKFLNGQD 868
A+ +LH + H +SDF + L +
Sbjct: 212 ---------AVSFLHA--------NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 869 QLSMQTQTLATIGYMAPE------YGVQGRVSTRGDVYSYGIML 906
+L + T GY+APE D+++ G++L
Sbjct: 255 KL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
+L +T T + L ++ + + + +S+ I +L + L L GNK I
Sbjct: 24 ANLKKKSVT-DAV-TQNELNSIDQIIANNSDI-KSVQG-IQYLPNVRYLALGGNKLH-DI 78
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
+ LT+L L L N+ S LP+ ++ D +L E
Sbjct: 79 SALKE-LTNLTYLILTGNQLQS-LPNGVF---------------DKLTNLK--------E 113
Query: 537 LNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
L L N L +P + L NL L LA+N+L+ F L++L LDLS N++ +
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+KL LK L L N+L+ +P G F LT
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKS-VPDGV-FDRLT 205
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 59/187 (31%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 407 VISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICH-LAKLDKL 465
I L N+ L LGGNKL I L NL L L N+L S+P+ + L L +L
Sbjct: 58 GIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKEL 114
Query: 466 ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
+L N+ LT+L L L N+ S LP + FD L
Sbjct: 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGV--------FD----KL----- 156
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPE-SFSGLSSLE 583
NL EL+LS N L +P + L L+ L L N+L+ +P+ F L+SL+
Sbjct: 157 ---TNLT---ELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQ 208
Query: 584 ILDLSKN 590
+ L N
Sbjct: 209 YIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 45/234 (19%)
Query: 241 RLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSG 300
+ L ++ V ++++ ++ + + S+ I LPNV +L LG N+
Sbjct: 23 KANLKKKSVTDAVTQN--ELNSIDQIIANNSDI-KSVQG-IQ-YLPNVRYLALGGNKLH- 76
Query: 301 NIPS--SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS 358
+I + +TN LT L GN L NL+ L + +N L S P+ F
Sbjct: 77 DISALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF-DK 131
Query: 359 LTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLD 418
LTN L LA N L SL V L+NL LD
Sbjct: 132 LTNLTY---LNLAHNQLQ------------SLP-------------KGVFDKLTNLTELD 163
Query: 419 LGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGN 470
L N+L S+P F +L L+ L L N+L +S+PD + L L + LH N
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 22/224 (9%)
Query: 29 SLLALKAHISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQL 88
+ K S T + + + + + +++ +
Sbjct: 9 IKQIFPDDAFAETIKANLKK-KSVTDAVTQNELN------SIDQIIANNSDIKS--VQGI 59
Query: 89 GNLSSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSFIFNMSSMLG-ID 146
L ++ L L NKL +I T L L NQL SL + +F+ + L +
Sbjct: 60 QYLPNVRYLALGGNKLH-DIS--ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELV 115
Query: 147 LSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTL-SKCKQLEGLYLRFNNLSGAI 205
L N+ LP + L NL L L N +P + K L L L +N L ++
Sbjct: 116 LVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SL 172
Query: 206 PKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATN 247
P+ + LT+LKD+ L N+L+ +P + L L + L N
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 34/144 (23%)
Query: 475 AIPS-CSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKV 533
P L T + L
Sbjct: 12 IFPDDAF---AETIKANLKKKSVTD-AVTQN-------------------------ELNS 42
Query: 534 VIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKIS 593
+ ++ + +++ I L N++ L L N+L I + L++L L L+ N++
Sbjct: 43 IDQIIANNSDIKSVQGIQY--LPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQ 98
Query: 594 GVIPTSLEKLLYLKKLNLSFNKLE 617
+ +KL LK+L L N+L+
Sbjct: 99 SLPNGVFDKLTNLKELVLVENQLQ 122
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 33/270 (12%), Positives = 76/270 (28%), Gaps = 77/270 (28%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYE---RALKSFQDECEVMKRIR-------- 780
+LG + A + G V V + A+K ++E ++ +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 781 -----------------HRNLVKIISACSNDDFKALIMEYM-PNGSLEN------RLYSG 816
+ ++++ + + Y +L+ S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 817 TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFL 864
L RL + + V L LH ++H ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 865 NGQDQLSMQTQTLATIGYMAPEY-----------GVQGRVSTRGDVYSYGIMLMETFTGK 913
+ + + + G+ PE + ++ D ++ G+++ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 914 KPTDE---------IFIGELSLSRWVNDLL 934
P + IF ++ + V LL
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALL 340
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 50/208 (24%), Positives = 77/208 (37%), Gaps = 35/208 (16%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEV-MKRIRHRNLVKIISA 790
+G G++GSV G +AVK E+ K + +V M+ +V+ A
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHS 844
+ + ME M + S + + Y + + I + AL +L
Sbjct: 90 LFREGDCWICMELM-STSFD-KFYK-YVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSM-QTQTLATIGYMAPE----Y 887
IIH + DF I+ GQ S+ +T+ YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ R DV+S GI L E TG+ P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 60/280 (21%), Positives = 99/280 (35%), Gaps = 61/280 (21%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKIISA 790
LG G++G V +A VAVK+ +R ++ + E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGHST 845
+ + L +EY G L +R+ M F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH----- 122
Query: 846 PIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
+ H ISDF +A ++ + + T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL- 178
Query: 889 VQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946
++ R + DV+S GI+L G+ P D+ S W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKTYLNPWKK 233
Query: 947 LSGEERYFAAKEQSLLS-ILNLATECTIESPGKRINAREI 985
+ +LL IL +P RI +I
Sbjct: 234 IDSAPL-------ALLHKILVE-------NPSARITIPDI 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 51/246 (20%), Positives = 82/246 (33%), Gaps = 49/246 (19%)
Query: 701 GSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH 759
GSS + + D +G G+ G V+ R + G +AVK
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 760 -QRYERALKSFQDECEV-MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGT 817
+ K + +V +K +V+ + + ME M GT
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-----------GT 108
Query: 818 CMLDIFQRLN----------IMIDVALALEYLHFGHSTPIIH------------YMVAHI 855
C + +R+ + + + AL YL H +IH +
Sbjct: 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKL 166
Query: 856 SDFSIAKFLNGQDQLSM-QTQTLATIGYMAPE-----YGVQGRVSTRGDVYSYGIMLMET 909
DF I+ L + ++ YMAPE + R DV+S GI L+E
Sbjct: 167 CDFGISGRLVD----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 910 FTGKKP 915
TG+ P
Sbjct: 223 ATGQFP 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 51/251 (20%), Positives = 87/251 (34%), Gaps = 65/251 (25%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFH----QRYERALKSFQDECEVMKRIRHRNLVK- 786
LLG GS+G V + AVK+ +R + + E ++++R+RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 787 ---IISACSNDDFKALIMEYMPNGSLE-------NRLYSGTCMLDIFQRLNIMIDVALAL 836
+ + + ++MEY G E R F +L ID L
Sbjct: 72 VDVLYNEEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQAH-GYFCQL---ID---GL 122
Query: 837 EYLHFGHSTPIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLAT 879
EYLH + H IS +A+ L+ + +
Sbjct: 123 EYLH--------SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 880 IGYMAPE--YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE---------IFIGELSLSR 928
+ PE G+ + D++S G+ L TG P + I G ++
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234
Query: 929 WVN----DLLP 935
DLL
Sbjct: 235 DCGPPLSDLLK 245
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 62/210 (29%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISA 790
+LG+G G V + G + A+K+ + + E + + ++V I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 791 CSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLN----------IMIDVALAL 836
N +IME M G L +R I +R + IM D+ A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSR---------IQERGDQAFTEREAAEIMRDIGTAI 141
Query: 837 EYLHFGHSTPIIHYMVAH--------------------ISDFSIAKFLNGQDQLSMQTQT 876
++LH + +AH ++DF AK ++QT
Sbjct: 142 QFLHSHN--------IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQT-P 189
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T Y+APE + D++S G+++
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 60/268 (22%), Positives = 98/268 (36%), Gaps = 38/268 (14%)
Query: 698 SITGSSNDGINSPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVK 756
G S Q + + D F +LG GSF +V +AR E A+K
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 757 VFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRL 813
+ +R+ E + E +VM R+ H VK+ +D+ + Y NG L +
Sbjct: 62 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121
Query: 814 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIA 861
+ R ++ ALEYL H IIH M I+DF A
Sbjct: 122 RKIGSFDETCTRFYTA-EIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 862 KFLNGQDQLSMQTQTL-ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP---- 915
K + + + + T Y++PE + + + + D+++ G ++ + G P
Sbjct: 178 K-VLSPESKQARANSFVGTAQYVSPEL-LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
Query: 916 -TDEIF--I--GELSLSRWVN----DLL 934
IF I E DL+
Sbjct: 236 NEYLIFQKIIKLEYDFPEKFFPKARDLV 263
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.0 bits (173), Expect = 2e-12
Identities = 96/617 (15%), Positives = 162/617 (26%), Gaps = 220/617 (35%)
Query: 437 NLQGLGLAFNKLARSIPDEIC----HLAKLDK---LILHGNKFSGAIPSCSGNLTSLRAL 489
L F K S L +L +++ G SG T +
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK--------TWVALD 169
Query: 490 YLGSNRFTSALPSTI-WNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNL-SRNNLSGD 547
S + + I W ++ + + + + L I+ N SR++ S +
Sbjct: 170 VCLSYKVQCKMDFKIFW-------LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 548 IPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILD-------------------LS 588
I + I ++ + L + E + L +L +
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYE----------NCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 589 KNK-----ISGVIPT--SLEKL-----------LYLKKLNLSFNKLEGEIPRGGPFA-NL 629
+ K +S T SL+ L LK L+ L E+ P ++
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 630 TAKSFLGNELLCGLPDLHNSPC------KLNKPKTHH---KS---------RKMMLLLVI 671
A+S + + +N K S RKM L +
Sbjct: 333 IAES------------IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 672 ALPLSTAALIIVVTLTLKWKLIRCWKSITGSSNDGINSPQAIRRFSYHELLQATDRFSKN 731
P S I + L+L W + I +N + ++S L+ ++ K
Sbjct: 381 -FPPSA--HIPTILLSLIW-----FDVIKSDVMVVVNK---LHKYS---LV---EKQPKE 423
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV---KII 788
+ + I Y ++E + HR++V I
Sbjct: 424 STISI----------------------PSIYLELKVKLENEYAL-----HRSIVDHYNIP 456
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
+DD L+ Y Y H GH
Sbjct: 457 KTFDSDDLIPP--------YLDQ--YF----------------------YSHIGH----- 479
Query: 849 HYMVAHISD----FSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGI 904
H + F FL+ Q + ++T + Y
Sbjct: 480 HLKNIEHPERMTLFR-MVFLD----FRFLEQKIRHDST--AWNASGSILNTLQQLKFYK- 531
Query: 905 MLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSI 964
P E R VN +L L EE +K LL I
Sbjct: 532 ---PYICDNDPKYE---------RLVNAIL---------DFLPKIEENLICSKYTDLLRI 570
Query: 965 -LNLATECTIESPGKRI 980
L E E K++
Sbjct: 571 ALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 3e-11
Identities = 80/471 (16%), Positives = 149/471 (31%), Gaps = 139/471 (29%)
Query: 27 QQSLLALKAHISYDPTNL-------FAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFN 79
+Q+LL L+ N+ K W + VC + C K+ LN+ N
Sbjct: 141 RQALLELRPA-----KNVLIDGVLGSGKTWVAL-DVCLSYKVQC-KMDFKIFWLNLKNCN 193
Query: 80 LQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLK-----------------LLD 122
T+ L L +D + S + + +H+++ +L
Sbjct: 194 SPETVLEMLQKLLY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 123 ----------F----------RDNQLFGSLSS------FIFNMSSMLGIDLSINRFS--- 153
F R Q+ LS+ + + S L D +
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 154 ----GELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI 209
+LP + P L + I L+ ++N K +
Sbjct: 312 DCRPQDLPREVLTTNP----RRLS--IIAESIRDGLA----------TWDNW-----KHV 350
Query: 210 GNLTKLKDII------LNDNELRG-----EIPQEMGNLPYLVRLTLATNNLVGVVPFTIF 258
N KL II L E R + ++P ++ L+L +++ +
Sbjct: 351 -NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-LSLIWFDVIKSDVMVV- 407
Query: 259 NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLR 318
++ L K SL+E P +S+P++ + SI + +
Sbjct: 408 -VNKLHKYSLVEK--Q---PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK-TFD 460
Query: 319 GNSFS-----GFIPNTIG-NLRNLE-------FLNIADNYLTSSTPELSFLSSLTNCQKI 365
+ + + IG +L+N+E F + +L + FL QKI
Sbjct: 461 SDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV---FL-----DFRFLE-----QKI 507
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
R A N SI N L+ ++ + C K ++++ + + L
Sbjct: 508 RHDSTAWNA-----SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/280 (21%), Positives = 99/280 (35%), Gaps = 61/280 (21%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRNLVKIISA 790
LG G++G V +A VAVK+ +R ++ + E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGHST 845
+ + L +EY G L +R+ M F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH----- 122
Query: 846 PIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
+ H ISDF +A ++ + + T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL- 178
Query: 889 VQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946
++ R + DV+S GI+L G+ P D+ S W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKTYLNPWKK 233
Query: 947 LSGEERYFAAKEQSLLS-ILNLATECTIESPGKRINAREI 985
+ +LL IL +P RI +I
Sbjct: 234 IDSAPL-------ALLHKILVE-------NPSARITIPDI 259
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 37/198 (18%), Positives = 76/198 (38%), Gaps = 36/198 (18%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR-NLVKIIS 789
LG G F V G E A K +R + E V++ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL------NIMIDVALALEYLHFGH 843
N LI+EY G + + C+ ++ + + ++ + + YLH +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSL-----CLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 844 STPIIH-------YMVAH--------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
I+H +++ I DF +++ + +L + + T Y+APE
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEIL 205
Query: 889 VQGRVSTRGDVYSYGIML 906
++T D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 53/245 (21%), Positives = 81/245 (33%), Gaps = 69/245 (28%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVF---------------HQRYERALKSFQD----- 771
+G GS+G V +A D A+KV R R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 772 ------ECEVMKRIRHRNLVKIIS--ACSNDDFKALIMEYMPNGSL-----ENRLYSGTC 818
E ++K++ H N+VK++ N+D ++ E + G + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 819 MLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNG 866
FQ D+ +EYL H IIH I+DF ++ G
Sbjct: 140 RF-YFQ------DLIKGIEYL---HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 867 QDQLSMQTQTLA-TIGYMAPE------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEI 919
D L T +MAPE G+ DV++ G+ L G+ P +
Sbjct: 190 SDAL---LSNTVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCPFMDE 243
Query: 920 FIGEL 924
I L
Sbjct: 244 RIMCL 248
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 41/209 (19%), Positives = 74/209 (35%), Gaps = 61/209 (29%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISAC 791
LG+G G V + + A+K+ + E E+ R + ++V+I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 792 ----SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN----------IMIDVALALE 837
+ ++ME + G L +R I R + IM + A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSR---------IQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 838 YLHFGHSTPIIHYMVAH--------------------ISDFSIAKFLNGQDQLSMQTQTL 877
YLH + +AH ++DF AK + L T
Sbjct: 176 YLHSIN--------IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC 224
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIML 906
T Y+APE + D++S G+++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 56/301 (18%), Positives = 101/301 (33%), Gaps = 57/301 (18%)
Query: 696 WKSITGSSNDGINSPQAIRRFSYHELLQATDRFSKNN-----LLGIGSFGSVYVARLQDG 750
+++ G RF + ++ + N+ ++G G FG VY R D
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT 213
Query: 751 MEV-AVKVFHQRYERALKSFQDEC--------EVMKRIRHRNLVKIISACSNDDFKALIM 801
++ A+K +R + ++ +V + A D + I+
Sbjct: 214 GKMYAMKCL--DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271
Query: 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY----------M 851
+ M G L L + R ++ L LE++ H+ +++
Sbjct: 272 DLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHM---HNRFVVYRDLKPANILLDE 327
Query: 852 VAHI--SDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYGVQGRVSTRG-DVYSYGIMLM 907
H+ SD +A + + + T GYMAPE +G D +S G ML
Sbjct: 328 HGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 908 ETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY---FAAKEQSLLSI 964
+ G P F + + ID L+ F+ + +SLL
Sbjct: 383 KLLRGHSP----FRQHKTKDK-----------HEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 965 L 965
L
Sbjct: 428 L 428
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKII 788
+G GSFG V + + D ++ A+K +++ +++ E ++M+ + H LV +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 848
+ +++ ++++ + G L L + +L I ++ +AL+YL + II
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYL---QNQRII 137
Query: 849 H--------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYGVQGRV 893
H + HI+DF+IA L + Q T+A T YMAPE +
Sbjct: 138 HRDMKPDNILLDEHGH--VHITDFNIAAMLPRET----QITTMAGTKPYMAPE--MFSSR 189
Query: 894 STRG-----DVYSYGIMLMETFTGKKP 915
G D +S G+ E G++P
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 53/232 (22%), Positives = 83/232 (35%), Gaps = 47/232 (20%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKV--------FHQRYERALKSFQDECEVMKRIRHRNL 784
LG G+FG V+ A + EV VK + L E ++ R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 785 VKIISACSNDDFKALIMEYMPNGS-LENRLYSGTCMLD-----IFQRLNIMIDVALALEY 838
+K++ N F L+ME +G L + + + IF++L A+ Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL------VSAVGY 145
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
L IIH + DF A +L T TI Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--T-FCGTIEYCAPE 199
Query: 887 YGVQGRVSTRG---DVYSYGIMLMETFTGKKP---TDEIFIGELSLSRWVND 932
+ G RG +++S G+ L + P +E + V+
Sbjct: 200 V-LMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 530 NLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSK 589
L + ++N S N ++ G + ++ L +NRLE + F GL SL+ L L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114
Query: 590 NKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTA 631
N+I+ V S L ++ L+L N++ + G F L +
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA-FDTLHS 154
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 6/116 (5%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLI 466
L L ++ NK+T I F + + L N+L ++ ++ L L L+
Sbjct: 54 KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLM 111
Query: 467 LHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
L N+ + + + S L+S+R L L N+ T+ P L + ++ +N +
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKD 509
IP+ I +L L+ N+F+ + L LR + +N+ T +
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGA----- 76
Query: 510 ILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRL 568
F+ + E+ L+ N L ++ + GL++L+ L L +NR+
Sbjct: 77 ---FE------------GASGVN---EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI 117
Query: 569 EGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
+SF GLSS+ +L L N+I+ V P + + L L LNL N
Sbjct: 118 TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 6/135 (4%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSFIFN-MSSMLGIDLSI 149
L L++N+ + + IF L+ ++F +N++ + F S + I L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTS 90
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI 209
NR + + K L +LK L+L N + + L L N ++ +
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 210 -GNLTKLKDIILNDN 223
L L + L N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 4/129 (3%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ L+ N F+ I K LP L+K+ N + + L N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 205 IPKEI-GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMST 262
+ ++ L LK ++L N + + + L + L+L N + V P + +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 263 LKKLSLLEN 271
L L+LL N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 36/180 (20%), Positives = 63/180 (35%), Gaps = 59/180 (32%)
Query: 417 LDLGGNKLTGSIPVT--FSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKFS 473
L L N+ T + T F +L L+ + + NK+ I + + +++++L N+
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE 94
Query: 474 GAIPSCSG---NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGN 530
+ L SL+ L L SNR T + + F
Sbjct: 95 -NVQ--HKMFKGLESLKTLMLRSNRITC-VGNDS--------FI---------------- 126
Query: 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
GL +++ L L +N++ P +F L SL L+L N
Sbjct: 127 -----------------------GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 13/148 (8%)
Query: 302 IPSSI-TNASKLTVFQLRGNSFSGFIPNTI-GNLRNLEFLNIADNYLTSSTPELSFLSSL 359
IP I ++L +L N F+ I L L +N ++N +T E +F
Sbjct: 26 IPEHIPQYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAF-EGA 80
Query: 360 TNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDL 419
+ + ++L N L+ + L SL+ + + RI+ LS++ LL L
Sbjct: 81 SG---VNEILLTSNRLENVQHKMFKGLE-SLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136
Query: 420 GGNKLTGSIPV-TFSRLLNLQGLGLAFN 446
N++T ++ F L +L L L N
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/143 (22%), Positives = 59/143 (41%), Gaps = 9/143 (6%)
Query: 157 PANICKNLPNLKKLLLGRNMFHGKIPST--LSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
P +I +L L N F + +T K QL + N ++ +
Sbjct: 27 PEHI---PQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 215 LKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTL 273
+ +I+L N L + +M L L L L +N + V + +S+++ LSL +N +
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 274 WGSLPSRIDLSLPNVEFLNLGTN 296
++ +L ++ LNL N
Sbjct: 142 -TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 24/110 (21%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 69 KVIVLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDN 126
++ +N S + I S + + L+ N+L N+ +F + +LK L R N
Sbjct: 58 QLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
Query: 127 QLFGSLSSFIF-NMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175
++ + + F +SS+ + L N+ + + L +L L L N
Sbjct: 116 RI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKS---FQDECEVMKRIRHRN 783
+ ++G G+FG V + R + +V A+K+ + F +E ++M
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVA--------LA 835
+V++ A +D + ++MEYMP G L +++ ++ A LA
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLA 180
Query: 836 LEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTL-ATIGY 882
L+ + HS IH H+ +DF +N + ++ T T Y
Sbjct: 181 LDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDY 235
Query: 883 MAPE----YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
++PE G G D +S G+ L E G P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 53/176 (30%), Positives = 72/176 (40%), Gaps = 28/176 (15%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKFSGA 475
LDL L TF L L L L +N+L ++ + L +L L L N+ +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 476 IPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVI 535
+LT L LYLG N+ S LPS + FD + LK
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGV--------FD------------RLTKLK--- 134
Query: 536 ELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
EL L+ N L IP L NLQ L L+ N+L+ +F L L+ + L N
Sbjct: 135 ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 32/183 (17%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
S+P I A +KL L + + LT L L L N+ + L + ++
Sbjct: 28 SVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVF----- 79
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLE 569
D L L L+ N L+ +P+ + L L KL+L N+L+
Sbjct: 80 ----------DDLTELG--------TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK 120
Query: 570 GPIPES-FSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 628
+P F L+ L+ L L+ N++ + + +KL L+ L+LS N+L+ +P G F
Sbjct: 121 S-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGA-FDR 177
Query: 629 LTA 631
L
Sbjct: 178 LGK 180
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 59/198 (29%), Positives = 78/198 (39%), Gaps = 39/198 (19%)
Query: 276 SLPSRIDLSLP-NVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLR 334
S+PS I P + E L+L + + ++ +KLT L N +L
Sbjct: 28 SVPSGI----PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT 83
Query: 335 NLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQ 394
L L +A+N L S P F LT K L L GN L LP
Sbjct: 84 ELGTLGLANNQLA-SLPLGVF-DHLTQLDK---LYLGGNQLKS-LP-------------- 123
Query: 395 MFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIP 453
V L+ L L L N+L SIP F +L NLQ L L+ N+L +S+P
Sbjct: 124 ----------SGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVP 171
Query: 454 DEI-CHLAKLDKLILHGN 470
L KL + L GN
Sbjct: 172 HGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 5/155 (3%)
Query: 95 ETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLG-IDLSINRFS 153
E LDL L+ ++ + L L+ NQL +LS+ +F+ + LG + L+ N+ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 154 GELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-GNL 212
LP + +L L KL LG N + +L+ L L N L +IP L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 213 TKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATN 247
T L+ + L+ N+L+ L L +TL N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 11/161 (6%)
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
L L L + ++ L+ L + ++ V +L+ L L L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLT-KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 426 GSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAIPSCSG-- 481
S+P+ F L L L L N+L +S+P + L KL +L L+ N+ +IP+ G
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAF 151
Query: 482 -NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
LT+L+ L L +N+ S L + + N D
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 46/189 (24%), Positives = 71/189 (37%), Gaps = 38/189 (20%)
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
E L L+ L+ LTKL + L+ N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ------------------------- 72
Query: 252 VVPFTIFN-MSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI-TNA 309
+ +F+ ++ L L L N L SLP + L ++ L LG N+ +PS +
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRL 130
Query: 310 SKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF--LSSLTNCQKIRV 367
+KL +L N L NL+ L+++ N L S P +F L L
Sbjct: 131 TKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQT------ 183
Query: 368 LILAGNPLD 376
+ L GN D
Sbjct: 184 ITLFGNQFD 192
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEICH-LAK 461
+P+ +SN +L L+DL N+++ ++ +FS + L L L++N+L R IP L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKS 103
Query: 462 LDKLILHGNKFSGAIPSCSG---NLTSLRALYLGSN 494
L L LHGN S +P G +L++L L +G+N
Sbjct: 104 LRLLSLHGNDIS-VVP--EGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
EL L N + +P + K+L + L+NNR+ +SFS ++ L L LS N++ +
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
P + + L L+ L+L N + +P G F +L+
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGA-FNDLS 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 37/175 (21%), Positives = 59/175 (33%), Gaps = 75/175 (42%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
L L GN+ T +P S +L + L+ N+++ ++ ++ FS
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQS---------------FS--- 75
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
N+T L L L NR +P FD
Sbjct: 76 -----NMTQLLTLILSYNRLRC-IPPRT--------FD---------------------- 99
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE-SFSGLSSLEILDLSKN 590
GLK+L+ L L N + +PE +F+ LS+L L + N
Sbjct: 100 -----------------GLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 53/223 (23%)
Query: 728 FSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFH-----QRYERALKSFQDECEVMKRIRH 781
F ++G G+FG V V +L++ +V A+K+ + +R E A F++E +V+
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVNGDS 133
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID---------- 831
+ + + A +D+ L+M+Y G L L + +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAE 183
Query: 832 VALALEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTL-A 878
+ +A++ + H +H M HI +DF L ++Q+
Sbjct: 184 MVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVG 238
Query: 879 TIGYMAPEYGVQGRVSTRG------DVYSYGIMLMETFTGKKP 915
T Y++PE +Q +G D +S G+ + E G+ P
Sbjct: 239 TPDYISPEI-LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 48/213 (22%), Positives = 73/213 (34%), Gaps = 46/213 (21%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISAC 791
+G G+FG + R VAVK +R ++ Q E + +RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 792 SNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGHSTP 846
A+IMEY G L R+ + FQ+L + + Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---LS---GVSYCH------ 133
Query: 847 IIHYMVAH-------------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY 887
+ H I DF +K Q T A Y+APE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEV 188
Query: 888 GVQGR--VSTRGDVYSYGIMLMETFTGKKPTDE 918
+ + DV+S G+ L G P ++
Sbjct: 189 -LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 2/91 (2%)
Query: 527 DIGNLKVVIELNLSRNNLSGDIP-ITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEIL 585
+ + + EL + + + GL L+ L + + L P++F L L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
+LS N + + + L L++L LS N L
Sbjct: 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 4/96 (4%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIP-VTFSRLLNLQGLGLAFNKLARSIPDEI-CHLAK 461
+ NL L + + + L L+ L + + L R + + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPR 81
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFT 497
L +L L N ++ + SL+ L L N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 16/102 (15%), Positives = 29/102 (28%), Gaps = 4/102 (3%)
Query: 422 NKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDE-ICHLAKLDKLILHGNKFSGAIPSCS 480
NL L + + + + + L +L L + + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 481 -GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
L L L N S T+ L + +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 83 TIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQLFGSLSSFIF-NMS 140
L +L L + + + ++ + L+ L + L ++ F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTP 80
Query: 141 SMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFH 178
+ ++LS N L + L L++L+L N H
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 20/112 (17%), Positives = 37/112 (33%), Gaps = 4/112 (3%)
Query: 188 CKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLAT 246
GL + + L ++ + + + + L L LT+
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 247 NNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRF 298
+ L V P L +L+L N L SL + + +++ L L N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 7/94 (7%)
Query: 284 SLPNVEFLNLGTNRFSGNIPS-SITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIA 342
N+ L + + ++ + +L + + P+ L LN++
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 343 DNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLD 376
N L S + + SL L+L+GNPL
Sbjct: 89 FNALESLSWKTVQGLSLQE------LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 24/124 (19%), Positives = 35/124 (28%), Gaps = 26/124 (20%)
Query: 446 NKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTI 504
A + L +L + + + L LR L + + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 505 WNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLA 564
L LNLS N L T+ GL +LQ+L L+
Sbjct: 77 HFTP---------------------RLS---RLNLSFNALESLSWKTVQGL-SLQELVLS 111
Query: 565 NNRL 568
N L
Sbjct: 112 GNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 5/95 (5%)
Query: 380 PSSIGNLSISLERFQMFNCRISGKIP-QVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLN 437
+ +L + N + + + + L L L + + L + F
Sbjct: 24 LHHLPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 438 LQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKF 472
L L L+FN L S+ + L +L+L GN
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 13/72 (18%), Positives = 21/72 (29%), Gaps = 6/72 (8%)
Query: 572 IPESFSGLSSLEILDLSKNKISGVIPT-SLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
G +L L + + + L L L+ L + + L + F
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA-FHFTP 80
Query: 631 AKSFL---GNEL 639
S L N L
Sbjct: 81 RLSRLNLSFNAL 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 8/97 (8%)
Query: 295 TNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPN-TIGNLRNLEFLNIADNYLTSSTPE- 352
T + + + A LT + + + L L L I + L P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 353 LSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS 389
F L L L+ N L+ + ++ LS+
Sbjct: 76 FHFTPRL------SRLNLSFNALESLSWKTVQGLSLQ 106
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 45/233 (19%), Positives = 79/233 (33%), Gaps = 49/233 (21%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVK------VFHQRYERALKSFQDECEVMKRIR----H 781
LLG G FG+V+ L D ++VA+K V + E ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 782 RNLVKIISACSNDDFKALIMEY-MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
+++++ + L++E +P L + + + + R V A+++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 841 FGHSTPIIHYMVAH------------------ISDFSIAKFLNGQDQLSMQTQTLATIGY 882
V H + DF L D+ T Y
Sbjct: 157 --------SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEP-YTD-FDGTRVY 204
Query: 883 MAPEYGVQGR--VSTRGDVYSYGIMLMETFTGKKP---TDEIFIGELSLSRWV 930
PE+ + + V+S GI+L + G P EI EL V
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 28/153 (18%)
Query: 484 TSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNN 543
++ + L N +P F K + ++LS N
Sbjct: 32 ETITEIRLEQNTIKV-IPPGA--------FS---------------PYKKLRRIDLSNNQ 67
Query: 544 LSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEK 602
+S ++ GL++L L L N++ F GL SL++L L+ NKI+ + + +
Sbjct: 68 IS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQD 126
Query: 603 LLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFL 635
L L L+L NKL+ I +G F+ L A +
Sbjct: 127 LHNLNLLSLYDNKLQ-TIAKGT-FSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/159 (20%), Positives = 58/159 (36%), Gaps = 31/159 (19%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
++ + L N + IP F+ + L+ +D +NQ+
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI---------------------- 68
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI- 209
EL + + L +L L+L N S L+ L L N ++ + +
Sbjct: 69 ---SELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 210 GNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATN 247
+L L + L DN+L+ I + L + + LA N
Sbjct: 125 QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 36/131 (27%), Positives = 55/131 (41%), Gaps = 5/131 (3%)
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
+ L N + I P + L R + N +IS P L +L L L GNK+T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYK-KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 426 GSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLDKLILHGNKFSGAIPSCSGNL 483
+P F L +LQ L L NK+ + + L L+ L L+ NK L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 484 TSLRALYLGSN 494
+++ ++L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 29/136 (21%), Positives = 47/136 (34%), Gaps = 29/136 (21%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIFN-MHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLS 148
L +DLS+N++S + F + +L L N++
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-------------------- 92
Query: 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKE 208
ELP ++ + L +L+ LLL N + L L L N L I K
Sbjct: 93 -----TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146
Query: 209 I-GNLTKLKDIILNDN 223
L ++ + L N
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 31/142 (21%), Positives = 59/142 (41%), Gaps = 8/142 (5%)
Query: 157 PANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI-GNLTKL 215
P N+ + ++ L +N P S K+L + L N +S + + L L
Sbjct: 27 PTNL---PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 216 KDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
++L N++ E+P+ + L L L L N + + ++ L LSL +N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL- 140
Query: 275 GSLPSRIDLSLPNVEFLNLGTN 296
++ L ++ ++L N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 29/131 (22%), Positives = 52/131 (39%), Gaps = 5/131 (3%)
Query: 194 LYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM-GNLPYLVRLTLATNNLVGV 252
+ L N + P KL+ I L++N++ E+ + L L L L N +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 253 VPFTIF-NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASK 311
+P ++F + +L+ L L N + L L N+ L+L N+ + +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 312 LTVFQLRGNSF 322
+ L N F
Sbjct: 154 IQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 38/187 (20%), Positives = 54/187 (28%), Gaps = 58/187 (31%)
Query: 286 PNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNY 345
+ + L N P + + KL L N S P+ LR+L L + N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 346 LTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIP 405
+T LP
Sbjct: 92 ITE------------------------------LP------------------------K 97
Query: 406 QVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEI-CHLAKLD 463
+ L +L LL L NK+ + V F L NL L L NKL ++I L +
Sbjct: 98 SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQ 155
Query: 464 KLILHGN 470
+ L N
Sbjct: 156 TMHLAQN 162
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 46/231 (19%), Positives = 81/231 (35%), Gaps = 47/231 (20%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVK------VFHQRYERALKSFQDECEVMKRIRHR--N 783
LLG G FGSVY + D + VA+K + E ++K++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 784 LVKIISACSNDDFKALIMEY-MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
+++++ D LI+E P L + + + + R + V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 843 HSTPIIHYMVAH------------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
+ V H + DF L ++ T T Y
Sbjct: 167 ------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSP 216
Query: 885 PEYGVQGR--VSTRGDVYSYGIMLMETFTGKKP---TDEIFIGELSLSRWV 930
PE+ ++ V+S GI+L + G P +EI G++ + V
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 45/276 (16%), Positives = 83/276 (30%), Gaps = 86/276 (31%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK-VFHQRYERALKSFQDECEVMKRIRHRN 783
F +G G FG V+ A+ D A+K + E A + E + + ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 784 LVKIISACSNDDFKAL-----------------------------------------IME 802
+V+ +A + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 803 YMPNGSLENRLY-------SGTCMLDIFQR-----------LNIMIDVALALEYLHFGHS 844
+ S + LY + +R L+I I +A A+E+L HS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HS 182
Query: 845 TPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLA----------TIGY 882
++H V + DF + ++ ++ + T Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDE 918
M+PE S + D++S G++L E E
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 53/226 (23%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFH-----QRYERALKSFQDECEVMKRI 779
D F ++G G+F V V +++ +V A+K+ + +R E + F++E +V+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS--CFREERDVLVNG 118
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID-------- 831
R + ++ A ++++ L+MEY G L L + I
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYL 168
Query: 832 --VALALEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTL 877
+ +A++ + H +H HI +DF L ++++
Sbjct: 169 AEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG--TVRSLVA 223
Query: 878 -ATIGYMAPE-YGVQGRVSTRG------DVYSYGIMLMETFTGKKP 915
T Y++PE G G D ++ G+ E F G+ P
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 49/231 (21%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDEC-----EVMKRI 779
D F +LG G FG V+ +++ ++ A K +R K + +++ ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL--NKKRLKKRKGYQGAMVEKKILAKV 242
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF--QRLNIMI-DVALAL 836
R +V + A L+M M G + +Y+ F R + L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 837 EYLHFGHSTPII---------------HYMVAHISDFSIAK-FLNGQDQLSMQTQTLA-T 879
E+L H II + ISD +A GQ +T+ A T
Sbjct: 303 EHL---HQRNIIYRDLKPENVLLDDDGNVR---ISDLGLAVELKAGQT----KTKGYAGT 352
Query: 880 IGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP---------TDEIF 920
G+MAPE + G D ++ G+ L E + P E+
Sbjct: 353 PGFMAPEL-LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 64/237 (27%)
Query: 723 QATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHR 782
Q ++ ++G GSFG V+ A+L + EVA+K Q + E ++M+ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHP 92
Query: 783 NLVK----IISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL-- 834
N+V S D L++EY+P E +Y + +L + + L
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYR---ASRHYAKLKQTMPMLLIK 144
Query: 835 --------ALEYLHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQ 873
+L Y+ HS I H V + DF AK L +
Sbjct: 145 LYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--- 198
Query: 874 TQTLATIGYMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ + Y APE Y +T D++S G ++ E G +P +F GE
Sbjct: 199 VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 31/174 (17%), Positives = 59/174 (33%), Gaps = 39/174 (22%)
Query: 460 AKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNS 519
A+ +L + + L + + L L +N I +L
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-----ISSL------------ 66
Query: 520 LDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGL----KNLQKLFLANNRLEGPIPES 575
++ + L+L RN + I L L++L+++ N++
Sbjct: 67 ---------SGMENLRILSLGRNLIK-----KIENLDAVADTLEELWISYNQIA--SLSG 110
Query: 576 FSGLSSLEILDLSKNKISGVIP-TSLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 628
L +L +L +S NKI+ L L L+ L L+ N L + +
Sbjct: 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 36/180 (20%), Positives = 65/180 (36%), Gaps = 35/180 (19%)
Query: 441 LGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG--NLTSLRALYLGSNRFTS 498
L + + + + L L L N I S + +LR L LG N
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNL--- 81
Query: 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNL 558
+K I D +++L+ EL +S N ++ + I L NL
Sbjct: 82 --------IKKIENLDAVADTLE--------------ELWISYNQIA-SLS-GIEKLVNL 117
Query: 559 QKLFLANNRLEGPIP-ESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
+ L+++NN++ + + L LE L L+ N + + Y ++ L+
Sbjct: 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 41/182 (22%), Positives = 64/182 (35%), Gaps = 30/182 (16%)
Query: 239 LVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRID--LSLPNVEFLNLGTN 296
V L + + T+ + K L+L N + +I + N+ L+LG N
Sbjct: 27 KVELHGMIPPIEKM-DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRN 80
Query: 297 RFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFL 356
I + A L + N + + I L NL L +++N +T +
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT----NWGEI 133
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
L K+ L+LAGNP L N S +V+ L NL
Sbjct: 134 DKLAALDKLEDLLLAGNP---------------LYNDYKENNATSEYRIEVVKRLPNLKK 178
Query: 417 LD 418
LD
Sbjct: 179 LD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 32/169 (18%), Positives = 57/169 (33%), Gaps = 35/169 (20%)
Query: 84 IPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSML 143
+ L L + + L LS N + I ++ ++ L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRI-------------------- 74
Query: 144 GIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSG 203
+ L N N+ L++L + N + S + K L LY+ N ++
Sbjct: 75 -LSLGRNLIKK--IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN 129
Query: 204 AIPKEI---GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL 249
EI L KL+D++L N L + + Y + + NL
Sbjct: 130 --WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 403 KIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKL 462
K+ +S L L L N + I + S + NL+ L L N + + I + L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTL 95
Query: 463 DKLILHGNKFSGAIPSCSG--NLTSLRALYLGSNRFTS 498
++L + N+ I S SG L +LR LY+ +N+ T+
Sbjct: 96 EELWISYNQ----IASLSGIEKLVNLRVLYMSNNKITN 129
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 35/213 (16%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIRHRNLVKIISA 790
+G G+F V +AR + G EVA+K+ Q +L+ E +MK + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 791 CSNDDFKALIMEYMPNGSLENRLYSGTCMLD-----IFQRLNIMIDVALALEYLHFGHST 845
+ LIMEY G + + L + M + F+++ A++Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYC---HQK 133
Query: 846 PIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
I+H M I+DF + +L Y APE QG+
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---YAAPEL-FQGKK 189
Query: 894 ST--RGDVYSYGIMLMETFTGKKPTDEIFIGEL 924
DV+S G++L +G P D + EL
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 59/223 (26%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQ---DECEVMKRIRH 781
D+F + LG GSFG V + + ++ A+K+ ++ LK + +E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSL-----------EN--RLYSGTCMLDIFQRLNI 828
LVK+ + ++ ++MEY+ G + E R Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA------------ 148
Query: 829 MIDVALALEYLHFGHSTPIIH--------------YMVAHISDFSIAKFLNGQDQLSMQT 874
+ L EYL HS +I+ Y+ ++DF AK + G +T
Sbjct: 149 --QIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQ--VTDFGFAKRVKG------RT 195
Query: 875 QTL-ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP 915
TL T +APE + + + D ++ G+++ E G P
Sbjct: 196 WTLCGTPEALAPEI-ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 25/97 (25%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
DR LG G+FG V A VAVK+ + ++ E +++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 779 I-RHRNLVKIISACSNDDFKA-LIMEYMPNGSLENRL 813
I H N+V ++ AC+ +I+E+ G+L L
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 33/162 (20%), Positives = 59/162 (36%), Gaps = 18/162 (11%)
Query: 767 KSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRL 826
K + V + R ++ S+ S+ + + + LY L + +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF--LTLEHLI 196
Query: 827 NIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQT 874
VA +E+L S IH V I DF +A+ + +
Sbjct: 197 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 875 QTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKP 915
+ +MAPE + + DV+S+G++L E F+ G P
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 31/204 (15%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDEC-----EVMKRIRHRNLVK 786
+LG G FG V +++ ++ A K +R K + ++++++ R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 787 IISACSNDDFKALIMEYMPNGSLENRLY-SGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ A D L++ M G L+ +Y G + + ++ LE L H
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRE 305
Query: 846 PIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPEYGVQGR 892
I++ HI SD +A + + T+GYMAPE V+
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEV-VKNE 360
Query: 893 VSTRG-DVYSYGIMLMETFTGKKP 915
T D ++ G +L E G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 42/218 (19%), Positives = 76/218 (34%), Gaps = 36/218 (16%)
Query: 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVK--VFHQRYERALKSFQD---------EC 773
++ + GS+G+V +G+ VA+K R + D E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 774 EVMKRIRHRNLVK---IISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNI 828
++ H N++ I L+ E M L ++ ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 829 MIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQT 876
M + L L L H ++H ++A I DF++A+ T
Sbjct: 140 MYHILLGLHVL---HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THY 193
Query: 877 LATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
+ Y APE +Q + T+ D++S G ++ E F K
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 725 TDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
++ ++G GSFG VY A+L D G VA+K Q + E ++M+++ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 784 LVKII------SACSNDDFKALIMEYMP---NGSLENRLYSGTCMLDIFQRLNIMIDVAL 834
+V++ ++ + L+++Y+P + + + I+ +L M +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFR 167
Query: 835 ALEYLHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIG 881
+L Y+ HS I H V + DF AK L + + +
Sbjct: 168 SLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRY 221
Query: 882 YMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
Y APE Y ++ DV+S G +L E G +P IF G+
Sbjct: 222 YRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 52/312 (16%), Positives = 101/312 (32%), Gaps = 62/312 (19%)
Query: 359 LTNCQKIRVLILAGNPLDGI----LPSSIGNLSISLERFQMFNCRISGKIPQVI-----S 409
+ + L L+ N L I L + N S+ + + K + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 410 NLSNLLLLDLGGNKLTGSIPVTFSRLL-----NLQGLGLAFNK--------LARSIPDEI 456
+N+ L+L GN L+ + L + L L +N ++ +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 457 CHLAKLDKLILHGNKFS--GAIPSCSG---NLTSLRALYLGSNRFT--------SALPST 503
+ L+ L GN + ++ +L L N L S
Sbjct: 138 ASITSLN---LRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 504 IWNLKDILFFDVSSNSLDGPLSLDIG-----NLKVVIELNLSRNNLSGD----IPITIGG 554
++ + D+S+N L ++ V+ LNL N L G + +
Sbjct: 195 PASVTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 555 LKNLQKLFLANNRLEGPIPESFSGL-------SSLEILDLSKNKI--SGV--IPTSLEKL 603
LK+LQ ++L + ++ E L + ++D + +I S I + +L
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311
Query: 604 -LYLKKLNLSFN 614
+L
Sbjct: 312 SGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 56/376 (14%), Positives = 113/376 (30%), Gaps = 78/376 (20%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIF-----NMHTLKLLDFRDNQL----FGSLSSFIFN 138
+ +LDLS N L + ++ L+ N L L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 139 MSSML-GIDLSINRFSGELPANICKNLPN----LKKLLLGRNMFHGK----IPSTLSKC- 188
+ + + ++LS N S + + K L + L LG N F K S
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNL-----TKLKDIILNDNELRGEIPQEMGNLPYLVRLT 243
+ L LR N+L E+ + + + L N L + E+
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF------- 190
Query: 244 LATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIP 303
LA+ +++ L L N L + + +
Sbjct: 191 LASIP------------ASVTSLDLSANLLGLKSYAELAYIFSS---------------- 222
Query: 304 SSITNASKLTVFQLRGNSFSG----FIPNTIGNLRNLEFLNIADNYLTSSTPEL--SFLS 357
+ + L N G + +L++L+ + + + + + + E + +
Sbjct: 223 ----IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278
Query: 358 SLTNCQKIRVLILAGNPL--DGI--LPSSIGNLSISLERFQMFNCRIS-----GKIPQVI 408
+ N QKI ++ G + + + I LS + + N + + +
Sbjct: 279 AFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDL 338
Query: 409 SNLSNLLLLDLGGNKL 424
+ L L
Sbjct: 339 NIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 48/265 (18%), Positives = 81/265 (30%), Gaps = 65/265 (24%)
Query: 395 MFNCRISGK----IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL-----NLQGLGLAF 445
M + + S + LDL N L V + ++ L L+
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 446 NK--------LARSIPDEICHLAKLDKLILHGNKFS--GAIPSCSG---NLTSLRALYLG 492
N L + + ++ L+ L GN S + ++ L LG
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLN---LSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117
Query: 493 SNRFT--------SALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNL-----KVVIELNL 539
N F+ A + ++ + ++ N L S ++ + V LNL
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSL---NLRGNDLGIKSSDELIQILAAIPANVNSLNL 174
Query: 540 SRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTS 599
NNL+ L K + +S+ LDLS N +
Sbjct: 175 RGNNLASK------NCAELAKFLASIP-------------ASVTSLDLSANLLGLKSYAE 215
Query: 600 LEKLL-----YLKKLNLSFNKLEGE 619
L + ++ LNL N L G
Sbjct: 216 LAYIFSSIPNHVVSLNLCLNCLHGP 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 52/223 (23%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQD------ECEVMKRIRHRNLV 785
LG+G+FG V + G +VAVK+ +++ ++S E + +K RH +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLH 840
K+ S ++MEY+ G L + + + +FQ++ + A++Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LS---AVDYCH 128
Query: 841 FGHSTPIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
+MV H I+DF ++ ++ + L + Y
Sbjct: 129 --------RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---YA 177
Query: 884 APEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL 924
APE + GR D++S G++L G P D+ + L
Sbjct: 178 APEV-ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 61/257 (23%), Positives = 95/257 (36%), Gaps = 90/257 (35%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVF------------HQRYERALKSFQDECEVMKRI 779
LG GSFG V++ R + A+KV H ER ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER---------LMLSIV 63
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSL-----------EN--RLYSGTCMLDIFQRL 826
H ++++ + +IM+Y+ G L + Y+
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---------- 113
Query: 827 NIMIDVALALEYLHFGHSTPIIH--------------YMVAHISDFSIAKFLNGQDQLSM 872
+V LALEYL HS II+ ++ I+DF AK++
Sbjct: 114 ----EVCLALEYL---HSKDIIYRDLKPENILLDKNGHIK--ITDFGFAKYVPD------ 158
Query: 873 QTQTL-ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF--I-- 921
T TL T Y+APE V + + D +S+GI++ E G P T + + I
Sbjct: 159 VTYTLCGTPDYIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
Query: 922 GELSLSRWVN----DLL 934
EL + N DLL
Sbjct: 218 AELRFPPFFNEDVKDLL 234
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 5/112 (4%)
Query: 530 NLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSK 589
N EL+L + I L + ++N + + + F L L+ L ++
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 590 NKISGVIPTSLEKLLYLKKLNLSFNKLE--GEIPRGGPFANLTAKSFLGNEL 639
N+I + + L L +L L+ N L G++ +LT L N +
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 26/134 (19%), Positives = 39/134 (29%), Gaps = 28/134 (20%)
Query: 482 NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSR 541
N R L L + I NL L ++ S
Sbjct: 17 NAVRDRELDLRGYKIPV-----IENLGATL-----------------DQFDA---IDFSD 51
Query: 542 NNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV-IPTSL 600
N + + L+ L+ L + NNR+ L L L L+ N + + L
Sbjct: 52 NEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 109
Query: 601 EKLLYLKKLNLSFN 614
L L L + N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 3/90 (3%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
+N LDL G K+ I + L + + N++ R + L +L L+++
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKTLLVN 72
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTS 498
N+ L L L L +N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 20/120 (16%), Positives = 40/120 (33%), Gaps = 14/120 (11%)
Query: 259 NMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNAS---KLTVF 315
N ++L L + + + +L + ++ S N + +L
Sbjct: 17 NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDF-----SDNEIRKLDGFPLLRRLKTL 69
Query: 316 QLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL 375
+ N L +L L + +N L EL L L + + + L + NP+
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 26/141 (18%), Positives = 40/141 (28%), Gaps = 29/141 (20%)
Query: 86 PQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI 145
Q N LDL K+ I + + +DF DN++ + G
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----------RKLDGF 60
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSG-A 204
L LK LL+ N L L L N+L
Sbjct: 61 P----------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 205 IPKEIGNLTKLKDIILNDNEL 225
+ +L L + + N +
Sbjct: 105 DLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 12/115 (10%)
Query: 159 NICKNLPNLKKLLLGRNMFHGKIPS--TLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
N+ L + N +I ++L+ L + N + L L
Sbjct: 36 NLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91
Query: 217 DIILNDNELR--GEIPQEMGNLPYLVRLTLATNNLVGVV---PFTIFNMSTLKKL 266
++IL +N L G++ + +L L L + N + + I+ + ++ L
Sbjct: 92 ELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 3/96 (3%)
Query: 536 ELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISG 594
EL L+ N L + G L +L KL L N+L G P +F G S ++ L L +NKI
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92
Query: 595 VIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+ L LK LNL N++ + G F +L
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC-VMPGS-FEHLN 126
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 407 VISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDK 464
+ L +L+ L+L N+LT I F ++Q L L NK+ + I +++ L +L
Sbjct: 49 LFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKT 106
Query: 465 LILHGNKFSGAIPSCSGNLTSLRALYLGSN 494
L L+ N+ S +P +L SL +L L SN
Sbjct: 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 4/107 (3%)
Query: 366 RVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLT 425
L+L N L I + L + ++ +++G P S++ L LG NK+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 426 GSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGN 470
I F L L+ L L N++ + HL L L L N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 40/154 (25%), Positives = 57/154 (37%), Gaps = 41/154 (26%)
Query: 478 SCSGN--------LTSL--------RALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLD 521
C G L + L L N + F
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGL--------FG------- 51
Query: 522 GPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE-SFSGLS 580
L +++L L RN L+G P G ++Q+L L N+++ I F GL
Sbjct: 52 --------RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLH 102
Query: 581 SLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
L+ L+L N+IS V+P S E L L LNL+ N
Sbjct: 103 QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ L+ N + LP+L KL L RN G P+ ++ L L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 205 IPKEI-GNLTKLKDIILNDNELRGEIPQEMG---NLPYLVRLTLATN 247
I ++ L +LK + L DN++ + G +L L L LA+N
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 33/143 (23%), Positives = 53/143 (37%), Gaps = 31/143 (21%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCS-GNLTSLRALYLGSNRFTSALPSTIWNLKD 509
IP +I +L+L+ N+ G L L L L N+ T +
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNA----- 73
Query: 510 ILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANNRL 568
F+ + EL L N + +I + GL L+ L L +N++
Sbjct: 74 ---FE---------------GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
Query: 569 EGPIPE-SFSGLSSLEILDLSKN 590
+ SF L+SL L+L+ N
Sbjct: 115 SC-VMPGSFEHLNSLTSLNLASN 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 43/266 (16%), Positives = 79/266 (29%), Gaps = 46/266 (17%)
Query: 389 SLERFQMFNCRISGK----IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL----NLQG 440
S+E + I+ + + V+ ++ + L GN + S + +L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 441 LGLAFNKL----------ARSIPDEICHLAKLDKLILHGNKFS--GAIPSCSG--NLTSL 486
+ R + + KL + L N F P T L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 487 RALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSG 546
LYL +N P + L + L + RN L
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPPL--------RSIICGRNRLEN 173
Query: 547 D----IPITIGGLKNLQKLFLANNRL-----EGPIPESFSGLSSLEILDLSKNKISG--- 594
T + L + + N + E + E + L++LDL N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 595 -VIPTSLEKLLYLKKLNLSFNKLEGE 619
+ +L+ L++L L+ L
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 55/367 (14%), Positives = 117/367 (31%), Gaps = 80/367 (21%)
Query: 88 LGNLSSLETLDLSHNKLSG----NIPSSIFNMHTLKLLDFRDNQL----FGSLSSFIFNM 139
+ S +E L + ++ ++ + + ++K + N + LS I +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 140 SSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFN 199
+ + S F+G + I + L L + L KC +L + L N
Sbjct: 60 KDLEIAEFSDI-FTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDN 104
Query: 200 NLSG----AIPKEIGNLTKLKDIILNDNELRGEIPQEMGN-LPYLVRLTLATNNLVGVVP 254
+ + T L+ + L++N L + ++ L L A N
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA------ 158
Query: 255 FTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTV 314
L+ + N L N + + L
Sbjct: 159 ------PPLRSIICGRNRL---------------------ENGSMKEWAKTFQSHRLLHT 191
Query: 315 FQLRGNSF-----SGFIPNTIGNLRNLEFLNIADNYLTSS-TPELSFLSSLTNCQKIRVL 368
++ N + + + L+ L++ DN T + L+ +L + +R L
Sbjct: 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA--IALKSWPNLREL 249
Query: 369 ILAGNPLD-----GILPSSIGNLSISLERFQMFNCRISGKIPQVI-----SNLSNLLLLD 418
L L ++ + +I L+ ++ I + + + +LL L+
Sbjct: 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309
Query: 419 LGGNKLT 425
L GN+ +
Sbjct: 310 LNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 58/331 (17%), Positives = 115/331 (34%), Gaps = 67/331 (20%)
Query: 334 RNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERF 393
++E ++ + +T+ + S + L ++ ++L+GN +IG +
Sbjct: 4 FSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGN--------TIGTEA------ 48
Query: 394 QMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL-------NLQGLGLAFN 446
R + +L D+ ++ IP LL L + L+ N
Sbjct: 49 ----ARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104
Query: 447 KL----ARSIPDEICHLAKLDKLILHGNKFS-------------GAIPSCSGNLTSLRAL 489
+ D + L+ L LH N A+ + N LR++
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 490 YLGSNRFT----SALPSTIWNLKDILFFDVSSNSL-----DGPLSLDIGNLKVVIELNLS 540
G NR T + + + + N + + L + + + L+L
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224
Query: 541 RNNLSGD----IPITIGGLKNLQKLFLANNRL--EG--PIPESFSGLS--SLEILDLSKN 590
N + + I + NL++L L + L G + ++FS L L+ L L N
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284
Query: 591 KISGVIPTSLEKLLY-----LKKLNLSFNKL 616
+I +L+ ++ L L L+ N+
Sbjct: 285 EIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 60/333 (18%), Positives = 110/333 (33%), Gaps = 80/333 (24%)
Query: 181 IPSTLSKCKQLEGLYLRFNNLSG----AIPKEIGNLTKLKDIILNDN---ELRGEIPQEM 233
+ + L + ++ + L N + + + I + L+ +D ++ EIP+ +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 234 GNL-------PYLVRLTLATNNL--VGVVPFT--IFNMSTLKKLSLLEN----------- 271
L P L + L+ N P + + L+ L L N
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 272 -TLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTI 330
L ++ + P + + G NR N T
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRL--------------------ENGSMKEWAKTF 183
Query: 331 GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL--DGI--LPSSIGNL 386
+ R L + + N + E L L CQ+++VL L N G L ++ +
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 387 SISLERFQMFNCRISGK----IPQVISNLSN--LLLLDLGGNKLTGSIPVTFSRLLNLQG 440
+L + +C +S + + S L N L L L N++
Sbjct: 244 P-NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD------------- 289
Query: 441 LGLAFNKLARSIPDEICHLAKLDKLILHGNKFS 473
A L I +++ L L+ L+GN+FS
Sbjct: 290 ---AVRTLKTVIDEKMPDLLFLE---LNGNRFS 316
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 53/235 (22%)
Query: 723 QATDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVK-VF-HQRYE-RALKSFQDECEVMKR 778
+ DRF + G G+FG+V + + + GM VA+K V R+ R L+ + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAV 75
Query: 779 IRHRNLVKII-------SACSNDDFKALIMEYMP---NGSLENRLYSGTCMLDIFQRLNI 828
+ H N+V++ D + ++MEY+P + N I ++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-F 134
Query: 829 MIDVALALEYLHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQ 875
+ + ++ LH S + H + DF AK L+ +
Sbjct: 135 LFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VA 190
Query: 876 TLATIGYMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ + Y APE Y +T D++S G + E G +P IF G+
Sbjct: 191 YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKII 788
LG+G+FG V V + G +VAVK+ +++ + + E + +K RH +++K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGH 843
S ++MEY+ G L + + + +FQ++ + ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LS---GVDYCH--- 133
Query: 844 STPIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLATIG---YM 883
+MV H I+DF ++ ++ + L +T + G Y
Sbjct: 134 -----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RT----SCGSPNYA 182
Query: 884 APEYGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL 924
APE + GR D++S G++L G P D+ + L
Sbjct: 183 APEV-ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 46/172 (26%), Positives = 62/172 (36%), Gaps = 40/172 (23%)
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLT 360
IP+ T L NS L +L L + N L S P F + LT
Sbjct: 25 GIPAQTTY------LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVF-NKLT 76
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
+ L L+ N L SL V L+ L L L
Sbjct: 77 SLTY---LNLSTNQLQ------------SLP-------------NGVFDKLTQLKELALN 108
Query: 421 GNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGN 470
N+L S+P F +L L+ L L N+L +S+PD + L L + LH N
Sbjct: 109 TNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 10/125 (8%)
Query: 379 LPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLN 437
S + + + V L++L L LGGNKL S+P F++L +
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 438 LQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGAIPSCSG---NLTSLRALYLGS 493
L L L+ N+L +S+P+ + L +L +L L+ N+ ++P G LT L+ L L
Sbjct: 78 LTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLP--DGVFDKLTQLKDLRLYQ 133
Query: 494 NRFTS 498
N+ S
Sbjct: 134 NQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 478 SCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIEL 537
SCSG ++ +++P+ I L D+ +NSL + L + +L
Sbjct: 6 SCSGTTVEC------YSQGRTSVPTGIPAQTTYL--DLETNSLKSLPNGVFDELTSLTQL 57
Query: 538 NLSRNNLSGDIPITI-GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L N L +P + L +L L L+ N+L+ F L+ L+ L L+ N++ +
Sbjct: 58 YLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLP 116
Query: 597 PTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
+KL LK L L N+L+ +P G F LT
Sbjct: 117 DGVFDKLTQLKDLRLYQNQLKS-VPDGV-FDRLT 148
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 45/155 (29%), Positives = 66/155 (42%), Gaps = 34/155 (21%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGA 475
LDL N L F L +L L L NKL S+P+ + L L L L N+ +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 476 IPSCSG---NLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLK 532
+P +G LT L+ L L +N+ S LP + FD + LK
Sbjct: 91 LP--NGVFDKLTQLKELALNTNQLQS-LPDGV--------FD------------KLTQLK 127
Query: 533 VVIELNLSRNNLSGDIPITI-GGLKNLQKLFLANN 566
+L L +N L +P + L +LQ ++L +N
Sbjct: 128 ---DLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 45/154 (29%), Positives = 61/154 (39%), Gaps = 28/154 (18%)
Query: 439 QGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTS 498
L L N L L L +L L GNK LTSL L L +N+ S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 499 ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITI-GGLKN 557
LP+ + FD L LK EL L+ N L +P + L
Sbjct: 91 -LPNGV--------FD----KL--------TQLK---ELALNTNQLQS-LPDGVFDKLTQ 125
Query: 558 LQKLFLANNRLEGPIPE-SFSGLSSLEILDLSKN 590
L+ L L N+L+ +P+ F L+SL+ + L N
Sbjct: 126 LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 41/135 (30%), Positives = 59/135 (43%), Gaps = 7/135 (5%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLSIN 150
+ LDL N L + +L L N+L SL + +FN + L +LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTN 86
Query: 151 RFSGELPANICKNLPNLKKLLLGRNMFHGKIPS-TLSKCKQLEGLYLRFNNLSGAIPKEI 209
+ LP + L LK+L L N +P K QL+ L L N L ++P +
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 210 -GNLTKLKDIILNDN 223
LT L+ I L+DN
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 45/217 (20%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYE--RALKSFQDECEVMK 777
R+ +G G+ G V A VA+K F + RA + E +MK
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79
Query: 778 RIRHRNLVKI----ISACSNDDFKA--LIMEYMP---NGSLENRLYSGTCMLDIFQRLNI 828
+ H+N++ + S ++F+ ++ME M ++ L ++Q L
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC- 138
Query: 829 MIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQT 876
+++L HS IIH +V I DF +A+ M T
Sbjct: 139 ------GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 186
Query: 877 LATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913
+ T Y APE + D++S G ++ E G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 4/92 (4%)
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKL 462
V L+ L L L N++ S+P F +L L L L NKL +S+P+ + L +L
Sbjct: 45 HGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKLTQL 102
Query: 463 DKLILHGNKFSGAIPSCSGNLTSLRALYLGSN 494
+L L N+ LTSL+ ++L +N
Sbjct: 103 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGA 475
L+L NKL F +L L L L+ N++ +S+PD + L KL L LH NK +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 476 IPSCSG---NLTSLRALYLGSNRFTS 498
+P +G LT L+ L L +N+ S
Sbjct: 91 LP--NGVFDKLTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/72 (34%), Positives = 36/72 (50%), Gaps = 2/72 (2%)
Query: 559 QKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEG 618
+L L +N+L+ F L+ L L LS+N+I + +KL L L L NKL+
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 619 EIPRGGPFANLT 630
+P G F LT
Sbjct: 90 SLPN-GVFDKLT 100
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 48/155 (30%), Positives = 66/155 (42%), Gaps = 31/155 (20%)
Query: 439 QGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSG---NLTSLRALYLGSNR 495
Q L L N++ + P L L +L L N+ A+P G +LT L L LG+N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSLTQLTVLDLGTNQ 99
Query: 496 FTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGL 555
T LPS + FD L +LK EL + N L+ +P I L
Sbjct: 100 LTV-LPSAV--------FD----------RL--VHLK---ELFMCCNKLTE-LPRGIERL 134
Query: 556 KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKN 590
+L L L N+L+ +F LSSL L N
Sbjct: 135 THLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 6/131 (4%)
Query: 95 ETLDLSHNKLSGNIPSSIFNMHT-LKLLDFRDNQLFGSLSSFIFNMSSMLGI-DLSINRF 152
+ L L N+++ + +F+ LK L NQL G+L +F+ + L + DL N+
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL 100
Query: 153 SGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNL 212
+ LP+ + L +LK+L + N ++P + + L L L N L L
Sbjct: 101 T-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158
Query: 213 TKLKDIILNDN 223
+ L L N
Sbjct: 159 SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 45/180 (25%), Positives = 66/180 (36%), Gaps = 53/180 (29%)
Query: 451 SIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI 510
S+P I L LH N+ + P +L +L+ LYLGSN+ + LP +
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGV------ 83
Query: 511 LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEG 570
FD L L L L N+L
Sbjct: 84 --FD---------------------------------------SLTQLTVLDLGTNQLTV 102
Query: 571 PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLT 630
F L L+ L + NK++ +P +E+L +L L L N+L+ IP G F L+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGA-FDRLS 159
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 49/188 (26%), Positives = 70/188 (37%), Gaps = 61/188 (32%)
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVG 251
+ LYL N ++ P +L LK++ L N+L LP VG
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG--------ALP------------VG 82
Query: 252 VVPFTIFN-MSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNAS 310
V F+ ++ L L L N L LPS + L +++ L + N
Sbjct: 83 V-----FDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCN-------------- 122
Query: 311 KLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSF--LSSLTNCQKIRVL 368
+L +P I L +L L + N L S P +F LSSLT+
Sbjct: 123 -----KLTE------LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTH------A 164
Query: 369 ILAGNPLD 376
L GNP D
Sbjct: 165 YLFGNPWD 172
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDL 587
+ + L+ L+ I + L L+KL L++NR+ G + +L L+L
Sbjct: 38 TDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 588 SKNKISGV-IPTSLEKLLYLKKLNLSFN 614
S NKI + L+KL LK L+L
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 535 IELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISG 594
+ L+ SR+N G + + L+ L N L + L+ L+ L+LS N++SG
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSG 78
Query: 595 VIPTSLEKLLYLKKLNLSFNKLE--GEIPRGGPFANLTAKSFLGNEL 639
+ EK L LNLS NK++ I NL + E+
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/138 (18%), Positives = 51/138 (36%), Gaps = 28/138 (20%)
Query: 458 HLAKLDKLILHGNKFS-GAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVS 516
+ + +L+L ++ + G + + L L + TS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS------------------ 56
Query: 517 SNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGP-IPES 575
+ + L + +L LS N +SG + + NL L L+ N+++ E
Sbjct: 57 ---IAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 576 FSGLSSLEILDLSKNKIS 593
L +L+ LDL +++
Sbjct: 109 LKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 4/100 (4%)
Query: 397 NCRIS-GKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
N R + GK+ + L L LT SI +L L+ L L+ N+++ +
Sbjct: 26 NSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVL 83
Query: 456 ICHLAKLDKLILHGNKFSG-AIPSCSGNLTSLRALYLGSN 494
L L L GNK + L +L++L L +
Sbjct: 84 AEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 20/104 (19%), Positives = 37/104 (35%), Gaps = 3/104 (2%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ L +R + + L+ L I + L K +L+ L L N +SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 205 IPKEIGNLTKLKDIILNDNELRG-EIPQEMGNLPYLVRLTLATN 247
+ L + L+ N+++ + + L L L L
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 31/145 (21%), Positives = 52/145 (35%), Gaps = 34/145 (23%)
Query: 308 NASKLTVFQLRGNSFS-GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIR 366
S + L + + G + LEFL+ + LTS +++L K++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-------IANLPKLNKLK 67
Query: 367 VLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTG 426
L L+ N R+SG + + NL L+L GNK+
Sbjct: 68 KLELSDN-------------------------RVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
Query: 427 -SIPVTFSRLLNLQGLGLAFNKLAR 450
S +L NL+ L L ++
Sbjct: 103 LSTIEPLKKLENLKSLDLFNCEVTN 127
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 6/99 (6%)
Query: 79 NLQGTIPPQLGNLSSLETLDLSHNKLS--GNIPSSIFNMHTLKLLDFRDNQLFGSLSSFI 136
+ +G + LE L + L+ N+P ++ LK L+ DN++ G L
Sbjct: 29 SNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLA 84
Query: 137 FNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175
++ ++LS N+ K L NLK L L
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 33/140 (23%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRN 783
D + +LG+G G V + + A+K+ + E E+ R + +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 784 LVKIISAC----SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLN----------IM 829
+V+I+ + ++ME + G L +R I R + IM
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSR---------IQDRGDQAFTEREASEIM 123
Query: 830 IDVALALEYLHFGHSTPIIH 849
+ A++YL HS I H
Sbjct: 124 KSIGEAIQYL---HSINIAH 140
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 35/119 (29%), Positives = 47/119 (39%), Gaps = 5/119 (4%)
Query: 524 LSLDIGNLKVVIELNLS-RNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSL 582
L L V EL L + G I NL+ L L N L + L L
Sbjct: 16 LELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKL 73
Query: 583 EILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE--GEIPRGGPFANLTAKSFLGNEL 639
+ L+LS+N+I G + EKL L LNLS NKL+ + L + E+
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 10/120 (8%)
Query: 308 NASKLTVFQLRGNSFS-GFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIR 366
+ + L + G I NLEFL++ + L S +S+L K++
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------VSNLPKLPKLK 74
Query: 367 VLILAGNPLDGILPSSIGNLSISLERFQMFNCRISG-KIPQVISNLSNLLLLDLGGNKLT 425
L L+ N + G L L +L + ++ + + L L LDL ++T
Sbjct: 75 KLELSENRIFGGLDMLAEKLP-NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 6/99 (6%)
Query: 79 NLQGTIPPQLGNLSSLETLDLSHNKLS--GNIPSSIFNMHTLKLLDFRDNQLFGSLSSFI 136
+ G I +LE L L + L N+P + LK L+ +N++FG L
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLA 91
Query: 137 FNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175
+ ++ ++LS N+ K L LK L L
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 26/127 (20%), Positives = 44/127 (34%), Gaps = 8/127 (6%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGA 204
+ L + + + NL+ L L + S L K +L+ L L N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86
Query: 205 IPKEIGNLTKLKDIILNDNELR--GEIPQEMGNLPYLVRLTLATN---NLVGVVPFTIFN 259
+ L L + L+ N+L+ + + + L L L L NL
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKL 145
Query: 260 MSTLKKL 266
+ L L
Sbjct: 146 LPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 5/101 (4%)
Query: 410 NLSNLLLLDLGGNKLT-GSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
+ + L L K G I + +NL+ L L L S+ + + L KL KL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELS 79
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKD 509
N+ G + + L +L L L N+ ST+ LK
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKK 118
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 25/113 (22%), Positives = 44/113 (38%), Gaps = 7/113 (6%)
Query: 361 NCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLG 420
+R L+L + + ++LE + N + + + L L L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 421 GNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKL---ILHGN 470
N++ G + + +L NL L L+ NKL + L KL+ L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 60/226 (26%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFH-----QRYERALKSFQDECEVMKRIRHRNLVK 786
LLG G+FG V + + + A+K+ + E + E V++ RH L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTA 212
Query: 787 IISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDVA 833
+ + D +MEY G L E+R Y ++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIV 258
Query: 834 LALEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTL-ATI 880
AL+YLH + +++ HI +DF + K +T T
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTP 313
Query: 881 GYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
Y+APE ++ R D + G+++ E G+ P +++F
Sbjct: 314 EYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 47/220 (21%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKII 788
LG GSFG V +A + +VA+K ++ + E +K +RH +++K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 789 SACSNDDFKALIMEYMPNGSLENRLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGH 843
+ +++EY G L + + M FQ++ I A+EY H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI---IC---AIEYCH--- 125
Query: 844 STPIIHYMVAH-----------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+ + H I+DF ++ + + L + Y APE
Sbjct: 126 -----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---YAAPE 177
Query: 887 YGVQGR--VSTRGDVYSYGIMLMETFTGKKPTDEIFIGEL 924
+ G+ DV+S GI+L G+ P D+ FI L
Sbjct: 178 V-INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 51/244 (20%), Positives = 93/244 (38%), Gaps = 49/244 (20%)
Query: 702 SSNDGINSPQAIRRFSYHELLQAT----DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK 756
+ + ++ + +F E+ +T R+ +G G+ G V A VA+K
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 757 ----VFHQRYE--RALKSFQDECEVMKRIRHRNLVKII----SACSNDDFKA--LIMEYM 804
F + RA + E +MK + H+N++ ++ + ++F+ L+ME M
Sbjct: 94 KLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 805 P---NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH 854
++ L ++Q L +++L HS IIH +V
Sbjct: 150 DANLCQVIQMELDHERMSYLLYQML-------CGIKHL---HSAGIIHRDLKPSNIVVKS 199
Query: 855 -----ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMET 909
I DF +A+ M T + T Y APE + D++S G ++ E
Sbjct: 200 DCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 910 FTGK 913
K
Sbjct: 257 VRHK 260
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 1e-06
Identities = 19/98 (19%), Positives = 40/98 (40%), Gaps = 14/98 (14%)
Query: 536 ELNLSRNNLSGDIPITI-------GGLKNLQKLFLANNRLEGPIPESFSG---LSSLEIL 585
L + + D + + NL+ L + + + + E F L LE +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 586 DLSKNKISGV----IPTSLEKLLYLKKLNLSFNKLEGE 619
D+S ++ + ++K+ +LK +N+ +N L E
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 8e-06
Identities = 26/164 (15%), Positives = 57/164 (34%), Gaps = 18/164 (10%)
Query: 459 LAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSA-----LPSTIWNLKDI-LF 512
L + L K + + +L++L + S + L S + NL+ + L+
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 513 FDVSSNSLDGPLS-----LDIGNLKVVIELNLSRNNLSGDIPITIGG---LKNLQKLFLA 564
V DG ++ + L + + L L+ + ++
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 565 NNRL--EG--PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLL 604
L EG + + + L+ +++ N +S + L+K L
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 22/181 (12%), Positives = 58/181 (32%), Gaps = 28/181 (15%)
Query: 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG- 234
+ + L L L ++ N + LK + + L + +++
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215
Query: 235 -NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL 293
+LP L +L L + +++ PN+++L +
Sbjct: 216 SDLPNLEKLVLYVGVE---------DYGFDGDMNVFRPLFSKD-------RFPNLKWLGI 259
Query: 294 GTNRFSGNIPSSITNA---SKLTVFQLRGNSFSGF----IPNTIGNLRNLEFLNIADNYL 346
+ + +L + + + + + +++L+F+N+ NYL
Sbjct: 260 VDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
Query: 347 T 347
+
Sbjct: 320 S 320
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 77/515 (14%), Positives = 157/515 (30%), Gaps = 89/515 (17%)
Query: 147 LSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIP 206
+++ P + + PNL+ L L + L N G +
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSL-------------KLKGKPRAAMFNLIPENWGGYVT 101
Query: 207 KEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL--VGVVPFTIFNMSTLK 264
+ ++ NL L + + + + L+
Sbjct: 102 PWVTEISN--------------------NLRQLKSVHFRRMIVSDLDLDRLAKARADDLE 141
Query: 265 KLSLLENTLWGSL-PSRIDLSLPNVEFLNLGTNRFSGNIPSSI----TNASKLTVFQLRG 319
L L + + + + I ++ L + + FS + + + L V
Sbjct: 142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYM 201
Query: 320 NSFSGFIPNTI----GNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPL 375
F+ P + N R+L + + D + + F + N ++ L +
Sbjct: 202 TEFAKISPKDLETIARNCRSLVSVKVGDFEILEL---VGFFKAAANLEEFCGGSLNEDIG 258
Query: 376 DGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVT-FSR 434
++ L R + + +P + + + LDL L T +
Sbjct: 259 MPEKYMNLVFPR-KLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQK 316
Query: 435 LLNLQGLGLAFNKLARSIPDE-ICHLA----KLDKLILHGNKFSGAIPSCSGNLT----- 484
NL+ L + I D + LA +L +L + + G ++
Sbjct: 317 CPNLEVL-----ETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371
Query: 485 -------SLRALYLGSNRFT----SALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKV 533
L + + + T ++ + + NL D + L LD G +
Sbjct: 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL 431
Query: 534 VIEL-NLSRNNLSGD-IPITIGGL-------KNLQKLFLANNRL--EGPIPESFSGLSSL 582
+I L R +T GL N++ + L EG + E G +L
Sbjct: 432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-LMEFSRGCPNL 490
Query: 583 EILDLSKNKISGV-IPTSLEKLLYLKKLNLSFNKL 616
+ L++ S I ++ KL L+ L + +
Sbjct: 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 47/257 (18%), Positives = 81/257 (31%), Gaps = 75/257 (29%)
Query: 725 TDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
+ ++S LG GSFG V + G A+K Q + E ++MK + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 784 LVKIIS---ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL- 839
++K++ +++ K N + + + + +EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 840 --------HFGHST---PIIH---YM--------------VAH----------------- 854
F S P+ Y+ + H
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 855 -ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-------YGVQGRVSTRGDVYSYGIML 906
+ DF AK L + + + Y APE Y + D++S G +
Sbjct: 182 KLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVF 232
Query: 907 METFTGKKPTDEIFIGE 923
E G KP +F GE
Sbjct: 233 GELILG-KP---LFSGE 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 40/211 (18%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
++ K +G G++G+V+ A+ + VA+K + AL+ E ++K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
++H+N+V++ +D L+ E+ L+ S LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
HS ++H +++F +A+ + + + T+ Y P+
Sbjct: 117 C---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPD 171
Query: 887 --YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+G + ST D++S G + E +P
Sbjct: 172 VLFGAK-LYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 29/131 (22%), Positives = 55/131 (41%), Gaps = 15/131 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
+++ K +G GS+G V+ R G VA+K F + + AL+ E ++K+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
++H NLV ++ L+ EY + ++ + L + +I A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 839 LHFGHSTPIIH 849
H IH
Sbjct: 118 C---HKHNCIH 125
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 69/490 (14%), Positives = 154/490 (31%), Gaps = 59/490 (12%)
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAI 205
+ I PA + + P ++ + L ++ A+
Sbjct: 47 KVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE------AM 100
Query: 206 PKEIGNLTKL--KDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIF--NMS 261
L ++ K +++ D+ L I + + L L++
Sbjct: 101 SSSYTWLEEIRLKRMVVTDDCLE-LIAK---SFKNFKVLVLSSCEGFSTDGLAAIAATCR 156
Query: 262 TLKKLSLLENTLW---GSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNAS-------- 310
LK+L L E+ + G S + ++ LN+ + S ++ ++
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI------SCLASEVSFSALERLVTRC 210
Query: 311 -KLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS-LTNCQKIRVL 368
L +L + + LE L S LS L+ C+++R L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 369 ILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK-IPQVISNLSNLLLLDLGGNKLTGS 427
+ + LP ++ ++ L + + + +++ L L +
Sbjct: 271 SGFWDAVPAYLP-AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAG 329
Query: 428 IPVTFSRLLNLQGLGLAFNKLARSIPDE----------ICHLAKLDKLILHGNKFSG--- 474
+ V S +L+ L + ++ P+ KL+ ++ + +
Sbjct: 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389
Query: 475 -AIPSCSGNLTSLR--------ALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
I N+T R YL + + + KD+ +S D
Sbjct: 390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFE 449
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITIG-GLKNLQKLFLANNRL-EGPIPESFSGLSSLE 583
K + L+++ S + G +L+KL + + + + + S L ++
Sbjct: 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509
Query: 584 ILDLSKNKIS 593
L +S +S
Sbjct: 510 SLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 69/389 (17%), Positives = 145/389 (37%), Gaps = 38/389 (9%)
Query: 90 NLSSLETLDLSH-NKLSGNIPSSIF-NMHTLKLLDFRDNQLFG----SLSSFIFNMSSML 143
+ + + L LS S + ++I LK LD R++ + LS F +S++
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 144 GIDLSI--NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRF--- 198
+++S + S + PNLK L L R + K+ + L + QLE L
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 199 ---NNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNL--VGVV 253
++ + + +L+ + + + +P L L L+ + +V
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307
Query: 254 PFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL-GTNRFSGNIPSSITNASKL 312
+ L++L +L+ L + + ++ L + + F ++T +
Sbjct: 308 KL-LCQCPKLQRLWVLDYIEDAGLEV-LASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365
Query: 313 TVFQ---------LRGNSFSGFIPNTIG-NLRNLEFLNI------ADNYLTSSTPELSFL 356
+V + TI N N+ + A +YLT ++ F
Sbjct: 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFG 425
Query: 357 SSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK-IPQVISNLSNLL 415
+ + +C+ +R L L+G D + IG + +E + S + V+S +L
Sbjct: 426 AIVEHCKDLRRLSLSGLLTDKVF-EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484
Query: 416 LLDLGGNKLTG-SIPVTFSRLLNLQGLGL 443
L++ ++ S+L ++ L +
Sbjct: 485 KLEIRDCPFGDKALLANASKLETMRSLWM 513
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 29/130 (22%), Positives = 54/130 (41%), Gaps = 14/130 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYER------ALKSFQDECEVMKRI 779
+++ K +G G++G VY A+ G VA+K E A++ E ++K +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKEL 76
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
H N+V +I ++ L+ E+M L+ L L Q + + + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 840 HFGHSTPIIH 849
H I+H
Sbjct: 136 ---HQHRILH 142
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 25/68 (36%), Positives = 33/68 (48%), Gaps = 4/68 (5%)
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKL 462
P V L+ L LDL N+LT +P F +L L L L N+L +SIP +L L
Sbjct: 47 PGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSL 104
Query: 463 DKLILHGN 470
+ L N
Sbjct: 105 THIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 8/82 (9%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGA 475
L L N++T P F RL L L L N+L +P + L +L +L L+ N+ +
Sbjct: 35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDNQLK-S 92
Query: 476 IPSCSG---NLTSLRALYLGSN 494
IP G NL SL ++L +N
Sbjct: 93 IP--RGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 2/74 (2%)
Query: 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
Q L+L +N++ P F L+ L LDL N+++ + +KL L +L+L+ N+L
Sbjct: 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90
Query: 617 EGEIPRGGPFANLT 630
+ IPRG F NL
Sbjct: 91 KS-IPRGA-FDNLK 102
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 51/219 (23%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYERALKSFQDECEVMKRI 779
D + LG G + V+ A + + +V VK V ++ +R +K +++ +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-------ILENL 87
Query: 780 R-HRNLVKII----SACSNDDFKALIMEYMPNGSLENRLYSGTCMLDI----FQRLNIMI 830
R N++ + S AL+ E++ N +LY DI ++ L
Sbjct: 88 RGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEILK--- 141
Query: 831 DVALALEYLHFGHSTPIIH-------YMVAH------ISDFSIAKFLNGQDQLSMQTQTL 877
AL+Y H S I+H M+ H + D+ +A+F + + +
Sbjct: 142 ----ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRV 191
Query: 878 ATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKP 915
A+ + PE V ++ D++S G ML K+P
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 52/226 (23%), Positives = 81/226 (35%), Gaps = 61/226 (26%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFH-----QRYERALKSFQDECEVMKRIRHRNLVK 786
LLG G+FG V + R + A+K+ + E + E V++ RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 69
Query: 787 IISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDVA 833
+ A D +MEY G L E R Y ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115
Query: 834 LALEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQLSMQTQTL-ATI 880
ALEYL HS +++ HI +DF + K D +T T
Sbjct: 116 SALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISD--GATMKTFCGTP 169
Query: 881 GYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
Y+APE ++ R D + G+++ E G+ P + +F
Sbjct: 170 EYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
+++ L+G GS+G V R G VA+K F + + A++ E +++K+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQ 80
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+RH NLV ++ C L+ E++ + ++ + L LD + + + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 839 LHFGHSTPIIH 849
HS IIH
Sbjct: 140 C---HSHNIIH 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 24/130 (18%), Positives = 52/130 (40%), Gaps = 14/130 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYER------ALKSFQDECEVMKRI 779
+++ +G G++G VY A+ G A+K E ++ E ++K +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+H N+VK+ L+ E++ L+ L L+ + ++ + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 840 HFGHSTPIIH 849
H ++H
Sbjct: 117 ---HDRRVLH 123
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 26/68 (38%), Positives = 33/68 (48%), Gaps = 4/68 (5%)
Query: 405 PQVISNLSNLLLLDLGGNKLTGSIPV-TFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKL 462
P V +L NL L NKLT +IP F +L L L L N L +SIP +L L
Sbjct: 50 PGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHL-KSIPRGAFDNLKSL 107
Query: 463 DKLILHGN 470
+ L+ N
Sbjct: 108 THIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 31/82 (37%), Positives = 42/82 (51%), Gaps = 8/82 (9%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEIC-HLAKLDKLILHGNKFSGA 475
L L N++T P F L+NLQ L NKL +IP + L +L +L L+ N +
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDNHLK-S 95
Query: 476 IPSCSG---NLTSLRALYLGSN 494
IP G NL SL +YL +N
Sbjct: 96 IP--RGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 557 NLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKL 616
+ Q+L+L NN++ P F L +L+ L + NK++ + +KL L +L+L+ N L
Sbjct: 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93
Query: 617 EGEIPRGGPFANLT 630
+ IPRG F NL
Sbjct: 94 KS-IPRGA-FDNLK 105
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 49/272 (18%), Positives = 95/272 (34%), Gaps = 24/272 (8%)
Query: 254 PFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNL-GTNRFSGNIPSSITNASKL 312
P + + ++ + P S V+ ++L + + ++ SKL
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 313 TVFQLRGNSFSGFIPNTIGNLRNLEFLNIAD-NYLTSSTPELSFLSSLTNCQKIRVLILA 371
L G S I NT+ NL LN++ + + L L S +C ++ L L+
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA--LQTLLS--SCSRLDELNLS 176
Query: 372 GNPL--DGILPSSIGNLSISLERFQMFNCR--ISGK-IPQVISNLSNLLLLDLGG-NKLT 425
+ + ++ ++S ++ + + R + + ++ NL+ LDL L
Sbjct: 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236
Query: 426 GSIPVTFSRLLNLQGLGLAFNKLARSIPDE----ICHLAKLDKLILHGNKFSGAIPSCSG 481
F +L LQ L L+ I E + + L L + G G +
Sbjct: 237 NDCFQEFFQLNYLQHLSLSRC---YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 293
Query: 482 NLTSLRAL-----YLGSNRFTSALPSTIWNLK 508
L L+ + + IW +K
Sbjct: 294 ALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 41/233 (17%)
Query: 709 SPQAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK--------VFH 759
+ A ++ R++ + +G G++G V A + + VA+K +
Sbjct: 10 AAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC 69
Query: 760 QRYERALKSFQDECEVMKRIRHRNLVK---IISACSNDDFKA--LIMEYMPNGSLENRLY 814
QR R +K ++ R RH N++ II A + + K ++ + M L L
Sbjct: 70 QRTLREIK-------ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK 121
Query: 815 SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAK 862
+ D + + L+Y+ HS ++H ++ I DF +A+
Sbjct: 122 TQHLSNDHIC--YFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 863 FLNGQ-DQLSMQTQTLATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
+ D T+ +AT Y APE + + T+ D++S G +L E + +
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 48/218 (22%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYE--RALKSFQDECEVMK 777
+ +G G++GSV A + G +VA+K F RA + E ++K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78
Query: 778 RIRHRNLVKI----ISACSNDDFKA--LIMEYMP---NGSLENRLYSGTCMLDIFQRLNI 828
++H N++ + A S +F L+M +M + + ++Q L
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137
Query: 829 MIDVALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQT 876
L+Y+ HS ++H V I DF +A+ + + T
Sbjct: 138 ------GLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183
Query: 877 LATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
+ T Y APE + + D++S G ++ E TGK
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 703 SNDGINSPQAIRRFSYHELLQA----TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKV 757
++ + Q F EL + +R+ + +G G++GSV A + G+ VAVK
Sbjct: 2 AHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 61
Query: 758 FHQRYE------RALKSFQDECEVMKRIRHRNLVKI----ISACSNDDFKA--LIMEYMP 805
+ ++ R + E ++K ++H N++ + A S ++F L+ M
Sbjct: 62 LSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 117
Query: 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH-------YMVAH---- 854
L N + D Q ++ + L+Y+ HS IIH V
Sbjct: 118 A-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCEL 171
Query: 855 -ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTG 912
I DF +A+ T +AT Y APE + + D++S G ++ E TG
Sbjct: 172 KILDFGLARHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 913 K 913
+
Sbjct: 227 R 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 27/126 (21%), Positives = 53/126 (42%), Gaps = 24/126 (19%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH-RNLVKIISAC 791
+G G+FG + + + L VA+K+ + E K++ + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 792 SNDDFKALIMEYMPNG-SLE------NRLYSGTCMLDI-FQRLNIMIDVALALEYLHFGH 843
+ A+++E + G SLE +R +S +L I Q +I +EY+ H
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQ----LIS---RMEYV---H 122
Query: 844 STPIIH 849
S +I+
Sbjct: 123 SKNLIY 128
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 83/238 (34%)
Query: 733 LLGIGSFGSVYVARLQDGMEV----AVKVF-----------HQRYERALKSFQDECEVMK 777
+LG GSFG V++ + G + A+KV + ER +++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER---------DILV 81
Query: 778 RIRHRNLVKIISACSNDDFKALIMEYMPNGSL-----------EN--RLYSGTCMLDIFQ 824
+ H +VK+ A + LI++++ G L E + Y
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-------- 133
Query: 825 RLNIMIDVALALEYLHFGHSTPII---------------HYMVAHISDFSIAKFLNGQDQ 869
++ALAL++L HS II H ++DF ++K ++
Sbjct: 134 ------ELALALDHL---HSLGIIYRDLKPENILLDEEGHIK---LTDFGLSKESIDHEK 181
Query: 870 LSMQTQTL-ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
+ + T+ YMAPE V R T+ D +S+G+++ E TG P E
Sbjct: 182 ---KAYSFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 68/230 (29%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDECEVM-KRI-----RHRNLV 785
+LG GSFG V ++ + E+ AVK+ + + ++ EC ++ KR+ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 786 KIISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDV 832
++ S D +MEY+ G L E Y+ ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451
Query: 833 ALALEYLHFGHSTPII---------------HYMVAHISDFSIAKFLNGQDQLSMQTQTL 877
A+ L +L S II H +A DF + K T+T
Sbjct: 452 AIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIA---DFGMCKENIWDGV---TTKTF 502
Query: 878 A-TIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE + + + D +++G++L E G+ P DE+F
Sbjct: 503 CGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 22/125 (17%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH-RNLVKIISAC 791
+G GSFG +Y+ + G EVA+K+ + + E ++ K ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 792 SNDDFKALIMEYMPNG-SLE------NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ D+ ++ME + G SLE +R +S +L + + MI +EY+ HS
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQ---MISR---IEYI---HS 123
Query: 845 TPIIH 849
IH
Sbjct: 124 KNFIH 128
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 44/223 (19%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK--VFHQRYE--RALKSFQDECEVMKRI 779
R+ LG G G V+ A VA+K V AL+ E ++++R+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRL 65
Query: 780 RHRNLVKII------------SACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQR 825
H N+VK+ S + + ++ EYM L N L G + + +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR- 123
Query: 826 LNIMIDVALALEYLHFGHSTPIIH-------------YMVAHISDFSIAKFL-NGQDQLS 871
M + L+Y+ HS ++H +V I DF +A+ +
Sbjct: 124 -LFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 872 MQTQTLATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
++ L T Y +P + T+ D+++ G + E TGK
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 15/125 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVA---VKVFHQRYER------ALKSFQDECEV 775
R+ K + LG G F +VY AR VA +K+ H+ + AL+ E ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR----EIKL 65
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALA 835
++ + H N++ ++ A + +L+ ++M LE + + +L M+
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 836 LEYLH 840
LEYLH
Sbjct: 125 LEYLH 129
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 29/137 (21%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYE--RALKSFQDECEVMK 777
DR+ +L+G GS+G V A + VA+K VF + R L+ E ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107
Query: 778 RIRHRNLVK---IISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDV 832
R+ H ++VK I+ + F +++E + + + + ++ + ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165
Query: 833 ALALEYLHFGHSTPIIH 849
+ ++Y+ HS I+H
Sbjct: 166 LVGVKYV---HSAGILH 179
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 48/327 (14%), Positives = 101/327 (30%), Gaps = 84/327 (25%)
Query: 726 DRFSKNNL-LGIGSFGSVYVARLQD---GMEVAVKVFHQRYERALKSFQDECEVMKRIRH 781
D F +G G++G VY A+ +D + A+K S E +++ ++H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKH 77
Query: 782 RNLVKIISACSNDDFKA--LIMEYMP-------NGSLENRLYSGTCMLDIFQRLNIMIDV 832
N++ + + + L+ +Y ++ L +++ +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 833 ALALEYLHFGHSTPIIH---------YMVAH-------ISDFSIA-KFLNGQDQLSMQTQ 875
+ YL H+ ++H M I+D A F + L+
Sbjct: 138 LDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 876 TLATIGYMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGK--------------- 913
+ T Y APE Y + D+++ G + E T +
Sbjct: 195 VVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 914 --------------KPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQ 959
P D+ + + + + +L+ E++ +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 960 SLLSILN--LATECTIESPGKRINARE 984
+L L + P KRI + +
Sbjct: 309 KAFHLLQKLLTMD-----PIKRITSEQ 330
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 9e-05
Identities = 24/121 (19%), Positives = 51/121 (42%), Gaps = 11/121 (9%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYE-----RALKSFQDECEVMKRI 779
+ + K + LG G++ +VY + VA+K +E A++ E ++K +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
+H N+V + + L+ EY+ L+ L ++++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 840 H 840
H
Sbjct: 117 H 117
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 1e-04
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
+ F K +G G++G VY AR G VA+K E A++ E ++K
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 779 IRHRNLVKIISACSNDDFKALIMEYM 804
+ H N+VK++ ++ L+ E++
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFL 84
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 27/137 (19%), Positives = 59/137 (43%), Gaps = 21/137 (15%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYE--RALKSFQDECEVMK 777
D + +L+G GS+G VY+A VA+K +F + R L+ E ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILN 80
Query: 778 RIRHRNLVK---IISACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDV 832
R++ +++ +I F +++E + L+ + + + + I+ ++
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNL 138
Query: 833 ALALEYLHFGHSTPIIH 849
L ++ H + IIH
Sbjct: 139 LLGENFI---HESGIIH 152
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 51/237 (21%), Positives = 81/237 (34%), Gaps = 79/237 (33%)
Query: 733 LLGIGSFGSVYVARLQDGMEV----AVKVF-------------HQRYERALKSFQDECEV 775
+LG G +G V+ R G A+KV H + ER +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER---------NI 74
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPNGSL-----------EN--RLYSGTCMLDI 822
++ ++H +V +I A LI+EY+ G L E+ Y
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------ 128
Query: 823 FQRLNIMIDVALALEYLHFGHSTPIIHY----------MVAHI--SDFSIAKFLNGQDQL 870
++++AL +L H II+ H+ +DF + K
Sbjct: 129 --------EISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT- 176
Query: 871 SMQTQTLA-TIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
T T TI YMAPE + R D +S G ++ + TG P +
Sbjct: 177 --VTHTFCGTIEYMAPEI-LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 22/125 (17%), Positives = 49/125 (39%), Gaps = 22/125 (17%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRH-RNLVKIISAC 791
+G GSFG ++ L + +VA+K +R + +DE K + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 792 SNDDFKALIMEYMPNG-SLE------NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
L+++ + G SLE R +S + ++ M+ ++ + H
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQ---MLA---RVQSI---HE 124
Query: 845 TPIIH 849
+++
Sbjct: 125 KSLVY 129
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 44/218 (20%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDECEVM-KRI-----RHRNLV 785
+LG GSFG V +AR+++ ++ AVKV + + L+ EC + KRI H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ D +ME++ G L + + R ++ AL +L H
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFL---HDK 143
Query: 846 PII---------------HYMVAHISDFSIAK-FLNGQDQLSMQTQTL-ATIGYMAPEYG 888
II H +A DF + K + T T T Y+APE
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLA---DFGMCKEGICNGV----TTATFCGTPDYIAPEI- 195
Query: 889 VQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
+Q + D ++ G++L E G P D++F
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 13/106 (12%)
Query: 708 NSPQAIRRFSYHELLQAT--DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER 764
Q S AT DR+ + LG G++G VY A VA+K +E
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73
Query: 765 ------ALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804
A++ E ++K ++HRN++++ S ++ LI EY
Sbjct: 74 EGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 27/125 (21%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 734 LGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV-KIISAC 791
+G GSFG +Y+ +Q EVA+K+ + + + E ++ + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 792 SNDDFKALIMEYMPNG-SLE------NRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
D+ L+M+ + G SLE +R S +L + + MI+ +E++H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQ---MIN---RVEFVHSKS- 123
Query: 845 TPIIH 849
+H
Sbjct: 124 --FLH 126
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 68/230 (29%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDECEVMKR------IRHRNLV 785
++G GSFG V +AR + AVKV + + LK +++ + +R ++H LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 786 KIISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDV 832
+ + D +++Y+ G L E R Y+ ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148
Query: 833 ALALEYLHFGHSTPIIH--------------YMVAHISDFSIAK-FLNGQDQLSMQTQTL 877
A AL YLH S I++ ++V ++DF + K + T T
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQGHIV--LTDFGLCKENIEHNST----TSTF 199
Query: 878 -ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE + + R D + G +L E G P T E++
Sbjct: 200 CGTPEYLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 29/138 (21%), Positives = 59/138 (42%), Gaps = 17/138 (12%)
Query: 722 LQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER-----ALKSFQDECEV 775
+ ++ +F + LG G++ +VY G+ VA+K E A++ E +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISL 56
Query: 776 MKRIRHRNLVKIISACSNDDFKALIMEYMPN---GSLENRLYSGT-CMLDIFQRLNIMID 831
MK ++H N+V++ ++ L+ E+M N +++R T L++
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 832 VALALEYLHFGHSTPIIH 849
+ L + H I+H
Sbjct: 117 LLQGLAFCHENK---ILH 131
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 44/245 (17%), Positives = 81/245 (33%), Gaps = 42/245 (17%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIR- 780
R+ LG G F +V+++ +Q VA+KV + Y DE ++K +R
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 781 ----HRNLVKIISACSNDDFK---------ALIMEYM-PN-GSLENRLYSGTCMLDIFQR 825
N ++ DDFK ++ E + + + L ++
Sbjct: 93 SDPNDPNREMVVQLL--DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 826 LNIMIDVALALEYLHFGHSTPIIHYMVAHISDFSIAKFLNG-QDQLSMQTQTLATIGYMA 884
I+ V L+YLH IIH +D L +Q + AT +
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIH------TDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM----- 939
G + + ++ ++ I +L + WV+ +
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR 260
Query: 940 --EVI 942
EV+
Sbjct: 261 SLEVL 265
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 9/110 (8%)
Query: 513 FDVSSNSLD-GPLSLDIGNLKVVIELNLSR-NNLSGDIPITIGGLKNLQKLFLANNRLEG 570
+D S +LD L D + I++ L+R + ++ + I + L L L+NNRL
Sbjct: 125 YDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYR 184
Query: 571 --PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEG 618
+ +L+IL+LS N++ S +L +K L L L+G
Sbjct: 185 LDDMSSIVQKAPNLKILNLSGNELK-----SERELDKIKGLKLEELWLDG 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 4e-04
Identities = 36/264 (13%), Positives = 75/264 (28%), Gaps = 70/264 (26%)
Query: 711 QAIRRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKV--------FHQRY 762
+ FS+ T++ + +G G FG V+ D VA+K+ + +
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 763 ERALKSFQDECEVMKRI---------RHRNLVKIISAC---------------------- 791
++ + E + K + R + + S
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 792 --------SNDDFKALIMEYMPNG-SLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
DD +++E+ G LE + + +I+ + +L
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAE-- 178
Query: 843 HSTPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV---STRGDV 899
S H D L + L TL P G+Q + +
Sbjct: 179 ASLRFEHR------DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
Query: 900 YSYGIMLMETFTGKKPTDEIFIGE 923
++ + + ++F G+
Sbjct: 233 RDGIVVFCDVSMDE----DLFTGD 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 68/228 (29%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVF--HQRYERALKSFQDECEVMKRIRHRNLVKIIS 789
LG G F +V++A+ + + VA+K+ + Y A +DE ++++R+ + K S
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKEDS 82
Query: 790 ACSN------DDFKA---------LIMEYMPNGSLENRLYSGTCMLDI-----FQRLN-- 827
+N D F ++ E + G +L + + +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-----------GENLLALIKKYEHRGIPLI 131
Query: 828 ----IMIDVALALEYLHFGHSTPIIH------------------YMVAHISDFSIAKFLN 865
I + L L+Y+H IIH + I+D A + +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 866 GQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913
S+QT+ Y +PE + D++S ++ E TG
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 70/231 (30%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDECEVM-KRI-----RHRNLV 785
+LG GSFG V ++ + E+ AVK+ + + ++ EC ++ KR+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 786 KIISACSNDDFKALIMEYMPNGSL-----------ENR--LYSGTCMLDIFQRLNIMIDV 832
++ S D +MEY+ G L E Y+ ++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130
Query: 833 ALALEYLHFGHSTPII---------------HYMVAHISDFSIAK-FLNGQDQLSMQTQT 876
A+ L +L S II H +A DF + K + T+T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIA---DFGMCKENIWDGVT----TKT 180
Query: 877 L-ATIGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
T Y+APE + + + D +++G++L E G+ P DE+F
Sbjct: 181 FCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 47/224 (20%), Positives = 88/224 (39%), Gaps = 50/224 (22%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYER------ALKSFQDECEVMKR 778
++ K +G G+FG V+ AR + G +VA+K E+ AL+ E ++++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQL 72
Query: 779 IRHRNLVKIISACSNDDFKA--------LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI 830
++H N+V +I C L+ ++ + L L + + + +M
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 831 DVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKF--LNGQDQLSMQTQT 876
+ L Y+ H I+H V ++DF +A+ L Q + T
Sbjct: 132 MLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 877 LATIGYMAPE-------YGVQGRVSTRGDVYSYGIMLMETFTGK 913
+ T+ Y PE YG D++ G ++ E +T
Sbjct: 189 VVTLWYRPPELLLGERDYG------PPIDLWGAGCIMAEMWTRS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVK----VFHQRYE--RALKSFQDECEVMK 777
+ +G G++G+V A + G +VA+K F RA + E ++K
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLK 79
Query: 778 RIRHRNLVKII----SACSNDDFKA--LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID 831
+RH N++ ++ + DDF L+M +M L + D Q ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQ--FLVYQ 136
Query: 832 VALALEYLHFGHSTPIIH-------YMVAH-----ISDFSIAKFLNGQDQLSMQTQTLAT 879
+ L Y+ H+ IIH V I DF +A+ + + T + T
Sbjct: 137 MLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVT 188
Query: 880 IGYMAPEYGVQGRVSTRG-DVYSYGIMLMETFTGK 913
Y APE + T+ D++S G ++ E TGK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 90/237 (37%)
Query: 733 LLGIGSFGSVYVARLQDGMEV----AVKVF-------------HQRYERALKSFQDECEV 775
+LG G++G V++ R G + A+KV H R ER +V
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER---------QV 111
Query: 776 MKRIRHRN-LVKIISACSNDDFKALIMEYMPNGSL-----------EN--RLYSGTCMLD 821
++ IR LV + A + LI++Y+ G L E+ ++Y G
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----- 166
Query: 822 IFQRLNIMIDVALALEYLHFGHSTPII---------------HYMVAHISDFSIAK-FLN 865
++ LALE+L H II H + ++DF ++K F+
Sbjct: 167 ---------EIVLALEHL---HKLGIIYRDIKLENILLDSNGHVV---LTDFGLSKEFVA 211
Query: 866 GQDQLSMQTQTLA-TIGYMAPE------YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + TI YMAP+ G V D +S G+++ E TG P
Sbjct: 212 DETER---AYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 9e-04
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 733 LLGIGSFGSVYVARLQDGMEV-AVKVFHQRYERALKSFQDECEVM--KRI-----RHRNL 784
+LG GSFG V++A + + A+K + + L EC M KR+ H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVEC-TMVEKRVLSLAWEHPFL 80
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ + +MEY+ G L + S ++ L L++LH S
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH---S 136
Query: 845 TPIIH--------------YMVAHISDFSIAK-FLNGQDQLSMQTQTL-ATIGYMAPEYG 888
I++ ++ I+DF + K + G + T T T Y+APE
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIK--IADFGMCKENMLGDAK----TNTFCGTPDYIAPEI- 189
Query: 889 VQGRVSTRG-DVYSYGIMLMETFTGKKP-----TDEIF 920
+ G+ D +S+G++L E G+ P +E+F
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1007 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 1e-51
Identities = 61/290 (21%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRN 783
+ + +G GSFG+VY + +VAVK+ + + L++F++E V+++ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
++ + + A++ ++ SL + L+ ++ + ++I A ++YLH
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY---G 888
IIH + I DF +A + Q +I +MAPE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948
+ S + DVY++GI+L E TG+ P I + + L + +V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------- 234
Query: 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998
+ ++ L EC + +R +I+ + + +L K
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 1e-46
Identities = 63/309 (20%), Positives = 119/309 (38%), Gaps = 51/309 (16%)
Query: 713 IRRFSYHELLQATDRFSKN---------NLLGIGSFGSVYVARL----QDGMEVAVKVFH 759
I F++ + +A F+K ++G G FG V L + + VA+K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 760 QRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTC 818
Y E+ + F E +M + H N++ + + +I E+M NGSL++ L
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 819 MLDIFQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNG 866
+ Q + ++ +A ++YL + +H +V +SDF +++FL
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 867 QDQLSMQTQTL---ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
T L I + APE + ++ DV+SYGI++ E + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-------- 232
Query: 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983
D+ V+ I+ ++ ++ L +C + R
Sbjct: 233 -----PYWDMTNQDVINAIE------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 984 EIVTGLLKI 992
+IV L K+
Sbjct: 282 QIVNTLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 38/277 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++ +VAVK Q + +F E +MK+++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHS 844
++ + + + +I EYM NGSL + L + L I + L++ +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
IH + I+DF +A+ + ++ + + I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 893 VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952
+ + DV+S+GI+L E T + + + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE--------- 237
Query: 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
+ L C E P R + + L
Sbjct: 238 ----------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ +G G FG V++ + +VA+K + + + F +E EVM ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ C L+ E+M +G L + L + + L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEA 120
Query: 846 PIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV 893
+IH V +SDF + +F+ DQ + T T + + +PE R
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 894 STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERY 953
S++ DV+S+G+++ E F+ K + V+E I T + R
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI-------------PYENRSNSEVVEDISTGFRLYKPRL 226
Query: 954 FAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995
+ + + C E P R ++ L +I ++
Sbjct: 227 ASTH------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 55/276 (19%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V + + +VA+K+ + + F +E +VM + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ C+ +I EYM NG L N L Q L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 846 P---------IIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTR 896
+ V +SDF +++++ D+ + + + + PE + + S++
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 897 GDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAA 956
D++++G+++ E ++ K E E I L +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE-------------RFTNSETAEHIAQGLRLYRPHLASE 228
Query: 957 KEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
K + + C E +R + +++ +L +
Sbjct: 229 K------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-44
Identities = 59/299 (19%), Positives = 103/299 (34%), Gaps = 44/299 (14%)
Query: 724 ATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRH 781
D F K + LG G+ G V+ G+ +A K+ H E +V+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
+V A +D ++ ME+M GSL+ L + + I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR- 121
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
I+H + DF ++ L SM + T YM+PE
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 176
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP------TDEIFIGELSLSRWVNDLLPISVMEVID 943
S + D++S G+ L+E G+ P + + + + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 944 TNLLSGEERYFAAKEQSLLSILN-----------------LATECTIESPGKRINAREI 985
+ + R A + L I+N +C I++P +R + +++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 62/300 (20%), Positives = 113/300 (37%), Gaps = 43/300 (14%)
Query: 720 ELLQATDRFSKNNL-LGIGSFGSVYVARLQ---DGMEVAVKVFHQRYERA-LKSFQDECE 774
+L D ++ LG G+FGSV + ++VA+KV Q E+A + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 775 VMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL 834
+M ++ + +V++I C + L+ME G L L + + ++ V++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 835 ALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIG 881
++YL +H A ISDF ++K L D +
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVME 940
+ APE + S+R DV+SYG+ + E + G+KP + VM
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK--------------KMKGPEVMA 223
Query: 941 VIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKSV 1000
I+ + + + L ++C I R + + + +L V
Sbjct: 224 FIEQG------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 57/281 (20%), Positives = 107/281 (38%), Gaps = 46/281 (16%)
Query: 727 RFSK-NNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR 782
RF K + +G GSF +VY + +EVA R + + F++E E++K ++H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 783 NLVKIISAC----SNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
N+V+ + L+ E M +G+L+ L + I + + L++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQF 127
Query: 839 LHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAP 885
LH + PIIH I D +A S + T +MAP
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 182
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945
E + + DVY++G+ ++E T + P E R + + P S +V
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
+ + C ++ +R + ++++
Sbjct: 242 V------------------KEIIEGCIRQNKDERYSIKDLL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 44/282 (15%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+G G FG V + G +VAVK + ++F E VM ++RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 786 KIISACSNDDFK-ALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 843
+++ + ++ EYM GSL + L S G +L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 844 STPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
+H VA +SDF + K + S Q + + APE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175
Query: 892 RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951
+ ST+ DV+S+GI+L E ++ + + V+ ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYP-------------RIPLKDVVPRVEKG------ 216
Query: 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993
A + ++ + C R + ++ L I+
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 56/277 (20%), Positives = 112/277 (40%), Gaps = 38/277 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
+ LG G FG V++ VA+K + ++F E +VMK++RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIF-QRLNIMIDVALALEYLHFGHS 844
++ + S + ++ EYM GSL + L T Q +++ +A + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 845 TPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGR 892
+H +V ++DF +A+ + ++ + + I + APE + GR
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 893 VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952
+ + DV+S+GI+L E T + ++ V++ ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV-------------PYPGMVNREVLDQVERGY------ 231
Query: 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
+ S+ +L +C + P +R + L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 8e-42
Identities = 52/275 (18%), Positives = 102/275 (37%), Gaps = 38/275 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
D + LG G+FG V+ G K + Y + ++E +M ++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ + A + LI+E++ G L +R+ + + + +N M L+++ H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145
Query: 845 TPIIHYMVAH--------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
I+H + I DF +A LN + + + T AT + APE +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR 202
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
V D+++ G++ +G P F GE + ++ + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP----FAGE----------DDLETLQNVKRCDWEFD 248
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
E F++ + + P KR+ +
Sbjct: 249 EDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 37/275 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHRN 783
+ + LG G++G V +A VAVK+ +R ++ + E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+VK + + L +EY G L +R+ + + + YL H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYL---H 120
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
I H ISDF +A ++ + + T+ Y+APE +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 892 RVSTRG-DVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
DV+S GI+L G+ P D+ S W ++ + ID+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---- 236
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
L L + +E+P RI +I
Sbjct: 237 --------------LALLHKILVENPSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 56/274 (20%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRN 783
++++ +G G+ G+VY A + G EVA++ + + + + +E VM+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+V + + D ++MEY+ GSL + + D Q + + ALE+L H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFL---H 133
Query: 844 STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
S +IH ++DF + + S ++ + T +MAPE +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRK 191
Query: 892 RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951
+ D++S GIM +E G+ P ++ E + + + +G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP----YLNE-------------NPLRALYLIATNGTP 234
Query: 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
++ S + C KR +A+E+
Sbjct: 235 ELQNPEKLS-AIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 62/291 (21%), Positives = 105/291 (36%), Gaps = 34/291 (11%)
Query: 734 LGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN 793
+G G FG V+ + G EVAVK+F R ER+ + E +RH N++ I+A +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 794 DDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH-----FGHS 844
D+ L+ +Y +GSL + L T + + + + + A L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 845 TPIIHY------------MVAHISDFSIAKFLN-GQDQLSMQTQTLA-TIGYMAPEY--- 887
I H I+D +A + D + + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 888 ---GVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM-EVID 943
R D+Y+ G++ E +L V + M +V+
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994
L ++L + + EC + R+ A I L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-41
Identities = 56/288 (19%), Positives = 109/288 (37%), Gaps = 42/288 (14%)
Query: 731 NNLLGIGSFGSVYVARLQD----GMEVAVKVFHQ-RYERALKSFQDECEVMKRIRHRNLV 785
N ++G G FG VY L D + AVK ++ + F E +MK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 786 KIISACSNDDFKA-LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
++ C + +++ YM +G L N + + T + + + VA + F S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 845 TPIIH------------YMVAHISDFSIAKFLNGQD--QLSMQTQTLATIGYMAPEYGVQ 890
+H ++DF +A+ + ++ + +T + +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
+ +T+ DV+S+G++L E T P +++ LL +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL---------------Q 249
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998
R E + + +C R + E+V+ + I T +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 8e-41
Identities = 49/275 (17%), Positives = 98/275 (35%), Gaps = 38/275 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
D + + LG G+FG V+ G A K +E ++ + E + M +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
V + A +D+ +I E+M G L ++ + + + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 845 TPIIH--------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
+H + DF + L+ + + + T T + APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG 199
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
V D++S G++ +G P F GE + + + + +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE----------NDDETLRNVKSCDWNMD 245
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ F+ + + + + P R+ +
Sbjct: 246 DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 50/275 (18%), Positives = 101/275 (36%), Gaps = 36/275 (13%)
Query: 730 KNNLLGIGSFGSVYVARLQD---GMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNL 784
++ LG G+FG+V Q VAVK+ E VM+++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH- 843
V++I C + + L+ME G L L + + ++ V++ ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 844 --------STPIIHYMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
+ ++ A ISDF ++K L ++ QT + + APE + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 895 TRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYF 954
++ DV+S+G+++ E F+ + + V +++ +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQK-------------PYRGMKGSEVTAMLE------KGERM 229
Query: 955 AAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
+ +L C R + L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 58/293 (19%), Positives = 113/293 (38%), Gaps = 44/293 (15%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDG-----MEVAVKVFHQRY-ERALKSFQDECEVMKRI 779
++ ++G G FG VY L+ + VA+K Y E+ F E +M +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYL 839
H N++++ S +I EYM NG+L+ L + Q + ++ +A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA---AGM 123
Query: 840 HFGHSTPIIH------------YMVAHISDFSIAKFL-NGQDQLSMQTQTLATIGYMAPE 886
+ + +H +V +SDF +++ L + + + I + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946
+ ++ DV+S+GI++ E T + +L VM+ I+
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAINDGF 230
Query: 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT---GLLKIRDTL 996
+I L +C + +R +IV+ L++ D+L
Sbjct: 231 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 56/282 (19%), Positives = 104/282 (36%), Gaps = 41/282 (14%)
Query: 722 LQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR 780
L D + LG G+FG VY A+ + + A KV + E L+ + E +++
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H N+VK++ A ++ +++E+ G+++ + L Q + AL YL
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL- 126
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY- 887
H IIH ++DF ++ Q + + T +MAPE
Sbjct: 127 --HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVV 182
Query: 888 ----GVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
+ DV+S GI L+E + P E ++ M V+
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-----------------LNPMRVLL 225
Query: 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+ E A + + + +C ++ R ++
Sbjct: 226 -KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 2e-40
Identities = 59/293 (20%), Positives = 109/293 (37%), Gaps = 38/293 (12%)
Query: 714 RRFSYHELLQATDRFSKNNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRYERALKSFQDE 772
+Y + + + LG G +G VY + + VAVK + ++ F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63
Query: 773 CEVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY-SGTCMLDIFQRLNIMID 831
VMK I+H NLV+++ C+ + +I E+M G+L + L + L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 832 VALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLAT 879
++ A+EYL IH + ++DF +++ + G D +
Sbjct: 124 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 179
Query: 880 IGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM 939
I + APE + S + DV+++G++L E T + V
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVY 226
Query: 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
E+++ + E + L C +P R + EI +
Sbjct: 227 ELLEKDY------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-39
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 44/283 (15%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR 782
+ + +G GS+G R DG + K E + E +++ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 783 NLVKIISAC--SNDDFKALIMEYMPNGSLENRLYSGT---CMLDIFQRLNIMIDVALALE 837
N+V+ + ++MEY G L + + GT LD L +M + LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 838 YLHFGH--STPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
H ++H + DF +A+ LN S + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYM 181
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
+PE + + + D++S G +L E P F S E+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF-------------SQKELAG 224
Query: 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
+ G+ R + + + T R + EI+
Sbjct: 225 -KIREGKFRRIPYRYSD--ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 2e-39
Identities = 66/309 (21%), Positives = 105/309 (33%), Gaps = 64/309 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
+ +G G+FG V+ AR + VAVK+ + FQ E +M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS----------------------- 815
+ N+VK++ C+ L+ EYM G L L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 816 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKF 863
G L ++L I VA + YL +H MV I+DF +++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ D I +M PE R +T DV++YG++L E F+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241
Query: 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983
+ V+ + + A E L + NL C + P R +
Sbjct: 242 -----PYYGMAHEEVIYYVR------DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 984 EIVTGLLKI 992
I L ++
Sbjct: 291 SIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 4e-39
Identities = 54/281 (19%), Positives = 94/281 (33%), Gaps = 48/281 (17%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIR 780
FS +G GSFG+VY AR +++ VA+K + E ++++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H N ++ + L+MEY + + L + + L YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL- 131
Query: 841 FGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY- 887
HS +IH + + DF A + + T +MAPE
Sbjct: 132 --HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVI 183
Query: 888 --GVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945
+G+ + DV+S GI +E K P ++ M + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------------MNAMSALY-H 225
Query: 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
+ E + S N C + P R + ++
Sbjct: 226 IAQNESPALQSGHWS-EYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 63/288 (21%), Positives = 90/288 (31%), Gaps = 42/288 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL----QDGMEVAVKVFHQRY---ERALKSFQDECEVMKR 778
LG GSFG V + VAVK A+ F E M
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+ HRNL+++ K ++ E P GSL +RL + + VA + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 839 LHFGHSTPIIHYMV------------AHISDFSIAKFLN-GQDQLSMQTQTLATIGYMAP 885
L S IH + I DF + + L D MQ + AP
Sbjct: 127 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 886 EYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945
E S D + +G+ L E FT + L ++ ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------------GLNGSQILHKIDK- 229
Query: 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993
E E I N+ +C P R + LL+ +
Sbjct: 230 ----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-39
Identities = 62/304 (20%), Positives = 102/304 (33%), Gaps = 58/304 (19%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQ-RYERALKSFQDECEVMKR 778
+R S LG G+FG V A M VAVK+ + ++ E +V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 779 I-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY-----------------SGTCML 820
+ H N+V ++ AC+ +I EY G L N L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 821 DIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQD 868
D+ L+ VA + +L S IH + I DF +A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR 928
++ + +MAPE + DV+SYGI L E F+ + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 929 WVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988
+ + + E + ++ C P KR ++IV
Sbjct: 260 MIKEGFRMLSPEHAPAEM------------------YDIMKTCWDADPLKRPTFKQIVQL 301
Query: 989 LLKI 992
+ K
Sbjct: 302 IEKQ 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 20/209 (9%)
Query: 723 QATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKR 778
+ + F +LG GSF +V +AR L E A+K+ +R+ E + E +VM R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+ H VK+ +D+ + Y NG L + D ++ ALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
L H IIH M I+DF AK L+ + + + + T Y++PE
Sbjct: 124 L---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ D+++ G ++ + G P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 57/306 (18%), Positives = 103/306 (33%), Gaps = 63/306 (20%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
+ +LG G+FG V A ++VAVK+ ++ ++ E ++M +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 779 I-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYS---------------------- 815
+ H N+V ++ AC+ LI EY G L N L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 816 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKF 863
+L L VA +E+L +H V I DF +A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE 923
+ ++ + +MAPE +G + + DV+SYGI+L E F+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAR 983
+ + + + + + + C KR +
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEI------------------YIIMQSCWAFDSRKRPSFP 315
Query: 984 EIVTGL 989
+ + L
Sbjct: 316 NLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 55/291 (18%), Positives = 108/291 (37%), Gaps = 42/291 (14%)
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQD-----GMEVAVKVFHQRY-ERALKSFQDEC 773
+L+ T+ F K +LG G+FG+VY + VA+K + +A K DE
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 774 EVMKRIRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVA 833
VM + + ++ +++ C + LI + MP G L + + + LN + +A
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 834 LALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIG 881
+ YL ++H I+DF +AK L +++ I
Sbjct: 122 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 882 YMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941
+MA E + + + DV+SYG+ + E T + + + +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------PYDGIPASEISSI 225
Query: 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992
++ + + + +C + R RE++ K+
Sbjct: 226 LEKGE------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 59/277 (21%), Positives = 105/277 (37%), Gaps = 45/277 (16%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
+ F LG G FG+VY+AR Q +A+KV + + E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
N++++ + LI+EY P G++ L + D + + ++A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC-- 122
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
HS +IH I+DF + + ++ T+ Y+ PE
Sbjct: 123 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949
+ D++S G++ E GK P F + IS +E + ++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN----TYQETYKRISRVEFTFPDFVTE 229
Query: 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
R +L + +P +R RE++
Sbjct: 230 GAR-------------DLISRLLKHNPSQRPMLREVL 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 3e-37
Identities = 58/275 (21%), Positives = 96/275 (34%), Gaps = 35/275 (12%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH-QRYERALKSFQDECEVMKRIRHR 782
D + ++LG G+F V +A + VA+K + E S ++E V+ +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
N+V + + LIM+ + G L +R+ ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 843 HSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
ISDF ++K D S+ + T GY+APE Q
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
S D +S G++ G P F E + E I +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDE----------NDAKLFEQILKAEYEFD 229
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
Y+ S + + P KR +
Sbjct: 230 SPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (350), Expect = 3e-37
Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 37/289 (12%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIR 780
+DR+ +LG G V++AR L+ +VAVKV F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 781 HRNLVKIISACSNDDFKA----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
H +V + + ++MEY+ +L + +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 837 EYLHFG---------HSTPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLA-TIGYMAPE 886
+ H + I + DF IA+ + QT + T Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 887 YGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946
V R DVYS G +L E TG+ P F G+ S + V ++
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVSVAYQHV 227
Query: 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRI-NAREIVTGLLKIRD 994
A E + + + ++P R A E+ L+++ +
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-37
Identities = 58/303 (19%), Positives = 109/303 (35%), Gaps = 50/303 (16%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL------QDGMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
++ + + LG GSFG VY + VA+K ++ R F +E VMK
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLY---------SGTCMLDIFQRLNIM 829
++V+++ S +IME M G L++ L + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 830 IDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTL 877
++A + YL ++ +H I DF + + + D + L
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS 937
+ +M+PE G +T DV+S+G++L E T + + E L + L
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 938 VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997
D + L C +P R + EI++ + + +
Sbjct: 257 PDNCPD-------------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 998 KSV 1000
+ V
Sbjct: 298 REV 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 53/286 (18%), Positives = 97/286 (33%), Gaps = 41/286 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL----QDGMEVAVKVFHQRY-ERALKSFQDECEVMKRIR 780
+R +G G FG V+ + VA+K + + F E M++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H ++VK+I + ++ +IME G L + L LD+ + ++ AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL- 124
Query: 841 FGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
S +H + DF +++++ L I +MAPE
Sbjct: 125 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 181
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948
R ++ DV+ +G+ + E + + R N
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP----- 236
Query: 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994
++ +L T+C P +R E+ L I +
Sbjct: 237 --------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 57/301 (18%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDG---MEVAVKVFHQRYER-ALKSFQDECEVMKRI-R 780
+ +++G G+FG V AR++ M+ A+K + + + F E EV+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCM---------------LDIFQR 825
H N++ ++ AC + + L +EY P+G+L + L + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 826 LNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQ 873
L+ DVA ++YL IH VA I+DF +++ Q+ +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183
Query: 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDL 933
T + +MA E +T DV+SYG++L E + + G
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM---------- 230
Query: 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993
+ E+ + L G + +L +C E P +R + +I+ L ++
Sbjct: 231 ---TCAELYE-KLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 994 D 994
+
Sbjct: 285 E 285
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 59/304 (19%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL--------QDGMEVAVKVFHQRY-ERALKSFQDECEVM 776
DR LG G+FG V +A +VAVK+ E+ L E E+M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 777 KRI-RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCM---------------L 820
K I +H+N++ ++ AC+ D +I+EY G+L L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 821 DIFQRLNIMIDVALALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQD 868
++ VA +EYL S IH V I+DF +A+ ++ D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSR 928
T + +MAPE + + DV+S+G++L E FT
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 929 WVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988
+ + +++ E + + +C P +R +++V
Sbjct: 237 PYPGVPVEELFKLLK------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 989 LLKI 992
L +I
Sbjct: 291 LDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-35
Identities = 50/275 (18%), Positives = 98/275 (35%), Gaps = 39/275 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+++ LG G FG V+ K + + E ++ RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ + + + + +I E++ + R+ + L+ + ++ + V AL++L HS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HS 120
Query: 845 TPIIHYMVAH--------------ISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
I H+ + I +F A+ L D + Y APE
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQH 177
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
VST D++S G ++ +G P F+ E ++E I + +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP----FLAE----------TNQQIIENIMNAEYTFD 223
Query: 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
E F + ++ ++ R+ A E
Sbjct: 224 EEAFKEISIEAMDFVD---RLLVKERKSRMTASEA 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 23/207 (11%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKR-IR 780
+ F + +LG GSFG V++A + A+K + + ++ E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 781 HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH 840
H L + + +MEY+ G L + S D+ + ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 841 FGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYG 888
I++ I+DF + K D + T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEIL 175
Query: 889 VQGRVSTRGDVYSYGIMLMETFTGKKP 915
+ + + D +S+G++L E G+ P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 48/283 (16%), Positives = 97/283 (34%), Gaps = 47/283 (16%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY------ERALKSFQDECEVMKR 778
D + LG G F V R G++ A K +R + + + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
I+H N++ + N LI+E + G L + L + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-ATEFLKQILNG--- 125
Query: 839 LHFGHSTPIIHY----------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGY 882
+++ HS I H+ I DF +A ++ ++ T +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEF 182
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942
+APE + D++S G++ +G P F+G+ + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD----------TKQETLANV 228
Query: 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
E+ YF+ + ++ P KR+ ++
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 1e-31
Identities = 44/282 (15%), Positives = 86/282 (30%), Gaps = 39/282 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+R+ +G GSFG +Y+ + G EVA+K+ + + E ++ K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ I C + +++ + SLE+ + + L + + +EY+H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 845 TPIIH---------------YMVAHISDFSIAKFL-----NGQDQLSMQTQTLATIGYMA 884
IH + +I DF +AK + T Y +
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 885 PEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944
+ S R D+ S G +LM G P + +S +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIV 986
E C + + +
Sbjct: 242 KGYPSE-------------FATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (307), Expect = 2e-31
Identities = 52/283 (18%), Positives = 111/283 (39%), Gaps = 29/283 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFH--QRYERALKSFQDECEVMKRIRHRN 783
+++ +G G++G VY A+ G A+K + E + E ++K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 784 LVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 843
+VK+ L+ E++ + L+ L L+ + ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---H 117
Query: 844 STPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV-Q 890
++H I+DF +A+ + T + T+ Y AP+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKP------TDEIF-IGELSLSRWVNDLLPISVMEVID 943
+ ST D++S G + E G D++ I + + + ++ + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 944 TNLLSGEERYFAAKEQSL-LSILNLATECTIESPGKRINAREI 985
N E + + + L S ++L ++ P +RI A++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (306), Expect = 3e-31
Identities = 47/287 (16%), Positives = 97/287 (33%), Gaps = 49/287 (17%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH---------QRYERALKSFQDECEV 775
+ + +LG G V E AVK+ + + ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 776 MKRIR-HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL 834
++++ H N++++ + F L+ + M G L + L L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 835 ALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQT---LAT 879
+ L H I+H M ++DF + L+ ++L T LA
Sbjct: 122 VICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 880 IGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM 939
D++S G+++ G P F M
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR-------------KQM 221
Query: 940 EVIDTNLLSGEERYFAAKEQSL-LSILNLATECTIESPGKRINAREI 985
++ ++SG ++ + + ++ +L + + P KR A E
Sbjct: 222 LMLR-MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 52/291 (17%), Positives = 99/291 (34%), Gaps = 41/291 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL-QDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
++ ++G GSFG VY A+L G VA+K Q E ++M+++ H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 785 VKIISAC------SNDDFKALIMEYMPNGSLEN--RLYSGTCMLDIFQRLNIMIDVALAL 836
V++ ++ + L+++Y+P L + M + +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 837 EYLHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
Y+ HS I H V + DF AK L + + +
Sbjct: 136 AYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRA 190
Query: 884 APEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943
++ DV+S G +L E G+ + L + L + ++ +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249
Query: 944 TNLLSGEERYFAAKEQSLLSI---------LNLATECTIESPGKRINAREI 985
N E ++ K + + L + +P R+ E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-30
Identities = 53/277 (19%), Positives = 98/277 (35%), Gaps = 50/277 (18%)
Query: 733 LLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISA 790
+LG+G G V + + A+K+ + E E+ R + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 791 C----SNDDFKALIMEYMPNGSLENRLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHST 845
+ ++ME + G L +R+ G + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 846 PIIH---------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
I H + ++DF AK + L+ T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT---PYYVAPEVLGP 187
Query: 891 GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950
+ D++S G+++ G P F +++ + T + G+
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSN----------HGLAISPGMKTRIRMGQ 233
Query: 951 ERYFAAKEQSLLS--ILNLATECTIESPGKRINAREI 985
F E S +S + L P +R+ E
Sbjct: 234 YE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-30
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 25/206 (12%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
F LG GSFG V++ R +G A+KV + + ++ DE ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
++++ + +IM+Y+ G L L + +V LALEYL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKFYAAEVCLALEYL-- 120
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
HS II+ I+DF AK++ + T Y+APE
Sbjct: 121 -HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVS 174
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
+ D +S+GI++ E G P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 121 bits (304), Expect = 3e-30
Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 28/213 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY------ERALKSFQDECEVMKR 778
+ FS + ++G G FG VY R G A+K ++ E + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 779 IRHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEY 838
+V + A D + I++ M G L L + ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 839 LHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE 886
+ H+ +++ + ISD +A + ++ T GYMAPE
Sbjct: 123 M---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPE 175
Query: 887 YGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDE 918
+G + D +S G ML + G P +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 53/296 (17%), Positives = 109/296 (36%), Gaps = 35/296 (11%)
Query: 720 ELLQATDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQ-RYERALKSFQDECEVMK 777
++ R++ + +G G++G V A + + VA+K ++ + E +++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 778 RIRHRNLVKIISACSNDDFKAL----IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVA 833
R RH N++ I + + ++ ++ L L + L + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQIL 119
Query: 834 LALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLN-GQDQLSMQTQTLATI 880
L+Y+ HS ++H I DF +A+ + D T+ +AT
Sbjct: 120 RGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 881 GYMAPEYGVQGRVSTR-GDVYSYGIMLMETFTGKKP------TDEIFIGELSLSRWVNDL 933
Y APE + + T+ D++S G +L E + + D++ L +
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 934 LPISVMEVIDTNLLSGEERYFAAKEQSLLSI----LNLATECTIESPGKRINAREI 985
L + LLS + + + L+L + +P KRI +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-30
Identities = 51/286 (17%), Positives = 87/286 (30%), Gaps = 63/286 (22%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY------ERALKSFQDECEVMKR 778
++ LLG G FGSVY + D + VA+K + E ++K+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 779 IR--HRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
+ +++++ D LI+E + L + V A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 837 EYLHFGHSTPIIH-------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYM 883
+ H+ ++H + DF L ++ T T Y
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYS 176
Query: 884 APEYGVQGRVSTRG-DVYSYGIMLMETFTGKKP---TDEIFIGELSLSRWVNDLLPISVM 939
PE+ R R V+S GI+L + G P +EI G++ + V+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS------- 229
Query: 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREI 985
+L C P R EI
Sbjct: 230 -----------------------ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 53/284 (18%), Positives = 103/284 (36%), Gaps = 29/284 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH--QRYERALKSFQDECEVMKRIRHR 782
+ F K +G G++G VY AR G VA+K E + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
N+VK++ ++ L+ E++ + S + + + + + L +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 843 HSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPE-YGV 889
HS ++H ++DF +A+ + T + T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949
ST D++S G + E T + + + P V+ T++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 950 EERYFAAKEQSLLSI--------LNLATECTIESPGKRINAREI 985
+ + Q + +L ++ P KRI+A+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 57/303 (18%), Positives = 100/303 (33%), Gaps = 57/303 (18%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR------LQDGMEVAVKVFHQRY-ERALKSFQDECEVMKR 778
DR LG G+FG V A VAVK+ + ++ E +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 779 IRHR-NLVKIISACSNDDFK-ALIMEYMPNGSLENRLYS---------------GTCMLD 821
I H N+V ++ AC+ +I+E+ G+L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 822 IFQRLNIMIDVALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQ 869
+ + VA +E+L S IH V I DF +A+ +
Sbjct: 133 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRW 929
+ + +MAPE + + DV+S+G++L E F+ + R
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 930 VNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGL 989
+ + + + + +C P +R E+V L
Sbjct: 250 LKEGTRMRAPDYTTPEM------------------YQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 990 LKI 992
+
Sbjct: 292 GNL 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 53/278 (19%), Positives = 98/278 (35%), Gaps = 28/278 (10%)
Query: 732 NLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY-----ERALKSFQDECEVMKRIRHRNLV 785
+ LG G F +VY AR VA+K + + ++ E ++++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 786 KIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 845
++ A + +L+ ++M + + +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 846 P---------IIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRV-ST 895
+ V ++DF +AK T + T Y APE R+
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 896 RGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFA 955
D+++ G +L E + L+R L + + D L + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 956 AKEQSLLSI--------LNLATECTIESPGKRINAREI 985
L I L+L + +P RI A +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (284), Expect = 3e-28
Identities = 33/211 (15%), Positives = 72/211 (34%), Gaps = 28/211 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL 784
+ +G GSFG ++ L + +VA+K +R + +DE K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 785 VKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 844
+ + + +++ + SLE+ L + + ++ + H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HE 119
Query: 845 TPIIHYMV-----------------AHISDFSIAKFL----NGQDQLSMQTQTLA-TIGY 882
+++ + ++ DF + KF Q + + L+ T Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 883 MAPEYGVQGRVSTRGDVYSYGIMLMETFTGK 913
M+ + S R D+ + G + M G
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 45/285 (15%), Positives = 102/285 (35%), Gaps = 31/285 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFH--QRYERALKSFQDECEVMKRIRHR 782
++ K +G G++G+V+ A+ + VA+K E S E ++K ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 783 NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842
N+V++ +D L+ E+ + + D + + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120
Query: 843 HSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQ 890
+ ++H +++F +A+ + + + T+ Y P+
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG 175
Query: 891 GRVSTRG-DVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949
++ + D++S G + E +P + L R L + + L
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 950 EERYFAAKEQSLL---------SILNLATECTIESPGKRINAREI 985
+ Y + L + +L +P +RI+A E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-27
Identities = 59/303 (19%), Positives = 113/303 (37%), Gaps = 41/303 (13%)
Query: 716 FSYHELLQAT----DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKS 768
F E+ + + +G G++G+V A + G +VA+K ++ + E K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 769 FQDECEVMKRIRHRNLVKIISACSNDDFKA------LIMEYMPNGSLENRLYSGTCMLDI 822
E ++K +RH N++ ++ + D+ L+M +M G+ +L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120
Query: 823 FQRLNIMIDVALALEYLH---FGHSTP------IIHYMVAHISDFSIAKFLNGQDQLSMQ 873
+ ++ + L Y+H H + I DF +A+ + +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175
Query: 874 TQTLATIGYMAPEYGV-QGRVSTRGDVYSYGIMLMETFTGKKP---------TDEIFIGE 923
T + T Y APE + R + D++S G ++ E TGK EI
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSL-LSILNLATECTIESPGKRINA 982
+ L + L E++ FA+ + +NL + + +R+ A
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 983 REI 985
E
Sbjct: 296 GEA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 110 bits (275), Expect = 5e-27
Identities = 77/334 (23%), Positives = 127/334 (38%), Gaps = 38/334 (11%)
Query: 25 TDQQSLLALKAHISYDPTNLFAKNWTSSTSVC--SWIGITC--GVNSHKVIVLNISGFNL 80
D+Q+LL +K + +PT L +W +T C +W+G+ C +++V L++SG NL
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 81 QG--TIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFN 138
IP L NL L L + N L G + I
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGI-----------------------NNLVGPIPPAIAK 99
Query: 139 MSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRF 198
++ + + ++ SG + + L L N G +P ++S L G+
Sbjct: 100 LTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 199 NNLSGAIPKEIGNLTKLK-DIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTI 257
N +SGAIP G+ +KL + ++ N L G+IP NL ++
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML---EGDASV 215
Query: 258 FNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQL 317
S + + N+ L+L NR G +P +T L +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 318 RGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTP 351
N+ G IP GNL+ + A+N +P
Sbjct: 276 SFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.1 bits (214), Expect = 4e-19
Identities = 64/273 (23%), Positives = 97/273 (35%), Gaps = 33/273 (12%)
Query: 398 CRISGKIPQVISNLSNLLLLDLGGNKLTG--SIPVTFSRLLNLQGLGLAFN-KLARSIPD 454
C + +V + LDL G L IP + + L L L + L IP
Sbjct: 43 CDTDTQTYRVNN-------LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 455 EICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFD 514
I L +L L + SGAIP + +L L N + LP +I +L +++
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 515 VSSNSLDGPLSLDIGNLKVVIELNLSRNN-----------------------LSGDIPIT 551
N + G + G+ + N +
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 552 IGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNL 611
+ G + +L LDL N+I G +P L +L +L LN+
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 612 SFNKLEGEIPRGGPFANLTAKSFLGNELLCGLP 644
SFN L GEIP+GG ++ N+ LCG P
Sbjct: 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.9 bits (185), Expect = 2e-15
Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 26/260 (10%)
Query: 357 SSLTNCQKIRVLILAGNPLDGI--LPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNL 414
+ T ++ L L+G L +PSS+ NL + + G IP I+ L+ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 415 LLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSG 474
L + ++G+IP S++ L L ++N L+ ++P I L L + GN+ SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 475 AIPSCSGNLTSL-----------------------RALYLGSNRFTSALPSTIWNLKDIL 511
AIP G+ + L A S S ++
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 512 FFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGP 571
+ + +G K + L+L N + G +P + LK L L ++ N L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 572 IPESFSGLSSLEILDLSKNK 591
IP+ L ++ + NK
Sbjct: 284 IPQ-GGNLQRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 1e-13
Identities = 68/268 (25%), Positives = 99/268 (36%), Gaps = 24/268 (8%)
Query: 183 STLSKCKQLEGLYLRFNNLSGA--IPKEIGNLTKLKDIILNDNE-LRGEIPQEMGNLPYL 239
T ++ ++ L L NL IP + NL L + + L G IP + L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 240 VRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS 299
L + N+ G +P + + TL L N L G+LP I SLPN+ + NR S
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRIS 162
Query: 300 GNIPSSITNASKLTV-FQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSST-------- 350
G IP S + SKL + N +G IP T NL + ++
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 351 ---------PELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
L + + + L L N + G LP + L L + +
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLC 281
Query: 402 GKIPQVISNLSNLLLLDLGGNKLTGSIP 429
G+IPQ NL + NK P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 2e-13
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 13/275 (4%)
Query: 304 SSITNASKLTVFQLRGNSFSGF--IPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTN 361
+ T ++ L G + IP+++ NL L FL I ++
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP----IPPAIAK 99
Query: 362 CQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGG 421
++ L + + G + +L +SG +P IS+L NL+ + G
Sbjct: 100 LTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 422 NKLTGSIPVTFSRLLNLQGLGLAF-NKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCS 480
N+++G+IP ++ L N+L IP + + S
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVL 216
Query: 481 GNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLS 540
+ + + K++ D+ +N + G L + LK + LN+S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 541 RNNLSGDIPITIGGLKNLQKLFLANNRL--EGPIP 573
NNL G+IP G L+ ANN+ P+P
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.8 bits (156), Expect = 1e-11
Identities = 58/295 (19%), Positives = 97/295 (32%), Gaps = 36/295 (12%)
Query: 210 GNLTKLKDIILNDNELRG--EIPQEMGNLPYLVRLTLATN-NLVGVVPFTIFNMSTLKKL 266
++ ++ L+ L IP + NLPYL L + NLVG +P I ++ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 267 SLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFI 326
+ + G+ + + L+ N SG +P SI++ L GN SG I
Sbjct: 107 YITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 327 PNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNL 386
P++ G+ L + +F + + + +S+
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL-------SRNMLEGDASVLFG 218
Query: 387 SISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
S + + NL LDL N++ G++P
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP----------------- 261
Query: 447 KLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALP 501
+ L L L + N G IP GNL +N+ P
Sbjct: 262 -------QGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-27
Identities = 55/294 (18%), Positives = 109/294 (37%), Gaps = 40/294 (13%)
Query: 724 ATDRFSKNNLLGIGSFGSVYVAR--LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRI 779
A ++ +G G++G V+ AR G VA+K + E S E V++ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 780 ---RHRNLVKIISACSNDDFKA-----LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMID 831
H N+V++ C+ L+ E++ + ++M
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 832 VALALEYLHFGHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLAT 879
+ L++LH S ++H ++DF +A+ + Q T + T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 880 IGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVM 939
+ Y APE +Q +T D++S G + E F K ++ + D++ +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG--SSDVDQLGKILDVIGLPGE 236
Query: 940 EVIDTNLLSGEERYFAAKEQSLLSI--------LNLATECTIESPGKRINAREI 985
E ++ + + + Q + +L +C +P KRI+A
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-27
Identities = 51/297 (17%), Positives = 110/297 (37%), Gaps = 41/297 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR 782
++ K +G G+FG V+ AR + G +VA+K E + E ++++ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 783 NLVKIISACSNDDFKA--------LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVAL 834
N+V +I C L+ ++ + + + +M +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML-- 126
Query: 835 ALEYLHFGHSTPIIHY------------MVAHISDFSIAKFLN--GQDQLSMQTQTLATI 880
L L++ H I+H V ++DF +A+ + Q + T + T+
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 881 GYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKP-TDEIFIGELSLSRWVNDLLPISV 938
Y PE + R D++ G ++ E +T +L+L + + V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 939 MEVIDTNLLSGEERYFAAKEQSLLSIL----------NLATECTIESPGKRINAREI 985
+D L + +++ + L +L + + P +RI++ +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 3e-26
Identities = 50/292 (17%), Positives = 110/292 (37%), Gaps = 42/292 (14%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRN 783
D + LG G + V+ A + + +V VK+ + K + E ++++ +R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 784 LVKIISACSNDDFK--ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLH- 840
++ + + + AL+ E++ N + + L + M ++ AL+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 841 ------FGHSTPII---HYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQG 891
++ + + D+ +A+F + + +A+ + PE V
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 204
Query: 892 R-VSTRGDVYSYGIMLMETFTGKKPTDE--------IFIGELSLSRWVNDL-------LP 935
+ D++S G ML K+P + I ++ + + D L
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 936 ISVMEVIDTNLLSGEERYFAAKEQSLLS--ILNLATECTIESPGKRINAREI 985
+++ + ER+ ++ Q L+S L+ + R+ ARE
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (269), Expect = 1e-25
Identities = 83/389 (21%), Positives = 145/389 (37%), Gaps = 34/389 (8%)
Query: 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDL--SLPNVEFLN 292
L ++ L N+ V T ++ + L + ID L N+ +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-----KSIDGVEYLNNLTQIN 72
Query: 293 LGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLE-------FLNIADNY 345
N+ + P + N +KL + N + P
Sbjct: 73 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 346 LTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIP 405
LT+ +++++ + L G + + L+ ++
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 406 QVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKL 465
V++ L+NL L N+++ P+ NL L L N+L + L L L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQL--KDIGTLASLTNLTDL 246
Query: 466 ILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLS 525
L N+ S P LT L L LG+N+ ++ P + L + +++ N L+
Sbjct: 247 DLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS- 301
Query: 526 LDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEIL 585
I NLK + L L NN+S P+ L LQ+LF ANN++ S + L+++ L
Sbjct: 302 -PISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSDV--SSLANLTNINWL 356
Query: 586 DLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
N+IS + P L L + +L L+
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.0 bits (214), Expect = 1e-18
Identities = 83/405 (20%), Positives = 141/405 (34%), Gaps = 41/405 (10%)
Query: 90 NLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSI 149
L+ L ++ + + ++ + L + S+ + ++++ I+ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSN 75
Query: 150 NRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEI 209
N+ + P KNL L +L+ N P L+ +
Sbjct: 76 NQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPL 128
Query: 210 GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLL 269
NLT L + L+ N + + + + ++ L L L
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD--------LKPLANLTTLERL 180
Query: 270 ENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNT 329
+ + + L N+E L N+ S P I + L L GN T
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGT 236
Query: 330 IGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS 389
+ +L NL L++A+N +++ P L+ K+ L L N + I P + L+
Sbjct: 237 LASLTNLTDLDLANNQISNLAP-------LSGLTKLTELKLGANQISNISP--LAGLTAL 287
Query: 390 LERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLA 449
N ISNL NL L L N ++ P S L LQ L A NK+
Sbjct: 288 TNLELNENQLE---DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV- 341
Query: 450 RSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSN 494
S + +L ++ L N+ S P NLT + L L
Sbjct: 342 -SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 7e-16
Identities = 75/359 (20%), Positives = 136/359 (37%), Gaps = 37/359 (10%)
Query: 88 LGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDL 147
+ L++L ++ S+N+L+ P + N+ L + +NQ+ + L +
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 148 SINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPK 207
+ L N L + + S + K
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD----------LK 169
Query: 208 EIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLS 267
+ NLT L+ + ++ N + + L L L N + + P ++ L +LS
Sbjct: 170 PLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELS 225
Query: 268 LLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIP 327
L N L SL N+ L+L N+ S P ++ +KLT +L N S P
Sbjct: 226 LNGNQLKDIGTLA---SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
Query: 328 NTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLS 387
+ L L L + +N L +P +N + + L L N + I P + +L+
Sbjct: 281 --LAGLTALTNLELNENQLEDISPI-------SNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 388 ISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFN 446
L+R N ++S ++NL+N+ L G N+++ P + L + LGL
Sbjct: 330 -KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 2e-15
Identities = 43/200 (21%), Positives = 83/200 (41%), Gaps = 15/200 (7%)
Query: 48 NWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGN 107
+ + IT + L+++G L+ L +L++L LDL++N++S
Sbjct: 199 LESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 108 IPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNL 167
P + + L L NQ+ S + ++++ ++L+ N+ + NL NL
Sbjct: 257 AP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLE---DISPISNLKNL 309
Query: 168 KKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRG 227
L L N P +S +L+ L+ N +S + NLT + + N++
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 228 EIPQEMGNLPYLVRLTLATN 247
P + NL + +L L
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 21/227 (9%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKL----- 462
+ L+NL ++ N+LT P L L + + N++A P
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 463 -DKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSS---- 517
+ K + + ++ + S + S + D+ +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 518 ---NSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPE 574
+S + L + L + N +S P+ I NL +L L N+L+
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 575 SFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621
+ + L++L LDL+ N+IS + P L L L +L L N++ P
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 1e-07
Identities = 20/110 (18%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 41 PTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLS 100
P + I+ N + L + N+ P + +L+ L+ L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 101 HNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSIN 150
+NK+S SS+ N+ + L NQ+ + N++ + + L+
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 8/83 (9%)
Query: 543 NLSGDIPITI----GGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPT 598
++ D PI L K L + + ++ L + L + I +
Sbjct: 5 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--D 60
Query: 599 SLEKLLYLKKLNLSFNKLEGEIP 621
+E L L ++N S N+L P
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP 83
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-25
Identities = 43/206 (20%), Positives = 71/206 (34%), Gaps = 22/206 (10%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
+ F LLG G+FG V + R G A+K+ + + + E V++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
L + A D +MEY G L L + + ++ A L +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSA---LEY 120
Query: 842 GHSTPIIH------------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGV 889
HS +++ I+DF + K T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 890 QGRVSTRGDVYSYGIMLMETFTGKKP 915
D + G+++ E G+ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 4e-25
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 28/213 (13%)
Query: 726 DRFSKNNLLGIGSFGSVYVARL----QDGMEVAVKVFHQRY----ERALKSFQDECEVMK 777
+ F +LG G++G V++ R G A+KV + + + + E +V++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 778 RIRHR-NLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
IR LV + A + LI++Y+ G L L + + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139
Query: 837 EYLHFGHSTPIIHY------------MVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMA 884
L H II+ ++DF ++K + TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMA 198
Query: 885 PE--YGVQGRVSTRGDVYSYGIMLMETFTGKKP 915
P+ G D +S G+++ E TG P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-24
Identities = 42/288 (14%), Positives = 93/288 (32%), Gaps = 33/288 (11%)
Query: 725 TDRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRH 781
+R+ + +G G++GSV A + G+ VAVK + + K E ++K ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 782 RNLVKIISACS-----NDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
N++ ++ + + ++ ++ L N + ++ + L
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHVQFLIYQILRGL 134
Query: 837 EYLHFGHSTPIIH---------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY 887
+Y+H I DF +A+ + + M
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIM 190
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP---------TDEIFIGELSLSRWVNDLLPISV 938
+ D++S G ++ E TG+ I + + +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 939 MEVIDTNLLSGEERYFAAKEQSLLSI-LNLATECTIESPGKRINAREI 985
+L + FA + ++L + + KRI A +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 7e-24
Identities = 38/201 (18%), Positives = 79/201 (39%), Gaps = 15/201 (7%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRH 781
D+F + LG GSFG V + + + G A+K+ ++ + ++ +E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841
LVK+ + ++ ++MEY+ G + + L + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158
Query: 842 GHSTPIIH-------YMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVS 894
S +I+ ++ + F + T +APE + +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 895 TRGDVYSYGIMLMETFTGKKP 915
D ++ G+++ E G P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 5e-22
Identities = 48/299 (16%), Positives = 96/299 (32%), Gaps = 46/299 (15%)
Query: 726 DRFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHR 782
R+ +G G+ G V A VA+K + + + K E +MK + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 783 NLVKIISACSNDDFK------ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALAL 836
N++ +++ + L+ME M + LD + ++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGI 132
Query: 837 EYLHFGHS---------TPIIHYMVAHISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEY 887
++LH + I DF +A+ M T + T Y APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEV 189
Query: 888 GVQGRVSTRGDVYSYGIMLMETFTGKKP---------TDEIFIGELSLSRWVNDLLPISV 938
+ D++S G ++ E K +++ + L +V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 939 MEVIDTNLLSGEERYFAAKEQSLLSI------------LNLATECTIESPGKRINAREI 985
++ + SL +L ++ + P KRI+ +
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 1e-21
Identities = 44/247 (17%), Positives = 88/247 (35%), Gaps = 36/247 (14%)
Query: 727 RFSKNNLLGIGSFGSVYVAR-LQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLV 785
R+ LG G F +V++A+ + + VA+K+ + ++ +DE ++++R+ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 786 KIISACSNDDFK---------------ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMI 830
K S +N K ++ E + L + + I
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 831 DVALALEYLHFGHSTPIIHY-------------MVAHISDFSIAKFLNGQDQLSMQTQTL 877
+ L L+Y+H IIH ++ IA N T ++
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 878 ATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS 937
T Y +PE + D++S ++ E TG F + S +D
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQ 246
Query: 938 VMEVIDT 944
++E++
Sbjct: 247 IIELLGE 253
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 1e-20
Identities = 60/269 (22%), Positives = 98/269 (36%), Gaps = 11/269 (4%)
Query: 326 IPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGN 385
+P I + + + N ++ S C+ + +L L N L I ++
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 386 LSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAF 445
L++ + N ++ P L L L L L P F L LQ L L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 446 NKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIW 505
N L D L L L LHGN+ S L SL L L NR P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 506 NLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLAN 565
+L ++ + +N+L + + L+ + L L+ N D LQK ++
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSS 257
Query: 566 NRLEGPIPESFSGLSSLEILDLSKNKISG 594
+ + +P+ +G + L+ N + G
Sbjct: 258 SEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (223), Expect = 2e-20
Identities = 57/285 (20%), Positives = 101/285 (35%), Gaps = 8/285 (2%)
Query: 63 CGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLD 122
C + + + LQ +P + ++ + + L N++S +S L +L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 123 FRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP 182
N L ++ ++ + +DLS N + L L L L R P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 183 STLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRL 242
L+ LYL+ N L +L L + L+ N + + L L RL
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
L N + V P ++ L L L N +LP+ L +++L L N + +
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANN-LSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
+ + L F+ + +P L + +A N L
Sbjct: 242 R-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (190), Expect = 3e-16
Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 5/252 (1%)
Query: 397 NCRISG--KIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPD 454
+C G +P I + + L GN+++ +F NL L L N LAR
Sbjct: 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 455 EICHLAKLDKLILHGNKFSGAI-PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFF 513
LA L++L L N ++ P+ L L L+L P L + +
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 514 DVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573
+ N+L +L + L L N +S GL +L +L L NR+ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 574 ESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKS 633
+F L L L L N +S + +L L L+ L L+ N + +A L
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254
Query: 634 FLGNELLCGLPD 645
+E+ C LP
Sbjct: 255 GSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (174), Expect = 4e-14
Identities = 47/265 (17%), Positives = 81/265 (30%), Gaps = 26/265 (9%)
Query: 181 IPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLV 240
+P + + ++L N +S L + L+ N L L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 241 RLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSG 300
+L L+ N + V F+ L+ L + L +++L L N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPEL------- 353
+ + LT L GN S L +L+ L + N + P
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 354 ------------SFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
+L + ++ L L NP L L++F+ + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVP 261
Query: 402 GKIPQVISNLSNLLLLDLGGNKLTG 426
+P L+ L L N L G
Sbjct: 262 CSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 53/256 (20%), Positives = 89/256 (34%), Gaps = 9/256 (3%)
Query: 21 SNITTDQQSLLALKAHISYDPTNLFAK------NWTSSTSVCSWIGITCGVNSHKVIVLN 74
I Q + IS+ P F W S + + +
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 75 ISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSS 134
L+ P L L TL L L P + L+ L +DN L
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 135 FIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGL 194
++ ++ + L NR S +P + L +L +LLL +N P +L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 195 YLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVP 254
YL NNLS + + L L+ + LNDN + +L + +++ + +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP 265
Query: 255 FTIFNMSTLKKLSLLE 270
+ LK+L+ +
Sbjct: 266 QRLAGRD-LKRLAAND 280
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 6e-11
Identities = 37/195 (18%), Positives = 65/195 (33%), Gaps = 5/195 (2%)
Query: 57 SWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMH 116
+ ++ L++ LQ P L++L+ L L N L + ++
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 117 TLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNM 176
L L N++ + S+ + L NR + P +L L L L N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANN 212
Query: 177 FHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNL 236
L+ + L+ L L N L+ + +E+ +PQ +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 237 PYLVRLTLATNNLVG 251
LA N+L G
Sbjct: 272 DL---KRLAANDLQG 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (225), Expect = 2e-20
Identities = 49/259 (18%), Positives = 98/259 (37%), Gaps = 12/259 (4%)
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKL 424
+L L N + I NL +L + N +IS P + L L L L N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 425 TGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLT 484
L L+ K+ +S+ + + + ++ L + K SG +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150
Query: 485 SLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNL 544
L + + T+ +L ++ + N + + + L + +L LS N++
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 545 SGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTS----- 599
S ++ +L++L L NN+L +P + ++++ L N IS +
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 600 -LEKLLYLKKLNLSFNKLE 617
K ++L N ++
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 5e-19
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 20/275 (7%)
Query: 180 KIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYL 239
K+P L L L+ N ++ + NL L +IL +N++ P L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 240 VRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFS 299
RL L+ N L + + L+ + S+ + L+ V L + S
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG--LNQMIVVELGTNPLKSS 139
Query: 300 GNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSL 359
G + KL+ ++ + + G +L L++ N +T +SL
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDA-----ASL 191
Query: 360 TNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDL 419
+ L L+ N + + S+ N L + N ++ K+P +++ + ++ L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPH-LRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 420 GGNKLTGSIPVTF------SRLLNLQGLGLAFNKL 448
N ++ F ++ + G+ L N +
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 6/237 (2%)
Query: 403 KIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKL 462
K+P+ + + LLDL NK+T F L NL L L NK+++ P L KL
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 463 DKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDG 522
++L L N+ L LR + ++ + N ++ + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-GLNQMIVVELGTNPLKSSG 140
Query: 523 PLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSL 582
+ +K + + ++ N++ I G +L +L L N++ S GL++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 583 EILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNEL 639
L LS N IS V SL +L++L+L+ NKL + N +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 6e-18
Identities = 58/237 (24%), Positives = 84/237 (35%), Gaps = 7/237 (2%)
Query: 417 LDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAI 476
+ L +P + L L NK+ + +L L LIL NK S
Sbjct: 15 VQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
P L L LYL N+ LP + L + + + N +V+E
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L + SG G+K L + +A+ + IP+ SL L L NKI+ V
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187
Query: 597 PTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKL 653
SL+ L L KL LSFN + + L N L +P +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 2e-17
Identities = 53/303 (17%), Positives = 103/303 (33%), Gaps = 24/303 (7%)
Query: 56 CSWIGITCGVNSHKVI---------VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSG 106
C + C + + +L++ + NL +L TL L +NK+S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 107 NIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPN 166
P + + L+ L NQL + + + I + + N
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN--GLNQMI 127
Query: 167 LKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELR 226
+ +L G K+L + + N++ IP+ G L ++ L+ N++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 184
Query: 227 GEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLP 286
+ L L +L L+ N++ V ++ N L++L L N L D
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD--HK 242
Query: 287 NVEFLNLGTNRFSG------NIPSSITNASKLTVFQLRGN--SFSGFIPNTIGNLRNLEF 338
++ + L N S P T + + L N + P+T +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302
Query: 339 LNI 341
+ +
Sbjct: 303 VQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 48/293 (16%), Positives = 90/293 (30%), Gaps = 15/293 (5%)
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTK 214
++P ++ P+ L L N K L L L N +S P L K
Sbjct: 24 KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 215 LKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLW 274
L+ + L+ N+L+ + L L N + V ++FN + L
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVH----ENEITKVRKSVFNGLNQMIVVELGTNPL 136
Query: 275 GSLPSRIDL--SLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN 332
S + + ++ + + IP + LT L GN + ++
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKG 193
Query: 333 LRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLER 392
L NL L ++ N +++ + + L P I + +
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
Query: 393 FQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGS--IPVTFSRLLNLQGLGL 443
P + ++ + L N + P TF + + L
Sbjct: 254 ISAIG-SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 6e-09
Identities = 27/119 (22%), Positives = 44/119 (36%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
L+L N ++ LKNL L L NN++ P +F+ L LE L LSKN++ +
Sbjct: 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 94
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLN 654
+ L L+ K+ + G + + KL+
Sbjct: 95 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 28/140 (20%), Positives = 50/140 (35%), Gaps = 4/140 (2%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV 595
+ S L +P + + L L NN++ F L +L L L NKIS +
Sbjct: 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPR-GGPFANLTAKSFLGNELLCGLPDLHNSPCKLN 654
P + L+ L++L LS N+L+ + L ++ + + N +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 655 KPKTHHKSRKMMLLLVIALP 674
KS + +
Sbjct: 131 LGTNPLKSSGIENGAFQGMK 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 3e-07
Identities = 33/178 (18%), Positives = 62/178 (34%), Gaps = 6/178 (3%)
Query: 477 PSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIE 536
C +L ++ LG + LP L D+ +N + D NLK +
Sbjct: 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHT 59
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVI 596
L L N +S P L L++L+L+ N+L+ + L L + + K+ +
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 597 PTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLN 654
L +++ ++ E L+ + L S +L+
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH 177
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 5e-14
Identities = 18/156 (11%), Positives = 41/156 (26%), Gaps = 30/156 (19%)
Query: 732 NLLGIGSFGSVYVARLQDGMEVAVKVFH----------QRYERALKSFQDECEVMKRIRH 781
L+G G +V+ + E VK ++ + F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 782 RNLVKIISACSNDDF----KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALE 837
R L K+ + A++ME + + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRVENPDEVLDMILEEVA 117
Query: 838 YLHFGH--------STPIIHYMVAHISDFSIAKFLN 865
+ ++ I DF + +
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVG 153
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 43/187 (22%), Positives = 65/187 (34%), Gaps = 6/187 (3%)
Query: 404 IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLD 463
+P + + +L L N L T L L L + + L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLG 80
Query: 464 KLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGP 523
L L N+ +L L + NR TS + L ++ + N L
Sbjct: 81 TLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 524 LSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLE 583
+ + +L+L+ NNL+ + GL+NL L L N L IP+ F G L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 584 ILDLSKN 590
L N
Sbjct: 199 FAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 41/199 (20%), Positives = 63/199 (31%), Gaps = 8/199 (4%)
Query: 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSL 132
+N NL +PP L L LS N L +++ L L+ +L
Sbjct: 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 133 SSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLE 192
+ L + + + L + N L +L+
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPLGALRGLGELQ 127
Query: 193 GLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGV 252
LYL+ N L P + KL+ + L +N L + L L L L N+L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 253 VPFTIFNMSTLKKLSLLEN 271
+P F L L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 46/212 (21%), Positives = 72/212 (33%), Gaps = 18/212 (8%)
Query: 276 SLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRN 335
+LP + + L+L N +++ ++LT L + G L
Sbjct: 24 ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPV 78
Query: 336 LEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQM 395
L L+++ N L S L +LT N L + ++ L E +
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSF------NRLTSLPLGALRGLGELQELYLK 132
Query: 396 FNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDE 455
N P +++ L L L N LT + L NL L L N L +IP
Sbjct: 133 GNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 456 ICHLAKLDKLILHGNKFSGAIPSCSGNLTSLR 487
L LHGN + C+ + R
Sbjct: 191 FFGSHLLPFAFLHGNPW-----LCNCEILYFR 217
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 9e-07
Identities = 13/65 (20%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 527 DIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILD 586
++ + +E+N + NL+ +P + K+ L L+ N L + + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 587 LSKNK 591
L + +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 51/235 (21%), Positives = 80/235 (34%), Gaps = 32/235 (13%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+S +++ L ++ LT ++P ++ L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-------------------------ALPPDL--PKDTTILHL 38
Query: 468 HGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLD 527
N + T L L L T + +L S++ L L
Sbjct: 39 SENLLYTFSLATLMPYTRLTQLNLDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLL 95
Query: 528 IGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDL 587
L + L++S N L+ + GL LQ+L+L N L+ P + LE L L
Sbjct: 96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 588 SKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRG-GPFANLTAKSFLGNELLC 641
+ N ++ + L L L L L N L IP+G L GN LC
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 18/73 (24%), Positives = 26/73 (35%), Gaps = 1/73 (1%)
Query: 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNM 115
+ + K+ L+++ NL L L +L+TL L N L IP F
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 116 HTLKLLDFRDNQL 128
H L N
Sbjct: 195 HLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 551 TIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLN 610
+ + + ++ L +P IL LS+N + +L L +LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 611 LS 612
L
Sbjct: 62 LD 63
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 5e-09
Identities = 37/217 (17%), Positives = 72/217 (33%), Gaps = 22/217 (10%)
Query: 410 NLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHG 469
L+N + + G + +T VT + L + L + +I + +L L L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKD 72
Query: 470 NKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIG 529
N+ + P + + L + SA+ L ++ ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 530 NLKVVIELNLSRNNL--------------SGDIPITIGGLKNLQKLFLANNRLEGPIPES 575
L + + + + L + L L L +N++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 576 FSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLS 612
+ L +L + L N+IS V P L L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 37/213 (17%), Positives = 73/213 (34%), Gaps = 21/213 (9%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128
I + N+ T+ +L + TL ++ + ++ L L+ +DNQ+
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 129 FGS-------LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGR------N 175
+ + + L +I ++ L G
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGN 235
+ +I + YL N + + NL+KL + +DN++ P + +
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193
Query: 236 LPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
LP L+ + L N + V P N S L ++L
Sbjct: 194 LPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 32/222 (14%), Positives = 75/222 (33%), Gaps = 26/222 (11%)
Query: 162 KNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILN 221
L N K+ G++ + T + + L ++ + + L L + L
Sbjct: 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 222 DNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI 281
DN++ P + + L+ V + + + + + + S +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 282 DLSLPNVEFL-------------NLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPN 328
+ ++ + L + + + N SKLT + N S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 329 TIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLIL 370
+ +L NL +++ +N ++ +S L N + ++ L
Sbjct: 191 -LASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 29/214 (13%), Positives = 70/214 (32%), Gaps = 11/214 (5%)
Query: 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTL-----WGSLPSRIDLSLPNVE 289
L +++ +N+ V ++ + LS + L + I L L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74
Query: 290 FLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSS 349
+L + I + + L S + + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 350 TPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVIS 409
+L+ +++++ + L + + L + + +IS P ++
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 410 NLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
+L NL+ + L N+++ P + NL + L
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 4/78 (5%)
Query: 48 NWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGN 107
S +T N K+ L + P L +L +L + L +N++S
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210
Query: 108 IPSSIFNMHTLKLLDFRD 125
P + N L ++ +
Sbjct: 211 SP--LANTSNLFIVTLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 8e-09
Identities = 42/266 (15%), Positives = 84/266 (31%), Gaps = 16/266 (6%)
Query: 96 TLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSF-IFNMSSMLGIDLSINRFSG 154
TLDL+ L ++ + + ++ FR + F F+ + +DLS +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS---QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 155 ELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLR--FNNLSGAIPKEIGNL 212
I L+ L L I +TL+K L L L A+ + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 213 TKLKDIILNDNELRG------EIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKL 266
++L ++ L+ + + L N + + L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 267 SLLENTLWGSLPSRIDLSLPNVEFLNL-GTNRFSGNIPSSITNASKLTVFQLRGNSFSGF 325
L ++ + + + L ++ L+L + L Q+ G G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 326 IPNTIGNLRNLEFLNIADNYLTSSTP 351
+ L + L I ++ T+
Sbjct: 241 LQLLKEALPH---LQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 42/249 (16%), Positives = 91/249 (36%), Gaps = 16/249 (6%)
Query: 363 QKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK-IPQVISNLSNLLLLDLGG 421
Q + + +D L ++ + N I + ++S S L L L G
Sbjct: 23 QGVIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 422 NKLTGSIPVTFSRLLNLQGL--GLAFNKLARSIPDEICHLAKLDKLILHGNKFSG----- 474
+L+ I T ++ NL L ++ + ++LD+L L
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140
Query: 475 -AIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSL-DGPLSLDIGNLK 532
A+ S +T L N S L + + +++ D+S + + + L
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200
Query: 533 VVIELNLSR-NNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNK 591
+ L+LSR ++ + + +G + L+ L + +G + L L+I + +
Sbjct: 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSH 257
Query: 592 ISGVIPTSL 600
+ + ++
Sbjct: 258 FTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 40/269 (14%), Positives = 96/269 (35%), Gaps = 15/269 (5%)
Query: 60 GITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIF-NMHTL 118
+T + S VI + + ++ +DLS++ + + I L
Sbjct: 15 DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 119 KLLDFRDNQLFGSLSSFIFNMSSMLGIDL----SINRFSGELPANICKNLPNLKKLLLGR 174
+ L +L + + + S+++ ++L + F+ + + C L L
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 175 NMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDN----ELRGEIP 230
+ + + L L + + + +++ D L+ +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 231 QEMGNLPYLVRLTLA-TNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVE 289
QE L YL L+L+ +++ + + TLK L + G+L + +LP+
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ-LLKEALPH-- 250
Query: 290 FLNLGTNRFSGNIPSSITNASKLTVFQLR 318
L + + F+ +I N ++ ++
Sbjct: 251 -LQINCSHFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 43/256 (16%), Positives = 85/256 (33%), Gaps = 16/256 (6%)
Query: 378 ILPSSIGNL-SISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTG-SIPVTFSRL 435
+ P G L S + F+ + + + S + +DL + + ++ S+
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQC 70
Query: 436 LNLQGLGLAFNKLARSIPDEICHLAKLDKLILHG--NKFSGAIPSCSGNLTSLRALYLGS 493
LQ L L +L+ I + + + L +L L G A+ + + + L L L
Sbjct: 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130
Query: 494 NRFTS------ALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRN-NLSG 546
+ A+ + + N LS + ++ L+LS + L
Sbjct: 131 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 190
Query: 547 DIPITIGGLKNLQKLFLAN-NRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605
D L LQ L L+ + + +L+ L + G + E
Sbjct: 191 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA--- 247
Query: 606 LKKLNLSFNKLEGEIP 621
L L ++ +
Sbjct: 248 LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 19/87 (21%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 537 LNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGV- 595
L+L+ NL D+ + + + ++ P+ E FS ++ +DLS + I
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 596 IPTSLEKLLYLKKLNLSFNKLEGEIPR 622
+ L + L+ L+L +L I
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 2e-08
Identities = 17/87 (19%), Positives = 33/87 (37%), Gaps = 10/87 (11%)
Query: 536 ELNLSRNNLS-GDIPITIGGLKNLQKLFLANNRLEG----PIPESFSGLSSLEILDLSKN 590
L++ LS + L+ Q + L + L I + +L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 591 KISGVIPTSLEKLL-----YLKKLNLS 612
++ V + + L ++KL+L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 16/88 (18%), Positives = 26/88 (29%), Gaps = 9/88 (10%)
Query: 145 IDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGK----IPSTLSKCKQLEGLYLRFNN 200
+D+ S A + L + + L I S L L L LR N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 201 LSGAIPKEIG-----NLTKLKDIILNDN 223
L + K++ + L +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 14/95 (14%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 93 SLETLDLSHNKLSGNIPSSIF-NMHTLKLLDFRDNQL----FGSLSSFIFNMSSMLGIDL 147
+++LD+ +LS + + + +++ D L +SS + ++ ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 148 SINRFSGELPANICKNL----PNLKKLLLGRNMFH 178
N + + L ++KL L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 14/71 (19%), Positives = 27/71 (38%), Gaps = 5/71 (7%)
Query: 557 NLQKLFLANNRL-EGPIPESFSGLSSLEILDLSKNKISGV----IPTSLEKLLYLKKLNL 611
++Q L + L + E L +++ L ++ I ++L L +LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 612 SFNKLEGEIPR 622
N+L
Sbjct: 63 RSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/85 (18%), Positives = 27/85 (31%), Gaps = 9/85 (10%)
Query: 161 CKNLPNLKKLLLGRNMFHGK----IPSTLSKCKQLEGLYLRFNNLSGAIPKEIG-----N 211
+ L+ L L + +TL L L L N L A ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 212 LTKLKDIILNDNELRGEIPQEMGNL 236
L+ ++L D E+ + L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 556 KNLQKLFLANNRLEG----PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLL-----YL 606
L+ L+LA+ + + + SL LDLS N + L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 607 KKLNLSFNKLEGEIPR 622
++L L E+
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 18/81 (22%), Positives = 29/81 (35%), Gaps = 9/81 (11%)
Query: 536 ELNLSRNNLSGD----IPITIGGLKNLQKLFLANNRLEGPIPESFSG-----LSSLEILD 586
L L+ ++S + T+ +L++L L+NN L LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 587 LSKNKISGVIPTSLEKLLYLK 607
L S + L+ L K
Sbjct: 433 LYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 5/92 (5%)
Query: 287 NVEFLNLGTNRFSGNIPSSITNA-SKLTVFQLRGNSFSG----FIPNTIGNLRNLEFLNI 341
+++ L++ S + + + V +L + I + + L LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 342 ADNYLTSSTPELSFLSSLTNCQKIRVLILAGN 373
N L T KI+ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 14/61 (22%), Positives = 24/61 (39%), Gaps = 5/61 (8%)
Query: 73 LNISGFNLQGTIPPQL-GNLSSLETLDLSHNKLSG----NIPSSIFNMHTLKLLDFRDNQ 127
L+I L +L L + + L L+ +I S++ L L+ R N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 128 L 128
L
Sbjct: 67 L 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 21/142 (14%), Positives = 43/142 (30%), Gaps = 26/142 (18%)
Query: 36 HISYDPTNLFAKNWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGT----IPPQLGNL 91
+ L N + + G + VL ++ ++ + + L
Sbjct: 337 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 396
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINR 151
SL LDLS+N L + + S + + L
Sbjct: 397 HSLRELDLSNNCLGDAGILQL-------------------VESVRQPGCLLEQLVLYDIY 437
Query: 152 FSGELP---ANICKNLPNLKKL 170
+S E+ + K+ P+L+ +
Sbjct: 438 WSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 15/85 (17%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 114 NMHTLKLLDFRDNQL----FGSLSSFIFNMSSMLGIDLSINRFSGE----LPANICKNLP 165
L++L D + SL++ + S+ +DLS N L ++ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 166 NLKKLLLGRNMFHGKIPSTLSKCKQ 190
L++L+L + ++ L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 13/98 (13%), Positives = 28/98 (28%), Gaps = 4/98 (4%)
Query: 365 IRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGK----IPQVISNLSNLLLLDLG 420
I+ L + L + + L + ++ +C ++ I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 421 GNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICH 458
N+L + L + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 15/82 (18%), Positives = 28/82 (34%), Gaps = 9/82 (10%)
Query: 389 SLERFQMFNCRISGK----IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL-----NLQ 439
L + +C +S + + +L LDL N L + + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 440 GLGLAFNKLARSIPDEICHLAK 461
L L + + D + L K
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 9e-04
Identities = 16/92 (17%), Positives = 28/92 (30%), Gaps = 8/92 (8%)
Query: 133 SSFIFNMSSMLGIDLSINRFSGELPANIC---KNLPNLKKLLLGRNMFHGKIPSTLSK-- 187
S + + L+ S +++ +L++L L N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 188 ---CKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
LE L L S + + L K K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 17/96 (17%), Positives = 31/96 (32%), Gaps = 10/96 (10%)
Query: 387 SISLERFQMFNCRISGK-IPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLL----NLQGL 441
S+ ++ + +S +++ L ++ L LT + S L L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 442 GLAFNKLARSIPDEICHL-----AKLDKLILHGNKF 472
L N+L + K+ KL L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 14/83 (16%), Positives = 26/83 (31%), Gaps = 4/83 (4%)
Query: 308 NASKLTVFQLRGNSFSG----FIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQ 363
S L V L S + T+ +L L++++N L + S
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 364 KIRVLILAGNPLDGILPSSIGNL 386
+ L+L + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 8/126 (6%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
VL+++ +L T+ L L + LDLSHN+L P ++ + L++L DN L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGK---IPSTLSKC 188
L L NR + P L L L N +
Sbjct: 59 DGVANLPRLQEL--LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 189 KQLEGL 194
+ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 27/125 (21%), Positives = 43/125 (34%), Gaps = 6/125 (4%)
Query: 487 RALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSG 546
R L+L T + L + D+S N L + L+ + L S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 547 DIPITIGGLKNLQKLFLANNRLEG-PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605
+ LQ+L L NNRL+ + L +L+L N +
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 606 LKKLN 610
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 514 DVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573
++ L L L +V L+LS N L P + L+ L+ L +
Sbjct: 4 HLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALENV 58
Query: 574 ESFSGLSSLEILDLSKNKISGV-IPTSLEKLLYLKKLNLSFNKLEGE 619
+ + L L+ L L N++ L L LNL N L E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 23/125 (18%), Positives = 41/125 (32%), Gaps = 11/125 (8%)
Query: 314 VFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGN 373
V L + + + L + L+++ N L + P L+ L L Q + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 374 PLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFS 433
+ + L N Q + + L+LL+L GN L
Sbjct: 60 GVANLPRLQELLLC--------NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 110
Query: 434 RLLNL 438
RL +
Sbjct: 111 RLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 25/111 (22%), Positives = 41/111 (36%), Gaps = 10/111 (9%)
Query: 408 ISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLIL 467
+ L + LDL N+L P + L L+ L + A D + +L +L +L+L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNALENVDGVANLPRLQELLL 72
Query: 468 HGNKF-SGAIPSCSGNLTSLRALYLGSNRFT------SALPSTIWNLKDIL 511
N+ A + L L L N L + ++ IL
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 0.001
Identities = 22/126 (17%), Positives = 40/126 (31%), Gaps = 9/126 (7%)
Query: 441 LGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSAL 500
L LA L ++ + L + L L N+ P+ L L L N +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENVD 59
Query: 501 PSTIWNLKDILFFDVSSNSL-DGPLSLDIGNLKVVIELNLSRNNLSGD---IPITIGGLK 556
L + +N L + + ++ LNL N+L + L
Sbjct: 60 GVANLPRLQEL--LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 557 NLQKLF 562
++ +
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 194 LYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVV 253
L+L +L+ + + L + + L+ N LR P + L L L + N L V
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 254 PFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSG 300
++L L N L S + +S P + LNL N
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 47/329 (14%), Positives = 92/329 (27%), Gaps = 29/329 (8%)
Query: 72 VLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131
L ++ L ++P +L E+L S N L+ +P ++ +L + + L
Sbjct: 42 ELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 96
Query: 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQL 191
+ S ++ + I + +LKKL +
Sbjct: 97 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP 156
Query: 192 EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM---------GNLPYLVRL 242
E L F A + L L + + + + L
Sbjct: 157 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 216
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNI 302
+ + + + L ++ + + I L + N S I
Sbjct: 217 KTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 276
Query: 303 PSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNC 362
S L + N +P L L + N+L L
Sbjct: 277 RSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLAEVPELPQNL------ 326
Query: 363 QKIRVLILAGNPLDGI--LPSSIGNLSIS 389
+ L + NPL +P S+ +L ++
Sbjct: 327 ---KQLHVEYNPLREFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 23/103 (22%), Positives = 40/103 (38%), Gaps = 10/103 (9%)
Query: 503 TIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562
L ++ N+ + + ELN+S N L ++P L++L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLI 310
Query: 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGV--IPTSLEKL 603
+ N L +PE +L+ L + N + IP S+E L
Sbjct: 311 ASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 54/326 (16%), Positives = 104/326 (31%), Gaps = 18/326 (5%)
Query: 166 NLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNEL 225
+L L +P LE L N+L+ +P+ +L L N L
Sbjct: 39 QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 226 RGEIPQEMGNLPYLVRLTLATNN--LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDL 283
P +L + + N S K L + + + +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 284 SLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIAD 343
LP ++ L T ++ N L++ + + + NL L + +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 344 NYLTSS--TPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRIS 401
N L + P ++ + + L + + +I + L + S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 402 GKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAK 461
+I + +L L++ NKL +P L+ L +FN L +P+ +L +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQNLKQ 328
Query: 462 LDKLILHGNKFSGAIPSCSGNLTSLR 487
L + N P ++ LR
Sbjct: 329 LH---VEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 22/84 (26%), Positives = 38/84 (45%), Gaps = 9/84 (10%)
Query: 538 NLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIP 597
N S +I +L++L ++NN+L +P LE L S N ++ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VP 320
Query: 598 TSLEKLLYLKKLNLSFNKLEGEIP 621
+ LK+L++ +N L E P
Sbjct: 321 ELPQN---LKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 467 LHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSL 526
+ N S I S SL L + +N+ LP+ L+ + S N L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAE-VPE 321
Query: 527 DIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQ 559
NLK +L++ N L P +++L+
Sbjct: 322 LPQNLK---QLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 20/113 (17%), Positives = 39/113 (34%), Gaps = 10/113 (8%)
Query: 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNM 115
+ ++ I SLE L++S+NKL +P+
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR- 305
Query: 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLK 168
L+ L N L + N+ + + N E P +I +++ +L+
Sbjct: 306 --LERLIASFNHL-AEVPELPQNLKQ---LHVEYNPLR-EFP-DIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 15/94 (15%), Positives = 31/94 (32%), Gaps = 10/94 (10%)
Query: 247 NNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSI 306
N + +L++L++ N L + P +E L N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-----IELPALPPRLERLIASFNHLA-EVPELP 323
Query: 307 TNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLN 340
N L + N P+ ++ +L +
Sbjct: 324 QN---LKQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 3e-04
Identities = 19/81 (23%), Positives = 26/81 (32%), Gaps = 8/81 (9%)
Query: 48 NWTSSTSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGN 107
+ S + + LN+S L +P L E L S N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-E 318
Query: 108 IPSSIFNMHTLKLLDFRDNQL 128
+P N LK L N L
Sbjct: 319 VPELPQN---LKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 5e-04
Identities = 25/88 (28%), Positives = 34/88 (38%), Gaps = 8/88 (9%)
Query: 562 FLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621
N I SLE L++S NK+ +P + L++L SFN L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320
Query: 622 RGGPFANLTAKSFLGNELLCGLPDLHNS 649
NL N L PD+ S
Sbjct: 321 EL--PQNLKQLHVEYNP-LREFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 47/334 (14%), Positives = 103/334 (30%), Gaps = 29/334 (8%)
Query: 92 SSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQ------LFGSLSSFIFNMSSMLGI 145
L+L++ LS ++P + L+ L N L SL S + + +++ +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 93
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLG---RNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
+N + ++ + + LE + N L
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMST 262
+ N + ++P + ++ + L + T
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 263 LKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSF 322
+L + + D L ++ L + F + + S+L N+
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELP-QSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 323 SGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSS 382
S I + +LE LN+++N L L LI + N L + P
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIELPALPPRL---------ERLIASFNHLAEV-PEL 322
Query: 383 IGNLSISLERFQMFNCRISGKIPQVISNLSNLLL 416
N L++ + + + P + ++ +L +
Sbjct: 323 PQN----LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 6e-08
Identities = 34/196 (17%), Positives = 70/196 (35%), Gaps = 24/196 (12%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
+ + +L +T ++ T + L ++ + + + I +L + KL L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDI 528
GNK + NL +L L+L N+ L + + S L
Sbjct: 77 GNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 529 GNLKVVIELNLSRN----------------NLSGDIPITIGGLKNLQKLFLANNRLEGPI 572
+ + N + + + + GL LQ L+L+ N +
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-- 192
Query: 573 PESFSGLSSLEILDLS 588
+ +GL +L++L+L
Sbjct: 193 LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 40/214 (18%), Positives = 70/214 (32%), Gaps = 17/214 (7%)
Query: 352 ELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNL 411
+ + S + L + + + L+ S+++ N I I L
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIKSVQG--IQYL 67
Query: 412 SNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNK 471
N+ L L GNKLT P+ + L L K S+ D + + +
Sbjct: 68 PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 472 FSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNL 531
+L + +L+D D+ + L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV----------PLAGL 177
Query: 532 KVVIELNLSRNNLSGDIPITIGGLKNLQKLFLAN 565
+ L LS+N++S D+ + GLKNL L L +
Sbjct: 178 TKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 33/197 (16%), Positives = 67/197 (34%), Gaps = 24/197 (12%)
Query: 189 KQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNN 248
+ L+ +++ A+ + L + II N+++++ + LP + +L L N
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 249 LVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNV------------EFLNLGTN 296
L + P L + SL L ++ L +
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 297 RFSGNIPSSITNASKLTVFQLRGNSFSGFI-PNTIGNLRNLEFLNIADNYLTSSTPELSF 355
N + IT S+LT + + L L+ L ++ N+++
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD------- 192
Query: 356 LSSLTNCQKIRVLILAG 372
L +L + + VL L
Sbjct: 193 LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 27/164 (16%), Positives = 55/164 (33%), Gaps = 21/164 (12%)
Query: 68 HKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDN- 126
+ + + + +++ + L ++ L L+ NKL+ P + LD
Sbjct: 46 NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK 103
Query: 127 --------------QLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLL 172
L + S I + + ++ + + L L L L
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL 163
Query: 173 GRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLK 216
N +P L+ +L+ LYL N++S + + L L
Sbjct: 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLD 203
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 42/226 (18%), Positives = 75/226 (33%), Gaps = 8/226 (3%)
Query: 396 FNCRISG--KIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIP 453
F C+ S +IP + N + L KL FS +L+ + ++ N + I
Sbjct: 13 FLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 454 DEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFT----SALPSTIWNLKD 509
++ I + + YL + + K
Sbjct: 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130
Query: 510 ILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE 569
+L + N + +G + L L++N + G + + NN LE
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190
Query: 570 GPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNK 615
+ F G S ILD+S+ +I + LE L L+ + K
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 14/78 (17%), Positives = 27/78 (34%), Gaps = 1/78 (1%)
Query: 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQ-LGNLSSLETLDLSHNKLSGNIPSSIFN 114
C N ++ LN+S N +P S LD+S ++ + N
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 115 MHTLKLLDFRDNQLFGSL 132
+ L+ + + +L
Sbjct: 224 LKKLRARSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 29/251 (11%), Positives = 62/251 (24%), Gaps = 45/251 (17%)
Query: 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNM 115
CS C + IP L + L KL +
Sbjct: 8 CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 116 HTLKLLDFR---------------------------DNQLFGSLSSFIFNMSSMLGIDLS 148
L+ ++ +N L+ + +F + + +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 149 INRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKE 208
I L + N+ + S + + L+L N +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 209 IGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSL 268
+ + ++N L V L ++ + + + + N+ L+ S
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 269 LENTLWGSLPS 279
LP+
Sbjct: 233 YNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 24/226 (10%), Positives = 65/226 (28%), Gaps = 6/226 (2%)
Query: 218 IILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSL 277
+ ++++ EIP ++ + L L + L+K+ + +N + +
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 278 PSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLE 337
+ + N+ L+ + N+ A + + I + +
Sbjct: 70 EADVF---SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 338 FLNIADNYLTSSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFN 397
+ + + +S V++ + + N + E N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 398 CRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGL 443
+ V S ++LD+ ++ L L+
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 3e-06
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 6/114 (5%)
Query: 513 FDVSSNSLDG---PLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLE 569
+D S +LD D+ + + LN ++++ + I + L L L+NNRL
Sbjct: 20 YDGSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLY 78
Query: 570 G--PIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621
+ +L+IL+LS N++ K L L++L L N L
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 7/137 (5%)
Query: 485 SLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNL 544
S +AL L R L + ++I +S+ L + N+ ++ LNLS N L
Sbjct: 23 SQQALDLKGLRSDPDLVA-----QNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 545 SG--DIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEK 602
D+ + NL+ L L+ N L+ LE L L N +S
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 603 LLYLKKLNLSFNKLEGE 619
+ +++ +L+G
Sbjct: 138 ISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 9/152 (5%)
Query: 84 IPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSML 143
+ + L L + + +L+ R + + +L N+ +L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLN-RRSSMAATLRIIEENIPELL 68
Query: 144 GIDLSINRFSGELPANIC-KNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202
++LS NR + + PNLK L L N + K +LE L+L N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 203 GAIPKEIGNLTKLKDI-----ILNDNELRGEI 229
+ ++ +++ L+ +EL I
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 6e-06
Identities = 37/314 (11%), Positives = 88/314 (28%), Gaps = 25/314 (7%)
Query: 181 IPSTLSKCKQLEGLYLRFNNLSG----AIPKEIGNLTKLKDIILNDN---ELRGEIPQEM 233
+ + L + ++ + L N + + + I + L+ +D ++ EIP+ +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 234 GNLPYL------VRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPN 287
L + ++N G K L L + +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 288 VEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLT 347
L N+ + N P + + + L ++ +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 348 SSTPELSFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQV 407
L L+ + + + L + +L + +C +S +
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 408 ISN------LSNLLLLDLGGNKLTGSIPVT-----FSRLLNLQGLGLAFNKLARSIPDEI 456
+ + L L L N++ T ++ +L L L N+ D +
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVV 321
Query: 457 CHLAKLDKLILHGN 470
+ ++ G
Sbjct: 322 DEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 4e-05
Identities = 41/339 (12%), Positives = 83/339 (24%), Gaps = 31/339 (9%)
Query: 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGN----IPSSIFNMHTLKLLDFR 124
K + L+ + ++ L S++ + LS N + + +I + L++ +F
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 125 DNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPST 184
D + I +L P L + L N F
Sbjct: 68 DIFTG-RVKDEIPEALRLL--------------LQALLKCPKLHTVRLSDNAFGPTAQEP 112
Query: 185 LSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTL 244
L + + + G L N+ P + RL
Sbjct: 113 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172
Query: 245 ATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLS-----LPNVEFLNLGTNRFS 299
+ + + T+K + L+ N T+ S
Sbjct: 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232
Query: 300 GNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN------LRNLEFLNIADNYLTSSTPEL 353
+ ++ + L L S + + L+ L + N +
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292
Query: 354 SFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLER 392
+ L L GN + +
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 45/354 (12%), Positives = 106/354 (29%), Gaps = 42/354 (11%)
Query: 279 SRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSG----FIPNTIGNLR 334
+R + +++ + T ++ + + + L GN+ ++ I + +
Sbjct: 1 ARFSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 335 NLEFLNIADNYLTSSTPELS-----FLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSIS 389
+LE +D + E+ L +L C K+ + L+ N + +
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 390 LERFQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLA 449
+ +G PQ + ++ ++ L+ + N+L
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIAR--------ALQELAVNKKAKNAPPLRSIICGRNRL- 170
Query: 450 RSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKD 509
+ + +LH K G + L
Sbjct: 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI----------EHLLLEGLAYCQELKVL 220
Query: 510 ILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIG------GLKNLQKLFL 563
L + ++ L++ + + + EL L+ LS + LQ L L
Sbjct: 221 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280
Query: 564 ANNRLEGPIPES-----FSGLSSLEILDLSKNKIS--GVIPTSLEKLLYLKKLN 610
N +E + + L L+L+ N+ S + + ++ +
Sbjct: 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 15/68 (22%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 575 SFSGLSSLEILDLSKNKISGVIPTSL-----EKLLYLKKLNLSFNKLEGEIPRGGPFANL 629
S L+ L L N+I +L EK+ L L L+ N+ E +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 630 TAKSFLGN 637
+ G
Sbjct: 328 FSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 39/340 (11%), Positives = 88/340 (25%), Gaps = 30/340 (8%)
Query: 118 LKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANIC---KNLPNLKKLLLGR 174
LKL S+ + + S+ I LS N E + + +L+
Sbjct: 10 LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 175 NMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMG 234
+ L + + KL + L+DN + +
Sbjct: 69 IFTGRVKDEIPEALRLL--------------LQALLKCPKLHTVRLSDNAFGPTAQEPLI 114
Query: 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLG 294
+ + L N + P + N
Sbjct: 115 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 174
Query: 295 TNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELS 354
++ S + V + + + + +
Sbjct: 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234
Query: 355 FLSSLTNCQKIRVLILAGNPLDGILPSSIGNL-----SISLERFQMFNCRISGKIPQVI- 408
+L + +R L L L +++ + +I L+ ++ I + +
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294
Query: 409 ----SNLSNLLLLDLGGNKLT--GSIPVTFSRLLNLQGLG 442
+ +LL L+L GN+ + + + + +G G
Sbjct: 295 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 37/343 (10%), Positives = 88/343 (25%), Gaps = 41/343 (11%)
Query: 191 LEGLYLRFNNLSG----AIPKEIGNLTKLKDIILNDNELRGE----IPQEMGNLPYLVRL 242
+EG L+ + ++ ++ + +K+I+L+ N + E + + + + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 243 TLATNNLVGVVPFTIFNMSTLKKLSLLENTL--WGSLPSRIDLSLPNVEFLNLGTNRFSG 300
+ V + L + L L + + L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 301 NIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSS-- 358
++ ++ + N L + N L + + + +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 359 -----LTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSN 413
+ + L + L + + F S + + + N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 414 LLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFS 473
L L L L+ + L L L N+
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSK------------------LENIGLQTLRLQYNEIE 286
Query: 474 GAIPSC-----SGNLTSLRALYLGSNRFTSALPSTIWNLKDIL 511
+ L L L NRF+ + ++++
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 14/115 (12%), Positives = 31/115 (26%), Gaps = 5/115 (4%)
Query: 556 KNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISG----VIPTSLEKLLYLKKLNL 611
K+L+ + + + S++ + LS N I + ++ L+
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 612 SFNKLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPCKLNKPKTHHKSRKMM 666
S L ++ L L + N+ + K
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 9e-06
Identities = 29/194 (14%), Positives = 51/194 (26%), Gaps = 19/194 (9%)
Query: 56 CSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNM 115
C + C +G L+ IP + L L+ N+L +F
Sbjct: 8 CEGTTVDC------------TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGR 52
Query: 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175
+ + F +S + E+ + L LK L L N
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112
Query: 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGN 235
+P + L +N L+ LN R P ++ +
Sbjct: 113 QISCVMPGSFEHLNSLT-SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD 171
Query: 236 LPYLVRLTLATNNL 249
+ L +
Sbjct: 172 VQI---KDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 4/111 (3%)
Query: 393 FQMFNCRISGKIPQVISNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSI 452
Q+ +I ++ L L L+L N+++ +P +F L +L +
Sbjct: 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT-SLNLASNPFNCN 141
Query: 453 PDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPST 503
L K L+G PS + ++ L + F + ++
Sbjct: 142 CHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENS 189
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 21/146 (14%), Positives = 48/146 (32%), Gaps = 8/146 (5%)
Query: 86 PQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGI 145
Q N LDL K+ I + + +DF DN++ + + +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68
Query: 146 DLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLR---FNNLS 202
++ NR + +L ++ L+ K L L + N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 203 GAIPKEIGNLTKLKDIILNDNELRGE 228
I + +++ +L+ +++ +
Sbjct: 129 HYRLYVIYKVPQVR--VLDFQKVKLK 152
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 4e-04
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 3/97 (3%)
Query: 555 LKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFN 614
++L L ++ I + L + +D S N+I + L LK L ++ N
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 615 KLEGEIPRGGPFANLTAKSFLGNELLCGLPDLHNSPC 651
++ + L N L L DL
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 3/93 (3%)
Query: 525 SLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEI 584
+ N EL+L + I L + ++N + + F L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 585 LDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLE 617
L ++ N+I + + L L +L L+ N L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 23/141 (16%), Positives = 47/141 (33%), Gaps = 11/141 (7%)
Query: 304 SSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPELSFLSSLTNCQ 363
+ TNA + LRG I N L + ++ +DN + L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPLLR 63
Query: 364 KIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSNLLLLDLGGNK 423
+++ L++ N + I L E N + +++L +L L + N
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 424 ---LTGSIPVTFSRLLNLQGL 441
++ ++ L
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 20/133 (15%), Positives = 44/133 (33%), Gaps = 6/133 (4%)
Query: 65 VNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFR 124
N+ + L++ G+ + I L + +D S N++ + LK L
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 125 DNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLG---RNMFHGKI 181
+N++ + + + L+ N + +L +L L +
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 182 PSTLSKCKQLEGL 194
+ K Q+ L
Sbjct: 132 LYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 3/90 (3%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
+N LDL G K+ I + L + + N++ D L +L L+++
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTS 498
N+ L L L L +N
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVE 101
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 8e-05
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 2/107 (1%)
Query: 536 ELNLSRNNLSGDIPITIGGLKNLQKLFLANNR-LEGPIPESFSGLSSLEILDLSKNKISG 594
L +R+ D + G +NL +L++ N + L+ GL L L + K+ +
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 595 VIPTSLEKLLYLKKLNLSFNKLEGEIPRGGPFANLTAKSFLGNELLC 641
V P + L +LNLSFN LE + +L GN L C
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 19/111 (17%), Positives = 40/111 (36%), Gaps = 2/111 (1%)
Query: 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRN 175
H L + SL + ++ + + + L + L L+ L + ++
Sbjct: 8 HGSSGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 176 MFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELR 226
P +L L L FN L ++ + L++++L+ N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 39/201 (19%), Positives = 80/201 (39%), Gaps = 16/201 (7%)
Query: 409 SNLSNLLLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH 468
+ L+ + LG +T V+ + L + L + +SI D + +L L ++
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI-KSI-DGVEYLNNLTQINFS 70
Query: 469 GNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDI 528
N+ + P + + + L + LF + ++
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD--------ID 122
Query: 529 GNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLS 588
+ L ++ + + GL +LQ+L ++N++ P + L++LE LD+S
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 589 KNKISGVIPTSLEKLLYLKKL 609
NK+S + + L KL L+ L
Sbjct: 181 SNKVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 25/208 (12%)
Query: 235 NLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFL-NL 293
L ++ L N+ V T ++ + L + S+ VE+L NL
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI---------KSIDGVEYLNNL 64
Query: 294 GTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNIADNYLTSSTPEL 353
FS N + IT LT + + T N + L
Sbjct: 65 TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 354 SFLSSLTNCQKIRVLILAGNPLDGILPSSIGNLSISLERFQMFNCRISGKIPQVISNLSN 413
L++L + + I S + SL++ + +++ P ++NL+
Sbjct: 125 KNLTNLNRLELSS---------NTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTT 173
Query: 414 LLLLDLGGNKLTGSIPVTFSRLLNLQGL 441
L LD+ NK++ I V ++L NL+ L
Sbjct: 174 LERLDISSNKVS-DISV-LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 33/204 (16%), Positives = 69/204 (33%), Gaps = 19/204 (9%)
Query: 162 KNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILN 221
L K +LG+ + + + Q+ L + + L L I +
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 70
Query: 222 DNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRI 281
+N+L P + + + + + TL+ + + I
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLT---------GLTLFNNQITDI 121
Query: 282 DLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGNLRNLEFLNI 341
D L + + + S+++ + L N + P + NL LE L+I
Sbjct: 122 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDI 179
Query: 342 ADNYLTSSTPELSFLSSLTNCQKI 365
+ N ++ +S L+ LTN + +
Sbjct: 180 SSNKVSD----ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1007 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.92 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.92 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.73 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.73 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.98 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.83 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.79 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.68 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=198.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 1346556413345855999999768953899993064--29999999999999985399961279988863991399998
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 802 (1007)
.++|...+.||+|+||+||+|+.+ ..||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCC
Q ss_conf 028999667651299888999999999999999999870399991460643------------10204250203789853
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~ 870 (1007)
||++|+|.+++......+++..+..++.|+|+||+|| |+++|+|||++ ||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 5899888999852357899999999999999998887---5099951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHC
Q ss_conf 22335668754354234466---888950358999999999981999998432375307799874269418888533101
Q 001838 871 SMQTQTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~ 947 (1007)
.......||+.|||||++.. ..|+.++|||||||++|||+||+.||.+................+....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-------- 232 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 232 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG--------
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCH--------
T ss_conf 312566557431799999505689999531516359999999978899899896999999996588898600--------
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 552556788999999999999461898988999979999999997998
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
..+..++.++.+++.+||..||++||||+||+++|+.+++.
T Consensus 233 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 -------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -------03655549999999997588976892999999999999970
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.65 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=203.5
Q ss_pred CCCCHHHHHHHCC---------CCCCCCEECCCCCEEEEEEEECC-C---CEEEEEEECHH-HHHHHHHHHHHHHHHHHC
Q ss_conf 5323889998313---------46556413345855999999768-9---53899993064-299999999999999853
Q 001838 714 RRFSYHELLQATD---------RFSKNNLLGIGSFGSVYVARLQD-G---MEVAVKVFHQR-YERALKSFQDECEVMKRI 779 (1007)
Q Consensus 714 ~~~~~~~~~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l 779 (1007)
..++++++..++. +|...+.||+|+||+||+|+++. + ..||||++... .....+.|.+|+++++++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC
T ss_conf 98887989999960462208004278569802788299999995799788999999978445989999999999999857
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------
Q ss_conf 99961279988863991399998028999667651299888999999999999999999870399991460643------
Q 001838 780 RHRNLVKIISACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------ 853 (1007)
Q Consensus 780 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------ 853 (1007)
+|||||+++|+|.+++..|+|||||++|+|.+++......+++..+.+++.|+|.||.|| |+++|+|||++
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred CCCCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCEEEE
T ss_conf 998886189999628877999972279853002104567999999999999999988988---52798357615044898
Q ss_pred ------CCCEEECCEECCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf ------102042502037898532---2335668754354234466888950358999999999981-999998432375
Q 001838 854 ------HISDFSIAKFLNGQDQLS---MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGE 923 (1007)
Q Consensus 854 ------ki~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~ 923 (1007)
||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 89991998884431575677776536502566688300387888369978612144535789999867999999999999
Q ss_pred CHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 307799874269418888533101552556788999999999999461898988999979999999997998
Q 001838 924 LSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 924 ~~l~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
+...+.... . .+.+.+++.++.+++.+||+.||++||||.||++.|+++...
T Consensus 242 --~~~~i~~~~------------~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 --VINAIEQDY------------R------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHHHHHTTC------------C------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHCCC------------C------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf --999997378------------8------999742269999999997587976892999999999998418
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.12 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=198.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf 34655641334585599999976895389999306429999999999999985399961279988863991399998028
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMP 805 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 805 (1007)
++|+..+.||+|+||+||+|++.++..||||+++.... ..++|.+|++++++++|||||+++|+|.+++..|+|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 99588889820888299999988999999999878867-68999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCCCC
Q ss_conf 999667651299888999999999999999999870399991460643------------10204250203789853223
Q 001838 806 NGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSMQ 873 (1007)
Q Consensus 806 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~~~ 873 (1007)
+|+|.+++......+++..+..++.|+|.||.|| |+.+|+|||++ ||+|||+++........ ..
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-EE
T ss_conf 9918997520134788999999999999987765---3164310443153266668877686553210023688733-50
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHHH
Q ss_conf 356687543542344668889503589999999999819-9999843237530779987426941888853310155255
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTG-KKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~~ 952 (1007)
....||+.|+|||++.+..|+.++|||||||++|||+|+ ++|+...... .+.+........
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~~~~~---------------- 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL---------------- 221 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHHTCCC----------------
T ss_pred CCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHHCCCC----------------
T ss_conf 43001766678578607999840332105999999987898887789999--999999806888----------------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 6788999999999999461898988999979999999997998
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
..+..++.++.+++.+||+.||++||||+||+++|++|+++
T Consensus 222 --~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 --YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --99543679999999997657976891999999999999857
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=347.33 Aligned_cols=241 Identities=20% Similarity=0.260 Sum_probs=197.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 134655641334585599999976-8953899993064299999999999999853999612799888639913999980
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
.++|++.+.||+|+||+||+|+.. +|..||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC--------------CCCEEECCEECCCCCC
Q ss_conf 28999667651299888999999999999999999870399991460643--------------1020425020378985
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~--------------ki~Dfgla~~~~~~~~ 869 (1007)
|+||+|.+++....+.+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHH---HHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC
T ss_conf 799889999976237899999999999999999999---75697600015467364168898699954521044256543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||......+. +..........
T Consensus 182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~------------- 244 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNM------------- 244 (350)
T ss_dssp ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCS-------------
T ss_pred ---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCC-------------
T ss_conf ---2000686242188997589987267655465999999859899899799999-99998478898-------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255678899999999999946189898899997999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
. .......+.++.+++.+||+.||++|||++|++++
T Consensus 245 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 D---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9---42235899999999999756896679089998629
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.06 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=195.5
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 134655641334585599999976-89538999930642-9999999999999985399961279988863991399998
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 802 (1007)
.++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCC
Q ss_conf 028999667651299888999999999999999999870399991460643------------10204250203789853
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~ 870 (1007)
||++|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 458980899975379-999999999999999999999---9759835754689978878998798323142240468865
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 22335668754354234466888-95035899999999998199999843237530779987426941888853310155
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
...+...||+.|||||++.+..+ +.++||||+||++|||+||+.||............+........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~------------ 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------------ 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST------------
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC------------
T ss_conf 31113255747428728618999997101617379999998299788889859999999863888788------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255678899999999999946189898899997999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.....+.++.+++.+||+.||++|||++|++++
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------644699999999999767996689099999619
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.01 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCCCCCE-ECCCCCEEEEEEEEC---CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 34655641-334585599999976---89538999930642-99999999999999853999612799888639913999
Q 001838 726 DRFSKNNL-LGIGSFGSVYVARLQ---DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|...+. ||+|+||+||+|.++ ++..||||+++... ....+.|.+|++++++++|||||+++|+|.++ ..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC-EEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368-07999
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCC
Q ss_conf 98028999667651299888999999999999999999870399991460643------------102042502037898
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~ 868 (1007)
||||++|+|.+++......+++..+.+++.|+|.||.|| |+++|+|||++ ||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCC
T ss_conf 980789968997521256999999999999999987899---86881057676466045468854203313421155434
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHH
Q ss_conf 532-2335668754354234466888950358999999999981-99999843237530779987426941888853310
Q 001838 869 QLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 869 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~ 946 (1007)
... ......||+.|+|||++....++.++|||||||++|||+| |+.||.+....+ +........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~------------ 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGK------------ 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTC------------
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCC------------
T ss_conf 321135621137433586887279999541232201789999938999999979999--999998189------------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHC
Q ss_conf 15525567889999999999994618989889999799999999979986430
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
+...++.++.++.+++.+||+.+|++||||.+|++.|+.+...+...
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHC
T ss_conf ------99999767899999999975779768909999999999999985411
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.06 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=196.3
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC------CCEEEEEEECHHH-HHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCCE
Q ss_conf 1346556413345855999999768------9538999930642-99999999999999853-99961279988863991
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD------GMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 796 (1007)
.++|+..+.||+|+||+||+|+... ...||+|++.... ......+.+|+.+++++ +|||||+++|+|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-
Q ss_conf 399998028999667651299----------------------888999999999999999999870399991460643-
Q 001838 797 KALIMEYMPNGSLENRLYSGT----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA- 853 (1007)
Q Consensus 797 ~~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~- 853 (1007)
.|+|||||++|+|.++++... ..+++..+..++.|++.||+|| |+.+|+|||++
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCH
T ss_conf 89999727999599999862577751022100001222001257789999999999999999999---739905052703
Q ss_pred -----------CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf -----------1020425020378985322335668754354234466888950358999999999981-9999984323
Q 001838 854 -----------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFI 921 (1007)
Q Consensus 854 -----------ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~ 921 (1007)
||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 753077998742694188885331015525567889999999999994618989889999799999999
Q 001838 922 GELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 922 ~~~~l~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.. .+.+......+ .+.+..++.++.+++.+||+.||++||||+||+++|.
T Consensus 273 ~~-~~~~~~~~~~~------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA-NFYKLIQNGFK------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH-HHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-HHHHHHHCCCC------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99-99999856998------------------9988767899999999975889668939999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.92 Aligned_cols=238 Identities=23% Similarity=0.323 Sum_probs=193.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 34655641334585599999976-89538999930642999999999999998539996127998886399139999802
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCCC
Q ss_conf 8999667651299888999999999999999999870399991460643------------1020425020378985322
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~~ 872 (1007)
++|+|.+++..+ .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+....... .
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC--C
T ss_conf 798089886415--999999999999999999999---987972267768886887899686425156413213666--4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHHH
Q ss_conf 33566875435423446688895035899999999998199999843237530779987426941888853310155255
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~~ 952 (1007)
.....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+..... .+........+.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~---------------- 235 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE---------------- 235 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC----------------
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC----------------
T ss_conf 444444777368266447998801203137299999804889989979999-999998579998----------------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 678899999999999946189898899997999999
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
...+...+.++.+++.+||+.||++|||+.|++++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -88855379999999999866996689099999649
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=344.17 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=196.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 34655641334585599999976-89538999930642999999999999998539996127998886399139999802
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
++|++.+.||+|+||+||+|+.. +|+.||||++..........+.+|+.++++++|||||+++++|.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 03599899931778299999998999799999988726467999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC--------------CCCEEECCEECCCCCCC
Q ss_conf 8999667651299888999999999999999999870399991460643--------------10204250203789853
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~--------------ki~Dfgla~~~~~~~~~ 870 (1007)
+||+|.+++......+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+.......
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC-
T ss_conf 99808888986389989999999999999999999---97792651314455311346788489952563034378872-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCH
Q ss_conf 22335668754354234466888950358999999999981999998432375307799874269418888533101552
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~ 950 (1007)
.....|++.|+|||++.+..|+.++||||+||++|||+||+.||.+...... +.......... .
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~-------------~ 248 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEF-------------D 248 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCC-------------C
T ss_pred --EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCC-------------C
T ss_conf --0100476453489997479989763338989999999968899899799999-99998478898-------------9
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 55678899999999999946189898899997999999
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.......+.++.+++.+||+.||++|||+.|++++
T Consensus 249 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---30024799999999999756996689189999609
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.76 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=198.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 13465564133458559999997689-----53899993064-2999999999999998539996127998886399139
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDG-----MEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
.+.|+..+.||+|+||+||+|.++.. ..||||++... .......|.+|++++++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCC
Q ss_conf 9998028999667651299888999999999999999999870399991460643------------1020425020378
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~ 866 (1007)
+|||||.+|++.+++......+++..+.+++.|++.|+.|| |+.+|+|||++ ||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 99972135740222102345420899999999999854121---212342576564427888998499845510300357
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHH
Q ss_conf 98532-23356687543542344668889503589999999999819999984323753077998742694188885331
Q 001838 867 QDQLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTN 945 (1007)
Q Consensus 867 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~ 945 (1007)
..... ......||+.|||||++.+..++.++|||||||++|||+||..|+....... .+.+.+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~------------ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDG------------ 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTT------------
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHHHHHHCC------------
T ss_conf 8765267426777734348888704999973556344898999996798865568999-999998635------------
Q ss_pred HCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 015525567889999999999994618989889999799999999979986
Q 001838 946 LLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
.. .+.+.+++.++.+++.+||+.||++||||.||++.|+.+.+.-
T Consensus 230 ~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 230 FR------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CC------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CC------CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 78------9985045799999999977679768939999999999986695
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.66 Aligned_cols=243 Identities=23% Similarity=0.403 Sum_probs=199.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 13465564133458559999997689538999930642999999999999998539996127998886399139999802
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
.++|+..+.||+|+||+||+|+++++..||||+++.... ..+.|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 699799689820788399999988998999999874757-7899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCCC
Q ss_conf 8999667651299888999999999999999999870399991460643------------1020425020378985322
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~~ 872 (1007)
++|++.+++......+++..+.+++.|+++||.|| |+.+|+||+++ ||+|||+++........ .
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-E
T ss_conf 89938886410246776899999999999999987---5468434665413588769984798861442023578722-5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHH
Q ss_conf 335668754354234466888950358999999999981-9999984323753077998742694188885331015525
Q 001838 873 QTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~ 951 (1007)
.....||+.|+|||++....|+.++|||||||++|||+| |+.||......+. .........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-~~~i~~~~~----------------- 219 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGLR----------------- 219 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HHHHHTTCC-----------------
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH-HHHHHHCCC-----------------
T ss_conf 24657887757807863799885210336432467397559999889999999-999980797-----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 56788999999999999461898988999979999999997
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
...+...+.++.+++.+||+.||++|||++|++++|.+|
T Consensus 220 --~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf --899654659999999997668976893999999874188
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.93 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=193.1
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 13465564133458559999997689538999930642999999999999998539996127998886399139999802
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
.++|+..+.||+|+||+||+|+++++..||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..|+|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 899388679810798289999999999999999864768-88999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC
Q ss_conf 8999667651299-888999999999999999999870399991460643------------102042502037898532
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~ 871 (1007)
++|+|.+++.... ..+++..+.+++.|+++||.|| |+.+|+|||++ ||+|||+|+....... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC-C
T ss_conf 898288887514789887889999999999999999---748954675642251562024404234101477358864-4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHH
Q ss_conf 23356687543542344668889503589999999999819999984323753077998742694188885331015525
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~ 951 (1007)
......|++.|+|||++....|+.++|||||||++|||+||..|+.........+........+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---------------- 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---------------- 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC----------------
T ss_conf 2035677444458289837999824564525799999996898888888999999999706888----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 5678899999999999946189898899997999999999799
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
..+..++.++.+++.+||+.||++||||+||++.|+.+-.
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---8965571999999999758897689399999998611321
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=343.98 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=192.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 134655641334585599999976-89538999930642-9999999999999985399961279988863991399998
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 802 (1007)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC---------------CCCEEECCEECCCC
Q ss_conf 028999667651299888999999999999999999870399991460643---------------10204250203789
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~---------------ki~Dfgla~~~~~~ 867 (1007)
||+||+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---HHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 268984888653036-788789999999999998752---4130556870463001104688824998315435872589
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHC
Q ss_conf 85322335668754354234466888950358999999999981999998432375307799874269418888533101
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~ 947 (1007)
.. .....||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ +........
T Consensus 164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~------------- 225 (307)
T d1a06a_ 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAE------------- 225 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHTTC-------------
T ss_pred CE---EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCC-------------
T ss_conf 70---440032842259188737999807873451599999985979999989999--999986168-------------
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 55255678899999999999946189898899997999999
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.....+.....+.++.+++.+||+.||++|||+.|++++
T Consensus 226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --777876666789999999999760897579189998629
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=345.06 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=196.1
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 134655641334585599999976-8953899993064299999999999999853999612799888639913999980
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
.++|+..+.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..|+||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 7993986598208880899999999996999999777610-399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCC
Q ss_conf 2899966765129-9888999999999999999999870399991460643------------10204250203789853
Q 001838 804 MPNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 804 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~ 870 (1007)
|++|+|.+++... ...+++..+..++.|+|.||.|| |+++|+|||++ ||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCE
T ss_conf 4676067775303554157999999999999978889---8789305760457689989992898324454653788722
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCH
Q ss_conf 22335668754354234466888950358999999999981999998432375307799874269418888533101552
Q 001838 871 SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~ 950 (1007)
..+...|++.|+|||++.+..|+.++|||||||++|||++|..|+....... .+.+.. .....
T Consensus 172 -~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i------------~~~~~--- 234 (287)
T d1opja_ 172 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL------------EKDYR--- 234 (287)
T ss_dssp -EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHH------------HTTCC---
T ss_pred -EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH------------HCCCC---
T ss_conf -1035566546669278727999810430217899999986799887742599-999998------------55888---
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 5567889999999999994618989889999799999999979
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
...+..++.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ---8887433099999999975779768939999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.08 Aligned_cols=240 Identities=22% Similarity=0.305 Sum_probs=192.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 34655641334585599999976-89538999930642999999999999998539996127998886399139999802
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
+.|++.+.||+|+||+||+|+.. +|..||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCCC
Q ss_conf 8999667651299888999999999999999999870399991460643------------1020425020378985322
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLSM 872 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~~ 872 (1007)
++|+|.+++.+....+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--CC
T ss_conf 99818899986289999999999999999999999---98898871407003148789998997161230357786--41
Q ss_pred CCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHC
Q ss_conf 33566875435423446-----6888950358999999999981999998432375307799874269418888533101
Q 001838 873 QTQTLATIGYMAPEYGV-----QGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLL 947 (1007)
Q Consensus 873 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~ 947 (1007)
.....||+.|+|||++. ...|+.++||||+||++|||+||+.||.+....+. +.+......+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~------------ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP------------ 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCC------------
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHCCCCC------------
T ss_conf 001025626479999832025788888066578789999998208899999899999-9999707998------------
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 55255678899999999999946189898899997999999
Q 001838 948 SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
....+...+.++.+++.+||+.||++|||+.|++++
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----777656699999999999766996689199999629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.77 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=196.9
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 3134655641334585599999976-8953899993064-2999999999999998539996127998886399139999
Q 001838 724 ATDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 724 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
..++|+..+.||+|+||+||+|+.. +|..||+|+++.. .......+.+|+.++++++|||||+++++|.+++..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
|||++|+|.+++.+.. .+++..+..++.|++.||.|||. ..+|+|||++ ||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC--
T ss_conf 7679986899874249-99999999999999999999998--599971445779946878998999548776256788--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH------------------
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987------------------
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVN------------------ 931 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~------------------ 931 (1007)
......||++|+|||++.+.+|+.++||||+||++|||+||+.||...............
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf --621113771411946875899894888998999999999888998998878999999887517754577421233322
Q ss_pred -------HHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHH
Q ss_conf -------426941888853310155255678899999999999946189898899997999999--99979
Q 001838 932 -------DLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIR 993 (1007)
Q Consensus 932 -------~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~--L~~i~ 993 (1007)
...+....+..+.......... .....+.++.+++.+||+.||++|||++|++++ +++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 11112223541347788766502687667--6444899999999998689946790899996098647698
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.42 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=192.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 134655641334585599999976-89538999930642------99999999999999853999612799888639913
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY------ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 797 (1007)
.++|+..+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|+.++++++|||||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC----------------CCCEEECC
Q ss_conf 99998028999667651299888999999999999999999870399991460643----------------10204250
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA----------------HISDFSIA 861 (1007)
Q Consensus 798 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~----------------ki~Dfgla 861 (1007)
|+|||||++|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHH
T ss_conf 99998677864310010356-421557899999999998766---62542211333012798258986664696433442
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHH
Q ss_conf 20378985322335668754354234466888950358999999999981999998432375307799874269418888
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
+....... .....|++.|+|||++.+..|+.++||||+||++|||+||+.||......+. +.......
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~-------- 232 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVN-------- 232 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTC--------
T ss_pred HHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHCC--------
T ss_conf 10577763---1224777743099998189999766522140999999708899889999999-99998168--------
Q ss_pred HHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 53310155255678899999999999946189898899997999999
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
...........+..+.+++.+||..||++|||++|++++
T Consensus 233 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------888701047889999999999863896689199999619
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.80 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=200.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCC----EEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 34655641334585599999976-895----3899993064-29999999999999985399961279988863991399
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGM----EVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
++|+..+.||+|+||+||+|++. +|+ .||+|+++.. ..+..+.|.+|++++++++|||||+++|+|.+++ .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EEE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996198-369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCC
Q ss_conf 998028999667651299888999999999999999999870399991460643------------10204250203789
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~ 867 (1007)
++||+.+|+|.+++......+++..+.+++.|+|.||.|| |+++|+|||++ ||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf 9984268740101113345799999999999999999999---8769504762120311679987586025522233544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHH
Q ss_conf 85322335668754354234466888950358999999999981-99999843237530779987426941888853310
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~ 946 (1007)
..........||+.|+|||++.+..|+.++|||||||++|||+| |++||+.....+ +.........
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~----------- 231 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER----------- 231 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCC-----------
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCCC-----------
T ss_conf 453223651058644670887469998356544079999999977999999999899--9999975998-----------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHC
Q ss_conf 15525567889999999999994618989889999799999999979986430
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKS 999 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~~~~ 999 (1007)
.+.++.++.++.+++.+||+.||++|||+.||+.+|..+......+
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~ 277 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCHHHH
T ss_conf -------9998556899999999847899346919999999999987586864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.67 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=189.7
Q ss_pred CEECCCCCEEEEEEEECC---CCEEEEEEECHHH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf 413345855999999768---9538999930642--99999999999999853999612799888639913999980289
Q 001838 732 NLLGIGSFGSVYVARLQD---GMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYMPN 806 (1007)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~---g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 806 (1007)
+.||+|+||+||+|.++. ++.||||+++... ....+.|.+|++++++++|||||+++|+|.++ ..|+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC-CC
Q ss_conf 99667651299888999999999999999999870399991460643------------102042502037898532-23
Q 001838 807 GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS-MQ 873 (1007)
Q Consensus 807 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~-~~ 873 (1007)
|+|.++++... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+......... ..
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 96899975225-789999999999999997668---74795567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHHH
Q ss_conf 35668754354234466888950358999999999981-99999843237530779987426941888853310155255
Q 001838 874 TQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEER 952 (1007)
Q Consensus 874 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~~ 952 (1007)
....||+.|||||++....|+.++|||||||++|||+| |+.||.+....+ +........
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~------------------ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGE------------------ 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC------------------
T ss_pred CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCC------------------
T ss_conf 456778420391665379998434430340313289658999999989999--999998289------------------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 6788999999999999461898988999979999999997998
Q 001838 953 YFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 953 ~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
+.+.+..++.++.+++.+||+.||++||||++|+++|+.....
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 9999865679999999997588976890989999985288750
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.68 Aligned_cols=234 Identities=24% Similarity=0.357 Sum_probs=191.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 34655641334585599999976-89538999930642---999999999999998539996127998886399139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
|||++|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-
T ss_conf 5047985898875048-999999999999999999999---98894652202344146689987115556335448885-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||+.....+ .+.........
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~-------------- 222 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEFT-------------- 222 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCC--------------
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHCCCCC--------------
T ss_conf ---235578876349999758998931440467599999832999988899999-99999718999--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255678899999999999946189898899997999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.+...+.++.+++.+||+.||++|||++|++++
T Consensus 223 ------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------986689999999999764797689099999719
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=336.89 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=199.7
Q ss_pred HHHHCCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 9983134655641334585599999976------89538999930642-9999999999999985399961279988863
Q 001838 721 LLQATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSN 793 (1007)
Q Consensus 721 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 793 (1007)
++...++|+..+.||+|+||+||+|+.+ ++..||||+++... ....++|.+|+.++++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 13898893886798207883999999888765778829999998821085799999999999996689976552466605
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEC
Q ss_conf 991399998028999667651299-----------------------888999999999999999999870399991460
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGT-----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHY 850 (1007)
Q Consensus 794 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~ 850 (1007)
.+..++||||+++|+|.+++.... ..+++..+.+|+.|++.||+|| |+.+++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHC---CCCCEEEE
T ss_conf 980389998158992999998527554210000111001210346788989999999999999985541---35786854
Q ss_pred CCC------------CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCC
Q ss_conf 643------------102042502037898532233566875435423446688895035899999999998199-9998
Q 001838 851 MVA------------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK-KPTD 917 (1007)
Q Consensus 851 ~~~------------ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~-~p~~ 917 (1007)
|++ ||+|||+|+...........+...|++.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCC
T ss_conf 88401168989992898331442113677641115777767676798997268898056302523629999806899999
Q ss_pred CCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 4323753077998742694188885331015525567889999999999994618989889999799999999979
Q 001838 918 EIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 918 ~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.....+ +...+.... . +..+..++.++.+++.+||+.+|++||||.||+++|++|.
T Consensus 245 ~~~~~e--~~~~v~~~~-----------~-------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEE--VIYYVRDGN-----------I-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHH--HHHHHHTTC-----------C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHH--HHHHHHCCC-----------C-------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 989999--999997399-----------7-------8887325299999999974889657939999999999842
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.60 Aligned_cols=235 Identities=22% Similarity=0.354 Sum_probs=182.4
Q ss_pred CCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----CCEEEEEE
Q ss_conf 55641334585599999976-8953899993064--29999999999999985399961279988863----99139999
Q 001838 729 SKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSN----DDFKALIM 801 (1007)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 801 (1007)
...+.||+|+||+||+|+.. ++..||+|++... .....+.+.+|++++++++|||||++++++.+ +..+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-------------CCCEEECCEECCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643-------------102042502037898
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-------------ki~Dfgla~~~~~~~ 868 (1007)
|||++|+|.+++.+.. .+++..+..++.|++.||+|||. +.++|+|||++ ||+|||+|+......
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH-CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCCC
T ss_conf 5789894899975135-54699999999999999999997-899799687674351166799988980057654236876
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCC
Q ss_conf 53223356687543542344668889503589999999999819999984323753077998742694188885331015
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~ 948 (1007)
.....||+.|||||++.+ +|+.++||||+||++|||+||+.||.+................+..
T Consensus 170 ----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~----------- 233 (270)
T d1t4ha_ 170 ----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----------- 233 (270)
T ss_dssp ----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG-----------
T ss_pred ----CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC-----------
T ss_conf ----677553813008988478-9998671100799999998788999876559999999973899865-----------
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5255678899999999999946189898899997999999
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.+...+.++.+++.+||+.||++|||++|++++
T Consensus 234 -------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------675578999999999763797589299999677
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.34 Aligned_cols=265 Identities=23% Similarity=0.251 Sum_probs=193.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EEEEEE
Q ss_conf 3465564133458559999997689538999930642999999999999998539996127998886399----139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDD----FKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 801 (1007)
.+|...+.||+|+||.||+|++. |..||||+++..... ....+.|+..+.+++|||||+++|+|.+++ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 68999889820788199999999-989999998720046-7999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCCEECCCC------------CCCEEECCEEC
Q ss_conf 80289996676512998889999999999999999998703-----99991460643------------10204250203
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG-----HSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~-----~~~~i~H~~~~------------ki~Dfgla~~~ 864 (1007)
|||++|+|.+++++.. ++|..+.+++.|+|.||.|+|.. |+++|+|||++ ||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ECCCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf 6466989899986589--99899999999999999998876652046898661531731357868877688763866234
Q ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 7898532--23356687543542344668------889503589999999999819999984323753077998742694
Q 001838 865 NGQDQLS--MQTQTLATIGYMAPEYGVQG------RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI 936 (1007)
Q Consensus 865 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~ 936 (1007)
....... ......||+.|+|||++... .++.++|||||||++|||+||.+|+............... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~--~~~ 236 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SDP 236 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SSC
T ss_pred CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC--CCC
T ss_conf 677762001355250354767822105654546777675012201599999996289988766311241012255--643
Q ss_pred CHHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 1888853310---15525567889999999999994618989889999799999999979986
Q 001838 937 SVMEVIDTNL---LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 937 ~~~~~id~~~---~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
...+..+... .+............+..+.+++.+||+.||++||||.||+++|+++.+.-
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 099999987502468887765577689999999999976069858959999999999888865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.48 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=194.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 34655641334585599999976-89538999930642---999999999999998539996127998886399139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
|||++|+|.+++...+ .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+.......
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---CCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC
T ss_conf 7048987777653159-999999999999999999762---165088476774123668885388603210242256776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
........||+.|+|||++.+..|+.++||||+||++|||+||+.||........ ..+..... . .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~------------~-~- 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKIIKLE------------Y-D- 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTC------------C-C-
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHCCC------------C-C-
T ss_conf 4333555677552584400268989666230456999998038899899599999-99997189------------9-9-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 25567889999999999994618989889999799999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLL 990 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~ 990 (1007)
.+...+.++.+++.+||+.||++|||++|++..-.
T Consensus 229 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 229 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf ------98547999999999985579768919789737789
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=334.73 Aligned_cols=233 Identities=24% Similarity=0.293 Sum_probs=186.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH---HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 34655641334585599999976-8953899993064---2999999999999998539996127998886399139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
+.|+..+.||+|+||+||+|+.. +|..||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
|||.+|++..++..+ ..+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC--
T ss_conf 806999457899737-9999999999999999999999---8689766678842179879997898443653346778--
Q ss_pred CCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHH
Q ss_conf 322335668754354234466---88895035899999999998199999843237530779987426941888853310
Q 001838 870 LSMQTQTLATIGYMAPEYGVQ---GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~ 946 (1007)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+....+. +.+......+. .
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~---------~ 234 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPA---------L 234 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCC---------C
T ss_pred ----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCC---------C
T ss_conf ----731347663688998346788867214545589999999878899999799999-99998289998---------8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 15525567889999999999994618989889999799999
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVT 987 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~ 987 (1007)
. ....+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~---------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 Q---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp S---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8---------7888999999999977379657918999971
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.15 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=197.1
Q ss_pred HHHHHCCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHC-CCCCEEEEEEEE
Q ss_conf 99983134655641334585599999976------89538999930642-99999999999999853-999612799888
Q 001838 720 ELLQATDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISAC 791 (1007)
Q Consensus 720 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 791 (1007)
+.....++|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+|||.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE
T ss_conf 52616799798449841678399999986777555783999999860017178999999999988614998499741154
Q ss_pred ECC-CEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC--
Q ss_conf 639-91399998028999667651299---------------888999999999999999999870399991460643--
Q 001838 792 SND-DFKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-- 853 (1007)
Q Consensus 792 ~~~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-- 853 (1007)
.++ ...++|||||++|+|.++++... ..+++..+..++.|++.||.|| |+++|+|||++
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGG
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCC
T ss_conf 0479757999984589929999985366666532220233214689999999999999999988---7379717867731
Q ss_pred ----------CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf ----------10204250203789853223356687543542344668889503589999999999819-9999843237
Q 001838 854 ----------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTG-KKPTDEIFIG 922 (1007)
Q Consensus 854 ----------ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~~~ 922 (1007)
||+|||+|+...........+...||+.|+|||++.+..++.++|||||||++|||+|| ++||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 06577998289845752001135665222475166721020368646889966322136789999986889999899989
Q ss_pred CCHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 5307799874269418888533101552556788999999999999461898988999979999999997998
Q 001838 923 ELSLSRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 923 ~~~l~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
............+. .+...+.++.+++.+||+.||++||||+|++++|+++.+.
T Consensus 244 ~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 244 EEFCRRLKEGTRMR-------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCC-------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99999996389888-------------------8865789999999997677966791999999999799867
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.24 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=198.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 1346556413345855999999768----953899993064-29999999999999985399961279988863991399
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 799 (1007)
.++|+..+.||+|+||+||+|++.. +..||||+++.. .....+.+.+|+.++++++|||||+++|+|.+ +..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953-74799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCC
Q ss_conf 998028999667651299888999999999999999999870399991460643------------10204250203789
Q 001838 800 IMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQ 867 (1007)
Q Consensus 800 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~ 867 (1007)
|||||++|++.+++......+++..+..++.|++.||.|| |+.+++|||++ |++|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---CCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 9984069807765422478999999999999998775230---2267441410265532067896787650342133677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHH
Q ss_conf 85322335668754354234466888950358999999999981-99999843237530779987426941888853310
Q 001838 868 DQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNL 946 (1007)
Q Consensus 868 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~ 946 (1007)
... ..+...||+.|+|||++....|+.++|||||||++|||+| |++||......+. ...+......
T Consensus 162 ~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i~~~~~~---------- 228 (273)
T d1mp8a_ 162 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGERL---------- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCC----------
T ss_pred CCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--HHHHHCCCCC----------
T ss_conf 623-305400583103266751699887452444247899998269999888999999--9999818999----------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 15525567889999999999994618989889999799999999979986
Q 001838 947 LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTL 996 (1007)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~ 996 (1007)
+.+..++.++.+++.+||..||++|||+.||++.|+.+.+.-
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf --------898777999999999976879768929999999999997786
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.80 Aligned_cols=240 Identities=19% Similarity=0.254 Sum_probs=194.6
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 134655641334585599999976-8953899993064299999999999999853999612799888639913999980
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
.++|.+.+.||+|+||+||+|... +|+.||||.++..... ...+.+|++++++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 01058878983177839999999899969999997578665-99999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC--------------CCCEEECCEECCCCCC
Q ss_conf 28999667651299888999999999999999999870399991460643--------------1020425020378985
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA--------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~--------------ki~Dfgla~~~~~~~~ 869 (1007)
|+||+|.+++......+++..+..++.|++.||.|| |+.+|+|||++ |++|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC
T ss_conf 899808899875389999999999999999999999---87699751355444344378851899764411100346775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
.....+++.|+|||...+..|+.++||||+||++|||++|+.||........ +........
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~~~--------------- 220 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEY--------------- 220 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC---------------
T ss_pred ---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCC---------------
T ss_conf ---3212233222340210487778401130279999999828999999899999-999983899---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255678899999999999946189898899997999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
..........+.++.+++.+|+..||++|||++|++++
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -98802236789999999999866996689099999639
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.77 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=198.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCCE
Q ss_conf 134655641334585599999976------89538999930642-99999999999999853-99961279988863991
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSNDDF 796 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 796 (1007)
.++|+..+.||+|+||+||+|++. +++.||||+++... ......+.+|+.+++++ +|||||+++|+|.++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred EEEEEEECCCCCHHHHHHCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------
Q ss_conf 399998028999667651299-----------------888999999999999999999870399991460643------
Q 001838 797 KALIMEYMPNGSLENRLYSGT-----------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------ 853 (1007)
Q Consensus 797 ~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------ 853 (1007)
.|+|||||++|+|.++++... ..+++..+.+++.|++.||+|| |+.+++|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCCCCCCC
T ss_conf 899997379987999998535665444445332223345889999999999999999988---75792666241021000
Q ss_pred ------CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf ------1020425020378985322335668754354234466888950358999999999981-999998432375307
Q 001838 854 ------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSL 926 (1007)
Q Consensus 854 ------ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l 926 (1007)
|++|||.++...........+...||+.|+|||++....++.++|||||||++|||+| |++|+.... ....+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SSHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-HHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899-89999
Q ss_pred HHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 799874269418888533101552556788999999999999461898988999979999999997998
Q 001838 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 927 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.+.+....+.. .++..+.++.+|+.+||+.||++||||.||+++|+++...
T Consensus 258 ~~~i~~~~~~~------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRML------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCC------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99986689889------------------8543659999999997577965792999999999876534
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.90 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=194.8
Q ss_pred CCEECCCCCEEEEEEEECC----CCEEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEEC
Q ss_conf 6413345855999999768----953899993064-29999999999999985399961279988863-99139999802
Q 001838 731 NNLLGIGSFGSVYVARLQD----GMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSN-DDFKALIMEYM 804 (1007)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~----g~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 804 (1007)
.+.||+|+||+||+|++.. ...||||+++.. .....++|.+|++++++++|||||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC-
Q ss_conf 8999667651299888999999999999999999870399991460643------------102042502037898532-
Q 001838 805 PNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS- 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~- 871 (1007)
++|+|.+++.......++..+++++.|+|.||.|+ |+++|+|||++ ||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCC
T ss_conf 06741442101345404899999999988765200---336762577668757677999889910652322556655531
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCH
Q ss_conf -2335668754354234466888950358999999999981999998432375307799874269418888533101552
Q 001838 872 -MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~ 950 (1007)
......||+.|+|||++....++.++||||||+++|||+||..|+........ +..+.......
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i~~g~~~-------------- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRL-------------- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC--------------
T ss_pred EECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHCCCCC--------------
T ss_conf 002565556455676887437999745746619999999978999988899999-99999808988--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 556788999999999999461898988999979999999997998643
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVK 998 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~~~ 998 (1007)
..+..++.++.+++.+||+.||++||+|.||+++|+++...+..
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf ----99644759999999997688976893999999999999975201
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.62 Aligned_cols=242 Identities=20% Similarity=0.263 Sum_probs=192.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEEEE
Q ss_conf 134655641334585599999976-8953899993064--29999999999999985399961279988863--991399
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSN--DDFKAL 799 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 799 (1007)
.++|+..+.||+|+||+||+|+.+ +|+.||||.+... .+...+.+.+|++++++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCEECCCC------------CCCEEECCE
Q ss_conf 9980289996676512---9988899999999999999999987039--9991460643------------102042502
Q 001838 800 IMEYMPNGSLENRLYS---GTCMLDIFQRLNIMIDVALALEYLHFGH--STPIIHYMVA------------HISDFSIAK 862 (1007)
Q Consensus 800 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLh~~~--~~~i~H~~~~------------ki~Dfgla~ 862 (1007)
|||||++|+|.+++.. ....+++..+..++.|++.||.|||... ..+|+|||++ ||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHH
Q ss_conf 03789853223356687543542344668889503589999999999819999984323753077998742694188885
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~i 942 (1007)
....... ......||+.|||||++.+..|+.++|||||||++|||+||+.||......+ ..........+
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~~~~~------- 232 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFR------- 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-------
T ss_pred ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH-HHHHHHCCCCC-------
T ss_conf 2245777--5566778823279999839999938988752789999801889989989999-99999718998-------
Q ss_pred HHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3310155255678899999999999946189898899997999999
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
. .+...+.++.+++.+||+.||++|||+.|++++
T Consensus 233 -----~-------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 -----R-------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----C-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----C-------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -----8-------974359999999999767995579189999729
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.59 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=196.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC--EEEEEEECHH-HHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCCEEEEE
Q ss_conf 346556413345855999999768-95--3899993064-299999999999999853-999612799888639913999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD-GM--EVAVKVFHQR-YERALKSFQDECEVMKRI-RHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|+..+.||+|+||+||+|+++. |. .||||+++.. .....+.+.+|+++++++ +|||||+++|+|.+.+..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------
Q ss_conf 9802899966765129---------------9888999999999999999999870399991460643------------
Q 001838 801 MEYMPNGSLENRLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------ 853 (1007)
Q Consensus 801 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ 853 (1007)
||||++|+|.++++.. ...+++..+.+++.|+|.||.|+ |+.+|+|||++
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCCCE
T ss_conf 980289869999864035555512310123457899999999999999998766---30895455505204898688763
Q ss_pred CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 1020425020378985322335668754354234466888950358999999999981999-998432375307799874
Q 001838 854 HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKK-PTDEIFIGELSLSRWVND 932 (1007)
Q Consensus 854 ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~-p~~~~~~~~~~l~~~~~~ 932 (1007)
||+|||+|+....... .....||..|+|||.+....|+.++|||||||++|||++|.. ||...... .+...+..
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGG
T ss_pred EECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHH
T ss_conf 8743443224442234---553013775555387526999962215313889999983689999999999--99999982
Q ss_pred HCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC
Q ss_conf 26941888853310155255678899999999999946189898899997999999999799864303
Q 001838 933 LLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLVKSV 1000 (1007)
Q Consensus 933 ~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~~~~~ 1000 (1007)
.. . ...+...+.++.+++.+||+.||++||||+||++.|+++.+.....+
T Consensus 242 ~~----------------~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 242 GY----------------R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp TC----------------C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred CC----------------C--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCC
T ss_conf 68----------------8--88876678999999999767896689499999999999986186778
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.70 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=192.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf 13465564133458559999997689538999930642999999999999998539996127998886399139999802
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEYM 804 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 804 (1007)
.++|+..+.||+|+||+||+|+++++..||||+++.... ..+.|.+|+.++++++|||||+++|+|.+ +..|+|||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 799798469930798099999999999999999880448-88999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC
Q ss_conf 899966765129-9888999999999999999999870399991460643------------102042502037898532
Q 001838 805 PNGSLENRLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~ 871 (1007)
++|+|..++... ...++|..+..++.|+|.||.|| |+.+|+|||++ ||+|||+|+....... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC-E
T ss_conf 799435420000355305999999999999999987---541143353123079998999299844255542568873-3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCHH
Q ss_conf 23356687543542344668889503589999999999819999984323753077998742694188885331015525
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGEE 951 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~~ 951 (1007)
......||+.|+|||++....++.++|||||||++|||+||..|+.........+..+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----------------- 232 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------- 232 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-----------------
T ss_conf 524545566545808983799891774132358999998689999988889999999982689-----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 567889999999999994618989889999799999999979
Q 001838 952 RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIR 993 (1007)
Q Consensus 952 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~ 993 (1007)
.+.+..++.++.+++.+||+.||++||+|++|++.|+...
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf --9998323799999999975669758919999999876662
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=323.12 Aligned_cols=295 Identities=30% Similarity=0.504 Sum_probs=217.9
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCEEECCCC--CCEEEEEECCCCCCC--CCCCCCCCCCCC
Q ss_conf 599100999999997334599974446878999986--43204737999--938999907998754--476366699999
Q 001838 21 SNITTDQQSLLALKAHISYDPTNLFAKNWTSSTSVC--SWIGITCGVNS--HKVIVLNISGFNLQG--TIPPQLGNLSSL 94 (1007)
Q Consensus 21 ~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~L~L~~n~l~~--~~~~~l~~l~~L 94 (1007)
-|.++|++||++||+++. ||. .++ +|..++||| .|.||+|+..+ .||+.|||+++++.| .+|+.+++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~~-~l~-sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCC-CCC-CCC-CCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf 989899999999999779-998-677-88999999889488969748999479889989899888888798478467533
Q ss_pred CEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCCCCCCCHHHHHCCCCCCEEECC
Q ss_conf 9997699-979998895433756672874667645786224464048887011667645897725685129998689766
Q 001838 95 ETLDLSH-NKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLG 173 (1007)
Q Consensus 95 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~~~~l~~L~~L~Ls 173 (1007)
++|||++ |.+.|.+|..|++|++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+. .+++|+.++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~-~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-GCTTCCEEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHC-CCCCCCEEECC
T ss_conf 52020265433300243114542001102035643443322222011100111122455556851220-67400000023
Q ss_pred CCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 852445698645688889-5898313447798985655656565588026867898884457855444432147646544
Q 001838 174 RNMFHGKIPSTLSKCKQL-EGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGV 252 (1007)
Q Consensus 174 ~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 252 (1007)
+|.+.+.+|..+..+..+ +.+++++|++++..|..+.++.. ..++++.+...+.+|..+..+++++.++++.|.+.
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~-- 234 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA-- 234 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC--
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 553356203121443112323102246435332433222222-23333334332222222222222111222222222--
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 54111278888838812654667688000037998757962587788779944436689989992389767877754446
Q 001838 253 VPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVEFLNLGTNRFSGNIPSSITNASKLTVFQLRGNSFSGFIPNTIGN 332 (1007)
Q Consensus 253 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 332 (1007)
+.++. ....++++.|+|++|++++.+|..+..+++|++|++++|+++|.+| .+..
T Consensus 235 ----------------------~~~~~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~ 289 (313)
T d1ogqa_ 235 ----------------------FDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289 (313)
T ss_dssp ----------------------CBGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTT
T ss_pred ----------------------CCCCC--CCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC-CCCC
T ss_conf ----------------------22222--2245544444476570666087688479999989795883516689-8666
Q ss_pred CCCCCCCCCCCCCCC
Q ss_conf 455330123250112
Q 001838 333 LRNLEFLNIADNYLT 347 (1007)
Q Consensus 333 l~~L~~L~Ls~N~l~ 347 (1007)
+.+|+.+++++|+..
T Consensus 290 L~~L~~l~l~~N~~l 304 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCL 304 (313)
T ss_dssp GGGSCGGGTCSSSEE
T ss_pred CCCCCHHHHCCCCCC
T ss_conf 799897886889500
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.40 Aligned_cols=237 Identities=22% Similarity=0.276 Sum_probs=192.3
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 134655641334585599999976-89538999930642---99999999999999853999612799888639913999
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
.++|+..+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCC
Q ss_conf 98028999667651299888999999999999999999870399991460643------------102042502037898
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~ 868 (1007)
||||+||+|.+++.... .+++.....++.|++.||.|| |+.+|+|||++ ||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 00357986055553256-775999999999996521134---31596224647778476589988882056520035678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCC
Q ss_conf 53223356687543542344668889503589999999999819999984323753077998742694188885331015
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~ 948 (1007)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|++||......+.. ........ .
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~i~~~~~-------------~ 223 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILMEEI-------------R 223 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCC-------------C
T ss_pred C--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHH-HHHHCCCC-------------C
T ss_conf 6--205510088996666504898883331022306788998789999996999999-99852899-------------8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 525567889999999999994618989889999-----7999999
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt-----~~evl~~ 988 (1007)
.+...+.++.+++.+||+.||++||+ ++|++++
T Consensus 224 -------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -------98668999999998666389344225652349999729
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.24 Aligned_cols=240 Identities=20% Similarity=0.236 Sum_probs=186.4
Q ss_pred CCCCCCC-CEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEC----CCEE
Q ss_conf 1346556-41334585599999976-8953899993064299999999999999853-99961279988863----9913
Q 001838 725 TDRFSKN-NLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRI-RHRNLVKIISACSN----DDFK 797 (1007)
Q Consensus 725 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 797 (1007)
.++|.+. +.||+|+||+||+|+.. +++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC---------------CCCEEECC
Q ss_conf 99998028999667651299-888999999999999999999870399991460643---------------10204250
Q 001838 798 ALIMEYMPNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIA 861 (1007)
Q Consensus 798 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~---------------ki~Dfgla 861 (1007)
|+|||||+||+|.+++.... ..+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 9999778998499999862787757999999999999999999---9769864441002201135555663113545512
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHH
Q ss_conf 20378985322335668754354234466888950358999999999981999998432375307799874269418888
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
+....... .....||+.|||||++.+..|+.++||||+||++|||+||+.||........ ..........
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i~~------ 231 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRM------ 231 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCS------
T ss_pred EECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHHHC------
T ss_conf 33368886---4322677563792777489888888887645167788658899889887788-9999999853------
Q ss_pred HHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 53310155255678899999999999946189898899997999999
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.............+.++.+++.+||+.||++|||+.|++.+
T Consensus 232 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 ------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------88888985434699999999999756996579099999709
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=322.51 Aligned_cols=238 Identities=20% Similarity=0.253 Sum_probs=185.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHH---HHHHHHHH---HHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 134655641334585599999976-895389999306429---99999999---99999853999612799888639913
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQD---ECEVMKRIRHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~ 797 (1007)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+ |+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECC
Q ss_conf 99998028999667651299888999999999999999999870399991460643------------102042502037
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLN 865 (1007)
Q Consensus 798 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~ 865 (1007)
|+|||||+||+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 99999148983899987325-532789999999999999999---97796220444221678588967982201023337
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHH
Q ss_conf 8985322335668754354234466-888950358999999999981999998432375307799874269418888533
Q 001838 866 GQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 866 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~ 944 (1007)
... .....||+.|+|||++.. ..|+.++||||+||++|||+||+.||......... .........
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~-------- 224 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTM-------- 224 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSC--------
T ss_pred CCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHCCCC--------
T ss_conf 886----433113455421687603899984410467789999998599988889989999--999860468--------
Q ss_pred HHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 1015525567889999999999994618989889999-----7999999
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt-----~~evl~~ 988 (1007)
... .+...+.++.+++.+||+.||++||| ++|++++
T Consensus 225 ----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ----AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----CCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----CCC----CCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ----887----88778999999999985669888088743579999749
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=325.47 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=196.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH---HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----E
Q ss_conf 134655641334585599999976-8953899993064---2999999999999998539996127998886399----1
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR---YERALKSFQDECEVMKRIRHRNLVKIISACSNDD----F 796 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~ 796 (1007)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. .......+.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEEC
Q ss_conf 399998028999667651299888999999999999999999870399991460643------------10204250203
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~ 864 (1007)
.|+|||||+||+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ +++|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 999997788987101120358-999999999999999999999---8579527634675566575432010034443221
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHH
Q ss_conf 789853-2233566875435423446688895035899999999998199999843237530779987426941888853
Q 001838 865 NGQDQL-SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID 943 (1007)
Q Consensus 865 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id 943 (1007)
...... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||......+... +.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~~~~~~---------- 230 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVRED---------- 230 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCC----------
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHH-HHHHCC----------
T ss_conf 235443333464257624369999839999966320265289999976979989969999999-998469----------
Q ss_pred HHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 3101552556788999999999999461898988999-97999999999799
Q 001838 944 TNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRI-NAREIVTGLLKIRD 994 (1007)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rp-t~~evl~~L~~i~~ 994 (1007)
...........+.++.+++.+|++.||++|| |++++...|..++.
T Consensus 231 ------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 231 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ------CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf ------9997100347899999999998667976777399999999999758
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.39 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=193.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEECHHH---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 346556413345855999999768----9538999930642---999999999999998539996127998886399139
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQD----GMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKA 798 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 798 (1007)
++|+..+.||+|+||+||+|+... ...||||++.... .+..+.|.+|+.++++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCC
Q ss_conf 9998028999667651299888999999999999999999870399991460643------------1020425020378
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~ 866 (1007)
+|||||++|++.+++......+++..+.+++.|+|.||.|| |+++|+|||++ |++|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 14654238612544421268999999999999999999875---217875205668881565565433256115553035
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHH
Q ss_conf 98532-2335668754354234466888950358999999999981-999998432375307799874269418888533
Q 001838 867 QDQLS-MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDT 944 (1007)
Q Consensus 867 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~ 944 (1007)
..... ......|++.|+|||++.+..++.++|||||||++|||+| |+.||......+ ...+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~----------- 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE----------- 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTS-----------
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHHC-----------
T ss_conf 88752654763257310799998379999421566148999999968999999969999--99999847-----------
Q ss_pred HHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 101552556788999999999999461898988999979999999997
Q 001838 945 NLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKI 992 (1007)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i 992 (1007)
.. +++.+...+.++.+++.+||+.||++||||.||.+.|++.
T Consensus 231 ----~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ----GE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ----99--9998544539999999997688966792999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=320.53 Aligned_cols=233 Identities=23% Similarity=0.312 Sum_probs=190.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 34655641334585599999976-89538999930642---999999999999998539996127998886399139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
|||+||++..++.... .+++.....++.|++.|+.|| |+++|+|||++ ||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred EECCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHH---CCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC-
T ss_conf 5037863223432222-111007999999998765541---24767705568105038689988983175216712456-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
....||+.|||||++.+..|+.++||||+||++|||+||+.||......+. ..+..... .
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~------------~--- 218 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAE------------L--- 218 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCC------------C---
T ss_pred ----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH-HHHHHCCC------------C---
T ss_conf ----434576343599998389998043046533368999759899999699999-99997089------------8---
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 2556788999999999999461898988999-----97999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rp-----t~~evl~~ 988 (1007)
. .+...+.++.+++.+|+..||++|| |++|++++
T Consensus 219 -~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C----CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf -8----99778999999999995449976664310219999819
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.40 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=192.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEEC
Q ss_conf 34655641334585599999976895389999306429999999999999985399961279988863-99139999802
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSN-DDFKALIMEYM 804 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 804 (1007)
++|+..+.||+|+||.||+|+++ |..||||+++... ..+.+.+|++++++++|||||+++|+|.+ ++.+|+||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-9099999988577--79999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC
Q ss_conf 8999667651299-888999999999999999999870399991460643------------102042502037898532
Q 001838 805 PNGSLENRLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 805 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~ 871 (1007)
++|+|.+++.... ..+++..+++++.|++.||.|| |+.+|+||+++ |++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCC---CCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 999899998745788889999999999998523211---33765536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCCH
Q ss_conf 2335668754354234466888950358999999999981-999998432375307799874269418888533101552
Q 001838 872 MQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSGE 950 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~~ 950 (1007)
....+++.|+|||++.+..++.++|||||||++|||+| |++|+...... .+..+.......
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~~-------------- 219 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM-------------- 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCC--------------
T ss_pred --CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCCCC--------------
T ss_conf --65566646778178727988858877757999999997899999999999--999999808999--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 55678899999999999946189898899997999999999799
Q 001838 951 ERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRD 994 (1007)
Q Consensus 951 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~ 994 (1007)
+.+...+.++.+++.+||+.||++||||.|++++|+.++.
T Consensus 220 ----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----9976579999999999756697689399999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.70 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=199.6
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEECHHH-HHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECC
Q ss_conf 1346556413345855999999768--------9538999930642-99999999999999853-999612799888639
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQD--------GMEVAVKVFHQRY-ERALKSFQDECEVMKRI-RHRNLVKIISACSND 794 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 794 (1007)
.++|...+.||+|+||.||+|+... +..||||+++... ......+.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------
Q ss_conf 91399998028999667651299---------------888999999999999999999870399991460643------
Q 001838 795 DFKALIMEYMPNGSLENRLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------ 853 (1007)
Q Consensus 795 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------ 853 (1007)
+..++|||||++|+|.+++.... ..+++..+..++.|++.||+|| |+.+|+|||++
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEEEECCCCEEE
T ss_conf 868999973699909999986067764322233457434679999999999999999876---63797863022102245
Q ss_pred ------CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf ------1020425020378985322335668754354234466888950358999999999981-999998432375307
Q 001838 854 ------HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFT-GKKPTDEIFIGELSL 926 (1007)
Q Consensus 854 ------ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~l 926 (1007)
|++|||+++...............|++.|+|||.+.+..|+.++|||||||++|||+| |++||....... +
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH--H
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999--9
Q ss_pred HHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 799874269418888533101552556788999999999999461898988999979999999997998
Q 001838 927 SRWVNDLLPISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 927 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.++....... ..+...+.++.+++.+||+.||++||||.||++.|+++...
T Consensus 247 ~~~i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLLKEGHRM------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHTTCCC------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCC------------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9999728888------------------98743529999999997667976793999999999888604
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.50 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=197.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECHH-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 134655641334585599999976------8953899993064-299999999999999853999612799888639913
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ------DGMEVAVKVFHQR-YERALKSFQDECEVMKRIRHRNLVKIISACSNDDFK 797 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 797 (1007)
.++|...+.||+|+||+||+|.+. ++..||||+++.. .......|.+|+.++++++|||||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCC
Q ss_conf 9999802899966765129---------9888999999999999999999870399991460643------------102
Q 001838 798 ALIMEYMPNGSLENRLYSG---------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HIS 856 (1007)
Q Consensus 798 ~lv~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~ 856 (1007)
++|||||++|+|.+++... ...+++..+.+++.|+|+||.|| |+.+|+|||++ ||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECEECCCCEEECCCCEEEEE
T ss_conf 677760489988999875033211344468879999999999999999987---64796543286775403599649994
Q ss_pred EEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 042502037898532233566875435423446688895035899999999998199-9998432375307799874269
Q 001838 857 DFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGK-KPTDEIFIGELSLSRWVNDLLP 935 (1007)
Q Consensus 857 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~-~p~~~~~~~~~~l~~~~~~~~~ 935 (1007)
|||+|+...........+...|++.|+|||.+.+..++.++|||||||++|||+||. +||...... ++....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----~~~~~i-- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFV-- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HHHHHH--
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH-----HHHHHH--
T ss_conf 2454202357763031340231632378888736998833344437899999996899999998999-----999999--
Q ss_pred CCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 418888533101552556788999999999999461898988999979999999997998
Q 001838 936 ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 936 ~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.+... ...+..++..+.+++.+||+.+|++||||.||+++|++..+.
T Consensus 249 ------~~~~~-------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 ------MEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ------HTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------HHCCC-------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf ------80888-------888633539999999997577965893999999997876177
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=320.00 Aligned_cols=233 Identities=20% Similarity=0.269 Sum_probs=190.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHH---HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 34655641334585599999976-895389999306429---99999999999998539996127998886399139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE---RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 801 (1007)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643------------1020425020378985
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQ 869 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~ 869 (1007)
||+.+|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred CCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC-
T ss_conf 2334662266675158-989999999999999989999---85998617679999360778978861010333225666-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCCC
Q ss_conf 32233566875435423446688895035899999999998199999843237530779987426941888853310155
Q 001838 870 LSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLSG 949 (1007)
Q Consensus 870 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~~ 949 (1007)
....||+.|||||++.+..|+.++||||+||++|||+||+.||....... .+.+.......
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~-------------- 256 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVR-------------- 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC--------------
T ss_pred ----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHCCCCC--------------
T ss_conf ----43367635678899717998853311450078999975889989959999-99998617988--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 2556788999999999999461898988999-----97999999
Q 001838 950 EERYFAAKEQSLLSILNLATECTIESPGKRI-----NAREIVTG 988 (1007)
Q Consensus 950 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rp-----t~~evl~~ 988 (1007)
.+...+.++.+++.+||+.||++|+ |++|++++
T Consensus 257 ------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 ------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf ------97668999999999983409986065534549999719
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=318.26 Aligned_cols=240 Identities=18% Similarity=0.247 Sum_probs=190.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---------HHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 134655641334585599999976-89538999930642---------999999999999998539-9961279988863
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---------ERALKSFQDECEVMKRIR-HRNLVKIISACSN 793 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 793 (1007)
-++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECC
Q ss_conf 991399998028999667651299888999999999999999999870399991460643------------10204250
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIA 861 (1007)
Q Consensus 794 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla 861 (1007)
++..|+|||||++|+|.++++... .+++.++..++.|++.||.|| |+.+|+|||++ ||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 760599997689866899998659-999999999999999999999---8759943234625489868998387124031
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 20378985322335668754354234466------888950358999999999981999998432375307799874269
Q 001838 862 KFLNGQDQLSMQTQTLATIGYMAPEYGVQ------GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLP 935 (1007)
Q Consensus 862 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~ 935 (1007)
+....... .+...||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... ...........
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~ 233 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ 233 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred EECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH-HHHHHHHCCCC
T ss_conf 67268872---134524678889888605344567889923318565602310322888988999999-99999818988
Q ss_pred CCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 41888853310155255678899999999999946189898899997999999
Q 001838 936 ISVMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 936 ~~~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
. .. ......+.++.+++.+||++||++|||++||+++
T Consensus 234 ~-------------~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 F-------------GS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C-------------CT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C-------------CC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8-------------98---5434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.09 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=186.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH---HHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 34655641334585599999976-89538999930642---999999999999998-53999612799888639913999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY---ERALKSFQDECEVMK-RIRHRNLVKIISACSNDDFKALI 800 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv 800 (1007)
++|...+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCC
Q ss_conf 98028999667651299888999999999999999999870399991460643------------102042502037898
Q 001838 801 MEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 801 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~ 868 (1007)
||||++|+|.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEECCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC
T ss_conf 75037980899864047-899999999999999999999---86893403476540444489963015553023235665
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHHHHHCC
Q ss_conf 53223356687543542344668889503589999999999819999984323753077998742694188885331015
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVIDTNLLS 948 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id~~~~~ 948 (1007)
. ..+...||+.|+|||++.+..|+.++||||+||++|||+||+.||......+ +..-.....+
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~------------- 220 (320)
T d1xjda_ 158 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP------------- 220 (320)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-------------
T ss_pred C--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCC-------------
T ss_conf 3--3454578777689999827998832320112278989873889999989999--9999971899-------------
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 52556788999999999999461898988999979-9999
Q 001838 949 GEERYFAAKEQSLLSILNLATECTIESPGKRINAR-EIVT 987 (1007)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~-evl~ 987 (1007)
..+...+.++.+++.+||..||++||++. |+++
T Consensus 221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ------8975679999999999654489878388999980
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.73 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=189.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 34655641334585599999976-89538999930642--9999999999999985399961279988863991399998
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 802 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||+++... +...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCC
Q ss_conf 028999667651299888999999999999999999870399991460643------------10204250203789853
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~ 870 (1007)
||.++.+..........+++..+..++.|++.||.|| |+.+|+|||++ |++|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC-
T ss_conf 2377445554420256888899999999999999986---528899213571140113467621035786134368864-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC-CC-CHHHHHH----
Q ss_conf 2233566875435423446688-895035899999999998199999843237530779987426-94-1888853----
Q 001838 871 SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-PI-SVMEVID---- 943 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~-~~~~~id---- 943 (1007)
......||+.|+|||...... ++.++||||+||++|||++|+.||....... .+........ +. .....+.
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf -10010365215411221366577742210333313427966879989889999-9999998328983331444222421
Q ss_pred --HHHCC-CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --31015-5255678899999999999946189898899997999999
Q 001838 944 --TNLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 --~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
..... ............+.++.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.38 Aligned_cols=252 Identities=21% Similarity=0.201 Sum_probs=183.7
Q ss_pred CCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 5641334585599999976-895389999306429-----9999999999999853999612799888639913999980
Q 001838 730 KNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE-----RALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
..+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC
Q ss_conf 28999667651299888999999999999999999870399991460643------------102042502037898532
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~ 871 (1007)
|.+|++..... ....+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred HCCHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 34507765541-266778999999999999999886---316355035776258853778411465761000578755--
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHH------H
Q ss_conf 23356687543542344668-8895035899999999998199999843237530779987426941888853------3
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID------T 944 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id------~ 944 (1007)
......||+.|+|||++... .|+.++||||+||++|||+||++||......+ .+................+ .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCHHCCCHH
T ss_conf 43302047333639997267788805643630428999985969999999999-99999985189972545210002134
Q ss_pred H-HCCC-HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1-0155-255678899999999999946189898899997999999
Q 001838 945 N-LLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 945 ~-~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
. .... .............++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4303478988678565689999999999763894569089999679
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.81 Aligned_cols=259 Identities=21% Similarity=0.238 Sum_probs=186.2
Q ss_pred HHCCCCCCCCEECCCCCEEEEEEEEC-C-CCEEEEEEECHHH--HHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEC--
Q ss_conf 83134655641334585599999976-8-9538999930642--99999999999999853---99961279988863--
Q 001838 723 QATDRFSKNNLLGIGSFGSVYVARLQ-D-GMEVAVKVFHQRY--ERALKSFQDECEVMKRI---RHRNLVKIISACSN-- 793 (1007)
Q Consensus 723 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-- 793 (1007)
++.++|++.+.||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 87589798889921558699999998889989999998023245167999999999999874258988023663221466
Q ss_pred ---CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEE
Q ss_conf ---991399998028999667651299888999999999999999999870399991460643------------10204
Q 001838 794 ---DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDF 858 (1007)
Q Consensus 794 ---~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Df 858 (1007)
....+++||||.+|.+..........+++..+..++.|++.||+|| |+.+|+|||++ |++||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCCCEEEECCCCCEEECCH
T ss_conf 6667469999974058714444430378999899999999999999999---7588983579862789858997542100
Q ss_pred ECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCH
Q ss_conf 25020378985322335668754354234466888950358999999999981999998432375307799874269418
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISV 938 (1007)
Q Consensus 859 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~ 938 (1007)
|+++...... ......||+.|+|||++.+.+|+.++||||+||++|||+||++||......+ .+............
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred HHHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCH
T ss_conf 0101100234---5777654851148310017988811100032899999987879989989899-99999984079961
Q ss_pred HHH-HH-----HHHCC-CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 888-53-----31015-5255678899999999999946189898899997999999
Q 001838 939 MEV-ID-----TNLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 ~~~-id-----~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
... .+ ..... ...............+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 105321111033302234564544044589999999999874896679189999669
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=299.16 Aligned_cols=258 Identities=18% Similarity=0.214 Sum_probs=187.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EEE
Q ss_conf 134655641334585599999976-89538999930642-999999999999998539996127998886399----139
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY-ERALKSFQDECEVMKRIRHRNLVKIISACSNDD----FKA 798 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 798 (1007)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCC
Q ss_conf 9998028999667651299888999999999999999999870399991460643------------1020425020378
Q 001838 799 LIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNG 866 (1007)
Q Consensus 799 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~ 866 (1007)
++++|+.+|+|.+++..+ .+++..+..++.|++.||+|| |+.+|+|||++ ||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 999962598656644058--999999999999999999999---978986777876437887999778754570565047
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC-CCCH-----
Q ss_conf 9853-22335668754354234466-88895035899999999998199999843237530779987426-9418-----
Q 001838 867 QDQL-SMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL-PISV----- 938 (1007)
Q Consensus 867 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~~~----- 938 (1007)
.... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||......... ........ +...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHTC
T ss_pred CCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHH-HHHHHHCCCCCHHHHHHH
T ss_conf 7764101011026520003878604788874101004670133776697997888889999-987652069975664234
Q ss_pred -----HHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----88853310155255678899999999999946189898899997999999
Q 001838 939 -----MEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 939 -----~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
.......-................++.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322220244677557787778378999999999999764895679089998619
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.56 Aligned_cols=228 Identities=21% Similarity=0.248 Sum_probs=183.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHH------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCCE
Q ss_conf 34655641334585599999976-895389999306429------99999999999998539--9961279988863991
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYE------RALKSFQDECEVMKRIR--HRNLVKIISACSNDDF 796 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 796 (1007)
++|++.+.||+|+||+||+|+.. +|..||||++..... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-------------CCCEEECCE
Q ss_conf 3999980289-99667651299888999999999999999999870399991460643-------------102042502
Q 001838 797 KALIMEYMPN-GSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAK 862 (1007)
Q Consensus 797 ~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-------------ki~Dfgla~ 862 (1007)
.|+||||+.+ +++.+++.... .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 8999983368622899986158-999999999999999999999---877975566761114774478848977546535
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHH
Q ss_conf 0378985322335668754354234466888-950358999999999981999998432375307799874269418888
Q 001838 863 FLNGQDQLSMQTQTLATIGYMAPEYGVQGRV-STRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEV 941 (1007)
Q Consensus 863 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 941 (1007)
...... .+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .....
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~--------- 219 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG--------- 219 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC---------
T ss_pred ECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-------HHHHC---------
T ss_conf 324445----5665658774799998489978865332554034536756889988736-------77615---------
Q ss_pred HHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 53310155255678899999999999946189898899997999999
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 942 id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
... .. ...+.++.+++.+||+.||++|||++|++++
T Consensus 220 ---~~~-~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ---QVF-FR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCC-CS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCC-CC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---447-78-------7799999999999760897589399998539
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=300.29 Aligned_cols=252 Identities=21% Similarity=0.232 Sum_probs=188.6
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC------
Q ss_conf 134655641334585599999976-8953899993064--2999999999999998539996127998886399------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSNDD------ 795 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 795 (1007)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEE
Q ss_conf 1399998028999667651299888999999999999999999870399991460643------------1020425020
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~ 863 (1007)
..|+||||| +++|..+.+.. .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEC
T ss_conf 599998405-52189998740--226999999999999999998---737876456685111121001221134310220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCC--C---
Q ss_conf 3789853223356687543542344668-889503589999999999819999984323753077998742694--1---
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI--S--- 937 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~--~--- 937 (1007)
.... .+...|++.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.......... .
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred CCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCCCCCHHHHH
T ss_conf 6876-----310245533358899817878996501030038999999786998889768-9999998503788488886
Q ss_pred -----HHHHHHHHHCCC-HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----888853310155-255678899999999999946189898899997999999
Q 001838 938 -----VMEVIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 -----~~~~id~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
............ ..............+.+|+.+|+..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 530003443311578666556677556899999999999772995579299999639
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=306.14 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=189.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 3465564133458559999997689538999930642--99999999999999853999612799888639913999980
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
++|+..+.||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.++++++|||||+++++|.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCCC
Q ss_conf 28999667651299888999999999999999999870399991460643------------102042502037898532
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQLS 871 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~~ 871 (1007)
+.++.+..+... ...+++..+..++.|++.||+|| |+.+|+|||++ |++|||.|........
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHH---CCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC--
T ss_conf 004567899860-47751445689999999999986---057488267877505686899787323664301146765--
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCC---CHHHH-----H
Q ss_conf 23356687543542344668-889503589999999999819999984323753077998742694---18888-----5
Q 001838 872 MQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPI---SVMEV-----I 942 (1007)
Q Consensus 872 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~---~~~~~-----i 942 (1007)
......|++.|+|||.+... .++.++||||+||++|||++|+.||.+....+. +.+........ ..... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 410102431101378871788888410021117589999779799898898999-9999986389971104212333221
Q ss_pred HHHHCC-CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 331015-5255678899999999999946189898899997999999
Q 001838 943 DTNLLS-GEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 943 d~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
+..... .........+..+.++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43333356764666512589999999999866896689099998569
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=297.60 Aligned_cols=249 Identities=19% Similarity=0.196 Sum_probs=190.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCE-EEEEEEEECCCEEEEEEEE
Q ss_conf 34655641334585599999976-895389999306429999999999999985399961-2799888639913999980
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL-VKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~ 803 (1007)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+..|+++++.++|+|+ +.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC---------------CCCEEECCEECCCCC
Q ss_conf 28999667651299888999999999999999999870399991460643---------------102042502037898
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~---------------ki~Dfgla~~~~~~~ 868 (1007)
+ +|++...+......+++..+..++.|++.||+|| |+.+|+|||++ |++|||+|+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred C-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCC
T ss_conf 3-8713332443068876899999999999999999---97994426678766064335777615650467513425544
Q ss_pred CC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHH--HHHHHHHCCCCHHHH
Q ss_conf 53-----22335668754354234466888950358999999999981999998432375307--799874269418888
Q 001838 869 QL-----SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSL--SRWVNDLLPISVMEV 941 (1007)
Q Consensus 869 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~ 941 (1007)
.. .......||+.|||||++.+..++.++|||||||++|||+||+.||.......... .++.........
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH---
T ss_pred CCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH---
T ss_conf 55410001357767873532999991899898321886177899998498766553057799999985235678983---
Q ss_pred HHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 533101552556788999999999999461898988999979999999997998
Q 001838 942 IDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDT 995 (1007)
Q Consensus 942 id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~ 995 (1007)
.......+.++.+++.+||+.+|++||++.++.+.|+.+...
T Consensus 238 ------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ------------575347889999999998439955791999999999999997
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=297.96 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=183.0
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC------CEEEE
Q ss_conf 4655641334585599999976-8953899993064299999999999999853999612799888639------91399
Q 001838 727 RFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNLVKIISACSND------DFKAL 799 (1007)
Q Consensus 727 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 799 (1007)
+|...++||+|+||+||+|+.. +|+.||||++.... ....+|++++++++|||||+++++|... .++|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 7675169821768399999999999799999988160----689999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-------------CCCEEECCEEC
Q ss_conf 998028999667651--299888999999999999999999870399991460643-------------10204250203
Q 001838 800 IMEYMPNGSLENRLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFL 864 (1007)
Q Consensus 800 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-------------ki~Dfgla~~~ 864 (1007)
|||||++|.+..... .....+++..+..++.|++.||.|| |+.+|+|||++ ||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 984168860788886310368999999999999999999999---86687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHH--H
Q ss_conf 78985322335668754354234466-88895035899999999998199999843237530779987426941888--8
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQ-GRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVME--V 941 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~ 941 (1007)
...... ....|++.|+|||.+.+ ..|+.++||||+||++|||++|++||....... .+.............. .
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHHCCCHHHHHHH
T ss_conf 477653---200255555682776404688821000246527785502879989879999-9999999748981776543
Q ss_pred HHHHHCC-----C--HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHHH
Q ss_conf 5331015-----5--255678899999999999946189898899997999999--999799
Q 001838 942 IDTNLLS-----G--EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG--LLKIRD 994 (1007)
Q Consensus 942 id~~~~~-----~--~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~--L~~i~~ 994 (1007)
....... . ...........+.++.+|+.+||..||++|||+.|++++ ++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 06210110355445674444315689999999999976589557929999966984524667
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=295.48 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=185.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECC--CEEEEEE
Q ss_conf 34655641334585599999976-89538999930642999999999999998539-99612799888639--9139999
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSND--DFKALIM 801 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 801 (1007)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .+.+.+|++++++++ ||||++++++|... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-------------CCCEEECCEECCCCC
Q ss_conf 8028999667651299888999999999999999999870399991460643-------------102042502037898
Q 001838 802 EYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-------------HISDFSIAKFLNGQD 868 (1007)
Q Consensus 802 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-------------ki~Dfgla~~~~~~~ 868 (1007)
|||.+|+|..+.+ .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+......
T Consensus 112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 6317985899746----899999999999999999887---643344345644123774899836641565426646887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHHH----
Q ss_conf 53223356687543542344668-8895035899999999998199999843237530779987426941888853----
Q 001838 869 QLSMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVID---- 943 (1007)
Q Consensus 869 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~id---- 943 (1007)
. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......................+...
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 4---4432248642476102688888845232335455587604889998876018999999998788415555542254
Q ss_pred -------HHH----CCCHH--HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------310----15525--5678899999999999946189898899997999999
Q 001838 944 -------TNL----LSGEE--RYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 -------~~~----~~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
... ..... .........+.++.+|+.+|++.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4474300000333433112115521124489999999999866995689089999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.99 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=188.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC------C
Q ss_conf 134655641334585599999976-8953899993064--299999999999999853999612799888639------9
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSND------D 795 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 795 (1007)
.++|++.+.||+|+||+||+|... +|..||||++... ......++.+|+.++++++|||||+++++|... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEE
Q ss_conf 1399998028999667651299888999999999999999999870399991460643------------1020425020
Q 001838 796 FKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKF 863 (1007)
Q Consensus 796 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~ 863 (1007)
.+|+|||||.+|.+ +.+.. .+++..+..++.|++.||.|| |+.+|+|||++ |++|||+++.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~---~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEEECCCHHHH-HHHHC---CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 26999841446778-76503---899999999999999999886---522112456776321136544313201023211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC---------
Q ss_conf 37898532233566875435423446688895035899999999998199999843237530779987426---------
Q 001838 864 LNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--------- 934 (1007)
Q Consensus 864 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~--------- 934 (1007)
..... ..+...+|+.|+|||++.+..++.++||||+||++|||++|+.||....... ...+......
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred CCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHHHH
T ss_conf 46665---5332214655558133147777877433356625789865989988897788-9999997205898799987
Q ss_pred -CCC---------------HHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -941---------------888853310155255678899999999999946189898899997999999
Q 001838 935 -PIS---------------VMEVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 935 -~~~---------------~~~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
... ....+........ .......+.++.+|+.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD---SEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCS---SHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 65667777641754356664212643335432---10133379999999999876994579089999669
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=294.45 Aligned_cols=259 Identities=17% Similarity=0.219 Sum_probs=186.5
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--------
Q ss_conf 134655641334585599999976-89538999930642--9999999999999985399961279988863--------
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSN-------- 793 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 793 (1007)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECC
Q ss_conf 991399998028999667651299888999999999999999999870399991460643------------10204250
Q 001838 794 DDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIA 861 (1007)
Q Consensus 794 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla 861 (1007)
++..|+|||||+++.+.... .....++...+..++.|++.||.|| |+.+|+|||++ |++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHH---CCCCEEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 76389998535787410122-2034433089999999999999885---2299885676722203668996876313500
Q ss_pred EECCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC--CC
Q ss_conf 203789853--223356687543542344668-8895035899999999998199999843237530779987426--94
Q 001838 862 KFLNGQDQL--SMQTQTLATIGYMAPEYGVQG-RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLL--PI 936 (1007)
Q Consensus 862 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~--~~ 936 (1007)
+........ .......||+.|+|||++.+. .|+.++||||+||++|||++|+.||....... .+........ +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred EECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHH-HHHHHHHHCCCCCH
T ss_conf 22355444321135660249787428997079998917870067864661744879989989999-99999984189982
Q ss_pred C---------HHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1---------8888533101-55255678899999999999946189898899997999999
Q 001838 937 S---------VMEVIDTNLL-SGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 937 ~---------~~~~id~~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
. ....+..... ................+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=288.74 Aligned_cols=251 Identities=14% Similarity=0.139 Sum_probs=196.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 34655641334585599999976-89538999930642999999999999998539-99612799888639913999980
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFKALIMEY 803 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 803 (1007)
++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.++ |+|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 806997998417882999999988997999999750258--299999999999964899987799996018811799996
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-----------------CCCEEECCEECCC
Q ss_conf 28999667651299888999999999999999999870399991460643-----------------1020425020378
Q 001838 804 MPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------------HISDFSIAKFLNG 866 (1007)
Q Consensus 804 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-----------------ki~Dfgla~~~~~ 866 (1007)
+ +|+|.+++......+++..+..++.|++.||.|| |+.+|+|||++ |++|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHH---HHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCC
T ss_conf 4-8887999975203110689999999999999999---97796626677131523475434479568723660577146
Q ss_pred CCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHH--HHHHHHHCCCCHH
Q ss_conf 9853-----22335668754354234466888950358999999999981999998432375307--7998742694188
Q 001838 867 QDQL-----SMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSL--SRWVNDLLPISVM 939 (1007)
Q Consensus 867 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l--~~~~~~~~~~~~~ 939 (1007)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.......... .+...........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHH
T ss_conf 76654111024676277510267989648888869998983199999986987678853021999999997056799958
Q ss_pred HHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 8853310155255678899999999999946189898899997999999999799864
Q 001838 940 EVIDTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTGLLKIRDTLV 997 (1007)
Q Consensus 940 ~~id~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~L~~i~~~~~ 997 (1007)
+ .....+.++.+++..|+..+|++||+++.+.+.++++.+...
T Consensus 239 ~---------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 239 E---------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp H---------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H---------------HCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 9---------------657998999999999843993008599999999999999759
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=292.16 Aligned_cols=257 Identities=18% Similarity=0.194 Sum_probs=191.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 34655641334585599999976-89538999930642--9999999999999985399961279988863991399998
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRY--ERALKSFQDECEVMKRIRHRNLVKIISACSNDDFKALIME 802 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 802 (1007)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++|||||+++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEECCCCCCC
Q ss_conf 028999667651299888999999999999999999870399991460643------------10204250203789853
Q 001838 803 YMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFLNGQDQL 870 (1007)
Q Consensus 803 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~~~~~~~ 870 (1007)
++.++++..++... +.+++..+..++.|++.||+|| |+.+|+|||++ |++|||.|+........
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHH---HCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCC
T ss_conf 02332221121235-6540367899999999998774---3399860014676121133782665204601104688751
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCC---H---HHHHH
Q ss_conf 2233566875435423446688-895035899999999998199999843237530779987426941---8---88853
Q 001838 871 SMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS---V---MEVID 943 (1007)
Q Consensus 871 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~---~---~~~id 943 (1007)
.....+++.|+|||.+.... ++.++||||+||++|||++|+.||.........+........... . ....+
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred --CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCC
T ss_conf --001034431014667506988880444026541889985189999889999999999986118997355134432221
Q ss_pred HHH---CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 310---155255678899999999999946189898899997999999
Q 001838 944 TNL---LSGEERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 944 ~~~---~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
... .................+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=294.89 Aligned_cols=241 Identities=24% Similarity=0.291 Sum_probs=186.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEEECHHH----HHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECCCE
Q ss_conf 34655641334585599999976----89538999930642----9999999999999985399-961279988863991
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ----DGMEVAVKVFHQRY----ERALKSFQDECEVMKRIRH-RNLVKIISACSNDDF 796 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 796 (1007)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEEC
Q ss_conf 399998028999667651299888999999999999999999870399991460643------------10204250203
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~ 864 (1007)
.++|||||.+|+|.+++..... +.......++.|++.|+.|+ |+.+|+|||++ |++|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHH---HCCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 0012312341179999873045-43788888899999999885---1499896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCHHHHH
Q ss_conf 789853223356687543542344668--889503589999999999819999984323753077998742694188885
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQG--RVSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPISVMEVI 942 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~i 942 (1007)
...... ......|++.|+|||.+... .++.++||||+||++|||+||+.||............+.....
T Consensus 180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-------- 250 (322)
T d1vzoa_ 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-------- 250 (322)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--------
T ss_pred CCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC--------
T ss_conf 344443-22122233333106876057768871325177779999997689998888777799999983356--------
Q ss_pred HHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 331015525567889999999999994618989889999-----7999999
Q 001838 943 DTNLLSGEERYFAAKEQSLLSILNLATECTIESPGKRIN-----AREIVTG 988 (1007)
Q Consensus 943 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt-----~~evl~~ 988 (1007)
.. ...+.+.+.++.+++.+||++||++||| ++|++++
T Consensus 251 -~~--------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 -SE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -89--------9886547999999999974458988199974509999749
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=289.95 Aligned_cols=253 Identities=20% Similarity=0.222 Sum_probs=185.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHH--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-----CE
Q ss_conf 134655641334585599999976-8953899993064--299999999999999853999612799888639-----91
Q 001838 725 TDRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQR--YERALKSFQDECEVMKRIRHRNLVKIISACSND-----DF 796 (1007)
Q Consensus 725 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 796 (1007)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC------------CCCEEECCEEC
Q ss_conf 399998028999667651299888999999999999999999870399991460643------------10204250203
Q 001838 797 KALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA------------HISDFSIAKFL 864 (1007)
Q Consensus 797 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~------------ki~Dfgla~~~ 864 (1007)
.++++||+.+|+|.+++..+ .+++..+..++.|++.||.|| |+.+|+|||++ |++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 49999962588623200224--530999999999999999999---7388765166776334554322001321000125
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCC------
Q ss_conf 7898532233566875435423446688-895035899999999998199999843237530779987426941------
Q 001838 865 NGQDQLSMQTQTLATIGYMAPEYGVQGR-VSTRGDVYSYGIMLMETFTGKKPTDEIFIGELSLSRWVNDLLPIS------ 937 (1007)
Q Consensus 865 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~------ 937 (1007)
... .....|++.|+|||...+.. ++.++||||+||++|||++|+.||........ ............
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKK 245 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred CCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHHH
T ss_conf 754-----44434543555835533775678551243205899999768899788988999-999997307997577320
Q ss_pred ----HHHHHHHHHCCC-HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----888853310155-255678899999999999946189898899997999999
Q 001838 938 ----VMEVIDTNLLSG-EERYFAAKEQSLLSILNLATECTIESPGKRINAREIVTG 988 (1007)
Q Consensus 938 ----~~~~id~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~evl~~ 988 (1007)
............ .............++.+|+.+|+..||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 01024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-44 Score=260.99 Aligned_cols=255 Identities=17% Similarity=0.220 Sum_probs=180.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECHHHHHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEC
Q ss_conf 34655641334585599999976-89538999930642999999999999998539-----------9961279988863
Q 001838 726 DRFSKNNLLGIGSFGSVYVARLQ-DGMEVAVKVFHQRYERALKSFQDECEVMKRIR-----------HRNLVKIISACSN 793 (1007)
Q Consensus 726 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 793 (1007)
.+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred --CCEEEEEEEECCCCCHHHH--HHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC----------------
Q ss_conf --9913999980289996676--51299888999999999999999999870399991460643----------------
Q 001838 794 --DDFKALIMEYMPNGSLENR--LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA---------------- 853 (1007)
Q Consensus 794 --~~~~~lv~e~~~~gsL~~~--l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~---------------- 853 (1007)
....+++++++..+..... .......+++..+..++.|++.|+.||| +..+|+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 256520234320003542000001223467868999999999999988876--405864656770570563057656443
Q ss_pred --CCCEEECCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC-----CHH
Q ss_conf --1020425020378985322335668754354234466888950358999999999981999998432375-----307
Q 001838 854 --HISDFSIAKFLNGQDQLSMQTQTLATIGYMAPEYGVQGRVSTRGDVYSYGIMLMETFTGKKPTDEIFIGE-----LSL 926 (1007)
Q Consensus 854 --ki~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~-----~~l 926 (1007)
+++|||.+....... ....|++.|+|||++....|+.++||||+||+++||++|+.||....... ..+
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred EEEEEECCCCCCCCCCC-----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 05675314421234454-----2236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHHHHHCC--CCH-------HHHHHHH-----HCC---CH-----HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 799874269--418-------8885331-----015---52-----5567889999999999994618989889999799
Q 001838 927 SRWVNDLLP--ISV-------MEVIDTN-----LLS---GE-----ERYFAAKEQSLLSILNLATECTIESPGKRINARE 984 (1007)
Q Consensus 927 ~~~~~~~~~--~~~-------~~~id~~-----~~~---~~-----~~~~~~~~~~~~~~~~l~~~Cl~~~p~~Rpt~~e 984 (1007)
......... ... ....+.. ... .. .......+....++.+|+.+|+..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHH
Q ss_conf 9999
Q 001838 985 IVTG 988 (1007)
Q Consensus 985 vl~~ 988 (1007)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HHCC
T ss_conf 9669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.9e-43 Score=252.87 Aligned_cols=258 Identities=32% Similarity=0.545 Sum_probs=201.4
Q ss_pred CCEEEECCCCCCC--CCCHHHHCCCCCCEEECCC-CEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCEEE
Q ss_conf 2424501443466--6895342147875898129-800133453222024668313588735888862110366566421
Q 001838 390 LERFQMFNCRISG--KIPQVISNLSNLLLLDLGG-NKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLI 466 (1007)
Q Consensus 390 l~~L~l~~n~l~~--~~p~~~~~l~~L~~LdLs~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 466 (1007)
+..|+++++.+.+ .+|..++.+++|++|||++ |++.|.+|..|..+++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88998989988888879847846753352020265433300243114542001102035643443322222011100111
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 33344568888877776657152027865566788210134333-12037989767988655466333465847564377
Q 001838 467 LHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDI-LFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLS 545 (1007)
Q Consensus 467 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 545 (1007)
+++|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+..+ ..++++.|++++..+..+..+... .++++.|...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCC
T ss_conf 122455556851220674000000235533562031214431123231022464353324332222222-3333334332
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 87520014888864895656656565684476999998887879846435994322205798344858954012599996
Q 001838 546 GDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIPRGGP 625 (1007)
Q Consensus 546 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 625 (1007)
+.+|..+..+++++.+++++|.+++.+| .+..+++|+.|++++|++++.+|..+..+++|+.|+|++|+++|.+|..+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 2222222222221112222222222222-222455444444765706660876884799999897958835166898666
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 777764433445535898888899888
Q 001838 626 FANLTAKSFLGNELLCGLPDLHNSPCK 652 (1007)
Q Consensus 626 ~~~~~~~~~~~n~~lc~~p~~~~~~c~ 652 (1007)
+..+....+.+|+.+||.|. ++|+
T Consensus 290 L~~L~~l~l~~N~~l~g~pl---p~c~ 313 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPL---PACT 313 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTS---SCCC
T ss_pred CCCCCHHHHCCCCCCCCCCC---CCCC
T ss_conf 79989788688950019898---8989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3e-37 Score=221.08 Aligned_cols=100 Identities=31% Similarity=0.456 Sum_probs=54.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 43331203798976798865546633346584756437787520014888864895656656565684476999998887
Q 001838 507 LKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILD 586 (1007)
Q Consensus 507 l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 586 (1007)
++.+..++++.|.+.+. ..+..++.++.+++++|++++.. .+..+++|+.|++++|+++++ + .+.++++|+.|+
T Consensus 284 ~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~ 357 (384)
T d2omza2 284 LTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLS 357 (384)
T ss_dssp CTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC-H-HHCCCCCCCEEE
T ss_conf 65222233232333332--21000024676777788778984--536689889898989989997-4-670899999898
Q ss_pred CCCCCCCCCCCCCHHHHCCCCEEECCCC
Q ss_conf 8798464359943222057983448589
Q 001838 587 LSKNKISGVIPTSLEKLLYLKKLNLSFN 614 (1007)
Q Consensus 587 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 614 (1007)
+++|++++.+| +..+++|+.|++++|
T Consensus 358 l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 97995899800--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3e-37 Score=221.03 Aligned_cols=148 Identities=27% Similarity=0.422 Sum_probs=83.7
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 22024668313588735888862110366566421333445688888777766571520278655667882101343331
Q 001838 432 FSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILHGNKFSGAIPSCSGNLTSLRALYLGSNRFTSALPSTIWNLKDIL 511 (1007)
Q Consensus 432 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 511 (1007)
+..+++|+.+++++|.+.+..+ +..+++|+.|++++|++++..+ +..++.++.++++.|.+.+. ..+..+++++
T Consensus 237 l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~ 310 (384)
T d2omza2 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLT 310 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCS
T ss_pred HHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCHHCCCC
T ss_conf 4325653410044674478775--3554668775456744578773--23565222233232333332--2100002467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 20379897679886554663334658475643778752001488886489565665656568447699999888787984
Q 001838 512 FFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNK 591 (1007)
Q Consensus 512 ~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 591 (1007)
.|++++|++.+.. .+..++.|+.|++++|++++ ++ .+..+++|+.|++++|++++++| +.++++|+.|++++|.
T Consensus 311 ~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 311 YLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp EEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred EEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf 6777788778984--53668988989898998999-74-67089999989897995899800--0039999996397895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-33 Score=200.81 Aligned_cols=193 Identities=23% Similarity=0.306 Sum_probs=108.3
Q ss_pred CCCCCCCCCEEECCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 99986432047379999389999079987544763666999999997699979998895433756672874667645786
Q 001838 52 STSVCSWIGITCGVNSHKVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGS 131 (1007)
Q Consensus 52 ~~~~c~w~gv~c~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 131 (1007)
..+-|.|.+|.|+. ++++ .+|..+. +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+...
T Consensus 6 ~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 6 FRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp TTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCEECCCEEEECC------------CCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 98895599998559------------9988-5198889--9979897849918986965760465652311234434452
Q ss_pred CHHHHHHCCCCCEECCCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCCCCC
Q ss_conf 22446404888701166764589772568512999868976685244569864568888958983134477--9898565
Q 001838 132 LSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS--GAIPKEI 209 (1007)
Q Consensus 132 ~~~~~~~l~~L~~LdLs~N~~~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~ 209 (1007)
.+..|.++++|+.|++++|+++ .+|... ...++.|+++.|.+.+..+..+.....+..++...|... ...+..+
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~ 146 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred CHHHHHCCCCCCEECCCCCCCC-CCCCCH---HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3566527985578315687567-676400---111323210246102344445401331100001233333467776422
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 565656558802686789888445785544443214764654454111278888838
Q 001838 210 GNLTKLKDIILNDNELRGEIPQEMGNLPYLVRLTLATNNLVGVVPFTIFNMSTLKKL 266 (1007)
Q Consensus 210 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 266 (1007)
..+++|+.+++++|.+.. +|..+ .++|+.|++++|...+..+..|..++.+++|
T Consensus 147 ~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 147 QGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp GGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCCC-CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 345656712034677451-67101--7766789897886778882676413413301
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=205.95 Aligned_cols=179 Identities=22% Similarity=0.224 Sum_probs=92.1
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCCC
Q ss_conf 90799875447636669999999976999799988954337566728746676457862244640488870116676458
Q 001838 74 NISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFS 153 (1007)
Q Consensus 74 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~~ 153 (1007)
+.++.+++ .+|..+. +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..+..+..+..++.+.+...
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred ECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 84799989-4497889--99888977488179879778641421300001344543321112122222222222210223
Q ss_pred CCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 97725685129998689766852445698645688889589831344779898565565656558802686789888445
Q 001838 154 GELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQEM 233 (1007)
Q Consensus 154 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 233 (1007)
..+++..+.++++|+.|++++|.+....+..+....+|+.+++++|+++.+.+..|..+++|+.|++++|+++...+..|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHH
T ss_conf 54462010101027787568854432013533200012110200143144580574043405022314176566256665
Q ss_pred CCCCCCCEEECCCCCCCCCCCC
Q ss_conf 7855444432147646544541
Q 001838 234 GNLPYLVRLTLATNNLVGVVPF 255 (1007)
Q Consensus 234 ~~l~~L~~L~Ls~N~l~~~~p~ 255 (1007)
.++++|+.++++.|.+.++.|.
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~~ 195 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHPH 195 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTT
T ss_pred CCCCCCCHHHHHHCCCCCCCHH
T ss_conf 4656341314211434662816
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=201.22 Aligned_cols=207 Identities=25% Similarity=0.262 Sum_probs=81.7
Q ss_pred CEEECCCCEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 589812980013345322202466831358873588886211036656642133-3445688888777766571520278
Q 001838 415 LLLDLGGNKLTGSIPVTFSRLLNLQGLGLAFNKLARSIPDEICHLAKLDKLILH-GNKFSGAIPSCSGNLTSLRALYLGS 493 (1007)
Q Consensus 415 ~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls~ 493 (1007)
++|+|++|+|+...+..|.++.+|+.|++++|++....+..+.....+..++.. .|.++...+..+.++++|+.|++++
T Consensus 35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~ 114 (284)
T d1ozna_ 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114 (284)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCC
T ss_conf 88977488179879778641421300001344543321112122222222222210223544620101010277875688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 65566788210134333120379897679886554663334658475643778752001488886489565665656568
Q 001838 494 NRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIP 573 (1007)
Q Consensus 494 N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 573 (1007)
|.+....+..+....+|+.+++++|.+++..+..+...+.++.|++++|++++..+.+|.++++|+.+++++|+++++.|
T Consensus 115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCH
T ss_conf 54432013533200012110200143144580574043405022314176566256665465634131421143466281
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCEEECCCCCCCCCCC
Q ss_conf 447699999888787984643599432220579834485895401259
Q 001838 574 ESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEIP 621 (1007)
Q Consensus 574 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 621 (1007)
..|..+++|+.||+++|++.+..|..|..+++|+.+++++|++.|.++
T Consensus 195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
T ss_conf 676653200023333352210000023554656889811998878756
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.5e-31 Score=188.00 Aligned_cols=136 Identities=29% Similarity=0.237 Sum_probs=70.3
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 66571520278655667882101343331203798976798865546633346584756437787520014888864895
Q 001838 483 LTSLRALYLGSNRFTSALPSTIWNLKDILFFDVSSNSLDGPLSLDIGNLKVVIELNLSRNNLSGDIPITIGGLKNLQKLF 562 (1007)
Q Consensus 483 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 562 (1007)
+++|+.|++++|++.. .+..+..++.|++|++++|.+....+..+..+..+.+|++++|.+....+..+..+++++.++
T Consensus 76 l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCC
T ss_conf 2232111112222211-111212222222222222311011001122221111221243421022123332211100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCEEECCCCCCCCCC
Q ss_conf 6566565656844769999988878798464359943222057983448589540125
Q 001838 563 LANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNLSFNKLEGEI 620 (1007)
Q Consensus 563 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 620 (1007)
+++|++++.++..|..+++|+.|||++|+|+ .+|..+..+++|+.|+|++|++.|.+
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCC
T ss_conf 0015652237200134212423430139785-56866777888999983699987886
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-30 Score=181.65 Aligned_cols=169 Identities=25% Similarity=0.271 Sum_probs=63.5
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCC
Q ss_conf 99079987544763666999999997699979998895433756672874667645786224464048887011667645
Q 001838 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF 152 (1007)
Q Consensus 73 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~ 152 (1007)
.|.++++++ .+|+.+. +++++|||++|.|+++.+.+|.++++|++|+|++|+|+...+ +..+++|+.|+|++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCC
T ss_pred EECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCC
T ss_conf 980699988-6196757--688989884992898597786345655221356654444311--11122321111122222
Q ss_pred CCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 89772568512999868976685244569864568888958983134477989856556565655880268678988844
Q 001838 153 SGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQE 232 (1007)
Q Consensus 153 ~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 232 (1007)
.+ .+.. +.++++|+.|++++|.+....+..+..+.+++.|++++|.+....+..+..+++++.+++++|++++..+..
T Consensus 90 ~~-~~~~-~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 90 QS-LPLL-GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp SS-CCCC-TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred CC-CCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCC
T ss_conf 11-1112-122222222222223110110011222211112212434210221233322111000000015652237200
Q ss_pred CCCCCCCCEEECCCCC
Q ss_conf 5785544443214764
Q 001838 233 MGNLPYLVRLTLATNN 248 (1007)
Q Consensus 233 ~~~l~~L~~L~Ls~N~ 248 (1007)
|..+++|++|+|++|.
T Consensus 168 ~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENS 183 (266)
T ss_dssp TTTCTTCCEEECCSSC
T ss_pred CCCCCCCCEEECCCCC
T ss_conf 1342124234301397
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=1.2e-24 Score=150.78 Aligned_cols=52 Identities=29% Similarity=0.420 Sum_probs=25.0
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 389999079987544763666999999997699979998895433756672874667645
Q 001838 69 KVIVLNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128 (1007)
Q Consensus 69 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 128 (1007)
+++.|||++++++ .+|+. .++|++|+|++|+|+ .+|.. +.+|+.|++++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l 90 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNL 90 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCC
T ss_conf 9989993799988-78898---789888989999796-33620---33203326655143
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.94 E-value=3.2e-23 Score=142.86 Aligned_cols=33 Identities=27% Similarity=0.240 Sum_probs=18.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9999976999799988954337566728746676457
Q 001838 93 SLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLF 129 (1007)
Q Consensus 93 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 129 (1007)
++++|||++|.++. +|+. +++|++|+|++|+|+
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~ 71 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT 71 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS
T ss_pred CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC
T ss_conf 99899937999887-8898---789888989999796
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.4e-30 Score=181.72 Aligned_cols=62 Identities=24% Similarity=0.175 Sum_probs=25.4
Q ss_pred CCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCHH-----HHCCCCEEECCCCCCC
Q ss_conf 8864895656656565----684476999998887879846435994322-----2057983448589540
Q 001838 556 KNLQKLFLANNRLEGP----IPESFSGLSSLEILDLSKNKISGVIPTSLE-----KLLYLKKLNLSFNKLE 617 (1007)
Q Consensus 556 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~ 617 (1007)
+.|+.|+|++|.|+.. +.+.+...++|++||+++|+|+......+. ....|+.+++.+|.+.
T Consensus 369 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 77788989799797599999999996299889898999969879999999999747886678989898789
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.3e-29 Score=175.57 Aligned_cols=70 Identities=26% Similarity=0.105 Sum_probs=41.6
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCC----CCC-CCCCCCEEECCCCCCCCCCCCCH
Q ss_conf 33346584756437787----520014888864895656656565684----476-99999888787984643599432
Q 001838 531 LKVVIELNLSRNNLSGD----IPITIGGLKNLQKLFLANNRLEGPIPE----SFS-GLSSLEILDLSKNKISGVIPTSL 600 (1007)
Q Consensus 531 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~-~l~~L~~L~Ls~N~l~~~~p~~~ 600 (1007)
.+.|++|+|++|.|+.. ++..+...++|++|+|++|+|+..... .+. ....|+.|++++|.+.......+
T Consensus 368 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHH
T ss_conf 6777889897997975999999999962998898989999698799999999997478866789898987898999999
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.3e-25 Score=151.69 Aligned_cols=214 Identities=15% Similarity=0.141 Sum_probs=112.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCCCCC
Q ss_conf 79987544763666999999997699979998895433756672874667645786224464048887011667645897
Q 001838 76 SGFNLQGTIPPQLGNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGE 155 (1007)
Q Consensus 76 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~~~~ 155 (1007)
++.+++ .+|+.+. +++++|||++|.|..+.+.+|.++++|++|+|++|.+. ..
T Consensus 16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~------------------------~~ 68 (242)
T d1xwdc1 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL------------------------EV 68 (242)
T ss_dssp ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTC------------------------CE
T ss_pred ECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCC------------------------CE
T ss_conf 189988-7688889--98899987699189649668614643232110221124------------------------20
Q ss_pred CCHHHHHCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 725685129998689766-8524456986456888895898313447798985-65565656558802686789888445
Q 001838 156 LPANICKNLPNLKKLLLG-RNMFHGKIPSTLSKCKQLEGLYLRFNNLSGAIPK-EIGNLTKLKDIILNDNELRGEIPQEM 233 (1007)
Q Consensus 156 ~p~~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~ 233 (1007)
++...|.++++++.+.+. .|.+....+..|.++++|+.+++++|.+....+. .+..+..+..+..+++.+....+..|
T Consensus 69 i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~ 148 (242)
T d1xwdc1 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148 (242)
T ss_dssp ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSS
T ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 10011222222222111112343222222122222222223421111255433322211112222222121112222222
Q ss_pred CCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCC-EEECCCCCCCCCCCCCCCCCCC
Q ss_conf 7855-4444321476465445411127888883881265466768800003799875-7962587788779944436689
Q 001838 234 GNLP-YLVRLTLATNNLVGVVPFTIFNMSTLKKLSLLENTLWGSLPSRIDLSLPNVE-FLNLGTNRFSGNIPSSITNASK 311 (1007)
Q Consensus 234 ~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~~~~ 311 (1007)
..++ .++.++++.|.+..+.+. .+ ..++++ .+++++|+++...+..|.++++
T Consensus 149 ~~~~~~l~~L~l~~n~l~~i~~~-------------------------~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~ 202 (242)
T d1xwdc1 149 VGLSFESVILWLNKNGIQEIHNC-------------------------AF-NGTQLDELNLSDNNNLEELPNDVFHGASG 202 (242)
T ss_dssp TTSBSSCEEEECCSSCCCEECTT-------------------------TT-TTCCEEEEECTTCTTCCCCCTTTTTTSCC
T ss_pred CCCCCCCEEEECCCCCCCCCCCC-------------------------CC-CCHHHHCCCCCCCCCCCCCCHHHHCCCCC
T ss_conf 22233100122001233332222-------------------------22-20111012123543246424788668999
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9899923897678777544464553301232
Q 001838 312 LTVFQLRGNSFSGFIPNTIGNLRNLEFLNIA 342 (1007)
Q Consensus 312 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 342 (1007)
|+.|++++|+++.+.+..|..+.+|+.+++.
T Consensus 203 L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 203 PVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred CCEEECCCCCCCCCCHHHHCCCCCCCCCCCC
T ss_conf 9989897992894597797377134147678
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=2.2e-24 Score=149.27 Aligned_cols=126 Identities=23% Similarity=0.291 Sum_probs=82.8
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCC
Q ss_conf 9907998754476366699999999769997999-889543375667287466764578622446404888701166764
Q 001838 73 LNISGFNLQGTIPPQLGNLSSLETLDLSHNKLSG-NIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINR 151 (1007)
Q Consensus 73 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~ 151 (1007)
++.++++++ .+|..+. +++++|+|++|+|++ +.+..|.++++|++|+|++|.+....+..|..+++|+.|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 997089967-0298989--7878898489877553020025787627213013632212121222112222101003553
Q ss_pred CCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 589772568512999868976685244569864568888958983134477
Q 001838 152 FSGELPANICKNLPNLKKLLLGRNMFHGKIPSTLSKCKQLEGLYLRFNNLS 202 (1007)
Q Consensus 152 ~~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 202 (1007)
+. .+++..|.++++|+.|+|++|+|+++.+++|..+++|++|+|++|.+.
T Consensus 90 l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 90 IK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CC-CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 44-349799807974655245774535359778568753342000364434
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=4e-23 Score=142.27 Aligned_cols=76 Identities=22% Similarity=0.272 Sum_probs=29.1
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCEEE
Q ss_conf 33346584756437787520014888864895656656565684476999998887879846435994322205798344
Q 001838 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLN 610 (1007)
Q Consensus 531 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 610 (1007)
.+.++.|++++|.+.+.. .+..+++|+.|+|++|+++++. .+..+++|+.|++++|+++... .+..+++|+.|+
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ 223 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVT 223 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCCCH--HHCCCCCCCEEECCCCCCCCCC--CCCCCCCCCEEE
T ss_conf 211100233333333100--1056463356445888417785--3447999998979599689980--203699989897
Q ss_pred CC
Q ss_conf 85
Q 001838 611 LS 612 (1007)
Q Consensus 611 ls 612 (1007)
++
T Consensus 224 ls 225 (227)
T d1h6ua2 224 LT 225 (227)
T ss_dssp EE
T ss_pred EE
T ss_conf 12
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=1.9e-22 Score=138.47 Aligned_cols=39 Identities=38% Similarity=0.590 Sum_probs=12.3
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 888864895656656565684476999998887879846
Q 001838 554 GLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKI 592 (1007)
Q Consensus 554 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 592 (1007)
++++|+.|+|++|+|+++.++.|..+++|+.|+|++|.+
T Consensus 100 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 100 GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp TCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 797465524577453535977856875334200036443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.2e-21 Score=134.13 Aligned_cols=75 Identities=32% Similarity=0.446 Sum_probs=29.3
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCEEEC
Q ss_conf 33465847564377875200148888648956566565656844769999988878798464359943222057983448
Q 001838 532 KVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKKLNL 611 (1007)
Q Consensus 532 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 611 (1007)
+.+..+++++|.+++ +..+..+++|+.+++++|+++++.+ +.++++|+.|++++|+|+.. | .+..+++|+.|++
T Consensus 134 ~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L 207 (210)
T d1h6ta2 134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLEL 207 (210)
T ss_dssp TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEE
T ss_pred CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC-H-HHCCCCCCCEEEC
T ss_conf 112221122233345--4310001332100134643025645--36789899998979989987-2-1169999899971
Q ss_pred C
Q ss_conf 5
Q 001838 612 S 612 (1007)
Q Consensus 612 s 612 (1007)
+
T Consensus 208 s 208 (210)
T d1h6ta2 208 F 208 (210)
T ss_dssp E
T ss_pred C
T ss_conf 1
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=4.2e-21 Score=131.04 Aligned_cols=73 Identities=37% Similarity=0.547 Sum_probs=31.6
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCE
Q ss_conf 6333465847564377875200148888648956566565656844769999988878798464359943222057983
Q 001838 530 NLKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLYLKK 608 (1007)
Q Consensus 530 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 608 (1007)
.++.|+.+++++|.+.. ++ .+..+++|+.|++++|++++.. .++++++|+.|++++|+++.. + .+..+++|+.
T Consensus 126 ~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~ 198 (199)
T d2omxa2 126 NLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLES 198 (199)
T ss_dssp TCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSE
T ss_pred HHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCC
T ss_conf 12236776431111002-34-3332111111223455556770--116799899997879979988-1-0127899894
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=3.7e-21 Score=131.34 Aligned_cols=54 Identities=31% Similarity=0.546 Sum_probs=20.1
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 3334658475643778752001488886489565665656568447699999888787
Q 001838 531 LKVVIELNLSRNNLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLS 588 (1007)
Q Consensus 531 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 588 (1007)
++.|+.+++++|++++. + .+..+++|+.|+|++|+++.+ | .+.++++|+.|+|+
T Consensus 155 l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 155 LTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp CTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred CCCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCCCC-H-HHCCCCCCCEEECC
T ss_conf 13321001346430256-4-536789899998979989987-2-11699998999711
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.6e-21 Score=133.32 Aligned_cols=155 Identities=15% Similarity=0.112 Sum_probs=110.4
Q ss_pred CCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHH------------------HHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 65564133458559999997689538999930642------------------999999999999998539996127998
Q 001838 728 FSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRY------------------ERALKSFQDECEVMKRIRHRNLVKIIS 789 (1007)
Q Consensus 728 ~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~~ 789 (1007)
+.+++.||+|+||+||+|+..+|+.||||+++... .........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC-----------CCCEE
Q ss_conf 8863991399998028999667651299888999999999999999999870399991460643-----------10204
Q 001838 790 ACSNDDFKALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHYMVA-----------HISDF 858 (1007)
Q Consensus 790 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~~~~~i~H~~~~-----------ki~Df 858 (1007)
+. ..+++|||++++.+.+ ++......++.|++.++.|| |+.+|+|+|++ +++||
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEEGIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETTEEEECCC
T ss_pred EC----CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHH---HHCCEEECCCCHHHEEEECCCEEEEEC
T ss_conf 62----8889999504565420--------01578999999999999998---268889836890361142898999877
Q ss_pred ECCEECCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHH
Q ss_conf 25020378985322335668754354234-----46688895035899999999
Q 001838 859 SIAKFLNGQDQLSMQTQTLATIGYMAPEY-----GVQGRVSTRGDVYSYGIMLM 907 (1007)
Q Consensus 859 gla~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~Dvws~Gvil~ 907 (1007)
|.|+........ .|...++ .....|+.++|+||..--+.
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCH----------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 884308998709----------99987799999997578998446899999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=9.9e-19 Score=117.80 Aligned_cols=14 Identities=14% Similarity=0.328 Sum_probs=4.9
Q ss_pred CCCCCCCCEEECCC
Q ss_conf 76999998887879
Q 001838 576 FSGLSSLEILDLSK 589 (1007)
Q Consensus 576 ~~~l~~L~~L~Ls~ 589 (1007)
++.+++|+.|++++
T Consensus 221 L~~~~~L~~L~l~~ 234 (284)
T d2astb2 221 LGEIPTLKTLQVFG 234 (284)
T ss_dssp GGGCTTCCEEECTT
T ss_pred HHCCCCCCEEEEEC
T ss_conf 72699989896448
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.5e-18 Score=116.77 Aligned_cols=39 Identities=23% Similarity=0.261 Sum_probs=14.6
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 6999999997699979998895433756672874667645
Q 001838 89 GNLSSLETLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128 (1007)
Q Consensus 89 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 128 (1007)
.+...+++|||++|+|+.+ +..+..+++|++|||++|.|
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i 53 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEI 53 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCC
T ss_pred CCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCC
T ss_conf 6857484897889978865-76200414599898979978
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.73 E-value=1.4e-19 Score=122.55 Aligned_cols=11 Identities=36% Similarity=0.356 Sum_probs=3.7
Q ss_pred CCEEECCCCCC
Q ss_conf 98344858954
Q 001838 606 LKKLNLSFNKL 616 (1007)
Q Consensus 606 L~~L~ls~N~l 616 (1007)
|+.|++++|++
T Consensus 304 L~~L~l~~N~~ 314 (344)
T d2ca6a1 304 LLFLELNGNRF 314 (344)
T ss_dssp CCEEECTTSBS
T ss_pred CCEEECCCCCC
T ss_conf 99897879808
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=5.8e-16 Score=102.37 Aligned_cols=31 Identities=26% Similarity=0.346 Sum_probs=11.8
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 997699979998895433756672874667645
Q 001838 96 TLDLSHNKLSGNIPSSIFNMHTLKLLDFRDNQL 128 (1007)
Q Consensus 96 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 128 (1007)
.|||++|+++.. + .+..+++|++||+++|+|
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l 32 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRL 32 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCC
T ss_pred EEECCCCCCCCC-C-CCCCCCCCCEEECCCCCC
T ss_conf 898689989887-1-010589889897978716
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.61 E-value=3.2e-18 Score=114.95 Aligned_cols=14 Identities=36% Similarity=0.515 Sum_probs=4.4
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 99999997699979
Q 001838 91 LSSLETLDLSHNKL 104 (1007)
Q Consensus 91 l~~L~~L~Ls~N~l 104 (1007)
+++|++|+|++|.|
T Consensus 47 L~~L~~L~Ls~n~I 60 (198)
T d1m9la_ 47 LKACKHLALSTNNI 60 (198)
T ss_dssp TTTCCEEECSEEEE
T ss_pred CCCCCEEECCCCCC
T ss_conf 60461519944689
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.7e-15 Score=99.73 Aligned_cols=68 Identities=15% Similarity=0.105 Sum_probs=29.1
Q ss_pred CCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCC
Q ss_conf 636669999999976999-79998895433756672874667645786224464048887011667645
Q 001838 85 PPQLGNLSSLETLDLSHN-KLSGNIPSSIFNMHTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRF 152 (1007)
Q Consensus 85 ~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~ 152 (1007)
|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|..+.+.+|..+++|+.|||++|++
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 92 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCC
T ss_conf 600257656574316898664436921225666667216202124774201112455433332267878
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.1e-15 Score=100.78 Aligned_cols=93 Identities=24% Similarity=0.250 Sum_probs=55.6
Q ss_pred CCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCC
Q ss_conf 5466333465847564-377875200148888648956566565656844769999988878798464359943222057
Q 001838 527 DIGNLKVVIELNLSRN-NLSGDIPITIGGLKNLQKLFLANNRLEGPIPESFSGLSSLEILDLSKNKISGVIPTSLEKLLY 605 (1007)
Q Consensus 527 ~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 605 (1007)
.+..++.+++|++++| .|+...+.+|.++++|+.|+|++|+|+.+.+++|.++++|+.|+|++|+|+...+..|..+ .
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~ 104 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-S 104 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-C
T ss_pred CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-C
T ss_conf 025765657431689866443692122566666721620212477420111245543333226787851574563353-2
Q ss_pred CCEEECCCCCCCCCC
Q ss_conf 983448589540125
Q 001838 606 LKKLNLSFNKLEGEI 620 (1007)
Q Consensus 606 L~~L~ls~N~l~~~~ 620 (1007)
|+.|+|++|+|.+.+
T Consensus 105 l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 105 LQELVLSGNPLHCSC 119 (156)
T ss_dssp CCEEECCSSCCCCCG
T ss_pred CCCCCCCCCCCCCCC
T ss_conf 124335798633881
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=7.5e-11 Score=73.85 Aligned_cols=122 Identities=20% Similarity=0.182 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCHHHHHHCCCCCEECCCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCE
Q ss_conf 6672874667645786224464048887011667645897725685129998689766852445698--64568888958
Q 001838 116 HTLKLLDFRDNQLFGSLSSFIFNMSSMLGIDLSINRFSGELPANICKNLPNLKKLLLGRNMFHGKIP--STLSKCKQLEG 193 (1007)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 193 (1007)
...+.||++++.. ...+..+..+..++.+.+... ....++..+++|++|+|++|+++...+ ..+..+++|+.
T Consensus 22 ~~~~~Ldls~l~~----~~~l~~~~~~~~l~~~~~~~~--~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~ 95 (162)
T d1koha1 22 GSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95 (162)
T ss_dssp SSSCCBCCCCCSS----CTTTTTTTCCCCTTSHHHHHH--HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCC
T ss_pred HHHCEEECCCCCC----CCHHHHCCCHHHCCHHHHHHH--HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCC
T ss_conf 3308653435989----821554664011225556766--6078897487878863777666677315889865885610
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 983134477989856556565655880268678988844-------57855444432
Q 001838 194 LYLRFNNLSGAIPKEIGNLTKLKDIILNDNELRGEIPQE-------MGNLPYLVRLT 243 (1007)
Q Consensus 194 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------~~~l~~L~~L~ 243 (1007)
|+|++|.++...+-.+....+|+.+++++|.+....... +..+|+|+.||
T Consensus 96 L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 004357213423442220331042664899767676661569999999889978799
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.98 E-value=3.1e-06 Score=48.08 Aligned_cols=112 Identities=12% Similarity=0.068 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCC----CHHHHHHCCCCCEECCCCCCCC---CCCCHHHHHCCCCCCEEECCCCCCCC----C
Q ss_conf 3756672874667-645786----2244640488870116676458---97725685129998689766852445----6
Q 001838 113 FNMHTLKLLDFRD-NQLFGS----LSSFIFNMSSMLGIDLSINRFS---GELPANICKNLPNLKKLLLGRNMFHG----K 180 (1007)
Q Consensus 113 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~LdLs~N~~~---~~~p~~~~~~l~~L~~L~Ls~N~l~~----~ 180 (1007)
.+.+.|++|+|++ +.+... ....+...++|+.|+|++|.+. ...-...+...+.|+.|+|++|.+.. .
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf 986456888895898313447798-------98565565656558802686
Q 001838 181 IPSTLSKCKQLEGLYLRFNNLSGA-------IPKEIGNLTKLKDIILNDNE 224 (1007)
Q Consensus 181 ~p~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 224 (1007)
+-.++...+.|++|++++|..... +...+..-+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.83 E-value=0.00011 Score=39.47 Aligned_cols=117 Identities=15% Similarity=0.089 Sum_probs=78.2
Q ss_pred HHHHHHCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCEE
Q ss_conf 89998313465564133458559999997689538999930642999999999999998539-99612799888639913
Q 001838 719 HELLQATDRFSKNNLLGIGSFGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR-HRNLVKIISACSNDDFK 797 (1007)
Q Consensus 719 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 797 (1007)
.++....+.|...+..+.++...||+.... +..+.+|+...........+.+|...+..++ +--+-++++++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999975135279976789987718999908-9869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 999980289996676512998889999999999999999998703
Q 001838 798 ALIMEYMPNGSLENRLYSGTCMLDIFQRLNIMIDVALALEYLHFG 842 (1007)
Q Consensus 798 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~~ 842 (1007)
++||++.+|.++.+..... .....++.++++.++.||..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~ 124 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSI 124 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTS
T ss_pred EEEEEECCCCCCCCCCCCC------CCHHHHHHHHHHHHHHHHCC
T ss_conf 9999860433435433440------26999999899999998556
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.12 E-value=0.00011 Score=39.39 Aligned_cols=112 Identities=15% Similarity=0.156 Sum_probs=0.0
Q ss_pred CCCCCEEEEEECC-CCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCH--
Q ss_conf 9999389999079-98754----4763666999999997699979998----89543375667287466764578622--
Q 001838 65 VNSHKVIVLNISG-FNLQG----TIPPQLGNLSSLETLDLSHNKLSGN----IPSSIFNMHTLKLLDFRDNQLFGSLS-- 133 (1007)
Q Consensus 65 ~~~~~v~~L~L~~-n~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~-- 133 (1007)
.....++.|+|++ +.++. .+-..+...++|++|+|++|.+... +...+...+.++.+++++|.+.....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHHHCCCCCE--ECCCCCCCCCCCCHHHHH---CCCCCCEEECCCCC
Q ss_conf --44640488870--116676458977256851---29998689766852
Q 001838 134 --SFIFNMSSMLG--IDLSINRFSGELPANICK---NLPNLKKLLLGRNM 176 (1007)
Q Consensus 134 --~~~~~l~~L~~--LdLs~N~~~~~~p~~~~~---~l~~L~~L~Ls~N~ 176 (1007)
..+...++|+. |++++|.+.......+.. ..++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.59 E-value=0.0019 Score=32.57 Aligned_cols=97 Identities=18% Similarity=0.114 Sum_probs=65.0
Q ss_pred EECCCC-CEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCCEEEEEEEECCCCCH
Q ss_conf 133458-559999997689538999930642999999999999998539--99612799888639913999980289996
Q 001838 733 LLGIGS-FGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIR--HRNLVKIISACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 733 ~lg~G~-~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL 809 (1007)
.+..|. .+.||+....++..+.+|....... ..+..|...++.+. .-.+.++++++.+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 67651299888999999999999999999870
Q 001838 810 ENRLYSGTCMLDIFQRLNIMIDVALALEYLHF 841 (1007)
Q Consensus 810 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLh~ 841 (1007)
.+.. ... ...+.++++.+.-||.
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~ 116 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHT 116 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTT
T ss_pred CCCC------CCH---HHHHHHHHHHHHHHCC
T ss_conf 3221------268---9999999999998736
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.10 E-value=0.13 Score=22.38 Aligned_cols=82 Identities=13% Similarity=0.174 Sum_probs=50.3
Q ss_pred CCEECCCCCEEEEEEEECC-CCEEEEEEECHHH---H----HHHHHHHHHHHHHHHCC-C--CCEEEEEEEEECCCEEEE
Q ss_conf 6413345855999999768-9538999930642---9----99999999999998539-9--961279988863991399
Q 001838 731 NNLLGIGSFGSVYVARLQD-GMEVAVKVFHQRY---E----RALKSFQDECEVMKRIR-H--RNLVKIISACSNDDFKAL 799 (1007)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~-g~~vaiK~~~~~~---~----~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l 799 (1007)
.+.+|.|....||+.+..+ ++.|+||.-.... . ....+...|.+.++.+. + ..+.+++++ +++.-++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH-HHHHH
Q ss_conf 9980289996-67651
Q 001838 800 IMEYMPNGSL-ENRLY 814 (1007)
Q Consensus 800 v~e~~~~gsL-~~~l~ 814 (1007)
|||+..+..+ ...+.
T Consensus 109 vmE~L~~~~~~~~~l~ 124 (392)
T d2pula1 109 VMEDLSHLKIARKGLI 124 (392)
T ss_dssp EECCCTTSEEHHHHHH
T ss_pred EEECCCCCCCCHHHHC
T ss_conf 8713577653022201
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.79 E-value=0.41 Score=19.55 Aligned_cols=70 Identities=10% Similarity=0.152 Sum_probs=44.3
Q ss_pred CEEEEEEEECCCCEEEEEEECHHHHHHHHHHHHHHHHHHHCCCCCE--EEEE-----EEEECCCEEEEEEEECCCCCH
Q ss_conf 5599999976895389999306429999999999999985399961--2799-----888639913999980289996
Q 001838 739 FGSVYVARLQDGMEVAVKVFHQRYERALKSFQDECEVMKRIRHRNL--VKII-----SACSNDDFKALIMEYMPNGSL 809 (1007)
Q Consensus 739 ~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL 809 (1007)
--.||+++..+|..|++|..++.. ....++..|...+..+....+ +... ..+...+..+.+++++.|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 202699983899979999847877-88999999999999998559987875206898056653479999865277688
|